documentId,Paragraph,Compound
US04814329,6.86 g (25 mmoles) of 5-phenylsulfinyl-benzimidazoline-2-thione and 4.9 ml (60 mmoles) of allylchloride are refluxed in 50 ml of ethanol for 24 hours. Then the reaction mixture is concentrated and the residue is crystallized from acetonitrile. The weight of the filtered endproduct is 7.68 g (87.55%). After recrystallization from ethanol it melts at 168° C.,5-phenylsulfinyl-benzimidazoline-2-thione | allylchloride | ethanol | acetonitrile | ethanol
US20120245161A1,"A mixture of [2-bromo-4-(tert-butoxycarbonylamino-methyl)-phenoxy]-acetic acid methyl ester (2.0 g, 5.34 mmol), pyridine-4-boronic acid (0.78 g, 6.41 mmol), Cs2CO3 (3.48 g, 10.68 mol), Pd(dppf)Cl2.CH2Cl2 (0.29 g, 10% mol) in dioxane/H2O (29 mL, 10/1) is heated at 80° C. for 4 h. The reaction mixture is cooled to r.t., and then concentrated in vacuo. The residue is partitioned between CH2Cl2 and H2O. The two layers are separated, and the organic layer is washed with H2O, and brine, dried over Na2SO4, filtered, and concentrated in vacuo. The crude material is purified on silica gel with CH2Cl2/MeOH (100/0 to 96/4) as eluent to give the product (1.17 g, 58%) as a light brown foam.",[2-bromo-4-(tert-butoxycarbonylamino-methyl)-phenoxy]-acetic acid methyl ester | pyridine-4-boronic acid | Cs2CO3 | Pd(dppf)Cl2 | CH2Cl2 | dioxane/H2O | H2O | CH2Cl2 | H2O | brine | Na2SO4 | crude material | silica gel | CH2Cl2/MeOH | product
US20090270380A1,"1.560 ml of trimethylsilyl bromide are added dropwise to a solution of 2.067 g of [4-(3-methoxypropyl)-2,2-dimethyl-2H-Chromen-6-yl]methanol in chloroform at room temperature. The reaction solution is stirred at room temperature for 30 minutes and then evaporated. The title compound is obtained from the residue by flash chromatography (SiO2 60F) and identified on the basis of the Rf.","trimethylsilyl bromide | [4-(3-methoxypropyl)-2,2-dimethyl-2H-Chromen-6-yl]methanol | chloroform | title compound | SiO2"
US04072685,"A solution of 4.8 g of N-isopropyl-3-(3',4'-dimethoxyphenyl)-piperidine in 48 ml of 66% hydrobromic acid was refluxed for an hour and was evaporated to dryness. The residue was crystallized from isopropanol and then acetone to obtain 4.2 g of N-isopropyl-3-(3',4'-dihydroxyphenyl)-piperidine hydrobromide melting at 182° C.","N-isopropyl-3-(3',4'-dimethoxyphenyl)-piperidine | hydrobromic acid | isopropanol | acetone | N-isopropyl-3-(3',4'-dihydroxyphenyl)-piperidine hydrobromide"
US20080188460A1,"14.5 ml of thionyl chloride are added dropwise using a dropping funnel to a suspension of 20 g of 5-methoxy-1H-indole-2-carboxylic acid in 100 ml of absolute ethanol at 0° C. The mixture is allowed to return gradually to ambient temperature once the addition is complete, and is then heated at gentle reflux for 4 hours. The reaction mixture is then concentrated and the resulting solid is triturated in diisopropyl ether, filtered and dried. The title product is obtained in the form of a dark brown solid.",thionyl chloride | 5-methoxy-1H-indole-2-carboxylic acid | ethanol | diisopropyl ether | title product
US08283369B2,"A solution of 5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazole-3-thiol (100 mg, 0.289 mmol), ethyl 1-bromocyclobutanecarboxylate (47 μL, 0.289 mmol) and diisopropylethylamine (151 μL, 0.866 mmol) in DMF (1 mL) was heated at 60° C. for 4 days. After cooling to room temperature, the mixture was concentrated and partitioned between dichloromethane (15 mL) and HCl (1N aqueous, 15 mL). The aqueous layer was extracted with dichloromethane (2×15 mL) and the combined organic extracts dried over sodium sulfate, concentrated and purified by column chromatography (40% EtOAc/hexanes) to provide ethyl 1-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)cyclobutanecarboxylate as a light yellow sticky foam (75 mg, 55% yield).","5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazole-3-thiol | ethyl 1-bromocyclobutanecarboxylate | diisopropylethylamine | DMF | dichloromethane | HCl | dichloromethane | sodium sulfate | EtOAc/hexanes | ethyl 1-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)cyclobutanecarboxylate"
US08124788B2,"The aldol product 34 (10 mmol) was dissolved in absolute THF (20 ml) under an argon atmosphere. BH3xTHF (40 ml, 1 M solution, 40 mmol) was then added to the mixture, and the mixture was stirred at room temperature for 14 hours. The course of the reaction was monitored of TLC. When the reaction had ended, the reaction solution was added to a mixture of ethyl acetate (50 ml) and H2O (50 ml). After separation of the phases, the aqueous phase was extracted twice with 30 ml portions of ethyl acetate. The combined organic phases were dried over Na2SO4 and concentrated under reduced pressure. The residue was filtered over silica gel with ethyl acetate. After removal of the solvent, the product was obtained in the form of a sufficiently pure oil and crystallized spontaneously.",product 34 | THF | argon | ethyl acetate | H2O | ethyl acetate | Na2SO4 | silica gel | ethyl acetate
US05969070,"N-Butyllithium (1.6M in hexanes, 4.2 mL, 6.7 mmol) was added dropwise to a solution of 2-(4-methyl)phenyl)indene (1.323 g, 6.4 mmol) in Et2O (20 mL). The red-orange solution was stirred at ambient temperature for 30 min after which time the solvent was removed in vacuo. In a drybox, to the resulting solid was added ZrCl4 (0.754 g, 3.2 mmol). The solids were cooled to -78° C. and methylene chloride (60 mL) was slowly added. The solution was warmed to room temperature and kept there overnight. The resulting yellow-orange turbid solution was then filtered over a plug of Celite and the Celite was washed with CH2Cl2 until the washings were colorless (ca. 60 mL). The product was recrystallized from CH2Cl2 /hexane at -18° C. Yield: 577 mg (31%). 1H NMR (C6D6, 23° C., 400 MHz): d 7.36 (d, J=8 Hz, 4H); 7.11 (m, 4H); 7.02 (d, J=8 Hz, 4H); 6.92 (m, 4H); 6.43 (s, 4H, Cp-H); 2.17 (s, 6H, CH3). C, H analysis (crystallizes with 1/2 CH2Cl2): Anal. Found (Calcd.): C, 63.21 (63.46); H, 4.41 (4.42).",N-Butyllithium | 2-(4-methyl)phenyl | indene | Et2O | ZrCl4 | methylene chloride | CH2Cl2 | CH2Cl2
US05589495,"A stirred mixture of N-[3-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidiny]propoxy]phenyl]acetamide (9.2 g, 22 mmol), prepared as described in the previous example, in 15% hydrochloric acid (110 ml) was heated at 100° C. for 2.5 hours until a homogeneous solution resulted. The reaction was cooled to 0° C. in an ice bath and basified with 50% NaOH. The product was extracted with ethyl acetate (3×200 ml). The ethyl acetate solution was washed with water, brine, then dried over Na2SO4. The solvent was removed. The crude product was purified on a flash chromatography column. The product thus obtained was a solid: 6.6 g (80%). Recrystallization from hot ethanol (50 ml) gave 3-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-aniline as off-white crystals: 3.46 g, m.p.=115°-117° C.","N-[3-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidiny]propoxy]phenyl]acetamide | hydrochloric acid | ice | NaOH | ethyl acetate | ethyl acetate | water | brine | Na2SO4 | crude product | ethanol | 3-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-aniline"
US06326369B1,"To a solution of 2-(1,2,3,4-tetramethoxy-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-7-yl)ethanol (2.50 g) and triethylamine (1.68 ml) in acetonitrile (50 ml) was dropwise added methanesufonyl chloride (0.750 ml) with cooling with ice. After the reaction mixture was stirred for 15 min, saturated aqueous sodium bicarbonate was added to the solution with cooling with ice, which was extracted with ethyl acetate. The organic layer was washed with 1N hydrochloric acid, water, saturated aqueous sodium bicarbonate, water, and saturated aqueous sodium chloride, and dried. The solvent was removed in vacuo to yield the entitled compound (3.12 g) as an oil.","2-(1,2,3,4-tetramethoxy-6,7,8,9-tetrahydro-5H-benzo[a]cyclohepten-7-yl)ethanol | triethylamine | acetonitrile | methanesufonyl chloride | ice | sodium bicarbonate | ice | ethyl acetate | hydrochloric acid | water | sodium bicarbonate | water | sodium chloride | compound"
US20060030609A1,"(2-Fluoro-5-nitrophenyl)acetic acid (Step 1, Example 11, 3.00 g, 15.07 mmol) and t-butylamine (4.8 ml, 45.2 mmol) are mixed in dimethyl sulfoxide (20 ml) and stirred at 45° C. overnight. The mixture is diluted with water and the resulting yellow precipitate filtered, washed with water and dried under vacuum to give the title compound. HPLC r.t. 5.04 min.",(2-Fluoro-5-nitrophenyl)acetic acid | t-butylamine | dimethyl sulfoxide | water | water | title compound
US04129586,"To a mixture of 10.2 grams (0.0876 mole) of levulinic acid in 25 ml. of water was added in the following sequence: 7.04 grams (0.0876 mole) of 50% sodium hydroxide, 5.88 grams (0.12 mole) of sodium cyanide and 10.9 grams (0.0438 mole) of t-butylhydrazine hydrochloride. The reaction mixture was stirred for 5 hours at room temperature, cooled to 5° C. and chlorine passed into the system holding the temperature below 15° C. until there was an increase in weight 10.0 grams (0.14 mole). After the chlorination was over, the product was extracted with methylene chloride, the methylene chloride solution washed twice with water, dried over anhydrous sodium sulfate, filtered, and the methylene chloride evaporated on a rotating evaporator to leave 9.70 grams (52.5% yield) of crude product. The crude material was recrystallized from benzene-pentane to give 8.0 grams of product having a melting range of 79°-81° C.",levulinic acid | water | sodium hydroxide | sodium cyanide | t-butylhydrazine hydrochloride | chlorine | product | methylene chloride | methylene chloride | water | sodium sulfate | methylene chloride | crude product | crude material | benzene-pentane
US09133104B2,"(S)-2-[4-({[2-(1-Isobutoxy-ethoxycarbamoyl)-benzo[b]thiophen-6-ylmethyl]-amino}-methyl)-benzylamino]-3-phenyl-propionic acid cyclopentyl ester was dissolved in DCM (2 mL) and MeOH (2 mL) and treated with TFA (1 mL). The mixture was stirred for 1 h at r.t then concentrated to dryness and DCM (5 mL) and heptane (5 mL) added. The mixture was evaporated to dryness. This process was repeated three times to yield compound (104) (20 mg, 59%) as a oil. LCMS purity 95%, m/z 558 [M++H]+, 1H NMR (300 MHz, MeOD), δ: 1.25-1.91 (8H, m, 4×CH2), 3.12-3.47 (2H, m, CH2), 4.26 (1H, m, CH), 4.33 (2H, d, J=5.5 Hz, CH2), 4.36 (2H, s, CH2), 4.43 (1H, s, CH2), 5.16 (1H, s, CH), 5.13 (1H, m, CH), 7.25-7.37 (6H, m, ArH), 7.54-7.63 (4H, m, ArH), 7.94 (2H, m, ArH), 8.09 (1H, s, ArH).",(S)-2-[4-({[2-(1-Isobutoxy-ethoxycarbamoyl)-benzo[b]thiophen-6-ylmethyl]-amino}-methyl)-benzylamino]-3-phenyl-propionic acid cyclopentyl ester | DCM | MeOH | TFA | DCM | heptane
US07273868B2,"To a suspension of lithium aluminium hydride 4.15 g in tetrahydrofuran 150 ml is added a solution of 2-methylthio-4-(3-chloro-4-methoxybenzylamino)-5-ethoxycarbonylpyrimidine (prepared in Example 67-(1)) 38.32 g in tetrahydrofuran 100 ml at 5-10° C. under ice cooling over a period of 1 hour. After addition the mixture is stirred for a hour without an ice bath. Water 4.15 ml is added under ice cooling thereto, followed by addition of 3N aqueous sodium hydroxide solution 4.15 ml. To the mixture is added water 4.15 ml three times and the mixture is stirred at room temperature for 1 hour. After treating with magnesium sulfate and filtration, the resulting cake-like substances are washed with terahydrofuran. The filtrate is concentrated in vacuo and triturated with ethyl acetate-isopropyl ether. The resulting crystals are filtered and washed well with isopropyl-ether to give 2-methylthio-4-(3-chloro-4-methoxybenzylamino)-5-hydroxymethylpyrimidine as a pale yellow crystalline powder.",lithium aluminium hydride | tetrahydrofuran | 2-methylthio-4-(3-chloro-4-methoxybenzylamino)-5-ethoxycarbonylpyrimidine | tetrahydrofuran | ice | ice | Water | ice | sodium hydroxide | water | magnesium sulfate | terahydrofuran | ethyl acetate-isopropyl ether | isopropyl-ether | 2-methylthio-4-(3-chloro-4-methoxybenzylamino)-5-hydroxymethylpyrimidine
US20120238568A1,"Method F2 was used with 8-(4-aminophenylthio)pyrido[2,3-b]pyrazin-3(4H)-one (36.7 mg, 136 mmol) and 2-fluoro-5-trifluoromethyl-phenylisocyanate (22.5 μL, 156 136 μmol) to afford the title compound. Yield: 53 mg (82%).","8-(4-aminophenylthio)pyrido[2,3-b]pyrazin-3(4H)-one | 2-fluoro-5-trifluoromethyl-phenylisocyanate | title compound"
US08785473B2,"55 mg (0.13 mmol) of 5-(cyclohexylethynyl)-2-{[(4-cyclohexylphenyl)carbonyl]amino}benzoic acid obtained in Example 92 and 55 mg of Pd—C were stirred in ethanol (4 mL) at room temperature for 5 days. Thereafter, the mixture was filtered, and the filtrate was condensed, thereby giving 45 mg of the target 5-(2-cyclohexylethyl)-2-{[(4-cyclohexylphenyl)carbonyl]amino}benzoic acid (yield: 81%).",5-(cyclohexylethynyl)-2-{[(4-cyclohexylphenyl)carbonyl]amino}benzoic acid | Pd—C | ethanol | 5-(2-cyclohexylethyl)-2-{[(4-cyclohexylphenyl)carbonyl]amino}benzoic acid
US06172070B2,"4-Amino-6-chloro-5-nitropyrimidine (Boon et al., J. Chem. Soc., 96-102 (1951)) (1.5 g, 8.6 mmol) was added to a solution of sodium (0.23 g, 9.9 mmol) in benzyl alcohol (14 mL). The solution was heated in a 130° C. oil bath for 3.5 h, and was poured into benzene (50 mL). A. yellow solid was collected by filtration and washed with benzene. Crystallization from benzene/ether afforded an analytically pure sample of 3a: yield, 0.71 g (34%); mp 149-150° C.; UV (pH 1) λmax 284 nm (ε=0.368×104), 333 (0.488×104); (pH 6.9) 284 (0.329×104), 336 (0.470×104); (pH 13) 290 (0.344×104), 333 (0.494×104); 1H NMR δ 5.50 (s, 2H, ArCH2), 7.33-7.49 (m, 5H, ArH), 8.12-8.24 (br d, 2H, NHa and NHb, exchange with D2O), 8.24 (s, 1H, H-2); MS (EI) calcd. m/z for C11H10N4O3 246.0752, found 246.0751; Anal. (C11H10N4O3) C, H, N.",4-Amino-6-chloro-5-nitropyrimidine | sodium | benzyl alcohol | benzene | benzene | benzene/ether | 3a
US06384014B1,"25 g of 4-tert-butylbenzyl bromide, 50 ml of anhydrous toluene and 3.1 g of sodium hydride as an 80% suspension in oil are added under a nitrogen atmosphere to a three-necked flask on which is mounted a condenser, followed by addition of 21.8 g of diethyl acetamidomalonate. The mixture is heated at 110° C. for 17 hours. After cooling, 15 ml of absolute ethanol, then 15 ml of 50% ethanol and then 50 ml of water are added slowly using a dropping funnel. The organic phase is separated out after settling has taken place and the aqueous phase is washed with 3 times 50 ml of diethyl ether. The organic phases are combined, washed with water and then dried over sodium sulphate. After filtering and concentrating under reduced pressure, the product is crystallized from petroleum ether to give 25 g of diethyl 4-(tert-butyl)benzylacetamidomalonate in the form of a white solid melting at 80° C.",4-tert-butylbenzyl bromide | toluene | sodium hydride | suspension | nitrogen | diethyl acetamidomalonate | ethanol | ethanol | water | diethyl ether | water | sodium sulphate | petroleum ether | diethyl 4-(tert-butyl)benzylacetamidomalonate | solid
US20150045560A1,"To a suspension of 3,7-dibromo-1,5-dimethylnaphthalene-2,6-diol (3.24 g), pyridine (4.5 mL) in dichloromethane (90 mL) was slowly added trifluoromethanesulfonic anhydride (3.6 mL) at 0° C. After the mixture was stirred for 4 h at room temperature, water and hydrochloric acid (1 M) were added. The resulting mixture was extracted with dichloromethane and combined organic layer was dried (MgSO4) and concentrated in vacuo. The residue was purified by column chromatography on silica gel to give 3,7-Dibromo-1,5-dimethylnaphthalene-2,6-diyl bis(trifluoromethanesulfonate) (80%). LRMS (ESI): Calcd. for C14H8Br2F6O6S2: 609.8013. Found: 609.9.","3,7-dibromo-1,5-dimethylnaphthalene-2,6-diol | pyridine | dichloromethane | trifluoromethanesulfonic anhydride | water | hydrochloric acid | dichloromethane | MgSO4 | silica gel | 3,7-Dibromo-1,5-dimethylnaphthalene-2,6-diyl bis(trifluoromethanesulfonate)"
US09212187B2,"10% Palladium on carbon(20 mg) was added to an ethanol/ethyl acetate solution (1:1, 4 ml) of 7-[3-(4-chloro-2-oxo-3-phenyl-2H-quinoline-1-yl)propoxy]-1-ethyl-3,3,5-trimethyl-1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione(0.19 g). The mixture was subjected to catalytic reduction at 50° C. under normal pressure for 6 hours. The reaction mixture was subjected to celite filtration to remove the catalyst. The filtrate was condensed under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate=1:1). The purified product was condensed under reduced pressure, and the residue was recrystallized from ether/hexane, thereby obtaining the title compound(0.1 g) as a white powder.","Palladium on carbon | ethanol/ethyl acetate | ethyl acetate | 7-[3-(4-chloro-2-oxo-3-phenyl-2H-quinoline-1-yl)propoxy]-1-ethyl-3,3,5-trimethyl-1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione | silica gel | hexane | ether/hexane | title compound"
US05952321,"To a solution of 1.64 gm (5.6 mmol) of 3,3-diethyl-4-(RS)-[4-(1-oxo-2-methoxyethyl) phenoxy]azetidin-2-one in 23 mL of dry DMF was added 78 mg (0.56 mmol) of powdered potassium carbonate and then 1.27 gm (6.8 mmol) of (R)-α-allyl-4-methyl-benzyl isocyanate, and the mixture was stirred for one hour. The solution was treated with 50 mL of water and was extracted with 100 mL of 50:50 hexanes: ethyl acetate, 80 mL of ethyl acetate and then 100 mL of hexanes: ethyl acetate. Each extract was washed with 10 mL of water and 10 mL of brine. The combined extracts were dried over sodium sulfate, filtered and concentrated in vacuo. The residue was purified by flash chromatography on 240 gm of silica with 4 L of 70:30 hexanes: ethyl acetate to give a small amount of higher Rf material (3,3-diethyl-1-[(R)-α-(allyl)-4-(methyl)benzylaminocarbonyl]-4-(S)-[4-(1-(oxo)-2-(methoxy) ethyl)phenoxy]azetidin-2-one) and a substantial amount of mixed fractions. The mixed fractions were purified by flash chromatography on 173 gm of silica eluting with 4 L of 75:25 hexanes:ethyl acetate, and the mixed cuts from that chromatography were fractionated again under the same conditions. The pooled fractions containing mostly desired product were subjected to a final purification by flash chromatography on 143 gm of silica eluting with 3 L of 98:2 methylene chloride: ethyl acetate to give 1.40 gm of product as an oil.","3,3-diethyl-4-(RS)-[4-(1-oxo-2-methoxyethyl) phenoxy]azetidin-2-one | DMF | potassium carbonate | (R)-α-allyl-4-methyl-benzyl isocyanate | water | hexanes | ethyl acetate | hexanes | water | brine | sodium sulfate | silica | 3,3-diethyl-1-[(R)-α-(allyl)-4-(methyl)benzylaminocarbonyl]-4-(S)-[4-(1-(oxo)-2-(methoxy) ethyl)phenoxy]azetidin-2-one"
US20150353570A1,"To a solution of methyl 6-((((benzyloxy)carbonyl)(2-methoxy-2-oxoethyl)amino)methyl)nicotinate (2.5 g, 6.7 mmol) in AcOH (25 mL) was added NaBH3CN (1.3 g, 20 mmol) portions at 10° C. The solution was stirred for overnight at room temperature. The reaction mixture was concentrated under reduced pressure to give to residue. The residue was dissolved in H2O (50 ml) was added aqueous NaHCO3 to pH=8, the mixture was extracted with EA (50 ml×3). The combined organic phase was washed with brine (100 mL), dried over Na2SO4, concentrated in vacuo to give crud methyl 6-((((benzyloxy)carbonyl)(2-methoxy-2-oxoethyl)amino)methyl)piperidine-3-carboxylate (2.8 g). The mixture of methyl 6-((((benzyloxy)carbonyl)(2-methoxy-2-oxoethyl)amino)methyl)piperidine-3-carboxylate (2.8 g, 7.9 mmol) in MeOH (30 mL) was stirred at 70° C. for 12 h under N2. Then the mixture was concentrated in vacuo, the residue was purified by silica gel column chromatography (PE/THF=1/1) to give (cis)-2-benzyl 7-methyl 4-oxohexahydro-1H-pyrido[1,2-a]pyrazine-2,7(6H)-dicarboxylate (0.8 g, yield 30%). 1H NMR (400 MHz, METHANOL-d4) δ=7.38-7.33 (m, 5H), 5.16 (d, J=3.2 Hz, 2H), 4.85-4.80 (m, 1H), 4.15-4.07 (m, 2H), 3.95-3.93 (m, 1H), 3.91-3.70 (m, 3H), 3.44-3.42 (m, 2H), 2.67-2.61 (m, 1H), 2.47-2.44 (m, 1H), 2.17-2.13 (m, 1H), 1.82 (s, 1H), 1.69-1.65 (m, 1H), 1.62-1.42 (m, 1H).",methyl 6-((((benzyloxy)carbonyl)(2-methoxy-2-oxoethyl)amino)methyl)nicotinate | AcOH | NaBH3CN | H2O | NaHCO3 | EA | brine | Na2SO4 | methyl 6-((((benzyloxy)carbonyl)(2-methoxy-2-oxoethyl)amino)methyl)piperidine-3-carboxylate
US20040102510A1,"The reaction mixture of 5-fluorooxindole (100 mg, 0.66 mmol), 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (133 mg, 0.79 mmol), and 10 drops of piperidine in ethanol (3 mL) was stirred at 60° C. overnight and filtered. The solid was washed with 1 M of aqueous hydrochloride solution, water, and dried to afford 5-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (201 mg, quantitative) as a yellow solid. MS m/z (relative intensity, %) 299 ( [M−1]+., 100).","5-fluorooxindole | 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | piperidine | ethanol | hydrochloride | water | 5-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid"
US08492387B2,"To a −78° C. tetrahydrofuran solution containing methyl indane-1-carboxylate (2.10 g, 11.9 mmol) from Step A, was added a 1M tetrahydrofuran solution of NaHMDS (23.8 mL, 23.8 mmol). The mixture was stirred at −78° C. for 30 minutes. Benzyl bromide (1.49 mL, 12.5 mmol) was added and the reaction was warmed to 0° C. and stirred for 90 minutes. The reaction was quenched with aqueous sodium bicarbonate and then extracted into EtOAc (3×50 mL) and the combined organic washings were dried over MgSO4 and evaporated. The resulting residue was purified by column chromatography (98/2 hexanes/EtOAc) to afford of methyl 1-benzylindane-1-carboxylate (2.5 g, 79%) as a partially pure oil that was taken to the next step.",tetrahydrofuran | methyl indane-1-carboxylate | tetrahydrofuran | NaHMDS | Benzyl bromide | sodium bicarbonate | EtOAc | MgSO4 | hexanes/EtOAc | methyl 1-benzylindane-1-carboxylate
US08618140B2,"To a suspension of 1-(4-(2-(4-amino-1H-imidazol-1-yl)ethoxy)naphthalen-1-yl)-3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)urea (Intermediate I) (50 mg, 0.095 mmol) in DCM (2.0 mL) was added DIPEA (33 μl, 0.191 mmol) and 2-methoxyacetyl chloride (10 μl, 0.105 mmol). The mixture was stirred at RT overnight and then partitioned between saturated aq NaHCO3 solution (5.0 mL) and DCM (2.0 mL). The layers were separated through a phase separator cartridge and the organics were collected and evaporated under reduced pressure. The resulting residue was subjected to SCX capture and release and column chromatography (12 g), eluting with 0 to 10% MeOH in EtOAc. Trituration with EtOAc (5.0 mL) gave N-(1-(2-(4-(3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)naphthalen-1-yloxy)ethyl)-1H-imidazol-4-yl)-2-methoxyacetamide (Example 24) as a white solid (8 mg, 14%): m/z 596 (M+H)+ (ES+). 1H NMR (400 MHz, DMSO-d6) δ: 1.26 (9 H, s), 2.38 (3 H, s), 3.29 (3 H, s), 3.93 (2 H, s), 4.37 (2 H, t), 4.47 (2 H, t), 6.34 (1 H, s), 6.93 (1 H, d), 7.34 (2 H, m), 7.41-7.45 (3 H, m), 7.48-7.62 (4 H, m), 7.88 (1 H, d), 8.13-8.15 (1 H, dd), 8.54 (1 H, s), 8.75 (1 H, s), 9.84 (1 H, s).",1-(4-(2-(4-amino-1H-imidazol-1-yl)ethoxy)naphthalen-1-yl)-3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)urea | Intermediate I | DCM | DIPEA | 2-methoxyacetyl chloride | NaHCO3 | DCM | MeOH | EtOAc | EtOAc | N-(1-(2-(4-(3-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)naphthalen-1-yloxy)ethyl)-1H-imidazol-4-yl)-2-methoxyacetamide
US06297276B1,"To a solution of 6.1 g (14.44 mmol) N5-((Benzyloxy)carbonyl-N2-(tert-butoxycarbonyl-L-ornithine tert-butyl ester in 100 mL ethyl acetate was added 1.0 g 10% palladium on carbon. The suspension was shaken at 22° C. under 50 psi H2 for 45 minutes in a 500 mL Parr bottle. The catalyst was removed by filtration through celite. The resulting solution was concentrated to yield a crude oil. The oil was disolved into 50 mL of diethyl ether and added dropwise to a 0° C. stirred solution of 1.52 g (14.3 mmol) of cyanogen bromide in 30 mL ether. The solution was stirred for 2 h, poured into aqueous sodium bicarbonate, and extraced with ether. The ether solution was dried (magnesium sulfate), concentrated, and purified by silica gel chromatography (100 g, 230-400 mesh silica gel). Elution with a gradient of ethyl acetate in hexanes (30%-60%) gave 3.0 g (67% yield) N2-(tert-butoxycarbonyl)-N5-cyano-L-ornithine tert-butyl ester as an oil.",N5- | (Benzyloxy)carbonyl-N2- | tert-butoxycarbonyl-L-ornithine tert-butyl ester | ethyl acetate | palladium on carbon | H2 | diethyl ether | ether | cyanogen bromide | ether | sodium bicarbonate | ether | magnesium sulfate | silica gel | silica gel | ethyl acetate | hexanes | N2-(tert-butoxycarbonyl)-N5-cyano-L-ornithine tert-butyl ester
US05053509,"A suspension of (RS)-3-ethoxycarbonyl-7-fluoro-8-[3-(2-furyl)-1-piperazinyl]-1-methyl-4-oxo-1,4-dihydrobenzo[b][1,8]naphthyridine (1.3 g) in 0.5 N aqueous potassium hydroxide (12 cc) and ethanol (12 cc) is heated for 1 hour to a temperature in the region of 80° C. and then treated at the same temperature with an N aqueous solution (6 cc) of methanesulphonic acid. After cooling to approximately 20° C., the insoluble water is drained, washed with water (3×10 cc), ethanol (3×10 cc) and ethyl ether (3×10 cc) and recrystallized in a mixture of ethanol (13 cc) and dimethylformamide (27 cc). (RS)-7-Fluoro-8-[3-(2-furyl)-1-piperazinyl]-1-methyl-4-oxo-1,4-dihydrobenzo[b][1,8]naphthyridine-3-carboxylic acid (0.570 g) obtained in the form of a yellow solid, m.p. 258°-260° C.","(RS)-3-ethoxycarbonyl-7-fluoro-8-[3-(2-furyl)-1-piperazinyl]-1-methyl-4-oxo-1,4-dihydrobenzo[b][1,8]naphthyridine | potassium hydroxide | ethanol | aqueous solution | methanesulphonic acid | water | water | ethanol | ethyl ether | ethanol | dimethylformamide | (RS)-7-Fluoro-8-[3-(2-furyl)-1-piperazinyl]-1-methyl-4-oxo-1,4-dihydrobenzo[b][1,8]naphthyridine-3-carboxylic acid"
US07598232B2,"A solution of trifluoroacetic anhydride (20 mmol) and (E)-2,4,6-trimethoxystyryl-3-amino-4-methoxy benzylsulfone (10 mmol) in dry dichloromethane (25 mL) was stirred for 2 hours at room temperature and excess of trifluoroacetic anhydride was removed under vacuum and the product obtained was purified by washing with diethyl ether, yield 98%, m.p. 179-180° C.","trifluoroacetic anhydride | (E)-2,4,6-trimethoxystyryl-3-amino-4-methoxy benzylsulfone | dichloromethane | trifluoroacetic anhydride | diethyl ether"
US20060287373A1,"To the alcohol (95.7 g) from Step 1 dissolved in dichloroethane (925 mL) was added pyridine (625 mL) and the mixture was cooled to 0-5° C. Anhydrous p-toluenesulfonic anhydride (105.7 g.) was added and the mixture was warmed to room temperature and stirred for 1 hour. It was then heated to 90° C. for 2 hours. The mixture was cooled, diluted with dichloromethane (1000 mL) and washed with 1N HCl (3×600 mL). The organic layer was washed with brine, dried with sodium sulfate and the solvents were removed in vacuo. The residue was purified by chromatography on SiO2 using ethyl acetate and hexanes in a 1:1 ratio followed by ethyl acetate to yield benzyl [(4S)-2-oxo-1,3-oxazolidin-4-yl]acetate.","alcohol | dichloroethane | pyridine | p-toluenesulfonic anhydride | dichloromethane | HCl | brine | sodium sulfate | SiO2 | benzyl [(4S)-2-oxo-1,3-oxazolidin-4-yl]acetate"
US20160096836A1,"To a solution of methyl 3,9-diazaspiro[5.5]undecane-10-carboxylate (30 mg, 0.14 mmol) in dioxane (2 mL)/i-PrOH (2 mL) was added 4-chloro-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoro-ethoxy]pyrimidin-2-amine (92 mg, 0.22 mmol), and the reaction was heated at 100° C. under microwave for 3 h. The reaction was cooled to RT, and concentrated in vacuo. The residue was purified by reversed phase HPLC (MeOH/H2O/0.5% TFA) to provide methyl 9-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)-3,9-diazaspiro[5.5]undecane-2-carboxylate as an off-white solid.","methyl 3,9-diazaspiro[5.5]undecane-10-carboxylate | dioxane | i-PrOH | 4-chloro-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoro-ethoxy]pyrimidin-2-amine | MeOH/H2O | methyl 9-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)-3,9-diazaspiro[5.5]undecane-2-carboxylate"
US08044242B2,"To 9B (575 mg, 1.43 mmol) in acetic acid (14 mL) was added acetic anhydride (0.155 mL, 1.64 mmol) and 10% Pd/C (90 mg). The mixture was hydrogenated with a hydrogen balloon at rt for 3.0 h. After removal of solvent, 9C (580 mg, 100% yield) was obtained as a white solid. 1H NMR (400 MHz, CDCl3) δ ppm 1.24 (d, J=6.16 Hz, 6H) 1.30 (t, J=7.03 Hz, 3H) 1.69 (s, 3H) 3.66 (s, 3H) 4.00 (q, J=7.03 Hz, 2H) 4.46-4.50 (m, 1H) 6.09 (s, 1H) 6.90 (d, J=8.35 Hz, 1H) 6.97-7.14 (m, 4H) 7.72 (d, J=9.23 Hz, 2H). LC-MS 387 (M+H)+.",9B | acetic acid | acetic anhydride | Pd/C | hydrogen | 9C
US04183786,"6-mercaptopurine, 8-azaguanine, 2-fluoroadenine",6-mercaptopurine | 8-azaguanine | 2-fluoroadenine
US20040167188A1,"A solution of alcohol from Example 16A (2.65 g, 13.1 mmol), methyl-2,6-dihydroxybenzoate (3.51 g, 20.9 mmol), PPh3 (3.34 g, 15.7 mmol), and THF (20 mL) was cooled to 0° C. Diethylazodicarboxylate (2.51 g, 14.4 mmol) was added. The reaction was allowed to warm to room temperature and stir for 16 hours. The titled product (1.11 g, 24%) was obtained following silica gel column chromatography (10% ethyl acetate in hexanes).","alcohol | methyl-2,6-dihydroxybenzoate | PPh3 | THF | Diethylazodicarboxylate | titled product"
US07521457B2,"24 ml (349 mmol) 65% nitric acid are cooled to 0-5° C. 28 ml (518.5 mmol) of concentrated sulphuric acid are slowly added dropwise while cooling with ice. This solution is cooled to 5° C. and slowly added dropwise to 30 ml (232 mmol) indane cooled to 0-5° C., with vigorous stirring and further cooling with ice. The reaction mixture is stirred for 30 min at 0-5° C., and then heated to 25° C. for 1 h with stirring. Then the solution is added dropwise to 150 ml ice/water and stirred for 30 min. The aqueous phase is extracted three times with 200 ml diethyl ether. The combined organic phases are washed twice with 200 ml saturated sodium hydrogen carbonate solution and once with 150 ml distilled water. Then the organic phase is dried with MgSO4 and the solvent is eliminated in vacuo. The crude product is dissolved in 250 ml of methanol and combined with 4.5 g Raney nickel. The reaction mixture is hydrogenated for 16 h at 3 bar H2 pressure and 25° C. Then the catalyst is filtered off and the solvent is eliminated in vacuo. The crude product is purified by column chromatography. The carrier used is silica gel and the eluant used is a mixture of cyclohexane:ethyl acetate (75:25).",nitric acid | sulphuric acid | ice | indane | ice | ice/water | water | diethyl ether | sodium hydrogen carbonate | MgSO4 | crude product | methanol | H2 | crude product | cyclohexane:ethyl acetate
US07947712B2,"To a stirring solution of the 2-[8-(benzyloxy)quinolin-7-yl]-1-phenylethanol (0.302 mmol) in phenoxyacetonitrile (9.05 mmol, 30 eq.) at −10° C. was dropwise added conc. sulfuric acid (1.51 mmol, 5.0 eq.). On completion of addition, the reaction mixture was allowed to warm to room temperature and was stirred 16 h. The reaction was then diluted with ice that was allowed to melt and was then stirred 2 h. The mixture was next brought to pH=7 by the addition of saturated aqueous sodium bicarbonate solution and then diluted with water (5 mL) and extracted with ethyl acetate (2×5 mL). The organic layers were combined, dried (MgSO4), filtered and concentrated to give sulfuric acid mono-{7-[2-(2-phenoxy-acetylamino)-2-phenyl-ethyl]-quinolin-8-yl}ester as a yellow oil that was purified by column chromatography using 20% methanol/dichloromethane. To a stirring suspension of the sulfuric acid mono-{7-[2-(2-phenoxy-acetylamino)-2-phenyl-ethyl]-quinolin-8-yl}ester (0.089 mmol, 1.0 eq.) from the initial step in methanol (9 mL) was added 3N HCl (18 mL) and the resulting suspension was heated to 55° C. and stirred 2 h. The reaction mixture was then cooled to room temperature and organic solvents were removed by rotary evaporation resulting in a precipitate that was filtered yielding the pure product as a yellow solid (0.059 mmol, 12% for 2 steps). HRMS: calcd for C25H22N2O3+H+, 399.17032; found (ESI-FTMS, [M+H]1+), 399.17059.",2-[8-(benzyloxy)quinolin-7-yl]-1-phenylethanol | phenoxyacetonitrile | sulfuric acid | ice | sodium bicarbonate | water | ethyl acetate | MgSO4 | sulfuric acid mono-{7-[2-(2-phenoxy-acetylamino)-2-phenyl-ethyl]-quinolin-8-yl}ester
US08501746B2,"Following the procedure as described in Example 1, making variations only as required to use pyridin-3-ylmethanamine in place of benzylamine to react with 2-(4-(2-cyclopropylethoxy)-2-oxopyridin-1(2H)-yl)-4-methylthiazole-5-carboxylic acid, the title compound was obtained as a colorless solid in 47% yield: mp 170-172° C. (ethyl acetate); 1H NMR (300 MHz, CDCl3) δ 8.63 (d, J=8.1 Hz, 2H), 8.55 (s, 1H), 7.77 (d, J=7.8 Hz, 1H), 7.37-7.27 (m, 1H), 6.43 (t, J=5.7 Hz, 1H), 6.16 (dd, J=8.1, 2.6 Hz, 1H), 5.96 (d, J=2.6 Hz, 1H), 4.62 (d, J=5.7 Hz, 2H), 4.03 (t, J=6.6 Hz, 2H), 2.67 (s, 3H), 1.68 (q, J=6.6 Hz, 2H), 0.86-0.74 (m, 1H), 0.52-0.46 (m, 2H), 0.13-0.08 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 167.9, 162.5, 162.1, 153.7, 152.6, 148.6, 148.3, 136.3, 131.3, 121.7, 104.2, 96.6, 69.1, 41.4, 33.6, 17.3, 7.56, 4.2; MS (ES+) m/z 411.2 (M+1).",pyridin-3-ylmethanamine | 2-(4-(2-cyclopropylethoxy)-2-oxopyridin-1(2H)-yl)-4-methylthiazole-5-carboxylic acid | title compound
US08686150B2,"130 mg of 4-[6-(2-fluoro-4-Hydroxy-phenyl)-3-methyl-1-(tetrahydro-pyran-2-yl)-1H-pyrazolo[3,4-b]pyridine-4-carbonyl]-3,3-dimethyl-piperazine-1-carboxylic acid tert-butyl ester were dissolved in 4.6 mL of 4M hydrochloric acid in dioxane. After complete conversion, dioxan was removed in vacuo, water was added and the solution was extracted twice with dichloromethane/isopropanol (10/1). The aqueous layer was lyophilized, taken up in water three times and lyophilized again to give 96 mg (100%) of the title compound as the hydrochloride salt.","4-[6-(2-fluoro-4-Hydroxy-phenyl)-3-methyl-1-(tetrahydro-pyran-2-yl)-1H-pyrazolo[3,4-b]pyridine-4-carbonyl]-3,3-dimethyl-piperazine-1-carboxylic acid tert-butyl ester | hydrochloric acid | dioxane | dioxan | water | dichloromethane/isopropanol | title compound | hydrochloride salt"
US20080269286A1,"Preparation according to preparation 6: tert-butyl 4-(3,4-difluorophenyl)-4-hydroxypiperidine-1-carboxylate (8.7 g, 27.8 mmol), trifluoroacetic acid (40 ml). Yield. 7.5 g. MS m/z (rel. intensity, 70 eV) 195 (M+, 53), 138 (45), 136 (bp), 127 (78), 57 (76).","tert-butyl 4-(3,4-difluorophenyl)-4-hydroxypiperidine-1-carboxylate | trifluoroacetic acid | (45) | (78) | (76)"
US20100292210A1,"A mixture of 1-(1,3-dimethyl-1H-pyrazol-5-yl)-2-nitroethanol (1.2 g, 6.48 mmol), ammonium formate (2.0 g, 32.4 mmol) and palladium on activated carbon (10%, 300 mg) in anhydrous methanol (40 mL) was stirred at room temperature for 2 h. The reaction mixture was filtered through a pad of Celite and concentrated under reduced pressure. The to residue was purified by flash column chromatography using 5% methanol in dichloromethane to afford 0.8 g of the title compound (79% Yield).","1-(1,3-dimethyl-1H-pyrazol-5-yl)-2-nitroethanol | ammonium formate | palladium on activated carbon | methanol | title compound"
US20120277210A1,"4-Methoxycyclohexanecarboxylic acid (7 g) in tetrahydrofuran (20 ml) was treated with 1 M (in tetrahydrofuran) borane-tetrahydrofuran complex (100 ml) overnight. The mixture was concentrated and the residue was dissolved in methanol (100 ml) and concentrated HCl (10 ml). The resulting mixture was stirred for 1 hour and concentrated. The residue was dissolved in dichloromethane and washed with water. The organic layer was dried over Na2SO4, filtered, and concentrated to give the title compound.",4-Methoxycyclohexanecarboxylic acid | tetrahydrofuran | borane-tetrahydrofuran | methanol | dichloromethane | water | Na2SO4 | title compound
US04197305,"A solution of 4-methyl-5-((2-aminoethyl)thiomethyl) imidazole (10.2 g) in ethanol (75 ml) was added slowly, with stirring, to carbon disulphide (200 ml). The mixture was set aside overnight at room temperature and the solid formed was collected and recrystallised from aqueous isopropyl alcohol to afford N-[2-((5-methyl-4-imidazolyl)methylthio)ethyl]dithiocarbamic acid (9.8 g)., m.p. 127°-129°.",4-methyl-5-((2-aminoethyl)thiomethyl) imidazole | ethanol | carbon disulphide | isopropyl alcohol | N-[2-((5-methyl-4-imidazolyl)methylthio)ethyl]dithiocarbamic acid
US20150266848A1,"To stirred solution of LAH (LiAlH4, 3.3 g, 86.73 mmol) in THF (66 mL) was added dropwise a solution (E)-5-phenylpent-3-enoic acid (Preparation example 235, 11.0 g, 57.82 mmol) in THF (44 mL) at 0° C. then stirred at room temperature for 1 h. The reaction mixture was quenched with H2O at 0° C., filtered through celite, washed with EtOAc, dried over anhydrous magnesium sulfate (MgSO4), filtered and concentrated. The crude compound was purified by a silica gel column to produce the title compound (7.2 g, 70˜90%)",LAH | THF | (E)-5-phenylpent-3-enoic acid | THF | H2O | EtOAc | magnesium sulfate | crude compound | silica gel | title compound
US08436008B2,"This compound was prepared by using procedures analogous to those described for the synthesis of Example 18 starting from 5-{2-[2-amino-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl]-1,2,3,4-tetrahydroisoquinolin-7-yl}pyridine-2-carboxylic acid and 1-amino-2-methyl-2-propanol (Tyger, Cat. No. A57123). LCMS (M+H)+: m/z=517.4.","5-{2-[2-amino-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl]-1,2,3,4-tetrahydroisoquinolin-7-yl}pyridine-2-carboxylic acid | 1-amino-2-methyl-2-propanol | A57123"
US04362736,"In 300 ml of ehter solution of diazomethane prepared from 43 g of p-tosyl-N-methyl-N-nitrosoacetamide was added under stirring 30 ml of ether solution of 8 g of 5-chlorovalerylchloride dropwise at -5° to 0° C., and the solution was allowed to stand at the same temperature for 2 hours. Hydrogen chloride gas was passed through the reaction solution at 0° C. and the solution was allowed to stand at the same temperature for 0.5 hours. To the solution was added 100 ml of water and the ether layer was separated. The aqueous layer was further extracted twice each time with 100 ml of ether. The ether layers were combined and the obtained ether solution was dried over anhydrous magnesium sulfate and the solvent was distilled away and the residue was distilled under reduced pressure to provide 8.2 g of 1,6-dichloro-2-hexanone showing a boiling point of 120° to 125° C. (14 mm Hg). ##STR51##","diazomethane | p-tosyl-N-methyl-N-nitrosoacetamide | ether | 5-chlorovalerylchloride | Hydrogen chloride | water | ether | ether | ether | magnesium sulfate | 1,6-dichloro-2-hexanone"
US03949083,"To a solution of 41.1 g α-n-butyl-β-amino-β-ethoxyacrylic acid ethyl ester and a spatula tipfull of p-toluenesulphonic acid in 100 ml ethanol were added dropwise, under nitrogen, 36.5 g 3,4-dichlorobenzylhydrazine. After the mixture had been stirred afterwards for two hours, it was left to stand overnight. The solvent was distilled off, a mixture of ether/petroleum ether (1:1) was added to the residue; the product crystallized through.","α-n-butyl-β-amino-β-ethoxyacrylic acid ethyl ester | p-toluenesulphonic acid | ethanol | nitrogen | 3,4-dichlorobenzylhydrazine | ether/petroleum ether"
US08343963B2,The title compound was prepared from 4-(3-(3-cyanophenyl)ureido)-N-(4-sulfamoylbenzyl)benzenesulfonamide following procedure C and using 1 equivalent of methyl piperazine-1-carboxylate as secondary amine. The product was purified by preparative HPLC.,title compound | 4-(3-(3-cyanophenyl)ureido)-N-(4-sulfamoylbenzyl)benzenesulfonamide | methyl piperazine-1-carboxylate | secondary amine
US09034866B2,"Into a 250-mL 3-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen, was placed bromo(ethynyl)magnesium (0.5M in THF, 77 mL, 1.20 equiv). This was followed by the addition of a solution of 1-(1-methyl-1H-imidazol-2-yl)ethan-1-one (4.0 g, 32.22 mmol, 1.00 equiv) in tetrahydrofuran (15 mL) dropwise with stirring at 0° C. in 20 min. The resulting solution was stirred for 20 min at 0° C. The resulting solution was allowed to react with stirring for an additional 5 h at room temperature. The reaction was then quenched by the addition of 50 mL of saturated aqueous NH4Cl. The resulting solution was extracted with 3×100 mL of ethyl acetate and the organic layers combined and dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/hexane (1/3) to give 2.8 g (58%) of 2-(1-methyl-1H-imidazol-2-yl)but-3-yn-2-ol as a off-white solid. 1H-NMR (300 MHz, CDCl3, ppm) δ 7.065 (d, 1H), 6.842 (d, 1H), 3.935 (d, 3H), 3.092 (s, 3H), 1.950 (s, 3H).",nitrogen | bromo(ethynyl)magnesium | 1-(1-methyl-1H-imidazol-2-yl)ethan-1-one | tetrahydrofuran | NH4Cl | ethyl acetate | sodium sulfate | 2-(1-methyl-1H-imidazol-2-yl)but-3-yn-2-ol
US06812227B2,"To a solution of 6.62 g (0.017 mmol) of [{[4-(2-butynyloxy)phenyl]-sulfonyl}amino](4-hydroxyphenyl)acetate from Example 178 in 50 mL of DMF was added 3.08 g (0.020 mmol) of tert-butyldimethylsilyl chloride followed by 2.89 g (0.043 mmol) of imidazole. The reaction was stirred at room temperature for 5 h and then diluted with ether. The resulting mixture was washed with water, dried over magnesium sulfate, filtered and concentrated in vacuo to give 7.06 g of [4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-(4-but-2-ynyloxy-benzenesulfonylamino)-acetic acid methyl ester as a white solid. Electrospray Mass Spec 504.4 (M+H)+",[{[4-(2-butynyloxy)phenyl]-sulfonyl}amino](4-hydroxyphenyl)acetate | DMF | tert-butyldimethylsilyl chloride | imidazole | ether | water | magnesium sulfate | [4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-(4-but-2-ynyloxy-benzenesulfonylamino)-acetic acid methyl ester
US20100184809A1,"TBTU (0.177 g, 0.55 mmol) and triethylamine (0.056 g, 0.55 mmol) were added under stirring to a solution of 4-[({6-[3-(2,6-dichloro-phenyl)-5-isopropyl-isoxazol-4-yl methoxy]-2-trifluoromethyl-pyridin-3-yl}-methyl-amino)-methyl]-benzoic acid (example 28) (0.20 g, 0.34 mmol) in dry acetonitrile (6 ml) and stirred for 1 h at room temperature. (2,2-dimethyl-[1,3]dioxolan-4-yl)-methylamine (0.054 g, 0.41 mmol) was added and the reaction mixture was stirred for 5 h at room temperature. The volatiles were evaporated, the residue was redissolved in chloroform, washed with water and brine, dried over sodium sulfate and evaporated. The crude material was purified by preparative HPLC to give 0.112 g (47%) of 4-[({6-[3-(2,6-dichloro-phenyl)-5-isopropyl-isoxazol-4-ylmethoxy]-2-trifluoromethyl-pyridin-3-yl}-methyl-amino)methyl]-N-(2,3-dihydroxy-propyl)benzamide as a colorless oil.","TBTU | triethylamine | 4-[({6-[3-(2,6-dichloro-phenyl)-5-isopropyl-isoxazol-4-yl methoxy]-2-trifluoromethyl-pyridin-3-yl}-methyl-amino)-methyl]-benzoic acid | acetonitrile | (2,2-dimethyl-[1,3]dioxolan-4-yl)-methylamine | chloroform | water | brine | sodium sulfate | crude material | 4-[({6-[3-(2,6-dichloro-phenyl)-5-isopropyl-isoxazol-4-ylmethoxy]-2-trifluoromethyl-pyridin-3-yl}-methyl-amino)methyl]-N-(2,3-dihydroxy-propyl)benzamide"
US20060116368A1,"Using the procedure outlined in Example 1A, 1-isoquinolin-5-yl-piperidine-4-carboxylic acid is prepared from 5-bromo-isoquinoline (4 mmol). Using the procedure outlined in Example 8, the title compound is prepared from 2H-pyrazol-3-ylamine (0.5 mmol) and 1-isoquinolin-5-yl-piperidine-4-carboxylic acid (0.18 mmol).",1-isoquinolin-5-yl-piperidine-4-carboxylic acid | 5-bromo-isoquinoline | title compound | 2H-pyrazol-3-ylamine | 1-isoquinolin-5-yl-piperidine-4-carboxylic acid
US06329405B1,"3,4-dimethoxy-3-cyclobutene-1,2-dione (428 mg) was added to a solution of N-[(3-aminophenyl)-(4-methoxyphenyl)methyl]benzamide hydrochloride (555 mg) [prepared as described in step (d) above] in methanol (15 ml) at ambient temperature. After stirring for 10 minutes, a solution of triethylamine (153 mg) in methanol (10 ml) was added dropwise to the mixture. This mixture was stirred at ambient temperature for 1 hour. The reaction mixture was then slightly acidified with hydrochloric acid (0.5N) and extracted with ethyl acetate. The organic extract was washed with a saturated aqueous solution of sodium chloride, dried over anhydrous magnesium sulfate and concentrated by evaporation under reduced pressure. The residue was purified by chromatography through a silica gel column using a 1:1 by volume mixture of hexane and ethyl acetate as the eluant, to afford the title compound (505 mg) as a white foamy solid.","3,4-dimethoxy-3-cyclobutene-1,2-dione | N-[(3-aminophenyl)-(4-methoxyphenyl)methyl]benzamide hydrochloride | methanol | triethylamine | methanol | hydrochloric acid | ethyl acetate | sodium chloride | magnesium sulfate | silica gel | hexane | ethyl acetate | title compound"
US20110201599A1,"The title compound was synthesized in a manner similar to Example 63, with 3-(4-(1H-indol-4-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)benzenesulfonamide (114) instead of (S)-4-(1-(phenylsulfonyl)-4-(3-(3,3,3-trifluoropropylamino)pyrrolidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine (46) as substrate, NaOH instead of LiOH, and by heating the reaction mixture at 60° C. for 6 h, instead of rt.","title compound | 3-(4-(1H-indol-4-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)benzenesulfonamide | (S)-4-(1-(phenylsulfonyl)-4-(3-(3,3,3-trifluoropropylamino)pyrrolidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine | NaOH | LiOH"
US20090131431A1,"4-Fluorobenzoyl chloride [e.g. available from Aldrich Chemical Company] (0.04 ml) was added to a solution of Intermediate 15 (100 mg) and DIPEA (0.07 ml) in acetonitrile (2 ml). The solution was stirred at room temperature under an atmosphere of nitrogen for 16 h. It was then diluted with brine (2 ml) and dichloromethane (2 ml). The organic extract separated using a hydrophobic frit and evaporated to dryness. The residual gum was purified by SPE cartridge (5 g, aminopropyl) eluting with methanol. The eluent was blown down to dryness to give Example 313 as a white solid (104 mg). LCMS showed MH+=412; TRET=2.50 min.",4-Fluorobenzoyl chloride | Intermediate 15 | DIPEA | acetonitrile | nitrogen | brine | dichloromethane | aminopropyl | methanol | Example 313
US08940412B2,"In argon atmosphere, a mixture of 13.91 g (80.9 mmol) of 2-naphthaleneboronic acid, 30.0 g (80.9 mmol) of 2-bromo-7-iodo-9,9-dimethylfluorene, 4.67 g (4.0 mmol) of tetrakis(triphenylphosphine)palladium (0), 200 ml of toluene, 200 ml of dimethoxyethane, and 122.36 g of a 2 M sodium carbonate aqueous solution was refluxed under stirring for 8 h and left standing overnight. After adding water, the mixture was stirred at room temperature for one hour. After filtration and extraction with toluene, the organic phase was washed with water and then with a saturated saline solution. After drying over sodium sulfate, the toluene was distilled off under reduced pressure. The residue was purified by silica gel chromatography to obtain 21.3 g (yield: 76.1%) of 2-bromo-9,9-dimethyl-7-(naphthalene-2-yl)-9H-fluorene.","argon | 2-naphthaleneboronic acid | 2-bromo-7-iodo-9,9-dimethylfluorene | tetrakis(triphenylphosphine)palladium | toluene | dimethoxyethane | sodium carbonate | water | toluene | water | sodium sulfate | toluene | silica gel | 2-bromo-9,9-dimethyl-7-(naphthalene-2-yl)-9H-fluorene"
US06169212A,"1230 ml of a solution of CH3MgCl 3M in tetrahydrofurane (Fluka) was added to 26.5 g of CuBr (Fluka) in 11 of diisopropylether with stirring at 0° (bath temperature). After one night, the reaction mixture was cooled to −20° and 467 g of epoxymyrcene [2-(3,4-epoxy-4-methylpentyl)-1,3-butadiene] in 4 l of isopropylether were added dropwise. After the addition, the reaction mixture was warmed to room temperature. After 23 h the reaction was completed. After hydrolysis with a 15% NH4Cl-solution and washing with brine, the product was distilled to obtain 96.6% pure 2,3-dimethyl-6-methylene-7-octen-2-ol with a yield of 453.7 g (88%).","CH3MgCl | tetrahydrofurane | CuBr | diisopropylether | epoxymyrcene | isopropylether | NH4Cl | brine | 2,3-dimethyl-6-methylene-7-octen-2-ol"
US09199982B2,"To a mixture of 4-aminopyrido[2,3-d]pyrimidin-5(8H)-one (11.5 mg, 0.0708 mmol), cesium carbonate (34 mg, 0.10 mmol) and potassium iodide (1.2 mg, 0.0071 mmol) in N,N-dimethylformamide (0.2 mL) was added benzyl 3-[3-chloro-5-(1-chloroethyl)-6-ethoxy-2-methylphenyl]azetidine-1-carboxylate (30 mg, 0.07 mmol). The mixture was stirred at 140° C. for 1 hour, cooled and then diluted with water, extracted with ether. The combined organic layers were dried over MgSO4 and concentrated to afford the crude product which was used in the next step directly. LCMS calculated for C29H31ClN5O4 (M+H)+: m/z=548.2; Found: 548.2.","4-aminopyrido[2,3-d]pyrimidin-5(8H)-one | cesium carbonate | potassium iodide | N,N-dimethylformamide | benzyl 3-[3-chloro-5-(1-chloroethyl)-6-ethoxy-2-methylphenyl]azetidine-1-carboxylate | water | ether | MgSO4 | crude product"
US20070037888A1,"p-Toluenesulphonyl chloride (3.0 g, 15.7 mmol) was added to a mixture of 6-hydroxymethyl-2-(2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(5-methyl-1H-pyrazol-3-ylamino)pyrimidine (Example 80) (3.13 g, 7.49 mmol), triethylamine (2.5 ml, 18 mmol) in anhydrous THF (50 ml). The resulting mixture was stirred at ambient temperature for 1 hour then heated at reflux for 4 hours. The volatiles were removed by evaporation and the residue dissolved in water and extracted with DCM. The organic extracts were combined and the solvent removed by evaporation. The residue was purification by chromatography on silica gel, eluting with DCM (100%) and then with diethylether (100%) to give the title compound (contaminated with 31% of the 6-chloromethyl derivative) (1.69 g, 31%).",p-Toluenesulphonyl chloride | 6-hydroxymethyl-2-(2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(5-methyl-1H-pyrazol-3-ylamino)pyrimidine | triethylamine | THF | water | DCM | silica gel | DCM | diethylether | title compound | 6-chloromethyl
US09034866B2,"To a stirred mixture of 4-Acetylamino-9-bromo-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene-2-carboxylic acid methyl ester (180 mg, 0.453 mmol) in TEA (5 mL) and DMF (1 mL) were added Pd(OAc)2 (20.3 mg, 0.091 mmol), PPh3 (35.6 mg, 0.136 mmol), CuI (17.26 mg, 0.091 mmol) and 2-methylbut-3-yn-2-ol (190.6 mg, 2.266 mmol). The reaction mixture was degassed with N2 and heated in a microwave reactor at 80° C. for 2 h. Then the mixture was cooled to room temperature, and EtOAc was added. The mixture was filtered though Celite, and the filtrate was washed with saturated brine, dried over Na2SO4, filtered, concentrated in vacuo, and purified by flash column chromatography (silica gel, EtOAc in hexane from 10% to 20%) to afford 4-Acetylamino-9-(3-hydroxy-3-methyl-but-1-ynyl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene-2-carboxylic acid methyl ester (81 mg, 45%) as a light yellow solid. LC-MS (ESI & APCI): 399.1 (M−1).","4-Acetylamino-9-bromo-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene-2-carboxylic acid methyl ester | TEA | DMF | Pd(OAc)2 | PPh3 | CuI | 2-methylbut-3-yn-2-ol | N2 | EtOAc | brine | Na2SO4 | silica gel | EtOAc | hexane | 4-Acetylamino-9-(3-hydroxy-3-methyl-but-1-ynyl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene-2-carboxylic acid methyl ester"
US07550469B2,"Under inert conditions, add a 2.0 M solution (in tetrahydrofuran/n-heptane) of lithium diisopropylamide (29.65 mmol, 14.83 mL, 1.05 equivalents) to a cold (−78° C.) solution of 3-bromo-4-methylthiophene (28.24 mmol, 5.00 g, 1.00 equivalents) in dry tetrahydrofuran (27.33 mL). Stir at −78° C. for 1 hour and add a solution of 4-(methoxy-methyl-carbamoyl)-piperidine-1-carboxylic acid tert-butyl ester (28.24 mmol, 7.69 g, 1.00 equivalents), dropwise. Continue stirring at −78 ° C. for 3 hours. Quench the reaction mixture with saturated ammonium chloride (aqueous, 55 mL) and allow to warm to room temperature. Extract the reaction mixture with a mixture of ethyl acetate : diethyl ether (1:1, 3×40 mL). Combine the extracts and dry over magnesium sulfate, filter and evaporate. Purify the residue via flash column chromatography using a mixture of n-heptane:ethyl acetate (4:1) to yield a yellow, crystalline solid (9.84 g).",tetrahydrofuran | lithium diisopropylamide | 3-bromo-4-methylthiophene | 4-(methoxy-methyl-carbamoyl)-piperidine-1-carboxylic acid tert-butyl ester | ammonium chloride | magnesium sulfate | n-heptane:ethyl acetate | solid
US20150203442A1,"Bromoacetyl bromide (26 μL, 0.3 mmol) was injected slowly into the solution of (3) (50 mg, 0.2 mmol) in anhydrous 1,4-dioxane (5 mL). The mixture was stirred at room temperature for 2 h. The reaction mixture was followed by TLC (DCM:MeOH=10:1) and diluted by H2O (20 mL) and the suspension was extracted with CH2Cl2 (2×50 mL). The organic layers were combined, dried over MgSO4, filtered and concentrated in vacuo. The residue was purified with silica gel column chromatography. The product was eluted with DCM:ethyl acetate (20:1). Orange color solid was obtained as product (18 mg, 30% yield). 1H NMR (DMSO-d6): δ 12.05 (s, 1H), 10.18 (s, 1H), 7.88 (d, 1H, J=2.0 Hz), 7.82-7.80 (m, 2H), 7.78-7.76 (m, 1H), 7.35 (d, 1H, J=8.4 Hz), 4.14 (s, 2H); MS: m/z [M−H]− calculated C16H10BrNO5 392.9, found 392.1.","Bromoacetyl bromide | (3) | 1,4-dioxane | DCM | MeOH | H2O | CH2Cl2 | MgSO4 | silica gel | DCM:ethyl acetate | C16H10BrNO5"
US08450340B2,"To a solution of 3-morpholino-5-nitropyridin-4-amine (LIII) (1 eq) in MeOH was added 10% Pd/C. The solution was purged with hydrogen and stirred overnight at r.t. under hydrogen. The suspension was filtered through Celite and concentrated under vacuum to produce 5-morpholinopyridine-3,4-diamine (LIV) as a purple solid (37% yield). 1H NMR (DMSO-d6, 400 MHz,): δ 3.09-3.11 (m, 4H), 3.64-3.66 (m, 4H), 3.92 (s, 2H), 5.23 (s, 2H), 6.94 (s, 1H), 7.33 (s, 1H). ESIMS found C9H14N4O m/z 195 (M+H).","3-morpholino-5-nitropyridin-4-amine | MeOH | Pd/C | hydrogen | hydrogen | 5-morpholinopyridine-3,4-diamine"
US06291713B1,"1.94 ml of a 1.4-molar solution of n-butyllithium (2.71 mmol) in pentane were added dropwise at 0° C. under argon for 2 min to a stirred solution of 500 mg (2.71 mmol) 3-tert-butyl-2,2-dimethylhex-5-en-3-ol in 4 ml THF. The solution obtained was stirred for 15 minutes, and then a solution of 610 mg (2.71 mmol) ZnBr2 in 2 ml THF and subsequently 275 μl (2.71 mmol) benzaldehyde were added. The reaction mixture was stirred for 1 hour and heated to room temperature. Subsequently, 15 ml NH4Cl solution were added. The organic components were extracted three times with 15 ml Et2O each, the combined organic phases were washed with 10 ml brine, then dried and concentrated under reduced pressure. The raw product obtained was cleaned by means of a silica column with 15% diethyl ether/light gasoline. There was obtained the alcohol as a colorless oil.","n-butyllithium | pentane | argon | 3-tert-butyl-2,2-dimethylhex-5-en-3-ol | THF | ZnBr2 | THF | benzaldehyde | NH4Cl | Et2O | brine | raw product | diethyl ether | alcohol"
US08586616B2,"To 5,6-dichloro-1-methyl-2-isopropenyl-1H-benzimidazole (2.5 g) in acetone (30 mL) and water (6 mL) at room temperature was added trichloroisocyanuric acid (845 mg). The resulting mixture was stirred at room temperature for 18 h. The reaction mixture was quenched with water, extracted with EtOAc, and dried over Na2SO4. After removal of the desiccant by filtration, concentration yielded an orange crude oil. The crude product was purified by flash chromatography (10%-40% EtOAc/hexanes) to yield the title compound as a yellow solid.","5,6-dichloro-1-methyl-2-isopropenyl-1H-benzimidazole | acetone | water | trichloroisocyanuric acid | water | EtOAc | Na2SO4 | crude product | EtOAc/hexanes | title compound"
US08476043B2,"To a solution of ester 1076 (1 g, 2.3 mmol) in THF (100 mL) was added 1N NaOH solution (4.6 mL, 4.6 mmol) at room temperature. The reaction mixture was stirred overnight, at which time the reaction was quenched by addition of 1N HCl solution (5.5 mL). The resulting white precipitate was collected by filtration and recrystallized from methanol/water. Yield: 0.63 g (95% of theory). M.P.: 205° C. 1H NMR (300 MHz, DMSO-d6): δ 5.67 (d, J=8.2 Hz, 1H), 5.45 (s, 1H), 4.41 (s, 1H), 3.63-3.51 (m, 1H), 3.46-3.36 (m, 1H), 2.00-1.92 (m, 3H), 1.87-1.72 (m, 6H), 1.66-1.28 (m, 14H).",ester | THF | NaOH | HCl | methanol/water
US07652141B2,"To a solution of 4-oxo-6,7-dihydropyrido[2,1;a]isoquinoline-3-carboxylic acid (3-101-03) (76 mg) in DMF (2.0 mL) were added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloric acid salt (EDC, 83 mg), 1-hydroxybenzotriazole (HOBt, 58 mg), and phenethylamine (80 mg) at room temperature. After the reaction mixture was stirred for 18 h, the reaction was quenched with 0.5 mol/L hydrochloric acid. To the reaction mixture was added ethyl acetate and the organic layer was separated. The aqueous layer was extracted three times with ethyl acetate, and the combined organic layers were washed with water and brine, dried over anhydrous magnesium sulfate, and evaporated under reduced pressure. The obtained crude crystal was recrystallized to give 4-oxo-6,7-dihydropyrido[2,1,a]isoquinoline-3-carboxylic acid phenethylamide (3-101) (84 mg, 74%) as an yellow crystal.","4-oxo-6,7-dihydropyrido[2,1;a]isoquinoline-3-carboxylic acid | DMF | 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloric acid salt | hydrochloric acid | 1-hydroxybenzotriazole | phenethylamine | ethyl acetate | ethyl acetate | water | brine | magnesium sulfate | 4-oxo-6,7-dihydropyrido[2,1,a]isoquinoline-3-carboxylic acid phenethylamide"
US20100216788A1,"To a solution of N-(tert-butyl)-3-[2-chloro-4-({5-[2-(methylthio)ethyl]-5H-pyrrolo[3,2-d]pyrimidin-4-yl}amino)phenoxy]benzamide (255 mg) in methanol (2 mL) was added a solution of OXONE® monopersulfate compound (615 mg) in water (1 mL) under ice-cooling. Methanol (18 mL) and water (9 mL) were added thereto and the mixture was stirred at room temperature overnight. An aqueous sodium hydrogencarbonate solution was added to the reaction mixture and the mixture was extracted with ethyl acetate. The organic layer was washed successively with 5% aqueous sodium thiosulfate solution and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure and the obtained residue was subjected to silica gel column chromatography (eluent, ethyl acetate:hexane=60:40→100:0→methanol:ethyl acetate→10:90). The objective fractions were concentrated under reduced pressure. The residue was crystallized from ethyl acetate-diisopropyl ether to give the title compound (207 mg) as a white powder.","N-(tert-butyl)-3-[2-chloro-4-({5-[2-(methylthio)ethyl]-5H-pyrrolo[3,2-d]pyrimidin-4-yl}amino)phenoxy]benzamide | methanol | OXONE | monopersulfate | water | ice | Methanol | water | sodium hydrogencarbonate | ethyl acetate | sodium thiosulfate | brine | magnesium sulfate | ethyl acetate-diisopropyl ether | title compound"
US20090012075A1,"To a solution of 4-{1,1-difluoro-2-[2-(2-methoxybenzoyl)hydrazino]-2-oxoethyl}benzoic acid (65 mg, 0.18 mmol), tert-butyl (3-amino-1-phenyl-1H-pyrazol-4-yl)carbamate (74 mg, 0.27 mmol) and N,N-diisopropylethylamine (46 mg, 0.36 mmol) in methylene chloride (1.5 mL) was added (1H-1,2,3-benzotriazol-1-yloxy)(triisopropyl)phosphonium hexafluorophosphate (0.16 g, 0.36 mmol) and the reaction was sealed and heated to 60° C. for 16 hours. The reaction was purified by flash chromatography (0-4% methanol/methylene chloride) to give crude tert-butyl {3-[(4-{1,1-difluoro-2-[2-(2-methoxybenzoyl)hydrazino]-2-oxoethyl}benzoyl)amino]-phenyl-1H-pyrazol-4-yl}carbamate. ESIMS calcd 621.2 (M++H), found 621.2 (M++H).","4-{1,1-difluoro-2-[2-(2-methoxybenzoyl)hydrazino]-2-oxoethyl}benzoic acid | tert-butyl (3-amino-1-phenyl-1H-pyrazol-4-yl)carbamate | N,N-diisopropylethylamine | methylene chloride | (1H-1,2,3-benzotriazol-1-yloxy)(triisopropyl)phosphonium hexafluorophosphate | methanol/methylene chloride | tert-butyl {3-[(4-{1,1-difluoro-2-[2-(2-methoxybenzoyl)hydrazino]-2-oxoethyl}benzoyl)amino]-phenyl-1H-pyrazol-4-yl}carbamate"
US07612094B2,"Diphenylphosphoryl azide (0.070 mL, 0.324 mmol) was added to a solution of 4-[4-benzo[1,3]dioxol-5-yl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-2-yl]-bicyclo[2.2.2]octane-1-carboxylic acid (see Example 22; 0.140 g, 0.324 mmol) and diisopropylethylamine (0.068 mL, 0.39 mmol) in toluene (5 mL). The mixture was stirred for 2 hours. Benzyl alcohol (0.067 mL, 0.648 mmol) was added to the mixture. The mixture was stirred at room temperature for 18 hours. Solvent was removed. The mixture was partitioned between ethyl acetate and water. The organic solution was washed with brine, dried over sodium sulfate, filtered, and concentrated. HPLC purification eluting with acetonitrile:water gave 0.002 g (1%) of the title compound as a yellow solid. MS (ESP+) m/z 537.4 (M+1). 1H NMR (400 MHz, Methanol-d4) δ 7.71 (m, 1H), 7.33 (m, 5H), 7.22 (m, 2H), 6.97 (m, 3H), 6.05 (s, 2H), 5.02 (s, 2H), 2.63 (s, 3H), 2.17 (m, 6H), 2.06 (m, 6H).","Diphenylphosphoryl azide | 4-[4-benzo[1,3]dioxol-5-yl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-2-yl]-bicyclo[2.2.2]octane-1-carboxylic acid | diisopropylethylamine | toluene | Benzyl alcohol | ethyl acetate | water | brine | sodium sulfate | acetonitrile | water | title compound"
US20110082301A1,"To a 250 mL two necked flask equipped with a condenser containing e-caprolactone (3,3 mL, 30 mmol) and anhydrous tetrahydrofuran (60 mL) under nitrogen atmosphere, was added at 0° C. dropwise propylmagnesium chloride (33 mL, 66 mmol, 2,2 eq., 2.0 M solution in diethyl ether). After addition, the reaction was stirred for 10 minutes at room temperature before heating to reflux for 2 hours. The reaction was monitored by thin layer chromatography. The reaction was cooled to 0° C. and saturated aqueous ammonium chloride (18 mL) was added followed, at room temperature, by hydrochloric acid (18 mL, 1 M aqueous). The organic phase was decanted and the aqueous phase extracted with dichloromethane (3×140 mL). The combined organic phases were washed with saturated aqueous sodium bicarbonate (100 mL) before drying over magnesium sulfate. Evaporation of the solvent gave the title compound (6,543 g, 96%) as a viscous yellow oil. 1H NMR (CDCl3, 400 MHz) d?(ppm): 3,64 (t, J=6,7 Hz, 2H); 1,59 (tt, J=6,7 Hz, J=6,7 Hz, 2H); 1,46-1,24 (m, 15H); 0,88 (t, J=7,2 Hz, 6Hd). 13C NMR (CDCl3, 129,9 MHz) d?(ppm): 68,5; 64,2; 42,0(2C′); 39,8; 33,1; 26,8; 23,7; 17,1 (2C′); 14,5 (2C′). MS (IC+) m/z (%): 220,2 [M+18] (99); 202,2 (75); 203,3 [M+1] (30); 185,2 (100); 176,2 (60); 141,2 (25).",two | e-caprolactone | tetrahydrofuran | nitrogen | propylmagnesium chloride | ammonium chloride | hydrochloric acid | dichloromethane | sodium bicarbonate | magnesium sulfate | title compound
US08399489B2,"A solution of 5.6 ml (11.2 mmol) 2N AlMe3 in toluene was added to a dry ice-acetone bath of 1.14 g (5.2 mol) of methyl 4-acetyl-2-chloro-1,3-thiazole-5-carboxylate (Intermediate 212) in 20 ml dry CH2Cl2. The mixture was allowed to warm to room temperature slowly before being quenched with MeOH. After stirring at room temperature overnight, the mixture was diluted with 1N HCl and stirred 15 min before being diluted with water and extracted twice with EtOAc. The EtOAc was washed with brine, dried (MgSO4) and concentrated to give an oil that was purified by chromatography (50% hexanes in CH2Cl2 with gradient elution to 100% CH2Cl2) affording 720 mg of product as an oil. NMR (CDCl3): 1.5 (s, 6H), 3.8 (s, 3H), 5.7 (s, broad, 1H).","AlMe3 | toluene | dry ice-acetone | methyl 4-acetyl-2-chloro-1,3-thiazole-5-carboxylate | Intermediate 212 | CH2Cl2 | MeOH | HCl | water | EtOAc | EtOAc | brine | MgSO4 | hexanes | CH2Cl2 | CH2Cl2 | product"
US05968924,"To a solution of 33 mg (0.12 mmol) of 2-amino-2-methyl-N-[7-fluoro-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepin-3(R)-yl]propanamide (Step D) in 1 mL of methylene chloride was 32 mg (0.13 mmol) of N-(benzyloxycarbonyloxy)succinimide. The soution was stirred at room temperature for 24 hours then quenched with 5 drops of 33% aqueous ammonium hydroxide. The solvent was removed under vacuum and the residue was purified by flash column chromatography on silica gel eluting with ethyl acetate/hexanes (75:25) to afford 25 mg (46%) of the product as an off-white solid. 1H NMR (400 MHz, CDCl3): δ 1.48 (s, 3H), 1.50 (s, 3H), 1.82 (m, 1H), 2.56 (m, 1H), 2.71 (m, 1H), 2.86 (m, 1H), 4.42 (m, 1H), 5.05 (s, 2H), 5.43 (s, 1H), 6.90 (m, 2H), 7.09 (d, 8 Hz, 1H), 7.30 (m, 5H), 8.09 (s, 1H). FAB-MS: calculated for C22H24FN3O4 413; found 414 (M+H, 100%).","2-amino-2-methyl-N-[7-fluoro-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepin-3(R)-yl]propanamide | methylene chloride | N-(benzyloxycarbonyloxy)succinimide | ammonium hydroxide | silica gel | ethyl acetate/hexanes | product"
US04009170,"The reaction between 1-ethoxy-3-methyl-3,4-dihydroisoquinoline and hydrazine, which produced 1-hydrazino-3-methyl-3,4-dihydroisoquinoline, also produced a dimer, recrystallization of which from methanol-ethanol afforded 1,1'-azinobis(3-methyl-1,2,3,4-tetrahydroisoquinoline) (II: Y=CH3, Y' =Z=Z' =H) (2.2 g., m.p. 168°-171° C.).","1-ethoxy-3-methyl-3,4-dihydroisoquinoline | hydrazine | 1-hydrazino-3-methyl-3,4-dihydroisoquinoline"
US08129361B2,"A mixture of 1-iodo-2,5-dimethylbenzene (5.00 g), copper(I) iodide (82.1 mg), triphenylphosphine (283 mg), tris(dibenzylideneacetone)dipalladium(0) chloroform adduct (446 mg), propargyl alcohol (1.40 ml), diisopropylethylamine (15.0 ml) and tetrahydrofuran (100 ml) was stirred at room temperature for 5 hr. The reaction mixture was added to brine, and the mixture was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate=99:1-80:20) to give the object product (1.70 g) as a brown oil.","1-iodo-2,5-dimethylbenzene | copper(I) iodide | triphenylphosphine | tris(dibenzylideneacetone)dipalladium(0) chloroform adduct | propargyl alcohol | diisopropylethylamine | tetrahydrofuran | brine | ethyl acetate | brine | magnesium sulfate | silica gel | hexane | ethyl acetate | product"
US20150157739A1,"In analogy to the experimental procedure of example 85) (Z)-2-amino-5-(3-chloro-4-hydroxy-5-methoxybenzylidene)thiazol-4(5H)-one was converted using 4-(2-bromoacetyl)benzonitrile instead of 3-bromo-5-(2-bromoacetyl)benzonitrile into the title compound (81 mg, 56%) which was obtained as a yellow solid. MS m/e: 410.2 [M+H]+",(Z)-2-amino-5-(3-chloro-4-hydroxy-5-methoxybenzylidene)thiazol-4(5H)-one | 4-(2-bromoacetyl)benzonitrile | title compound
US07723376B2,"130 mg of the compound (c) (0.360 mM) prepared by the above Step 2 was added to the catalyst solution containing 20 mg of ruthenium (0.024 mM) dissolved in CH2Cl2. Then the mixture was stirred for 24 hrs at room temperature, filtered and concentrated in vacuo. The resultant was purified by Silica gel column chromatography with methanol/chloroform (1:10) solvent mixture as an eluant to give 108 mg of the title compound (d) (yield: 90%).",ruthenium | CH2Cl2 | Silica gel | methanol/chloroform
US20160102071A1,Ethyl 3-(6-((3-(4-(2-methoxyethoxy)-2-methylphenyl)benzo[b]thiophen-5-yl)methoxy)pyridin-3-yl)hex-4-ynoate was prepared from 5-(bromomethyl)-3-(4-(2-methoxyethoxy)-2-methylphenyl)benzo[b]thiophene and ethyl 3-(6-hydroxypyridin-3-yl)hex-4-ynoate (from Example 45E) following the procedure described in Example 45G at a reaction temperature of 60° C. overnight. LC/MS: mass calcd. for C32H33NO5S: 543.67. found: 544.4 [M+H]+.,Ethyl 3-(6-((3-(4-(2-methoxyethoxy)-2-methylphenyl)benzo[b]thiophen-5-yl)methoxy)pyridin-3-yl)hex-4-ynoate | 5-(bromomethyl)-3-(4-(2-methoxyethoxy)-2-methylphenyl)benzo[b]thiophene | ethyl 3-(6-hydroxypyridin-3-yl)hex-4-ynoate
US20160137649A1,"A 10-mL round-bottom flask, equipped with a magnetic stir bar, was charged with 4-(3-fluoro-4-((hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)methyl)phenyl)morpholine (Example 1, Step 2, 27.6 mg, 0.0904 mmol) and dichloromethane (1.5 mL) under nitrogen. The resulting suspension was cooled to 0° C., and N,N-diisopropylethylamine (32 μL, 2.0 equiv) was added via syringe, followed by bis(2,5-dioxopyrrolidin-1-yl)carbonate (35 mg, 0.14 mmol, 85% pure). The ice bath was removed, and the suspension was stirred at room temperature overnight. The solvent was removed by rotary evaporation, and the resulting oil was applied to a chromatography column containing 12 g silica and dichloromethane. A gradient solvent was used from 100% dichloromethane to 10% methanol in dichloromethane to provide 32 mg (79%) of 2,5-dioxopyrrolidin-1-yl 5-(2-fluoro-4-morpholinobenzyl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate as a powdery white solid. 1H NMR (400 MHz, Chloroform-d) δ 7.16 (t, J=8.6 Hz, 1H), 6.59 (d, J=8.4 Hz, 1H), 6.49 (d, J=13.0 Hz, 1H), 3.85-3.65 (m, 6H), 3.72-3.62 (m, 1H), 3.52 (s, 2H), 3.38-3.25 (m, 2H), 3.15-3.05 (m, 4H), 2.90-2.72 (m, 6H), 2.58-2.42 (m, 4H). LCMS (ESI, m/z): 447.1 [M+H]+.","4-(3-fluoro-4-((hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)methyl)phenyl)morpholine | dichloromethane | nitrogen | N,N-diisopropylethylamine | bis(2,5-dioxopyrrolidin-1-yl)carbonate | ice | silica | dichloromethane | 2,5-dioxopyrrolidin-1-yl 5-(2-fluoro-4-morpholinobenzyl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate"
US07368578B2,"A mixture of (2E)-3-{3-[(4-{[2-(2-furyl)-5-methyl-4-oxazolyl]methoxy}-3-methoxybenzyl)oxy]-1-phenyl-1H-pyrazol-4-yl}-2-propenoic acid (0.30 g), 1-hydroxybenzotriazole ammonia complex (0.17 g), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.22 g) and N,N-dimethylformamide (15 mL) was stirred at room temperature for 15 hrs. Water was poured into the reaction mixture, and the precipitated crystals were collected by filtration to give (2E)-3-{3-[(4-{[2-(2-furyl)-5-methyl-4-oxazolyl]methoxy}-3-methoxybenzyl)oxy]-1-phenyl-1H-pyrazol-4-yl}-2-propenamide as colorless crystals (0.25 g, yield 83%). Recrystallization from tetrahydrofuran-hexane gave colorless prism crystals. melting point: 187-188° C.","(2E)-3-{3-[(4-{[2-(2-furyl)-5-methyl-4-oxazolyl]methoxy}-3-methoxybenzyl)oxy]-1-phenyl-1H-pyrazol-4-yl}-2-propenoic acid | 1-hydroxybenzotriazole ammonia | 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride | N,N-dimethylformamide | Water | (2E)-3-{3-[(4-{[2-(2-furyl)-5-methyl-4-oxazolyl]methoxy}-3-methoxybenzyl)oxy]-1-phenyl-1H-pyrazol-4-yl}-2-propenamide"
US07538121B2,"Using the procedure outlined in Example 38, the title compound was prepared from 7-amino-1-trifluoroacetyl-1,2,3,4-tetrahydroquinoline (D5) (48 mg, 0.20 mmol) and 2-methyl-6-(2,3-difluorophenyl)-nicotinic acid (D26) (54 mg, 0.22 mmol) as an off-white solid. MS(ES): MH+ 380, M-H+ 378.","title compound | 7-amino-1-trifluoroacetyl-1,2,3,4-tetrahydroquinoline | 2-methyl-6-(2,3-difluorophenyl)-nicotinic acid"
US04444775,"A suspension of 26 g of 5-(5-ethoxycarbonylpentyl)imidazo[1,5-a]pyridine in 100 ml of 1 N aqueous sodium hydroxide solution is heated on a steam bath for two hours; 10 ml of ethanol is added and heating is continued for 45 minutes. The reaction mixture is cooled, washed with 300 ml of ether and the solution is adjusted to pH 5.5 with concentrated hydrochloric acid. The crystallized product is collected by filtration and washed with 50 ml of water to yield 5-(5-carboxypentyl)-imidazo[1,5-a]pyridine melting at 144°-7°.","5-(5-ethoxycarbonylpentyl)imidazo[1,5-a]pyridine | sodium hydroxide | ethanol | ether | water | 5-(5-carboxypentyl)-imidazo[1,5-a]pyridine"
US08519149B2,"The title compound was prepared by following the procedure as described for Example-137 using methyl 2-[(2-chloro-6-methylphenyl)amino]-7,7-dimethyl-7,8-dihydro-1H-furo[3,2-e]benzimidazole-5-carboxylate (Step-1 of Intermediate-35, 0.150 g, 0.301 mmol), 6-(trifluoromethyl)pyridine-3-amine (0.067 g, 0.451 mmol), trimethyl aluminium (2M solution in toluene) (1 mL) and dry toluene (5.0 mL) to afford 0.075 g of the desired product. 1HNMR (DMSO-d6): δ 1.56 (s, 6H), 2.23 (s, 3H), 3.09 (s, 2H), 7.23-7.31 (m, 2H), 7.40 (d, J=7.8 Hz, 1H), 7.47 (s, 1H), 7.87 (d, J=8.7 Hz, 1H), 8.45 (d, J=8.4 Hz, 1H), 8.98 (s, 1H), 9.10 (bs, 1H), 10.08 (s, 1H), 10.90 (bs, 1H); MS [M]+: 516.16.","title compound | methyl 2-[(2-chloro-6-methylphenyl)amino]-7,7-dimethyl-7,8-dihydro-1H-furo[3,2-e]benzimidazole-5-carboxylate | 6-(trifluoromethyl)pyridine-3-amine | trimethyl aluminium | toluene | desired product"
US09376445B2,"Benzophenone imine (200.04 g, 1103.8 mmol) was added dropwise over 20 minutes to a stirred solution of 3-amino-1-methylpyrrolidine-2-one (120 g, 1051.2 mmol) in DCE (1000 mL) at ambient temp under nitrogen in a 2 L flask fitted with a magnetic stirrer bar. The reagent was washed with further DCE (100 mL). The stirred solution was heated at reflux on a heat-on block at a block temp of 95° C. for 7 h, using a N2 bubbler with exhaled gas passing through a safety trap then into 2 L of water via an upturned funnel (for scrubbing NH3 gas, estimated to be approx 23 L). The reaction was left to stand at ambient temp overnight under N2. The mixture was evaporated to a thick, off-white oil. To this was added Et2O (700 ml) and to this stirred solution, as it began to crystallize, was added iso-hexane (700 ml) over 2 minutes. The mixture was stirred for 1 h then filtered under suction and washed with Et2O/iso-hexane (1:1) (500 ml). The white solid was dried at 35° C. under vacuum for 3 h to afford 3-(benzhydrylidene-amino)-1-methyl-pyrrolidin-2-one (D1) (259.4 g, 88.6%). The NMR was consistent with pure material.",Benzophenone imine | 3-amino-1-methylpyrrolidine-2-one | DCE | nitrogen | DCE | N2 | Et2O | iso-hexane | Et2O/iso-hexane | 3-(benzhydrylidene-amino)-1-methyl-pyrrolidin-2-one
US09156829B2,"To a solution of 3-(pyrimidin-2-yl)pyridine-2-carboxylic acid (CAS number 1228431-21-7; 155 mg, 0.77 mmol), DIPEA (0.27 ml, 1.54 mmol) and (1S,2S)-1-N-[3-methyl-5-(trifluoromethyl)pyridin-2-yl]cyclopentane-1,2-diamine hydrochloride (Intermediate 35; 200 mg, 0.68 mmol) in DCM (3 ml) and acetonitrile (5 ml) was added HATU (293 mg, 0.77 mmol). The reaction was stirred at room temperature for 16 hours and then concentrated in vacuo. The residue was purified by reverse phase column chromatography (C18 silica, 0-100% water (0.1% formic acid)/acetonitrile) and then by reverse phase column chromatography (C18 silica, 5-95% water (0.05% ammonia)/acetonitrile) to afford the title compound.","3-(pyrimidin-2-yl)pyridine-2-carboxylic acid | DIPEA | (1S,2S)-1-N-[3-methyl-5-(trifluoromethyl)pyridin-2-yl]cyclopentane-1,2-diamine hydrochloride | Intermediate 35 | DCM | acetonitrile | HATU | silica | water | formic acid | acetonitrile | silica | water | acetonitrile | title compound"
US07635684B2,"To a suspension of 3,3-dimethylacrylic acid (1.3 g) and potassium carbonate (2.07 g) in N,N-dimethylformamide (15 mL) was added benzyl bromide (1.19 mL), and the mixture was stirred at room temperature for 4 hours. The reaction mixture was poured into water, and the resulting mixture was extracted with diethyl ether. The extract was washed with water and brine, and dried over anhydrous sodium sulfate. The solvent was removed under reduced pressure, and the residue was dissolved in 2-propanol (20 mL). An ammonia gas was bubbled into the solution at −15° C. until saturation, and the mixture was stirred at 80° C. overnight. The reaction mixture was concentrated under reduced pressure, and the residue was purified by column chromatography on silica gel (eluent: dichloromethane/methanol=15/1-7/1) to give the title compound (0.31 g).","3,3-dimethylacrylic acid | potassium carbonate | N,N-dimethylformamide | benzyl bromide | water | diethyl ether | water | brine | sodium sulfate | 2-propanol | ammonia | silica gel | dichloromethane/methanol | title compound"
US20160115172A1,"N-bromosuccinimide (3.63 g) was added to a solution of the (S)-tert-butyl(1-(4-amino-5-(quinolin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)but-3-en-2-yl)carbamate (7.98 g) obtained in Step 3 in DMF (64 ml) at −15° C., and the mixture was stirred at −15° C. for one hour. A 10% aqueous sodium thiosulfate solution and ethyl acetate were added to the reaction mixture, and then the mixture was stirred at room temperature for 10 minutes. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate twice. The obtained organic layer was washed with a saturated sodium chloride solution twice, and dried over anhydrous magnesium sulfate, followed by distillation of the solvent under reduced pressure. The obtained residue was purified by silica gel column chromatography (developing solvent: ethyl acetate/methanol), thereby giving 6.30 g of the title compound as a pale brown solid.","N-bromosuccinimide | (S)-tert-butyl(1-(4-amino-5-(quinolin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)but-3-en-2-yl)carbamate | DMF | sodium thiosulfate | ethyl acetate | ethyl acetate | sodium chloride | magnesium sulfate | silica gel | ethyl acetate/methanol | title compound"
US20140350007A1,"In the compound prepared in Step 1 (5.52 kg, 28.0 mmol), acetonitrile (36 L) was added, and ethyl iodide (6.1 kg, 39.2 mol) and potassium carbonate (5.8 kg, 42.0 mol) were added thereto, followed by refluxing and stirring at 95° C. for 18 hours. After completing the reaction, the reactant was cooled to room temperature. Purified water (36 L) was added thereto, and acetonitrile was distilled off under a reduced pressure. The solid thus produced was filtered, washed with purified water and dried at 60° C. to obtain the title compound (6.1 kg, yield: 96.9%, yellow solid).",compound | acetonitrile | ethyl iodide | potassium carbonate | water | acetonitrile | water | title compound
US20070054344A1,"To the above reaction mixture, a mixture which has been prepared in advance by mixing 200 mM acetate buffer (pH 6.0) (750 μL), 4000-u/mL glucose oxidase (Toyobo Co., Ltd.) (450 μL), 0.15% 4-aminoantipyrine (300 μL), 0.3% TOOS (Dojindo Laboratories) (300 μL), 500-u/mL peroxidase (Toyobo Co., Ltd.: Type III) (300 μL), and 1% sodium azide (300 μL) is added, followed by heating for 10 minutes at 37° C.. Thereafter, absorbance is measured at 550 nm. A control system is prepared by repeating the above procedure, except that purified water is added instead of the substrate. The amount of glucosone is obtained from the amount of the dye produced. Specifically, a calibration curve is prepared by repeating the above-described procedure, except that serially diluted glucose is employed as a substrate, and purified water is employed instead of the enzyme solution of the present invention. Thus, the amount (in micromoles) of glucosone produced in one minute is calculated, and the obtained value is used as the activity unit of the enzyme solution.",acetate | glucose | 4-aminoantipyrine | TOOS | 500-u/mL | III | sodium azide | water | glucosone
US20110098324A1,"A mixture of methyl 5-({[2-(ethyloxy)-2-oxoethyl]amino}carbonyl)-2,4-dihydroxy-6-oxo-1-phenyl-1,6-dihydro-3-pyridinecarboxylate (300 mg, 0.769 mmol) and isobutylamine (84 uL, 0.845 mmol) in chloroform (5 ml) was sealed in a pressure flask and heated in a microwave reactor at 150° C. for 30 minutes. The mixture was cooled and evaporated, then stirred in ethanol (3 ml) and 6 molar sodium hydroxide solution (3 ml) until hydrolysis was complete. The mixture was acidified with 1 molar hydrochloric acid, extracted with ethyl acetate, the organic solution washed with 1 molar hydrochloric acid, dried and evaporated to a solid that recrystallized from acetic acid to give N-[(4,6-dihydroxy-5-{[(2-methylpropyl)amino]carbonyl}-2-oxo-1-phenyl-1,2-dihydro-3-pyridinyl)carbonyl]glycine (120 mg, 0.297 mmol, 38.7% yield) 1H NMR (400 MHz, DMSO-d6) δ ppm 12.96 (s, 1H), 9.79 (s, 1H), 9.64 (s, 1H), 7.37-7.60 (m, 3H), 7.10-7.36 (m, 2H), 4.09 (d, J=5.56 Hz, 2H), 3.21 (dd, J=6.44 Hz, 2H), 1.73-1.96 (m, 1H), 0.90 (d, J=6.82 Hz, 6H).","methyl 5-({[2-(ethyloxy)-2-oxoethyl]amino}carbonyl)-2,4-dihydroxy-6-oxo-1-phenyl-1,6-dihydro-3-pyridinecarboxylate | isobutylamine | chloroform | ethanol | sodium hydroxide | hydrochloric acid | ethyl acetate | hydrochloric acid | acetic acid | N-[(4,6-dihydroxy-5-{[(2-methylpropyl)amino]carbonyl}-2-oxo-1-phenyl-1,2-dihydro-3-pyridinyl)carbonyl]glycine"
US20100121048A1,"To solution of tert-butyl [2-(4-{[(2R)-2,4-dibenzylpiperazin-1-yl]carbonyl}-5-phenyl-1H-imidazol-1-yl)ethyl](tetrahydro-2H-pyran-4-yl)carbamate (5.43 g) in dichloromethane (2.5 ml) was added TFA (25 ml), and the mixture was stirred at room temperature for 40 min. The reaction mixture was poured into saturated aqueous sodium bicarbonate solution by small portions, and the mixture was basified by adding potassium carbonate by small portions, and the mixture was extracted with ethyl acetate. The extract was washed with brine, and dried over anhydrous magnesium sulfate. The solvent was evaporated in vacuo to give the desired product (4.36 g) as an amorphous solid.","tert-butyl [2-(4-{[(2R)-2,4-dibenzylpiperazin-1-yl]carbonyl}-5-phenyl-1H-imidazol-1-yl)ethyl](tetrahydro-2H-pyran-4-yl)carbamate | dichloromethane | TFA | sodium bicarbonate | potassium carbonate | ethyl acetate | brine | magnesium sulfate | desired product"
US20160176864A1,"A 24/40-3 neck 500 mL round bottom flask was charged with 2,5-dibromo-3-nitropyridine (12.1 g, 42.9 mmol) and (4-chlorophenyl)boronic acid (7.48 g, 47.8 mmol). The mixture was suspended with THF (150 mL) and potassium phosphate tribasic, (2M, 42.9 mL, 86.0 mmol). PdCl2(dppf) (0.314 g, 0.429 mmol) was added, and the flask was sealed and degassed using sonication and ultra pure argon for 5 min. The mixture was heated to 65° C. After 2 h, the contents of the flask was transferred into a 1 L-round bottom flask and concentrated under reduced pressure. The resulting black slurry was diluted with ethyl acetate and water and filtered through a pad of Celite. The contents of the flask were transferred to a separatory funnel, and the organic was washed with brine (3×). The organics were dried with magnesium sulfate, concentrated under reduced pressure, and purified by silica gel column chromatography (120 g ISCO RediSep Rf, loaded in/with: DCM and dried, fraction size: 18 mL 16×150 mm, and eluted with dichloromethane in hexanes 0% [300 mL], 0-20% [450 mL], 20% [1503 mL], 20-50% [756 mL], 50% [450 mL]). The fractions were collected to 10.8 g (80%). 1H NMR consistent with desired. 1H NMR (400 MHz, CDCl3) δ 8.92 (d, J=2.0 Hz, 1H), 8.31 (d, J=2.0 Hz, 1H), 7.53-7.43 (m, 4H). Mass found 314 [M+H]+.","2,5-dibromo-3-nitropyridine | (4-chlorophenyl)boronic acid | THF | potassium phosphate tribasic | PdCl2(dppf) | argon | ethyl acetate | water | brine | magnesium sulfate | silica gel | DCM | 16 | dichloromethane | hexanes"
US20100286152A1,"To a solution of 1.7 g of (±)-1,1-dimethylethyl 4-[cyano(5-pyrimidinyl)methyl]-1-piperazinecarboxylate (intermediate 109, 5.6 mmole) in 15 mL of MeOH were added 477 μL of DMSO (6.7 mmol, Aldrich), 6.1 mL of NaOH 2M in water (12.3 mmol) and 2.1 mL of H2O2 11% (6 mmol). The mixture was stirred at RT overnight. The mixture was then neutralized with a saturated solution of NH4Cl. The aqueous phase was then extracted 2 times with 20 mL of DCM. The aqueous phase was separated on a phase separator cartridge. The aqueous phase was then passed through HLB (Waters Oasis® HLB 35 cc (6 g) LP Extraction Cartridges) washed with 50 mL of water followed by 60 mL of MeOH. MeOH was removed under reduced pressure. The resulting crude was then purified by flash chromatography on a 20 g silica gel using a gradient of AcOEt/CH 1:1 to 10:0 as an eluent to give the title compound as a white solid (380 mg, 21%). 1H-NMR (400 MHz, DMSO-d6): δ 1.37 (9H, s), 2.32 (4H, m), 3.32 (4H, m), 4.09 (1H, s), 7.39 (1H, s), 7.75 (1H, s), 8.75 (2H, s), 9.13 (1H, s); UPLC-MS [Acquity™ UPLC BEH C18, 50×21 mm, 1.7 μm, gradient: A: H2O+0.1% HCOOH/B: MeCN+0.075% HCOOH: 1% to 6% B in 0.2 min., 6% to 60% B in 1.05 min, 60% to 100% B in 0.5 min., 100% B for 0.2 min, flow rate: 1 mL/min]: Rt=0.51 min. m/z (ES): 322 [M+H]+, 266 [M−CN]+.","(±)-1,1-dimethylethyl 4-[cyano(5-pyrimidinyl)methyl]-1-piperazinecarboxylate | intermediate 109 | MeOH | DMSO | NaOH | water | H2O2 | NH4Cl | DCM | water | MeOH | silica gel | AcOEt | title compound"
US09096565B2,"To a solution of diphenylmethanamine (3.00 g, 16.4 mmol) in methanol (80 mL) was added 4-methoxybenzaldehyde (2.45 g, 18.0 mmol) and sodium carbonate (2.60 g, 24.6 mmol). The reaction mixture was stirred at room temperature for 16 h prior to removal of all solvents under vacuum. The residue was then diluted with ethyl acetate, washed with brine, dried over anhydrous Na2SO4, filtered, and concentrated to afford compound 39 as a white solid (3.62 g, 73%). LRMS (ESI): (calc.) 301.4 (found) 302.4 (MH)+.",diphenylmethanamine | methanol | 4-methoxybenzaldehyde | sodium carbonate | ethyl acetate | brine | Na2SO4 | compound 39
US20150025098A1,"To a solution of ethyl pyruvate (20.22 g, 174.1 mmol) in ethanol (150 mL) was added t-butyl hydrazine hydrochloride (21.7 g, 174 mmol) and N,N-diisopropylethyl amine (33.4 mL, 192 mmol). After stirring at reflux for 18 hours, the reaction was cooled and the volatiles were removed under reduced pressure. The resultant golden oil was taken up in 300 mL ethyl acetate and washed with 200 mL water and 300 mL saturated aqueous sodium bicarbonate. The organic layer was dried over sodium sulfate, filtered and concentrated to yield (E)-ethyl 2-(2-tert-butylhydrazono)propanoate (23.1 g) as a clear pale yellow oil. +APCI (M+H) 187.3; 1H NMR (400 MHz, CDC3, δ): 5.51 (br. s., 1H), 4.25 (q, J=7.2 Hz, 2H), 1.89 (s, 3H), 1.32 (t, J=7.1 Hz, 3H), 1.28 (s, 9H).","ethyl pyruvate | ethanol | t-butyl hydrazine hydrochloride | N,N-diisopropylethyl amine | water | sodium bicarbonate | sodium sulfate | (E)-ethyl 2-(2-tert-butylhydrazono)propanoate"
US05665746,"A solution of 124 mg of (R)-15-hydroxy-13-methoxy-12-methyl-11-oxo-6-thioxo-3,4,5,6,7,8,9,11-octahydro-1H-10,2,5-benzoxathiaazacyclo-tridecine-4-carboxylic acid methyl ester in a mixture of 1.5 ml of methanol and 1.5 ml of allylamine was heated to 50° C. for 2.5 h. The solution was evaporated in vacuo. The residue was chromatographed on silica gel using ethyl acetate/hexane (2:1, v/v) as eluent, and the purified product was crystallized from ethyl acetate/hexane to afford 97 mg of (R)-15-hydroxy-13-methoxy-12-methyl-11-oxo-6-thioxo-3,4,5,6,7,8,9,11-octahydro-1H-10,2,5-benzoxathiaazacyclotridecine-4-carboxylic acid allylamide as a white solid.","(R)-15-hydroxy-13-methoxy-12-methyl-11-oxo-6-thioxo-3,4,5,6,7,8,9,11-octahydro-1H-10,2,5-benzoxathiaazacyclo-tridecine-4-carboxylic acid methyl ester | methanol | allylamine | silica gel | ethyl acetate/hexane | (R)-15-hydroxy-13-methoxy-12-methyl-11-oxo-6-thioxo-3,4,5,6,7,8,9,11-octahydro-1H-10,2,5-benzoxathiaazacyclotridecine-4-carboxylic acid allylamide"
US09242963B2,"3-Methyl-2-pyridin-3-yl-1H-indole hydrochloride (Example 1) and 3-bromomethyl-benzonitrile are processed according to the method described in Example 25 to give 3-(3-methyl-2-pyridin-3-yl-1H-indol-1-ylmethyl)-benzonitrile. 1H NMR (400 MHz, MeOD) δ ppm 2.33 (s, 3H), 5.41 (s, 2H), 7.08 (d, J=8.1 Hz, 1H), 7.16 (s, 1H), 7.20 (t, J=7.2 Hz, 1H), 7.27 (ddd, J=7.6, 1.0 Hz, 1H), 7.37 (d, J=5.8 Hz, 1H), 7.38-7.42 (m, 1H), 7.54-7.57 (m, 1H), 7.57 (s, 1H), 7.68 (d, J=7.8 Hz, 1H), 7.85 (dt, J=7.8, 1.9 Hz, 1H), 8.50 (d, J=2.0 Hz, 1H), 8.60 (dd, J=4.8, 1.5 Hz, 1H). HRMS (ESI) m/z 324.1491 [(M+H)+ Calcd for C22H18N3: 324.1501].",3-Methyl-2-pyridin-3-yl-1H-indole hydrochloride | 3-bromomethyl-benzonitrile | 3-(3-methyl-2-pyridin-3-yl-1H-indol-1-ylmethyl)-benzonitrile
US04072696,"2.1 G. 1,2-diamino-4-phenylsulfinylbenzene in 150 ml. acetone is treated with 6 g. methoxy carbonyl isothiocyanate overnight at 20°-25° C. The reaction mixture is stripped and the residue triturated with ether. Recrystallization from methanol yields pure 1,2-bis-(3-methoxycarbonyl-2-thioureido)- 4-phenylsulfinylbenzene.","1,2-diamino-4-phenylsulfinylbenzene | acetone | methoxy carbonyl isothiocyanate | ether | methanol | 1,2-bis-(3-methoxycarbonyl-2-thioureido)- 4-phenylsulfinylbenzene"
US20140148430A1,"A solution of 2-nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine (360 mg, 2.14 mmol) and triethylamine (650 mg, 6.42 mmol) in methylene chloride (16 mL) was treated dropwise with acetyl chloride (202 mg, 2.57 mmol) and the reaction was stirred at room temperature for 20 h. After this time, the reaction was concentrated under reduced pressure and the resulting residue partitioned between ethyl acetate (20 mL) and water (20 mL). The layers were separated and the aqueous phase extracted with ethyl acetate (20 mL). The combined organic layers were washed with brine (10 mL) and dried over sodium sulfate. The drying agent was removed by filtration and the filtrate concentrated under reduced pressure. The resulting residue was purified by chromatography (silica, gradient, methylene chloride to 49:1 methylene chloride/methanol) to afford 1-(2-nitro-6,7-dihydropyrazolo[1,5-a]pyrazin-5(4H)-yl)ethanone as a white solid: 1H NMR (400 MHz, DMSO-d6.) 6.95-6.92 (m, 1H), 4.81-4.72 (m, 2H), 4.32-1.17 (m, 2H), 4.00-3.96 (m, 2H), 2.14-2.10 (m, 3H).","2-nitro-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine | triethylamine | methylene chloride | acetyl chloride | ethyl acetate | water | ethyl acetate | brine | sodium sulfate | silica | methylene chloride | methylene chloride/methanol | 1-(2-nitro-6,7-dihydropyrazolo[1,5-a]pyrazin-5(4H)-yl)ethanone"
US20080103123A1,"The title compound was prepared from piperidin-4-ol and [4-(5-{[1-(tert-butoxycarbonyl)-piperidin-4-yl]methoxy}pyridin-2-yl)phenyl]acetic acid (Example B104; 0.070 mmol) using similar conditions as described for Example B89. Yield 2.1 mg (6%); Analytical HPLC: purity 99% (System A, RT=1.92 min); LRESIMS for C29H39N3O5 m/z 510 (M+H)+; HRESIMS, calc. monoiso mass (Da): 509.2890, found monoiso mass (Da): 509.2892.",title compound | piperidin-4-ol | [4-(5-{[1-(tert-butoxycarbonyl)-piperidin-4-yl]methoxy}pyridin-2-yl)phenyl]acetic acid
US09409858B2,"N-butylaniline (6a) Was synthesized in an analogous manner previously reported (Org Lett, 4, 581).11 Briefly, CuI (19 mg, 0.1 mmol) and freshly ground K3PO4 (849 mg, 4 mmol) were placed in a sealed tube followed by sequential addition of isopropanol (2 mL), ethylene glycol (0.222 mL, 4.0 mL), phenyl-iodide (0.224 mL, 2.0 mmol) and n-butylamine (0.237 mL, 2.4 mmol). The tube was then sealed and stirring commenced at 80° C. for 18 h. After cooling to room temperature the reaction was diluted with water:ethyl ether (1:1, 10 mL). The aqueous layer was extracted with ether (3×5 mL), washed with brine (15 mL), dried over sodium sulfate and concentrated in vacuo. Purification via flash chromatography afforded the title compound as a yellow oil (235 mg, 79%). 1H NMR (400 MHz, CDCl3) δ 7.19 (m, 2H), 6.70 (t, J=7.2 Hz, 1H), 6.61 (d, J=8.4 Hz, 2H), 3.60 (br, 1H), 3.12 (t, J=7.2 Hz, 2H), 1.62 (m, 2H), 1.44 (m, 2H), 0.98 (t, J=7.2 Hz, 3H). Spectra matches that reported in Okano et al., “Synthesis of secondary arylamines through copper-mediated intermolecular aryl amination,” Org Lett 2003, 5(26):4987-4990.",N-butylaniline | CuI | K3PO4 | isopropanol | ethylene glycol | phenyl-iodide | n-butylamine | water:ethyl ether | ether | brine | sodium sulfate | title compound
US04209532,"A one-neck round bottom flask was charged with 52.50 g (0.17 mol) of ethyl 6-(2', 4'-dimethylphenyl)-6-cyano-3,3-dimethylhexanoate, 250 ml of concentrated hydrochloric acid, 250 ml of glacial acetic acid, and 100 ml of water. The reaction mixture was stirred and refluxed for 48 hours. After 12 hours and 24 hrs. of refluxing, an additional 100 ml of conc. HCl and 100 ml glacial HOAC were added. After 48 hours, the mixture was stripped to dryness under reduced pressure. To the residue were added 150 ml of water and 150 ml of ethyl ether, and the mixture shaken vigorously. A white, crystalline precipitate formed, and this was removed by suction filtration to give 13.20g (32%) of 2-(2',4'-Dimethylphenyl)-5,5-dimethyl-1, 3-cyclohexanedione as white, crystalline solid, m.p. 167°-168.5° C.","ethyl 6-(2', 4'-dimethylphenyl)-6-cyano-3,3-dimethylhexanoate | hydrochloric acid | acetic acid | water | HCl | water | ethyl ether | 2-(2',4'-Dimethylphenyl)-5,5-dimethyl-1, 3-cyclohexanedione"
US06350762B1,"93 mg (0.30 mmol) of 4-(3-chlorophenyl)-2,6-dimethyl-5-nitro-1,4-dihydropyridine-3-carboxylic acid, 100 mg (0.75 mmol) of cinnamylamine, 138 mg (0.54 mmol) of 2-chloro-1-methylpyridinium iodide and 0.15 ml (1.08 mmol) of triethylamine were stirred in 5 ml of DMF at room temperature for 2 days. DMF was evaporated under reduced pressure. Ethyl acetate was added to the reaction mixture. After washing with 1 N hydrochloric acid, the organic layer was dried over anhydrous sodium sulfate. After the concentration under reduced pressure, the residue was purified by the silica gel chromatography (hexane/ethyl cetate=4/1) to obtain the title compound.","4-(3-chlorophenyl)-2,6-dimethyl-5-nitro-1,4-dihydropyridine-3-carboxylic acid | cinnamylamine | 2-chloro-1-methylpyridinium iodide | triethylamine | DMF | DMF | Ethyl acetate | hydrochloric acid | sodium sulfate | silica gel | hexane/ethyl | title compound"
US08481739B2,"To a solution of quinoline-6-carboxylic acid (183 g, 1.06 mol) in methanol (1 lit.), thionyl chloride (150.7 g, 1.2 mol) was added dropwise at 0° C. and then stirred at 65° C. for 12 h. The reaction mixture was concentrated and to the residue dichloromethane and aqueous sodium carbonate solutions were added. The organic layer was dried with sodium sulphate and concentrated to afford the title compound as a brown solid (150 g, 75%).",quinoline-6-carboxylic acid | methanol | thionyl chloride | dichloromethane | sodium carbonate | sodium sulphate | title compound
US06066638,"A mixture of 2-amino-3,5-diiodobenzoic acid (1.09 g, 2.57 mmol), tetrahydrofurfuryl isothiocyanate (0.35 g, 2.43 mmol) and triethylamine (0.26 g, 2.57 mmol) in 3.5 mL of ethanol was heated to reflux for about 6 h, and then was allowed to cool to room temperature. The ensuing precipitate was filtered and washed with ethanol (1×20 mL), hexanes (1×mL), and then dried to deliver 0.86 g of the title compound of Step A. 1H NMR (400 MHz, Me2SO-d6): δ 1.64-1.75 (m,1H), 1.75-1.85 (m,1H), 1.86-2.0 (m,2H), 3.57-3.65 (m,1H), 3.70-3.81 (m,1H), 4.26-4.34 (m,1H), 4.36-4.44 (m,1H), 4.52-4.60 (m,1H), 8.19 (d,1H), 8.56 (d,1H), 10.1 (br s,1H).","2-amino-3,5-diiodobenzoic acid | tetrahydrofurfuryl isothiocyanate | triethylamine | ethanol | ethanol | hexanes"
US06365588B1,"Isonipecotic acid (10 grams) (77.5 mmoles) and acetic anhydride (23.7 grams) (232.5 mmoles) were dissolved in MeOH (100 ml.) and the mixture was stirred at 25° C. for 24 hours. The mixture was evaporated to dryness and the residue was azeotroped with toluene to give the title compound (Yield: 12.8 grams, 97%, MH+ 172).",Isonipecotic acid | acetic anhydride | MeOH | toluene | title compound
US08785468B2,"(R)-2-acetoxy-3-phenylpropanoic acid 11.1.C (1170 mg, 5619 μmol) was azeotroped and dissolved in DCM under nitrogen. Pyridine (454 μl, 5619 μmol) was added followed by cyanuric fluoride (1423 μl, 16858 μmol) at −20° C. After 1 h, reaction was worked up with ice and DCM to afford 1.04 g (88%) crude (R)-1-fluoro-1-oxo-3-phenylpropan-2-yl acetate 11.1.D. The crude was directly used for next step.",(R)-2-acetoxy-3-phenylpropanoic acid | DCM | nitrogen | Pyridine | cyanuric fluoride | DCM | (R)-1-fluoro-1-oxo-3-phenylpropan-2-yl acetate
US09139584B2,"A solution of Intermediate 24b (485 mg, 2.82 mmol) and 1-(2-hydroxylethyl)-piperazine (1.39 mL, 11.3 mmol) in DMA (10 mL) was heated in the microwave at 170° C. for 8 h. The cooled mixture was concentrated in vacuo. The residue was purified by FCC, using 0-20% (2M NH3 in MeOH) in DCM, to give impure product. Further purified by FCC, using 0-7% (2M NH3 in MeOH) in DCM gave the title compound as a pale brown gum (175 mg, 23%). LCMS (Method 3): Rt 0.43 min, m/z 266 [MH+].",Intermediate 24b | 1-(2-hydroxylethyl)-piperazine | DMA | title compound
US20020045780A1,"HBr (30% in HOAc, 20 mL), 56 (2.9 g, 3.67 mmol), and phenol (3.25 g, 34.5 mmol) in CHCl3 (27 mL) were reacted, and product was isolated by the method of 2 to give 1.0 g (77%) of 26 as white crystals: NMR (D2O) δ 1.28 (t, 6H, J=7), 1.45 (m, 4H), 1.73 (m, 8H), 3.08 (m, 12H). Anal. (C14H36Cl3N3) C, H, N.",HBr | 56 | phenol | CHCl3 | 26
US20120214807A1,"The title compound was synthesized in similar fashion to N-[2-({(3R)-1-[1-(6-methoxypyridin-3-yl)piperidin-4-yl]pyrrolidin-3-yl}amino)-2-oxoethyl]-3-(trifluoromethyl)benzamide, whereby 2-methyltetrahydro-4H-pyran-4-one (prepared according to WO2004041161) was substituted for 1-(6-methoxypyridin-3-yl)piperidin-4-one, and was isolated as a white solid. 1H-NMR (CDCl3) δ: 1.57-2.06 (m, 8H), 2.34 (m, 1H), 2.65 (m, 1H), 2.92 (m, 2H), 3.26-3.89 (m, 5H), 4.09 (m, 1H), 4.69 (br, 1H), 7.54 (m, 1H), 7.71 (d, J=7.93 Hz, 1H), 7.88 (m, 1H), 8.04 (d, J=7.93 Hz, 1H), 8.13 (s, 1H). MS m/z: 414 (M+1).",title compound | N-[2-({(3R)-1-[1-(6-methoxypyridin-3-yl)piperidin-4-yl]pyrrolidin-3-yl}amino)-2-oxoethyl]-3-(trifluoromethyl)benzamide | 2-methyltetrahydro-4H-pyran-4-one | 1-(6-methoxypyridin-3-yl)piperidin-4-one
US06040311,"A mixture of 1-4 (500 mg, 2.20 mmol) and 6N HCl (50 mL) was heated at 60° C. for 20 h. Evaporative removal of the solvent provided 1-5 (530 mg, 96%) as a white solid.",1-4 | HCl | 1-5
US04590306,"methylating meta-cresol and para-cresol in the ortho position by reacting the meta-cresol and para-cresol with methanol, dimethyl ether or a mixture thereof at a temperature of 270° to 450° C., at a pressure of atmospheric to 100 bar and in the presence of a catalyst bed without a residence time of 0.01 to 10 seconds, whereby a mixture of 2,3,6-trimethylphenol and 2,4,6-trimethylphenol is produced;","meta-cresol | para-cresol | meta-cresol | para-cresol | methanol | dimethyl ether | 2,3,6-trimethylphenol | 2,4,6-trimethylphenol"
US07871998B2,"To a stirred solution of N-{[4-((2R,3R)-1-(4-fluorophenyl)-3-{[2-(4-fluorophenyl)-2-oxoethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycine, (20.3 mg, 0.038 mmol) in DMF (2 ml) was added N-methylmorpholine (15 μl, 0.14 mmol). TBTU (14.8 mg, 0.046 mmol) was added the mixture was stirred at 30° C. for 1.5 hours. O-benzyl-L-serine (8.8 mg, 0.045 mmol) was added and the mixture was stirred overnight. The formation of the ketone of the title compound was confirmed. M/z: 718.04 (M+1) and 716.02 (M−1). Methanol (3 ml) and sodium borohydride (10.3 mg, 0.27 mmol) were added and the mixture was stirred for 1.5 hours. Ammonium acetate (20 mg) was added and the methanol was removed under reduced pressure. The remaining DMF-solution was purified by preparative HPLC on a C8 column, UV 240/260 nm. A gradient from 20 to 45% MeCN in 0.1M NH4OAc buffer was used as eluent. The pure fractions were collected and the MeCN was removed under reduced pressure. The remaining water solution was acidified to pH 1 with HCl (1M) and extracted with DCM. The combined organic phases were concentrated and the residue was dissolved in MeCN and water. After lyophilisation, the title compound was obtained as a white solid (2.3 mg, 8.5%).","N-{[4-((2R,3R)-1-(4-fluorophenyl)-3-{[2-(4-fluorophenyl)-2-oxoethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycine | DMF | N-methylmorpholine | TBTU | O-benzyl-L-serine | ketone | title compound"
US05385996,"α-[4-(tert-Butyldimethylsilyloxymethyl)-benzyloxy][4-(tert-butyldimethylsilyloxymethyl)styrene] and α-[(tert-Butyldimethylsilyloxymethyl)-benzyloxy][3-(tert-butyldimethylsilyloxymethyl)styrene]. (Formula II, R1 =tert-butyldimethylsilyloxymethylphenyl, R2 =4-tert-butyldimethylsilyloxymethylbenzyl). Methyl 4-(hydroxymethyl)benzoate was treated with tert-butyldimethylsilyl chloride using the general procedure described in Journal of the American Chemical Society, 1972, 94, 6190. The resulting product was reduced with lithium aluminium hydride to afford 4-(tert-butyldimethylsilyloxymethyl)benzyl alcohol. This alcohol was converted into the required compound using Method C. 1H NMR (CCl4) δ 0.08 (12H, s), 0.91 (18H, s), 4.22 (1H, d, J 2 Hz), 4.68 (5H, br s), 4.90 (2H, s), 7.1-7.6 (8H, m); MS (CH4) 483 (M+ -CH3, 52%), 133 100%).",α-[4-(tert-Butyldimethylsilyloxymethyl)-benzyloxy][4-(tert-butyldimethylsilyloxymethyl)styrene] | α-[(tert-Butyldimethylsilyloxymethyl)-benzyloxy][3-(tert-butyldimethylsilyloxymethyl)styrene] | Formula II | Methyl 4-(hydroxymethyl)benzoate | tert-butyldimethylsilyl chloride | lithium aluminium hydride | 4-(tert-butyldimethylsilyloxymethyl)benzyl alcohol
US20110053923A1,"Triethylamine (17.4 mL, 0.13 mol) was added to a cooled (−5° C.) DCM solution of 2,4-dichloro-6-(methylsulfonylmethyl)pyrimidine (30 g, 0.13 mol). A DCM solution of (3S)-3-methylmorpholine was then added dropwise, while keeping the temperature below −5° C. The cooling bath was then removed and the mixture stirred for 1 h. The mixture was then heated to reflux for 2 h. The mixture was then washed with water, dried and concentrated in vacuo. Purification by preparative HPLC provided 2-chloro-4-[(3S)-3-methylmorpholin-4-yl]-6-(methylsulfonylmethyl)-pyrimidine (19.3 g); 1H NMR: 1.21-1.23 (m, 3H), 3.11 (s, 3H), 3.19-3.26 (m, 1H), 3.42-3.49 (m, 1H), 3.58-3.62 (1H, m), 3.73 (d, 1H), 3.92-3.96 (m, 2H), 4.27-4.31 (m, 1H), 4.45 (s, 2H), 6.92 (s, 1H); m/z: (ESI+) MH+, 306.","Triethylamine | DCM | 2,4-dichloro-6-(methylsulfonylmethyl)pyrimidine | DCM | (3S)-3-methylmorpholine | water | 2-chloro-4-[(3S)-3-methylmorpholin-4-yl]-6-(methylsulfonylmethyl)-pyrimidine"
US09346794B1,"The title compound is prepared in analogy to preparation 6c, substituting 2-(4-(N-cyano-S-methylsulfinimidoyl)benzyl)isoindoline-1,3-dione with 2-(4-(N-cyano-S-ethylsulfinimidoyl)benzyl)isoindoline-1,3-dione (preparation 13a). ESI mass spectrum: [M+H]+=354; r.t. HPLC: 3.33 min (LCMS-FA-8).","title compound | 6c | 2-(4-(N-cyano-S-ethylsulfinimidoyl)benzyl)isoindoline-1,3-dione"
US09133168B2,"150 mg of 4-fluoro-3,3-dimethyl-2,3-dihydro-1H-indole [reference example 2c] and 279 mg of N-[3-(dimethylamino)propyl]-N′-ethylcarbodiimide hydrochloride are added to a solution of 261 mg of sodium [1-methyl-4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetate (obtained in step 2c of example 1c) in 5 ml of N,N-dimethylformamide and 5 ml of pyridine. The reaction mixture is stirred at ambient temperature for 16 hours and then 30 ml of water are added and the mixture is extracted with ethyl acetate. The organic phase is washed successively with water and a saturated sodium chloride solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The residue is purified by trituration from a mixture of ethyl acetate and diisopropyl ether, so as to give 194 mg of 2-[2-(4-fluoro-3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-6-(morpholin-4-yl)pyrimidin-4(3H)-one, the characteristics of which are the following:","4-fluoro-3,3-dimethyl-2,3-dihydro-1H-indole | N-[3-(dimethylamino)propyl]-N′-ethylcarbodiimide hydrochloride | sodium [1-methyl-4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetate | N,N-dimethylformamide | pyridine | water | ethyl acetate | water | sodium chloride | magnesium sulfate | ethyl acetate | diisopropyl ether | 2-[2-(4-fluoro-3,3-dimethyl-2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-6-(morpholin-4-yl)pyrimidin-4(3H)-one"
US09085540B2,"A mixture of 3,5-dichloro-6-ethylpyrazine-2-carboxamide (500 mg), 5-methyl-6-(4-methylpiperazin-1-yl)pyridin-3-amine (470 mg), diisopropylethylamine (800 μL), and dioxane (10 mL) was stirred in a microwave reaction device at 150° C. for 30 minutes. After leaving to be cooled, water was added thereto, and the precipitated solid was collected by filtration and then dried under reduced pressure to obtain 5-chloro-6-ethyl-3-{[5-methyl-6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino}pyrazine-2-carboxamide (210 mg) as a yellow solid.","3,5-dichloro-6-ethylpyrazine-2-carboxamide | 5-methyl-6-(4-methylpiperazin-1-yl)pyridin-3-amine | diisopropylethylamine | dioxane | water | 5-chloro-6-ethyl-3-{[5-methyl-6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino}pyrazine-2-carboxamide"
US08299021B2,"(2R,6S,13aS,14aR,16aS,Z)-6-(tert-butoxycarbonylamino)-2-(4-fluoroisoindoline-2-carbonyloxy)-9-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa(n)pyrrolo[2,1-c][1,4,9]triazacyclopentadecine-14a-carboxylic acid (0.71 g, 0.87 mmol) in toluene (10 mL) was added di(1H-imidazol-1-yl)methanone (0.18 g, 1.13 mmol) in rt. The reaction was stirred at 60° C. for 3 hrs. Cyclopropanesulfonamide (0.16 g, 1.31 mmol) was added, followed by addition of DBU (0.26 ml, 1.74 mmol). The reaction was then stirred at rt for 17 hrs. Water (5 mL) was added and acidified with saturated potassium hydrogen sulfate until pH=2-3. The mixture was extracted with ethyl acetate (20 mL), washed with brine and dried over sodium sulfate. After removal of solvent, the residue was purified by chromatography (Ethyl acetate) to give (2R,6S,13aS,14aR,16aS,Z)-6-(tert-butoxycarbonylamino)-14a-(cyclopropylsulfonylcarbamoyl)-9-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa(n)pyrrolo[2,1-c][1,4,9]triazacyclopentadecine-2-yl 4-fluoroisoindoline-2-carboxylate as white solid (0.41 g, 51%). MS: Calcd.: 917. Found: [M+H]+ 918. 1H NMR (400 MHz, d6-DMSO) δ 0.99 (s, 1H), 9.12 (s, 1H), 8.04 (m, 1H), 7.98 (m, 1H), 7.87 (m, 2H), 7.33 (m, 2H), 7.08-7.21 (m, 2H), 5.48 (m, 1H), 5.32 (m, 1H), 5.27 (m, 1H), 4.67 & 4.65 (s, 4H), 4.42 (m, 1H), 4.33 (m, 1H), 4.00 (m, 1H), 3.70 (m, 1H), 3.61 (m, 1H), 3.43 (m, 1H), 3.32 (m, 1H), 3.03 (m, 1H), 2.90 (m, 2H), 2.48 (m, 2H), 2.13 (m, 1H), 1.99 (m, 2H), 1.63 (m, 1H), 083-1.24 (m, 15H).","(2R,6S,13aS,14aR,16aS,Z)-6-(tert-butoxycarbonylamino)-2-(4-fluoroisoindoline-2-carbonyloxy)-9-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa(n)pyrrolo[2,1-c][1,4,9]triazacyclopentadecine-14a-carboxylic acid | toluene | di(1H-imidazol-1-yl)methanone | Cyclopropanesulfonamide | DBU | Water | potassium hydrogen sulfate | ethyl acetate | brine | sodium sulfate | Ethyl acetate | (2R,6S,13aS,14aR,16aS,Z)-6-(tert-butoxycarbonylamino)-14a-(cyclopropylsulfonylcarbamoyl)-9-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa(n)pyrrolo[2,1-c][1,4,9]triazacyclopentadecine-2-yl 4-fluoroisoindoline-2-carboxylate"
US07608639B2,"The title compound is prepare by reacting the compound of 3-{4-[3-(2-bromo-4-trifluoromethyl-phenoxy)-phenoxy]-2-methyl-phenyl}-propionic acid methyl ester with o-cresol as in Example 45 to afford 0.229 g (21%). 1H NMR (400 MHz, CDCl3); MS (ES+) m/z mass calcd for C30H25O5F3 522, found 523 (M+1, 100%).",title compound | 3-{4-[3-(2-bromo-4-trifluoromethyl-phenoxy)-phenoxy]-2-methyl-phenyl}-propionic acid methyl ester | o-cresol
US20130336920A1,"Into a 50-mL round bottom flask, was placed a solution of tert-butyl 3-(3-((2-(4-((3-(trifluoromethyl)-benzyl)carbamoyl)pyridin-2-yl)-4-(dipropylamino)phenyl) carbamoyl)benzylthio)-propanoate (320 mg, 0.43 mmol, 1.00 equiv) in dichloromethane (10 mL), and trifluoroacetic acid (1 mL). The resulting solution was stirred overnight at 25° C. in an oil bath. The reaction progress was monitored by LCMS. The resulting mixture was concentrated under vacuum. The crude product (200 mg) was purified by reverse phase HPLC eluting with a water/CH3CN gradient containing 0.05% TFA. The product was obtained as 108 mg (30%) of a yellow solid. 1H-NMR (300 MHz, DMSO, ppm): δ 9.52 (t, J=6 Hz, 1H), 8.96 (d, J=5.1 Hz, 1H), 8.27 (s, 2H), 7.85 (s, 2H), 7.74 (m, 2H), 7.53 (m, 5H), 7.02 (s, 2H), 4.61 (d, J=5.7 Hz, 2H), 3.87 (s, 2H), 3.39 (s, 4H), 2.61 (m, 2H), 2.50 (m, 2H), 1.53 (t, J=9.3 Hz, 4H), 0.89 (t, J=7.2 Hz, 6H). MS (ES, m/z): 693 [M+H]+.",tert-butyl 3-(3-((2-(4-((3-(trifluoromethyl)-benzyl)carbamoyl)pyridin-2-yl)-4-(dipropylamino)phenyl) carbamoyl)benzylthio)-propanoate | dichloromethane | trifluoroacetic acid | crude product | water/CH3CN | TFA | yellow solid
US20150322008A1,"To a solution of 2-(dihydro-2H-pyran-4(3H)-ylidene)-2-(2-methylpyrimidin-5-yl)acetonitrile (0.22 mmol) in a 7M solution of NH3 in MeOH (3 mL) was added 10% palladium on activated charcoal (24 mg). The mixture was stirred under a hydrogen atmosphere for 24 h. It was filtered over Celite and the filtrate was treated with Actimet M Raney nickel (25 mg) at 0° C. The mixture was allowed to warm to RT and stirred under a hydrogen atmosphere for 4 h. It was filtered over Celite, washed with DCM/MeOH 8/2 and concentrated in vacuo to give the title compound as orange oil.",2-(dihydro-2H-pyran-4(3H)-ylidene)-2-(2-methylpyrimidin-5-yl)acetonitrile | NH3 | MeOH | palladium on activated charcoal | hydrogen | Raney nickel | hydrogen | DCM/MeOH | title compound
US06780855B2,"276 mg of 11β-fluoro-3-hydroxy-7α-(5-(methyl-amino)-pentyl)-estra-1,3,5(10)-trien-17-one is dissolved in 3 ml of N-methylpyrrolidone, mixed with 0.6 ml of 1,1,1,2,2,3,3,4,4-nonafluor-5-iodo-hexane and heated for 1.5 hours at a bath temperature of 80° C. For working-up, the reaction mixture is cooled to room temperature, stirred into saturated common salt solution, extracted with ethyl acetate, the organic phases are washed with water, dried on magnesium sulfate and concentrated by evaporation in a vacuum. Preparative column chromatography on silica gel with a methylene chloride-methanol gradient provides 176 mg of 11β-fluoro-3-hydroxy-7α-{5-[methyl-(3,3,4,4,5,5,6,6,6-nonafluoro-hexyl)-amino]-pentyl}-estra-1,3,5(10)-trien-17-one.","11β-fluoro-3-hydroxy-7α-(5-(methyl-amino)-pentyl)-estra-1,3,5(10)-trien-17-one | N-methylpyrrolidone | 1,1,1,2,2,3,3,4,4-nonafluor-5-iodo-hexane | ethyl acetate | water | magnesium sulfate | silica gel | methylene chloride-methanol | 11β-fluoro-3-hydroxy-7α-{5-[methyl-(3,3,4,4,5,5,6,6,6-nonafluoro-hexyl)-amino]-pentyl}-estra-1,3,5(10)-trien-17-one"
US08314091B2,"To a mixture of ethyl 5(tert-butoxycarbonyl)pyrazine-2-carboxylate (0.742 g, 2.78 mmol) and methanol (20 mL) was added potassium hydroxide (0.23 g, 4.1 mmol) in wafer (2 mL) and the reaction was stirred at room temperature overnight. The solvent was removed under vacuum and the residue was dissolved in wafer (5 mL) and acidified to pH 2 with 1M hydrochloric acid. The solid precipitate was collected by filtration to afford the title compound (0.61 g). MS (ESI) m/z 240.2 [M+H]+",ethyl 5(tert-butoxycarbonyl)pyrazine-2-carboxylate | methanol | potassium hydroxide | title compound
US09238668B2,"Under a nitrogen atmosphere, 10 mmol of 2-bromo-9H-carbazole, 15 mmol of 2-bromopyridine, 1 mmol of copper(I)iodide, 25 mmol of potassium carbonate, and 2 mmol of L-proline were combined in stirring degassed dimethyl sulfoxide. The mixture was heated to 90° C. for 3 days before being cooled and separated between dichloromethane and water. The water layer was washed twice with dichloromethane and the organics were combined and washed once with brine. The organic fraction was dried with magnesium sulfate and concentrated under reduced pressure and subjected to column chromatography of silica with dichloromethane as the eluent. After concentrating under reduced pressure, 2-bromo-9-(pyridin-2-yl)-9H-carbazole was isolated in a 70% yield.",2-bromo-9H-carbazole | 2-bromopyridine | copper(I)iodide | potassium carbonate | L-proline | dimethyl sulfoxide | dichloromethane | water | water | dichloromethane | brine | magnesium sulfate | 2-bromo-9-(pyridin-2-yl)-9H-carbazole
US20030092720A1,"3-[( E)-3-Hydroxy-1-propenyl]-8-[2-(4-isopropyl-1,3-thiazol-2-yl)ethyl]-2-morpholino-4H-pyrido[1,2-a]pyrimidin-4-one (81 mg, 0.18 mmol) was added with dichloromethane (3 ml) and a solution of diethyl zinc in hexane (1.02 M, 270 μl, 0.275 mmol) and subsequently added dropwise with iodomethane (30 μl, 0.366 mmol) at room temperature. After the reaction solution was stirred for 2 hours, the reaction was stopped with saturated aqueous ammonium chloride, and the reaction solution was extracted with chloroform. The organic layer was dried over magnesium sulfate and concentrated under reduced pressure. The resulting residue was purified by thin layer silica gel chromatography (chloroform:methanol=15:1) to obtain 61 mg (73%) of the title compound.","3-[( E)-3-Hydroxy-1-propenyl]-8-[2-(4-isopropyl-1,3-thiazol-2-yl)ethyl]-2-morpholino-4H-pyrido[1,2-a]pyrimidin-4-one | dichloromethane | diethyl zinc | hexane | iodomethane | ammonium chloride | chloroform | magnesium sulfate | silica gel | chloroform | methanol | title compound"
US06897231B2,"To a solution of 2-amino-5-(phenylmethoxy)phenyl phenyl ketone (2.6 g, 8.0 mmol) in 6N HCl (70 mL) at 0° C. was added a solution of sodium nitrite (NaNO2) (650 mg, 9.4 mmol) in water (2 mL). To this solution was added methanol and THF to keep it homogeneous. A solution of tin (II) chloride (SnCl2) (5.3 g, 23.6 mmol) in concentrated HCl (20 mL) was then added. The solution was stirred at room temperature overnight. The solid was then filtered and the solution concentrated and chromatographed on silica gel eluting with 20% ethyl acetate in hexane to give the title compound (1.15 g, 48% yield). 1H NMR (DMSO-d6) δ 13.1 (s, 1H), 7.95 (d, 2H), 7.56-7.48 (m, 6H), 7.44-7.3 (m, 4H), 7.14 (d, 1H), 5.12 (s, 2H); ES-MS (m/z) 301 [M+1]+.",2-amino-5-(phenylmethoxy)phenyl phenyl ketone | HCl | sodium nitrite | water | methanol | THF | tin (II) chloride | HCl | silica gel | ethyl acetate | hexane | title compound
US20090082434A1,"Treatment of (±)-(7-bromo-5-fluoro-2,3-dihydro-1-benzofuran-2-yl)methyl 4-methylbenzenesulfonate (2.00 g, 4.98 mmol) with 2-methylphenyl boronic acid (1.017 g, 7.48 mmol), dichlorobis(tri-o-tolylphosphine)palladium(II) (0.196 g, 0.249 mmol), and potassium carbonate (1.72 g, 12.46 mmol) generally according to the procedure described for Intermediate 37 provided 1.58 g (77%) of (±)-[5-fluoro-7-(2-methylphenyl)-2,3-dihydro-1-benzofuran-2-yl]methyl 4-methylbenzenesulfonate as a colorless oil. Rf=0.47 (silica, ethyl acetate:hexanes 3:17); Anal. calcd. for C22H19FO4S.0.2C4H8O2: C, 66.46; H, 5.30. Found: C, 66.25; H, 4.98.","(±)-(7-bromo-5-fluoro-2,3-dihydro-1-benzofuran-2-yl)methyl 4-methylbenzenesulfonate | 2-methylphenyl boronic acid | dichlorobis(tri-o-tolylphosphine)palladium(II) | potassium carbonate | Intermediate 37 | (±)-[5-fluoro-7-(2-methylphenyl)-2,3-dihydro-1-benzofuran-2-yl]methyl 4-methylbenzenesulfonate"
US20100035871A1,"To a solution of ethyl 8-bromo-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylate (6.13 g, 21 mmol) in tetrahydrofuran (75 mL) was added di-tert-butyl dicarbonate (11.5 g, 52.5 mmol) and DMAP (3.9 g, 31.5 mmol) at room temperature. The mixture was stirred at room temperature overnight. Then the reaction was quenched with water. The mixture was extracted with methylene chloride and washed with water. The solvent was removed under vacuum to afford a crude oil. ISCO CombiFlash® chromatography with 10-40% ethyl acetate in hexanes afforded 7.88 g (95%) of the title product as a yellow oil. MS (ES) m/z 403.1 [M+NH4]+.","ethyl 8-bromo-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylate | tetrahydrofuran | di-tert-butyl dicarbonate | DMAP | water | methylene chloride | water | ethyl acetate | hexanes | title product"
US09394305B2,"The title compound was prepared by the method similar to that of Example 31 employing 6-(2-(7-fluoro-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-yl)imidazo[1,2-a]pyridine-3-carboxylic acid (Int 42) and 1-Methylcyclopropane-1-sulfonamide (int-50) to afford an enantiomeric mixture, which was purified by chiral chromatography employing CHIRALPAK AD-H column with n-HEXANE:ETHANOL, 60:40 Isocratic solution as eluent. MS (ESI): m/z 515.2 (M+H); 1H NMR (600 MHz, DMSO-d6) δ 11.88 (1H, s), 8.74 (1H, s), 8.55 (1H, s), 7.65-7.64 (1H, d, J=10.4 Hz), 7.52-7.50 (1H, d, J=10.4 Hz), 6.51-6.45 (2H, m), 4.45-4.42 (3H, m), 4.30-4.22 (2H, m), 3.64-3.62 (1H, d), 2.79-2.73 (1H, m), 1.90-1.78 (4H, m), 1.57-1.53 (8H, m), 1.23-1.03 (2H, m) ppm.","title compound | 6-(2-(7-fluoro-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)piperidin-1-yl)imidazo[1,2-a]pyridine-3-carboxylic acid | 1-Methylcyclopropane-1-sulfonamide"
US05952355,"Substantially the same procedure as in Example 12 was repeated using 3',4',5'-trimethoxyacetophenone (2.1 g) and 5-bromoindole-3-carboxaldehyde (2.24 g) except that the obtained crystals were recrystallized from ethyl acetate, to give Compound 31 (2.73 g).","3',4',5'-trimethoxyacetophenone | 5-bromoindole-3-carboxaldehyde | ethyl acetate | Compound 31"
US04983328,"A mixture of 360 mg (2 mmoles) of 4-guanidinobutanamide hydrochloride, 701 mg (2.4 mmoles) of N-[4-(3-aminopropyl)aminobutyl]-2,2-dihydroxyethanamide dihydrochloride, 264 mg (2 mmoles) of glutaric acid and 0.36 ml of water was heated at 60° C. for 24 hours. After completion of the reaction, 5 ml of water was added to the reaction mixture, then passed through a column (20 mm inner diameter) packed with 150 ml of CM-Sephadex® C-25 (Na-type), and fractionated by the gradient elution method with 1.5 liters of water and 1.5 liters of 0.8M aqueous sodium chloride solution (15 ml fraction size). The fractions No. 125 to No. 137 corresponding to the sodium chloride concentrations of 0.48-0.56M were combined, then concentrated, and extracted three times with 10 ml of methanol. The methanol layer was passed through a column (20 mm inner diameter) packed with 150 ml of Sephadex® LH-20, and developed with methanol (7 ml fraction size). The fractions No. 9 to No. 15 were combined and evaporated to dryness, yielding 318 mg (35% yield) of a white powder of N-[4-(3-aminopropyl)aminobutyl]-2-(4-guanidinobutanamido)-2-hydroxyethanamide hydrochloride.","4-guanidinobutanamide hydrochloride | N-[4-(3-aminopropyl)aminobutyl]-2,2-dihydroxyethanamide dihydrochloride | glutaric acid | water | water | Sephadex | Na | water | sodium chloride | methanol | white powder | N-[4-(3-aminopropyl)aminobutyl]-2-(4-guanidinobutanamido)-2-hydroxyethanamide hydrochloride"
US08247566B2,"According to the present invention omeprazole sodium ethanol solvate is prepared by dissolving omeprazole (base) in a solution of NaOH in absolute ethanol. Mechanical particles are removed from the resulting solution, e.g. by filtration, and further seeded with crystals of omeprazole sodium form A to induce crystallisation. The slurry is then agitated for several hours at ambient temperature and additionally for several hours at low temperatures, e.g. from 0° to 5° C., in order to improve the yield. The precipitated omeprazole sodium form A is separated, e.g. by filtration or centrifugation, and washed with cooled absolute ethanol. Omeprazole sodium ethanol wet thus derived is dried under reduced pressure from 40° to 50° C., preferably at about 45° C. to yield stable anhydrous omeprazole sodium in ethanol solvate form. By the term “omeprazole sodium ethanol wet” is meant the product obtained before the step of drying under reduced pressure. The term “reduced pressure” generally refers to a pressure of about 10 mbar to about 50 mbar.",omeprazole sodium ethanol | omeprazole sodium | omeprazole | ethanol | NaOH | ethanol | omeprazole sodium | ethanol | Omeprazole sodium ethanol
US20120225061A1,"To a solution of 1-bromo-3,5-difluorobenzene (1.0 equiv.) in THF (0.26 M) under Ar was added Mg turnings (1.6 equiv.). A reflux condenser was attached and the solution was submerged in a 90° C. oil bath and refluxed for two hours. The oxetan-3-one (1.0 equiv.) was added in THF via syringe. The solution was left stirring at rt under Ar for 5 hrs. The reaction solution was quenched by addition of NH4Cl(sat) and the solution was extracted with EtOAc, washed with NaCl(sat.), dried over MgSO4, filtered, concentrated and purified by ISCO SiO2 chromatography (0-100% EtOAc/n-heptanes gradient) to yield 1-(3,5-difluorophenyl)cyclobutanol in 54% yield. 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 1.69-1.83 (m, 1H), 2.03-2.13 (m, 1H), 2.31-2.43 (m, 2H), 2.45-2.56 (m, 2H), 6.71 (tt, J=8.80, 2.35 Hz, 1H), 6.98-7.07 (m, 2H).","1-bromo-3,5-difluorobenzene | THF | Mg | oxetan-3-one | THF | NH4Cl(sat) | EtOAc | NaCl(sat.) | MgSO4 | SiO2 | EtOAc/n-heptanes | 1-(3,5-difluorophenyl)cyclobutanol"
US09174982B2,The title compound was prepared by substituting (S)-tert-butyl piperidin-3-ylcarbamate for tert-butyl piperazine-1-carboxylate and dihydro-2H-pyran-4(3H)-one for 4′-chlorobiphenyl-2-carboxaldehyde in EXAMPLE 1A.,title compound | tert-butyl piperazine-1-carboxylate | dihydro-2H-pyran-4(3H)-one | 4′-chlorobiphenyl-2-carboxaldehyde
US05019611,"N-phenyl-N'-(1,3-dimethylbutyl)-p-phenylenediamine (26.8g, 0.10 mol) is dissolved in 100 mL tetrahydrofuran in a 250 mL, 3-neck round bottom flask. Carbon disulfide (7.6g, 0.10 mol) is added over 0.5 hours with the concurrent addition of an aqueous solution of sodium hydroxide (4.0g, 0.10 mol). When addition is complete, methyl iodide (14.2g, 0.10 mol) is added and the mixture refluxed for 1 hour. The solvent is then stripped off on a rotary evaporator and the residue extracted with methylene chloride. The extract is dried with MgSO4 and the solvent is again removed on the rotary evaporator to yield the product.","N-phenyl-N'-(1,3-dimethylbutyl)-p-phenylenediamine | tetrahydrofuran | Carbon disulfide | sodium hydroxide | methyl iodide | methylene chloride | MgSO4"
US05037853,"To a solution of 2-bromo-6-methoxynaphthalene (0.5 g, 2.11 mmol) in THF (10 mL) at -78° C., was added n-butyllithium (1.69 mL of a 2.5 M in hexanes, 4.22 mmol) dropwise and the solution was stirred for 45 min at -78° C. N,N-dimethylformamide (0.31 g, 4.22 mmol) was then added and the reaction was allowed to stir for 15 min at -78° C. The reaction was quenched with saturated aqueous NH4Cl (10 mL). This solution was extracted with ethyl acetate (3×10 mL). The organics were combined, dried with MgSO4 and concentrated. The resulting residue was chromatographed (silica gel, ether:hexanes, 15:85) afforded 345 mg (88%) of 6-methoxy-2-napthaldehyde as an off-white solid.","2-bromo-6-methoxynaphthalene | THF | n-butyllithium | hexanes | N,N-dimethylformamide | NH4Cl | ethyl acetate | MgSO4 | silica gel | ether | hexanes | 6-methoxy-2-napthaldehyde"
US07557114B2,"Prepared in analogy to Example A16(a) from 4-Fluoro-6-trifluoromethyl-3H-isobenzofuran-1-one e and sodium borohydride. Colorless oil. MS (m/e): 225.1 ([M+H+, 100%).",4-Fluoro-6-trifluoromethyl-3H-isobenzofuran-1-one | sodium borohydride
US05192762,Anthracene (89.0 gm) was combined with methyl acrylate (51.5 gm) and xylenes (500 ml) in a Parr bomb and heated to 210° C. for 12 hours. The solvent was removed on a rotary evaporator and the residue was recrystallized from methanol to provide the product as a white solid (mp=113°-114° C.).,Anthracene | methyl acrylate | xylenes | methanol | product
US20100120798A1,"Trifluoroacetic acid (0.5 ml, 6.7 mmol) is added dropwise to a solution of 4-tert-butoxycarbonylamino-4-(3-benzooxazol-2-yl-phenylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester in dichloromethane (1 mL). The solution is stirred at rt for 45 min. The solvents are concentrated and the crude mixture is purified on SCX-II acidic resin, eluting with methanol then 2M ammonia-methanol, to give the title compound.",Trifluoroacetic acid | 4-tert-butoxycarbonylamino-4-(3-benzooxazol-2-yl-phenylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester | dichloromethane | crude mixture | methanol | ammonia-methanol | title compound
US05242468,"FIG. 7 depicts a subunit for sulfuric acid. Liquid sulfur dioxide is supplied by a cylinder 121 to a fractionating column 122 and then to a membrane filter 123. The purified sulfur dioxide gas is then fed to a catalytic oxidizer 124 where it is combined with purified air 125 over a platinum or other suitable catalyst to produce sulfur trioxide 126. The sulfur trioxide is combined with purified sulfuric acid 127 in an absorber 128 to form ultra-pure oleum 129, which is subsequently diluted with ultra-pure water 130 in a diluting vessel 131. An electrolysis cell 132 then converts this diluted oleum to a mixture of sulfuric and persulfuric acids 133. recycling some of the sulfuric acid back to the absorber 128. As in the other subunits, the product mixture is ready for application directly to the point of use on the fabrication line.",sulfuric acid | sulfur trioxide | oleum
US20150344485A1,"The title compound was prepared by a procedure similar to that described for E1 starting from 8-chloro-1,2-dimethyl-3,4-dihydro-1H-pyrimido[1,6-a]pyrimidin-6(2H)-one and (2,4,5-trifluoro-phenyl)methanol.","title compound | E1 | 8-chloro-1,2-dimethyl-3,4-dihydro-1H-pyrimido[1,6-a]pyrimidin-6(2H)-one | (2,4,5-trifluoro-phenyl)methanol"
US20110112103A1,"tert-Butyl 5-(benzyloxy)-2-{[1-(4-tert-butylphenyl)piperidin-4-yl]methyl}-6-methylpyrimidine-4-carboxylate (0.85 g, 1.6 mmol) was dissolved in a mixture of tetrahydrofuran (20 mL) and methanol (20 mL), and aqueous sodium hydroxide solution (8 M, 2.1 mL, 17 mmol) was added, followed by stirring at 60° C. for 1 hour. The reaction solution was cooled to room temperature, concentrated under reduced pressure, and subsequently hydrochloric acid (1 M, 100 mL, 100 mmol) was added to the resulting residue, followed by extraction with ethyl acetate. The extract was washed with brine, and the organic layer was concentrated under reduced pressure to afford 5-(benzyloxy)-2-{[1-(4-tert-butylphenyl)piperidin-4-yl]methyl}-6-methylpyrimidine-4-carboxylic acid as a pale yellow solid. This was dissolved in a mixture of tetrahydrofuran (20 mL) and ethanol (20 mL), and glycine ethyl ester hydrochloride (0.27 g, 1.9 mmol) and N-methylmorpholine (0.21 mL, 1.9 mmol) were added, followed by stirring at room temperature for 5 minutes. To the reaction solution was added 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (0.49 g, 1.9 mmol), followed by stirring at room temperature for 12 hours. After the reaction solution was concentrated under reduced pressure, the resulting residue was purified by silica gel column chromatography (Moritex Corporation, elution solvent:hexane/ethyl acetate), and a fraction corresponding to the Rf value=0.60 (hexane/ethyl acetate=1/1) by thin layer chromatography was concentrated under reduced pressure to afford the title compound (0.81 g, 1.5 mmol) as a pale yellow oil (yield 90%).",tert-Butyl 5-(benzyloxy)-2-{[1-(4-tert-butylphenyl)piperidin-4-yl]methyl}-6-methylpyrimidine-4-carboxylate | tetrahydrofuran | methanol | sodium hydroxide | hydrochloric acid | ethyl acetate | brine | 5-(benzyloxy)-2-{[1-(4-tert-butylphenyl)piperidin-4-yl]methyl}-6-methylpyrimidine-4-carboxylic acid
US08163728B2,"As described for example 144, 5-{[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethyl]-amino}-2-methyl-2H-pyrazole-3-carboxylic acid was converted, using 2-hydroxy-1-methylethylamine instead of 2-hydroxy-2-methylpropylamine, to the title compound (22 mg, 42%) which was obtained as a light yellow solid. MS: m/e=388.4 [M+H]+.",5-{[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethyl]-amino}-2-methyl-2H-pyrazole-3-carboxylic acid | 2-hydroxy-1-methylethylamine | title compound
US09145409B2,"To a stirred suspension of 2-[[3-[(S)-(tert-butoxycarbonylamino)-phenyl-methyl]phenoxy]methyl]oxazole-4-carboxylic acid (350 mg, 0.825 mmol) in DMF (12.3 mL) was added (1S)-2-(3,5-dichloro-1-oxido-pyridin-1-ium-4-yl)-1-(3,4-dimethoxyphenyl)ethanol (284 mg, 0.825 mmol), DMAP (50.4 mg, 0.412 mmol) and EDC hydrochloride (316.2 mg, 1.65 mmol). The reaction was stirred at room temperature for 23 h. The majority of the DMF was removed in vacuo and the residue was partitioned between ethyl acetate (30 mL) and saturated aqueous NaHCO3 solution (30 mL). The aqueous phase was extracted twice with ethyl acetate (20 mL) and the combined organic phases were washed with brine, dried on MgSO4, filtered then concentrated in vacuo. The residue was purified via silica gel chromatography, eluting with 0-50% EtOAc in dichloromethane, to give the title compound (225.6 mg, 36%) as a colourless solid.","2-[[3-[(S)-(tert-butoxycarbonylamino)-phenyl-methyl]phenoxy]methyl]oxazole-4-carboxylic acid | DMF | (1S)-2-(3,5-dichloro-1-oxido-pyridin-1-ium-4-yl)-1-(3,4-dimethoxyphenyl)ethanol | DMAP | EDC hydrochloride | DMF | ethyl acetate | NaHCO3 | ethyl acetate | brine | MgSO4 | silica gel | EtOAc | dichloromethane | title compound"
US05091425,"A solution of sodium 2-[8-propyl-6-(3-pyridyl)-1,2,4-triazolo[4,3-a]pyrazin-3-yl]-3-(3-pyridyl)propionate (A) (120 mg) in water (1 ml) was added to a solution of (2S,4S,5S)-5-amino-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropylhexanamide (98 mg) in DMF (9 ml). HOBT (40.5 mg) and EDAC (115 mg) were added and the solution was allowed to stand overnight. The reaction mixture was worked up by a similar procedure to that described in Example 1, followed by flash chromatography eluting with methanol/dichloromethane (7:93 v/v) to give (2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropyl-5-[(2RS)-2-(8-propyl-6-(3-pyridyl)-1,2,4-triazolo[4,3-a]pyrazin-3-yl)-3-(3-pyridyl)propionamido]hexanamide, as a foam (77 mg); NMR (d6 -DMSO/ D4 -acetic acid): 0.2-1.8 (complex m, 33H), 2.0 (m, 2H), 2.9-4.0 (complex m, 8 H), 4.9 (m, 1H), 7.4 (m, 1H), 7.5 (m, 1H), 7.9 (m, 1H), 8.5 (m, 2H), 8.7 (m, 2H), 9.3 (m, 2H); mass spectrum (+ve FAB, DMSO/m-nitrobenzyl alcohol): 697 (M+H)+, 624; microanalysis, found: C, 62.1; H, 7.9; N, 16.0%; C41H56N8O3. 2H2O requires: C, 67.2; H, 8.2; N, 15.3%.","sodium 2-[8-propyl-6-(3-pyridyl)-1,2,4-triazolo[4,3-a]pyrazin-3-yl]-3-(3-pyridyl)propionate | water | (2S,4S,5S)-5-amino-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropylhexanamide | DMF | HOBT | EDAC | methanol/dichloromethane | (2S,4S,5S)-N-butyl-6-cyclohexyl-4-hydroxy-2-isopropyl-5-[(2RS)-2-(8-propyl-6-(3-pyridyl)-1,2,4-triazolo[4,3-a]pyrazin-3-yl)-3-(3-pyridyl)propionamido]hexanamide"
US20130196984A1,"A solution of the crude (RS)-4-bromo-2-(1-cyclopropyl-2-iodo-1-isocyanato-ethyl)-1-fluoro-benzene (6.40 g, 16 mmol) in tert-butanol (200 ml) was treated at 23° C. with triethylamine (2.16 ml, 16 mmol) and the mixture was stirred overnight at reflux. For the workup, the reaction mixture was evaporated at reduced pressure to yield the crude title compound as a yellow oil which was directly used in the next step. Mass (calculated) C12H11BrFNO2[300.126]; (found) [M+H]+=300, [M+2-H]+=302.",(RS)-4-bromo-2-(1-cyclopropyl-2-iodo-1-isocyanato-ethyl)-1-fluoro-benzene | tert-butanol | triethylamine | crude title compound
US08207213B2,"Ethyl phenylmethyl(2-fluoro-4-nitrophenyl)propanedioate (3.86 g, 10.6 mmol) dissolved in ethanol, was treated with ammonium formate (6.7 g, 10.6 mmol) and palladium on carbon 10% paste (380 mg) was added under argon. The reaction mixture was refluxed for 3 hours, cooled and filtered. Evaporated and purified by chromatography on silica gel eluting with ethyl acetate/hexane (1:1) to give the title compound as a yellow oil (1.26 g). LC/MS: Rt=2.10, [MH]+ 198.",Ethyl phenylmethyl(2-fluoro-4-nitrophenyl)propanedioate | ethanol | ammonium formate | palladium on carbon | argon | silica gel | ethyl acetate/hexane | title compound
US20150031709A1,"2,5-difluorobenzo[b]thiophene (340 mg, 2 mmol) and pyrimidine (320 mg, 4 mmol) were dissolved in TFA (1.0 mL) and the resulting mixture was put in the ultrasonic reactor for 4 hours. The reaction mixture was then poured into water and extracted with EtOAc (3×50 mL). The combined organic layers were washed with brine (3×50 mL) and dried over anhydrous Na2SO4. After filtration, the solution was concentrated to give the crude title compound.","2,5-difluorobenzo[b]thiophene | pyrimidine | TFA | water | EtOAc | brine | Na2SO4 | crude title compound"
US20070066624A1,"Following general procedure G: to a solution of (R)-1-tert-butyl-4-phenyl-3-piperidin-4-yl-imidazolidin-2-one (67 mg, 0.22 mmol) in acetonitrile (2 mL) was added DIPEA (0.055 mL, 0.30 mmol) followed by 4-(5-bromomethyl-pyridin-2-ylsulfanyl)-benzoic acid methyl ester (68 mg, 0.20 mmol) and the mixture was heated to 75° C. for 3 hours. Standard work-up and purification afforded 4-{5-[4-((R)-3-tert-butyl-2-oxo-5-phenyl-imidazolidin-1-yl)-piperidin-1-ylmethyl]-pyridin-2-ylsulfanyl}-benzoic acid methyl ester as a white foam (49 mg, 44%).",(R)-1-tert-butyl-4-phenyl-3-piperidin-4-yl-imidazolidin-2-one | acetonitrile | DIPEA | 4-(5-bromomethyl-pyridin-2-ylsulfanyl)-benzoic acid methyl ester | 4-{5-[4-((R)-3-tert-butyl-2-oxo-5-phenyl-imidazolidin-1-yl)-piperidin-1-ylmethyl]-pyridin-2-ylsulfanyl}-benzoic acid methyl ester
US08362044B2,"To a solution of 1,2,4-triazole (0.042 g, 0.61 mmol) in DMF at 0° C. was added sodium hydride (60% in mineral oil; 0.044 g, 1.1 mmol), and the mixture was stirred for 30 minutes. (2′-{[(2-Chloro-acetyl)-ethyl-amino]-methyl}-6-methoxy-4′-trifluoromethyl-biphenyl-3-yl)-acetic acid ethyl ester (0.55 mmol) in DMF was added, followed by tetrabutylammonium iodide (0.1022 g, 0.06 mmol), and the reaction was warmed to room temperature and stirred for 1.5 hours. The mixture was diluted with EtOAc and H2O, and the aqueous layer was extracted twice with EtOAc. The combined organic layers were washed three times with H2O, and then dried and concentrated, and the residue was purified by silica gel chromatography (40-90% EtOAc in hexanes) to give the title compound.","1,2,4-triazole | DMF | sodium hydride | (2′-{[(2-Chloro-acetyl)-ethyl-amino]-methyl}-6-methoxy-4′-trifluoromethyl-biphenyl-3-yl)-acetic acid ethyl ester | DMF | tetrabutylammonium iodide | EtOAc | H2O | EtOAc | H2O | silica gel | EtOAc | hexanes | title compound"
US05137653,"Then, 8.93 g (56.4 mmol) of the above (+)-2-methyl octanoic acid was added to 8.98 g (75.5 mmol) of thionyl chloride placed in a flask with stirring at room temperature. Thereafter, the reaction was carried out at room temperature for 10 minutes, at 30° C. for 20 minutes, at 40° C. for 30 minutes and at 70° C. for 2 hours with stirring. After the excessive amount of thionyl chloride was distilled off, there was obtained 9.80 g (55.5 mmol, yield 98%) of light brown (+)-2-methyl octanoic acid chloride.",(+)-2-methyl octanoic acid | thionyl chloride | thionyl chloride | (+)-2-methyl octanoic acid chloride
US07829155B1,"Also disclosed herein is a method of making 4-vinylbenzenepropanethiol. The method includes providing 1-bromo-3-phenylpropane, adding acetic anhydride and aluminum chloride, incubating the mixture at from about −20 to about 20 degrees Celsius for from about 1 hour to about 12 hours, isolating the resulting p-(3-bromopropyl)acetophenone, adding sodium borohydride to the p-(3-bromopropyl)acetophenone solution in methanol, incubating the mixture at about 0 degrees Celsius for about 2 hours, isolating the resulting p-(3-bromopropyl)-α-methylbenzenemethanol, adding toluensulfonic acid to the solution of p-(3-bromopropyl)-α-methylbenzenemethanol in toluene, refluxing the mixture under inert atmosphere for about 4 hours, isolating the resulting p-(3-Bromopropyl)styrene, adding thiourea to the p-(3-Bromopropyl)styrene, gently refluxing the mixture for about 16 hours, adding sodium hydroxide, and gently refluxing the mixture for about 4 hours.",p-(3-bromopropyl)acetophenone | sodium borohydride | methanol | p-(3-bromopropyl)-α-methylbenzenemethanol
US20100075948A1,"In a manner similar to the method described in Example 25a, rac-(2R,3R,4R,5S)-4-(4-chloro-2-fluorophenyl)-4-cyano-3-(3,4-dichloro-phenyl)-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carboxylic acid tert-butyl ester prepared in Example 68b (1.7 g, 3.1 mmol) was reacted with trifluoroacetic acid in dichloromethane at room temperature to give rac-(2R,3R,4R,5S)-4-(4-chloro-2-fluoro-phenyl)-4-cyano-3-(3,4-dichloro-phenyl)-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carboxylic acid trifluoroacetic acid as a white solid (1.8 g, 96%).","rac-(2R,3R,4R,5S)-4-(4-chloro-2-fluorophenyl)-4-cyano-3-(3,4-dichloro-phenyl)-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carboxylic acid tert-butyl ester | trifluoroacetic acid | dichloromethane | rac-(2R,3R,4R,5S)-4-(4-chloro-2-fluoro-phenyl)-4-cyano-3-(3,4-dichloro-phenyl)-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carboxylic acid trifluoroacetic acid"
US20140213586A1,"1-(1H-Indol-3-yl)-2-((6-methoxypyrazin-2-yl)amino)-2-(pyrazolo[1,5-a]pyridin-2-yl)ethanone was prepared according to general procedure L from a mixture of 3-benzyl-5-(2-hydroxyethyl)-4-methylthiazol-3-ium chloride (0.061 g; 0.226 mmol) and triethylamine (0.032 mL; 0.231 mmol) in ethanol (1 mL), tert-butyl 3-formyl-1H-indole-1-carboxylate (0.111 g; 0.453 mmol) and a solution of 6-methoxy-N-(pyrazolo[1,5-a]pyridin-2-ylmethylene)pyrazin-2-amine (0.452 mmol) in ethanol (1 mL), heated at 70° C. for 4 days. The residue was purified by flash chromatography on silica gel using a gradient of ethyl acetate (20% to 100%) in heptane followed by a gradient of methanol (0% to 12%) in dichloromethane. Further purification by flash chromatography on silica gel using a gradient of ethyl acetate (20% to 100%) in heptane furnished 0.004 g (2%) of the desired compound as a white solid. ESI/APCI(+): 399 (M+H). ESI/APCI(−): 397 (M−H).","1-(1H-Indol-3-yl)-2-((6-methoxypyrazin-2-yl)amino)-2-(pyrazolo[1,5-a]pyridin-2-yl)ethanone | 3-benzyl-5-(2-hydroxyethyl)-4-methylthiazol-3-ium chloride | triethylamine | ethanol | tert-butyl 3-formyl-1H-indole-1-carboxylate | 6-methoxy-N-(pyrazolo[1,5-a]pyridin-2-ylmethylene)pyrazin-2-amine | ethanol | silica gel | ethyl acetate | heptane | silica gel | ethyl acetate | heptane | desired compound"
US07378417B2,"The title compound was prepared from 7-difluoromethyl-5-(4-trifluoromethyl-phenyl)-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (example C.1) and 3-amino-4-chloro-N-(2-hydroxy-1,1-dimethyl-ethyl)-benzenesulfonamide (example B.10) according to general procedure II. Light yellow solid. MS (ISP) 616.2 [(M−H−]; mp 234° C.","title compound | 7-difluoromethyl-5-(4-trifluoromethyl-phenyl)-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid | 3-amino-4-chloro-N-(2-hydroxy-1,1-dimethyl-ethyl)-benzenesulfonamide"
US04328347,"Tribromoisothiazole (2.2 g, 0.007 mol) and 2.2 ml of methyl fluorosulfonate were heated at 65° for 10 min. under a nitrogen atmosphere. The resulting solid was washed with ether and benzene to yield 2.7 g (88%) of 2-methyl-3,4,5-tribromoisothiazolium fluorosulfonate, mp 121-129. Spectral data (NMR and IR) were consistent with the assigned structure.","Tribromoisothiazole | methyl fluorosulfonate | nitrogen | ether | benzene | 2-methyl-3,4,5-tribromoisothiazolium fluorosulfonate"
US07745646B2,"Sodium hydride (12 mg, 60%, 0.30 mmol) was added to a solution of 4-amino-8-(cyclopentyloxy)-7-methoxy-2H-chromen-2-one (40 mg, 0.15 mmol), 3,4,5-trichloropyridine (27 mg, 0.15 mmol), and anhydrous DMSO (3 mL) at rt under N2. After 4 h, the reaction was poured into 1M KH2PO4 (40 mL) and extracted with ethyl acetate (40 mL×2). The combined extracts were dried, filtered, concentrated, and purified by silica gel chromatography (13:7→9:11; hexanes:ethyl acetate) to give 8-(cyclopentyloxy)-4-(3,5-dichloropyridin-4-ylamino)-7-methoxy-2H-chromen-2-one: 1H NMR (400 MHz, DMSO-d6): δ 9.50 (s, 1H), 8.81 (s, 2H), 7.93 (d, 1H), 7.20 (d, 1H), 4.83 (m, 1H), 4.63 (s, 1H), 3.91 (s, 3H), 1.80-1.00 (m, 8H); MS (ESI): 421.1.","Sodium hydride | 4-amino-8-(cyclopentyloxy)-7-methoxy-2H-chromen-2-one | 3,4,5-trichloropyridine | DMSO | N2 | KH2PO4 | ethyl acetate | silica gel | hexanes | ethyl acetate | 8-(cyclopentyloxy)-4-(3,5-dichloropyridin-4-ylamino)-7-methoxy-2H-chromen-2-one"
US08008322B2,"A mixture of 1.2 g of 2-hydroxy-4-methoxynicotinonitrile and 30 mL of hydrazine hydrate is maintained at 140° C. for 18 hours in a bomb. The reaction medium is then evaporated to dryness. The residue is taken up in ethyl ether, and the resulting suspension is filtered. 1.1 g of 3-amino-1H-pyrazolo[4,3-c]pyrid-4-ol are obtained in the form of a grey solid.","2-hydroxy-4-methoxynicotinonitrile | hydrazine hydrate | 3-amino-1H-pyrazolo[4,3-c]pyrid-4-ol"
US20160271123A1,"To a mixture of ethyl 2,2-difluoro-3-(4-nitro-2-(trifluoromethyl)phenyl)propanoate (220 mg, 0.672 mmol) in MeOH (10 mL) was added Pd/C (71.6 mg, 0.672 mmol) under N2. The mixture was then stirred under a H2 atmosphere for 1 h. LCMS and TLC (PE/EA=5:1, Rf=0.3) showed the reaction was finished. The mixture was filtered and the filtrate was concentrated to give ethyl 3-(4-amino-2-(trifluoromethyl)phenyl)-2,2-difluoropropanoate (190 mg, 0.573 mmol, 85% yield): 1H NMR (400 MHz, CD3OD-d4) δ 7.15 (s, 1H), 6.97 (d, J=2.2 Hz, 1H), 6.81 (dd, J=2.1, 8.4 Hz, 1H), 4.24 (q, J=7.1 Hz, 2H), 3.42 (t, J=16.8 Hz, 2H), 1.24 (t, J=7.1 Hz, 3H). ES-LCMS m/z 298 (M+H).","ethyl 2,2-difluoro-3-(4-nitro-2-(trifluoromethyl)phenyl)propanoate | MeOH | Pd/C | N2 | H2 | EA | ethyl 3-(4-amino-2-(trifluoromethyl)phenyl)-2,2-difluoropropanoate"
US04161528,"A mixture consisting of 188 gm of ethylene bromide, 383 gm of 3-chloro-aniline and 300 gm of sodium carbonate was stirred at 140° C. for five hours. Thereafter, the reaction mixture was cooled to about 80° C., and by addition of water the inorganic substances were caused to go into solution. The mixture was then extracted with ethyl acetate, the organic extract was dried over sodium sulfate, and the solvent as well as unreacted 3-chloroaniline were distilled off in vacuo, leaving 205 gm (76% of theory) of raw N,N'-bis-(3-chlorophenyl)-ethylenediamine. The raw product may be purified by distillation at 16 mm Hg and about 285° C.","ethylene bromide | 3-chloro-aniline | sodium carbonate | water | ethyl acetate | sodium sulfate | 3-chloroaniline | N,N'-bis-(3-chlorophenyl)-ethylenediamine"
US06451842B1,"A solution of (R)-1-(4-chlorobenzyl)-3-(glycylamino)pyrrolidine (0.050 mmol) in CHCl3 (1.35 mL) and tert-butanol (0.15 mL) was treated with 3-bromo-4-methylbenzoic acid (0.060mmol), diisopropylcarbodiimide (0.060mmol), and HOBt (0.060 mmol). The reaction mixture was stirred at room temperature for 15 h. The mixture was loaded onto Varian™ SCX column, and washed with CH3OH/CHCl3 1:1 (12 mL) and CH3OH (12 mL). Product was eluted off using 2 N NH3 in CH3OH (5 mL) and concentrated to afford (R)-1-(4-chlorobenzyl)-3-[{N-(3-bromo-4-methylbenzoyl)glycyl}amino]pyrrolidine (Compound No. 1098) (11.6 mg, 50%): The purity was determined by RPLC/MS (94%); ESI/MS m/e 466.0 (C21H23BrClN3O2).",(R)-1-(4-chlorobenzyl)-3-(glycylamino)pyrrolidine | CHCl3 | tert-butanol | 3-bromo-4-methylbenzoic acid | diisopropylcarbodiimide | HOBt | CH3OH/CHCl3 | CH3OH | (R)-1-(4-chlorobenzyl)-3-[{N-(3-bromo-4-methylbenzoyl)glycyl}amino]pyrrolidine
US04230719,"In 5 ml of methanol was dissolved 3.32 g (0.010 mole) of 3-[4-(3-methyl-2-thienyl)phenyl]-2,3-epoxy-2-methoxycarbonylbutyramide, followed by gradual addition of 15 ml (0.015 mole) of 1 N methanol solution of potassium hydroxide. The mixture was stirred at room temperature for one hour and freed from methanol by distillation under reduced pressure, and 40 ml of water was added thereto and 20 ml of benzene was then added to remove impurities, and the mixture was shaken thoroughly. The aqueous layer was separated, and 17 ml (0.017 mole) of 1 N hydrochloric acid was gradually added thereto, after which the mixture was heated with stirring to 90° C. to effect decarboxylation. After one hour of heating, the aqueous mixture was cooled and extracted with 70 ml of diethyl ether. The ether extract solution was dried over anhydrous magnesium sulfate and freed from diethyl ether by distillation under reduced pressure to obtain 2.10 g (77% yield) of 3 -[4-(3-methyl-2-thienyl)phenyl]-2-oxobutyramide.","methanol | 3-[4-(3-methyl-2-thienyl)phenyl]-2,3-epoxy-2-methoxycarbonylbutyramide | methanol | potassium hydroxide | methanol | water | benzene | hydrochloric acid | diethyl ether | ether | magnesium sulfate | diethyl ether | 3 -[4-(3-methyl-2-thienyl)phenyl]-2-oxobutyramide"
US20150274661A1,"5-Piperidin-4-yl-1H-indole-2-carboxylic acid (4-fluoro-phenyl)-amide (50 mg, 0.15 mmol), methoxy-acetaldehyde (16 mg, 0.22 mmol), and molecular sieves were suspended in dichloromethane (1.5 mL) and stirred at 60° C. for 1 hour. On cooling, sodium triacetoxyborohydride (95 mg, 0.45 mmol) was added portion wise to the mixture and the reaction was heated at 60° C. for a further 3 hours. The reaction solution was allowed to cool to ambient temperature, washed with water (2×1 mL) and the aqueous layer was extracted with dichloromethane (3×3 mL). The combined organic layers were dried over magnesium sulfate, filtered and concentrated in vacuo. The residue was purified by prep-HPLC affording the title compound (8 mg, 14%).",5-Piperidin-4-yl-1H-indole-2-carboxylic acid (4-fluoro-phenyl)-amide | methoxy-acetaldehyde | dichloromethane | sodium triacetoxyborohydride | water | dichloromethane | magnesium sulfate | title compound
US07579470B2,"The title compound (306.0 mg) was prepared from 0.49 g of 4-oxo-piperidine-1-carboxylic acid tert-butyl ester, 268 μL of benzylamine, and 0.48 g of 5-(2-nitro-vinyl)-benzo[1,3]dioxole. MS (ESI): exact mass calculated for C21H20N2O2, 332.15; found, m/z 333.2 [M+H]+. 1H NMR (400 MHz, CD3OD): 7.36-7.30 (m, 2H), 7.29-7.24 (m, 1H), 7.18-7.14 (m, 2H), 7.01 (s, 1H), 6.85-6.75 (m, 3H), 5.93 (s, 2H), 5.12 (s, 2H), 4.31 (s, 2H), 3.49 (t, J=6.3 Hz, 2H), 2.85 (t, J=6.3 Hz, 2H).","title compound | 4-oxo-piperidine-1-carboxylic acid tert-butyl ester | benzylamine | 5-(2-nitro-vinyl)-benzo[1,3]dioxole"
US09179681B2,"The title compound was prepared using perfluoroalkylation conditions originally described by Popov et. al. J. Fluorine Chem. 1982, 21, 365. To a solution of 4-bromobenzenethiol (500 mg, 2.64 mmol, 1.00 eq) and triethylbenzyl ammonium chloride (60 mg, 0.26 mmol, 0.10 eq) in 10 mL of 1:1 Et2O/NaOH (25% aq) at 0° C. was bubbled 1,1,1,2,2-pentafluoro-2-iodoethane gas for 30 min (>5 eq). During this time a UV lamp was directed at the reaction vessel while the temperature was maintained below 10° C. by intermittent use of an ice bath. The contents were then warmed to room temperature, extracted into Et2O (300 mL), dried (MgSO4), and concentrated under reduced pressure. A portion of this crude material was used in subsequent reactions without further purification (200 mg residue: 120 mg product, 0.39 mmol, 1.2 eq).","title compound | Fluorine | 4-bromobenzenethiol | triethylbenzyl ammonium chloride | Et2O/NaOH | Et2O | 1,1,1,2,2-pentafluoro-2-iodoethane | ice | MgSO4 | crude material | residue | product"
US06482829B2,"The title compound, MS: m/e=615.1 (M+H+), was prepared in accordance with the general method of example 71 from 8-(3,5-bis-trifluoromethyl-benzoyl)-1-(2-chloro-phenyl)-1,3,8-triaza-spiro[4.5]decan-4-one and 4-(chloromethyl)-3,5-dimethylisoxazole.","title compound | H+ | 8-(3,5-bis-trifluoromethyl-benzoyl)-1-(2-chloro-phenyl)-1,3,8-triaza-spiro[4.5]decan-4-one | 4-(chloromethyl)-3,5-dimethylisoxazole"
US20150110772A1,"(4-vinylbenzyl) amine (0.500 g, 3.75 mmol) was added dropwise to a solution of Boc-Phe-OSu (1.960 g, 4.88 mmol) in dichloromethane (DCM, 10 mL) at 0° C. Triethylamine (0.988 mL, 7.50 mmol) was then added dropwise to the cooled solution and the reaction was allowed to warm to room temperature and stirred for 24 hours. The reaction was quenched with saturated sodium carbonate solution and the product extracted with DCM (×3). The combined organic extracts were dried with magnesium sulfate, filtered and concentrated in vacuo. The crude residue was redissolved in a 50:50 mixture of hexane and ethyl acetate and washed through a pad of silica. Removal of the solvent in vacuo yielded the title compound as an amorphous white solid which was dried under a high vacuum overnight (1.541 g, 98%).",(4-vinylbenzyl) amine | Boc-Phe-OSu | dichloromethane | DCM | Triethylamine | sodium carbonate | magnesium sulfate | crude residue | hexane | ethyl acetate | silica | title compound
US08362016B2,"N-Propargylmorpholine (0.64 g, 5.1 mmol) was added under nitrogen atmosphere to a degassed solution of ethyl (Z)-[7-[3-(4-iodophenyl)-3-(4-trifluoromethylphenyl)allyloxy]-benzo[b]furan-4-yl]oxyacetate (0.68 g, 1.09 mmol) in a mixture of tetrahydrofuran (20 mL) and triethylamine (10 mL) The solution was cooled to 0° C., tetrakis(triphenylphosphine)-palladium (0.17 g, 0.147 mmol) and copper(I) iodide (0.03 g, 0.16 mmol) were added. The reaction mixture was stirred at ambient temperature for 120 h, diluted with benzene (100 mL), decanted and evaporated in vacuo. The residue was purified by column chromatography (silica gel Fluka 60, benzene/ethyl acetate 1:0-0:1) yielding ethyl (E)-[7-[3-[4-[3-(morpholin-4-yl)propynyl]phenyl]-3-(4-trifluoromethylphenyl)allyloxy]benzo[b]furan-4-yl]oxyacetate.",N-Propargylmorpholine | nitrogen | ethyl (Z)-[7-[3-(4-iodophenyl)-3-(4-trifluoromethylphenyl)allyloxy]-benzo[b]furan-4-yl]oxyacetate | tetrahydrofuran | triethylamine | tetrakis(triphenylphosphine)-palladium | copper(I) iodide | benzene | silica gel | benzene/ethyl acetate | ethyl (E)-[7-[3-[4-[3-(morpholin-4-yl)propynyl]phenyl]-3-(4-trifluoromethylphenyl)allyloxy]benzo[b]furan-4-yl]oxyacetate
US06251898B1,"This synthesis requires a brominated intermediate, which is prepared by a four-step process, as illustrated in FIG. 3. p-Toluic acid is first converted to N-(2-hydroxyethyl)-4-toluamide, using carbonyldiimidazole (CDI) and ethanolamine. This first intermediate is then converted to a N-[2-methanesulfonyloxy]-4-toluamide, using methanesulfonyl chloride. This second intermediate is then cyclized to form 2-(4-methylphenyl)oxazoline by processes analogous to those described in Example 7, below. This third intermediate is then brominated, using N-bromosuccinimide and benzoyl peroxide as described in Example 3, to produce 2-[(4-bromomethyl)phenyl]-oxazoline. This intermediate is then reacted with hydroxy compound [2], using a procedure similar to that described in Example 3, to give the desired compound, GERI-E6.",p-Toluic acid | N-(2-hydroxyethyl)-4-toluamide | carbonyldiimidazole | ethanolamine | N-[2-methanesulfonyloxy]-4-toluamide | methanesulfonyl chloride | 2-(4-methylphenyl)oxazoline
US06352839B1,"4 g of ethyl (RS)-N-acetyl-3-aminophenylalaninate, prepared as described in Example 35-8, in 15 ml of DMF are placed in a three-necked flask under a nitrogen atmosphere, and 5.5 ml of triethylamine, and then 2.5 ml of methyl iodide and 4 ml of dichloromethane, are added while maintaining the temperature in the region of 30° C. using an icebath. The mixture is then warmed at 35° C. for 18 h. 1 ml of methyl iodide dissolved in 1 ml of DMF is then added slowly while maintaining the temperature in the region of 30° C.; 2.2 ml of triethylamine are then added and the mixture is subsequently warmed for a further 5 h at 35° C. The mixture is brought to room temperature and then extracted with 100 ml of ethyl acetate and 150 ml of distilled water. The aqueous phase is separated off after settling and then rewashed with 2 times 70 ml of ethyl acetate. The organic phases are combined, washed with 2 times 80 ml of distilled water and then with 50 ml of distilled water which is saturated with NaCl. The organic phase is separated off after settling, dried over magnesium sulphate, filtered and then concentrated to dryness under reduced pressure in order to yield 2.4 g of a product which is purified by flash chromatography (dichloromethane, MeOH 90/10). 0.72 g (16%) of ethyl (RS)-3-N-acetyl-3-dimethylamino phenylalaninate is thus obtained in the form of yellow crystals.",ethyl (RS)-N-acetyl-3-aminophenylalaninate | DMF | nitrogen | triethylamine | methyl iodide | dichloromethane | methyl iodide | DMF | triethylamine | ethyl acetate | water | water | magnesium sulphate | product
US06777428B1,"4-[3-aminobenzoyl]-1-methylpiperidine (25 mg, 0.115 mmol) and phenyl isocyanate (37 μL, 0.344 mmol) in methylene chloride (2 mL) were mixed for 72 h at ambient temperature. The solution was diluted with 10% acetic acid in methanol and poured over a Varian Mega Bond Elut™ strong cation exchange column. The column was rinsed extensively with methanol to remove impurities, then treated with a 2M ammonia in methanol to elute the product from the column. The solvent was evaporated and the residue was stirred with 5N sodium hydroxide solution (1 mL). The solvent was removed under vacuum and the residue was purified by silica gel chromatography (methylene chloride:methanol:ammonium hydroxide, 97.5:2.5:0.25 then 95:5:0.5). The solvent was evaporated to give 28.5 mg (74%) of the title compound.",4-[3-aminobenzoyl]-1-methylpiperidine | phenyl isocyanate | methylene chloride | acetic acid | methanol | methanol | ammonia | methanol | sodium hydroxide | silica gel | methylene chloride | title compound
US04133829,"Starting from a 5α-alkoxymethyl-2β,4α-dihydroxycyclopentyl-1β-acetic acid-γ-lactone, wherein the alkoxy group is a methoxy, benzyloxy and p-methoxybenzyloxy group, esterification in pyridine with 1.3 molar equivalents of both acetic, acetic-formic or propionic anhydride and benzoyl or p-phenylbenzoyl chloride, gave the 4α-formate, acetate, m.p. 76-77°, [α]D = -29.5°, [α]365° = -74° (CHCl3), propionate, benzoate and p-phenylbenzoate.","5α-alkoxymethyl-2β,4α-dihydroxycyclopentyl-1β-acetic acid-γ-lactone | acetic | methoxy | pyridine | acetic-formic | propionic anhydride | benzoyl or p-phenylbenzoyl chloride | 4α-formate | acetate | CHCl3 | propionate | benzoate | p-phenylbenzoate"
US20130296332A1,"CH3SO2NHNH2 (25.5 mg, 1.5 equiv) and i-Pr2NEt (26.5 μL, 1 equiv) were added to a solution of 2-(4-chloro-phenoxycarbonylamino)-5-(1-methyl-1H-pyrrol-2-yl)-4-trifluoromethyl-benzoic acid methyl ester (70 mg, 0.155 mmol) in dioxane (2 mL). The mixture was stirred for 2 h (TLC control) at 95° C. CH3SO2NHNH2 (25.5 mg, 1.5 equiv) and i-Pr2NEt (26.5 μL, 1 equiv) were then added. The mixture was stirred for 48 h at 95° C. The mixture was evaporated to dryness. The crude product was purified by column chromatography (silica gel 60, EtOAc/hexanes 7/3) to give N-[6-(1-methyl-1H-pyrrol-2-yl)-2,4-dioxo-7-trifluoromethly-1,4-dihydro-2H-quinazolin-3-yl]-methanesulfonamide (50 mg, 80%) as a yellow solid. ESI-MS: m/z 420 [M+NH4]+, rt: 4.83 min. 1H-NMR (DMSO-d6, 400 MHz) 7.91 (s, 2H), 7.57 (s, 1H), 7.54 (s, 1H), 3.88 (s, 3H), 3.14 (s, 3H).","CH3SO2NHNH2 | i-Pr2NEt | 2-(4-chloro-phenoxycarbonylamino)-5-(1-methyl-1H-pyrrol-2-yl)-4-trifluoromethyl-benzoic acid methyl ester | dioxane | CH3SO2NHNH2 | i-Pr2NEt | crude product | silica gel | EtOAc/hexanes | N-[6-(1-methyl-1H-pyrrol-2-yl)-2,4-dioxo-7-trifluoromethly-1,4-dihydro-2H-quinazolin-3-yl]-methanesulfonamide"
US05338856,"A mixture of 20 mL of dichloromethane, 2.01 g (10 mmol) of 2-(3-methyl-5-isoxazolyl)-1-phenylethanone and 1.12 g (11 mmol) of N,N,N',N'-tetramethyldiaminomethane was prepared and cooled to -15° C. and 1.25 g (11 mmol) of trifluoroacetic acid in 5 mL of dichloromethane was added with cooling and stirring. Stirring was continued for 5 min at about 0° C. and then the mixture was allowed to warm to ambient temperature and stir for another 1.75 hr. A proton NMR spectrum of the mixture was taken which indicated complete disappearance of the starting material. Anhydrous hydrazine (0.96 g, 30 mmol) was added and the mixture was allowed to react with stirring for 2 hr. A proton NMR spectrum of the mixture indicated complete conversion to 4,5-dihydro-4-(3-methyl-5-isoxazolyl)-3-phenyl-1H-pyrazole. The mixture was washed with saturated aqueous sodium bicarbonate solution, dried over sodium sulfate, and filtered. 4-(Trifluoromethoxy)phenyl isocyanate (2.19 g, 10.8 mmol) was then added with stirring. The mixture was allowed to react for 1 hr and then 1 mL of acetic acid was added and the mixture was allowed to react for 5 min. It was then washed with saturated aqueous sodium bicarbonate, dried over sodium sulfate, filtered, and concentrated by evaporation under reduced pressure. The resulting solid was extracted with boiling ether and air dried to obtain 3.1 g (72 percent of theory) of the title compound as a white solid melting at 195°-197° C.","dichloromethane | 2-(3-methyl-5-isoxazolyl)-1-phenylethanone | N,N,N',N'-tetramethyldiaminomethane | trifluoroacetic acid | dichloromethane | hydrazine | 4,5-dihydro-4-(3-methyl-5-isoxazolyl)-3-phenyl-1H-pyrazole | sodium bicarbonate | sodium sulfate | 4-(Trifluoromethoxy)phenyl isocyanate | acetic acid | sodium bicarbonate | sodium sulfate | ether | title compound"
US08952034B2,"1-bromo-6-(4-(trifluoromethoxy)phenyl)-3-(trifluoromethyl)imidazo[1,5-a]pyridine (50.0 mg, 0.118 mmol), NaCN (7.0 mg, 0.142 mmol, 1.2 equiv.), CuI (2.2 mg, 0.0118 mmol, 0.1 equiv.) and KI (3.9 mg, 0.0236 mmol, 0.2 equiv.) were successively placed in a 5 mL Samith vial. To the vial was added a solution of N,N′-dimethylethylenediamine (10.4 mg, 0.118 mmol, 1.0 equiv.) in toluene (5 mL). The suspension was heated by the microwave reactor (Biotage, Personal Chemistry) at 130° C. for 60 min. The suspension was filtered through Celite (3 g) using EtOAc (70 mL). The solvent was removed from the filtrate under a reduced pressure to give a crude mixture. The crude mixture was purified by a preparative TLC (SiO2=1 plate, EtOAc/hexane=1:7 Rf=0.1) to give 6-(4-(trifluoromethoxy)phenyl)-3-(trifluoromethyl)imidazo[1,5-a]pyridine-1-carbonitrile as colorless crystals.","1-bromo-6-(4-(trifluoromethoxy)phenyl)-3-(trifluoromethyl)imidazo[1,5-a]pyridine | NaCN | CuI | N,N′-dimethylethylenediamine | toluene | crude mixture | crude mixture | SiO2 | EtOAc/hexane | 6-(4-(trifluoromethoxy)phenyl)-3-(trifluoromethyl)imidazo[1,5-a]pyridine-1-carbonitrile"
US04294842,"4-Bromobenzenethiol (3.78 g, 0.02 mol) was added to a solution of sodium (0.46 g, 0.02 mol) in ethanol (50 ml.) and 3,5-di-(chloromethyl)-1,2,4-oxadiazole (1.67 g, 0.01 mol) was added dropwise. The solution was then filtered and evaporated to give a solid which was recrystallised from isopropanol to give 3,5-di-(4-bromophenylthiomethyl)-1,2,4-oxadiazole, m.p. 80°.","4-Bromobenzenethiol | sodium | ethanol | 3,5-di-(chloromethyl)-1,2,4-oxadiazole | isopropanol | 3,5-di-(4-bromophenylthiomethyl)-1,2,4-oxadiazole"
US20060148791A1,"Prepared the isocyanate from 4-iodo-2-nitroaniline (12.0 g, 45.5 mmol; prepared from 2-nitroaniline according to Wilson, J. Gerald; Hunt, Frederick C. Aust. J. Chem. 1983, 36, 2317-25; CAS-No. [20691-72-9]) with diphosgene (4.1 mL, 34.1 mmol) in EtOAc (250 mL), followed by treatment with tert.-BuOH (12 mL) in CH2Cl2 (60 mL) according to the general procedure A (method a). Obtained as a yellow solid (8.23 g, 82%). MS (EI) 390 (M+); mp 92-94° C.",isocyanate | 4-iodo-2-nitroaniline | diphosgene | EtOAc | BuOH | CH2Cl2 | solid
US20160168156A1,"To a solution of tert-butyl 4-hydroxypiperidine-1-carboxylate (1.01 g, 5.02 mmol) in DCM (16 mL) was added TEA (0.909 mL, 6.52 mmol) and DMAP (61.0 mg, 0.502 mmol) followed by MsCl (0.469 mL, 6.02 mmol) at 0° C. The reaction mixture was stirred at room temperature for 3 hours. The reaction mixture was diluted with DCM, washed with water, 2 N aq. HCl, saturated aq. NaHCO3, and brine successively, dried over Na2SO4, filtered and concentrated in vacuo to afford tert-butyl 4-(methylsulfonyloxy)piperidine-1-carboxylate (1.40 g, 100%) as a white solid, which was used for the next reaction without further purification. 1H-NMR (CDCl3, Varian, 400 MHz): δ 1.46 (9H, s), 1.78-1.86 (2H, m), 1.94-1.99 (2H, m), 3.04 (3H, s), 3.27-3.34 (2H, m), 3.68-3.72 (2H, m), 4.86-4.91 (1H, m).",tert-butyl 4-hydroxypiperidine-1-carboxylate | DCM | TEA | DMAP | MsCl | DCM | water | HCl | NaHCO3 | brine | Na2SO4 | tert-butyl 4-(methylsulfonyloxy)piperidine-1-carboxylate
US08193246B2,"Synthesis was performed as described in example 19 step b using 17.89 g Hexadecanoic acid 1-dimethylaminomethyl-2-hexadecanoyloxy-ethyl ester, 11.33 g 20-Bromo-icosan-1-ol and 500 ml acetonitrile. The crude product was recrystallized from chloroform/methanol 3:1 and purity of the product was judged by thin layer chromatography and 1H-NMR.",Hexadecanoic acid 1-dimethylaminomethyl-2-hexadecanoyloxy-ethyl ester | 20-Bromo-icosan-1-ol | acetonitrile | crude product | chloroform/methanol
US04703053,"A mixture of 8.0 g (0.036 mole) of 3-hydroxy-5-methoxy-2-benzofurancarboxylic acid, methyl ester and 10.0 g (0.043 mole) of O-phenylmethoxy-N,N'-diisopropylisourea (L. J. Mathias, Synthesis, 561 (1979)) in 200 ml of acetonitrile is stirred at reflux under a nitrogen atmosphere for 22 hours. The mixture is cooled and filtered to remove by-product 1,3-diisopropylurea. The insoluble material is washed with hexane and the combined filtrates are evaporated (vacuum). The residue is treated with 250 ml of diethyl ether, and the mixture is again filtered and evaporated. The crude oil residue is chromatographed over silica gel using dichloromethane/hexane (2:1) elution to obtain 7.2 g 64% yield) of the purified 5-methoxy-3-(phenylmethoxy)2-benzofurancarboxylic acid, methyl ester as an oil. The ester is saponified without additional purification.","3-hydroxy-5-methoxy-2-benzofurancarboxylic acid, methyl ester | O-phenylmethoxy-N,N'-diisopropylisourea | acetonitrile | nitrogen | 1,3-diisopropylurea | hexane | diethyl ether | silica gel | dichloromethane/hexane | 5-methoxy-3-(phenylmethoxy)2-benzofurancarboxylic acid, methyl ester"
US07091228B2,"1,2-Diamino-5-trifluoromethylbenzene (0.50 g, 2.84 mmol) was diluted in dichloromethane (5 mL) and treated with 4-bromo-2-fluoro-phenylisothiocyanate (0.66 g, 2.84 mmol). The dark solution was stirred at 45° C. for 15 minutes, then 1,3-dicyclohexylcarbodiimide (0.44 g, 2.13 mmol) was added all at once. The reaction was heated in a 45° C. oil bath overnight, then cooled and concentrated at reduced pressure. The dark residue was diluted with ethyl acetate, and the organic layer was washed with water. The organic layer was dried (MgSO4) and concentrated in vacuo. The resulting dark brown oil was purified by flash chromatography on silica gel eluted on a gradient from 9:1 hexanes/ethyl acetate to 100% ethyl acetate. The title compound was collected as a light pink solid (0.60 g, 57%). 1H NMR (300 MHz, DMSO-d6) δ 11.3 (broad d, 1H), 9.87 (d, 1H), 7.50 (d, 2H), 7.61 (d, 1H), 7.55–7.41 (m, 3H), 7.35–7.30 (m, 1H); LC/MS m/z 356.2 (MH+), retention time 2.33 minutes.","1,2-Diamino-5-trifluoromethylbenzene | dichloromethane | 4-bromo-2-fluoro-phenylisothiocyanate | 1,3-dicyclohexylcarbodiimide | ethyl acetate | water | MgSO4 | silica gel | hexanes/ethyl acetate | ethyl acetate | title compound | solid"
US07348346B2,"(2R′, 3S, 5S)-2-Hydroxy-4-phenyl-N-[5-(thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-butyramide;",2R | 3S | 5S | 2-Hydroxy-4-phenyl-N-[5-(thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-butyramide
US07534796B2,"Following the procedure of Recl. Trav. Chim. Pays-Bas 88(11): 1263 (1969), 4-Chloro-pyridin-2-ylamine (A) (6.8 g, 67 mmol) was carefully dissolved in H2SO4 (45.2 ml) at 0° C. Nitric acid (2.3 ml) was added, maintaining the temperature at 0° C. The solution was stirred at 5° C. for 2 days. After it was judged complete by TLC (40% ethyl acetate/hexane), the mixture was carefully made basic with the addition of solid Na2CO3. The mixture was then extracted with ethyl acetate several times. The ethyl acetate was dried over magnesium sulfate and the solvents were removed under vacuum. The resulting crude was dissolved in DMSO (25 ml) with t-butyl-1-piperazine carboxylate (14.3 g, 75 mmol) and DIEA (10.3 g, 80 mmol). This mixture was heated to 50° C. for 3 hours before it was judged complete by MS. The mixture was purified by HPLC Method E to yield the title product 5 (2.8 g (13%), 8.6 mmol). 1H NMR (DMSO-d6): δ 7.82 (d, J=5.8 Hz, 1H), 6.98 (bs, 2H), 6.31 (d, J=5.8 Hz, 1H), 3.41 (m, 4H), 3.13 (m, 4H), 1.41 (s, 9H). MS (ESI-POS): [M+H]+=324.",4-Chloro-pyridin-2-ylamine | H2SO4 | Nitric acid | ethyl acetate/hexane | ethyl acetate | Na2CO3 | ethyl acetate | magnesium sulfate | DMSO | t-butyl-1-piperazine carboxylate | DIEA | title product 5
US07816371B2,"A round bottom flask was charged with (R)-methyl 3-hydroxy-2-(5-nitro-1-oxoisoquinolin-2(1H)-yl)propanoate (4 g, 0.01 mol), methylene chloride (40 mL, 0.5 mol) and 1H-imidazole (1.6 g, 0.023 mol) and tert-butyldimethylsilyl chloride (2.3 g, 0.015 mol) were added at 0° C. and the reaction allowed to warm to room temperature and stirred for 16 h. The reaction mixture was quenched with water and extracted with methylene chloride. Solvent was removed under reduced pressure to recover the pure product as an orange solid. MS m/z=407.5 (M+H).",(R)-methyl 3-hydroxy-2-(5-nitro-1-oxoisoquinolin-2(1H)-yl)propanoate | methylene chloride | 1H-imidazole | tert-butyldimethylsilyl chloride | water | methylene chloride | product
US20150152047A1,"The title compound was synthesized from (5-chloro-2-ethylsulfonyl-3-methoxyphenyl)methanamine hydrochloride (Compound dd45) under the same conditions as for Compound bb10. However, 3-chloro-4-[[(3S)-3-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]piperidin-1-yl]methyl]-5-(trifluoromethyl)benzoic acid (Compound dd34) was used in place of 4-[[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]methyl]-3-(trifluoromethyl)benzoic acid (Compound b3).",title compound | (5-chloro-2-ethylsulfonyl-3-methoxyphenyl)methanamine hydrochloride | Compound bb10 | 3-chloro-4-[[(3S)-3-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]piperidin-1-yl]methyl]-5-(trifluoromethyl)benzoic acid | Compound b3
US20070185096A1,"A mixture of 2,4-difluoro-benzoic acid (0.5 g), thiomorpholine (0.33 ml) and triethylamine (0.88 ml) in acetonitrile (2 ml) was heated to 200 C in a microwave reactor for 20 mins. The residue was partitioned between water and dichloromethane. The dried organic layer was evaporated and then purified on a silica gel SPE cartridge. Elution with dichloromethane followed by a gradient of dichloromethane:ethanol:0.880 ammonia; 800:8:1 to 200:8:1 gave the title material as a white solid (292 mg)","2,4-difluoro-benzoic acid | thiomorpholine | triethylamine | acetonitrile | water | dichloromethane | silica gel | dichloromethane | title material"
US07910363B1,"A concentrated solution of the amine 16 (0.097 g, 0.13 mmol) in ethyl acetate was added cooled to 0° C. A total of 4 mL of a freshly prepared saturated solution of HCl in ethyl acetate was added dropwise and the solution stirred for 1 h at room temperature during which time a white precipitate formed. The ethyl acetate was removed in vacuo and the residue co-evaporated with ethyl acetate and chloroform to give the product 23 as an off white powder (0.104 g, 98%); 1H NMR (CDCl3) d 7.24 (s, 1H, aryl), 7.05 (d, 1H, aryl), 6.85 (d, 1H, aryl), 5.35 (m, 4H, olefinic), 4.07 (q, 4H, OCH2), 3.95 (t, 2H, benzylic), 3.07 (m, 2H, CH2) 2.79 (m, 2H, CH2), 2.05 (m, 8H, CH2C═C), 1.82 (m, 8H, CH2CH2O, 2×CH2), 1.58-1.21 (m, 52H, 26×CH2), 0.89 (t, 6H, CH3); 13C NMR (300 MHz, CDCl3) d 149.36, 148.78, 130.85, 130.33, 129.74, 122.23, 115.56, 113.45, 69.56, 69.32, 51.56, 51.15, 45.96, 39.86, 32.53, 30.44, 30.44, 30.23, 30.12, 30.00, 29.71, 27.61, 27.51, 27.10, 26.83, 26.69, 24.82, 23.77, 23.08, 14.54; HRMS (FAB): theory for C51H95N2O2 (M+1), 767.7394; found (M+1), 767.7419; Anal. (C51H96Cl2N2O2.0.3H2O): C, H, N.",amine | ethyl acetate | HCl | ethyl acetate | ethyl acetate | ethyl acetate | chloroform | product 23 | powder
US05104641,"This compound was prepared according to the method of Sandris and Ourisson, Bull. Soc. Chim. Fr. 25: 345 (1958), in which 25 gms (180 mmoles) of phorone and 180 mls of ammonium hydroxide are stirred at 35° C. for 12 hrs. The solution is then cooled in an ice bath and concentrated HCl is added until the pH of the solution is 1. This solution is then saturated with NaCl and extracted with ether. The pH of the remaining liquid is raised to 10 with ammonium hydroxide followed by ether extraction. The ether solution is then dried with anhydrous sodium sulfate and evaporated to dryness, in vacuo, giving 20 gms (78%) of the desired product, B. P. 80°-85° C. at 15 mm Hg.",phorone | ammonium hydroxide | ice | HCl | NaCl | ether | ammonium hydroxide | ether | ether | sodium sulfate | desired product
US06503917B1,"A mixture of 3-(3,4-difluorophenyl)-1-(2-hydroxyphenyl)-5-(naphthalen-2-yl)-1,5-pentanedione on Wang resin (2.0 g, 1.76 mmol), NH4OAc (1.0 g), and ACOH (1.5 mL) in dimethylformamide (40 mL) was heated at 100° C. for 18 h. The resin was filtered, and washed with dimethylformamide (×2) and alternating MeOH and CH2Cl2 (×5), and dried under high vacuum overnight. The dried resin was treated with 50% TFA/CH2Cl2 (15 mL) for 1 h. After filtration of the reaction mixture, the filtrate was concentrated to dryness. The residue was repeatedly dissolved in CH2Cl2 (10 mL) and concentrated to remove traces of TFA. Purification by flash chromatography gave 2-[4-(3,4-difluoro-phenyl)-6-naphthalen-2-yl-pyridin-2-yl]-phenol; mp 165-167° C.; 1H NMR (DMSO-d6) d 6.99 (m, 2 H), 7.38 (m, 1 H), 7.65 (m, 4 H), 8.06 (m, 4 H), 8.24 (d, J=6.8 Hz, 1 H), 8.42 (m, 2 H), 8.49 (d, J=1.2 Hz, 1 H), 8.74 (s, 1 H), 14.35 (s, 1 H); IR (KBr) 1602 cm−1; MS [M+H]+m/z =410. Anal. calcd for C27H17F2NO: C, 79.21; H, 4.19; N, 3.42; Found: C, 79.33; H, 4.19; N, 3.22.","3-(3,4-difluorophenyl)-1-(2-hydroxyphenyl)-5-(naphthalen-2-yl)-1,5-pentanedione | resin | NH4OAc | dimethylformamide | dimethylformamide | CH2Cl2 | TFA/CH2Cl2 | TFA | 2-[4-(3,4-difluoro-phenyl)-6-naphthalen-2-yl-pyridin-2-yl]-phenol"
US07879873B2,"A solution of [(S)-1-(2-carbamoyl-pyridin-4-yl)-propyl]carbamic acid tert-butyl ester (1 g, 3.58 mmol) in MeOH (16.6 mL) and glacial acetic acid (3.3 mL) was added to a flask containing 10% palladium on carbon (0.38 g, 0.36 mmol) under nitrogen. The reaction was stirred at 60° C. under hydrogen at 400 psi using a Biotage Endeavour Argonaut instrument. After 20 hours, the reaction was filtered and concentrated. The crude material was diluted with EtOAc (100 mL), washed with saturated sodium carbonate solution (20 mL), brine, dried over sodium sulfate, filtered and concentrated to afford [(S)-1-(2-carbamoyl-piperidin-4-yl)-propyl]carbamic acid tert-butyl ester as a white solid.",[(S)-1-(2-carbamoyl-pyridin-4-yl)-propyl]carbamic acid tert-butyl ester | MeOH | acetic acid | palladium on carbon | nitrogen | hydrogen | crude material | EtOAc | sodium carbonate | brine | sodium sulfate | [(S)-1-(2-carbamoyl-piperidin-4-yl)-propyl]carbamic acid tert-butyl ester
US20120035218A1,"A quantity of 500 mg of the 5-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-fluoronitroaniline produced by Reference Production Example 17 was dissolved in 2 mL of 1,4-dioxane, and 4 mL of concentrated hydrochloric acid was added at room temperature. After stirring for 20 minutes at the same temperature, the solution was cooled to 0° C. and a solution obtained by dissolving 96 mg of sodium nitrite in 5 mL of water was added dropwise. After stirring for 15 minutes at the same temperature, a solution obtained by dissolving 528 mg of tin(II) chloride in 1 mL of concentrated hydrochloric acid was added dropwise to the reaction solution. Next, after adding 2N sodium hydroxide to the reaction mixture and neutralizing it, the water layer was extracted by ethyl acetate. The organic layer was dried by anhydrous sodium sulfate and concentrated under reduced pressure, and 412 mg of crude 5-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-fluorophenylhydrazine was obtained.","5-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-fluoronitroaniline | 1,4-dioxane | hydrochloric acid | sodium nitrite | water | tin(II) chloride | hydrochloric acid | sodium hydroxide | water | ethyl acetate | sodium sulfate | 5-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-fluorophenylhydrazine"
US07875613B2,"To a suspension of 1g/A (200 mg, 0.79 mmol) and molecular sieves in toluene (4 ml), aniline (72 μl, 0.79 mmol) was added. The mixture was stirred at 130° C. for 4 h, then the solvent was evaporated and he crude purified by flash chromatography (CH2Cl2/EtOAc/MeOH 80:18:2), affording 11 (231 mg, 90%) as orange solid in diastereoisomeric ratio 1:1.",1g/A | toluene | aniline | CH2Cl2/EtOAc/MeOH | 11
US04064106,"n-Butyl bromide was reacted with the ammonium salt of dicyclohexylphosphinodithioic acid to obtain n-butyl dicyclohexylphosphinodithioate, a viscous liquid, b.p. 167°-175° C at 0.15 mm., which on testing lasted 900 hours longer than the control. The total number of hours required to reach failure was 2.8 times that of the control.",n-Butyl bromide | ammonium salt | dicyclohexylphosphinodithioic acid | n-butyl dicyclohexylphosphinodithioate
US08586614B2,"The title compound was prepared via {2-[3-cyclopentylmethyl-3-(6-methoxy-pyridin-3-yl)ureido]-thiazol-5-ylsulfanyl}-acetic acid ethyl ester in a similar manner as described for the synthesis of {2-[3-cyclopentylmethyl-3-(4-methanesulfonyl-phenyl)-ureido]-thiazol-4-yl}-acetic acid, using cyclopentylmethyl-(6-methoxy-pyridin-3-yl)-amine and (2-amino-thiazol-5-ylsulfanyl)acetic acid ethyl ester",title compound | {2-[3-cyclopentylmethyl-3-(6-methoxy-pyridin-3-yl)ureido]-thiazol-5-ylsulfanyl}-acetic acid ethyl ester | {2-[3-cyclopentylmethyl-3-(4-methanesulfonyl-phenyl)-ureido]-thiazol-4-yl}-acetic acid | cyclopentylmethyl-(6-methoxy-pyridin-3-yl)-amine | (2-amino-thiazol-5-ylsulfanyl)acetic acid ethyl ester
US05919797,Benzoyl chloride (60 mmole) is added to a solution of 38 (60 mmole) in pyridine at 4 C. The mixture is allowed to stir for about 1-2 hrs and then further stirred at room temp for 12 hrs. The reaction mixture is made acidic and then extracted with methylene chloride. Following work-up and flash chromatography affords 39.,Benzoyl chloride | 38 | pyridine | methylene chloride | 39
US20110301122A1,"A mixture of 5.0 g (31.7 mmol) of 6-chloronicotinic acid and 15.1 ml (79.4 mmol) of 3,4-dimethoxy-N-methylbenzylamine was heated at 150° C. overnight, while stirring. After cooling to RT, 300 ml of ethyl acetate and 600 ml of water were added. The solid formed was filtered off in the course of the phase separation and dried in vacuo. 7.38 g (77% of th.) of the title compound were obtained.","6-chloronicotinic acid | 3,4-dimethoxy-N-methylbenzylamine | ethyl acetate | water | title compound"
US20040186103A1,"Example 96 was prepared from 2,2-diphenyl propanoic acid and N-{3-[1-(3-aminopropyl)-4-piperidinyl]-4-methyl phenyl}-2-methylpropanamide according to the procedures described in Scheme 10: 1H NMR (400 MHz, CDCl3) δ 7.37-7.23 (m, 13H), 7.08 (d, 1H, J=8.8 Hz), 6.14 (t, 1H, J=5.6 Hz), 3.37 (dd, 2H, J=6.4, 12.0 Hz), 2.90 (d, 2H, J=11.6 Hz), 2.63 (m, 1H), 2.49 (m, 1H), 2.31 (t, 2H, J=6.8 Hz), 2.27 (s, 3H), 2.02 (s, 3H), 1.99-1.94 (m, 2H), 1.71-1.59 (m, 6H), 1.25 (d, 6H, J=7.2 Hz); ESMS m/e: 526.3 (M+H)+.","2,2-diphenyl propanoic acid | N-{3-[1-(3-aminopropyl)-4-piperidinyl]-4-methyl phenyl}-2-methylpropanamide"
US03966792,"135 g. of dimethyl methylphosphonate were dissolved in 800 ml. of tetrahydrofuran, and to the solution cooled to -65°C., a solution of butyllithium [prepared from 163 g. of butyl bromide and 16 g. of lithium] in 610 ml. of diethyl ether was added drop-wise. To the reaction mixture was added drop-wise a solution of 62.5 g. of ethyl 3-cyclohexylpropionate in 300 ml. of tetrahydrofuran and the resulting mixture was stirred at the same temperature for two hours and afterwards at 0°C., overnight. The reaction mixture was then neutralised with acetic acid, concentrated under reduced pressure and after the addition of water extracted with diethyl ether. The ethereal extract was dried and the solvent distilled off. The residue was subjected to distillation under reduced pressure to obtain 51 g. (yield 52.3%) of the title product as a colourless oil, b.p. 143°-148°C./0.2 - 0.4 mm.Hg. NMR spectrum (tetrachloromethane): δ = 3.82 (6H, doublet), 3.16 (2H, doublet), 2.4 (2H, triplet), 1.97 - 1.08 (13H, multiplet).",dimethyl methylphosphonate | tetrahydrofuran | butyllithium | diethyl ether | ethyl 3-cyclohexylpropionate | tetrahydrofuran | acetic acid | water | diethyl ether | title product
US07517902B2,"A suspension of 3 g of tert-butyl[4-(3-amino-7-fluoro-1H-indazol-6-yl)phenyl]carbamate in 60 mL of dichloromethane is admixed at ambient temperature with 6 mL of trifluoroacetic acid. The reaction mixture is stirred at ambient temperature for 18 h and concentrated to dryness under reduced pressure. The solid obtained is taken up in ethyl acetate and the solution is treated with 4N aqueous sodium hydroxide solution and then decanted. The organic phase is subsequently washed with distilled water, then with saturated aqueous sodium chloride solution, dried over magnesium sulfate, filtered and then concentrated to dryness under reduced pressure. The yellow solid obtained (2.08 g) is chromatographed on a silica column (eluent: ethyl acetate). Evaporation to dryness under reduced pressure of the fractions containing the expected product gives 1.88 g of 6-(4-aminophenyl)-7-fluoro-1H-indazol-3-ylamine in the form of a yellow solid, whose characteristics are as follows:",tert-butyl[4-(3-amino-7-fluoro-1H-indazol-6-yl)phenyl]carbamate | dichloromethane | trifluoroacetic acid | ethyl acetate | sodium hydroxide | water | sodium chloride | magnesium sulfate | silica | ethyl acetate | expected product | 6-(4-aminophenyl)-7-fluoro-1H-indazol-3-ylamine
US04172829,"The procedure of Example 8 was repeated except that the 9-(2-cyclohexenyl)-2-ethoxy-9H-adenine used therein was replaced by an equivalent weight of 9-(2-cyclohexenyl)-2-n-hexyloxy-9H-adenine. There was produced the title product in 90% yield; m.p. 57°-60° C. IR(neat): 3500, 1635, 1595, 1500, 1465, 1420, 1400 cm-1. UV: λmaxEtOH 253 nm(ε 7200), 270 nm(ε 10900). NMR(CDCl3): 1.5(21H, m), 4.25(2H, t, J=6.5 Hz), 4.40(1H, m), 6.07(2H, s), 7.54(1H, s).",9-(2-cyclohexenyl)-2-ethoxy-9H-adenine | 9-(2-cyclohexenyl)-2-n-hexyloxy-9H-adenine | title product
US20050014759A1,"6-Chloro-1-phenacyl-quinolinium bromide: The title compound was prepared from 2-bromo-1-phenyl-ethanone (483 mg, 2.43 mmol), 6-chloro-quinoline (312 mg, 1.91 mmol) and acetonitrile (5 mL), similar to Example 1a, and yielded 433 mg (63%) as an off white solid: 1H NMR (CDCl3) 10.40 (d, J=5.7 Hz, 1H), 8.95 (d, J=8.7 Hz, 1H), 8.31 (m, 1H), 8.29 (m 1H), 8.24 (d, J=2.1 Hz, 1H), 8.19-8.14 (m, 2H), 7.99 (dd, J=2.1, 9.3 Hz, 1H), 7.70-7.65 (m, 3H), 7.53 (t, J=7.8 Hz, 2H).",6-Chloro-1-phenacyl-quinolinium bromide | title compound | 2-bromo-1-phenyl-ethanone | 6-chloro-quinoline | acetonitrile
US09169251B2,"1M Lithium hydroxide (57 μl) is added dropwise to a cooled (0° C.) solution of [1-(4-cyano-3-ethoxy-benzenesulfonyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid methyl ester (0.024 g, 0.057 mmol) in THF/water (4 ml of a 1:1 mixture). After stirring at 0° C. for 10 minutes, the reaction mixture is stirred at room temperature for 2.5 hours and then diluted with DCM (4 ml). The resulting mixture is passed through a phase separation cartridge and the aqueous portion is acidified to pH 4 with 1M HCl. This portion is extracted with DCM (2×4 ml) and the organic extracts are combined, passed through a phase separation cartridge, and concentrated in vacuo. The resulting solid is dissolved in ethyl acetate (2 ml) and triturated with iso-hexane (7 ml) to yield the titled compound as a white solid. (MH+400)","Lithium hydroxide | [1-(4-cyano-3-ethoxy-benzenesulfonyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid methyl ester | THF/water | DCM | DCM | ethyl acetate | iso-hexane | titled compound"
US20090036495A1,"The title compound was prepared according to the procedure described in step 2 of Example 58 from methyl 2,5-dichloronicotinate and 3-chlorobenzylzinc chloride: 1H-NMR (CDCl3) 8.65 (1H, d, J=2.6 Hz), 8.17 (1H, d, J=2.6 Hz), 7.26-7.12 (4H, m), 4.52 (2H, s), 3.89 (3H, s)","title compound | methyl 2,5-dichloronicotinate | 3-chlorobenzylzinc chloride"
US20040063789A1,"A solution of the amine 23 and lactam 24 (500 mg) in 3 M hydrochloric acid were heated to reflux for 9 hours, then stirred at room temperature for 15 hours. The solution was concentrated and the resultant solid subjected to a sequential purification which involved ion exchange chromatography (Dowex 50WX8, strongly acidic), oxalate salt formation then further purification by ion exchange chromatography (Dowex 50WX8, strongly acidic) to give the Example 2 (343 mg) as a white solid. 1H NMR (D2O) δ 2.87 (m, 2H), 2.22 (dd, 1H, J=15.4 and 3.4 Hz), 2.12 (m, 1H), 1.93 (dd, 1H, J=15.4 and 9.5 Hz), 1.38 (m, 1H), 1.12 (m, 1H), 0.77 (d, 1H, J=6.6 Hz), 0.74 (d, 1H, J=6.6 Hz), 0.70 (d, 1H, J=6.8 Hz). MS, m/z (relative intensity): 174 [M+H, 100%].",amine | lactam | hydrochloric acid | oxalate salt | Example 2
US09315495B2,"To a solution of diisopropylamine (0.13 mL, 0.918 mmol) in 2 mL anhydrous tetrahydrofuran at −40° C. was added n-butyllithium (0.34 mL, 2.5 M in hexanes) dropwise. The solution was stirred while warming to −20° C. over 20 minutes. After cooling to −78° C., 4-butyl-1-methyl-1H-imidazole (95 mg, 0.765 mmol) was added dropwise as a solution in 2 mL anhydrous tetrahydrofuran. The resulting solution was stirred for 40 minutes at −78° C. Dimethylformamide (0.24 mL, 3.06 mmol) was added and the solution stirred while warming to room temperature. The reaction mixture was poured into 15 mL of 1 N hydrochloric acid and stirred for 5 minutes. The pH of the reaction mixture was adjusted to 7-8 by careful addition of saturated sodium bicarbonate solution. Organics were extracted with dichloromethane (3×20 mL), dried over magnesium sulfate, filtered and concentrated. The crude residue was subjected to chromatography on silica gel with gradient elution (5-50% ethyl acetate in hexanes) to give 1-methyl-4-propyl-1H-imidazole-2-carbaldehyde (9 mg, 8%) as an off-white solid. Used without further characterization.",diisopropylamine | tetrahydrofuran | n-butyllithium | hexanes | 4-butyl-1-methyl-1H-imidazole | tetrahydrofuran | Dimethylformamide | hydrochloric acid | sodium bicarbonate | dichloromethane | magnesium sulfate | crude residue | silica gel | ethyl acetate | 1-methyl-4-propyl-1H-imidazole-2-carbaldehyde
US20160115158A1,"To a stiffing solution of 4-chloro-3-formylbenzonitrile (5.00 g, 30.2 mmol) in ethanol (50 mL), NaBH4 (571 mg, 15.1 mmol) was added batch-wise over 1 minute under stiffing at room temperature. After 1 hr, the reaction mixture was concentrated in vacuo to afford an off-white solid, treated with 2M HCl (200 mL) and DCM (260 mL), effervescence and dissolution occurred. The layers were separated, the organic layer was dried over Na2SO4, the mixture filtered and concentrated in vacuo to afford the title compound (4.86 g, 96%) as an off-white solid; 1H NMR (500 MHz, DMSO) δ 4.58 (d, 2H), 5.63 (t, 1H), 7.65 (d, 1H), 7.78 (dd, 1H), 7.85-7.94 (m, 1H).",4-chloro-3-formylbenzonitrile | ethanol | NaBH4 | HCl | DCM | Na2SO4 | title compound
US20150315157A1,"A mixture of ethyl N-[(1-cyclohexyl-6-hydroxy-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)carbonyl]glycinate (340 mg, 1.0 mmoles), pulv. potassium carbonate (1.5 g, 11 mmoles) and 3,5-dimethoxybenzyl bromide (300 mg, 1.3 mmoles) in dimethylacetamide (5 mL) was vigorously stirred at 100° C. for 3 hours. The mixture was poured into 1 molar hydrochloric acid and extracted with ethyl acetate. The organic solution was washed with 1 molar hydrochloric acid and evaporated. The residue was purified by flash chromatography (10-50% ethyl acetate in hexane), the required fractions evaporated, dissolved in ethanol (5 mL) and 1 molar sodium hydroxide solution (1.0 mL) and 6 molar sodium hydroxide solution (1.0 mL) added. The mixture was stirred overnight, acidified and extracted with ethyl acetate (×2), the combined extracts washed with 1 molar hydrochloric acid, dried and evaporated. Recrystallization from toluene gave the title compound (190 mg, 41%). 1H NMR (400 MHz, DMSO-d6) δ ppm 13.11 (s, 1H), 10.15 (s, 1H), 6.40 (s, 3H), 4.92 (s, 2H), 4.64 (t, J=11.87 Hz, 1H), 4.09-4.17 (m, 2H), 3.70 (s, 6H), 2.26 (s, 2H), 1.78 (d, J=12.63 Hz, 2H), 1.62 (d, J=11.62 Hz, 3H), 1.28 (q, J=13.05 Hz, 2H), 1.06-1.17 (m, 1H).","ethyl N-[(1-cyclohexyl-6-hydroxy-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)carbonyl]glycinate | potassium carbonate | 3,5-dimethoxybenzyl bromide | dimethylacetamide | hydrochloric acid | ethyl acetate | hydrochloric acid | ethyl acetate | hexane | ethanol | sodium hydroxide | sodium hydroxide | ethyl acetate | hydrochloric acid | toluene | title compound"
US07253198B2,"NaH (60% w/w in mineral oil, 680 mg, 17 mmol, 0.9 equiv) was added portionwise to a solution of 3-(5-chloro-pentanoylamino)-5-nitro-benzoic acid methyl ester (D3) (6 g, 19 mmol, 1 equiv) in THF (40 ml) under nitrogen. The resulting mixture was stirred at room temperature for 1 h and then MeOH was added dropwise. The solution was concentrated in vacuo and the residue diluted with AcOEt. The organic phase was washed with H2O, dried over MgSO4 and concentrated in vacuo. Purification by flash chromatography on silica gel (AcOEt/iso-hexane: 1/2) gave 3-nitro-5-(2-oxo-piperidin-1-yl)-benzoic acid methyl ester (B82) (2.8 g, 53%) as a pale orange oil.",NaH | 3-(5-chloro-pentanoylamino)-5-nitro-benzoic acid methyl ester | THF | nitrogen | MeOH | AcOEt | H2O | MgSO4 | silica gel | AcOEt/iso-hexane | 3-nitro-5-(2-oxo-piperidin-1-yl)-benzoic acid methyl ester
US20120202794A1,"(3S,6S)-6-(cyclopropylmethyl)-3-isobutylpiperazin-2-one 13 (50 mg, 0.24 mmol) and 5-(4-fluorophenyl)isoxazole-3-carboxylic acid (53 mg, 0.24 mmol) were coupled according to the procedure described for compound 71 to furnish 167 (53 mg, 54% yield) as white solid.","(3S,6S)-6-(cyclopropylmethyl)-3-isobutylpiperazin-2-one | 5-(4-fluorophenyl)isoxazole-3-carboxylic acid | compound 71 | 167"
US09096524B2,"3-[4-(4-Isobutoxy-phenyl)-piperazin-1-yl]-propionic acid lithium salt (35 mg; 0.11 mmol, prepared in accordance with Example 25), diisopropylethyl amine (50 μL; 0.10 mmol) and tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate (38 mg; 0.10 mmol) are diluted in a 2 to 1 mixture of dimethylformamide and tetrahydrofuran (1.5 mL) and the resulting solution is stirred for 5 minutes. A solution of (4-nitro-3-trifluoromethyl-phenyl)-piperidin-4-yl-amine hydrochloride (33 mg; 0.10 mmol, prepared in accordance with Example 8) in dimethylformamide (0.5 mL) is added and the reaction is then stirred for 3 hours at room temperature. Following dilution with dichloromethane (10 mL), the organic layer is sequentially washed with water (5 mL), aq. sat. sodium hydrogen carbonate (5 mL), is dried over magnesium sulfate and concentrated under reduced pressure. The residue obtained is finally purified by preparative HPLC to deliver the desired product in pure form (30 mg; 0.05 mmol). The structure was confirmed using Protocol II-A. Calculated mass=578; observed mass=578; HPLC retention time=3.54 min.",3-[4-(4-Isobutoxy-phenyl)-piperazin-1-yl]-propionic acid lithium salt | diisopropylethyl amine | tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate | dimethylformamide | tetrahydrofuran | (4-nitro-3-trifluoromethyl-phenyl)-piperidin-4-yl-amine hydrochloride | dimethylformamide | dichloromethane | water | sodium hydrogen carbonate | magnesium sulfate
US20120316147A1,"The title compound was synthesized in analogy to Example 280 c, using 5-bromo-6-(2,2,2-trifluoro-ethoxy)-pyridine-2-carboxylic acid (Example 282 a) and α,α-dimethyl-2-thiazolemethanamine (Example 12 c) as starting materials, MS (EI): m/e=424.3 [M+H]+.","title compound | 5-bromo-6-(2,2,2-trifluoro-ethoxy)-pyridine-2-carboxylic acid | α,α-dimethyl-2-thiazolemethanamine"
US05489602,"To a suspension of lithium aluminum hydride (LiAlH4) (0.7 g) in ethyl ether (40 ml), a solution of ethyl 2-(4-benzyl-5-methyl-2-oxazolyl)acetate (4.76 g) in ethyl ether (60 ml) was added dropwise under ice cooling conditions, followed by stirring for 1 hour. After water (5 ml) was added dropwise to the reaction mixture, the insoluble substances were filtered off, and the filtrate was concentrated under reduced pressure. The residue was subjected to silica gel chromatography. From the fraction eluted with chloroform-ethyl acetate (2:1, v/v), 2-(4-benzyl-5-methyl-2-oxazolyl)ethanol (3.0 g, 75%) was obtained as an oily substance.",lithium aluminum hydride | ethyl ether | ethyl 2-(4-benzyl-5-methyl-2-oxazolyl)acetate | ethyl ether | ice | water | chloroform-ethyl acetate | 2-(4-benzyl-5-methyl-2-oxazolyl)ethanol
US08507491B2,"A mixture containing (S)-5-bromo-2-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-1,2,3,4-tetrahydroisoquinoline (303 mg, 0.93 mmol), KMnO4 (176 mg, 1.12 mmol), 18-crown-6 (245 mg, 0.93 mmol) in dichloromethane (4 ml) is stirred at room temperature for 18 hours. The reaction mixture is filtered through a celite pad and the filtrate is concentrated to dryness by rotary evaporation to give (S)-5-Bromo-2-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (LC-MS m/z: 341.2 (M+1)), which is used without further purification in the next step.","(S)-5-bromo-2-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-1,2,3,4-tetrahydroisoquinoline | KMnO4 | 18-crown-6 | dichloromethane | (S)-5-Bromo-2-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one"
US06441017B1,"(S)-1-[2-Bromo-7-(tert-butyldimethylsilyloxy)naphthalen-1-yl]-3-(tert-butoxycarbonylamino)-2-oxopyrrolidine, as described above in Step I, (245 mg, 0.458 mmol) was dissolved in a 10% TFA solution in CH2Cl2 (5 mL). After 30 min, the mixture was poured into saturated aqueous Na2CO3 and extracted with CH2Cl2 (3×). The combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The residue was chromatographed on silica gel, eluting with a gradient of CH2Cl2—1% to 4% MeOH—0.1% to 0.4% NH4OH, to yield the above-titled compound.",(S)-1-[2-Bromo-7-(tert-butyldimethylsilyloxy)naphthalen-1-yl]-3-(tert-butoxycarbonylamino)-2-oxopyrrolidine | TFA | CH2Cl2 | Na2CO3 | CH2Cl2 | Na2SO4 | silica gel | CH2Cl2 | above-titled compound
US08778934B2,"A solution of 9-[4-(4-{[tert-butyl(dimethyl)silyl]oxy}phenoxy)phenyl]-3,4-dihydropyrido[2,1-c][1,2,4]thiadiazine 2,2-dioxide (1.82 g) in THF (dry) (55 mL) was added to tetrabutylammonium fluoride (1 M in THF) (6.79 mL) at room temperature. After stirring for 0.5 hr, the mixture was added with sat. NH4Cl aq. and silica gel, then concentrated in vacuo. The residue was purified by column chromatography (silica gel, eluted with EtOAc in hexane then MeOH in EtOAc), recrystallized from THF-IPE, then preparative HPLC (C18, eluent; H2O/MeCN with 0.1% TFA). The collected fraction was concentrated in vacuo. The residue was recrystallized from MeCN—H2O to give the title compound (492 mg) as a white solid.","9-[4-(4-{[tert-butyl(dimethyl)silyl]oxy}phenoxy)phenyl]-3,4-dihydropyrido[2,1-c][1,2,4]thiadiazine 2,2-dioxide | THF | tetrabutylammonium fluoride | THF | NH4Cl | silica gel | silica gel | EtOAc | hexane | MeOH | EtOAc | MeCN—H2O | title compound"
US05008036,"77 grams of triethanolamine (0.52 mole) is added to 200 grams of water with stirring, followed by the addition of 20 grams of an 85% solution of phosphoric acid (0.17 mole phosphoric acid), to form a solution of triethanolamine phosphate. 221 grams (0.76 mole) of antimony trioxide, 1201 grams of water, and 147 grams (1.51 moles) of hydrogen peroxide are heated at reflux for approximately 22 minutes. The triethanolamine phosphate solution from above is then charged to the reaction mixture. The product is a colloidal dispersion of hydrous antimony pentoxide particles in an essentially aqueous medium. The dispersion contains approximately 9% antimony, has an average particle size of less than 40 Å, and is stabilized with approximately 0.3 moles of the alkanolamine salt per mole of antimony.",triethanolamine | water | phosphoric acid | triethanolamine phosphate
US04820719,"To N,N-dimethylformamide (30 ml) and 2-(7-bromoheptyl) benzaldehyde (1.5 g, 5 mmoles) was added a solution of 3-trifluoromethylthiophenol (1.0 ml, 8 mmoles) and triethylamine (3.0 ml, 0.02 mole) in N,N-dimethylformamide (20 ml). The reaction mixture was heated to 90° C. for 1 hour and then stirred for 11/2 hours while slowly cooling to room temperature. The mixture was diluted with toluene and evaporated, followed by dilution with methylene chloride. The solution was evaporated and flash chromatographed using 8% ethyl acetate in hexane to give the desired product.","N,N-dimethylformamide | 2-(7-bromoheptyl) benzaldehyde | 3-trifluoromethylthiophenol | triethylamine | N,N-dimethylformamide | toluene | desired product"
US05710139,"3,4-Dichloro-6-aminobenzaldehyde (2.85 g, 15 mmol) was stirred with dimethylmalonate (10 ml) at 140° C. for 20 h. The mixture was diluted with ethyl ether (100 ml). The precipitate was collected, washed twice with ethyl ether and dried in vacuo to give 2.86 g of methyl 6,7-dichloro-2-hydroxyquinoline-3-carboxylate.","3,4-Dichloro-6-aminobenzaldehyde | dimethylmalonate | ethyl ether | ethyl ether | methyl 6,7-dichloro-2-hydroxyquinoline-3-carboxylate"
US07786169B2,"To a mixture of ethyl 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy -2-propylphenylthio)propoxy]-2-propylphenoxy]butyrate (2.1 g) in ethanol (10 ml) was added a solution of sodium hydroxide (0.26 g) dissolved into water (10 ml). After heating on a hot water bath for 5 minutes, the mixture was cooled by adding ice-water and was made acidic by addition of hydrochloric acid, followed by extraction with ethyl acetate. The organic layer was washed with water, dried over sodium sulfate and concentrated. The resultant residue was separated and purified by silica-gel column chromatography (eluting with ethanol:methylene chloride=3:100) to give the title compound (1.3 g, 65.2%) as colorless crystals, mp 79-81° C.",ethyl 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy -2-propylphenylthio)propoxy]-2-propylphenoxy]butyrate | ethanol | sodium hydroxide | water | water | ice-water | water | hydrochloric acid | ethyl acetate | sodium sulfate | resultant residue | silica | ethanol | methylene chloride | title compound
US08563760B2,"1-Bromododecanol (2.511 g, 9.47 mmol), tert-butyldiphenylsilylchloride (2.66 mL, 15.15 mmol), and imidazole (1.418 g, 20.83 mmol) were dissolved in dry DMF (20 mL) and the resulting mixture was stirred under nitrogen for 3 h at room temperature. Upon completion of reaction, water (15 mL) and diethyl ether (25 mL) were added, the two layers were separated and the water layer was extracted with diethyl ether (3×25 mL). The combined organic extracts were washed with water, brine, dried over MgSO4, filtered and filtrate evaporated. The crude was purified by silica gel column chromatography using 100% hexane to 5% ethyl acetate/hexane as eluent to afford the title product as a clear thick oil (3.57 g, 75%). 1H NMR (CDCl3): δ7.66 (m, 4H), 7.39 (m, 6H), 3.62 (t, 2H, J=6.5 Hz), 3.40 (t, 2H, J=6.9 Hz), 1.85 (m, 2H), 1.54 (m, 2H), 1.44-1.25 (m, 16H), 1.04 (s, 9H). m/z (APCI) 505.37 (M++1).",1-Bromododecanol | tert-butyldiphenylsilylchloride | imidazole | DMF | nitrogen | water | diethyl ether | water | diethyl ether | water | brine | MgSO4 | silica gel | title product
US06642248B2,"To 178 mg of the compound obtained in Step 6 above in 10 ml of acetic acid and 1 ml of water there are added 621 mg of zinc wool. The reaction mixture is stirred at ambient temperature for 2.5 hours and is then filtered. The filtrate is made alkaline using 10% aqueous ammonium hydroxide solution; the precipitate formed is then separated off by filtration. The crude residue is purified by chromatography over silica gel (dichloromethane/methanol: gradient from 0.1 to 0.5%), allowing the expected product to be isolated.",compound | acetic acid | water | zinc | crude residue | silica gel | dichloromethane/methanol
US20160159809A1,"This compound was prepared from 2-chloro-N-(2,2-diphenylethyl)quinazolin-4-amine and (2-(piperidin-1-yl)pyrimidin-5-yl)boronic acid according to the procedure described for the preparation of compound 8. Yield 57%. Mp 92° C. TLC Rf 0.30 (cyclohexane-EtOAc, 2:1). 1H NMR (400 MHz, DMSO-d6) δ 9.29 (s, 2H), 8.37 (t, J=5.5 Hz, 1H), 8.12-8.05 (m, 1H), 7.75-7.62 (m, 2H), 7.42-7.34 (m, 5H), 7.29 (dd, J=8.3, 6.9 Hz, 4H), 7.22-7.13 (m, 2H), 4.70 (t, J=7.7 Hz, 1H), 4.29 (dd, J=7.7, 5.4 Hz, 2H), 3.87 (t, J=5.4 Hz, 4H), 1.67 (q, J=6.1 Hz, 2H), 1.58 (dd, J=7.4, 4.0 Hz, 4H). HRMS m/z calcd for C31H30N6+H+ [M+H+]: 487.2605. found: 487.2607. HPLC: 100% (tR=20.2 min).","2-chloro-N-(2,2-diphenylethyl)quinazolin-4-amine | (2-(piperidin-1-yl)pyrimidin-5-yl)boronic acid | compound 8 | cyclohexane-EtOAc"
US08247430B2,"To a solution of 381 mg (0.93 mmol) N-[3-(2-amino-ethoxy)-4-pentafluoroethyl-phenyl]-2-chloro-nicotinamide in 10 ml CH2Cl2 at 0° C. was added 0.389 ml Et3N and 0.072 ml (0.93 mmol) methanesulfonylchloride. After 5 min, the reaction was stirred at RT for 30 min. The reaction was diluted with CH2Cl2, washed with brine, dried over Na2SO4, filtered, concentrated, and dried under vacuum, yielding the titled compound as a white foamy solid.",N-[3-(2-amino-ethoxy)-4-pentafluoroethyl-phenyl]-2-chloro-nicotinamide | CH2Cl2 | Et3N | methanesulfonylchloride | CH2Cl2 | brine | Na2SO4 | titled compound
US09096605B2,"To a suspension of 5-amino-4-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-1,2-dihydro-3H-pyrazol-3-one (136 mg, 0.5 mmol) in ethanol (1 mL) were added ethyl 3-oxo-3-(tetrahydro-2H-pyran-4-yl)propanoate (100 mg, 0.5 mmol) and 4 M HCl solution in dioxane (25 uL, 0.1 mmol). The reaction mixture was irradiated (microwave) at 110° C. for 30 minutes. Reaction was cooled down. The precipitate was collected by filtration. It was washed with acetic acid (1 mL), then methanol (1 mL) and dried. The titled compound was obtained. (52 mg, 25%); LC/MS: MS (ES+) m/e 408 (MH+); 1H NMR (400 MHz, DMSO-d6) δ ppm 1.69 (dd, J=12.51, 4.17 Hz, 1H) 1.73-1.80 (m, 3H) 2.46 (s, 3H) 2.72 (s, 1H) 3.34-3.45 (m, 2H) 3.83 (s, 2H) 3.93 (br. s., 2H) 5.51 (s, 1H) 7.15 (d, J=7.58 Hz, 1H) 7.29 (t, J=7.71 Hz, 1H) 7.54 (d, J=8.34 Hz, 1H) 11.46 (s, 1H).","5-amino-4-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-1,2-dihydro-3H-pyrazol-3-one | ethanol | ethyl 3-oxo-3-(tetrahydro-2H-pyran-4-yl)propanoate | HCl | dioxane | acetic acid | methanol | titled compound"
US09108946B2,"In step e of Scheme 9, 3-chloro-1-(pyridin-3-yl)-1H-pyrazole-5-carboxylic acid hydrochloride (6e) is decarboxylated in the presence of copper (II) oxide in polar solvents such as N,N-dimethylformamide at temperatures from about 80° C. to about 140° C. to yield 3-(3-chloro-1H-pyrazol-1-yl)pyridine (5b). It was surprisingly discovered that this decarboxylation only occurs in the presence of copper (II) oxide. Several known decarboxylation agents from the literature such as, for example, hydrochloric acid (See alternate synthetic route, Example 17), sulfuric acid, and palladium (II) trifluoroacetate/trifluoroacetic acid (See “CE-7”) did not yield the desired product.","3-chloro-1-(pyridin-3-yl)-1H-pyrazole-5-carboxylic acid hydrochloride | copper (II) oxide | N,N-dimethylformamide | 3-(3-chloro-1H-pyrazol-1-yl)pyridine"
US06727264B1,Prepared by Procedure E and Scheme M using 2-methyl-N-[3-(1-{5-oxo-5-[4-(trifluoromethyl)phenyl]pentyl}-4-piperidinyl)phenyl]propanamide and 1-methyl-1-phenylhydrazine: ESMS m/e: 562.2 (M+H)+.,2-methyl-N-[3-(1-{5-oxo-5-[4-(trifluoromethyl)phenyl]pentyl}-4-piperidinyl)phenyl]propanamide | 1-methyl-1-phenylhydrazine
US08841289B2,"To a solution of 2M lithium diisopropylamide (19.73 mL, 39.5 mmol) in tetrahydrofuran (30 mL) at −78° C. was added dropwise a solution of 5-bromo-N,2-dimethylbenzamide (Intermediate 22A) (3.0 g, 13.15 mmol) in THF (14 mL) followed by a solution of 3-chlorobenzonitrile (1.809 g, 13.15 mmol) in THF (14 mL) and the mixture was stirred at −78° C. for 2.5 hours. Reaction allowed to warm to room temperature and saturated NH4Cl (aq) was added. The THF was removed under reduced pressure and the resulting mixture extracted into ethyl acetate and washed with brine (precipitate was observed in both layers). Organics were evaporated to dryness, washed with methanol and dried in a vacuum oven to afford 7-bromo-3-(3-chlorophenyl)isoquinolin-1(2H)-one (0.9 g, 2.69 mmol).","lithium diisopropylamide | tetrahydrofuran | 5-bromo-N,2-dimethylbenzamide | Intermediate 22A | THF | 3-chlorobenzonitrile | THF | NH4Cl | THF | ethyl acetate | brine | methanol | 7-bromo-3-(3-chlorophenyl)isoquinolin-1(2H)-one"
US08575360B2,"A suspension of 1-{[(R)-5-(4-cyano-benzyl)-7-(3,5-dichloro-4-fluoro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carbonyl]-amino}-cyclopropanecarboxylic acid, (500 mg, 0.92 mmol), (R)-1-(5-bromo-pyridin-2-yl)-ethylamine dihydrochloride (303 mg, 1.11 mmol) and diisopropylethylamine (0.640 mL, 3.69 mmol) in 4 mL of DMF was stirred at room temperature for 10 min HATU (386 mg, 1.01 mmol) was added, and the clear yellow reaction mixture was stirred at room temperature for 3 h. The reaction mixture was partitioned between 75 mL of ethyl acetate and 25 mL of water. The organic phase was washed with 2×25 mL of 5% aqueous NaCl solution and 25 mL of brine, dried over Na2SO4, filtered, and concentrated in vacuo. The residue was purified by flash chromatography on silica gel, eluting with 0-3% MeOH in CH2Cl2, to provide 653 mg (98%) of title compound as a yellow foam, m/z 726.4 [M+1]+.","1-{[(R)-5-(4-cyano-benzyl)-7-(3,5-dichloro-4-fluoro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carbonyl]-amino}-cyclopropanecarboxylic acid | (R)-1-(5-bromo-pyridin-2-yl)-ethylamine dihydrochloride | diisopropylethylamine | DMF | HATU | ethyl acetate | water | NaCl | brine | Na2SO4 | silica gel | MeOH | CH2Cl2 | title compound"
US07947738B2,"Potassium acetate (4.16 g, 42.4 mmol) was added to an acetic anhydride (20 mL) solution of 3-hydroxy-4-cyclopentylhept-6-enoic acid (4.00 g, 17.7 mmol at the maximum), and the mixture was stirred at room temperature for 1 hour and then stirred at 120° C. for 3.5 hours. The mixture was treated with ice water, followed by extraction with diethyl ether. The organic layer was washed with a saturated aqueous solution of sodium bicarbonate. The organic layer was dried over anhydrous magnesium sulfate. Then, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography to obtain the compound of interest as a yellow oil substance (2.30 g, 74%).",Potassium acetate | acetic anhydride | 3-hydroxy-4-cyclopentylhept-6-enoic acid | ice water | diethyl ether | sodium bicarbonate | magnesium sulfate | silica gel
US08933105B2,"tert-Butyl ({5-(2-fluoropyridin-3-yl)-1-[(3-methoxyphenyl)sulfonyl]-1H-pyrrol-3-yl}methyl)methylcarbamate (303 mg) was dissolved in ethyl acetate (1 mL) and methanol (1 mL) and 4 mol/L hydrogen chloride-ethyl acetate solution (3 mL) were added. The mixture was stirred at room temperature for 2 hr, and concentrated under reduced pressure. Saturated aqueous sodium hydrogen carbonate solution was added to the residue, and the mixture was extracted with ethyl acetate. The extract was washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified by basic silica gel column chromatography (eluent: hexane-ethyl acetate=1:1→1:9) to give the title compound as a free base (149 mg). A solution of the obtained free base (149 mg) in ethyl acetate (2 mL) was added to a solution of fumaric acid (46 mg) in methanol (2 mL), and the mixture was concentrated under reduced pressure. The obtained crystals were recrystallized from a mixed solvent of ethanol-water=9:1 to give the title compound as colorless crystals (yield 138 mg, 44%).",tert-Butyl ({5-(2-fluoropyridin-3-yl)-1-[(3-methoxyphenyl)sulfonyl]-1H-pyrrol-3-yl}methyl)methylcarbamate | ethyl acetate | methanol | hydrogen chloride-ethyl acetate | ethyl acetate | sodium hydrogen carbonate | brine | sodium sulfate | silica gel | hexane-ethyl acetate | title compound | base
US04236005,"A mixture of 17.5 g. of 3-dimethylaminoacrylophenone and 15.52 g. of 3-amino-4-carbethoxypyrazole in 50 ml. of glacial acetic acid is refluxed for 4 hours and then evaporated. The residue is treated as described in Example 1, giving the desired product, m.p. 129°-130° C.",3-dimethylaminoacrylophenone | 3-amino-4-carbethoxypyrazole | acetic acid | desired product
US20160141499A1,"A solution of 3-(2-octyldodecyl)selenophene (5.00 g, 13.7 mmol) in 50 mL THF was cooled to −78° C. under N2. Lithium diisopropylamide (2 M, 8.3 mL, 16.6 mmol) was added dropwise and the mixture was stirred at −78° C. for 1 h and then return to 0° C. and stirred for additional 1 h. Then the mixture was cooled to −78° C. and tri-n-butyltin chloride (6.50 g, 20 mmol) was added in one portion. The reaction mixture was return to r.t. and stirred overnight. A solution of KF in water was added and the organic phase was washed with water for three times, then dried with Na2SO4. The solvent was evaporated to get the crude product as yellow oil, which is directly used without further purification.",3-(2-octyldodecyl)selenophene | THF | N2 | Lithium diisopropylamide | tri-n-butyltin chloride | KF | water | water | Na2SO4 | crude product
US20090203667A1,"3-Nitro-2-(oxiranylmethyl)phenol (2.0 g, 8.4 mmol) and sodium iodide (1.3 g) were heated in acetone (10 mL) at 50° C. for 3 hours. After the reaction mixture was concentrated under reduced pressure, the residue was diluted with ethyl acetate, and the mixture was washed with water. The organic layer was dried over anhydrous magnesium sulfate, and the solvent was evaporated to give 3-acetoxy-5-nitrochroman (1.6 g, 81%).",3-Nitro-2-(oxiranylmethyl)phenol | sodium iodide | acetone | ethyl acetate | water | magnesium sulfate | 3-acetoxy-5-nitrochroman
US07087778B2,"At room temperature, potassium hydroxide (330 mg) and tetrabutylammonium hydrogensulfate (82.7 mg) were dissolved in DMF (15 ml). After adding a solution (5 ml) of (2S)-2-(2,3,4-trifluoroanilino)propanol (1 g, 99.8% ee) and diethylethoxymethylenemalonate (2.09 g) in DMF, the resultant mixture was stirred for 1 hour. After adding water, the liquid reaction mixture was extracted with a solvent mixture of ethyl acetate and n-hexane (3:2). The organic layer was washed with water and dried over anhydrous magnesium sulfate. After evaporating the solvent, IPE was added to the obtained residue and the mixture was stirred at 0° C. for 1 hour. The crystals thus precipitated were collected by filtration and the moist product thus obtained was dried under reduced pressure. Thus, the title compound (1.65 g, 99. 8% ee) was obtained as colorless crystals. The 1H-NMR and IR spectral data of this product was identical with those of the compound obtained in Example 63.","potassium hydroxide | tetrabutylammonium hydrogensulfate | DMF | (2S)-2-(2,3,4-trifluoroanilino)propanol | diethylethoxymethylenemalonate | DMF | resultant mixture | water | ethyl acetate | n-hexane | water | magnesium sulfate | title compound"
US08518983B2,"Compound (3r) (0.65 g, 2 mmol), potassium carbonate (0.34 g, 2.4 mmol), CsF (0.46 g, 3 mmol), 2,5-difluorobenzonitrile (0.56 g, 4.1 mmol) and DMF (5 mL) were placed in a 60 mL reaction vial and the vial was sealed. The mixture was heated to 100° C. for 16 hours. Excess DMF was removed under reduced pressure. This material was taken up in DCM (50 mL) and washed with water (20 mL). The aqueous layer was extracted with DCM (3×). The combined organic layers were washed with brine (2×) and dried over MgSO4, filtered through a plug of celite/silica gel and concentrated under reduced pressure. The residue was purified by silica gel chromatography with hexane/EtOAc (20%) to give the final product as a viscous liquid (4r) (0.43 g, 75% isolated yield). 1H NMR (400 MHz, CDCl3) δ 7.99 (s, 1H), 7.97 (s, 1H), 7.46 (dd, J=16.8, 8.8 Hz, 2H), 7.35-7.32 (m, 1H), 7.14-7.07 (m, 1H), 7.05-7.01 (m, 1H), 4.1 (s, 3H); MS (ESI) m/z 284.2 (M+H)+.","potassium carbonate | CsF | 2,5-difluorobenzonitrile | DMF | DMF | DCM | water | brine | MgSO4 | silica gel | silica gel | hexane/EtOAc | final product"
US07129327B2,"HCl were dissolved in 2 ml of butan-1.4-diol. To this solution were added approximately 2 ml of 0.5 M tris-base in butane-1,4-diol/H2O (4:1, v/v), until the pH (glass electrode) was 6.5. 100 mg of solid Zn-free insulin were added to 3.1 ml of the buffered methyl ester solution. Most of the insulin went into solution after incubation at 37° C. for 30 minutes. Trypsin (12 mg. Worthington TPCK grade) was dissolved in 120 μl of water and 100 μl of the solution were added. After 90 minutes at 37° C., during which time the insulin dissolved completely, cellulose-acetate electrophoresis at pH 8 revealed that more than half of the insulin had been converted to a product that migrated more slowly than insulin. Since the pK of an aromatic amino group is well below 8, this is the expected behaviour of the desired product. The reaction mixture was cooled and 3.1 ml of glacial acetic acid were added to stop the enzymic reaction. The resulting mixture was then diluted with an equal volume of 10% (v/v) acetic acid and subjected to gel filtration on a 90×2.6 cm column of Sephadex G-50 (fine), elution with 1% (v/v) acetic acid.","HCl | butan-1.4-diol | tris-base | butane-1,4-diol/H2O | solid | Zn | methyl ester | TPCK | water | cellulose-acetate | desired product"
US09394300B2,"To a stirring solution of methyl 3-aminothiophene-2-carboxylate (5 g, 31.8 mmol) in Conc. HCl (4.77 ml) was added aq. solution of sodium nitrite (2.195 g, 31.8 mmol) slowly at 0-5° C. Reaction mixture was stirred at 0-5° C. for 1 h. To this was added aq. solution of sodium tetrafluoroborate (5.24 g, 47.7 mmol) in one lot. After 30 min. precipitated product was filtered. The product was added to the stirring suspension of copper bronze (6.06 g, 95 mmol) and sodium nitrite (26.3 g, 382 mmol) in water (100 ml). Reaction mixture was stirred at 25° C. for 1 h. Reaction mixture was diluted with water and EtOAc and filtered through Hyflow bed. The organic layer was separated and distilled out to get crude product which was column purified using 0-5% EtOAC in hexane to get titled compound as light yellow solid in 63% yield.",methyl 3-aminothiophene-2-carboxylate | HCl | sodium nitrite | sodium tetrafluoroborate | copper bronze | sodium nitrite | water | water | EtOAc | crude product | titled compound
US08268822B2,"2,4 dichloropyrimidine was coupled with 3-butoxyphenylboronic acid following procedure A. LC-MS showed the product had the expected M+H+ of 263.","2,4 dichloropyrimidine | 3-butoxyphenylboronic acid | 263"
US08183262B2,"The title compound was prepared from 2-(4-iodo-imidazol-1-yl)-4-trifluoromethyl-6-(4-trifluoromethyl-phenyl)-pyridine (example E.23) (0.966 g, 2.0 mmol) and N-tert-butyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-thiophene-2-sulfonamide (example F.1) (0.829 g, 2.4 mmol) according to the general procedure VI. Obtained as a white solid (0.158 g, 14%). MS (ISP) 575.2 [(M+H)+].","title compound | 2-(4-iodo-imidazol-1-yl)-4-trifluoromethyl-6-(4-trifluoromethyl-phenyl)-pyridine | N-tert-butyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-thiophene-2-sulfonamide | solid"
US20160009691A1,"3-(3-(Difluoromethoxy)phenyl)-2-ethoxy-5-methylpyrazine. A solution of 3-bromo-2-ethoxy-5-methylpyrazine (1.80 g, 8.29 mmol), 3-(difluoromethoxy)phenyl)boronic acid (2.03 g, 10.78 mmol), Pd(PPh3)4 (958.25 mg, 0.83 mmol), Na2CO3 (21.63 mL, 1.15 mol/L, 24.88 mmol), in EtOH (22 mL) and toluene (118 mL), under nitrogen, was heated at 88° C. for 1 h. The reaction mixture was extracted with EtOAc. The combined organic layers were dried (Na2SO4), and the solvent was removed under reduced pressure. Purification (FCC, SiO2, 0-50%, EtOAc/hexanes) afforded the title compound as a colorless oil (2.09 g, 90%). [M+H]=281.19.",3-(3-(Difluoromethoxy)phenyl)-2-ethoxy-5-methylpyrazine | 3-bromo-2-ethoxy-5-methylpyrazine | 3-(difluoromethoxy)phenyl | boronic acid | Pd(PPh3)4 | Na2CO3 | EtOH | toluene | nitrogen | EtOAc | Na2SO4 | SiO2 | EtOAc/hexanes | title compound
US09018175B2,"To a suspension of 1-[(1-ethyl-1H-pyrazol-4-yl)methyl]-6-phenyl-3-(piperidin-4-yl)thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione hydrochloride (300 mg; compound B42), 4-[(4aR,10bR)-9-ethoxy-8-methoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]benzoic acid (253 mg; compound C10), EDCI (122 mg) and HOBT hydrate (86 mg) in DCM (10 ml) DIPEA (0.28 ml) is added. After 45 min additional 4-[(4aR,10bR)-9-ethoxy-8-methoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]benzoic acid (126 mg; compound C10) is added and the reaction mixture is stirred for 14 h at RT. Water and aqueous potassium hydrogen sulfate solution (10% w/w) are added and the mixture is extracted with DCM. The combined organic layers are dried (sodium sulfate) and concentrated under reduced pressure. The residue is purified by flash column chromatography [silica gel, eluation gradient: DCM/MeOH, 1/0 to 1/1 (v/v)] and preparative HPLC to afford the title compound as a solid.","1-[(1-ethyl-1H-pyrazol-4-yl)methyl]-6-phenyl-3-(piperidin-4-yl)thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione hydrochloride | 4-[(4aR,10bR)-9-ethoxy-8-methoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]benzoic acid | EDCI | HOBT hydrate | DCM | 4-[(4aR,10bR)-9-ethoxy-8-methoxy-3,4,4a,10b-tetrahydro-1H-thiopyrano[4,3-c]isoquinolin-6-yl]benzoic acid | Water | potassium hydrogen sulfate | DCM | sodium sulfate | silica gel | DCM/MeOH | title compound"
US07041702B1,"A solution of 2-methyl-2-thiopseudourea sulfate (6.9 g, 0.025 mol) in 30 ml of sodium hydroxide (4%) was added a solution of 4-methylbenzoyl chloride (3.4 g, 0.022 mol) in ether (10 ml) at room temperature. The reaction mixture was stirred overnight and the precipitated solid was filtered, washed with water, later hexanes and dried under high vacuum. N-(4-methylbenzoyl)-S-methylisothiourea: yield 4.60 g (quantitative); purity 98% (HPLC); 1H-NMR (CD3OD) δ 2.4 (s, 3H, CH3), 2.6 (s, 3H, SMe), 7.2 (d, 2H, ArH), 8.1 (d, 2H, ArH).",2-methyl-2-thiopseudourea sulfate | sodium hydroxide | 4-methylbenzoyl chloride | ether | water | hexanes
US20070218136A1,"To a solution of 4-azidomethyl-N-methoxy-benzamidine (11.3 g, 0.055 mol; see step (i) above) in 200 mL of ethanol was added 200 mg of PtO2.",4-azidomethyl-N-methoxy-benzamidine | ethanol | PtO2
US20150307534A1,"Dimethylformamide (0.5 ml) was added to a stirred suspension of 7-(4-hydroxy-butoxy)quinazolin-4(3H)-one (4.86 g, 20.0 mmol) in thionyl chloride (50 ml) and the reaction heated at reflux for 1 hour. The reaction was cooled, the excess thionyl chloride was evaporated in vacuo and the residue was azeotroped with toluene (2×50 ml) before being taken up in dimethylacetamide (50 ml). 5-amino-1H-pyrazole-3-acetic acid (2.82 g, 20 mmol) and 4.0 N hydrochloric acid in dioxan (5.0 ml, 20 mmol) were added and the reaction was stirred at 90° C. for 40 minutes. The reaction was cooled to ambient temperature, poured into ice-water (500 ml) and acidified to pH >12 with 40% aqueous sodium hydroxide solution. The reaction was filtered, the filtrate was acidified to pH<4.8 and the solid which precipitated was collected by suction filtration to yield (3-{[7-(4-chlorobutoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)acetic acid (7.07 g, 91% yield) as a pale orange solid:",Dimethylformamide | 7-(4-hydroxy-butoxy)quinazolin-4(3H)-one | thionyl chloride | thionyl chloride | toluene | 5-amino-1H-pyrazole-3-acetic acid | hydrochloric acid | dioxan | ice-water | sodium hydroxide | (3-{[7-(4-chlorobutoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)acetic acid
US20160194284A1,"The synthesis was carried out as described for 10a using 8 (50 mg, 0.139 mmol) and 2-methoxyaniline (18.85 mg, 0.153 mmol) in DMF (2 mL) followed by DIEA (53.5 μl, 0.306 mmol) to afford the desired product 10j (37 mg, 0.095 mmol, 68% yield) as a white solid. 1H NMR (500 MHz, CD3OD) δ: 8.09 (m, 2H), 7.99 (dd, J=9.0 Hz, J=7.5 Hz, 1H), 7.51 (t, J=7.5 Hz, 1H), 7.40 (dt, J=7.5 Hz, J=1.0 Hz, 2H), 7.07 (d, J=2.5 Hz, 1H), 7.06 (d, J=1.0 Hz, 1H), 7.02-6.98 (m, 2H), 6.94-6.89 (m, 1H), 3.92 (s, 3H), 3.71 (t, J=7.0 Hz, 4H), 2.17 (quintet, J=3.5 Hz, 4H). MS m/z (M++1): 389.2.",10a | 8 | 2-methoxyaniline | DMF | DIEA | desired product 10j
US20080280933A1,"Formaldehyde (37% solution in water, 315 mL, 4.208 mol) was added to a stirred solution of 2-methylbenzimidazole (97.0 g, 734 mmol) in MeOH (500 mL). The mixture was refluxed overnight. The formed precipitate was separated by filtration and dried in vacuo to afford (2-Methyl-1H-benzimidazol-1-yl)methanol (388.0 g 74%).",Formaldehyde | 2-methylbenzimidazole | MeOH | (2-Methyl-1H-benzimidazol-1-yl)methanol
US07531532B2,"After adding a 2-(4-fluorophenyl)acetyl isothiocyanate-toluene (0.2 M, 2.2 ml) solution to a solution of 4-(4-amino-2-fluorophenoxy)-6-{[(3S)-3-(dimethylaminomethyl)pyrrolidin-1-yl]carbonylamino}pyrimidine (105 mg) and (+)-10-camphorsulfonic acid (65 mg) in ethanol (2.5 ml) at room temperature, the mixture was stirred for 1 hour. The reaction mixture was partitioned between ethyl acetate and saturated aqueous sodium hydrogencarbonate. The organic layer was washed with saturated aqueous sodium hydrogencarbonate and brine and dried over anhydrous sodium sulfate. The solvent was distilled off, and the residue was purified by silica gel column chromatography (Fuji Silysia NH, eluent; ethyl acetate:heptane=2:1, then ethyl acetate) to provide the title compound (60.5 mg, 38%) as white powder.",2-(4-fluorophenyl)acetyl isothiocyanate-toluene | 4-(4-amino-2-fluorophenoxy)-6-{[(3S)-3-(dimethylaminomethyl)pyrrolidin-1-yl]carbonylamino}pyrimidine | (+)-10-camphorsulfonic acid | ethanol | ethyl acetate | sodium hydrogencarbonate | sodium hydrogencarbonate | brine | sodium sulfate | silica gel | ethyl acetate | heptane | ethyl acetate | title compound
US08367706B2,"2-Bromo-6-ethynylpyridine (Example 465, Step 1) (350 mg, 1.92 mmol) and ethyl azidoacetate (1.08 ml, 1.92 mmol) were combined in t-BuOH (4.0 mL) and water (2.0 mL). CuSO4.5H2O (24 mg, 0.096 mmol) in water (1.0 mL) was added, followed by sodium ascorbate (76 mg, 0.39 mmol) in water (1.0 mL). The reaction was stirred at room temperature for 5 h, diluted with saturated NaHCO3, and extracted with EtOAc (2×). The combined organic layers were washed with brine, dried (MgSO4), filtered, and evaporated to a yellow residue that was purified by flash chromatography (0-30% EtOAc/hexanes) to afford the title compound as a colorless solid.",2-Bromo-6-ethynylpyridine | ethyl azidoacetate | t-BuOH | water | CuSO4.5H2O | water | sodium ascorbate | water | NaHCO3 | EtOAc | brine | MgSO4 | EtOAc/hexanes | title compound
US04167569,"A solution of 3-(2-amino-5-benzoylbenzimidazol-1-yl)-propionic acid (6.1 g.) in methanol (30 ml.) was treated with a saturated solution (30 ml.) of hydrogen chloride in methanol. The mixture was left at room temperature for 16 hours and then evaporated. The residue was dissolved in water. The solution obtained was adjusted to pH 8.5 with aqueous sodium bicarbonate solution and then extracted with ethyl acetate (3×50 ml.). The extracts were dried (MgSO4) and evaporated to give methyl 3-(2-amino-5-benzoylbenzimidazol-1-yl)propionate as an oil. This oil was dissolved in methanol (60 ml.) and the solution heated at reflux for 5 hours. The solid which precipitated was collected and washed successively with methanol, acetone and then ether to give 8-benzoyl-3,4-dihydropyrimido[1,2-a]-benzimidazol-2(1H)-one (3.4 g.), m.p. 323°-330° C., microanalysis, C17H13N3O2 requires: C, 70.1; H, 4.5; N, 14.4% found: C, 69.9; H, 4.4; N, 14.0%.",3-(2-amino-5-benzoylbenzimidazol-1-yl)-propionic acid | methanol | hydrogen chloride | methanol | water | sodium bicarbonate | ethyl acetate | MgSO4 | methyl 3-(2-amino-5-benzoylbenzimidazol-1-yl)propionate
US20160120878A1,"To a solution of 4-((3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-3a-(2-((tert-butoxycarbonyl)amino)ethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2H-cyclopenta[a]chrysen-9-yl) 1-tert-butyl 2,2-dimethylsuccinate (37) (6.7 g, 8.88 mmol) in DCM (20 mL) stirred at it was added TFA (4 ml, 51.9 mmol). The reaction mixture was stirred at it for 2 h. The reaction mixture was washed with sat. NaHCO3. A solid was formed and collected by filtration to give 4-(((3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-3a-(2-aminoethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2H-cyclopenta[a]chrysen-9-yl)oxy)-2,2-dimethyl-4-oxobutanoic acid (38) (4 g, 6.55 mmol, 73.7% yield) as a white solid. 1H NMR (400 MHz, DMSO-d6) δ=4.44-4.28 (m, 1H), 3.20-3.05 (m, 1H), 2.87-2.75 (m, 1H), 2.46-2.16 (m, 6H), 1.97-0.66 (m, 47H); LC/MS: m/z calculated 597.4. found 598.3 (M+1)+.","4-((3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-3a-(2-((tert-butoxycarbonyl)amino)ethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2H-cyclopenta[a]chrysen-9-yl) 1-tert-butyl 2,2-dimethylsuccinate | DCM | TFA | NaHCO3 | 4-(((3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-3a-(2-aminoethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2H-cyclopenta[a]chrysen-9-yl)oxy)-2,2-dimethyl-4-oxobutanoic acid"
US07354932B2,"To a solution of 2-amino-3-nitroanisole (465 mg, 2.94 mmol) in methanol (50 mL) was added palladium on carbon (10% Pd, 100 mg). The mixture was then placed under an atmosphere of hydrogen gas (1 atm) and was stirred for one hour. The mixture was then filtered through celite and concentrated to give 2,3-diaminoanisole as a yellow foam in a yield of 400 mg (98%). 1H NMR (CDCl3) δ 3.45 (br s, 4H(NH)), 3.84 (s, 3H), 6.40 (m, 2H), 6.67 (t, 1H, J=7.8 Hz)","2-amino-3-nitroanisole | methanol | palladium on carbon | 2,3-diaminoanisole"
US08664246B2,"500 mg (2.11 mmol) of tert-butyl 3-aminopiperidine-1-carboxylate, 772 mg (4.22 mmol) of 2-amino-6-chloro-3-nitropyridine and 1.05 ml (6.34 mmol) of diisopropylethylamine were suspended in 18 ml of DMSO and heated to 120° C. in a microwave reactor for 45 min. The reaction mixture was purified by means of preparative reversed-phase HPLC (method 13). 600 mg (81% of theory) of the product were isolated in solid form.",tert-butyl 3-aminopiperidine-1-carboxylate | 2-amino-6-chloro-3-nitropyridine | diisopropylethylamine | DMSO
US08084481B2,"560 mg (1.67 mmol) of ethyl 3-[3-(4-chlorophenyl)-4-cyclopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-propionate from Example 87A are placed in 1.5 ml methanol, treated with 0.5 ml 20% aqueous potassium hydroxide and stirred for 2 hrs at room temperature. The methanol is removed in vacuo, the aqueous residue acidified to pH 1 with 2 N hydrochloric acid and the resulting precipitate isolated by filtration. 439 mg (73% of theory) of the target compound are thus obtained.","ethyl 3-[3-(4-chlorophenyl)-4-cyclopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-propionate | methanol | potassium hydroxide | methanol"
US20150218124A1,"The title compound was prepared from 4-bromo-3,5-dicyano-1,2-phenylene diacetate (300 mg) and 4-(dipropylcarbamoyl)phenylboronic acid (301 mg) instead of 3,4,5-trifluorophenylboronic acid as described in Example 7. Reaction conditions: 10 min at 150° C. Yield 150 mg","title compound | 4-bromo-3,5-dicyano-1,2-phenylene diacetate | 4-(dipropylcarbamoyl)phenylboronic acid | 3,4,5-trifluorophenylboronic acid"
US05589517,"In a 100 ml round-bottom flask, 8.5 g of N,N-dimethyl-2-chloroethylamine hydrochloride, 8.7 g of sodium thiosulfate and 50 ml of distilled water were charged and heated under reflux for 2 hours. 36% hydrochloric acid (5.1 g) was added, and the mixture was further heated under reflux for 1 hour. With cooling the mixture on an ice bath, 5.5 g of sodium hydroxide was slowly added to make the mixture alkaline, which was then subjected to extraction twice with 50 ml of ethyl acetate. After desiccating with anhydrous potassium carbonate, the solvent was removed by distillation and distilled under reduced pressure to give 7.0 g of bis(N,N-dimethyl-2-aminoethyl)disulfide, the precursor.","N,N-dimethyl-2-chloroethylamine hydrochloride | sodium thiosulfate | water | hydrochloric acid | ice | sodium hydroxide | ethyl acetate | bis(N,N-dimethyl-2-aminoethyl)disulfide"
US04728645,"A solution of 2.13 g of 5-(p-aminophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine in 4 ml of concentrated hydrochloric acid and 10 ml of water is added in an ice-bath and a solution of 0.78 g of sodium nitrite in 2 ml of water is added slowly. The solution is added via dropping funnel to an ice cooled solution of 3.0 g of copper(I) cyanide in 10 ml of water, keeping the temperature between 30°-40°. The reaction mixture is heated on a steam bath for 1 hr, cooled and brought to pH 9. The organic extracts are dried over sodium sulfate and evaporated and the residue is chromatographed on silica gel with ethyl acetate to yield the title compound.","5-(p-aminophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine | hydrochloric acid | water | ice | sodium nitrite | water | ice | copper(I) cyanide | water | sodium sulfate | silica gel | ethyl acetate | title compound"
US08816082B2,"A sample of tetraisopropyl (2-(5-bromopyridin-3-yl)-1-fluoroethane-1,1-diyl)bis(phosphonate) (85 mg; 0.16 mmol), Pd(Ph3)4 (36.9 mg; 0.032 mmol) and (3,5-dimethylisoxazol-4-yl)boronic acid (34 mg; 0.24 mmol) are added in a vial, the vial is capped with a septum and added DME (4 mL) is added. The mixture is immediately flushed with argon, potassium carbonate solution (2.5 eq.) is added and flushed again with argon. The reaction mixture is stirred at 80° C. for 36 h under argon. The mixture is cooled, diluted with EtOAc and filtered through Celite™, the Celite™ is rinsed 3× with EtOAc/MeOH (1:1). The combined filtrate is concentrated under vacuum and deposited on silica gel. Purification by column chromatography on silica gel (pre washed with 1% NEt3 in hexanes) using a solvent gradient from hexanes to EtOAc, and then to 50% MeOH in EtOAc lead to the isolation of the product as a brown oil (41 mg; 47% yield).","tetraisopropyl (2-(5-bromopyridin-3-yl)-1-fluoroethane-1,1-diyl)bis(phosphonate) | Pd(Ph3)4 | (3,5-dimethylisoxazol-4-yl)boronic acid | DME | argon | potassium carbonate | argon | argon | EtOAc | EtOAc/MeOH | silica gel | NEt3 | hexanes | product"
US20090082308A1,"Di-tert-butyl [2-(ethoxycarbonyl)-1-benzothien-6-yl](methyl)malonate (0.26 g, 0.598 mmol) was dissolved in DCM (1.5 mL) and TFA (1.5 mL) was added. The solution was stirred at room temperature for 2 hours. The solvent was removed in vacuo and the residue partitioned between saturated NaHCO3-EtOAc. The aqueous phase was acidified with 2N HCl and extracted with EtOAc. The combined organic extracts were dried over MgSO4 and concentrated in vacuo to give the product (pale yellow solid). 1H NMR (DMSO-d6) δ 13.12 (br s, 2H), 8.14 (s, 1H), 8.03 (d, J=1.8 Hz, 1H), 7.95 (d, J=8.4 Hz, 1H), 7.47 (dd, J=8.4, 1.8 Hz, 1H), 4.32 (q, J=7.2 Hz, 2H), 1.77 (s, 3H), 1.31 (t, J=7.2 Hz. 3H).",Di-tert-butyl [2-(ethoxycarbonyl)-1-benzothien-6-yl](methyl)malonate | DCM | TFA | NaHCO3-EtOAc | EtOAc | MgSO4
US08445692B2,"Sodium nitrite (450 mg, 6.5 mmol, in H2O) (10 mL) was added dropwise, over 10 minutes, to a suspension of 1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazole-4-carbohydrazide (example 10-1b) (1 g, 4.3 mmol) in 10% aqueous acetic acid (50 mL) and cooled to 0° C. via an ice water bath. The reaction was stirred for an additional 15 minutes then extracted with ethyl acetate (3×, 75 mL). The combined organic extracts were washed with aqueous saturated sodium carbonate (100 mL) followed by H2O (100 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated. The solid product was triturated with ethyl acetate/hexanes (1/9) and dried en vacuo to afford 1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazole-4-carbonyl azide (1 g, 93%) as a white solid. 1H NMR (CDCl3, 400 MHz): δ2.20 (s, 3H), 2.44 (s, 3H), 5.07 (s, 2H), 7.81 (s, 1H), 7.93 (s, 1H).","Sodium nitrite | 1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazole-4-carbohydrazide | acetic acid | ice water | ethyl acetate | sodium carbonate | sodium sulfate | ethyl acetate/hexanes | 1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazole-4-carbonyl azide"
US20130029954A1,"To a solution of tert-butyl 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-(aziridin-1-ylmethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoate (62 mg, 0.099 mmol) in DCM (4 mL) was added TFA (0.4 ml, 5.19 mmol). The mixture was stirred at rt for 6 h. The solvents were removed in vacuo and the residue was purified by reverse phase prep. HPLC to afford the title compound as a white foam (15 mg, 26.6%) LCMS: m/e 570.36 (MH+), 2.363 min (method 9). 1H NMR (400 MHz, METHANOL-d4) δ 8.02-7.84 (m, 2H), 7.24 (d, J=8.3 Hz, 2H), 5.33 (s, 1H), 4.78 (s, 1H), 4.66 (s, 1H), 3.28-3.14 (m, 1H), 2.93-2.72 (m, 1H), 2.59-2.41 (m, 1H), 2.24-1.95 (m, 2H), 1.92-1.68 (m, 12H), 1.56 (br. s., 8H), 1.31 (m, 5H), 1.19 (m, 5H) 1.10 (s, 3H), 1.06 (s, 3H), 0.99 (s, 3H), 0.97 (s, 3H).","tert-butyl 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-(aziridin-1-ylmethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoate | DCM | TFA | title compound"
US07335778B2,"In 200 ml of N,N-dimethylformamide was dissolved 100 g of (4R)-4-[(1R)-1-(N-benzylamino)-1-carbamoylmethyl]-3-benzylthiazolidin-2-one, and under nitrogen atmosphere, the solution was stirred at 85° C. for 5 hours. At 90° C. to 95° C., 200 ml of 35% hydrochloric acid was added dropwise to the solution, and the mixture was stirred for 1 hour and 15 minutes. Moreover, 100 ml of 35% hydrochloric acid was added dropwise, and the mixture was stirred for 2 hours. Then, 200 ml of water was added dropwise to the mixture at 85° C. The solution was ice-cooled, and precipitated crystal was collected by filtration, washed with water and then dried at 50° C. for 17 hours to give 93.1 g of (4R,5R)-1,3-dibenzyl-2-oxo-5-(mercaptomethyl)-imidazolidin-4-carboxylic acid as colorless crystal.","N,N-dimethylformamide | (4R)-4-[(1R)-1-(N-benzylamino)-1-carbamoylmethyl]-3-benzylthiazolidin-2-one | nitrogen | hydrochloric acid | hydrochloric acid | water | water | (4R,5R)-1,3-dibenzyl-2-oxo-5-(mercaptomethyl)-imidazolidin-4-carboxylic acid"
US05614633,"In 40 ml of tetrahydrofuran was dissolved 0.36 g of cyclopentan-1,3-dione and 0.13 g of sodium hydride (60%) was added thereto under nitrogen stream with cooling at -20° C. after the mixture was stirred at room temperature for 15 minutes, 0.72 g of a complex of copper (I) bromide and dimethyl sulfide was added. To the reaction mixture was added 0.92 g of 3,4-epoxy-6-pentafluoroethyl-2,2-bisfluoromethyl-3,4-dihydro-2H-1-benzopyran dissolved in 10 ml of tetrahydrofuran. The mixture was stirred for 6 days. To the mixture were added water and a small amount of concentrated sulfuric acid. The mixture was extracted with methylene chloride and the organic layer was washed with water and dried. The solvent was distilled off and the resultant residue was purified using silica gel column chromatography (developing solution, MeOH:CH2Cl2 =1:99) and another silica gel column chromatography (developing solution, AcOEt:hexane=1:1) to obtain 0.04 g of trans-6-pentafluoroethyl-2,2-bisfluoromethyl-3,4-dihydro-4-(3-oxo-cyclopent-1-enyloxy)-2H-1-benzopyran-3-ol represented by the following formula having a melting point of 165°-167° C.","tetrahydrofuran | cyclopentan-1,3-dione | sodium hydride | nitrogen | complex | copper (I) bromide | dimethyl sulfide | 3,4-epoxy-6-pentafluoroethyl-2,2-bisfluoromethyl-3,4-dihydro-2H-1-benzopyran | tetrahydrofuran | water | sulfuric acid | methylene chloride | water | resultant residue | silica gel | AcOEt | hexane | trans-6-pentafluoroethyl-2,2-bisfluoromethyl-3,4-dihydro-4-(3-oxo-cyclopent-1-enyloxy)-2H-1-benzopyran-3-ol"
US20040127482A1,"To a solution of 5,6,9,10,11,12.-hexahydro-4H,8H-azepino[3′,4′:4,5]pyrrolo[3,2,1-ij]quinoline (240 mg, 1.06 mmol) in TFA (4.0 mL) was added Et3SiH (2.0 mL). The mixture was stirred for 3 days then concentrated in vacuo. The residue was dissolved in dilute AcOH and washed with Et2O. The aqueous solution was basified with 1N NaOH. A white solid was precipitated and filtered to yield the title compound as a pale yellow viscous oil (200 mg, 83%). MS (CI, NH3): 229.4 (base, M+H).","hexahydro-4H,8H-azepino[3′,4′:4,5]pyrrolo[3,2,1-ij]quinoline | TFA | Et3SiH | AcOH | Et2O | title compound"
US07514452B2,"Boron tribromide (1 M dichloromethane solution; 5.10 ml) was added to a dichloromethane (10 ml) solution of the compound of Example 70 (0.86 g) at 0° C. and stirred at 25° C. for 3 hours. The reaction solution was mixed with 2 M aqueous sodium hydroxide solution, stirred for 0.3 hours, and mixed with 2 M hydrochloric acid and chloroform. The organic layer was washed with saturated brine and dried over MgSO4. The solvent was evaporated under reduced pressure, and the residue was purified by silica gel column chromatography (eluent: 0→15% methanol/chloroform gradient) and recrystallized from isopropyl alcohol, thereby giving 0.29 g of the desired compound. Melting point: 230-231° C.",Boron tribromide | dichloromethane | compound | sodium hydroxide | hydrochloric acid | chloroform | brine | MgSO4 | silica gel | methanol/chloroform | isopropyl alcohol | desired compound
US20160122336A1,"The title compound was prepared as described in Example 15, using (S)—N-(2-hydroxy-2-methylpropyl)-4-(2-methylpiperidine-1-carbonyl)thiazole-2-carboxamide (Intermediate 15/3) in place of (S)—N-(2-hydroxy-2-methylpropyl)-4-(2-methylpyrrolidine-1-carbonyl)thiazole-2-carboxamide and 2-(5-bromo-4-methylpyridin-2-yl)-1,1,1,3,3,3-hexafluoropropan-2-ol (Intermediate 23/1) in place of 2-(4-bromo-3-(difluoromethyl)phenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol. 1H NMR (CDCl3, 500 MHz) δ ppm 8.67 (d, J=8.6 Hz, 1H), 7.66-7.60 (m, 1H), 7.42-7.34 (m, 1H), 5.47-5.33 (m, 1H), 5.12-4.65 (m, 1H), 3.69-3.12 (m, 3H), 3.04-2.88 (m, 1H), 2.57 (d, J=7.5 Hz, 3H), 2.19-2.12 (m, 1H), 1.84-1.69 (m, 1H), 1.64-1.55 (m, 2H), 1.50-1.43 (m, 1H), 1.40-1.31 (m, 1H), 1.31-1.28 (m, 8H), 1.10 (d, J=6.9 Hz, 1H). MS (ESI): m/z 583.0 [M+H]+.","title compound | (S)—N-(2-hydroxy-2-methylpropyl)-4-(2-methylpiperidine-1-carbonyl)thiazole-2-carboxamide | Intermediate 15/3 | 2-(5-bromo-4-methylpyridin-2-yl)-1,1,1,3,3,3-hexafluoropropan-2-ol | Intermediate 23/1"
US05120738,"N,N'-Dicyclohexylcarbodiimide (2.27 g) was added to a solution of 2.82 g of oleic acid and 1.62 g of o-phenylenediamine in 50 ml of methylene chloride with stirring under ice cooling. The mixture was stirred at room temperature for one night. After completion of the reaction insoluble matter was filtered, followed by removal of the solvent by evaporation. The residue obtained was purified by silica gel column chromatography to obtain 2.84 g of the objective compound (yield: 76%).","N,N'-Dicyclohexylcarbodiimide | oleic acid | o-phenylenediamine | methylene chloride | ice | silica gel | objective compound"
US20150051160A1,"456 mg (0.68 mmol) of the compound from example 2A was dissolved in 8 ml dichloromethane. 300 mg (0.68 mmol)N-Phenyl-S-trityl-L-cysteinamide, 0.12 ml (0.68 mmol) N,N-diisopropylethylamine and 260 mg (0.68 mmol) HATU were added. The reaction mixture was stirred at room temperature for 4 h. From the reaction mixture the solvent was removed under reduced pressure. The raw product was purified in two portions by preparative RP-HPLC on a C18 column with a water methanol gradient from 9/1 to 1/9. The product-containing fractions were combined and concentrated to dryness under reduced pressure. This gave 361 mg (0.37 mmol, 53% of theory) of the desired product.","compound | dichloromethane | N-Phenyl-S-trityl-L-cysteinamide | N,N-diisopropylethylamine | HATU | raw product | water methanol"
US20120149723A1,"To a solution of 1,1-dimethylethyl (2S,5S)-2-ethenyl-5-methyl-1-piperidinecarboxylate D12 (2 g, 8.88 mmol) in THF (40 ml) stirred under nitrogen at room temperature was added a solution of BH3. THF 1 M in THF (26.6 mL, 26.6 mmol) dropwise. The reaction mixture was stirred at 70° C. for 20 hours. Then at room temperature water (0.480 ml, 26.6 mmol) was added (caution!) and NaOH 1 M in water (3.55 mL, 3.55 mmol) and slowly H2O2 30% Wt in water (1.360 ml, 13.31 mmol) the reaction mixture was stirred at room temperature for 2 hours. Et2O was added and then water, the aqueous extracted with Et2O, the phases were separated, the combined organic solvents were passed through a hydrophobic filter and the organic solvent removed to give the crude which was purified by flash chromatography (silica 100 g column, gradient elution from Cy to Cy/EtOAc 65/35) to afford the title compound D13 N10649-63-1 (1.25 g, 5.14 mmol, 58% yield) as yellow oil. MS: (ES/+) m/z: 244 (M+1). C13H25NO3 requires 243. 1H NMR (400 MHz, DMSO-d6) δ ppm 4.27-4.46 (m, 1H), 3.66-3.96 (m, 2H), 3.34-3.49 (m, 2H), 2.21-2.45 (m, 1H), 1.65-1.95 (m, 2H), 1.46-1.65 (m, 3H), 1.16-1.45 (m, 11H), 0.76-0.95 (m, 3H).","1,1-dimethylethyl (2S,5S)-2-ethenyl-5-methyl-1-piperidinecarboxylate | THF | nitrogen | THF | THF | water | NaOH | water | H2O2 | water | Et2O | water | Et2O | silica | EtOAc | title compound"
US07232924B2,"To a stirred solution of compound (15) (1 g, 2.7 mmol) in acetonitrile (10 mL) under nitrogen was added (10 mg, 0.008 mmol) of tetrakis(triphenylphosphine) palladium (0) followed by morpholine (0.28 mL, 0.28 g, 3.2 mmol). After one hour, the solvent was removed in vacuo. The resulting oil was dissolved in diethyl ether (50 mL) and the organic phase was washed with 2N HCl (20 mL), water (20 mL) and brine (20 mL). The ether layer was dried over anhydrous sodium sulfate and concentrated to give an oil, which was purified by column chromatography on silica gel, eluting with 30% ethyl acetate:hexane. The desired product (11) was isolated as a white crystalline solid (0.75 g, 84% yield), m.p 63–64° C.",acetonitrile | nitrogen | tetrakis(triphenylphosphine) palladium (0) | morpholine | diethyl ether | ether | HCl | water | brine | sodium sulfate | silica gel | ethyl acetate | solid
US20160257651A1,"To a solution of 3-bromo-4-methylaniline (5.00 g, 26.9 mmol) in xylene (50 mL), methyl acetoacetate (6.20 g, 53.8 mmol) and pyridine (4.30 g, 53.8 mmol) were added. The mixture was heated to 135° C. overnight. Consumption of the compound represented by the structural formula (X-1) was shown by LCMS. Then, the mixture was cooled to room temperature, and diluted with water, aqueous HCl was added to the mixture, and the resulting mixture was extracted with ethyl acetate (3×100 mL). The organic layer was dried over anhydrous Na2SO4, and concentrated, and the residue was purified by flash silica gel chromatography (petroleum ether:ethyl acetate=20:1 to 5:1) to give N-(3-bromo-4-methylphenyl)-3-oxobutanamide as white solid (4.10 g, yield 56%).",3-bromo-4-methylaniline | xylene | methyl acetoacetate | pyridine | water | HCl | ethyl acetate | Na2SO4 | silica gel | petroleum ether | ethyl acetate | N-(3-bromo-4-methylphenyl)-3-oxobutanamide
US05034401,"A mixture of 4.19 g (20 mmoles) 5-chloroacetyl-3H-indol-2-one 4 g dry sodium carbonate, 4.27 g (20 mmoles) 4-phenoxypiperidine hydrochloride and 100 ml ethanol is heated under reflux fo 1 h 15 min under an argon atmosphere. The mixture is left to cool, 10 ml water, then 8 g potassium borohydride are added and stirring is continued for 2 h 30 min at ambient temperature. A further 200 ml water are added, the mixture is stirred for 30 min and filtered, and the solid is washed with water and dried. 4.67 g of oohre orystals are obtained, which are purified by chromatography on a silica column, eluting with a 95/5 mixture of dichloromethane/ methanol.",5-chloroacetyl-3H-indol-2-one | 4-phenoxypiperidine hydrochloride | ethanol | argon | water | potassium borohydride | water | water | silica
US06103737,"A mixture of 4-chloro-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidine (425 mg, prepared as described by Y. L. Chen in Patent Application WO94/13676), 2-(trifluoromethyl)phenylboronic acid (310 mg) tetrakis(triphenylphoshine)palladium(0) (50 mg), 1M aqueous sodium carbonate (2 mL), ethanol (0.75 mL) and benzene (6 mL) was refluxed for 6 hr. The cooled mixture was diluted with ethyl acetate and the aqueous layer was removed. The organic layer was washed with 1N aqueous sodium hydroxide, and brine, dried, and concentrated in vacuo. The crude reaction product was chromatographed on silica gel using ethyl acetate/hexanes (1:3) as eluent. The title compound was obtained as a glass (300 mg) that crystallized on trituration with ether to give crystals, mp 176.5-177.5°. Elemental Analysis: Calcd. for C22H24N3F3 : C, 70.91: H, 5.71; N, 9.92. Found: C, 70.69; H, 5.72; N, 9.84.","4-chloro-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidine | 2-(trifluoromethyl)phenylboronic acid | sodium carbonate | ethanol | benzene | ethyl acetate | sodium hydroxide | brine | silica gel | title compound | glass"
US04935536,"The fully protected derivative Z-Asn(Tmob)-OBzl prepared in Step 1 (2.0 g, 3.75 mmol) was dissolved in acetic acid (50 ml), water (14 ml) and DMF (10 ml) by slight warming and vigorous stirring, nitrogen was flushed through the low pressure hydrogenation flask, 5% palladium on carbon catalyst (400 mg) was added, and a gentle stream of hydrogen continuously passed over the vigorously stirred solution for 2 hours. Nitrogen was once more flushed through the system and the catalyst removed by filtration through a doubled fluted Whatman No. 1 filter paper. The filtrate was evaporated, the residue dried in vacuo, and triturated under ethyl acetate to give a white solid. The suspension was cooled overnight to 4 degrees, then filtered and washed with ethyl acetate. Yield after drying 1.16 g (96%), Rf 0.55 single spot n-butanol/acetic acid/water (3:1:1).",Z-Asn(Tmob)-OBzl | acetic acid | water | DMF | nitrogen | palladium on carbon | hydrogen | Nitrogen | ethyl acetate | ethyl acetate | n-butanol/acetic acid/water
US20040209921A1,"Using General Procedure A: Reaction of 2-[4-(5,6,7,8-tetrahydro-quinolin-8-ylamino)-butyl)-isoindole-1,3-dione, 2-bromomethyl-6-methoxymethyl-pyridine (Gillespie, R. J. et al. PCT Int. Appl. (2002), WO 2002055083), and DIPEA in CH3CN gave 2-{4-[(6-methoxymethyl-pyridin-2-ylmethyl)-(5,6,7,8-tetrahydro-quinolin-8-yl)-amino]-butyl}-isoindole-1,3-dione as a yellow oil. Deprotection with H2NNH2—H2O following General Procedure E gave the free base. Conversion to the HBr salt using General Procedure D gave COMPOUND 356 as a white solid. 1H NMR (D2O) δ 1.52-1.70 (m, 4H), 1.75-1.89 (m, 1H), 1.98-2.10 (m, 1H), 2.16-2.22 (m, 1H), 2.39-2.43 (m, 1H), 2.59-2.68 (m, 1H), 2.84-3.02 (m, 5H), 3.53 (s, 3H), 4.28 (d, 1H, J=15.9 Hz), 4.36 (d, 1H, J=15.9 Hz), 4.49 (dd, 1H, J=5.7, 10.5 Hz), 4.88 (s, 2H), 7.80 (dd, 1H, J=5.7, 7.8 Hz), 7.91 (d, 1H, J=7.8 Hz), 8.08 (d, 1H, J=7.8 Hz), 8.26 (d, 1H, J=8.1 Hz), 8.47 (dd, 1H, J=7.8, 8.1 Hz), 8.57 (d, 1H, J=5.7 Hz); 13C NMR (D2O) δ 20.42 (2 carbons), 24.93, 25.01, 27.62, 39.53, 51.42, 53.24, 59.28, 60.01, 70.38, 125.20, 125.72, 126.27, 140.04, 140.29, 146.84, 146.93, 151.24, 153.50, 153.82; ES-MS m/z 355 (M+H). Anal. Calcd. for C21H30N4.3.4HBr.1.2H2O: C, 38.73; H, 5.54; N, 8.60; Br, 41.72. Found: C, 39.06; H, 5.54; N, 8.44; Br, 41.42.","2-[4-(5,6,7,8-tetrahydro-quinolin-8-ylamino)-butyl)-isoindole-1,3-dione | 2-bromomethyl-6-methoxymethyl-pyridine | DIPEA | CH3CN | 2-{4-[(6-methoxymethyl-pyridin-2-ylmethyl)-(5,6,7,8-tetrahydro-quinolin-8-yl)-amino]-butyl}-isoindole-1,3-dione"
US07598244B2,"(S)-1-[7-(4-benzyloxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-[1-(3-methoxyphenyl)ethyl]urea (the compound obtained in Example 222; 7.83 g) was dissolved in acetic acid (600 ml). Thereafter, 10% palladium carbon (50% water content; 2.0 g) was added to the solution, and the obtained mixture was stirred at 40° C. overnight in a hydrogen atmosphere. The reaction solution was filtrated with a filter medium (Celite), and the resultant was then concentrated under a reduced pressure. The residue was purified by silica gel column chromatography (eluted with 4% methanol-containing methylene chloride) to obtain the captioned compound (5.37 g).","(S)-1-[7-(4-benzyloxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-3-[1-(3-methoxyphenyl)ethyl]urea | compound | acetic acid | palladium carbon | hydrogen | silica gel | methanol | methylene chloride | compound"
US20120077801A1,"A solution of N-{cis-4-[1-{4′-[(dimethylamino)methyl]biphenyl-3-yl}-6-fluoro-2,4-dioxo-1,4-dihydropyrido[2,3-d]pyrimidin-3(2H)-yl]cyclohexyl}-6-fluoroimidazo[1,2-a]pyridine-2-carboxamide (75 mg, 0.12 mmol) and iodomethane (0.014 mL, 0.23 mmol) were dissolved in acetonitrile (3 mL) and the solution was stirred at 80° C. for 24 h. The reaction was concentrated and was purified by preparative HPLC on a Phenomenex Gemini column using a 75-5% gradient of aqueous 0.2% ammonia in acetonitrile as eluent. The fractions containing the desired compound were evaporated to dryness to afford the title compound as a white solid (26 mg, 32%).","N-{cis-4-[1-{4′-[(dimethylamino)methyl]biphenyl-3-yl}-6-fluoro-2,4-dioxo-1,4-dihydropyrido[2,3-d]pyrimidin-3(2H)-yl]cyclohexyl}-6-fluoroimidazo[1,2-a]pyridine-2-carboxamide | iodomethane | acetonitrile | desired compound | title compound"
US06194396B1,"To a solution of 4-benzyloxy-l-ethyl-2-methyl-1H-benzimidazole (370 mg) in ethyl acetate (3.7 ml) was added 10% palladium on carbon (18 mg), and the mixture was stirred for 5 hours at ambient temperature under hydrogen atmosphere. Insoluble material was filtered off, and the filtrate was concentrated in vacuo. The residue was crystallized with diisopropyl ether to give 1-ethyl-4-hydroxy-2-methyl-1H-benzimidazole (220 mg).",4-benzyloxy-l-ethyl-2-methyl-1H-benzimidazole | ethyl acetate | palladium on carbon | hydrogen | diisopropyl ether | 1-ethyl-4-hydroxy-2-methyl-1H-benzimidazole
US07429609B2,"To a solution of 222 mg of 1-methanesulfonyloxymethyl-cyclopropane carboxylic acid ethyl ester in 5 mL of tetrahydrofuran was added 3 mL of 2M dimethyl amine in tetrahydrofuran, and stirred at room temperature for 3 days. The solvent was distilled off, and the residue was added with 2 mL of 1N hydrochloric acid, and washed with diethyl ether. The aqueous layer was added with 10% potassium carbonate aqueous solution, and extracted with ethyl acetate. The extracted layer was washed with saturated brine, and dried over anhydrous magnesium sulfate. The solvent was evaporated, to afford 56 mg of the title compound as a pale yellow oil.",1-methanesulfonyloxymethyl-cyclopropane carboxylic acid ethyl ester | tetrahydrofuran | dimethyl amine | tetrahydrofuran | hydrochloric acid | diethyl ether | potassium carbonate | ethyl acetate | brine | magnesium sulfate | title compound
US06849649B2,"4-Chromanol (Aldrich) (2.77 g, 18.4 mmol) was taken up in acetic anhydride (3.5 ml, 36.9 mmol) and acetic acid (30 ml) and refluxed for 3 h, and then allowed to cool to room temperature over 16 h. 10% w/w Pd/C was then added to the solution and the whole hydrogenated at 40 p.s.i. hydrogen pressure for 16 h. The catalyst was filtered through a pad of Arbocel and the filtrate evaporated to low (5 ml) volume. The remaining liquid was dissolved in EtOAc (30 ml) and washed with water, then NaHCO3 solution (100 ml of each). The organic layer was dried over MgSO4 and evaporated to a pale yellow oil. This oil was columned in 10% EtOAc/pentane to give the title product (2.1 g, 85%);",4-Chromanol | acetic anhydride | acetic acid | Pd/C | hydrogen | Arbocel | EtOAc | water | MgSO4 | title product
US08053581B2,"A procedure similar to that in Example 4 was used. 5-benzyl-4-(4-methoxy-phenyl)-thiazol-2-ylamine prepared in Example 1 and p-cyanobenzoyl chloride prepared in the step 1 were used as starting materials, allowed to react at room temperature overnight, followed by post-treatment to obtain a crude product, which was purified by a silica gel column chromatography eluted with a gradient of petroleum ether and ethyl acetate (20:1-10:1) to obtain a product as a white solid in a yield of 39.5%, mp: 194-196 └. 1H-NMR (CDCl3, 400 MHz) δ: 3.77 (3H, s, OCH3), 4.21 (2H, s, CH2), 6.69 (2H, d, J=8.68 Hz, ArH), 7.23˜7.32 (5H, m, ArH), 7.36 (2H, d, J=8.68 Hz, ArH), 7.48 (2H, d, J=8.16 Hz, ArH), 7.72 (2H, d, J=8.16 Hz, ArH); EI-MS m/e (%): 425.2 (M+, 100), 130.0 (40); HREI-MS Calcd. for C25H19N3O2S: 425.1198. found: 425.1191. Anal. Calcd. for C25H19N3O2S: C, 70.57; H, 4.50; N, 9.88. found: C, 70.50; H, 4.39; N, 9.99.",5-benzyl-4-(4-methoxy-phenyl)-thiazol-2-ylamine | p-cyanobenzoyl chloride | crude product | product | silica gel | petroleum ether | ethyl acetate
US08399476B2,"The compound was synthesized by treatment of 2-(4-fluoro-phenyl)-N-ethoxycarbonyloxy-imidazo[1,2-a]pyridine-6-carboxamidine (example 60) with aqueous sodium carbonate. Yield: 14%. MS: M+H+=296.95.","2-(4-fluoro-phenyl)-N-ethoxycarbonyloxy-imidazo[1,2-a]pyridine-6-carboxamidine | sodium carbonate"
US20150274661A1,"To a solution of 1-benzylpyrrolidine-3-carbonyl chloride (3.65 g, 16.3 mmol) in 1,2-dichloroethane (23 mL) was added under an atmosphere of nitrogen at 0° C. aluminum chloride (3.26 g, 24.5 mmol). After stirring for 30 minutes at 0° C. ethyl 1H-indole-2-carboxylate (3.09 g, 16.3 mmol) was added and stirred for 18 hours at room temperature. After the addition of aluminum chloride (3.26 g, 24.5 mmol) the reaction was stirred for 3 hours at 70° C. After cooling to 0° C. the reaction was diluted with ethyl acetate (100 mL) and basified by drop wise addition of a 1 M aqueous solution of sodium carbonate (200 mL). After stirring for 30 minutes the suspension was filtered over Hyflo and was washed well with ethyl acetate. The aqueous layer was extracted with ethyl acetate (150 mL). The organic layers were washed with a 1 M aqueous solution of sodium carbonate (100 mL). The combined organic layers were dried over sodium sulfate, filtered and purified by flash chromatography on silica gel using heptane/(ethyl acetate:NEt3 95:5) (50.50 to 30:70) to yield the title compound as a light brown foam (5.38 g, 88%).","1-benzylpyrrolidine-3-carbonyl chloride | 1,2-dichloroethane | nitrogen | aluminum chloride | ethyl 1H-indole-2-carboxylate | aluminum chloride | ethyl acetate | aqueous solution | sodium carbonate | ethyl acetate | ethyl acetate | aqueous solution | sodium carbonate | sodium sulfate | silica gel | title compound"
US07375226B2,"To 8-trifluoromethoxy-1,2,3,4-tetrahydro-pyrazino[1,2-a]indole (0.41 g) in THF (2.2 mL) and TFA (4.4 mL) at 0° C. was added portion wise sodium borohydride (0.124 g). The reaction mixture was allowed to warm up to room temperature and stirred for 35 minutes. After such time, the reaction mixture was concentrated in vacuo, and the residue was dissolved in dichloromethane and poured over water. A sodium hydroxide solution (10 M) was the added until reaching pH 13.5. After 15 minutes, the phases were separated. The aqueous phase was extracted with dichloromethane twice. The combined organic layers were then washed with brine, dried with magnesium sulfate, concentrated in vacuo and purified by column chromatography to yield the title compound (0.31 g, 76%).","8-trifluoromethoxy-1,2,3,4-tetrahydro-pyrazino[1,2-a]indole | THF | TFA | sodium borohydride | dichloromethane | water | dichloromethane | brine | magnesium sulfate | title compound"
US05376685,"9.02 ml of triethylamine and 1.365 g of Lindlar catalyst are added to 13.65 g (59.17 mmol) of 6-chloro-4-methyl-2-(2-phenylethenyl)pyrimidine in 220 ml of absolute ethanol and hydrogenation is carried out at room temperature under normal pressure. When 1 equivalent of hydrogen has been absorbed, hydrogenation is terminated (after about 7.5 hours), and the reaction mixture is filtered with suction over Hyflo Super Cel® and concentrated in a rotary evaporator. Chromatography twice on silica gel with chloroform and then n-hexane/ethyl acetate 5-20% as eluants yields the pure title compound; m.p. 65°-67°.",triethylamine | Lindlar catalyst | 6-chloro-4-methyl-2-(2-phenylethenyl)pyrimidine | ethanol | hydrogen | silica gel | chloroform | n-hexane/ethyl acetate | title compound
US20040019190A1,"A suspension of 3-amino-2-hydroxybiphenyl-3′-carboxylic acid;, hydrochloride salt (0.2 g; 0.00076 mol.) in 1M aqu. hydrochloric acid; (3.0 mL) and tetrahydrofuran (3.0 mL) was cooled to 5° C. then treated dropwise with a solution of sodium nitrite (0.057 g; 0.00083 mol.) in water (1.0 mL). The yellow mixture was stirred at 5° C. for a further 10 min. then treated with a solution of 1-(3,4-dimethylphenyl)-5-chloro-3-oxo-pyrazolidine (0.168 g; 0.00076 mol.) in tetrahydrofuran (3.0 mL), followed by the portionwise addition of sodium hydrogen carbonate solution ensuring the final pH of the reaction mixture is approximately 7-8. The red solution was then stirred at room temperature for 24 h. The mixture was diluted with water and acid;ified with 1M aq. hydrochloric acid;, stirred for a further 30 minutes and filtered to give a brown solid which was washed with water to afford the title compound (0.3 g; 85%) as a brown powder, mp=210° C. (dec.). MS m/e 463 [M+H]+.","3-amino-2-hydroxybiphenyl-3′-carboxylic acid | hydrochloride salt | hydrochloric acid | tetrahydrofuran | sodium nitrite | water | 1-(3,4-dimethylphenyl)-5-chloro-3-oxo-pyrazolidine | tetrahydrofuran | sodium hydrogen carbonate | water | hydrochloric acid | water | title compound"
US08431563B2,"A 20-mL microwave vial was charged with ((2R)-4-(thiophen-2-ylsulfonyl)-1-(4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)phenyl)piperazin-2-yl)methyl methanesulfonate (1.0 g, 1.9 mmol, Intermediate B), cyclopropylamine (4.0 mL, 57 mmol, Alfa Aesar, Ward Hill, Mass.) and MeOH (10.0 mL). The vial was sealed and heated in an Initiator microwave reactor (Biotage AB, Inc., Uppsala, Sweden) at 140° C. for 30 min. After cooling to room temperature, the reaction mixture was concentrated and the crude product was purified by column chromatography (120 g of silica, 2 to 8% 2M NH3 in MeOH/CH2Cl2) to afford 2-(4-((2S)-2-((cyclopropylamino)methyl)-4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-1,1,1-trifluoro-2-propanol (0.613 g) as mixture of two isomers.","((2R)-4-(thiophen-2-ylsulfonyl)-1-(4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)phenyl)piperazin-2-yl)methyl methanesulfonate | Intermediate B | cyclopropylamine | MeOH | crude product | silica | NH3 | MeOH/CH2Cl2 | 2-(4-((2S)-2-((cyclopropylamino)methyl)-4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-1,1,1-trifluoro-2-propanol"
US05985870,"To a solution of N-benzyloxycarbonyl-L-phenylalanine chloromethyl ketone (75 g, 0.2 mol) in a mixture of 800 mL of methanol and 800 mL of tetrahydrofuran was added sodium borohydride (13.17 g, 0.348 mol, 1.54 equiv.) over 100 min. The solution was stirred at room temperature for 2 hours and then concentrated in vacuo. The residue was dissolved in 1000 mL of ethyl acetate and washed with 1N KHSO4, saturated aqueous NaHCO31 saturated aqueous NaCl, dried over anhydrous MgSO4, filtered and concentrated in vacuo to give an oil. The crude product was dissolved in 1000 mL of hexanes at 60° C. and allowed to cool to room temperature where upon crystals formed that were isolated by filtration and washed with copious amounts of hexanes. This solid was then recrystallized from hot ethyl acetate and hexanes to provide 32.3 g 43% of N-benzyloxycarbonyl-3(S)-amino-1-chloro-4-phenyl-2(S)-butanol, mp 150-151° C., FAB MS: MLi+ =340.",N-benzyloxycarbonyl-L-phenylalanine chloromethyl ketone | methanol | tetrahydrofuran | sodium borohydride | ethyl acetate | KHSO4 | NaCl | MgSO4 | crude product | hexanes | hexanes | ethyl acetate | hexanes | N-benzyloxycarbonyl-3(S)-amino-1-chloro-4-phenyl-2(S)-butanol
US20050143427A1,"To a Parr bottle containing 10% Pd/C (0.3 g) was added methanol (30 mL) under an atmosphere of nitrogen. The mixture was shaken with hydrogen (40 psi) for 20 minutes to pre-reduce the catalyst. A solution of (2S,3aR,7aR)-1-benzyl-6-ethylidene-octahydro-indole-2-carboxylic acid benzyl ester (1.5 g, 4.0 mmol) in methanol (70 mL) was added to the pre-reduced catalyst, and the reaction mixture shaken overnight under hydrogen (50 psi). The mixture was filtered through a pad of celite, and the filtrate was concentrated to afford a crude amino acid (0.8 g). To this amino acid (0.8 g, 4.0 mmol) in 1,4-dioxane (20 mL) was added a solution of sodium carbonate (0.4 g, 4.0 mmol) in water (40 mL). A solution of di-tert-butyldicarbonate (1.3 g, 6.1 mmol) in 1,4-dioxane (4 mL) was added to the reaction mixture, and the mixture was stirred at room temperature overnight. The reaction mixture was diluted with ethyl acetate (150 mL) and aqueous 1 M HCl (20 mL). The organic layer was separated, and the aqueous phase was extracted with ethyl acetate (2×50 mL). The organic layers were combined and washed with brine, and dried over sodium sulfate. Solvent removal in vacuo followed by purification of the residue by silica gel chromatography (eluant 8:2 dichloromethane/methanol) afforded the desired (2S,3aR,7aR)-6-ethyl-octahydro-indole-1,2-dicarboxylic acid 1-tert-butyl ester (1.0 g, 85%) as a colorless foam: 1H NMR (300 MHz, CDCl3, 1:1 mixture of regioisomers) δ 0.75-0.80 (m, 1H), 0.85-0.91 (m, 3H), 0.93-0.94 (m, 1H), 1.10-1.12 (m, 1H), 1.18-1.26 (m, 1H), 1.40 (s, 4.5H), 1.46 (s, 4.5H), 1.50-1.95 (m, 6H), 2.07-2.50 (m 3H), 3.79 (dt, J=6.3, 11.6, 17.4 Hz, 0.5H), 3.96 (dt, J=6.3, 11.8, 17.4 Hz, 0.5H), 4.22 (d, J=9.1 Hz, 0.5H), 4.30 (d, J=9.2 Hz, 0.5H); MS (ESI) m/z 298 [M+H]+.","Pd/C | methanol | nitrogen | hydrogen | (2S,3aR,7aR)-1-benzyl-6-ethylidene-octahydro-indole-2-carboxylic acid benzyl ester | methanol | hydrogen | amino acid | amino acid | 1,4-dioxane | sodium carbonate | water | di-tert-butyldicarbonate | 1,4-dioxane | ethyl acetate | HCl | ethyl acetate | brine | sodium sulfate | silica gel | dichloromethane/methanol | (2S,3aR,7aR)-6-ethyl-octahydro-indole-1,2-dicarboxylic acid 1-tert-butyl ester"
US05180833,"To a mixture of 0.22 g of N-acetyl-S-methyl-N'-nitroisothiourea and 5 ml of acetonitrile was dropwise added 0.2 g of 5-(aminomethyl)-2-chlorothiazole at -2° C. Stirring was continued at the same temperature for additional 1 hour, and then the reaction mixture concentrated. The residue solidified was recrystallized from ethanol to give 0.31 g of N-actyl-N'-(2-chloro-5-thiazolylmethyl)-N""-nitroguanidine (reference compound No. 5), mp 132°-133° C. NMR (CDCl3): 2.33(3H, s), 4.68(2H, d, J=6 Hz), 7.50(1H, s), 9.60(1H, br), 11.85(1H, br).","N-acetyl-S-methyl-N'-nitroisothiourea | acetonitrile | 5-(aminomethyl)-2-chlorothiazole | ethanol | N-actyl-N'-(2-chloro-5-thiazolylmethyl)-N""-nitroguanidine"
US06881746B2,"To a mixture of 3-(4-{2-(4-chlorophenyl)-2-[4-(4-trifluoromethoxyphenyl)thiazol-2-yl]ethyl}benzoylamino)propionic acid methyl ester (the product from step 5) (0.15 g, 0.255 mmol), N-bromosuccinimide (50 mg, 0.28 mmol) in tetrachloromethane (9 mL) was added a catalytic amount of dibenzoylperoxide and the resulting mixture was stirred at reflux for 4 hours. After cooling, the mixture was concentrated in vacuo and the residue was partitioned between ethyl acetate and water. The aqueous phase was extracted with ethyl acetate and the combined organic phases were washed with water (2×) and brine, dried over MgSO4, treated with active carbon, filtered and concentrated in vacuo. The residue (157 mg) was dissolved in DMF (5 mL) and lithium carbonate (21 mg, 0.28 mmol) and lithium bromide (24 mg, 0.28 mmol) were added and the resulting mixture was refluxed for 3.5 hours. After cooling, the mixture was partitioned between water and ethyl acetate. The aqueous phase was extracted with ethyl acetate and the combined organic phases were washed with water (3×) treated with active carbon, dried (MgSO4) and concentrated in vacuo. The residue (56 mg) was purified by HPLC to afford 14 mg of 3-(4-{2-(4-chlorophenyl)-2-[4-(4-trifluoromethoxyphenyl)-thiazol-2-yl]vinyl}benzoylamino)propionic acid methyl ester.",3-(4-{2-(4-chlorophenyl)-2-[4-(4-trifluoromethoxyphenyl)thiazol-2-yl]ethyl}benzoylamino)propionic acid methyl ester | product | N-bromosuccinimide | tetrachloromethane | dibenzoylperoxide | residue | ethyl acetate | water | ethyl acetate | water | brine | MgSO4 | carbon | residue | DMF | lithium carbonate | lithium bromide | water | ethyl acetate | ethyl acetate | water | carbon | MgSO4 | 3-(4-{2-(4-chlorophenyl)-2-[4-(4-trifluoromethoxyphenyl)-thiazol-2-yl]vinyl}benzoylamino)propionic acid methyl ester
US08710224B2,"To benzyl 4-(2-{(3R)-3-[(4-{[(3,4-dichlorophenyl)amino]carbonyl}piperazin-1-yl)methyl]piperidin-1-yl}ethyl)piperidine-1-carboxylate (805 mg) was added 4M HCl in dioxane (5 ml). After removal of the solvent, 1-methyl-2-pyrrolidinone (5 ml) and zinc bromide (20 mg) were added, the mixture purged with Argon, 10% Pd/C (100 mg) added and stirred under hydrogen for 60 hours. Catalyst was filtered off through Celite, fresh catalyst and zinc bromide added and stirring continued for a further 48 hours under hydrogen. After filtration, the mixture was purified on a SCX2.50 g column, eluting sequentially with isohexane, ethyl acetate, 50% ethyl acetate/MeOH, MeOH and finally with 10% ammonia in MeOH to give the title compound (205 mg, 34%).","benzyl 4-(2-{(3R)-3-[(4-{[(3,4-dichlorophenyl)amino]carbonyl}piperazin-1-yl)methyl]piperidin-1-yl}ethyl)piperidine-1-carboxylate | HCl | dioxane | 1-methyl-2-pyrrolidinone | zinc bromide | Argon | Pd/C | hydrogen | zinc bromide | hydrogen | SCX2 | isohexane | ethyl acetate | ethyl acetate/MeOH | MeOH | MeOH | ammonia | title compound"
US04554018,"A blend of 25 mole % acrylic acid and 75 mole % ammonium acrylate was polymerised by the same general technique as in Example 1 except that the dispersion stabiliser mixture was formed of 75% by weight of a 2:1 molar copolymer of ceto stearyl methacrylate to methacrylic acid and 25% by weight sorbitan monooleate and the aqueous phase contained 0.4722 mole % of monomers based on weight of aqueous phase, 0.795×10-4 mole % of penta sodium diethylenetriamine pentaacetate based on weight of aqueous phase, 5.13×10-2 mole % of mono-sodium phosphate dihydrate based on weight of aqueous phase, 21.76×10-3 mole % of cross-linking agent (methylene-bisacrylamide) based on moles of monomers and 9.2×10-3 mole % of azobisamidinopropane hydrochloride based on moles of monomers. The dispersion obtained upon polymerisation and distillation was rendered water dispersible by adding 7.3% by weight on weight of final oil phase a phosphoric acid ester of a 5 mole ethoxylate of tridecanol and 7.3% by weight on weight of final oil phase of a 7 mole ethoxylate of nonyl phenol.",acrylic acid | ammonium acrylate | copolymer | ceto stearyl methacrylate | methacrylic acid | sorbitan monooleate | penta sodium diethylenetriamine pentaacetate | mono-sodium phosphate dihydrate | methylene-bisacrylamide | azobisamidinopropane hydrochloride | water | phosphoric acid ester | tridecanol | nonyl phenol
US05639748,"A 35% dispersion of potassium hydride in mineral oil (2.6 g, 23 mmol) in dimethylformamide (40 ml) was stirred and treated with 9-chloro-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepin-6-ol (4.0 g, 19 mmol), stirred for 20 minutes, treated with ethyl bromoacetate (3.8 g, 23 mmol) and stirred for 72 hours. The mixture was concentrated, partitioned between water and methylene chloride and the organic phase was washed, dried with magnesium sulfate and concentrated. The residue was chromatographed on silica gel eluted with methanol-methylene chloride (8:92) to give 4.3 g of ethyl [(9-chloro-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepin-6-yl)oxy]acetate.","potassium hydride | oil | dimethylformamide | 9-chloro-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepin-6-ol | ethyl bromoacetate | water | methylene chloride | magnesium sulfate | silica gel | methanol-methylene chloride | ethyl [(9-chloro-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepin-6-yl)oxy]acetate"
US08148572B2,"2-Chloro-3-methyl-5-bromopyridine (1.0 g) was added to a stirred solution of butyllithium (2.5M in hexanes, 1.94 ml) in dry THF (20 ml) at −78° C. The mixture was left at −78° C. for 5 minutes before treating with diphenyldisulphide (1.06 g). The mixture was allowed to warm to RT. After 1 h, the mixture was quenched with 2M HCl, extracted with ether (discarded) then the aqueous layer basified with saturated sodium hydrogen carbonate solution, extracted with ethyl acetate, dried (MgSO4) and evaporated under reduced pressure to give a brown oil. The oil was subjected to flash column chromatography (eluent 3:2 DCM/ethyl acetate) to give the subtitle compound (2.30 g).",2-Chloro-3-methyl-5-bromopyridine | butyllithium | THF | diphenyldisulphide | HCl | ether | ethyl acetate | MgSO4 | DCM/ethyl acetate | subtitle compound
US20140142085A1,"Compound 286 was prepared (8 mg) according to the method presented in the synthesis of Example 57 utilizing Compound 55D and 2-(4,5,6,7-tetrahydro-1H-benzo[d]imidazol-1-yl)acetic acid to afford the title compound. MS (m/z) 475.1 [M+H]+. 1H NMR (400 MHz, cdcl3) δ 8.72 (s, 1H), 8.52 (s, 1H), 8.11 (m, 1H), 7.98 (d, J=8.0 Hz, 1H), 6.73-6.54 (m, 3H), 5.78 (d, J=5.5 Hz, 1H), 4.78 (d, J=22.5 Hz, 2H), 3.18 (dd, J=13.6, 5.2 Hz, 1H), 3.00 (dd, J=13.5, 8.2 Hz, 1H), 2.66 (s, 2H), 2.42 (s, 2H), 1.84 (s, 4H).","Compound 286 | Compound 55D | 2-(4,5,6,7-tetrahydro-1H-benzo[d]imidazol-1-yl)acetic acid | title compound"
US08039474B2,"A mixture of 4-cyano-cyclohexanone (0.48 g, 3.9 mmol) and phenylhydrazine hydrochloride (0.42 g, 3.9 mmol) in glacial acetic acid (5 ml) is stirred at reflux for 1 h. The solvent is evaporated and the residue chromatographed on silica gel (heptane/EtOAc 2:1) to deliver the title compound as a brownish solid (158 mg) in 50% yield. tR (LC-5) 0.91 min; ESI-MS (positive ion): m/z 197.10 [M+H]+ (calcd 196.25 for C13H12N2). 1H-NMR (CDCl3): 2.25 (m, 2H); 2.96 (m, 5H); 7.14 (m, 2H); 7.30 (d, J=7.7 Hz, 1H); 7.45 (d, J=7.1 Hz, 1H); 7.79 (br s, 1H).",4-cyano-cyclohexanone | phenylhydrazine hydrochloride | acetic acid | silica gel
US20070099911A1,"1-[2-(Benzylmethylamino)ethyl]-3H,7H-pyrrolo[3,2-f]isoquinolin-6-one (1.07 g, 3.22 mmol) from Example 1020 was hydrogenated over 10% Pd/C at 50 psi H2 for 24 hours. The catalyst was removed by filtration, and the product was converted to its HCl salt by the action of ethanolic HCl. Recrystallization from EtOH/Et2O afforded the titled compound as a light brown colored solid (mp=160° C.; MW=377.75; HPLC single component).","1-[2-(Benzylmethylamino)ethyl]-3H,7H-pyrrolo[3,2-f]isoquinolin-6-one | Pd/C | H2 | EtOH/Et2O | titled compound"
US20130165440A1,"A pressure vessel was charged with 8-chloro-N-(3-(trifluoromethyl)phenyl)pyrido[2,3-d]pyridazin-5-amine (52 mg, 0.16 mmol, 1.0 eq.), 4-(methoxycarbonyl)phenylboronic acid (37 mg, 0.21 mmol, 1.3 eq.), 2.0 M aqueous sodium carbonate (0.16 mL, 0.42 mmol, 2.0 eq.) and 1,2-dimethoxyethane (3 mL). The reaction was purged with nitrogen before adding Pd(dppf)2Cl2 (14 mg, 0.012 mmol, 0.1 eq.) and was sealed and was heated at 90° C. for 16 h. The reaction was cooled to room temperature, was filtered through silica gel eluting with ethyl acetate and was concentrated to give the crude product. The product was purified by column chromatography (eluted with hexanes:ethyl acetate=1:1) to afford methyl 4-(5-{[3-(trifluoromethyl)phenyl]amino}pyrido[2,3-d]pyridazin-8-yl)benzoate (25 mg, 35% yield). 1H NMR (400 MHz, d6-DMSO) δ 9.82 (br s, 1H), 9.33-9.21 (m, 1H), 9.08 (d, 1H), 8.46 (s, 1H), 8.23 (d, 1H), 8.15 (d, 2H), 8.12-8.01 (m, 3H), 7.62 (t, 1H), 7.40 (d, 1H), 3.87 (s, 3H). MS (EI) for C22H15F3N4O2: 425 (MH+).","8-chloro-N-(3-(trifluoromethyl)phenyl)pyrido[2,3-d]pyridazin-5-amine | 4-(methoxycarbonyl)phenylboronic acid | sodium carbonate | 1,2-dimethoxyethane | nitrogen | Pd(dppf)2Cl2 | silica gel | ethyl acetate | crude product | hexanes | ethyl acetate | methyl 4-(5-{[3-(trifluoromethyl)phenyl]amino}pyrido[2,3-d]pyridazin-8-yl)benzoate"
US05739144,"Caesium carbonate (214 g, 0.66 mol) was added to a mixture of 3-hydroxy-4-methoxybenzaldehyde (1 00 g, 0.66 mol) and cyclopentyl bromide (98 g, 0.66 mol) in anhydrous DMF (50 ml). The reaction mixture was stirred at RT for 16 h then treated with a further portion of cyclopentyl bromide (98 g, 0.66 mol) and caesium carbonate (214 g, 0.66 mol). After a further 6 h at RT, the mixture was filtered and concentrated in vacuo. The residue was dissolved in dichloromethane (300 ml) and washed with sodium hydroxide solution (10%; 2×150 ml). The organic layer was dried (MgSO4), concentrated in vacuo, and distilled (150° C., 10-2 mbar) to afford the title compound (130 g) as a viscous colourless oil. (Found: C, 70.38; H, 7.48. C13H16O3 requires C, 70.89; H, 7.32%); δH (CDCl3) 1.5-2.0 (8H, br m, CH2)4), 3.87 (3H, s, OMe), 4.80 (1H, br m, OCHCH2), 6.90 (1H, d, J 8.7 Hz, ArH ortho to OMe), 7.30-7.45 (2H, m, 2×ArH meta to OMe), and 9.77 (1H, s, ArCHO).",Caesium carbonate | 3-hydroxy-4-methoxybenzaldehyde | cyclopentyl bromide | DMF | cyclopentyl bromide | caesium carbonate | dichloromethane | sodium hydroxide | MgSO4 | title compound
US09394297B2,"Prepared similar to that described in Example 131 using 2-(3-fluoro-2-methylquinoxalin-5-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one (Example 126; 40 mg, 0.090 mmol) and 2,2-dimethylpropan-1-amine (TCI America, Portland, Oreg.; 0.032 mL, 0.271 mmol) in DMSO (0.8 mL), heating at 80° C. for 2 h. Chromatographic purification (silica gel, 0-100% EtOAc/hexanes, then 0-10% MeOH/DCM) furnished 2-(2-methyl-3-(neopentylamino)quinoxalin-5-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one (31.4 mg, 0.086 mmol, 96% yield) as a yellow solid: 1H NMR (400 MHz, DMSO-d6) δ ppm 12.05 (1H, br. s.), 7.85 (1H, dd, J=7.7, 0.8 Hz), 7.55 (1H, dd, J=8.0, 0.9 Hz), 7.30 (1H, t, J=7.7 Hz), 7.21 (1H, d, J=2.2 Hz), 7.02 (1H, t, J=6.4 Hz), 6.92 (1H, br. s.), 3.41-3.48 (4H, m), 2.88 (2H, t, J=6.8 Hz), 2.57 (3H, s), 0.99 (9H, s). m/z (ESI, +ve) 364.2 (M+H)+.","2-(3-fluoro-2-methylquinoxalin-5-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one | 2,2-dimethylpropan-1-amine | DMSO | silica gel | EtOAc/hexanes | MeOH/DCM | 2-(2-methyl-3-(neopentylamino)quinoxalin-5-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one"
US07071218B2,"To a solution of 3-bromo-4-trifluoromethoxybenzaldehyde (10.0 g, 37.2 mmol), (3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl) boronic acid (11.0 g, 44.68 mmol, 1.2 eq) in a mixture of toluene (100 mL), ethanol (20 mL) and water (15 mL) was added potassium carbonate (10.28 g, 74.4 mmol, 2 eq). The mixture was degased with argon for 40 minutes. Tetrakis(triphenylphosphine)palladium(0) (0.86 g, 0.74 mmol, 0.02 eq) was added and the mixture heated at reflux under argon for 22 hours. The mixture was cooled to room temperature, diluted with ethyl acetate and washed successively with water and brine, dried over MgSO4, filtered and evaporated. The residue was chromatographed on silica gel (eluent: ethyl acetate/hexane 5:95) to give 3-trifluoromethoxy-4-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl) benzaldehyde (11.1 g, 76%), 1H NMR (300 MHz; CDCl3) 1.25 (s, 6 H); 1.32 (s, 6 H); 1.70 (s, 4 H); 2.08 (s, 3 H); 7.06 (s, 1 H); 7.18 (s, 1 H); 7.48 (dd, J1=8.4 Hz, J2=1.5 Hz, 1 H); 7.84 (d, J=2.0 Hz, 1 H); 7.88 (dd, J1=2.0 Hz, J2=8.5 Hz, 1 H), 9.91 (s, 1 H).","3-bromo-4-trifluoromethoxybenzaldehyde | (3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl) boronic acid | toluene | ethanol | water | potassium carbonate | argon | Tetrakis(triphenylphosphine)palladium(0) | argon | ethyl acetate | water | brine | MgSO4 | silica gel | 3-trifluoromethoxy-4-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl) benzaldehyde"
US20120129811A1,The title compound was prepared from Intermediate 94 and Intermediate 134 by the procedure of Intermediate 202.,title compound | Intermediate 94 | Intermediate 134 | Intermediate 202
US20150099737A1,"Following general N-C coupling procedure 1, 3-(6-Amino-pyridin-3-yl)-1-oxa-3,8-diaza-spiro[4.6]undecan-2-one (0.100 g, 0.276 mmol) was combined with 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide (0.081 g, 0.276 mmol, 1.0 eq) which gave 7-cyclopentyl-N,N-dimethyl-2-(5-(2-oxo-1-oxa-3,8-diazaspiro[4.6]undecan-3-yl)pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide as white solid (0.075 g, 0.139 mmol) in 50% yield. 1H NMR (400 MHz, CDCl3) 6 ppm 1.58-1.82 (m, 4H) 1.97-2.27 (m, 14H) 2.47-2.65 (m, 2H) 2.86-3.11 (m, 4H) 3.16 (s, 7H) 3.80-3.88 (m, 2H) 4.80 (qd, J=8.95, 8.78 Hz, 1H) 6.46 (s, 1H) 8.06 (s, 1H) 8.13 (dd, J=9.03, 3.01 Hz, 1H) 8.21-8.32 (m, 1H) 8.50 (d, J=9.03 Hz, 1H) 8.72 (s, 1H); HRMS calc for m/z=531.2832 and found m/z=531.2858 (M+H)+.","3-(6-Amino-pyridin-3-yl)-1-oxa-3,8-diaza-spiro[4.6]undecan-2-one | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide | 7-cyclopentyl-N,N-dimethyl-2-(5-(2-oxo-1-oxa-3,8-diazaspiro[4.6]undecan-3-yl)pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide"
US05258513,"A solution of 2.61 g (0.03 mole) of morpholine in 20 ml of chloroform is added in the course of 30 minutes to a solution of 5.7 g (0.03 mole) of 2,4-dichloro-6-cyclopropyl-1,3,5-triazine in 50 ml of chloroform, cooled to between 3° and 5° C. The temperature of the mixture is allowed to return to about 10° C., then the mixture is cooled again to 5° C. and a solution of 4.14 g (0.03 mole) of potassium carbonate in 15 ml of water is added dropwise. The mixture is then stirred at room temperature for two hours. 30 ml of water are added and the organic phase is separated off. The solution is washed with water and dried over sodium sulfate, and the solvent is evaporated under reduced pressure. The residue is purified by chromatography on silica (eluent: 96.5:3.5 (v/v) dichloromethane-ethylacetate) and then recrystallized from hexane. 5.5 g of 2-chloro-4-cyclopropyl-6-morpholino-1,3,5-triazine are thus obtained. Yield: 76.2%. M.P.: 99°-100° C.","morpholine | chloroform | 2,4-dichloro-6-cyclopropyl-1,3,5-triazine | chloroform | potassium carbonate | water | water | water | sodium sulfate | silica | dichloromethane-ethylacetate | hexane | 2-chloro-4-cyclopropyl-6-morpholino-1,3,5-triazine"
US08907098B2,"2.2 g (6.22 mmol) of 5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid hydrazide from step b were suspended in 15 ml of DMF together with 1.43 g (6.22 mmol) of 1-Boc-piperazine-4-carboxylic acid (preparation analogous to Bioorganic & Medicinal Chemistry Letters, 2001, vol. 11, #24 p. 3161-3164), 2.41 g (12.45 mmol) of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride and 867 mg (6.22 mmol) of 1-hydroxybenzotriazole hydrate. 1.40 ml (12.45 mmol) of 4-methylmorpholine were added to the reaction mixture, which was then stirred at room temperature overnight, stirred into 350 ml of water. The resultant precipitate was filtered off with suction, dissolved in DCM, dried, stripped off to dryness and purified by means of flash chromatography on silica gel.","5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid hydrazide | DMF | 1-Boc-piperazine-4-carboxylic acid | N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride | 1-hydroxybenzotriazole hydrate | 4-methylmorpholine | water | resultant precipitate | DCM | silica gel"
US20160168090A1,"The title compound was synthesized according to the procedure described in Example 2 using 4-Chloro-1-oxetan-3-yl-1H-indole-3-carboxylic acid (200.00 mg; 0.79 mmol; 1.00 eq.), 1-Aminomethyl-3-trifluoromethyl-cyclohexanol hydrochloride (213.54 mg; 0.91 mmol; 1.15 eq.), (3-Dimethylamino-propyl)-ethyl-carbodiimide hydrochloride (198.05 mg; 1.03 mmol; 1.30 eq.), Benzotriazol-1-ol (139.60 mg; 1.03 mmol; 1.30 eq.) and Ethyl-diisopropyl-amine (0.39 ml; 2.38 mmol; 3.00 eq.) to afford 4-chloro-N-((1-hydroxy-3-(trifluoromethyl)cyclohexyl)methyl)-1-(oxetan-3-yl)-1H-indole-3-carboxamide (125, 36%).",title compound | 4-Chloro-1-oxetan-3-yl-1H-indole-3-carboxylic acid | 1-Aminomethyl-3-trifluoromethyl-cyclohexanol hydrochloride | (3-Dimethylamino-propyl)-ethyl-carbodiimide hydrochloride | Benzotriazol-1-ol | Ethyl-diisopropyl-amine | 4-chloro-N-((1-hydroxy-3-(trifluoromethyl)cyclohexyl)methyl)-1-(oxetan-3-yl)-1H-indole-3-carboxamide
US07256177B2,"5-propyl-azepane-2-carboxylic acid [2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyl-tetrahydro-pyran-2-yl)-propyl]-amide prepared as described in example 47 (68 mg, 0.16 mmol) in MeOH (2 mL), acetic acid (0.1 mL) was added, followed by 1-[(ethyoxycyclopropyl)oxy]trimethylsilane (0.2 mL, 0.96 mmol), sodium cyanoborohydride (41 mg, 0.64 mmol), and 3 Å molecular sieves, heated to reflux for 3 h. Molecular sieves were filtered out and the reaction solvent was removed to obtain the crude material. Purification was carried by silica gel column chromatography (10% MeOH/DCM) and HPLC to provide the title compound (44 mg, 59%).","5-propyl-azepane-2-carboxylic acid [2-methyl-1-(3,4,5-trihydroxy-6-methylsulfanyl-tetrahydro-pyran-2-yl)-propyl]-amide | example 47 | MeOH | acetic acid | 1-[(ethyoxycyclopropyl)oxy]trimethylsilane | sodium cyanoborohydride | crude material | title compound"
US20120028919A1,"Into a microwave vial, 2-Methanesulfinyl-7-pyridin-3-yl-pyrrolo[2,1-f][1,2,4]triazine (0.104 g, 0.000404 mol), 4-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-phenylamine (0.209 g, 0.000888 mol), 1-Methoxy-2-propanol (0.971 mL, 0.00993 mol) and N,N-Diisopropylethylamine (0.155 mL, 0.000888 mol) were added. The reaction was microwaved on 300 watts , 170° C. for 50 minutes. The solvent was removed under vacuum. The desired product was isolated via ISCO column chromatography with DCM and methanol as eluant (0 to 12% methanol). The collected fractions afforded {4-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-phenyl}-(7-pyridin-3-yl-pyrrolo[2,1-f][1,2,4]triazin-2-yl)-amine as a yellow solid (28 mg, 16%). MP 107-110° C. LCMS (E/I+) 430.8 (M+H). NMR 1H (DSMO-d6)-9.42 (d, 1H, J=2.00), 9.39 (s, 1H), 9.04 (s, 1H), 8.66 (d, 1H, J=7.76 Hz), 8.61 (d, 1H, J=6.56 Hz), 7.60-7.70 (m, 3H), 7.32 (d, 1H, J=4.77 Hz), 6.98 (d, 1H, J=4.76 Hz), 6.95 (d, 2H, J=9.00 Hz), 4.16 (t, 2H, J=5.26 Hz), 2.40-3.50 (m, 13H).","2-Methanesulfinyl-7-pyridin-3-yl-pyrrolo[2,1-f][1,2,4]triazine | 4-[2-(4-Methyl-piperazin-1-yl)-ethoxy]-phenylamine | 1-Methoxy-2-propanol | N,N-Diisopropylethylamine | desired product | DCM | methanol | methanol"
US20150105373A1,"To a solution of 7-hydroxy-N-(2-methoxy-1-(4-(trifluoromethoxy)phenyl)ethyl)-2-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (43.3 mg) in N,N-dimethylformamide (1.00 mL) were added potassium carbonate (10.8 mg) and iodomethane (7.33 μL). The reaction mixture was stirred overnight at room temperature, water was added thereto, and the mixture was extracted with ethyl acetate. The extract was washed with saturated brine, and dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified by silica gel chromatography (hexane/ethyl acetate) to give the title compound (28.6 mg).","7-hydroxy-N-(2-methoxy-1-(4-(trifluoromethoxy)phenyl)ethyl)-2-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide | N,N-dimethylformamide | potassium carbonate | iodomethane | water | ethyl acetate | brine | sodium sulfate | silica gel | hexane/ethyl acetate | title compound"
US05565574,The reaction described above for Nα -Boc-4-Nitrophenyl-D-alanine was repeated for the L-isomer. About 123 grams of 4-nitrophenyl-L-alanine was reacted as described and resulted in about 155 grams of Nα -Boc-4-Nitrophenyl-L-alanine (about 86% yield). [α]D =+7.1° (c=1.0 in MeOH).,Nα -Boc-4-Nitrophenyl-D-alanine | 4-nitrophenyl-L-alanine | Nα -Boc-4-Nitrophenyl-L-alanine
US03972927,"In the manner of Example 1, di-n-dodecylamine was reacted with 3,5-di-t-butyl-4-hydroxybenzoyl chloride to produce N,N-di-n-dodecyl-3,5-di-t-butyl-4-hydroxybenzamide; an oil product. When tested by the procedure of Example 2, the sample containing this compound lasted 600 hours, about 2.0 times as long as the control.","di-n-dodecylamine | 3,5-di-t-butyl-4-hydroxybenzoyl chloride | N,N-di-n-dodecyl-3,5-di-t-butyl-4-hydroxybenzamide"
US04209616,"To a mixture of ethyl thien-3-yl-glyoxylate (10 g) and 2 N-sodium hydroxide (50 ml) was added sufficient methanol to produce a homogeneous solution, and the reaction was allowed to stand at room temperature for one hour. The solution was poured into water, extracted with ether, acidified with 2 N-hydrochloric acid and extracted with ether. The combined extracts were dried and evaporated to give an oil which was triturated with benzene-petroleum ether, and the resulting solid filtered and dried (7.5 g; 88%), m.p. 63°, νmax. (Nujol) 3600 and 1702 cm-1 (CO2H), τ (DMSO-d6) values include 1.29, 2.21, 2.38 (thien-3-yl protons).",ethyl thien-3-yl-glyoxylate | sodium hydroxide | methanol | water | ether | ether | benzene-petroleum ether
US05914328,"To a 330 mg sample of 4methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine (from Example 27 above) was added a solution of formic acid/ formaldehyde (1:2,2 mL). The mixture was heated at reflux for 5 hours, and the volatiles were removed by evaporation. The residue was dissolved in 1 mL of 20% NaOH. The solution was extracted with CH2Cl2 (3X), then the organic layer was dried (Na2SO4) and concentrated. The crude product was purified by chromatography over silica gel to afford 295 mg of the title compound. MS (DCI/NH3) m/e: 207 (M+H)+. 1H NMR (CDCl3, 300 MHz) δ: 8.17 (s, 1H), 8.12 (d, J=5.5 Hz, 1H), 7.06 (d, J=5.5 Hz, 1H), 4.07 (dd, J=3.3, 10.6 Hz, 1H), 3.98 (dd, J=7.4, 10.6 Hz, 1H), 3.15-3.08 (m, 1H), 2.76-2.68 (m, 1H), 2.53 (s, 3H), 2.38-2.25 (m, 1H), 2.26 (s, 3H), 2.12-1.67 (m, 4H).",4methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine | NaOH | CH2Cl2 | Na2SO4 | crude product | silica gel | title compound
US07399759B2,"A mixture of 2-mercapto-3,5-dimethylbenzoic acid (1.6 g, 8.8 mmol), 2-cyanopyridine (1.0 g, 9.7 mmol) and pyridine (15 ml) was refluxed for 12 hrs as described in Example 9. After cooling, the precipitated crystals were collected by filtration and recrystallized from hexane-chlorobenzene to give the titled compound (1.2 g, 52%).","2-mercapto-3,5-dimethylbenzoic acid | 2-cyanopyridine | pyridine | hexane-chlorobenzene | titled compound"
US06355796B1,"A mixture of ethyl α,α-dimethyl-5-nitro-1,2-benzisothiazole-3-acetate (0.714 g, 2.42 mmol), iron powder (0.500 g), 10% acetic acid (23.0 mL) and ethyl acetate (23.0 mL) is stirred at 54-58° C. for one hour, cooled, and poured into saturated sodium hydrogen carbonate solution. The resultant aqueous mixture is extracted with ethyl acetate. The combined organic extracts are washed sequentially with water and brine, dried over anhydrous sodium sulfate, and concentrated in vacuo to obtain a yellow oil. Column chromatography of the oil using silica gel and a 10% ethyl acetate in methylene chloride solution gives the title product as a light brown oil which is identified by NMR spectral analysis.","ethyl α,α-dimethyl-5-nitro-1,2-benzisothiazole-3-acetate | iron | acetic acid | ethyl acetate | sodium hydrogen carbonate | ethyl acetate | water | brine | sodium sulfate | ethyl acetate | methylene chloride | title product"
US04699928,"A solution of (Z)-1-fluoro-2-(2',4'-dichlorophenoxy) methyl-3-phthalimidopropene (0.67 g) and hydrazine hydrate (0.13 g) in ethanol (20 ml) is refluxed for 3 hours. The ethanol is evaporated, the residue extracted with ether and the ether solution washed with dilute aqueous sodium hydroxide, then with water, dried and evaporated. The residue is treated with di-tert-butyl dicarbonate (0.44 g), chloroform (20 ml) and water (6 ml), with added sodium chloride (1 g), for 1.5 hours at reflux to give (Z)-N-t-butyloxycarbonyl-2-(2',4'-dichlorophenoxy)methyl-3-fluoroallylamine. Pure colorless needles (0.43 g) are obtained by silica chromatography using 15% EtOAC in light petroleum as eluant. Cleavage of the butyloxycarbonyl group (HCl/ether) gave (Z)-2-(2',4'-dichlorophenoxy)methyl-3-fluoroallylamine as its hydrochloride salt; colorless needles (0.30 g; 59% yield); mp 135°-136° C.","(Z)-1-fluoro-2-(2',4'-dichlorophenoxy) methyl-3-phthalimidopropene | hydrazine hydrate | ethanol | ethanol | ether | ether | sodium hydroxide | water | di-tert-butyl dicarbonate | chloroform | water | sodium chloride | (Z)-N-t-butyloxycarbonyl-2-(2',4'-dichlorophenoxy)methyl-3-fluoroallylamine"
US20040180934A1,"To a suspension of trichloroaluminum (1.9 g, 14.4 mmol) in 1,2 dichloroethane (20 mL) at r.t. was added 4-chlorobenzoyl chloride (2.5 g, 14.4 mmol). The mixture was stirred for 5 minutes at r.t. and (+/−)-methyl (8-bromo-6-fluoro-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetate (Example 7, Step 8, 1.5 g, 4.8 mmol) in 1,2 dichloroethane (10 mL) was added. The mixture was stirred at 75° C. for 4 hours, cooled to r.t. and quenched with a solution of aqueous saturated NaHCO3 and poured into a mixture of EtOAc and 1N HCl. The phases were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with aqueous saturated NaHCO3 and brine, dried over Na2SO4 and concentrated. The residue was purified by silica gel chromatography eluted with 30% EtOAc/hexane to give 1.5 g of the title compound as a fade yellow solid.","trichloroaluminum | 1,2 dichloroethane | 4-chlorobenzoyl chloride | (+/−)-methyl (8-bromo-6-fluoro-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetate | 1,2 dichloroethane | NaHCO3 | EtOAc | HCl | EtOAc | NaHCO3 | brine | Na2SO4 | silica gel | EtOAc/hexane | title compound"
US07666898B2,"2-(3-(2-amino-2-oxoacetyl)-1-(biphenyl-2-ylmethyl)-2-ethyl-1H-pyrrolo[3,2-c]pyridin-4-yloxy)acetic acid, Ily-II-10: Compound 21 (0.227 mmol) is dissolved in methanol (20 mL). To the mixture the solution of KOH (1M, 0.25 mL) is added at room temperature. After addition the mixture was stirred at room temperature for 18 h. Then solution of lithium hydroxide monohydrate (90 mg) in H2O (5 mL) is added. After another hour stirring the mixture was concentrated and the residue is redissolved in methanol (10 mL) and ethanol (10 mL). The mixture is filtered and the filtrate was acidified by hydrogen chloride in ether (1.0 M) to pH=3-4. Solvent is evaporated and the residue is washed with a mixture of dichloromethane: ether (1:1), then water (5 mL) and ether to afford 2-(3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-pyrrolo[3,2-c]pyridin-4-yloxy)acetic acid, Ily-II-10.","2-(3-(2-amino-2-oxoacetyl)-1-(biphenyl-2-ylmethyl)-2-ethyl-1H-pyrrolo[3,2-c]pyridin-4-yloxy)acetic acid | Compound 21 | methanol | KOH | lithium hydroxide monohydrate | H2O | methanol | ether | water | 2-(3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-pyrrolo[3,2-c]pyridin-4-yloxy)acetic acid"
US08263622B2,"To a solution of 8-bromo-4-hydroxy-7-methylnaphthalene-2-carboxylic acid (0.45 g) in ethanol (8 mL) was added palladium-carbon (180 mg) in 3 parts, and the mixture was stirred at room temperature for 2 days under a hydrogen atmosphere. The insoluble material was removed by filtering through a Celite pad, and the filtrate was concentrated to give the title compound (0.32 g).",8-bromo-4-hydroxy-7-methylnaphthalene-2-carboxylic acid | ethanol | palladium-carbon | hydrogen | title compound
US04046901,"9.8 g of anhydrous sodium acetate were added to a mixture of 9.8 g of the product of Step B and 120 ml of acetic acid anhydride and the mixture was stirred at 20° C. for 3 hours and was then filtered. The filter was washed with ethanol and the filtrate was evaporated to dryness under reduced pressure. The residue was taken up in water and ethyl acetate and the solution was made alkaline with an aqueous solution saturated with sodium bicarbonate. The ethyl acetate phase was recovered by decanting, was dried and evaporated to dryness. The residue was dissolved in 50 ml of isopropanol and a solution of 4 g of oxalic acid in 50 ml of isopropanol was added thereto. The mixture was refluxed until dissolution occurred and was cooled to 20° C. and vacuum filtered to obtain 13.5 g of N-benzyl-3-(3',4'-diacetoxyphenyl)-piperidine oxalate melting at 145° C.","sodium acetate | product | acetic acid anhydride | ethanol | ethyl acetate | isopropanol | oxalic acid | isopropanol | N-benzyl-3-(3',4'-diacetoxyphenyl)-piperidine oxalate"
US20050165023A1,"A suspension of 4-bromopyridine hydrochloride (6.81 g, 35 mmol) in tetrahydrofuran (100 ml) was treated with sodium hydroxide (8.75 ml of a 4 N solution in water) and this mixture was stirred at ambient temperature for 5 min. 2,6-Difluorobenzeneboronic acid (6.36 g, 40 mmol) and potassium fluoride (6.71 g, 116 mmol) were added and this mixture was degassed with nitrogen for 10 min before adding tris(dibenzylideneacetone)dipalladium(0) (640 mg, 0.7 mmol) followed by tri-tert-butylphosphine (7 ml of a 0.2 M solution in 1,4-dioxane, 1.4 mmol). This mixture was stirred at ambient temperature for 15 min then heated at 50° C. for 30 min. The reaction mixture was diluted with dichloromethane then extracted with ice-cold 1 N sodium hydroxide solution (×2). The organics were dried over anhydrous magnesium sulphate, filtered and pre-adsorbed onto silica. Purification by chromatography (silica gel, 20-30% EtOAc/isohexane containing 0.5% methanol and 0.5% triethylamine) gave 4-(2,6-difluorophenyl)pyridine as a white solid (3.2 g, 48%): 1H NMR (360 MHz, CDCl3) δ 6.99-7.06 (2H, m), 7.32-7.39 (1H, m), 7.40-7.42 (2H, m), 8.71 (2H, d, J 6).","4-bromopyridine hydrochloride | tetrahydrofuran | sodium hydroxide | water | 2,6-Difluorobenzeneboronic acid | potassium fluoride | nitrogen | tris(dibenzylideneacetone)dipalladium(0) | tri-tert-butylphosphine | 1,4-dioxane | dichloromethane | ice | magnesium sulphate | silica | silica gel | EtOAc/isohexane | triethylamine | 4-(2,6-difluorophenyl)pyridine"
US20160039804A1,"(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl 3-({2-[cyclohexyl(ethyl)amino]-5-hydroxypyridin-3-yl}methyl)-oxazolidin-2-one of step 1 and MsCl were used in the same manner as in Example 32 to afford the title compound (18 mg, 12%).","(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl 3-({2-[cyclohexyl(ethyl)amino]-5-hydroxypyridin-3-yl}methyl)-oxazolidin-2-one | MsCl | title compound"
US05874573,"Reaction between 2,4-dimethyl-3-pentanone (1.2.4.3), trimethylsilyl chloride, and base gave 2,4-dimethyl-3-trimethysilyloxy-2-pentene (1.2.4.4) which was reacted with 1-fluoropyridinium triflate (1.2.4.5) to form 2,4-dimethyl-2-fluoro-3-pentanone (1.2.4.6). This product was reacted with (CH3)3S(O)+I- to form the title compound (1.2.4.2). ##STR31##","2,4-dimethyl-3-pentanone | trimethylsilyl chloride | 2,4-dimethyl-3-trimethysilyloxy-2-pentene"
US06680317B2,"To a solution of N-[4-chloro-2-tert-butyldimethylsilyloxy-3-(N″,N″-dimethylaminosulfonyl)phenyl]-N′-(2,3dichlorophenyl)carbodiimide (270 mg, 0.47 mmol) in acetonitrile (5 mL) at room temperature, cyanamide (79 mg, 1.88 mmol) and N,N-diisopropylethylamine (76 mg, 0.56 mmol) was added. The reaction mixture was stirred at room temperature for 1 hour. The reaction mixture was concentrated under reduced pressure. The residue was diluted with a mixture of tetrahydrofuran (3 mL) and methanol (1 mL). Cesium fluoride (86 mg, 0.56 mmol) was added at 0° C. The reaction mixture was stirred at 0° C. for 3 hours. The reaction mixture was concentrated under reduced pressure. The residue was purified by Gilson HPLC to give the desired product (98 mg, 48%). EI-MS m/z 473.75(M+).","N-[4-chloro-2-tert-butyldimethylsilyloxy-3-(N″,N″-dimethylaminosulfonyl)phenyl]-N′-(2,3dichlorophenyl)carbodiimide | acetonitrile | cyanamide | N,N-diisopropylethylamine | tetrahydrofuran | methanol | Cesium fluoride | desired product"
US20050075340A1,"General procedure A was followed with the reaction of oxo-thiophen-2-yl-acetaldehyde and 5-(4-fluoro-benzyl)-[1 ,2 ,4]triazole-3,4-diam ine to provide 3-(4-fluoro-benzyl)-7-th iophen-2-yl-[1,2,4]triazolo[4,3-b][1 ,2,4]triazine and 3-(4-fluoro-benzyl)-6-th iophen-2-yl-[1,2 ,4]triazolo[4,3-b][1,2,4]triazine (example 5).","oxo-thiophen-2-yl-acetaldehyde | 5-(4-fluoro-benzyl)-[1 ,2 ,4]triazole-3,4-diam ine | 3-(4-fluoro-benzyl)-7-th iophen-2-yl-[1,2,4]triazolo[4,3-b][1 ,2,4]triazine | 3-(4-fluoro-benzyl)-6-th iophen-2-yl-[1,2 ,4]triazolo[4,3-b][1,2,4]triazine"
US09045441B2,"The required 3-bromobutyric acid tert-butyl ester was prepared as follows: To a solution of 3-bromobutyric acid (5.0 mL; 47.0 mmol) in tetrahydrofuran (50 mL) was added dropwise trifluoroacetic anhydride (13.7 mL; 98.7 mmol) at −40° C. After 1 hour at −40° C. tert-butyl alcohol (20 mL) was added. The resulting mixture was allowed to warm to RT and stirred overnight. Subsequently, the reaction mixture was concentrated in vacuo. The residue was treated with 2M aqueous NaOH solution and extracted with Et2O. The organic layer was dried (Na2SO4), and concentrated in vacuo to afford 3-bromobutyric acid tert-butyl ester (6.05 g), which was used as such.",3-bromobutyric acid tert-butyl ester | 3-bromobutyric acid | tetrahydrofuran | trifluoroacetic anhydride | tert-butyl alcohol | NaOH | Et2O | Na2SO4 | 3-bromobutyric acid tert-butyl ester
US20070191448A1,"To the flask containing 2-(2-methoxy-phenyl)-1-p-tolyl-1H-imidazole-4-carboxylic acid (740 mg, 2.4 mmol), 4-fluoroaniline (0.23 mL, 2.4 mmol) and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (920 mg, 4.8 mmol) was added pyridine (10 mL). The mixture was stirred at room temperature for 1 hour and the volatile organics were removed. The residue was partitioned between methylene chloride and water. The combined organic layers were washed with water, brine, dried over anhydrous Na2SO4, filtered and concentrated under vacuum. Chromatography (SiO2, 30% ethyl acetate in hexanes) afforded 2-(2-methoxyphenyl)-1-p-tolyl-1H-imidazole-4-carboxylic acid (4-fluoro-phenyl)-amide (900 mg, 2.2 mmol) as a solid.",2-(2-methoxy-phenyl)-1-p-tolyl-1H-imidazole-4-carboxylic acid | 4-fluoroaniline | 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride | pyridine | methylene chloride | water | water | brine | Na2SO4 | SiO2 | ethyl acetate | hexanes | 2-(2-methoxyphenyl)-1-p-tolyl-1H-imidazole-4-carboxylic acid (4-fluoro-phenyl)-amide
US06432964B1,"A stirred mixture of methyl 4-formamido-3-thenoate (see below) (3.39 g) and ammonium formate (3,4 g) in formamide (5 ml) was heated at 140° C. for 7 hours. On cooling, the mixture was poured into water, and the mixture filtered to give a solid which was washed with water followed by light petroleum (b.p. 60-80° C.) and air dried to give the title product, m.p. 275-278° C.",methyl 4-formamido-3-thenoate | ammonium formate | formamide | water | water | title product
US08871790B2,"A mixture of 6-(4-Methoxyphenyl)-3-oxabicyclo[3.1.0]hexane-2,4-dione (crude product from the previous step) and (4-methoxyphenyl)methanamine was heated at 180° C. for 1.5 h. After cooling to room temperature, the reaction mixture was dissolved in CH2Cl2 and purified by flash column chromatography with EtOAc in hexane (20%, 30%, then 40%) to give the title compound as a yellow solid (0.71 g, 63% yield over three steps). MS [M+H]+: 338.","6-(4-Methoxyphenyl)-3-oxabicyclo[3.1.0]hexane-2,4-dione | hexane | crude product | (4-methoxyphenyl)methanamine | CH2Cl2 | EtOAc | title compound"
US04107324,"449 g of isoprene, stabilized with 1.35 g of phenothiazine, were added dropwise over the course of 5.5 hours to a solution of 771 g of m-chlorophenol, 77 g of 85% strength phosphoric acid and 6 ml of water in 1.44 liters of o-dichlorobenzene at 150° C. To complete the reaction, stirring was continued overnight at 150° C. After cooling, the acid phase was separated off and extracted by shaking with toluene. The combined organic phases were washed until neutral. Fractional distillation gives 194 g of 7-chloro-3,3-dimethyl-5-hydroxy-indane; boiling point 105°-110° C/0.5 mm Hg; melting point 86.5° - 87.5° C. ##STR38##","isoprene | phenothiazine | m-chlorophenol | phosphoric acid | water | o-dichlorobenzene | toluene | 7-chloro-3,3-dimethyl-5-hydroxy-indane"
US07164011B2,"4-Methoxypyridine-2-carboxylic acid, compound 10(b) (R9=methoxy), was made employing general Method P. To trimethylsilyl cyanide (0.95 g, 9.6 mmol), 4-methoxypyridine N-oxide (1 g, 8 mmol) in DCM (10 mL) was added, followed by dimethylcarbamoyl chloride (1.03 g, 9.6 mmol) in DCM (10 mL), dropwise. After stirring at room temperature overnight, sodium bicarbonate (100 mL, 10%) was added, and the organic layer was separated. The aqueous layer was extracted twice by DCM (50 mL each). The combined organic layer was dried over magnesium sulfate and the solvent was removed to obtain product, compound 10a (0.97 g, 90%):",4-Methoxypyridine-2-carboxylic acid | compound 10(b) | trimethylsilyl cyanide | 4-methoxypyridine N-oxide | DCM | dimethylcarbamoyl chloride | DCM | sodium bicarbonate | DCM | magnesium sulfate | compound 10a
US04874869,"With stirring under ice-cooling, 3 g of metallic sodium were added in 100 ml of absolute ethanol to dissolve the metal. Then, 12.5 g (0.045 mol) of 4-chloro-2-(2-bromoisobutyryl)phenol dissolved in 60 ml of benzene was added to the said solution dropwise for about 15 minutes under heating to reflux (internal temperature: 80° C.). After the completion of the dropping, the stirring was continued for additional 30-60 minutes with heating and the solution was vacuum-concentrated to one third in volume. The solution concentrated was diluted with large amount of water, and the solution was extracted with ether. The ether layer was washed with water, then vacuum-concentrated to dryness to produce 10 g of crude crystallized subject compound, 5-chloro-2,2-dimethyl-4-benzofuran. Then, the crude product was recrystallized from methanol, to obtain 7.3 g (yield: 82.5%) of the subject compound in colorless pillow crystal.",ice | sodium | ethanol | 4-chloro-2-(2-bromoisobutyryl)phenol | benzene | water | ether | ether | water | subject compound | crude product | methanol
US08962648B2,"Following the procedure outlined for Example 627, (2-(4-bromo-2-fluorophenyl)acetic acid) (10.8 g, 30.7 mmol) reacted with (S)-(+)-4-benzyl-2-oxazolidinone (5.44 g, 30.7 mmol) to obtain the desired product (4.5 g, 36%) as white solid. ESI MS nm/393 [C18H15BrFNO3+H]+",2-(4-bromo-2-fluorophenyl)acetic acid | (S)-(+)-4-benzyl-2-oxazolidinone | desired product
US20150361078A1,"4-Methylpyridin-2-amine (0.14 g, 1.26 mmol), 4-formyl-N,3-dimethylbenzamide (0.22 g, 1.26 mmol), (2S,5S)-tert-butyl 2-ethynyl-5-methylmorpholine-4-carboxylate (0.28 g, 1.26 mmol), and copper(I) chloride (62 mg, 0.63 mmol) were added to a round-bottom flask. Toluene (10 mL) and N,N-dimethylacetamide (5 drops) were then added. The flask was put under vacuum and then back-filled with N2 three times. The resulting mixture was stirred at 90° C. for 16 hr, and then cooled to room temperature. Afterward, ethanol and silica gel were added to the mixture, which was then concentrated under reduced pressure. The residue was purified by flash-chromatography on a 50 g silica gel cartridge eluting using 50% to 100% ethyl acetate in hexanes as eluent, followed by 0% to 20% methanol in ethyl acetate, to provide (2S,5S)-tert-butyl 5-methyl-2-((7-methyl-2-(2-methyl-4-(methylcarbamoyl)phenyl)imidazo[1,2-a]pyridin-3-yl)methyl)morpholine-4-carboxylate (0.37 g, 60%) as an oil which was used without further purification.","4-Methylpyridin-2-amine | 4-formyl-N,3-dimethylbenzamide | (2S,5S)-tert-butyl 2-ethynyl-5-methylmorpholine-4-carboxylate | copper(I) chloride | Toluene | N,N-dimethylacetamide | N2 | ethanol | silica gel | silica gel | (2S,5S)-tert-butyl 5-methyl-2-((7-methyl-2-(2-methyl-4-(methylcarbamoyl)phenyl)imidazo[1,2-a]pyridin-3-yl)methyl)morpholine-4-carboxylate"
US06159901,"2-bromo-4-[methyl(phenylmethyl)amino]-6-[3-(trifluoromethyl)phenoxy] pyridine (6.38 g, 0.0146 mol) was suspended in about 300 ml of diethyl ether. While cooling in a dry ice-acetone bath in an argon atmosphere, the obtained suspension was mixed with n-butyl lithium [10 ml (ca. 1.63M hexane solution), 0.0146×1.1 mol], and the obtained suspension was stirred for about 10 minutes. After replacing an interior of the reactor with a carbon dioxide gas, the solution was removed from the bath and stirred at room temperature for about one hour. The obtained reaction solution was mixed with about 30 ml of a 1N aqueous hydrochloric acid solution, distributed in ethyl acetate-water, and then washed with saturated brine. The organic phase separated from the solution was dried with anhydrous sodium sulfate, concentrated and purified by silica gel column chromatography (eluting solution: ethyl acetate/hexane), thereby obtaining an aimed product.",2-bromo-4-[methyl(phenylmethyl)amino]-6-[3-(trifluoromethyl)phenoxy] pyridine | diethyl ether | dry ice-acetone | argon | n-butyl lithium | carbon dioxide | hydrochloric acid | ethyl acetate-water | brine | sodium sulfate | silica gel | ethyl acetate/hexane | aimed product
US07425554B2,"A mixture of 4-[4-methyl-2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine-1-carboxylic acid t-butyl ester (124 mg, 0.299 mmol) produced in Example (70a), trifluoroacetic acid (1 mL, 12.9 mmol) and dichloromethane (2 mL) was stirred for 2 hours and 30 minutes at room temperature. Saturated aqueous solution of sodium hydrogencarbonate was added to the reaction mixture and extraction was performed with ethyl acetate. The separated organic layer was concentrated under reduced pressure. The resultant residue was purified by NH silica gel column chromatography (ethyl acetate/hexane) to give 85 mg of the title compound as yellow crystals.","4-[4-methyl-2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine-1-carboxylic acid t-butyl ester | trifluoroacetic acid | dichloromethane | sodium hydrogencarbonate | ethyl acetate | resultant residue | silica gel | ethyl acetate/hexane | title compound"
US07671085B2,"Thus, 29 is transesterified (0.5 equiv. of n-Bu2Sn═O, EtOH, or i-PrOH, 25° C., 48 h., 50% and 34%) to afford esters 30 and 31, respectively. 29 is reduced (1.2 equiv. of diisobutylaluminum hydride (Dibal-H), toluene, −78° C., 0.5 h., 52%) to provide the allyl alcohol 32. 32 is O-allylated (2.0 equiv. of NaH, 3.0 equiv. of MeI, 0° C., 1 h., 95%), or is acylated (1.2 equiv. of MeOC(O)Cl, 2.0 equiv. of Et3N, 0.1 equiv. of 4-DMAP, CH2Cl2, 25° C., 24 h., 90% or 1.2 equiv. of MeC(O)Cl, 2.0 equiv. of Et3N, 0.1 equiv. of 4-DMAP, CH2Cl2, 25° C., 24 h., 90%) to afford compounds 33, 42 and 43, respectively. 29 is hydrolyzed (4.0 equiv. of LiOH, THF:H2O (10:1), 25° C., 24 h. 88%) to the acid which is aminated by mixed anhydride formation followed by exposure to an amine, (1.2 equiv. of EtOC(O)Cl, 1.5 equiv. of Et3N, 0.1 equiv. of 4-DMAP, CH2Cl2, 25° C., 1 h., then 3.0 equiv. of NH3, MeNH2, PbNH2 or ((CH2)5)N, CH2Cl2, 25° C., 12 h., 85%-95%) to provide amides 37-40. 29 also undergoes cyclopropanation (10.0 equiv. of CH2N2, 0.2 equiv. of Pd(OAc)2, Et2O, 25° C., 12 h., 95%) to afford compound 35.",Et3N | 4-DMAP | CH2Cl2 | CH2Cl2 | LiOH | THF:H2O | anhydride | amine | EtOC(O)Cl | NH3 | MeNH2 | PbNH2 | ((CH2)5)N | amides
US20100099695A1,"N2 was bubbled through a solution of the compound from Step 5 (320 mg, 0.47 mmol) in DCM (80 mL) for 30 minutes, and then Neolyst M1 catalyst (75 mg, 23 wt %) was added. The dark solution was stirred for 6 hours, and N2 was bubbled through the solution for 30 minutes, after which additional NEOLYST M1 catalyst (75 mg, 23 wt %) was added, and the solution was stirred for 15 hours. Concentrated and purified the resulting residue on SiO2 (gradient elution, 10-40% EtOAc/hexanes) to yield the title compound as a yellow oil (259 mg). LRMS (M+H)+ Calcd.=654; found 654.",N2 | compound | DCM | N2 | SiO2 | title compound
US09440962B2,"The title compound, yellow solid (35 mg, 26%), MS (ISP) m/z=386.3 [(M+H)+], mp 153° C., was prepared in accordance with the general method of example 1 from 1-(4-fluoro-phenyl)-5-(4-nitro-phenyl)-1H-pyrazole (intermediate C) (100 mg, 353 μmol) and commercially available 2-(4-methoxy-phenyl)-acetonitrile.",title compound | solid | 1-(4-fluoro-phenyl)-5-(4-nitro-phenyl)-1H-pyrazole | intermediate C | 2-(4-methoxy-phenyl)-acetonitrile
US20150291572A1,"DMP (21.6 g, 50.97 mmol) was added portion wise to a stirred solution of (3-chloro-5-(difluoromethoxy)pyridin-2-yl)methanol (7.0 g, 33.98 mmol) in DCM (100 mL) at 0° C. and stirred for 16 h at RT. The RM was filtered through a celite bed and washed with DCM (3×100 mL). The clear filtrate was washed with aq. NaHCO3 (200 mL), water (200 mL), brine (250 mL), dried over anhydr. Na2SO4, filtered, concentrated under reduced pressure to get the crude product. The crude was purified by CC (0-5% EtOAc in PE) to give 3-chloro-5-(difluoromethoxy)picolinaldehyde (5.8 g, 85%) as liquid.",(3-chloro-5-(difluoromethoxy)pyridin-2-yl)methanol | DCM | DCM | NaHCO3 | water | brine | Na2SO4 | crude product | EtOAc | 3-chloro-5-(difluoromethoxy)picolinaldehyde
US08633312B2,"For the preparation of the compound by method C, 0.62 g (1.8 mmol) of 2-chloro-7-(2-acetoxyethoxy)-10,11-dihydrodibenzo[a,d]-cyclohepten-5-one, 0.25 g (1.9 mmol) of 2,4-difluoroaniline, 0.05 g (0.22 mmol) of Pd(OAc)2, 0.10 g (0.21 mmol) of 2-(dicyclohexylphosphino)-2′-,4′-,-6′-triisopropyl-biphenyl, 0.70 g (6.2 mmol) of KOt-Bu, 5 ml of toluene and 1 ml of t-BuOH are used. Yield: 34%; C23H19F2NO3 (Mr=395.41)","2-chloro-7-(2-acetoxyethoxy)-10,11-dihydrodibenzo[a,d]-cyclohepten-5-one | 2,4-difluoroaniline | Pd(OAc)2 | 2-(dicyclohexylphosphino)-2′-,4′-,-6′-triisopropyl-biphenyl | KOt-Bu | toluene | t-BuOH"
US20110112190A1,"To a solution of curcumin (200 mg, 0.54 mmol), cis-eicosapentaenoic acid (380 mg, 1.3 mmol) and catalytic amount of 4-(dimethylamino)pyridine in DCM (15 mL) was added a solution of N,N′-dicyclohexylcarbodiimide (358 mg, 1.73 mmol) in DCM (5 mL) for 5 min at ice cold temperature. The mixture was stirred at rt for 16 h and diluted with water. DCM layer was separated and the aqueous layer was extracted with DCM (3×100 mL). The combined DCM layer was washed with water, brine and dried over sodium sulfate. The solution was filtered and the residue was chromatographed over silica gel column using hexane-ethyl acetate mixture (90:10) as an eluent to give the product as an oil (250 mg, 49%). IR (neat) νmax 3011, 2969, 2930, 1763, 1630, 1597, 1299, 1256, 1200, 1123, 1033, 971 cm−1; 1H NMR (CDCl3) δ 7.62 (2H, d, J=15.6 Hz, H-1,7), 7.16 (2H, dd, J=8.0, 1.6 Hz, H-6′, 6″), 7.12 (2H, d, J=1.6 Hz, H-2′, 2″), 7.05 (2H, d, J=8.4 Hz, H-5′, 5″), 5.86 (1H, s, H-4), 5.30-5.49 (20H, m, 2× H-5″′, 6″′, 8″′, 9″′, 11″′, 12″′, 14′, 15″′, 17″′, 18″′), 3.87 (6H, s, 2× Ar—OCH3), 2.79-2.88 (16H, m, 2× H-7″′, 10″′, 13″′, 16″′), 2.52-2.67 (4H, m, 2× H-2″′), 2.20-2.25 (4H, m, 2× H-19″′), 2.04-2.11 (4H, m, 2× H-4″′), 1.82-189 (4H, m, 2× H-3″′), 0.97 (6H, t, J=7.6 Hz, 2× H-20″′).","curcumin | cis-eicosapentaenoic acid | 4-(dimethylamino)pyridine | DCM | N,N′-dicyclohexylcarbodiimide | DCM | ice | water | DCM | DCM | DCM | water | brine | sodium sulfate | silica gel | product"
US08946278B2,"The title compound was prepared as a white solid according to the procedure of Example 6, except substituting 2-[2-(methylamino)-3-phenylpropyl]-1H-isoindole-1,3(2H)-dione (200 mg, 0.7 mmol) [prepared according to the procedure of Preparation 6] for 2-{(2S)-2-amino-3-[2-(trifluoromethyl)phenyl]propyl}-1H-isoindole-1,3(2H)-dione-HCl and substituting 4-(1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxylic acid (150 mg, 0.72 mmol) for 4-bromo-5-(1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxylic acid. The reaction mixture was absorbed onto silica and purified via column chromatography (silica, 3% MeOH in DCM (1% NH4OH)) yielding the title compound, which was further purified by Gilson reverse phase chromatography 5-95% H2O (1% TFA)/MeCN (1% TFA) to afford the TFA salt: LC-MS (ES) m/z 355 (M+H)+, 1H NMR (400 MHz, MeOD) δ ppm 2.86 (s, 3H) 2.97 (dd, J=14.02, 8.72 Hz, 2H) 3.12-3.23 (m, 2H) 3.70 (m, 1H) 3.97 (s, 3H) 6.47 (d, J=2.02 Hz, 1H) 7.30-7.35 (m, 1H) 7.37-7.43 (m, 5H) 7.51 (d, J=2.02 Hz, 1H) 7.88 (d, J=1.52 Hz, 1H) 7.94 (d, J=1.52 Hz, 1H).","title compound | 2-{(2S)-2-amino-3-[2-(trifluoromethyl)phenyl]propyl}-1H-isoindole-1,3(2H)-dione-HCl | 4-(1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxylic acid | 4-bromo-5-(1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxylic acid | silica | silica | MeOH | DCM | NH4OH | title compound"
US20160031892A1,"A mixture of (4-bromophenyl)(pyrrolidin-1-yl)methanone (2.20 g, 8.70 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (2.43 g, 9.57 mmol), AcOK (1.17 g, 17.4 mmol) and Pd(dppf)Cl2 (110 mg) in dioxane (20 mL) was stirred at 100° C. for 16 hrs under N2. After LCMS and TLC (PE:EtOAc=2:1) showed the reaction was complete, the mixture was concentrated and purified by column chromatography on silica gel (PE:EtOAc=1:0˜50:1˜20:1˜10:1˜5:1˜3:1) to give the title compound (2.15 g, yield: 83.4%) as a white solid.","(4-bromophenyl)(pyrrolidin-1-yl)methanone | 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) | AcOK | Pd(dppf)Cl2 | dioxane | N2 | EtOAc | silica gel | EtOAc | title compound"
US08778939B2,"A solution of 5-bromo-2-hydroxybenzoic acid (5.2 g, 23.96 mmol), 3-pyridinamine (2.26 g, 23.96 mmol), EDC (4.59 g, 23.96 mmol), HOBT (3.67 g, 23.96 mmol) and triethylamine (3.34 ml, 23.96 mmol) in DMF (80 ml) was stirred for 3 h. The reaction mixture was filtered. 150 ml water was added to the filtrate to yield a white solid. This was filtered and dried to yield the title compound. 2.8 g.",5-bromo-2-hydroxybenzoic acid | 3-pyridinamine | EDC | HOBT | triethylamine | DMF | water | title compound
US05130119,"6.95 g (13.5 mmol) of 2 benzyloxy-5-fluoro-3-(2,2,2-trifluoroethylcarbamoyl)-benzoic acid-[2-hydroxy-2-(2,2-dimethyl-1,3-dioxolan-4-yl)-ethylamide] is dissolved in 20 ml of methanol, 5 ml of water and 5 ml of IN hydrochloric acid is added and stirred for 3 hours at room temperature. The solution is then adjusted to pH 6.3 by addition of anion exchanger Amberlite IRA 67, 200 mg of palladium-carbon (10%) is added and hydrogenated for 1 hour at normal pressure. The catalyst is then filtered off, the filtrate is evaporated to dryness in a vacuum and the residue is chromatographed on silica gel 60 (Merck) with dichloromethane/methanol. 3.76 g (9.77 mmol)=72.4% of the theoretical yield of the compound is obtained as an amorphous solid.","2 | benzyloxy-5-fluoro-3-(2,2,2-trifluoroethylcarbamoyl)-benzoic acid-[2-hydroxy-2-(2,2-dimethyl-1,3-dioxolan-4-yl)-ethylamide] | methanol | water | hydrochloric acid | palladium-carbon | silica gel | dichloromethane/methanol"
US20120046292A1,"To a mixture of benzyl 4-[(4-hydroxycyclohexyl)oxy]benzoate (800 mg), tert-butyl bromoacetate (726 mg), and THF (10 ml) was added 60% oily sodium hydride (110 mg), followed by stirring at room temperature for 16 hours. To the reaction mixture was added a saturated aqueous ammonium chloride solution, followed by carrying out a separation of the layers using ethyl acetate, and the organic layer was washed with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate=95:5 to 75:25) to obtain 272 mg of benzyl 4-{[4-(2-tert-butoxy-2-oxoethoxy)cyclohexyl]oxy}benzoate as a colorless oil.",benzyl 4-[(4-hydroxycyclohexyl)oxy]benzoate | tert-butyl bromoacetate | THF | sodium hydride | ammonium chloride | ethyl acetate | sodium chloride | magnesium sulfate | silica gel | hexane | benzyl 4-{[4-(2-tert-butoxy-2-oxoethoxy)cyclohexyl]oxy}benzoate
US20150148452A1,"In a 1,000 ml two-necked flask equipped with a refluxing condenser, 20.0 g of bisphenol A (Sigma-Aldrich), 36.35 g of K2CO3, and 500 ml of acetone were added and mixed at room temperature. Then, the temperature of a refluxing apparatus was set to 80° C., and a homogeneously well mixed solution was refluxed. While refluxing the homogeneously well mixed solution, 8.33 ml of allyl bromide (Sigma-Aldrich) was added dropwisely, followed by performing reaction overnight. After completing the reaction, the reactant was cooled to room temperature and filtered using celite filtration. Organic solvents were evaporated to produce a crude product. A target material in the crude product was extracted with ethyl acetate, washed with water three times, and dried with MgSO4. MgSO4 was removed using a filter, and solvents were removed using an evaporator to obtain 4-(2-(4-(allyloxy)phenyl)propane-2-yl)phenol as an intermediate (11). The Reaction Scheme of the first step and NMR data of the intermediate (11) thus obtained are as follows.",bisphenol A | K2CO3 | acetone | allyl bromide | crude product | crude product | ethyl acetate | water | MgSO4 | MgSO4 | 4-(2-(4-(allyloxy)phenyl)propane-2-yl)phenol | (11)
US07078414B2,"1.73 g (12.5 mmol) of potassium carbonate are added at 20° C. under an argon atmosphere to 0.625 g (5 mmol) of 3-methoxycarbonyl-1H-pyrrole and 0.82 g (5 mmol) of 2-chloroquinoline dissolved in 10 mL of dimethyl sulphoxide. After stirring at 100° C. for 23 hours, the reaction mixture is poured into 30 mL of water and is then allowed to crystallise at 20° C. for 1 hour. After filtering off and air-drying the solid residue, 0.83 g of 3-methoxycarbonyl-1-(quinol-2-yl)-1H-pyrrole is obtained in the form of a beige-coloured solid melting at 136° C.",potassium carbonate | argon | 3-methoxycarbonyl-1H-pyrrole | 2-chloroquinoline | dimethyl sulphoxide | water | solid | 3-methoxycarbonyl-1-(quinol-2-yl)-1H-pyrrole
US20020193616A1,"Under the same conditions as in Example 3, 1α-(tert-butyldimethylsilyloxy)-3β-hydroxy-20(S)-phenoxycarbonylthiopregna-5,7,16-triene (82.4 mg, 0.142 mmol), 1-bromo-4-methyl-4-triethylsilyloxypentane (209 mg, 0.709 mmol), tetrahydrofuran (1 ml) and 1M KOH solution in methanol (1 ml) were reacted and worked up, and then the residue was purified by preparative thin layer chromatography (0.5 mm×2, hexane:ethyl acetate=3:2, developed once) to give the title compound as a colorless oil (56.1 mg, 59%).","1α-(tert-butyldimethylsilyloxy)-3β-hydroxy-20(S)-phenoxycarbonylthiopregna-5,7,16-triene | 1-bromo-4-methyl-4-triethylsilyloxypentane | tetrahydrofuran | KOH | methanol | hexane | title compound"
US05212180,"A degassed suspension of the product of Step 1 (50.3 g, 156 mmol), n-Bu4NCl (86.0 g, 312 mmol), LiOAc.2H2O (41.2 g, 390 mmol), LiCl (6.84 g, 156 mmol), Pd(OAc)2 (1.00 g, 4.7 mmol), and methyl 2-iodobenzoate (41.00 g, 156 mmol) in DMF (300 mL) was stirred for 3 hours at 90° C. The dark red solution was then cooled to r.t. and poured into 2 L of ice cold H2O. The product was extracted with hot EtOAc, dried over Na2SO4, filtered and concentrated to dryness. It was dissolved in 600 ml of hot toluene and filtered through a small silica pad (1 L). The title product was finally recrystallized from EtOAc:hexane 1:1 (1.2 L). The title product was finally recrystallized from EtOAc:hexane 1:1 (1.2 L). Recrystallization of the mother liquors in EtOAc:hexane 1:3 ( 400 mL) afforded a second crop of the title compound.",product | n-Bu4NCl | LiOAc.2H2O | LiCl | Pd(OAc)2 | methyl 2-iodobenzoate | DMF | ice | EtOAc | Na2SO4 | toluene | silica | title product | EtOAc:hexane | title product | EtOAc:hexane | EtOAc:hexane | title compound
US03960970,"The hydrogenation of the crude piperitenone is expediently carried out at temperatures at which as much d,l-menthol as possible is present in the menthol isomer mixture and no splitting off of water to form p-menthane takes place. Temperatures of 100° to 260°C, especially of 160° to 220°C, have proved advantageous.","piperitenone | d,l-menthol | menthol | water | p-menthane"
US08377874B2,"To a solution of (1R,2R)-2-pent-4-en-1-ylcyclopentanol (105 mg, 0.68 mmol) in MeCN (1.4 mL) was added N,N′-disuccinimidyl carbonate (174 mg, 0.68 mmol) and Et3N (0.19 mL, 1.36 mmol) and the mixture was stirred at 40 C for 20 hours. The reaction mixture was cooled, concentrated and purified by silica chromatography (gradient elution 0 to 100% EtOAc in hexane). LCMS (M+Na)+=318.1.","(1R,2R)-2-pent-4-en-1-ylcyclopentanol | MeCN | N,N′-disuccinimidyl carbonate | Et3N | silica | EtOAc | hexane"
US20040198786A1,"25 g of rac-cis-3-[2-(4-fluorophenyl)-5-methyloxazol-4-ylmethoxy]cyclohexanol are dissolved in 320 ml of vinyl acetate, and 1.3 g of Chirazyme L-2 Lyo (Boehringer Mannheim) are added. The mixture is stirred at room temperature for three hours (checked by LC-MS for 40-45% conversion) and the enzyme is then filtered off and washed with ethyl acetate, and the solvent is removed under reduced pressure. The residue is purified by flash chromatography on silica gel (n-heptane/ethyl acetate=3:1). This gives 8 g of (1 R, 3S)-3-[2-(4-fluorophenyl)-5-methyloxazyol-4-ylmethoxy]cyclohexyl acetate as a colorless oil. C19H22FNO4 (347.39), MS (ESI): 348 (M+H+). The acetate is taken up in 170 ml of methanol and, after addition of 27 ml of 2N aqueous sodium hydroxide solution, stirred at room temperature for one hour. Most of the solvent is removed under reduced pressure. After addition of in each case 150 ml of water and ethyl acetate, the organic phase is washed with sodium chloride solution. The organic phase is dried over magnesium sulfate and the solvent is removed under reduced pressure. This gives 6.7 g of 3-(1R,3S)-3-[2-(4-fluorophenyl)-5-methyloxazol4-ylmethoxy]cyclohexanol as a yellowish solid. C17H20FNO3 (305.35), MS (ESI): 306 (M+H+).",rac-cis-3-[2-(4-fluorophenyl)-5-methyloxazol-4-ylmethoxy]cyclohexanol | vinyl acetate | ethyl acetate | silica gel | n-heptane/ethyl acetate | ethyl acetate | sodium hydroxide | water | sodium chloride | magnesium sulfate
US20160244445A1,"To a mixture of 7-chloro-N-((1S,2S)-2-hydroxycyclohexyl)-1H-pyrrolo[3,2-b]pyridine-3-carboxamide (Intermediate 17), (200 mg), 2-(bromomethyl)-6-methylpyridine (139 mg) and cesium carbonate (510 mg) was added DMF (3 mL) and left to stir at rt overnight. The crude product was diluted with EtOAc (150 mL) and washed with water (2×40 mL) and brine (40 mL), dried over MgSO4, filtered and evaporated under vacuum to give a solid which was purified by column chromatography (normal phase, 25 g, Biotage SNAP cartridge KP-Sil, 25 mL/min, gradient 20-100% EtOAc in n-hexane) to give the desired compound (143 mg).","7-chloro-N-((1S,2S)-2-hydroxycyclohexyl)-1H-pyrrolo[3,2-b]pyridine-3-carboxamide | Intermediate 17 | 2-(bromomethyl)-6-methylpyridine | cesium carbonate | DMF | crude product | EtOAc | water | brine | MgSO4 | EtOAc | n-hexane | desired compound"
US05663336,"A steady stream of argon is passed through a suspension of 5.0 g (12.12 mmol) of 4,5-bis-(4-fluoroanilino)phthalic acid dimethylester in 40 ml of methanol, and a solution of 2.04 g (48.6 mmol, 2 eq) of lithium hydroxide monohydrate in 20 ml of water is added. The reaction mixture is heated to reflux for 1 hour, cooled to RT and diluted with 50 ml water. Methanol is removed by evaporation, the resulting solution is cooled to 0°, and 12 ml 4N hydrochloric acid and thereafter 100 ml of water are added. After 15 rain at 0°, the gray crystals are filtered off, washed with water and resuspended twice in 100 ml toluene with removal of the toluene by distillation to yield the title compound in the form of gray crystals, FAB-MS: 385 [M+ +H].","argon | 4,5-bis-(4-fluoroanilino)phthalic acid dimethylester | methanol | lithium hydroxide monohydrate | water | water | Methanol | hydrochloric acid | water | water | toluene | toluene | title compound"
US06858605B2,"A mixture of 3.25 g (10 mmol) of (±)-8-methyl-5-(4-nitrophenyl)-8,9-dihydro-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine, 20 ml of dimethylformamide, 2.76 g (20 mmol) of potassium chloride and 1.80 g (17 mmol) of cyanogen bromide was stirred at room temperature for 20 h. After pouring into water, the precipitated crystals were filtered off, and washed with water to yield 3.34 g (95%) of the title compound, Mp.: 172-176° C.","(±)-8-methyl-5-(4-nitrophenyl)-8,9-dihydro-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine | dimethylformamide | potassium chloride | cyanogen bromide | water | water | title compound"
US09328106B2,"To a solution of (Z)-1-(1-methyl-4-nitro-1H-pyrazol-5-yl)cyclohept-4-enol (1.35 g, 5.70 mmol) in dry DCM (60 mL) was added dropwise a solution of deoxo-Fluor® (50% in THF, 6.2 mL, 17.1 mmol) and the reaction mixture was stirred at room temperature for 90 min. The mixture was cooled to 0° C. and saturated aqueous NaHCO3 solution (70 mL) was added, dropwise initially, and extracted with DCM (100 mL). The organic layer was separated, dried over MgSO4, and concentrated under reduced pressure. Purification via silica gel column chromatography (15-20% EtOAc/hexane) gave (Z)-5-(1-fluorocyclohept-4-enyl)-1-methyl-4-nitro-1H-pyrazole as an off-white solid (615 mg, 45%).",(Z)-1-(1-methyl-4-nitro-1H-pyrazol-5-yl)cyclohept-4-enol | DCM | deoxo-Fluor | THF | NaHCO3 | DCM | MgSO4 | silica gel | EtOAc/hexane | (Z)-5-(1-fluorocyclohept-4-enyl)-1-methyl-4-nitro-1H-pyrazole
US05254466,"Fermentation of dodecane with strain H534 under the standard fermentation conditions (Example 20) produced approximately 139 g/l within 233 hrs with a substrate conversion efficiency of 32.1%. The final production rate was 0.58 g/l/hr. The product was 82.7% dodecanedioic acid. The remaining product was predominantly adipic acid. With methyl laurate as the substrate, H534 produced 115.3 g/l dicarboxylic acid within 223 hrs with a substrate conversion efficiency of 34.6%. The production rate was 0.49 g/l/hr. The product was 89.1% dodecanedioic acid. The remaining product was predominantly adipic acid.",dodecanedioic acid | adipic acid | methyl laurate | dicarboxylic acid
US07964591B2,"Following the procedure of Example 15, making variations only as required to use 6-chloropyridazine-3-carboxylic acid (3-methylbutyl)amide in place of 6-chloropyridazine-3-carboxylic acid (2-cyclopropyl-2-hydroxyethyl)amide to react with piperazin-1-yl-(2-trifluoromethylphenyl)methanone, the title compound was obtained as a white powder (63.2% yield). 1H NMR (500 MHz, CDCl3) δ 8.05, 7.98, 7.75, 7.64, 7.57, 7.37, 7.00, 4.06, 3.89, 3.82-3.64, 3.49, 3.36, 1.70, 1.50, 0.95.",6-chloropyridazine-3-carboxylic acid (3-methylbutyl)amide | piperazin-1-yl-(2-trifluoromethylphenyl)methanone | title compound | powder
US04785003,"A cold solution of 1.65 g DCC in 3 ml dimethylformamide is added to a stirred ice-cooled solution of 1.0 g N-acetylsarcosine and 1.4 g N-benzylglycine ethylester in 9 ml dry dimethylformamide, and the resulting solution is stirred at 0° C. for 1 hour and then at room temperature for 2 hours. It is then filtered and the precipitate is washed with dimethylformamide. The filtrate and washings are combined and the solvent is evaporated to dryness in vacuo to yield a residue which is then dissolved in 30 ml chloroform, washed with 5% aq. NaHCO3 and water, and dried over anhydrous MgSO4. Evaporation of solvent produces the desired ester which is either isolated (m.p. 98°-101° C.) or hydrolyzed directly to form the corresponding acid, N-(N'-acetylsarcosyl)-N-benzylglycine.",DCC | dimethylformamide | ice | N-acetylsarcosine | N-benzylglycine ethylester | dimethylformamide | dimethylformamide | chloroform | NaHCO3 | water | MgSO4 | ester
US08258293B2,Skraup reaction of methyl 4-aminobenzoate (5.0 g) and iodine (1.7 g) in mesityl oxide (25 ml) was performed according to the method described in example 1.,methyl 4-aminobenzoate | iodine | mesityl oxide
US20160222014A1,"To a stirred solution of 2-chloro-5-(2-ethoxyvinyl)pyrimidin-4-amine (3.0 g, 0.0150 mol, 1.0 eq), in IPA in a two neck round bottomed flask, 3N HCl was added and the contents heated at 100° C. for 1 h while monitoring by TLC. After completion of starting material, the solvent was evaporated from the mixture to obtain residue. This residue was suspended in water and extracted with EtOAc (3×150 mL). The organic layer was dried over Na2SO4, filtered and concentrated to obtain the compound. This compound was purified by Combiflash® column chromatography using 100-200 silica gel with 30% EtOAc in hexane as the eluting solvent to obtain product 2-chloro-7H-pyrrolo[2,3-d]pyrimidine as yellow solid (0.680 g, 29.56%). 1H NMR (DMSO-d6, 400 MHz): δ 12.357 (brs, 1H), 8.918 (s, 1H), 7.614 (t, 1H), 6.644 (t, 1H).","2-chloro-5-(2-ethoxyvinyl)pyrimidin-4-amine | IPA | HCl | water | EtOAc | Na2SO4 | 2-chloro-7H-pyrrolo[2,3-d]pyrimidine"
US08063098B2,"Pyrrolidine (7.4 g, 104 mmol) was slowly added at 0° C. to acetic acid (33 mL). 3-Oxetanone (1.5 g, 21 mmol) and trimethylsilyl cyanide (5.3 g, 52 mmol) were also added at 0° C. The reaction mixture was stirred at room temperature overnight and diluted with 100 mL dichloromethane. 32% sodium hydroxide solution was pH-9 (˜50 mL). The mixture was extracted twice with dichloromethane. The combined organic phases were dried on sodium sulfate, filtered and carefully evaporated. Purification of the residue by flash chromatography on silica gel (dichloromethane/methanol 1:0→19:1) yielded 3-pyrrolidin-1-yl-oxetane-3-carbonitrile as a light yellow oil (3.22 g, contains 19% dichloromethane, 92%), MS: m/e=153.1 [(M+H)+].",Pyrrolidine | acetic acid | 3-Oxetanone | trimethylsilyl cyanide | dichloromethane | sodium hydroxide | dichloromethane | sodium sulfate | silica gel | dichloromethane/methanol | dichloromethane | 3-pyrrolidin-1-yl-oxetane-3-carbonitrile
US09108944B2,"To a solution of (5-bromo-2-chloropyridin-3-yl)methanol (6.8 g, 30.6 mmol) in DCM (200 mL), was added Dess-Martin periodinane (32.4 g, 76.6 mmol) at 0° C. The resulting mixture was stirred at room temperature for 12 h. The reaction mixture was concentrated in vacuo and the residue was purified by column chromatography on silica gel (0 to 30% EtOAc in petroleum ether) to afford 5.05 g of 5-bromo-2-chloronicotinaldehyde. LCMS [M+H]+ 221.1.",(5-bromo-2-chloropyridin-3-yl)methanol | DCM | Dess-Martin periodinane | silica gel | EtOAc | petroleum ether | 5-bromo-2-chloronicotinaldehyde
US09073871B2,"At −40° C., isopropylmagnesium chloride lithium chloride (15.3 mL, 1.3 M in THF, 19.9 mmol) was added dropwise to a solution of ethyl 4-iodobenzoate (5000 mg, 18.11 mmol) in tetrahydrofuran (30 mL). The solution was stirred at −40° C. for 40 minutes. Butyraldehyde (1830 mg, 25.4 mmol) was added. The mixture was allowed to warm to room temperature over 3 hours. The reaction was quenched with 1N HCl and extracted three times with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered and concentrated to give ethyl 4-(1-hydroxybutyl)benzoate. 1H NMR (400 MHz, CDCl3, δ): 8.02 (d, J=8.6 Hz, 2H), 7.41 (d, J=8.0 Hz, 2H), 4.83-4.66 (m, 1H), 4.38 (q, J=7.2 Hz, 2H), 1.86 (d, J=3.7 Hz, 1H), 1.83-1.61 (m, 2H), 1.51-1.42 (m, 1H), 1.39 (t, J=7.2 Hz, 3H), 1.36-1.23 (m, 1H), 0.94 (t, J=7.6 Hz, 3H).",isopropylmagnesium chloride lithium chloride | ethyl 4-iodobenzoate | tetrahydrofuran | Butyraldehyde | HCl | ethyl acetate | sodium sulfate | ethyl 4-(1-hydroxybutyl)benzoate
US04550118,"4-chloro-3-nitrobenzoic acid was subjected to borane reduction to yield 4-chloro-3-nitrobenzyl alcohol. The benzyl alcohol compound was treated with sodium sulfide, and 4,4'-dithiobis(3-aminobenzyl alcohol) thus obtained was caused to react with triphenylphosphine in dioxane, and further with 1-cyanoguanidine to yield 5-hydroxymethyl-2-guanidinobenzothiazole. Then, the hydroxymethyl compound (0.5 g) was refluxed with heating for 15 minutes in an aqueous 47% hydrobromic acid solution (5 ml) to yield 5-bromomethyl-2-guanidinobenzothiazole.hydrobromide (0.63 g).",4-chloro-3-nitrobenzoic acid | borane | 4-chloro-3-nitrobenzyl alcohol
US20140113882A1,"To a stirred solution of 3-Fluoroisonicotinonitrile (0.088 g, 0.71 mmol) in MeOH (5 mL) was added NaOMe (0.008 g, 0.15 mmol). After 1 hr 3-amino-5-methoxy-isonicotinic acid (0.1 g, 0.54 mmol) was added and the RM heated to 85° C. for 18 hr. The solution became yellow in colour. The reaction mixture was alloed to cool to RT and the white solid was collected by filtration and washed with MeOH to yield the title compound (0.07 g, 43% yield). LCMS method: 1, RT:1.19 min, MI 271.24 [M+H]",3-Fluoroisonicotinonitrile | MeOH | NaOMe | 3-amino-5-methoxy-isonicotinic acid | MeOH | title compound
US04272534,"2-(4-n-Butylpyrid-2-ylmethyl)isothiourea dihydrochloride can be prepared in accordance with the method described in Example 1 for the preparation of 2-(pyrid-2-ylmethyl)isothiourea dihydrochloride. Using 4-n-butyl-2-chloromethylpyridine hydrochloride (26.9 g) and thiourea (11.3 g) as the starting materials, 2-(4-n-butylpyrid-2-ylmethyl)isothiourea dihydrochloride (26.4 g), melting at 209° C., is obtained.",2-(4-n-Butylpyrid-2-ylmethyl)isothiourea dihydrochloride | 2-(pyrid-2-ylmethyl)isothiourea dihydrochloride | 4-n-butyl-2-chloromethylpyridine hydrochloride | thiourea | 2-(4-n-butylpyrid-2-ylmethyl)isothiourea dihydrochloride
US20150315198A1,"Into a 40-mL sealed tube, was placed a solution of 5-chloro-1-([4-[(4-[[(6-methoxy-2,4-dimethylpyridin-3-yl)methyl]amino]-2H-pyrazolo[3,4-d]pyrimidin-2-yl)methyl]phenyl]methyl)-1,2-dihydropyridin-2-one (180 mg, 0.35 mmol, 1.00 equiv)(Example 351) in dichloromethane (3 mL) with stirring, to which TMSI (217 mg, 1.08 mmol, 3.00 equiv) was then added. The reaction mixture was stirred for 6 h at 50° C. in an oil bath. The mixture was concentrated under vacuum and the residue was applied onto a silica gel column (eluent: dichloromethane/methanol=10/1). The product was further purified by Prep-HPLC with the following conditions. Column: Waters XBridge RP18 19*150 mm; mobile phase, CH3CN/water (0.05% NH3.H2O) with a gradient of acetonitrile from 27% to 32% in 5 min; flow rate: 20 mL/min; detector UV wavelength: 254 nm. The product was concentrated and lyophilized to afford 55.7 mg (32%) of 5-chloro-1-([4-[(4-[[(6-hydroxy-2,4-dimethylpyridin-3-yl)methyl]amino]-2H-pyrazolo[3,4-d]pyrimidin-2-yl)methyl]phenyl]methyl)-1,2-dihydropyridin-2-one as a off-white solid. This resulted in 55.7 mg (32%) of 5-chloro-1-([4-[(4-[[(6-hydroxy-2,4-dimethylpyridin-3-yl)methyl]amino]-2H-pyrazolo[3,4-d]pyrimidin-2-yl)methyl]phenyl]methyl)-1,2-dihydropyridin-2-one as a off-white solid. 1H NMR (300 MHz, DMSO-d6): δ 8.29-8.24 (m, 2H), 8.09 (d, J=3.0 Hz, 1H), 7.97 (brs, 1H), 7.47 (dd, J=9.6 Hz, 3.0 Hz, 1H), 7.31 (s, 4H), 6.44 (d, J=9.6 Hz, 1H), 6.04 (s, 1H), 5.51 (s, 2H), 5.05 (s, 2H), 4.39 (d, J=4.2 Hz, 2H), 2.25 (s, 3H), 2.13 (s, 3H). MS (ESI) m/z 502 [M+H]+.","5-chloro-1-([4-[(4-[[(6-methoxy-2,4-dimethylpyridin-3-yl)methyl]amino]-2H-pyrazolo[3,4-d]pyrimidin-2-yl)methyl]phenyl]methyl)-1,2-dihydropyridin-2-one | dichloromethane | TMSI | CH3CN/water | acetonitrile | 5-chloro-1-([4-[(4-[[(6-hydroxy-2,4-dimethylpyridin-3-yl)methyl]amino]-2H-pyrazolo[3,4-d]pyrimidin-2-yl)methyl]phenyl]methyl)-1,2-dihydropyridin-2-one"
US06800629B2,"In 5 mL of toluene was dissolved 1.0 g of 3-(allyloxy)-6-fluoro-2-pyrazinecarbonitrile. After adding 0.82 g of aluminum chloride, the mixture was stirred at room temperature for 1.5 hours. Water (5 mL) was added to the reaction mixture, the aqueous layer was separated, and the organic layer was extracted first with 3 mL of water and then with 2 ml of water. The aqueous layers were united and washed with 5 mL of toluene, and extracted with 15 mL of ethyl acetate. The organic layer thus obtained was washed with 3 mL of water and dried on anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. Thus, 0.45 g of 6-fluoro-3-oxo-3,4-dihydro-2-pyrazinecarbonitrile was obtained as a yellow-colored solid product.","toluene | 3-(allyloxy)-6-fluoro-2-pyrazinecarbonitrile | aluminum chloride | Water | water | water | toluene | ethyl acetate | magnesium sulfate | 6-fluoro-3-oxo-3,4-dihydro-2-pyrazinecarbonitrile"
US07488822B2,"To a mixture of N, O-dimethylhydroxylamine hydrochloride (9.42 g, 96 mmol) and triethyl amine (13.5 mL, 96 mmol) in ethanol and water (100 mL/10 mL) was added a solution of 5-bromoisatoic anhydride (20 g, 74 mmol) in ethanol and water (100 mL/10 mL) at ambient temperature under nitrogen. The reaction mixture was heated at reflux for 3 hours. The solvent was removed in vacuo and the residue was dissolved in ethyl acetate (100 mL), washed with 1N aqueous sodium hydroxide solution (2×20 mL), brine (30 mL), and dried with MgSO4. After removal of the solvent, the residue was purified by a silica gel flash chromatography (hexane: ethyl acetate/3:2) to give 2-amino-5-bromo-N-methoxy-N-methylbenzamide as an off-white solid (13 g, 68%): mp 80-81° C.; 1H-NMR (CDCl3) δ 7.49 (d, 1H, J=2.1 Hz), 7.26 (dd, 1H, J=8.3, 2.0 Hz), 6.59 (d, 1H, J=8.4 Hz), 4.69 (br, 2H), 3.58 (s, 3H), 3.34 (s, 3H); Anal. Calc. For C9H11BrN2O2: C, 41.72; H, 4.28; N, 10.81. Found: C, 41.99, H, 4.16; N, 10.82.",N | O-dimethylhydroxylamine hydrochloride | triethyl amine | ethanol | water | 5-bromoisatoic anhydride | ethanol | water | nitrogen | ethyl acetate | sodium hydroxide | brine | MgSO4 | silica gel | hexane | ethyl acetate | 2-amino-5-bromo-N-methoxy-N-methylbenzamide
US04180669,"5-Isopropyl resorcinol (5.40 g), N-isopropyl-4-piperidone (5.00 g) and 12 ml acetic acid was treated with HCl as described in Example I to give 5.48 g product (50% yield); m.p. 247°-248°.",5-Isopropyl resorcinol | N-isopropyl-4-piperidone | acetic acid | HCl | product
US07091357B2,"To a stirred solution of (S)-nicotine (0.52 g, 3.2 mmol) in AcOH (10 ml) was added 10-bromo-dec-1-ene (1.66 g, 7.58 mmol). The mixture was heated at reflux for 3 days. AcOH was evaporated and the residue was dissolved in CHCl3. The mixture was washed with saturated aqueous NaHCO3, water and brine successively and dried. Evaporation of the solvent followed by titration with ether afforded 0.74 g (61%) of (S)-1-dec-9-enyl-3-(1-methyl-pyrrolidin-2-yl)-pyridinium bromide (NDNB-9e) as a brown oil. 1H NMR (300 MHz, CDCl3) δ 9.65 (1H, d, J=5.1 Hz), 9.14 (1H, s), 8.41(1H, d, J=8.1 Hz), 8.09 (1H, dd, J=8.1, 5.1 Hz), 5.75 (1H, m), 4.88–5.10 (4H, m), 3.54 (1H, t, J=8.1 Hz), 3.23 (1H, m), 2.45 (2H, m), 2.22 (3H, s), 1.70–2.10 (6H, m), 1.61 (1H, m), 1.10–1.40 (10H, m); 13C NMR (75 MHz, CDCl3) δ 146.46, 144.39, 143.74, 142.97, 139.07, 128.50, 114.33, 67.17, 62.25, 56.92, 40.74, 36.11, 33.93, 32.35, 29.42, 29.24, 29.15, 29.03, 26.35, 23.41.",(S)-nicotine | AcOH | 10-bromo-dec-1-ene | AcOH | CHCl3 | NaHCO3 | water | brine | (S)-1-dec-9-enyl-3-(1-methyl-pyrrolidin-2-yl)-pyridinium bromide
US20160083387A1,"A suspension of ((3aS,4R,5S,7aS)-5-((1R,2S,4S)-4-((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-1-methylcyclohexyl)-7a-methyl-1-oxooctahydro-1H-inden-4-yl)methyl acetate (Compound No. 150, 4.50 g) and potassium carbonate (2.1 g, 15 mmol) in MeOH (76 mL) was heated to 50° C. for 18 h. The mixture was concentrated, and the residue was partitioned between CH2Cl2 (100 mL), H2O (100 mL) and brine (50 mL). The aqueous phase was extracted with CH2Cl2 (2×50 mL), and the combined organic layers were dried (MgSO4) and concentrated to give (3aS,4R,5S,7aS)-5-((1R,2S,4S)-4-((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-1-methylcyclohexyl)-4-(hydroxymethyl)-7a-methyloctahydro-1H-inden-1-one (Compound No. 151, 4.21 g) as a pale foam.","((3aS,4R,5S,7aS)-5-((1R,2S,4S)-4-((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-1-methylcyclohexyl)-7a-methyl-1-oxooctahydro-1H-inden-4-yl)methyl acetate | potassium carbonate | MeOH | CH2Cl2 | H2O | brine | CH2Cl2 | MgSO4 | (3aS,4R,5S,7aS)-5-((1R,2S,4S)-4-((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-1-methylcyclohexyl)-4-(hydroxymethyl)-7a-methyloctahydro-1H-inden-1-one"
US06133253,"The procedures of examples 10c and 10d were used, substituting Boc-(R)-hydroxymethylazetidine for the Boc-(S)-hydroxymethylazetidine used in step 10c, and 2-chloro-3-hydroxypyridine for 3-fluoro-5-hydroxypyridine in step 10d. The title compound was obtained as an oil (535 mg, 93%): 1H NMR (CDCl3, 300 MHz) δ 1.40 (s, 9H), 2.40 (m, 2H), 3.90-4.00(m, 2H), 4.16 (m, 1H), 4.55 (m, 2H), 7.20 (m, 1H), 7.35 (m, 1H), 8.00 (m, 1H); MS (CI/NH3) m/z: 299 (M+H)+.",10d | Boc-(S)-hydroxymethylazetidine | 2-chloro-3-hydroxypyridine | 3-fluoro-5-hydroxypyridine | title compound | oil
US20120068123A1,"3-Fluorophthalonitrile (30 mmol, 4.38 g) and lithium chloride (2.54 g, 60 mmol) were refluxed at 250° C. in anhydrous N-methylpyrrolidone (NMP) for 5 hours. The resulting brown solution was cooled and poured on crushed ice and the resulting precipitate was washed well with water and filtered. The solid obtained was air-dried for 24 h and dried under vacuum at 60° C. for 15 h to give 4.55 g (93.6%) of the title compound. The compound was used without any further purification in the next step.",3-Fluorophthalonitrile | lithium chloride | N-methylpyrrolidone | ice | water | title compound
US07057051B2,"To a solution of 4,5-di-(2,4-dichlorophenyl)-1-methylimidazole (200 mg, 0.54 mmol) from Step C in THF (5 mL) cooled to −70° C. in a dry ice/acetone bath was added 1.6N n-butyl lithium in hexanes (0.40 mL, 0.65 mmol). The reaction was stirred for 1 hr and then ethyl chloroformate (0.10 mL, 1.1 mmol) was added via syringe. The reaction was allowed to warm to rt for 1 hr and was then quenched with aq. sodium bicarbonate and extracted twice with ethyl acetate. The organic layers were washed with brine, dried over sodium sulfate, and evaporated. The residue was purified by Prep TLC (2×1 mm, silica) (25% ethyl acetate in hexanes) to afford the title compound. HPLC/MS: 497 (M+1), 499 (100%, M+3), 501 (M+5); Rt=3.95 min.","4,5-di-(2,4-dichlorophenyl)-1-methylimidazole | THF | dry ice/acetone | n-butyl lithium | hexanes | ethyl chloroformate | sodium bicarbonate | ethyl acetate | brine | sodium sulfate | silica | ethyl acetate | hexanes | title compound"
US06391870B2,"To a stirring solution of 20c (2.07 g, 11.34 mmol), carbon tetrachloride (62 ml) and glacial acetic acid (2.07 ml) was added at room temperature a solution of bromine (μL 546.6, 10.66 mmol) in carbon tetrachloride (34 ml). The first drop was added and after 20 minutes the solution was added dropwise in 4 hours. After stirring for 16 hours the solvent was distilled and to the residue was added water and solid sodium bicarbonate (to pH 7), the organic phase was separated and water extracted with dichloromethane (3×30 ml), the organic layers were dried and evaporated. The crude product was chromatographed (70% petroleum ether 40-60° in dichloromethane) to give 1.90 g of 21c as a yellowish solid (64% yield). 1H NMR (CDCl3) δ7.47-7.42 (dd, 1H, J=8.85, 2.84 Hz); 7.38-7.18(m, 2H); 4.42 (s, 2H); 2.43 (s, 3H).",20c | carbon tetrachloride | acetic acid | bromine | carbon tetrachloride | water | sodium bicarbonate | water | dichloromethane | crude product | petroleum ether | dichloromethane | 21c
US04711890,"The procedure of Example 24 is followed using ethyl 2-phenylquinazoline-4-carboxylate (3 g), 3-methylpiperidine (3 ml), a 1.6M solution of butyllithium in hexane (15 ml) and tetrahydrofuran (20 ml) as the starting materials. After recrystallisation from isopropyl ether, 3-methyl-1-[(2-phenylquinazolin-4-yl)-carbonyl]piperidine (1 g), melting at 116° C., is obtained.",ethyl 2-phenylquinazoline-4-carboxylate | 3-methylpiperidine | butyllithium | hexane | tetrahydrofuran | isopropyl ether | 3-methyl-1-[(2-phenylquinazolin-4-yl)-carbonyl]piperidine
US20150307507A1,"A solution of methyl 5-(6-chloro-3-methylpyridazin-4-yl)thiophene-2-carboxylate (0.398 g, 1.40 mmol) in MeOH (50 mL) was degassed with N2. Palladium (10% on activated carbon, 0.556 g, 5.23 mmol) was added. The mixture was saturated with H2 by alternating vacuum/H2 purges. H2 was then bubbled through the mixture for 1.5 h. The mixture was filtered over Celite. The filter layer was rinsed with warm MeOH (3×30 mL). The filtrate was concentrated and purified by trituration with DCM. The mother liquor was concentrated and purified by FC (EtOAc/heptane 0:1→8:2). The triturated portion and the purified mother liquor were combined to obtain methyl 5-(3-methylpyridazin-4-yl)thiophene-2-carboxylate (0.196 g, 0.812 mmol, 58%) as a white solid. LCMS: calc. for [M+H]+=235.05. found 235.1.",methyl 5-(6-chloro-3-methylpyridazin-4-yl)thiophene-2-carboxylate | MeOH | N2 | Palladium | H2 | MeOH | DCM | EtOAc/heptane | methyl 5-(3-methylpyridazin-4-yl)thiophene-2-carboxylate
US20150311465A1,"In a 200 mL three-neck flask were put 3.2 g (8.1 mmol) of 9-(3-bromophenyl)-9-phenylfluorene and 2.3 g (24.1 mmol) of sodium tert-butoxide. The air in the flask was replaced with nitrogen. To this mixture were added 40.0 mL of toluene, 0.9 mL (8.3 mmol) of m-toluidine, and 0.2 mL of a 10% hexane solution of tri(tert-butyl)phosphine. The temperature of this mixture was set to 60° C., and 44.5 mg (0.1 mmol) of bis(dibenzylideneacetone)palladium(0) was added to the mixture. The mixture was stirred at 80° C. for 2.0 hours. After the stirring, the mixture was suction-filtered through Florisil (produced by Wako Pure Chemical Industries, Ltd., Catalog No. 540-00135), Celite (produced by Wako Pure Chemical Industries, Ltd., Catalog No. 531-16855), and alumina to give a filtrate. The filtrate was concentrated to give a solid, which was then purified by silica gel column chromatography (the developing solvent has a 1:1 ratio of hexane to toluene). Recrystallization from a mixed solvent of toluene and hexane was performed. Accordingly, 2.8 g of a white solid which was a target substance was obtained in a yield of 82%. The synthesis scheme of Step 1 is shown in (A−1) below.",9-(3-bromophenyl)-9-phenylfluorene | sodium tert-butoxide | toluene | m-toluidine | hexane | tri(tert-butyl)phosphine | bis(dibenzylideneacetone)palladium(0) | Florisil | alumina | silica gel | hexane | toluene
US06797820B2,"To mono-4-methyl 2-(R)-butylsuccinic acid (0.2 mmol) in dioxane (1 mL) was added amine 2 (0.2 mmol), DIEA (0.4 mmol) and an activating reagent (e.g. EDC, PyBOP, DIC, DCC, etc.; 0.2 mmol); and the mixture was stirred for 2 h. Aqueous 50% hydroxylamine was added (1.5 mL) and the mixture was stirred an additional 1-2 days. The reaction mixture can then be purified by preparative reverse-phase (C18) HPLC to afford N-hydroxy-3-(R)-n-butyl-3-aminocarbonylpropionamide.",mono-4-methyl 2-(R)-butylsuccinic acid | dioxane | amine | DIEA | EDC | PyBOP | DIC | DCC | hydroxylamine | N-hydroxy-3-(R)-n-butyl-3-aminocarbonylpropionamide
US20100197908A1,"417 mg (9.55 mmol) sodium hydride (55%) are added to a solution of 1-phenyl-ethanol in 70 ml THF. The reaction mixture is stirred for 30 minutes at room temperature. Then 2.882 g (8.68 mmol) 3,6-diiodo-pyridazine are added. The reaction mixture is stirred for 18 hours at room temperature. After that time the reaction mixture is poured into water and extracted with EtOAc. The organic phase is extracted with water three times, dried over sodium sulphate and concentrated. The residue is purified by silica gel column chromatography with cyclohexan/EtOAc as eluent.","sodium hydride | 1-phenyl-ethanol | THF | 3,6-diiodo-pyridazine | water | EtOAc | water | sodium sulphate | silica gel | cyclohexan/EtOAc"
US04929639,"A solution of (2R,4R)-4-t-butyldimethylsiloxymethyl -5-ethoxycarbonylmethylene-2-methyl-1,3-dioxane (17.0 g) in ethanol (170 ml) was shaken under hydrogen (3 atm) with 10% palladium on carbon at room temperature for 1.5 hours. After removal of the catalyst by filtration, the solvent was evaporated in vacuo and the residue was chromatographed on a silica gel column (500 g) with a mixture of n-hexane and ethyl acetate (20:1) as an eluent to give (2R,4R,5S)-4-t-butyldimethylsiloxymethyl-5 -ethoxycarbonylmethyl-2-methyl-1,3-dioxane (9.52 g) as a pale yellow oil.","(2R,4R)-4-t-butyldimethylsiloxymethyl -5-ethoxycarbonylmethylene-2-methyl-1,3-dioxane | ethanol | hydrogen | palladium on carbon | silica gel | n-hexane | ethyl acetate | (2R,4R,5S)-4-t-butyldimethylsiloxymethyl-5 -ethoxycarbonylmethyl-2-methyl-1,3-dioxane"
US07879907B2,"A solution of 125 g (370 mmol) of 3-benzyloxy-4-iodobenzyl alcohol and 160 g (1.84 mol) of manganese dioxide in 750 ml of dichloromethane is stirred at room temperature for 18 hours. Since the reaction is not complete, a further 160 g (1.84 mol) of manganese dioxide are added and the medium is stirred for 6 hours. The reaction medium is filtered through Celite and the filtrate is then concentrated under vacuum. 114 g (92%) of 3-benzyloxy-4-iodobenzaldehyde are obtained in the form of a yellow oil.",3-benzyloxy-4-iodobenzyl alcohol | manganese dioxide | dichloromethane | manganese dioxide | 3-benzyloxy-4-iodobenzaldehyde
US05304658,"In methanol (90 ml) was dissolved 9.00 g (30 mmole) methyl 6-[4-(1-imidazolyl)benzoyl]hexanoate, and the solution was stirred under ice-cooling. 0.86 Gram (30×0.75 mmole) of of sodium boron hydride was added to it, and stirring was continued for 30 minutes under ice-cooling. After acetone was added, the solvent was distilled off, and chloroform and water were added to the residue to effect extraction. The chloroform layer was separated out, washed with aqueous sodium chloride solution, dried (magnesium sulfate) and evaporated to give 9.10 g (100%) of methyl 7-hydroxy-7-[4-(1-imidazolyl)phenyl]heptanoate (part of the compound was recrystallized from ethyl acetate/isopropyl ether. m.p. 77°-78° C.).",methanol | methyl 6-[4-(1-imidazolyl)benzoyl]hexanoate | ice | sodium boron hydride | ice | acetone | chloroform | water | chloroform | sodium chloride | magnesium sulfate | methyl 7-hydroxy-7-[4-(1-imidazolyl)phenyl]heptanoate
US20130190309A1,"in place of 8-amino-2-(3-(trifluoromethyl)phenyl)phthalazin-1(2H)-one 11. 8-amino-2-(3-(trifluoromethoxy)phenyl)phthalazin-1(2H)-one 21 was prepared by the process of steps 1-2 of Example 2, using 8-nitro-2-(3-(trifluoromethoxy)phenyl)phthalazin-1(2H)-one in place of 8-nitro-2-(3-(trifluoromethyl)phenyl)phthalazin-1(2H)-one 20 in step 1.",8-amino-2-(3-(trifluoromethyl)phenyl)phthalazin-1(2H)-one | 8-amino-2-(3-(trifluoromethoxy)phenyl)phthalazin-1(2H)-one | 8-nitro-2-(3-(trifluoromethoxy)phenyl)phthalazin-1(2H)-one
US08822503B2,"48% hydrobromic acid (3 mL) was added to a solution of 5-cyclopropyl-6-methoxypyridine-2-carbaldehyde obtained in Reference Example 1-51(6) (437 mg) in 1,4-dioxane (6 mL), and the mixture was stirred at 65° C. for two hours. The reaction solution was poured into water, followed by extraction with chloroform/methanol (2:1). The organic layer was dried over anhydrous magnesium sulfate and filtered. The filtrate was concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (hexane:ethyl acetate=75:25→0:100) to give 5-cyclopropyl-6-oxo-1,6-dihydropyridine-2-carbaldehyde as a yellow powder (278 mg, 69%).","hydrobromic acid | 5-cyclopropyl-6-methoxypyridine-2-carbaldehyde | Example 1-51(6) | 1,4-dioxane | water | chloroform/methanol | magnesium sulfate | silica gel | hexane | ethyl acetate | 5-cyclopropyl-6-oxo-1,6-dihydropyridine-2-carbaldehyde"
US20070167421A1,"To pyrazinecarbonitrile (11.7 g, 0.11 mol), 28% methanol solution of sodium methoxide (2.0 g, 10 mmol) was added and the mixture was refluxed for 4 hours and, after adding ammonium chloride (6.4 g, 0.12 mol), for further 6 hours. After finishing the reaction, the precipitation, formed by adding diethyl ether (50 ml) to the mixture, was filtered, washed with diethyl ether and then with acetone, and dried in a desiccator to obtain amidinopyrazine hydrochloride (17.2 g), which was used in further reaction without purification.",pyrazinecarbonitrile | methanol | sodium methoxide | ammonium chloride | diethyl ether | diethyl ether | acetone | amidinopyrazine hydrochloride
US04198501,"A 500-ml. Parr bottle was charged with 3.17 g. (10 mmol) of 4-[3-dimethylamino-2-(4-methyl-2-nitrophenyl)-2-propen-1-ylidene]-2-methyl-2-oxazolin-5-one, 5 ml. of acetic anhydride, 95 ml. of glacial acetic acid, and 600 mg. of 10% platinum on charcoal, and was shaken under 3 atmospheres of hydrogen for 12 hours. During this time, 34 mmol of hydrogen were absorbed. The reaction was treated as in Example 4. 0.83 g. (35%) of (Z)-4-(6-methylindol-3-ylmethylene)-2-methyl-2-oxazolin-5-one (mp 194°-196° C.) was thereby obtained.",4-[3-dimethylamino-2-(4-methyl-2-nitrophenyl)-2-propen-1-ylidene]-2-methyl-2-oxazolin-5-one | acetic anhydride | acetic acid | platinum on charcoal | hydrogen | hydrogen | (Z)-4-(6-methylindol-3-ylmethylene)-2-methyl-2-oxazolin-5-one
US08822699B2,"A mixture of 1-(3,4,5-trifluoro-2-hydroxyphenyl)ethanone (7.5 g), p-toluenesulfonic acid monohydrate (0.375 g), morpholine (10 mL) and sulfur (2.0 g) was stirred at 120° C. for 5 hr, and allowed to cool to room temperature, and hydrochloric acid (20 mL) and acetic acid (20 mL) were added to the reaction mixture. The reaction mixture was stirred at 100° C. for 3 hr, allowed to cool to room temperature, and extracted with ethyl acetate. The extract was washed with saturated brine, and dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate/hexane) to give the title compound (6.0 g).","1-(3,4,5-trifluoro-2-hydroxyphenyl)ethanone | p-toluenesulfonic acid monohydrate | morpholine | sulfur | hydrochloric acid | acetic acid | ethyl acetate | brine | magnesium sulfate | silica gel | ethyl acetate/hexane | title compound"
US08461158B2,"Reaction of N-[3-({2-(difluoromethyl)-1-[4-(4-morpholinyl)-6-(1-piperazinyl)-1,3,5-triazin-2-yl]-1H-benzimidazol-4-yl}oxy)propyl]-N,N-dimethylamine from the previous step with methanesulphonyl chloride and powdered K2CO3 in CH2Cl2, followed by chromatography on alumina eluting with CH2Cl2/EtOAc (1:1) g, and acidification with HCl in MeOH gave N-[3-({2-(difluoromethyl)-1-[4-{[1-(methylsulfonyl)-4-piperidinyl]oxy}-6-(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazol-4-yl}oxy)propyl]-N,N-dimethylamine hydrochloride in 71% yield: 1H NMR (DMSO-d6) δ 10.07 (br s, exchangeable with D2O, 1H), 7.99 (d, J=8.2 Hz, 1H), 7.73 (t, JHF=52.7 Hz, 1H), 7.46 (t, J=8.2 Hz, 1H), 7.02 (d, J=8.0 Hz, 1H), 5.27-5.21 (m, 1H), 4.34 (t, J=6.1 Hz, 2H), 3.86-3.85 (m, 4H), 3.74-3.71 (m, 4H), 3.44-3.38 (m, 2H), 3.20-3.14 2.93 (s, 3H), 2.82 (s, 6H), (m 2H), 2.28-2.26 (m, 2H), 2.15-2.10 (m, 2H); Anal. Calcd. for C26H29ClF2N8O5S.0.75 H2O: C, 47.3; H, 5.9; Cl, 5.4; N, 17.0. Found: C, 47.3; H, 5.8; Cl, 5.4; N, 17.0%.","N-[3-({2-(difluoromethyl)-1-[4-(4-morpholinyl)-6-(1-piperazinyl)-1,3,5-triazin-2-yl]-1H-benzimidazol-4-yl}oxy)propyl]-N,N-dimethylamine | methanesulphonyl chloride | K2CO3 | CH2Cl2 | CH2Cl2/EtOAc | HCl | MeOH | N-[3-({2-(difluoromethyl)-1-[4-{[1-(methylsulfonyl)-4-piperidinyl]oxy}-6-(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazol-4-yl}oxy)propyl]-N,N-dimethylamine hydrochloride"
US20100152252A1,"2-(3-Bromo-phenyl)-ethylamine (15 mmol) was dissolved in DME/H2O 1/1 under argon atmosphere. 1,3,5-Trimethyl-1H-pyrazole-4-boronic acid pinacol ester (15 mmol), K2CO3 (45 mmol), and tetrakis-(triphenylphosphine)palladium (1 mol %, 0.15 mmol) were added and the reaction mixture was stirred at 100° C. for 1.5 h. Then, a second fraction of 1,3,5-trimethyl-1H-pyrazole-4-boronic acid pinacol ester (4.5 mmol) was added and the reaction mixture was stirred at 100° C. for 2 h more. The reaction mixture was evaporated to dryness, then dissolved in CH2Cl2 and filtered through Celite® to give the crude product 2-[3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-phenyl]-ethylamine. The filtrate was acidified with HCl aqueous solution (6 N). The organic layer was discarded, and the aqueous layer was taken to pH >13 with NaOH aqueous solution (6 N). It was extracted with CH2Cl2 (3×300 mL), and the organic layer was dried over anhydrous Na2SO4, filtered and concentrated, to give the crude product 2-[3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-phenyl]-ethylamine. The crude was purified by flash column chromatography (CH2Cl2-MeOH as eluents) by using a CombiFlash Companion™ system to yield the title compound (80%).","2-(3-Bromo-phenyl)-ethylamine | DME/H2O | argon | 1,3,5-Trimethyl-1H-pyrazole-4-boronic acid pinacol ester | K2CO3 | tetrakis-(triphenylphosphine)palladium | 1,3,5-trimethyl-1H-pyrazole-4-boronic acid pinacol ester | CH2Cl2 | crude product | 2-[3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-phenyl]-ethylamine"
US08828908B2,"To a microwave vial containing 3-(2,4-dioxobicyclo[3.2.1]oct-3-yl)-4-ethylphenylboronic acid (0.15 g, 0.52 mmol) and potassium phosphate (0.667 g, 3.15 mmol) is added 2-bromo-5-chloropyridine (0.121 g, 0.63 mmol), palladium acetate (4.0 mg, 0.016 mmol) and tris(3-sulfophenyl)phosphine trisodium salt (21 mg, 0.038 mmol). A degassed solvent mixture of water/acetonitrile (1.6 ml, 2:1 ratio) is then added, followed by flushing with nitrogen, then stirring at ambient temperature for 5 minutes before heating at 160° C. under microwave irradiation for 15 minutes. After cooling to room temperature the reaction is partitioned between 2M aqueous hydrochloric acid and dichloromethane, and the organic phase is separated. The aqueous phase is further extracted with dichloromethane and all organic fractions are combined then evaporated. The residue is purified by preparative reverse-phase HPLC to give 3-[5-(5-chloropyridin-2-yl)-2-ethylphenyl]bicyclo[3.2.1]octane-2,4-dione.","3-(2,4-dioxobicyclo[3.2.1]oct-3-yl)-4-ethylphenylboronic acid | potassium phosphate | 2-bromo-5-chloropyridine | palladium acetate | tris(3-sulfophenyl)phosphine trisodium salt | water/acetonitrile | nitrogen | hydrochloric acid | dichloromethane | dichloromethane | 3-[5-(5-chloropyridin-2-yl)-2-ethylphenyl]bicyclo[3.2.1]octane-2,4-dione"
US07067516B2,"A solution of ethyl γ-chloro-α-oximinoacetoacetate (2.10 g, 10.8 mmol) and thiobenzamide (1.49 g, 10.8 mmol) in dry benzene (15 mL) was heated to reflux. After 4 hours, the reaction mixture was poured onto NaHCO3 (sat., aq., 50 mL); The resulting mixture was extracted with ethyl acetate (2×50 mL); and the combined extracts dried over MgSO4 and evaporated under reduced pressure. Flash chromatography (ethyl acetate:hexane 1:4, Rf 0.30) then afforded impure ethyl α-oximino-2-phenylthiazole-4-acetate (3.22 g). The crude oxime was then dissolved in methanol (15 mL) and formic acid (50% aq., 15 mL) was added. The mixture was cooled to 0° C. and zinc dust (2.00 g, 30.6 mmol) was added portionwise over 30 minutes. The reaction mixture was allowed to warm to room temperature, and stirred for 6 hours. The solution was then filtered, basified to pH 9 with solid NaHCO3, and extracted with ethyl acetate (3×80 mL). The combined extracts were then dried and evaporated to afford D/L-2-phenylthiazol-4-ylglycine ethyl ester (1.43 g, 5.45 mmol, 50% from the chloro-oxime). The ester (194 mg, 0.74 mmol) was then dissolved in tetrahydrofuran (5 mL). Triethylamine (120 μL, 87 mg, 0.86 mmol) was added, followed by di-t-butyl dicarbonate (180 mg, 0.82 mmol). After stirring at room temperature for 4 days, water (20 mL) was added and the solution extracted with dichloromethane (2×20 mL). The combined extracts were evaporated and purified by flash column chromatography (ethyl acetate:hexane 1:4, Rf 0.45) to afford N-t-butyloxycarbonyl-D/L-2-phenylthiazol-4-ylglycine ethyl ester (158 mg, 0.44 mmol, 59%) as a clear oil. The oil was dissolved in tetrahydrofuran (2 mL) and LiOH.H2O (80 mg as a solution in 2 mL water) was added. After stirring at room temperature for 2 hours, water (10 mL) was added, and the solution extracted with ethyl acetate (5 mL). The aqueous layer was then acidified to pH 4 with 2N HCl, and extracted with ethyl acetate (2×20 mL); The latter extracts were combined and evaporated to afford N-BOC-D/L-2-phenylthiazol-4-ylglycine (116 mg, 0.35 mmol, 75%) as a white powder.",ethyl γ-chloro-α-oximinoacetoacetate | thiobenzamide | benzene | NaHCO3 | ethyl acetate | MgSO4 | ethyl acetate:hexane | ethyl α-oximino-2-phenylthiazole-4-acetate
US07071218B2,"To a mixture of 7-bromo-5-isobutyl-3,3-dimethyl-2,3-dihydro-benzofuran (9.9 g, 34.96 mmol) in THF (50 mL) cooled to −78° C. under an atmosphere of argon was added n-BuLi (25.17 mL, 2.5 M, 62.93 mmol) dropwise. The reaction mixture was stirred for 5 minutes and triisopropylborate (24.2 mL, 104.87 mmol) was added dropwise. The mixture was stirred at −50° C. for 2 hours then warmed up to room temperature and stirred overnight at room temperature. 1.0 N HCl (100 mL) was slowly added to the reaction mixture. After 1 hour the mixture was diluted with ethyl acetate and the layers separated. The organic layer was further washed with water, brine, dried (Mg2SO4), filtered and evaporated. The residue was chromatographed on silica gel (0 to 20% ethyl acetate in hexane) to give 4.3 g of 5-isobutyl-3,3-dimethyl-2,3-dihydro-benzofuran-7-boronic acid (46%). 1H NMR (300 MHz; CDCL3): 0.90 (d, J=6.6 Hz, 6 H), 1.33 (s, 6 H), 1.81 (m, 1 H), 2.43 (d, J=7.5 Hz, 2 H), 4.28 (s, 2 H), 5.86 (br s, 2 H), 6.98 (d, J=2.1 Hz, 1 H), 7.33 (d, J=2.1 Hz, 1 H).","7-bromo-5-isobutyl-3,3-dimethyl-2,3-dihydro-benzofuran | THF | argon | n-BuLi | triisopropylborate | HCl | ethyl acetate | water | brine | Mg2SO4 | silica gel | 5-isobutyl-3,3-dimethyl-2,3-dihydro-benzofuran-7-boronic acid"
US09132127B2,"Ethyl 7-(2,3-dip-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoate (step 1) was dissolved in THF (94 ml) and lithium hydroxide monohydrate (7.79 g, 186 mmol) in water (94 ml) was added dropwise. The reaction mixture was warmed to 50° C. and stirred for 7.5 hours. The reaction mixture was concentrated in vacuo to remove the THF and diluted with water (500 ml). The pH of the aqueous layer was adjusted to pH 2 with 1 N HCl (100 ml) and extracted with EtOAc (3×500 ml). The combined organic layers were washed with brine (200 ml), dried over anhydrous sodium sulfate and concentrated in vacuo. The crude solid was suspended in TBME/hexane (1:1, 100 ml) and rotated on the rotary evaporator (no vacuum) at RT until crystals formed. The solid was removed by filtration, washed with heptanes (50 ml) and dried at RT overnight. The solid was re-crystallized from a hot mixture of EtOH (211 ml) and water (159 ml). After seeding and stirring for 1 h at 5° C., the crystals were filtered off and the product dried overnight at 40° C. in a vacuum oven to afford the title compound; See Table 4 for characterising data.","Ethyl 7-(2,3-dip-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoate | THF | lithium hydroxide monohydrate | water | THF | water | EtOAc | brine | sodium sulfate | heptanes | EtOH | water | title compound"
US08772483B2,"1-(4-Chloro-2-iodo-phenyl)-2,2,2-trifluoro-ethanol (0.840 g, 2.5 mmol), 3-methyl pyrazole (0.230 g, 2.8 mmol), CuI (0.190 g, 1.0 mmol), K2CO3 (0.863 g, 6.25 mmol), (1R,2R)—N,N′-dimethyl-cyclohexane-1,2-diamine (0.071 g, 0.5 mmol) and toluene (10 ml) were combined in a 20 ml pressure tube, and the mixture was heated at 130° C. (oil bath temperature) for 12 hours. The mixture was diluted with ethyl acetate and washed with H2O (2×20 ml), brine, and dried over sodium sulfate. Removal of solvent gave a crude product, which was purified by ISCO column chromatography using 5-10% ethyl acetate in hexane as solvent to afford 1-[4-chloro-2-(3-methyl-pyrazol-1-yl)-phenyl]-2,2,2-trifluoro-ethanol (240 mg).","1-(4-Chloro-2-iodo-phenyl)-2,2,2-trifluoro-ethanol | 3-methyl pyrazole | CuI | K2CO3 | (1R,2R)—N,N′-dimethyl-cyclohexane-1,2-diamine | toluene | ethyl acetate | H2O | brine | sodium sulfate | crude product | 1-[4-chloro-2-(3-methyl-pyrazol-1-yl)-phenyl]-2,2,2-trifluoro-ethanol"
US05480883,"To a 25 mL flask with 10 ml of abs. EtOH is added 0.137 g of 4-chloro-6,7-dimethoxyquinazoline and 0.087 g of 1-aminonaphthalene. The solution is heated to reflux whereupon the insoluble materials dissolve. After 5 minutes at reflux a precipatate forms. The solution is allowed to stir an additional 10 min before cooling and isolation of the product as the hydrochloride salt by simple filtration. High-vacuum drying of the solid provided analytically pure (6,7-dimethoxy-quinazolin-4-yl)-alpha-naphthalenylamine (0.142 g, white powder, m.p. 271°-273° C.","EtOH | 4-chloro-6,7-dimethoxyquinazoline | 1-aminonaphthalene | hydrochloride salt | (6,7-dimethoxy-quinazolin-4-yl)-alpha-naphthalenylamine"
US09199990B2,"To a solution of 2-amino-4,6-dimethoxybenzamide (451 mg, 2.3 mmol) and 3,5-dimethyl-4-(2-morpholin-4yl-ethoxy)-benzaldehyde (550 mg, 2.09 mmol) in N,N-dimethyl formamide (20 mL), iodine (636 mg, 2.5 mmol) and potassium carbonate (288 mg, 2.09 mmol) were added and the reaction mixture was stirred at 70° C. for 48 h. The reaction mixture was poured into ice. The mixture was extracted with ethyl acetate. The organic layer was washed with water, brine and dried over anhydrous Na2SO4. Removal of the solvent gave the crude product was purified by column chromatography and converted to the hydrochloride salt of 2-(3,5-dimethyl-4-(2-morpholinoethoxy)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one (40 mg, 4%) as an off-white solid. Selected data: MS (ES) m/z: 440.1; MP 185-187° C. (HCl salt).","2-amino-4,6-dimethoxybenzamide | 3,5-dimethyl-4-(2-morpholin-4yl-ethoxy)-benzaldehyde | N,N-dimethyl formamide | iodine | potassium carbonate | ice | ethyl acetate | water | brine | Na2SO4 | crude product"
US20090054413A1,"Ethyl 2-cyano-3-ethoxypent-2-enoate (5 g, 25.3 mmol), cyclopentylhydrazine hydrochloride (4.16 g, 30.4 mmol) and triethylamine (17.7 ml, 0.128 mol) were dissolved in methanol (100 mL) and refluxed for 16 h. The solvent was removed under vacuum, after which the residue was redissolved in dichloromethane and washed with water. The organic solvent was dried over Na2SO4, filtered and removed in vacuum. The residue was purified by flash chromatography (SiO2, heptane/EtOAc 1/1) to give the title compound (4.92 g, 77%).",Ethyl 2-cyano-3-ethoxypent-2-enoate | cyclopentylhydrazine hydrochloride | triethylamine | methanol | dichloromethane | water | Na2SO4 | SiO2 | heptane/EtOAc | title compound
US20120004246A1,"Was prepared according to Example 2 from N-(3,4-difluoro-phenyl)-formamide— and 2,6-dichloro-9-methyl-9H-purine.","N-(3,4-difluoro-phenyl)-formamide | 2,6-dichloro-9-methyl-9H-purine"
US20110306597A1,"A solution of LiOH (51.9 g, 2.16 mol) in water (3 L) was added to a solution of methyl 2-{2[(tert-butoxycarbonyl)amino]ethyl}-1-ethyl-1H-benzimidazole-5-carboxylate (500 g, 1.44 mol) in MeOH (7 L). The resulting mixture was stirred at room temperature overnight. The mixture was then evaporated in vacuo and the residue was neutralized with concentrated hydrochloric acid. The mixture was then filtered and the filter cake was washed with water and dried in vacuo to give 2-{2-[(tert-butoxycarbonyl)amino]ethyl}-1-ethyl-1H-benzimidazole-5-carboxylic acid (450 g, 87.5%) as a grey solid.",LiOH | water | methyl 2-{2[(tert-butoxycarbonyl)amino]ethyl}-1-ethyl-1H-benzimidazole-5-carboxylate | MeOH | water | 2-{2-[(tert-butoxycarbonyl)amino]ethyl}-1-ethyl-1H-benzimidazole-5-carboxylic acid
US07820660B2,"A solution of benzyl-(2S)-2-[amino(hydroxyimino)methyl]-4,4-difluoropyrrolidine-1-carboxylate and dimethylacetylendicarboxylate (1.2 eq.) in chloroform was refluxed for 1 hour under nitrogen and the solution was concentrated. Residue was purified by flash chromatography on silica gel, (eluent: petroleum ether:ethyl acetate=7.5:2.5), to give the desired product as a 3:1 mixture of two isomers by 1H NMR.","benzyl-(2S)-2-[amino(hydroxyimino)methyl]-4,4-difluoropyrrolidine-1-carboxylate | dimethylacetylendicarboxylate | chloroform | nitrogen | silica gel | petroleum ether | ethyl acetate | desired product"
US20150329497A1,"As described for compound (315), starting from methyl 2-amino-4,5-dimethoxy benzoate (1.00 g, 4.73 mmol), isobutyronitrile (0.98 g, 14.2 mmol), and 10 mL of 4 M HCl/dioxane, 2-isopropyl-6,7-dimethoxyquinazolin-4-ol (307e) was obtained as an off-white solid (0.187 g, 16%) and used without purification. 1H NMR (400 MHz, DMSO-d6) δ 11.98 (s, 1H), 7.41 (s, 1H), 7.08 (d, J=2.6 Hz, 1H), 3.90 (s, 3H), 3.85 (s, 3H), 2.85 (m, 1H), 1.25 (d, J=4.5 Hz, 6H). MS (ESI+ve): Calculated for C13H17N2O3, [M+H]=249.12. observed [M+H]=249.11.","methyl 2-amino-4,5-dimethoxy benzoate | isobutyronitrile | HCl/dioxane | 2-isopropyl-6,7-dimethoxyquinazolin-4-ol | solid"
US06162918,"3-Amino-5,5-dimethyl-2-cyclohexen-1-one was reacted with 5-nitro-furfuraldehyde in an analogous manner to that described in Example 1 to give 3,4,6,7,9,10-hexahydro-3,3,6,6-tetramethyl-9-(5-nitro-2-furyl)-1,8(2H,5H)-acridinedione. Crystallization from ethyl acetate/methanol gave a beige crystalline solid of melting point 248-250° C. (decomposition).","3-Amino-5,5-dimethyl-2-cyclohexen-1-one | 5-nitro-furfuraldehyde | 3,4,6,7,9,10-hexahydro-3,3,6,6-tetramethyl-9-(5-nitro-2-furyl)-1,8(2H,5H)-acridinedione"
US20130005750A1,"A solution of {4-[1-(3-trifluoromethyl-phenylcarbamoyl)-1H-indol-5-yloxy]-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl}-acetic acid tert-butyl ester (250 mg, 0.44 mmol), DCM (5 mL), and TFA (5 mL) is stirred at rt for 1 h. The solution is concentrated in vacuo and separated via semi-prep HPLC(C18; 10-100% I/H2O with 0.1% NH4OH) to give the title compound. MS (ESI) m/z 512.0 (M+1); 1H NMR (400 MHz, MeOD) δ ppm 8.41 (s, 1H), 8.33 (d, J=9.1 Hz, 1H), 8.06 (s, 1H), 7.93 (d, J=3.5 Hz, 1H), 7.89 (s, 1H), 7.57 (t, J=8.1 Hz, 1H), 7.38-7.47 (m, 2H), 7.12 (dd, J=9.0, 2.4 Hz, 1H), 6.74 (d, J=3.5 Hz, 1H), 4.08 (s, 2H), 3.56 (s, 2H), 3.26 (t, J=6.1 Hz, 2H), 3.07 (t, J=5.7 Hz, 2H).","{4-[1-(3-trifluoromethyl-phenylcarbamoyl)-1H-indol-5-yloxy]-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl}-acetic acid tert-butyl ester | DCM | TFA | H2O | NH4OH | title compound"
US20150225422A1,"A solution of N-{6-chloro-5-[(2-hydroxyethyl)sulfamoyl]-3,4′-bipyridin-2′-yl}acetamide (0.033 g, 0.089 mmol) in DMSO (0.6 mL, 8 mmol) was treated with KOt-Bu (0.0210 g, 0.187 mmol) as a solution in THF, The reaction mixture was allowed to stir at rt for 3 h and then concentrated. The crude product was purified by column chromatography to give N-(4-(1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-8-yl)pyridin-2-yl)acetamide (I-484). LCMS (FA): m/z=335.1 (M+H).","N-{6-chloro-5-[(2-hydroxyethyl)sulfamoyl]-3,4′-bipyridin-2′-yl}acetamide | DMSO | KOt-Bu | THF | crude product | N-(4-(1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-b][1,4,5]oxathiazepin-8-yl)pyridin-2-yl)acetamide"
US20100022522A1,"To a solution of cyclopentylacetylene (0.50 g, 5.3 mmol) in THF (5 mL) at −78° C. was added 2.5 M n-butyllithium in hexane (2.23 mL). The mixture was stirred for 15 min followed by the dropwise addition of phenyl cyanate (0.70 g, 5.8 mmol) in THF (3 mL). The reaction was warmed to room temperature. Into the reaction mixture was poured 6 N NaOH, and the mixture was stirred for 5 minutes. The product was extracted with diethyl ether. The extracts were washed with 6 N NaOH and with brine, then dried over sodium sulfate, decanted and the solvent was removed in vacuo to afford product (600.mg, 95%). 1H NMR (300 MHz, CDCl3): 2.81-2.68 (m, 1H), 2.07-1.54 (m, 8H).",cyclopentylacetylene | THF | n-butyllithium | hexane | phenyl cyanate | THF | NaOH | diethyl ether | NaOH | brine | sodium sulfate
US08148391B2,"Title compound was prepared from 8-Amino-1,3,4,5-tetrahydro-benzo[b]azepin-2-one and 2-(2,5-Dichloro-pyrimidin-4-ylamino)-3-fluoro-benzamide in an analogous manner to Example 1221d. Title compound isolated as a moss green solid (86 mg, 69%). HPLC purity 90%, LCMS 443.03 (M+H), HNMR (DMSO) 9.92 (bs, 1H), 9.82 (bs, 1H), 9.32 (s, 1H), 8.30 (d, J=1.9 Hz, 1H), 8.03 (s, 1H), 7.71 (s, 1H), 7.54 (s, 1H), 7.47-7.38 (m, 3H), 7.15-7.13 (m, 1H), 6.99-6.90 (m, 2H). 2.60-2.56 (m, 2H), 2.07-2.03 (m, 4H).","Title compound | 8-Amino-1,3,4,5-tetrahydro-benzo[b]azepin-2-one | 2-(2,5-Dichloro-pyrimidin-4-ylamino)-3-fluoro-benzamide | Title compound | solid"
US05374772,"Sodium hydroxide hydrolysis of 3-[3-[4-(methylsulfinyl) phenoxy]propoxy]-5-(octadecyloxy)benzoic acid methyl ester as in earlier Examples gave 3-[3-[4-(methylsulfinyl)phenoxy]propoxy]-5-(octadecyloxy)benzoic acid (88% yield, mp 77°-80°).",Sodium hydroxide | 3-[3-[4-(methylsulfinyl) phenoxy]propoxy]-5-(octadecyloxy)benzoic acid methyl ester | 3-[3-[4-(methylsulfinyl)phenoxy]propoxy]-5-(octadecyloxy)benzoic acid
US06521620B1,"A mixture of 7-amino-4-methylthiopyrido[4,3-d]pyrimidine (236 mg, 1.23 mmol) (described in a previous experimental) and 3-dimethylamino-benzylamine (1.36 g, 9.07 mmol) in isopropanol (5 mL) is stirred under N2 at reflux for 1 h, and the resulting product is chromatographed on silica gel (10-15% EtOH/EtOAc), then on alumina (1% EtOH/CHCl3) to give 7-amino-4-(3-dimethylaminobenzylamino)pyrido[4,3-d]pyrimidine (145 mg, 40%) as a white solid. 1H NMR (DMSO) δ 9.11 (1H, s), 8.79 (1H, t, J=5.9 Hz), 8.26 (1H, s), 7.11 (1H, dd, J=8.0, 7.7 Hz), 6.73 (1H, brs), 6.63 (1H, d, J=7.6 Hz), 6.60 (1H, dd, J=8.1, 2.2 Hz), 6.44 (2H, brs), 6.35 (1H, S), 4.67 (2H, d, J=5.8 Hz), 2.86 (6H, s).","7-amino-4-methylthiopyrido[4,3-d]pyrimidine | 3-dimethylamino-benzylamine | isopropanol | N2 | silica gel | alumina | 7-amino-4-(3-dimethylaminobenzylamino)pyrido[4,3-d]pyrimidine"
US07091353B2,"To a suspension of 4-amino-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione (0.55 g, 2 mmol) in acetic acid (20 ml) was added furan-2-carbaldehyde (0.20 g, 2.05 mmol). The mixture was heated to reflux for 5 hours and allowed to cool at room temperature. Sodium borohydride (80 mg, 2 mmol) was added to the reaction mixture. The reaction mixture was stirred for 24 hours. The solvent was evaporated in vacuo and the residue was dissolved in ethyl acetate (100 ml), washed with H2O (3×100 ml), saturated aqueous NaHCO3 (2×100 ml), brine (1×100 ml), and dried. The solvent was evaporated and the residue was purified by chromatography (ethyl acetate/hexane, 1:1) to give 0.25 g (35%) of product as a yellow solid: mp 171–173° C.; 1H NMR (DMSO-d6) δ 11.10 (s, 1H), 7.58 (t, J=7.1 Hz, 2H), 7.18 (d, J=8.6 Hz, 1H), 7.08–6.97 (m, 2H), 6.39–6.36 (m, 2H), 5.06 (dd, J=5.2 and 12.4 Hz, 1H), 4.57 (d, J=6.0 Hz, 2H), 2.96–2.82 (m, 1H), 2.63–2.46 (m, 2H), 2.06–2.02 (m, 1H; 13C NMR (DMSO-d6) δ 172.76, 170.01, 168.75, 167.21, 151.97, 145.81, 142.42, 136.05, 132.09, 117.60, 111.04, 110.42, 109.73, 107.38, 48.57,30.95,22.10; Anal. Calcd. For C18H15N3O5: C, 61.19; H, 4.28; N, 11.89. Found: C, 61.02; H, 4.24; N, 11.81.","4-amino-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione | acetic acid | furan-2-carbaldehyde | Sodium borohydride | ethyl acetate | H2O | NaHCO3 | brine | ethyl acetate/hexane | product"
US04675397,"In a mixture of 25 ml of water and 25 ml of tetrahydrofuran is dissolved 500 mg of sodium cis-3-{2-(2-amino-4-thiazolyl)-2-[1-methyl-1-(p-nitrobenzyloxycarbonyl)ethyloxyimino]acetamido}-4-methoxycarbonyl-2-oxoazetidine-1-sulfonate (syn-isomer), followed by addition of 500 mg of 10% palladium-on-carbon. The mixture is stirred in a hydrogen atmosphere at room temperature for one hour. After addition of 25 ml of an aqueous solution of sodium hydrogen carbonate (62 mg), the catalyst is filtered off and the filtrate is washed with ethyl acetate and concentrated under reduced pressure. The residue is chromatographed on an Amberlite XAD-II column and lyophilized to give cis-3-[2-(2-amino-4thiazolyl)-2-(1-methyl-1-carboxyethyloxyimino)acetamido]-4-methoxycarbonyl-2-oxoazetidine-1-sulfonic acid disodium salt (syn-isomer).",water | tetrahydrofuran | sodium cis-3-{2-(2-amino-4-thiazolyl)-2-[1-methyl-1-(p-nitrobenzyloxycarbonyl)ethyloxyimino]acetamido}-4-methoxycarbonyl-2-oxoazetidine-1-sulfonate | palladium-on-carbon | hydrogen | aqueous solution | sodium hydrogen carbonate | ethyl acetate | cis-3-[2-(2-amino-4thiazolyl)-2-(1-methyl-1-carboxyethyloxyimino)acetamido]-4-methoxycarbonyl-2-oxoazetidine-1-sulfonic acid disodium salt
US05475114,"A mixture consisting of 8.83 g of 2,7-diethyl-5-[[2'-(tetrazol-5-yl)biphenyl-4-yl]methyl]-5H-pyrazolo[1,5-b][1,2,4]triazole-6-carboxylic acid, 60 ml of N,N-dimethylformamide, 2.82 ml of triethylamine and 5.66 g of triphenylmethyl chloride was stirred overnight at room temperature. After removing the solvent by distillation under a reduced pressure, the thus obtained residue was mixed with 250 ml of ethyl acetate and then washed with 150 ml of water. Thereafter, the ethyl acetate layer was stirred overnight at room temperature, and the solid material thus precipitated was collected by filtration to give 6.98 g of 2,7-diethyl-5-[[2'-(N-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl]methyl]-5H-pyrazolo[1,5-b][1,2,4]triazole-6-carboxylic acid.","2,7-diethyl-5-[[2'-(tetrazol-5-yl)biphenyl-4-yl]methyl]-5H-pyrazolo[1,5-b][1,2,4]triazole-6-carboxylic acid | N,N-dimethylformamide | triethylamine | triphenylmethyl chloride | ethyl acetate | water | ethyl acetate | 2,7-diethyl-5-[[2'-(N-triphenylmethyl-tetrazol-5-yl)biphenyl-4-yl]methyl]-5H-pyrazolo[1,5-b][1,2,4]triazole-6-carboxylic acid"
US20110269652A1,"Treatment of a solution of compound 8b (Example 8B) (16.0 g, 25.0 mmol) in pyrrolidine (100 mL) containing potassium carbonate (8.69 g, 62.8 mmol, 2.5 eq) following the procedure of Example 11A gives a light brown syrup, 1,3-bis(1-azacyclopentyl)-2,2-bis(decyloxymethyl)propane: yield 11.93 g. Addition of ice cold 2 M HCl (100 mL) gives a light yellow crystalline solid that is recrystallized from ethyl acetate to give colorless crystals: yield 10.9 g, 76%; mp 125-126° C., RF 0.24 on basic alumina (hexanes, ethyl acetate, methanol, 96:4:0.4); 1H NMR δ 0.88 ppm (t, 6H, J=6.8 Hz, 2×Me), 1.26-1.28 (br s, 28H, 14×CH2), 1.55 (pentet, 4H, J=6.3 Hz, 2 OCH2CH2), 2.05 (YY′ part of AA′BB′XX′YY′ pattern, 4H, 1/2 of 2 2 N(CH2CH2)2), 2.25 (XX′ part of AA′BB′XX′YY′ pattern, 4H, 1/2 of 2 2 N(CH2CH2)2), 3.21 (BB′ part of AA′BB′XX′YY′ pattern, 4H, N(CH2)2), 3.45 (t, 4H, J=6.6 Hz, decyl OCH2), 3.58 (s, 4H, OCH2C), 3.84 (s, 4H, CH2N), 3.91 (BB′ part of AA′BB′XX′YY′ pattern, 4H, N(CH2)2), 11.5 (br s, HN); 13C NMR δ 71.7 (CH2CH2OC), 67.5 (CCH2O), 57.9 (NCH2), 57.0 ((CH2)2N), 44.5 (q C), 32.0 (CH2CH2CH3), 29.71, 29.66, 29.59, 29.47, 29.40 (6 decyl CH2), 26.3 (CH2CH2CH2O), 23.6 (N(CH2CH2)2), 22.8 (CH2CH3), 14.2 (Me); HR ESI MS m/z calcd for C33H67N2O2 (M−H−2Cl) 523.5203. found 523.5204.","compound 8b | pyrrolidine | potassium carbonate | 1,3-bis(1-azacyclopentyl)-2,2-bis(decyloxymethyl)propane"
US06586441B2,"From 2-amino-4-furan-2-yl-6-methanesulfinyl-pyrimidine-5-carbonitrile, 4-dimethylaminobenzylamine dihydrochloride and DBU in DME. ES-MS m/e (%): 335 (M+H+, 100).",2-amino-4-furan-2-yl-6-methanesulfinyl-pyrimidine-5-carbonitrile | 4-dimethylaminobenzylamine dihydrochloride | DBU | DME
US20160016948A1,"4-(1-((2-Chloro-5-nitropyridin-4-yl)amino)ethyl)benzonitrile (900 mg, 60%) was prepared from 2,4-dichloro-5-nitro-pyridine (1.0 g, 5.18 mmol) and 4-(1-aminoethyl)benzonitrile (833.25 mg, 5.70 mmol) in a method analogous to Example 349, Step 1. LCMS (ESI): [M+H]+ 303.2; 1H NMR (400 MHz, DMSO-d6) δ 8.89 (s, 1H), 8.47 (d, J=7.3 Hz, 1H), 7.90-7.78 (m, 2H), 7.78-7.62 (m, 2H), 6.86 (s, 1H), 5.17 (p, J=6.9 Hz, 1H), 1.60 (d, J=6.8 Hz, 3H).","4-(1-((2-Chloro-5-nitropyridin-4-yl)amino)ethyl)benzonitrile | 2,4-dichloro-5-nitro-pyridine | 4-(1-aminoethyl)benzonitrile"
US08183238B2,"tert-Butyl [(3S)-1-[(tert-butoxycarbonyl)oxy]-6-(3-cyanophenoxy)-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl]carbonate (88) Sodium acetate trihydrate (4.9 g, 36.3 mmol) was added to a 0° C. solution of 3-(3-cyanophenoxy)-6-nitro-L-phenylalanine (87) (1.3 g, 3.6 mmol) in THF (50 mL) and MeOH (50 mL). The mixture was stirred until all of the salts dissolved, and tin(II) chloride dihydrate (4.2 g, 18.1 mmol) was added. The reaction suspension was stirred at 0° C. for 6 h. Triethylamine (5.1 mL, 36.3 mmol) and BOC2O (1.9 g, 8.7 mmol) were added and the mixture was allowed to stir for 18 h at RT. The reaction mixture was concentrated in vacuo, and the resulting residue was slurried in EtOAc. Insoluble solids were filtered off and washed with EtOAc, and the combined EtOAc fractions were washed with water and concentrated in vacuo. The resulting residue was purified by silica gel chromatography (Gradient: 0% to 50% EtOAc in heptane) to afford the title compound as a white solid (1.1 g, 61%). LCMS m/z 496.2 (M+1). 1H NMR (400 MHz, CDCl3) δ 1.47 (s, 9H), 1.58 (br s, 9H), 2.98 (br dd, J=14, 14 Hz, 1H), 3.41 (v br d, J=14 Hz, 1H), 4.51-4.60 (m, 1H), 5.59 (br s, 1H), 6.91 (br s, 1H), 6.97 (br dd, J=8.5, 2.6 Hz, 1H), 7.0-7.2 (v br s, 1H), 7.19-7.25 (m, 2H), 7.38-7.47 (m, 2H).","tert-Butyl [(3S)-1-[(tert-butoxycarbonyl)oxy]-6-(3-cyanophenoxy)-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl]carbonate | 3-(3-cyanophenoxy)-6-nitro-L-phenylalanine | THF | MeOH | tin(II) chloride dihydrate | Triethylamine | BOC2O | EtOAc | EtOAc | EtOAc | water | silica gel | heptane | title compound"
US20150175623A1,"10.0 g 2-chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (Preparation 5a) (37.2 mmol), 8.7 g 2-(4-methylpiperazin-1-yl)ethanol (60.3 mmol) and 15.8 g PPh3 (60.3 mmol) were dissolved in 100 mL dry toluene and then 27 mL diethyl azodicarboxylate (60.3 mmol, 40% solution in toluene) was added dropwise. The mixture was stirred at 50° C. under argon for 1.5 hours. The volatiles were evaporated under reduced pressure and 100 mL Et2O was added. The precipitated white crystals were filtered off and washed with Et2O. The filtrate was concentrated under reduced pressure and purified via flash chromatography using CHCl3 and MeOH as eluents. The resulting light brown oil was crystallized from hexane to give Preparation 5b as an off-white solid.","2-chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | 2-(4-methylpiperazin-1-yl)ethanol | PPh3 | toluene | diethyl azodicarboxylate | argon | Et2O | Et2O | hexane | 5b"
US05691336,"4-Fluoro-α-[(phenylmethyl)amino]benzeneacetic acid (12.2 kg, 47.1 moles) was slurried in methanol (37 L), then hydrogen chloride gas was passed over the mixture. The resulting slurry was stirred at 35°-45° C. for 3 hours, then concentrated to 30-35 L by distillation. Methyl-t-butyl ether (20 L) was added and the batch was seeded with 4-Fluoro-α-[(phenylmethyl)amino]benzeneacetic acid methyl ester hydrochloride. Upon development of the seed-bed, methyl-t-butyl ether (20 L) was added. The slurry was aged for 1 hour, then filtered. The falter cake was washed with methyl-t-butyl ether:methanol (95:5, 8.0 L), then dried under vacuum at 30° C. to give 12.2 kg (84% yield) of 4-fluoro-α-[(phenylmethyl)amino]-benzeneacetic acid methyl ester hydrochloride.",4-Fluoro-α-[(phenylmethyl)amino]benzeneacetic acid | methanol | hydrogen chloride | Methyl-t-butyl ether | methyl-t-butyl ether | methyl-t-butyl ether:methanol | 4-fluoro-α-[(phenylmethyl)amino]-benzeneacetic acid methyl ester hydrochloride
US08232390B2,"(2-Bromo-5-methoxyphenyl)methanol (1 eq.) was dissolved in anhydrous DMF (1.1M solution) and imidazole (1.05 eq.) was added. To the stirred solution triisopropylsilyl chloride (1.1 eq.) was added and the resulting mixture was left stirring at RT for 8 h. All volatiles were evaporated in vacuo and the residual material was filtered with PE/EtOAc (9:1) over a pad of silica gel. After evaporation in vacuo the product was obtained as a colorless oil (94%), which was used without further characterization in the next reaction.",(2-Bromo-5-methoxyphenyl)methanol | DMF | imidazole | triisopropylsilyl chloride | EtOAc | silica gel | oil
US08580780B2,"Heat a mixture of 5-chloro-3H-benzothiazol-2-one (9.3 g, 50 mmol), nickel(II) bromide (10.9 g, 50 mmol) and sodium cyanide (4.91 g, 100 mmol) in 1-methyl-pyrrolidinone (100 mL) in a microwave reactor to 200° C. over 15 min and hold 1 h. Filter the cooled mixture through a glass frit, add diethyl ether and brine and filter again. Wash the organic phase with brine three times and concentrate in vacuo. Pass the residue through a plug of silica gel eluting with hexane/EtOAc (2:1) and then dichloromethane/methanol (9:1) to obtain the desired intermediate (3.2 g, 36%). MS (ES+) m/z: 177 (M+H)+.",5-chloro-3H-benzothiazol-2-one | nickel(II) bromide | sodium cyanide | 1-methyl-pyrrolidinone | diethyl ether | brine | brine | silica gel | hexane/EtOAc | dichloromethane/methanol | desired intermediate
US08466186B2,"A solution of BH3/THF (7.5 mL; 7.5 mmol) was added dropwise to a solution of 4-chloro-3-fluoro-5-nitrobenzonitrile (750 mg; 3.74 mmol) in THF (5 mL) at 0° C. The mixture was stirred at 0° C. for 3 h, it was acidified to pH ˜1 and stirred at rt for 1 h and then basicified to pH ˜8 and extracted with EtOAc. The organic layer was dried over Na2SO4, filtered and concentrated. The residue was dissolved in Et2O and precipitated with PE to give the sub-title compound.",BH3/THF | THF | 4-chloro-3-fluoro-5-nitrobenzonitrile | EtOAc | Na2SO4 | Et2O | sub-title compound
US04518597,"Prepared analogously to Example 4 from 5-chloro-6-hydroxy-4H-3,1-benzoxazin-2-one and 4-(4-methyl-phenylmercapto)-butylchloride.","5-chloro-6-hydroxy-4H-3,1-benzoxazin-2-one | 4-(4-methyl-phenylmercapto)-butylchloride"
US06596772B1,"To a solution of diethyl 3,5-dihydroxybenzamide (100 mg, 0.6553 mmol) in THF was added sodium hydride (60 mg of 60% dispersion in mineral oil) followed by 2-nitro-4-(trifluoromethylsulfonyl) chlorobenzene (378 mg, 1.306 mmol). The mixture was stirred at room temperature for overnight. The reaction was extracted with ethyl acetate, the organic layer was washed with water and brine, dried, concentrated and purified to give the title compound. 1H NMR (300 MHz, DMSO-d6) δ 11.32 (br s, 1H, NH), 10.58 (br s, 1H, NH), 8.78 (d, J=2.2 Hz, 1H), 8.57 (br s, 1H), 8.47 (br d, 1H), 8.33 (dd, J=2.2 & 8.8 Hz, 1H), 8.25 (d, J=8.8 Hz, 1H), 7.40 (d, J=9.3 Hz, 1H), 7.35 (m, 2H), 7.01 (br s, 1H).","diethyl 3,5-dihydroxybenzamide | THF | sodium hydride | 2-nitro-4-(trifluoromethylsulfonyl) chlorobenzene | ethyl acetate | water | brine | title compound"
US20150191461A1,"Methanesulfonic acid (0.13 mL, 1.97 mmol) was added to a solution of 2-chloro-5-fluoro-4-methoxypyrimidine (0.32 g, 1.97 mmol) and 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (0.40 g, 1.72 mmol) in dioxane (17 mL). The reaction mixture was heated at 100° C. overnight. The reaction was then cooled to room temperature, diluted with EtOAc, washed with water, dried over magnesium sulfate, filtered and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel to afford 5-fluoro-4-methoxy-N-[3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-pyrimidin-2-amine MS ESI calc'd for C18H24BFN3O3 [M+H]+ 360, found 360. 1H NMR (500 MHz, DMSO-d6) δ 9.51 (s, 1H), 8.27 (d, J=3.2, 1H), 8.00 (s, 1H), 7.57 (s, 1H), 7.07 (s, 1H), 4.01 (s, 3H), 2.25 (s, 3H), 1.26 (s, 12H).","Methanesulfonic acid | 2-chloro-5-fluoro-4-methoxypyrimidine | 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | dioxane | EtOAc | water | magnesium sulfate | silica gel | 5-fluoro-4-methoxy-N-[3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-pyrimidin-2-amine"
US08044206B2,"454 μl of 37% aqueous formaldehyde solution and 175 μl of acetic acid were added to a solution of 219 mg of (2-{4-[(E)-2-(2,6-dimethylphenyl)vinyl]piperidin-1-yl}-2-oxoethyl)tetrahydro-2H-pyran-4-ylamine in 5 ml of dichloroethane, followed by stirring at ambient temperature for 2 hours. Subsequently, 388 mg of sodium triacetoxyborohydride was added to the reaction mixture, followed by stirring at ambient temperature for 1 hour. Saturated aqueous sodium hydrogencarbonate solution and chloroform were added to the mixture, then the organic layer was fractionated and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (chloroform-methanol-ammonia water). The resulting oil was dissolved in 5 ml of ethanol, and 172 μl of 4N hydrochloric acid-ethyl acetate was added to the mixture. The solvent was evaporated under reduced pressure. The residue was crystallized from 2-propanol-diisopropyl ether. The crystals were recrystallized from 2-propanol-diisopropyl ether to give 201 mg of (2-{4-[(E)-2-(2,6-dimethylphenyl)vinyl]piperidin-1-yl}-2-oxoethyl)methyl(tetrahydro-2H-pyran-4-yl)amine monohydrochloride.","formaldehyde | acetic acid | (2-{4-[(E)-2-(2,6-dimethylphenyl)vinyl]piperidin-1-yl}-2-oxoethyl)tetrahydro-2H-pyran-4-ylamine | dichloroethane | sodium triacetoxyborohydride | sodium hydrogencarbonate | chloroform | silica gel | chloroform-methanol-ammonia water | ethanol | hydrochloric acid-ethyl acetate | 2-propanol-diisopropyl ether | 2-propanol-diisopropyl ether | (2-{4-[(E)-2-(2,6-dimethylphenyl)vinyl]piperidin-1-yl}-2-oxoethyl)methyl(tetrahydro-2H-pyran-4-yl)amine monohydrochloride"
US07786108B2,"Add cyanogen bromide (0.352 g, 3.33 mmol) to a solution of (S)-5-(3,5-Bis-trifluoromethyl-benzylamino)-7-ethyl-8-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid tert-butyl ester (0.647 g, 1.11 mmol) and diisopropylethylamine (0.679 mL, 3.89 mmol) in tetrahydrofuran (3 mL) at room temperature under nitrogen and heat the mixture at 65-70° C. for 16 hours and then for another 90° C. 16 h. Partition the cooled mixture between dichloromethane (40 mL) and brine (40 mL), separated layers. Extract aqueous with more dichloromethane (40 mL). Combine organic layers, dry over anhydrous sodium sulfate, filter and concentrated under reduced pressure. Purify the residue by column chromatography on silica gel, eluting with ethyl acetate/hexanes (0-20%), to provide the title compound (0.517 g, 76%), MS (ES+): 627 (M+NH4), 632 (M+Na).","cyanogen bromide | (S)-5-(3,5-Bis-trifluoromethyl-benzylamino)-7-ethyl-8-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid tert-butyl ester | diisopropylethylamine | tetrahydrofuran | nitrogen | dichloromethane | brine | sodium sulfate | silica gel | ethyl acetate/hexanes | title compound"
US06166057,"A solution of 1.3M s-BuLi in cyclohexane (140.6 mL, 182.8 mmol) was added dropwise to a dry-ice/acetone cooled solution of N-ethyl-N-(1-methoxy-2,2-dimethylpropyl)benzamide (35 g, 140.6 mmol) and TMEDA (25.44 mL, 168.6 mmol) in THF (280 mL), maintaining the internal reaction temperature ≤-60° C. The yellow solution was stirred at -78° C. for 1 h, then was cannulated into a dry-ice/acetone cooled solution of TMSCl (26.72 mL, 210.6 mmol) in THF (140 mL) at a rate which maintained the internal reaction temperature ≤-55° C. The resulting mixture was warmed to 0° C. and partitioned between ether and sat aq NaHCO3. The ether solution was dried (MgSO4) concentrated, and kugelrohr distilled under vacuum to give 44.8 g of the title compound as a pale yellow solid, a 99% yield. m.p. 76-78° C.","s-BuLi | cyclohexane | dry-ice/acetone | N-ethyl-N-(1-methoxy-2,2-dimethylpropyl)benzamide | TMEDA | THF | dry-ice/acetone | TMSCl | THF | ether | ether | MgSO4 | title compound"
US20020128232A1,"3,5-Dimethoxyphenyl isocyanate (51 mg, 0.28 mmol), 1,3-dihydrobenzo[1,2,5]thiadiazole-2,2-dioxide (38 mg, 0.22 mmol), and triethyl amine (50 μL, 0.36 mmol) were dissolved in THF and heated at reflux for 16 h. Solvent was removed in vacuo and the crude product purified by chromatography on silica gel (5% methanol in dichloromethane as eluent) to give 2,2-dioxo-2,3-dihydro-2λ6-benzo[1,2,5]thiadiazole-1-carboxylic acid (3,5-dimethoxyphenyl)amide as a fawn colored oil. 1H NMR (200 MHz, CDCl3) δ3.79 (s, 6H), 6.25 (t, J=2.4 Hz, 1H), 6.75 (d, J=2.2 Hz, 2H), 6.83-7.00 (m, 4H), 7.83-7.88 (m, 1H), 8.23 (s, 1H); MS (APC+) m/z 350 (M+H); MS (APCI−) m/z 348 (M−H).","3,5-Dimethoxyphenyl isocyanate | 1,3-dihydrobenzo[1,2,5]thiadiazole-2,2-dioxide | triethyl amine | THF | crude product | silica gel | methanol | dichloromethane | 2,2-dioxo-2,3-dihydro-2λ6-benzo[1,2,5]thiadiazole-1-carboxylic acid (3,5-dimethoxyphenyl)amide"
US20090221653A1,"2-(3-Methylamino-propylsulfanyl)-ethanol hydrochloride prepared as described in Example 12b) (2.5 g) was converted to the free base using a solid phase extraction with a sulfonic acid sorbent, yielding 1.68 g. A solution of this material (800 mg) in dichloromethane (20 mL) was treated with phenylacetaldehyde (708 mg) and acetic acid (483 mg), followed by sodium triacetoxyborohydride (2.28 g) and the mixture was stirred for 3 hours at room temperature. The reaction mixture was then partitioned between dichloromethane and saturated aqueous sodium bicarbonate solution and the organic layer was extracted with dilute aqueous hydrochloric acid. Excess solid sodium bicarbonate was added to the acidic washing and the mixture was extracted with fresh dichloromethane. The organic layer was dried over magnesium sulphate and the solvent was removed under reduced pressure. The crude product was purified by flash chromatography on silica gel eluting with 1% triethylamine and 4% methanol in dichloromethane to yield the sub-titled compound (0.8 g).",2-(3-Methylamino-propylsulfanyl)-ethanol hydrochloride | sulfonic acid | material | dichloromethane | phenylacetaldehyde | acetic acid | sodium triacetoxyborohydride | dichloromethane | sodium bicarbonate | hydrochloric acid | sodium bicarbonate | dichloromethane | magnesium sulphate | crude product | silica gel | triethylamine | methanol | dichloromethane | sub-titled compound
US07754711B2,"Following the procedure of Example 15, making variations only as required to use 6-chloropyridazine-3-carboxylic acid (2-cyclopropylethyl)amide in place of 6-chloropyridazine-3-carboxylic acid (2-cyclopropyl-2-hydroxyethyl)amide to react with piperazin-1-yl-(2-methylcyclopropyl)methanone, the title compound was obtained as a white solid (88% yield). 13C NMR (75 MHz, CDCl3) δ 177.1, 163.5, 159.5, 144.9, 131.3, 126.4, 115.1, 49.7, 45.2, 39.5, 37.5, 37.2, 35.3, 34.6, 29.9, 28.5, 26.5, 23.4, 8.6, 4.2. MS (ES+) m/z 360 (M+1).",6-chloropyridazine-3-carboxylic acid (2-cyclopropylethyl)amide | piperazin-1-yl-(2-methylcyclopropyl)methanone | title compound | solid
US09278910B2,"Prepared using General Procedure 20. To a stirred solution of tert-butyl 2-(N-(4-(N-hydroxycarbamimidoyl)benzyl)-4-nitrobenzamido)acetate (7.25 g, 16.6 mmol) INT-57 in dioxanes (25 mL) was added DIEA (3.19 mL, 18.24 mmol) then 4′-methyl-[1,1′-biphenyl]-4-carbonyl chloride (3.83 g, 16.6 mmol). The reaction mixture was stirred at room temperature for 30 mins then at 120° C. for 3 h. The reaction mixture was allowed to cool to room temperature, diluted with EA (400 mL) and washed with brine (500 mL). The organics were pre-absorbed onto silica gel and purified by chromatography (MeCN/DCM) to provide 7.35 g (73%) of tert-butyl 2-(N-(4-(5-(4′-methyl-[1,1′-biphenyl]-4-yl)-1,2,4-oxadiazol-3-yl)benzyl)-4-nitrobenzamido)acetate INT-58 as a white powder. LCMS-ESI (m/z) calculated for C35H32N4O6: 604; found 549 [M-t-Bu+H]+, tR=3.24 min (Method 10).","tert-butyl 2-(N-(4-(N-hydroxycarbamimidoyl)benzyl)-4-nitrobenzamido)acetate | dioxanes | DIEA | 4′-methyl-[1,1′-biphenyl]-4-carbonyl chloride | EA | brine | silica gel | MeCN/DCM | tert-butyl 2-(N-(4-(5-(4′-methyl-[1,1′-biphenyl]-4-yl)-1,2,4-oxadiazol-3-yl)benzyl)-4-nitrobenzamido)acetate"
US04675332,"A mixture of 10.8 g (0.036 mole) of 3-hydroxy-5-methoxy-1-phenyl-1H-indole-2-carboxylic acid methyl ester [P. C. Unangst and M. E. Carethers, J. Heterocyclic Chem., 21, 709 (1984)] and 5.5 g (0.040 mole) of anhydrous potassium carbonate in 100 ml of acetone was treated with 3.7 ml (4.9 g; 0.039 mole) of dimethyl sulfate. The mixture was stirred and heated at reflux for 16 hours, cooled, and filtered. The filter cake was washed several times with fresh acetone, and the combined filtrates were evaporated (vacuum) to yield a crude residue of 3,5-dimethoxy-1-phenyl-1H-indole-2-carboxylic acid methyl ester.","3-hydroxy-5-methoxy-1-phenyl-1H-indole-2-carboxylic acid methyl ester | potassium carbonate | acetone | dimethyl sulfate | acetone | crude residue | 3,5-dimethoxy-1-phenyl-1H-indole-2-carboxylic acid methyl ester"
US09150556B2,"To a stirred solution of 3-[3-(1,2-dimethyl-1H-indol-7-ylmethyl)-2-oxo-2,3-dihydro-benzimidazol-1-yl]-propionic acid methyl ester (90 mg, 0.24 mmol) in THF (3 ml) and water (0.5 ml) was added lithium hydroxide monohydrate (15 mg, 0.36 mmol). The reaction was stirred for 0.5 h and concentrated to low volume. The remaining residue was diluted with water and acetic acid (0.3 ml). The resulting suspension was stirred at ambient temperature over night. The precipitate was collected via filtration, washed with water and then suspended in 1:1 acetonitrile/water. The solid precipitate was isolated via filtration and dried to give 65 mg (87%) of 3-[3-(1,2-dimethyl-1H-indol-7-ylmethyl)-2-oxo-2,3-dihydro-benzimidazol-1-yl]-propionic acid. LCMS (ESMS): m/z 364.41 (M+H).","3-[3-(1,2-dimethyl-1H-indol-7-ylmethyl)-2-oxo-2,3-dihydro-benzimidazol-1-yl]-propionic acid methyl ester | 3-[3-(1,2-dimethyl-1H-indol-7-ylmethyl)-2-oxo-2,3-dihydro-benzimidazol-1-yl]-propionic acid | THF | water | lithium hydroxide monohydrate | water | acetic acid | water"
US08841455B2,"To (3S,4S)-tert-butyl 3-(3-(3-ethyl-1-((6-methylpyridin-2-yl)methyl)-1H-indazol-4-ylcarbamoyl)imidazo[1,2-a]pyridin-7-yloxy)-4-hydroxypyrrolidine-1-carboxylate (22 mg, 0.036 mmol) in DCM (1 mL) was added TFA (1 mL). The reaction mixture was stirred for one hour, and then concentrated under reduced pressure. Silica gel chromatography (DCM/MeOH/NH4OH 10:1:0.1) provided the desired product (10 mg). MS (ES+APCI) m/z=512 (M+H).","(3S,4S)-tert-butyl 3-(3-(3-ethyl-1-((6-methylpyridin-2-yl)methyl)-1H-indazol-4-ylcarbamoyl)imidazo[1,2-a]pyridin-7-yloxy)-4-hydroxypyrrolidine-1-carboxylate | DCM | TFA | Silica gel | DCM/MeOH/NH4OH | desired product"
US09073892B2,"LAH (1M in THF, 107 μl; 0.26 mmol; 2.0 eq.) was added dropwise to a cooled (0° C.) solution of 3-{1-[3-(2-morpholin-4-yl-2-oxoethyl)phenyl]-1H-1,2,3-triazol-4-yl}-1H-indazole (50 mg, 0.13 mmol, 1 eq.) in dry THF (1 mL). The reaction mixture was allowed to warm to RT and stirred overnight. Water was added and the reaction mixture was extrated three times with EtOAc. Combined organic phases were dried over magnesium sulfate, filtered and concentratd. The crude was purified by preparative HPLC to give the title compound as a beige powder. 1H NMR (300 MHz, DMSO-d6) δ 13.37 (brs, 1H), 9.31 (s, 1H), 8.37 (dt, J=8.2 Hz, 1.0 Hz, 1H), 7.96 (t, J=1.5 Hz, 1H), 7.90-7.87 (m, 1H), 7.61 (dt, J=1.0, 8.4 Hz, 1H), 7.53 (t, J=7.9 Hz, 1H), 7.47-7.41 (m, 1H), 7.40-7.38 (m, 1H), 7.28-7.23 (m, 1H), 3.59 (t, J=4.6 Hz, 4H), 2.91-2.86 (m, 2H), 2.64-2.59 (m, 2H), 2.47 (t, J=4.6 Hz, 4H). HPLC (Condition A): Rt 2.47 min (purity 95.5%). MS (ESI+): 375.2, MS (ESI−): 373.3.","LAH | THF | 3-{1-[3-(2-morpholin-4-yl-2-oxoethyl)phenyl]-1H-1,2,3-triazol-4-yl}-1H-indazole | Water | EtOAc | magnesium sulfate | title compound"
US08921397B2,"The title compound, yellow solid (110 mg, 90%), MS (ISP) m/z=487.5 [(M+H)+], mp 180° C., was prepared in accordance with the general method of example 1 from trans-4-[2-(4-benzofuran-3-yl-piperidin-1-yl)-ethyl]-cyclohexylamine dihydrochloride (intermediate A) (100 mg, 0.25 mmol) and 4-tert-butyl-benzoic acid.",title compound | solid | trans-4-[2-(4-benzofuran-3-yl-piperidin-1-yl)-ethyl]-cyclohexylamine dihydrochloride | intermediate A | 4-tert-butyl-benzoic acid
US20110294668A1,"4-Prop-2-ynyl-1H-imidazol-2-ylamine hydrochloride (0.095 g, 0.603 mmol) was reacted with benzyl azide (0.096 g, 0.723 mmol) following the general procedure for click reactions outlined above to produce 4-(1-Benzyl-1H-[1,2,3]triazol-4-ylmethyl)-1H-imidazol 2-ylamine hydrochloride (0.151 g. 86%) of a pale yellow solid. 1H NMR (300 MHz, D2O) δ 7.79 (s, 1H), δ 7.42-7.35 (m, 5H), δ 6.43 (s, 1H), δ 5.58 (s, 2H), δ 3.86 (s, 2H) ppm; 13C δ 145.4, 136.6, 135.4, 128.8, 128.7, 126.9, 126.8, 126.3, 124.1, 121.8, 109.6, 53.3, 24.1 ppm; HRMS (ESI) calcd for C13H16N6O (M+) 254.1352, found 254.1352.","4-Prop-2-ynyl-1H-imidazol-2-ylamine hydrochloride | benzyl azide | 4-(1-Benzyl-1H-[1,2,3]triazol-4-ylmethyl)-1H-imidazol 2-ylamine hydrochloride"
US08604022B2,"Saturated aqueous sodium hydrogen carbonate solution (25.00 ml) was added to methyl 2-chloropyrimidine-5-carboxylate (0.863 g, 5 mmol), tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate (1.855 g, 6.00 mmol), palladium(II) acetate (0.056 g, 0.25 mmol) and triphenylphosphine (0.262 g, 1.00 mmol) in 1,2-dimethoxyethane (25.00 ml) at 25° C. under nitrogen. The resulting mixture was stirred at 80° C. for 4 h. The cooled reaction mixture was taken up in water (50 mL), washed with EtOAc (50 mL) and then the aqueous layer was acidified to pH1 with 2N HCl. The aqueous layer was extracted with EtOAc (3×25 mL) and the combined organics washed with brine, dried over MgSO4 and concentrated under reduced pressure to afford 2-(1-(tert-butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl)pyrimidine-5-carboxylic acid (1.280 g, 84%) as a yellow solid. This was used directly with no further purification.","sodium hydrogen carbonate | methyl 2-chloropyrimidine-5-carboxylate | tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate | palladium(II) acetate | triphenylphosphine | 1,2-dimethoxyethane | nitrogen | water | EtOAc | EtOAc | brine | MgSO4 | 2-(1-(tert-butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl)pyrimidine-5-carboxylic acid"
US07420097B2,"A 1 L round bottomed flask was charged with 1-phenyl-4-penten-1-one (49.1 g, 307 mmol), THF (200 mL), and a stir bar, and cooled in an ice bath. Cyclopentadienyl magnesium chloride (330 mL of approximately 1 M solution in THF, 330 mmol) was added dropwise over 1 hour. The pale red solution was stirred overnight while warming to room temperature. The solution was then refluxed for 4.5 hours, during which time the red color intensified. After being stirred overnight at room temperature again, the solution was acidified by first adding 5.5 g of ammonium chloride in 100 mL of water, and then adding 50 mL of 1 M HCl. The product was extracted with pentane, and the pentane extracts were collected, washed with water, and dried over sodium sulfate. Elution through silica with heptane and concentration under vacuum afforded 38.6 g (55% isolated and purified yield) of the product 6-phenyl-6-(3-butenyl)fulvene as a red oil.",1-phenyl-4-penten-1-one | THF | ice | Cyclopentadienyl magnesium chloride | ammonium chloride | water | HCl | pentane | pentane | water | sodium sulfate | silica | heptane | 6-phenyl-6-(3-butenyl)fulvene
US08304437B2,"197 mg of ethyl 5-chloro-1,6-dimethyl-4-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxylate and 76 mg of 2-amino-1,3,4-thiadiazole were added to 2 ml of bromobenzene, then, the mixture was stirred for 5 hours under heat refluxing condition. The reaction mixture was cooled to room temperature, then, to the reaction mixture was added n-hexane. The resulting solid was collected by filtration, and washed with a mixture of t-butyl methyl ether and n-hexane and dried to obtain 183 mg of N-(1,3,4-thiadiazol-2-yl)-5-chloro-1,6-dimethyl-4-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide (hereinafter, referred to as present compound 14) represented by the formula:","ethyl 5-chloro-1,6-dimethyl-4-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxylate | 2-amino-1,3,4-thiadiazole | bromobenzene | n-hexane | t-butyl methyl ether | n-hexane | N-(1,3,4-thiadiazol-2-yl)-5-chloro-1,6-dimethyl-4-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide"
US20090275537A1,"To a solution of (S)-5-amino-2-(3-(2-chloro-3-fluorobenzyl)-1-methylureido)pentyl 6-fluoroisoquinolin-3-ylcarbamate (96 mg, 0.19 mmol), 2-(tert-butoxycarbonylamino)acetic acid (51 mg, 0.29 mmol) and HBTU (110 mg, 0.29 mmol) in DMF (1.0 mL) was added DIEA (63 μL, 0.38 mmol). The mixture was stirred at RT for 30 min. The mixture was filtered and the filtrate was purified by RP-HPLC using a mixture of acetonitrile and water to give (6-Fluoro-isoquinolin-3-yl)-carbamic acid (S)-5-(2-tert-butoxycarbonylamino-acetylamino)-2-[3-(2-chloro-3-fluoro-benzyl)-1-methyl-ureido]-pentyl ester (105 mg, 83%). LRMS (M+Na+) m/z 663.2.",(S)-5-amino-2-(3-(2-chloro-3-fluorobenzyl)-1-methylureido)pentyl 6-fluoroisoquinolin-3-ylcarbamate | 2-(tert-butoxycarbonylamino)acetic acid | HBTU | DMF | DIEA | acetonitrile | water | (6-Fluoro-isoquinolin-3-yl)-carbamic acid (S)-5-(2-tert-butoxycarbonylamino-acetylamino)-2-[3-(2-chloro-3-fluoro-benzyl)-1-methyl-ureido]-pentyl ester
US04272435,"Next, 266 g (0.286 mole) of a 8% aqueous sodium hypochlorite solution (pH 12) was cooled to 5° C., and to the aqueous solution was added 150 ml of an acetonitrile solution containing 17.7 g (0.2 mole) of the resulting 95%-pure 2-amino-2-methylpropionitrile and 0.6 g of tetrabutylammonium bromide over 30 minutes with stirring. The resulting reaction mixture was stirred at 7° to 10° C. for 30 minutes to complete the reaction. By iodometry, it was found that the total oxidative compounds in both the water and acetonitrile phases after reaction was 0.08 equivalent. This reaction mixture was adjusted to a pH of 6 with a dilute hydrochloric acid and 4.2 g (0.12 equivalent) of sodium nitrite was added thereto, followed by stirring at 15° C. for 20 minutes. Thereafter, the reaction mixture was diluted with 1050 g of water, and the thus precipitated white crystals were filtered, washed with water and dried to obtain 16 g of 2,2'-azobis(isobutyronitrile). The resulting white crystals had a melting point of 104°-105.5° C. and a purity of 99% or more.","sodium hypochlorite | acetonitrile | 2-amino-2-methylpropionitrile | tetrabutylammonium bromide | water | acetonitrile | hydrochloric acid | sodium nitrite | water | water | 2,2'-azobis(isobutyronitrile)"
US08198448B2,"A mixture of palladium (II) acetate (0.0375 g, 0.167 mmol), potassium phosphate (2.13 g, 10.0 mmol), 3,5-difluorophenylboronic acid (1.58 g, 10.0 mmol), X-Phos (0.159 g, 0.334 mmol) and 5-chloro-2,3-difluoropyridine (0.347 ml, 3.34 mmol) was diluted with 1,4-dioxane (0.1M, 33.4 mL) and water (0.3M, 11.0 mL) and was heated under nitrogen at 100° C. for 45 minutes. The reaction was concentrated in vacuo. The concentrated material was triturated with water, filtered and rinsed with MeCN. The crude solid was taken up in dichloromethane and filtered over a plug of Celite to eliminate residual palladium. The material was dissolved in minimal DCM, and purified via MPLC (eluting with 0-10% EtOAc in hexanes) to yield 5-(3,5-difluorophenyl)-2,3-difluoropyridine. The material was converted to the hydrazine in a method similar to that in the synthesis of (S)-6-(1-(8-fluoro-6-(3-methylisothiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)quinoline. The following compounds were prepared using a similar method as 1-(5-(3,5-difluorophenyl)-3-fluoropyridin-2-yl)hydrazine:","palladium (II) acetate | potassium phosphate | 3,5-difluorophenylboronic acid | X-Phos | 5-chloro-2,3-difluoropyridine | 1,4-dioxane | water | nitrogen | water | MeCN | DCM | EtOAc | hexanes | 5-(3,5-difluorophenyl)-2,3-difluoropyridine"
US20160108028A1,"A suspension of 2,2-dimethyl-3-(5-(quinolin-2-ylmethoxy)-1H-benzo[d]imidazol-2-yl)propanoic acid (300 mg, 0.75 mmol), 5-(bromomethyl)benzo[c][1,2,5]oxadiazole (168 mg, 0.75 mmol) and potassium carbonate (310 mg, 2.25 mmol) in DMF (20 mL) was heated to 70° C. for 18 h. The mixture was cooled to RT and concentrated to dryness. The residue was dissolved in THF/MeOH (18 mL, 1:1) and treated with 5% aq. NaOH (2 mL). The mixture was stirred at 40° C. for 16 h. The reaction was allowed to cool to RT and then concentrated to dryness. The residue was diluted with water (30 mL), washed with EtOAc (20 mL), and then treated with 6N aq. HCl to ˜pH 6. The aqueous was then extracted with DCM (2×30 mL). The organics were combined, dried with Na2SO4, filtered and concentrated to dryness. The residue was purified by reverse phase HPLC to afford the title compound. MS (ESI): mass calcd. for C29H25N5O4, 507.19; m/z found, 507.9 [M+H]+. 1H NMR (300 MHz, DMSO-d6) δ 8.44 (d, J=8.6, 1H), 8.11-7.98 (m, 3H), 7.85-7.77 (m, 1H), 7.71 (d, J=8.5, 1H), 7.68-7.61 (m, 2H), 7.58-7.52 (m, 1H), 3.35-3.33 (m, 2H), 7.50-7.43 (m, 1H), 7.38-7.33 (m, 1H), 7.21-7.12 (m, 1H), 5.84 (s, 2H), 5.47 (s, 2H), 1.30 (s, 6H).","2,2-dimethyl-3-(5-(quinolin-2-ylmethoxy)-1H-benzo[d]imidazol-2-yl)propanoic acid | 5-(bromomethyl)benzo[c][1,2,5]oxadiazole | potassium carbonate | DMF | THF/MeOH | NaOH | water | EtOAc | HCl | DCM | Na2SO4 | title compound"
US08017630B2,"Chlorotrimethylsilane (0.06 ml, 0.48 mmol) was added to a solution of the more polar diastereoisomer of 2-(4-dimethylamino-4-phenylcyclohexylidene)-N-[2-(1H-indol-3-yl)-1-methylethyl]acetamide (133 mg, 0.32 mmol) in ethyl methyl ketone (5 ml) and the mixture was stirred at RT for 1.5 h. The hydrochloride (Example 5) (66 mg, 46%) thereby precipitated out as a colourless solid with an m.p. of 182-186° C.",Chlorotrimethylsilane | 2-(4-dimethylamino-4-phenylcyclohexylidene)-N-[2-(1H-indol-3-yl)-1-methylethyl]acetamide | ethyl methyl ketone | hydrochloride
US08158775B2,"N2-Phenoxyacetyl-2′-O-(2-cyanoethoxymethyl)guanosine (660 mg, 1.32 mmol) was subjected to azeotropic distillation with pyridine, and then was dried with a vacuum pump for 30 minutes. The residue was dissolved in 9 mL of THF, and 2.1 g of pyridine (26.4 mmol) and 600 mg of molecular sieve 4 A were added under an argon atmosphere, and the reaction solution was stirred for 10 minutes. To the solution was added 540 mg of 4,4′-dimethoxytritylchloride (1.58 mmol) by 3 portions every 1 hour, and the reaction solution was further stirred for 1 hour. After 2 mL of methanol was added and the reaction solution was stirred for 2 minutes, the reaction solution was filtrated with a celite, and was washed with ethyl acetate. After concentrating the filtrate with evaporation, the residue was dissolved in ethyl acetate, and was separated with a saturated aqueous sodium bicarbonate solution. After the organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate, the solvent was distilled off. The obtained residue was purified by silica gel chromatography to obtain the objective compound (800 mg, yield 75%).","N2-Phenoxyacetyl-2′-O-(2-cyanoethoxymethyl)guanosine | pyridine | THF | pyridine | argon | 4,4′-dimethoxytritylchloride | methanol | ethyl acetate | ethyl acetate | sodium bicarbonate | brine | magnesium sulfate | silica gel | compound"
US04748276,"Eisleb in Example 2 of U.S. Patent 2,167,351, issued July 25, 1939, shows the preparation of 1-benzyl-4-phenylpiperidine-4-carbonitrile hydrochloride, m.p. 259°-260° C., as an intermediate for normeperidine, namely, ethyl 4-phenylpiperidine-4-carboxylate, by first reacting benzyl chloride with N,N-bis(2-hydroxyethyl)amine to produce N,N-bis(2-hydroxyethyl)benzylamine, next reacting the latter compound with thionyl chloride to produce N,N-bis(2-chloroethyl)benzylamine and isolating it in free base form as ""an oil of feebly brownish color""; and then heating N,N-bis(2-chloroethyl)benzylamine with benzyl cyanide (same as phenylacetonitrile) in toluene in the presence of sodium amide (same as sodamide).","1-benzyl-4-phenylpiperidine-4-carbonitrile hydrochloride | normeperidine | ethyl 4-phenylpiperidine-4-carboxylate | benzyl chloride | N,N-bis(2-hydroxyethyl)amine | N,N-bis(2-hydroxyethyl)benzylamine"
US20030065193A1,"Trans-4-hydroxy-L-proline was treated with EtOH and HCl gas, and the mixture was evaporated to give trans-4-hydroxy-L-proline ethyl ester hydrochloride. This product was treated with TsCl in pyridine, to give after aqueous workup N-(toluene-4-sulfonyl)-trans-4-(O-(toluene-4-sulfonyl))-L-proline ethyl ester. This product was treated with PhSH and DBU in DMF to give after aqueous workup and flash chromatography on silica gel, N-(Toluene-4-sulfonyl)-cis4-(phenylthio)-L-proline ethyl ester. This product was treated with NaOH in CH3OH and H2O, to give after acidification, extraction, drying with MgSO4, filtration and evaporation, N-(toluene-4-sulfonyl)-cis4-(phenylthio)-L-proline. This product was treated with HCl.Phe-OMe, BOP, and NMM in DMF, to give, after aqueous workup and flash chromatography, N-(toluene-4-sulfonyl)-cis-4-(phenylthio)-Pro-Phe-OMe. This product was treated with NaOH in CH3OH and H2O, to give, after acidification, extraction, drying with MgSO4, filtration and evaporation, the title compound as a clear oil.",Trans-4-hydroxy-L-proline | EtOH | HCl | trans-4-hydroxy-L-proline ethyl ester hydrochloride
US20070244159A1,"To a solution of 4-tert-butyl-5-nitro-2-trimethylsilanylethynyl-phenylamine (25 g, 86 mmol) in DMF (100 mL) was added CuI (8.2 g, 43 mmol) under a nitrogen atmosphere. The mixture was heated at 135° C. in a sealed pressure flask overnight, cooled down to room temperature and filtered through a short plug of Celite. The filter cake washed with EtOAc. The combined filtrate washed with water, dried over Na2SO4 and concentrated. The crude product was purified by column chromatography (10-20% ethyl aetate/hexane) to provide 5-tert-butyl-6-nitro-1H-indole as a yellow solid (13 g, 69%).",4-tert-butyl-5-nitro-2-trimethylsilanylethynyl-phenylamine | DMF | CuI | nitrogen | EtOAc | water | Na2SO4 | crude product | ethyl | hexane | 5-tert-butyl-6-nitro-1H-indole
US04962109,"4-(Methoxymethyl)-2,3,5,6-tetrafluorobenzoic acid [5.0 g prepared by a process similar to that described in European Patent Application No. 54360] was dissolved in thionyl chloride (50 cm3) and heated to the reflux temperature with stirring for 3 hours. The excess thionyl chloride was evaporated under reduced pressure to yield 4-(methoxymethyl)-2,3,5,6-tetrafluorobenzoyl chloride (ca 5 g) as a pale yellow liquid.","4-(Methoxymethyl)-2,3,5,6-tetrafluorobenzoic acid | thionyl chloride | thionyl chloride | 4-(methoxymethyl)-2,3,5,6-tetrafluorobenzoyl chloride"
US20120238588A1,"A solution of 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (6 g, 27.4 mmol), N-phthaloylglycine (5.5 g, 27 mmol) and HOBT (6.2 g, 32.4 mmol) in DMF (85 mL) was treated with the water soluble carbodiimide EDC (5.1 g, 37.8 mmol) and stirred at ambient temperature for 18 hours. The reaction mixture was poured into ice water (500 mL). The precipitated solids were collected by filtration, washed with water (3×200 mL) and Et2O (3×200 mL) and dried to give the title compound (6.6 g, 60%).","3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | N-phthaloylglycine | HOBT | DMF | water soluble carbodiimide EDC | water | ice water | Et2O | title compound"
US08569341B2,"To a solution of (S)-ethyl 2-((3R,5R,6S)-3-(2-tert-butoxy-2-oxoethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-2-oxopiperidin-1-yl)butanoate (1.94 g, 3.54 mmol, Example 21, Step A) in Et2O (35.4 mL) was added 90% lithium borohydride (0.154 g, 7.07 mmol) at 0° C. After being stirred at 0° C. for 30 min, the reaction was quenched (ice cold 10% citric acid), extracted (2×EtOAc) and washed (sat. aq. NaCl solution). The combined organic layers were washed with sat. NaCl solution, dried over Na2SO4, filtered and the filtrate was concentrated under reduced pressure. Purification by chromatography on silica gel (50% to 100% EtOAc/Hexanes, gradient elution) provided the title compound.","(S)-ethyl 2-((3R,5R,6S)-3-(2-tert-butoxy-2-oxoethyl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-2-oxopiperidin-1-yl)butanoate | Et2O | lithium borohydride | ice | EtOAc | NaCl | NaCl | Na2SO4 | silica gel | EtOAc/Hexanes | title compound"
US20080262036A1,"To a solution of 1 g of 4-fluoro-2-methoxy-benzonitrile in 15 mL of dichloroethane was added 1.1 g of aluminum trichloride. The resulting mixture was refluxed for 1 day then poured slowly into water and extracted with ethyl acetate. The organic extracts were washed twice with 10% aqueous solution of sodium hydroxide. The combined basic layers were washed twice with ethyl acetate, acidified with concentrated aqueous solution of hydrochloric acid and extracted three times with ethyl acetate. The combined organic extracts were washed with water, with brine, dried over magnesium sulfate, filtered and concentrated under reduced pressure to give 0.78 g of 4-fluoro-2-hydroxy-benzonitrile as a white solid. 5 JP9143139",4-fluoro-2-methoxy-benzonitrile | dichloroethane | aluminum trichloride | water | ethyl acetate | aqueous solution | sodium hydroxide | ethyl acetate | ethyl acetate | water | brine | magnesium sulfate | 4-fluoro-2-hydroxy-benzonitrile
US05153211,"Synthetic substrates 8H-indeno[2,1-b]furan-8-one and 8H-indeno[2,1-b]furan and their derivatives are prepared in accordance with the following. Substituted and unsubstituted 3-arylfuran-2-carboxylic acids are prepared according to a general procedure of Burgess, J. Org. Chem., 21, 102 (1956), wherein, 4,5-dimethoxy-1-phenyl-2-butanone and related 2' to 4' substituted phenyl analogs (e.g., 4,4-dimethoxy-1-(4'-fluorophenyl)-2-butanone, prepared according to the general procedure of Royals and Brannoch, J. Amer. Chem. Soc., 75, 2050 (1953)) are converted into 3-phenylfuran-2-carboxylic acid methyl ester (e.g., 3'-(4'-fluorophenylfuran-2-carboxylic acid methyl ester) by the Darzens glycidic ester condensation (Darzens, Compt. Rend., 139, 1214 (1904)). This rearrangement of the glycidic ester yields the furoic ester. The furoic ester can be hydrolyzed in alkaline methanolic solution to yield, for example, 3-(4'-fluorophenyl)-furan-2-carboxylic acid. The furoic acid product can be cyclized via the aroyl chloride in the presence of stannic chloride or aluminum chloride to yield the ketone, e.g., 6-fluoro-8H-indeno[2,1-b]furan-8-one. This ketone can be derivatized in accordance with Method V. Hydantoin derivatization (Method I) yields the spirohydantoin, e.g., spiro-(6-fluoro-8H-indeno[2,1-b]furan-8,4'-imidazolidine)-2',5'-dione. Reduction according to methods cited in Method VIII yields the corresponding 8H-indeno[2,1-b]furan derivative which can be derivatized in accordance with Methods II, III and IV into the corresponding spiro-thiazolidinedione, spiro-oxazolidinedione and spiro-succinimide. Furthermore, the spiro-derivatives may be further derivatized according to Method VI.","8H-indeno[2,1-b]furan-8-one | 8H-indeno[2,1-b]furan | Substituted and unsubstituted 3-arylfuran-2-carboxylic acids | 4,5-dimethoxy-1-phenyl-2-butanone | 4' substituted phenyl | 4,4-dimethoxy-1-(4'-fluorophenyl)-2-butanone | 3-phenylfuran-2-carboxylic acid methyl ester | 3'-(4'-fluorophenylfuran-2-carboxylic acid methyl ester) | glycidic ester | glycidic ester | furoic ester"
US20090281114A1,"To a solution of 135 g (682 mmol, 1.0 equiv.) of 1-t-butyldimethylsilyloxy-4-pentyne in 700 mL of THF at −78° C. was added 311 mL (716 mmol, 1.05 equiv.) of a 2.3M solution of n-butyllithium in hexane. The −78° C. bath was removed and the reaction temperature was monitored as it rose to 0° C. The reaction was recooled to −78° C. and 90.8 mL (716 mmol, 1.05 equiv.) of trimethylsilyl chloride was added dropwise. The reaction was then allowed to warm slowly in the cold bath for 16 hours. The reaction was diluted with 2000 mL of hexane, washed with 500 mL of saturated aqueous sodium bicarbonate, dried over anhydrous sodium sulfate and concentrated in vacuo. The resulting liquid was distilled at 71°-74° C. at 0.05 mm Hg to yield 168 g (91%) of 1-t-butyldimethylsilyloxy-5-trimethylsilyl-4-pentyne.",1-t-butyldimethylsilyloxy-4-pentyne | THF | n-butyllithium | hexane | trimethylsilyl chloride | hexane | sodium bicarbonate | sodium sulfate | 1-t-butyldimethylsilyloxy-5-trimethylsilyl-4-pentyne
US08987256B2,"13.27 g (37.2 mmol, 95% pure) of tert-butyl(+/−)-{4-[(acetyloxy)methyl]phenyl}(cyclopentyl)acetate were dissolved in 117 ml of dichloromethane, the mixture was cooled to 0° C. and 58.4 ml of trifluoroacetic acid were added. The reaction mixture was initially stirred at 0° C. for 1.5 h and then at RT for a further 1.5 h. The mixture was then concentrated under reduced pressure and the residue was dried under high vacuum. The residue was taken up in 50 ml of dichloromethane, and the solution was washed four times with water. The organic phase was dried over magnesium sulfate and concentrated under reduced pressure. Drying under high vacuum gave 11.41 g of the title compound which were used without further purification for the next reaction.",tert-butyl(+/−)-{4-[(acetyloxy)methyl]phenyl}(cyclopentyl)acetate | dichloromethane | trifluoroacetic acid | water | magnesium sulfate | title compound
US08048907B2,"5-oxo-1-(3-pyridinylmethyl)proline (0.210 g, 1 mmol, prepared as described below), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (0.383 g, 2 mmol), and 1-hydroxybenzotriazole (0.306 g, 2 mmol) were stirred together in dichloromethane (10 ml) at room temperature for 30 minutes. The mixture was then treated with {[2-chloro-3-(trifluoromethyl)phenyl]methyl}amine (0.314 g, 1.5 mmol) and the mixture was stirred overnight at room temperature. The mixture was concentrated and partitioned between ethyl acetate and saturated aqueous sodium hydrogen carbonate. The aqueous layer was separated and extracted with more ethyl acetate and then the combined ethyl acetate fractions were washed sequentially with 3 portions of water and then with saturated aqueous sodium chloride solution. Drying over magnesium sulphate and concentration gave a solid residue which was purified by mass-directed automated HPLC to give pure N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-5-oxo-1-(3-pyridinylmethyl)prolinamide (0.031 g).",5-oxo-1-(3-pyridinylmethyl)proline | N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride | 1-hydroxybenzotriazole | dichloromethane | {[2-chloro-3-(trifluoromethyl)phenyl]methyl}amine | ethyl acetate | sodium hydrogen carbonate | ethyl acetate | ethyl acetate | water | magnesium sulphate | N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-5-oxo-1-(3-pyridinylmethyl)prolinamide
US08211919B2,"To a solution of 3-methyl-4-nitrophenol (1.5 g) in pyridine (15 mL) was added dropwise trifluoromethanesulfonic anhydride (3.32 g) at ambient temperature and the mixture was stirred for 1 hour. The mixture was poured into water and extracted with ethyl acetate. The organic layer was washed with 1N hydrochloric acid and brine, dried over magnesium sulfate, and evaporated in vacuo. The residue was purified by column chromatography on silica gel eluting with hexane/ethyl acetate (9:1) to afford 3-methyl-4-nitrophenyl trifluoromethanesulfonate (1.91 g) as a yellow oil.",3-methyl-4-nitrophenol | pyridine | trifluoromethanesulfonic anhydride | water | ethyl acetate | hydrochloric acid | brine | magnesium sulfate | silica gel | hexane/ethyl acetate | 3-methyl-4-nitrophenyl trifluoromethanesulfonate
US20120196845A1,"2-(3-oxo-5-{[4-(1H-pyrazol-1-yl)phenyl]methyl}-3,5-dihydro-2H-pyrazolo[4,3-c]quinolin-2-yl)benzaldehyde (Example 529, 75 mg, 0.17 mmol) was suspended in tetrahydrofuran (5 mL) and cooled to 0° C. Sodium cyanoborohydride (0.067 mL, 1 M tetrahydrofuran solution, 0.067 mmol, 0.4 equiv) was added dropwise and the mixture was stirred for 1 hour at 0° C. The mixture was diluted with dichloromethane (3 mL) until homogeneous and stirred for an additional 1 hour at 0° C. Sodium borohydride (1 spatula tip, excess) was added and the mixture was stirred at 0° C. for 30 minutes. The mixture was warmed to ambient temperature, opened to the air and treated with dichloro-5,6-dicyanobenzoquinone (DDQ, 40 mg, 0.17 mmol, 1 equiv). After stirring for 30 minutes, the mixture was poured into sodium bicarbonate (50 mL, aqueous saturated) and extracted with ethyl acetate (3×50 mL) and chloroform (3×50 mL). The combined organic extracts were dried with sodium sulfate, filtered and concentrated in vacuo. The residue was purified by silica gel gradient chromatography (100:0 to 0:100 hexanes:ethyl acetate; then 100:0 to 0:100 ethyl acetate: ethyl acetate containing 5% methanol), providing the titled compound: 1H-NMR (400 MHz, CDCl3) δ 8.61 (1H, s), 8.35 (1H, d, J=7.4 Hz), 7.90 (1H, d, J=2.6 Hz), 7.72-7.70 (3H, m), 7.61 (1H, d, J=7.6 Hz), 7.57 (1H, d, J=7.5 Hz), 7.53 (1H, dd, J=7.6, 1.9 Hz), 7.51-7.47 (1H, m), 7.42 (1H, td, J=7.4, 1.5 Hz), 7.37 (1H, t, J=7.4 Hz), 7.29 (2H, d, J=8.6 Hz), 7.27 (1H, m), 6.47 (1H, m), 5.53 (2H, s), 5.21 (1H, br t, J=6.5 Hz), 4.53 (2H, d, J=5.8 Hz) ppm; high resolution mass spectrometry (ES+) m/z 448.1781 [(M+H)+; calculated for C27H22N5O2: 448.1768].","2-(3-oxo-5-{[4-(1H-pyrazol-1-yl)phenyl]methyl}-3,5-dihydro-2H-pyrazolo[4,3-c]quinolin-2-yl)benzaldehyde | tetrahydrofuran | Sodium cyanoborohydride | dichloromethane | Sodium borohydride | dichloro-5,6-dicyanobenzoquinone | sodium bicarbonate | ethyl acetate | chloroform | sodium sulfate | silica gel | hexanes | ethyl acetate | ethyl acetate | titled compound"
US20040029861A1,"20 g (106 mmol) 4-(3-cyanoprop-1-yl)-piperidin hydrochloride, 40.2 g (127 mmol) bis(2-chlorophenyl)-bromomethane and 35.2 g (254 mmol) potassium carbonate are heated to boiling in 90 ml acetone for six hours. After cooling, the mixture is freed from solution under vacuum. The residue is dispersed between 90 ml toluene and 90 ml water. The aqueous phase is extracted with 10 ml tolueneand the combined organic phases are washed with 10 ml water. The organic phase is concentrated and the residue is chromatographically purified over silica gel with CHCL3. Yield: 11.2 g (27%)",4-(3-cyanoprop-1-yl)-piperidin hydrochloride | bis(2-chlorophenyl)-bromomethane | potassium carbonate | acetone | toluene | water | water | silica gel
US20100204221A1,"To a large round bottom flask was added acetonitrile (45 mL), 3,4-difluoronitrobenzene (0.313 mL, 2.83 mmol), and 4-methylpiperidine (0.418 mL, 3.39 mmol). The solution was refluxed (80° C.) with stirring overnight (16 h). TLC (30% DCM/Hexanes) showed reaction completion. CombiFlash (10 g, Hexanes to DCM) afforded Cmpd AC as a yellow oil. 1HNMR (300 MHz, CDCl3): 8.00-7.99 (ddd, J1=0.97 Hz, J2=2.68 Hz, J3=9.03 Hz, 1H), 7.92-7.87 (dd, J1=2.68 Hz, J2=13.5 Hz, 1H), 7.11-7.05 (dd, J1=J2=9.03 Hz, 1H), 3.72-3.67 (m, 2H), 2.93-2.84 (m, 2H), 1.79-1.74 (m, 2H), 1.64-1.57 (m, 1H), 1.42-1.28 (m, 2H), 1.01-0.99 (d, J=6.6 Hz, 3H) 19FNMR (300 MHz, CDCl3): −203.11 to −203.19 (dd, J1=9.15 Hz, J2=13.73 Hz) MS: 239.2 (M+H)+","acetonitrile | 3,4-difluoronitrobenzene | 4-methylpiperidine | DCM/Hexanes | DCM | Hexanes"
US05576321,"The title compound was prepared in a fashion similar to that described in Example 193 from 7-chloro-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole (0.50 g, 2.2 mmol) and (S)-(+)-4-(oxiranylmethoxy)-1H-indole (0.41 g, 2.2 mmol). The product was isolated as a white foam. Yield 370 mg (41%). mp 85°-90° C. FDMS m/e=421 (M+ of free base). α[D]589 =+3.62 (c=1.00, methanol/dimethylsulfoxide).","title compound | 7-chloro-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole | (S)-(+)-4-(oxiranylmethoxy)-1H-indole | methanol/dimethylsulfoxide"
US07199135B2,"Trifluoroacetic acid (1.0 mL) was added to a solution of tert-butyl 3-{4-[3-(acetylamino)phenyl]-1-piperidinyl}propylcarbamate (340 mg) in dry dichloromethane (10 mL) and the reaction mixture was stirred at room temperature for 5 h. The reaction mixture was basified to pH 12 by addition of a 10% aqueous solution of KOH and then the dichloromethane was removed in vacuo. The aqueous layer was frozen and lyophilized to give a solid, which was extracted with methanol. Removal of the solvent gave the desired product (120 mg) as an oil: 1H NMR (400 MHz, CDCl3) δ 7.48 (m, 1H), 7.38 (d, 1H, J=7.7 Hz), 7.24 (t, 1H, J=7.7 Hz), 6.99 (d, 1H, J=7.7 Hz), 3.11 (d, 2H, J=11.6 Hz), 2.84 (t, 2H, J=6.6 Hz), 2.59–2.52 (m, 1H), 2.50 (t, 2H, J=6.6 Hz), 2.18–2.09 (m, 2H), 2.13 (s, 3H), 1.90–1.72 (m, 6H).",Trifluoroacetic acid | tert-butyl 3-{4-[3-(acetylamino)phenyl]-1-piperidinyl}propylcarbamate | dichloromethane | aqueous solution | KOH | dichloromethane | methanol | desired product
US08084459B2,"To a solution of 2-chloromethyl-5,7-dichloro-8-hydroxy-3-n-propyl-3H-quinazolin-4-one (285 mg, 0.886 mmol) in anhydrous THF (1.3 mL) was added a solution of methylamine in ethanol (7.5 mL of a 8.0M solution, 60 mmol) dropwise under an argon atmosphere. The mixture was stirred at room temperature for 18 h, then concentrated, and to the resulting residue was added 2M HCl (5 mL). The mixture was evaporated and more 2M HCl (5 mL) was added. The residue was evaporated and the procedure repeated two more times. The mixture was triturated with dichloromethane and dried in vacuo to yield 5,7-dichloro-8-hydroxy-2-methylaminomethyl-3-n-propyl-3H-quinazolin-4-one hydrochloride (4-9A) as a yellow solid (157 mg, 50%)(Table 6).","2-chloromethyl-5,7-dichloro-8-hydroxy-3-n-propyl-3H-quinazolin-4-one | THF | methylamine | ethanol | argon | HCl | HCl | dichloromethane | 5,7-dichloro-8-hydroxy-2-methylaminomethyl-3-n-propyl-3H-quinazolin-4-one hydrochloride"
US08344001B2,"5-Bromo-1′,2′,3′,4′,5′,6′-hexahydro-[2,4′]bipyridinyl (6.4 g, 18.02 mmol) was dissolved in 2% acetic acid in MeOH (40 ml). Propanone (8 mL, 113 mmol) and Na(CN)BH3 (3.6 g, 57 mmol) were added. The reaction mixture was stirred at RT overnight. The reaction mixture was added 1N HCl, filtered and concentrated in vacuo. The compound was dissolved in water and the pH was adjusted to 12, then extracted with DCM (3×200 mL). The crude product was treated with 1N HCl for 1 hour and extracted with diethyl ether to remove impurities. The aqueous phase was pH adjusted to pH=5.8-9. Extraction with ethyl acetate (3×100 mL) The organic phase was dried with Na2CO3, filtered and evaporation gave 4.6 g (86%) white crystals.","5-Bromo-1′,2′,3′,4′,5′,6′-hexahydro-[2,4′]bipyridinyl | acetic acid | MeOH | Propanone | Na(CN)BH3 | HCl | water | DCM | crude product | HCl | diethyl ether | ethyl acetate | Na2CO3 | white crystals"
US07368578B2,"To a solution of ethyl 1-benzyl-3-[(4-{[2-(2-furyl)-5-methyl-1,3-oxazol-4-yl]methoxy}-3-methylbenzyl)oxy]-1H-pyrazole-4-carboxylate (0.49 g) in tetrahydrofuran (10 mL) was added lithium aluminum hydride (0.06 g) at 0° C. and the mixture was stirred at room temperature for 1 hr. Sodium sulfate decahydrate (0.45 g) was added to the reaction mixture, and the mixture was stirred at room temperature for 30 min. The reaction mixture was diluted with ethyl acetate and the precipitate was filtered off. The filtrate was concentrated to give {1-benzyl-3-[(4-{[2-(2-furyl)-5-methyl-1,3-oxazol-4-yl]methoxy}-3-methylbenzyl)oxy]-1H-pyrazol-4-yl}methanol as colorless crystals (0.41 g, yield 91%). Recrystallization from ethyl acetate-hexane gave colorless prism crystals. melting point: 91-92° C.","ethyl 1-benzyl-3-[(4-{[2-(2-furyl)-5-methyl-1,3-oxazol-4-yl]methoxy}-3-methylbenzyl)oxy]-1H-pyrazole-4-carboxylate | tetrahydrofuran | lithium aluminum hydride | Sodium sulfate decahydrate | ethyl acetate | {1-benzyl-3-[(4-{[2-(2-furyl)-5-methyl-1,3-oxazol-4-yl]methoxy}-3-methylbenzyl)oxy]-1H-pyrazol-4-yl}methanol"
US09051265B2,"The (S)-1-(2-chloro-5-((1-methoxy-1-oxopropan-2-yl)oxy)benzyl)-2,3-dimethyl-1H-indole-5-carboxylic acid (71 mg, 0.17 mmol), the (S)-1-(3-isopropylphenyl)ethanamine hydrochloride (53 mg, 0.27 mmol) and HATU (88 mg, 0.23 mmol) were dissolved in DMF (3 mL) and DIEA (0.15 mL). It was stirred for 15 h. The solution was filtered and purified by preparative HPLC.","(S)-1-(2-chloro-5-((1-methoxy-1-oxopropan-2-yl)oxy)benzyl)-2,3-dimethyl-1H-indole-5-carboxylic acid | (S)-1-(3-isopropylphenyl)ethanamine hydrochloride | HATU | DMF | DIEA"
US20150133446A1,"A solution of 5-hydroxy-7-methoxy-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one (30.00 g, 0.134 mol) in N,N-dimethylformamide (400 mL) was treated with powdered anhydrous potassium carbonate (19.41 g, 0.14 mol) added all at once. The resulting mixture was stirred in vacuo for 10 min. and then flushed with nitrogen. The reaction flask was placed in a water bath (22° C.) an treated with benzyl bromide (24.03 g, 0.14 mol) added dropwise over 15 min. The resulting mixture was then stirred at 22° C. for 18 h (no starting material left by tlc). The solid was filtered and washed with N,N-dimethylformamide. The filtrate was evaporated in vacuo and the residual oil was diluted with ethyl acetate (500 mL), washed with cold 0.1 N hydrochloric acid, saturated sodium bicarbonate and brine. After drying over anhydrous magnesium sulfate, evaporation of the solvent gave a thick syrup. Crystallization form ethyl acetate (50 mL) and hexane (150 mL) gave 35.17 g of 5-(benzyloxy)-7-methoxy-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one as large colorless prisms. Chromatography of the mother liquors on silica gel (4×13 cm, elution toluene-ethyl acetate 0-5%) gave 6.64 g of additional material to afford a total yield of 41.81 g (99%). HRMS(ESI) calcd for C18H19O5 [M+H]+ m/z 315.1227. found 315.1386. 1H NMR (CDCl3, 600 MHz) δ 1.68 (s, 6H), 3.77 (s, 3H), 5.19 (s, 2H), 5.19 (s, 2H), 6.04 (d, J=2.03 Hz, 1H), 6.15 (d, J=2.03 Hz, 1H), 7.27 (broad t, 1H), 7.36 (broad t, 2H), 7.52 (broad d, 2H).","5-hydroxy-7-methoxy-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one | N,N-dimethylformamide | potassium carbonate | nitrogen | water | benzyl bromide | N,N-dimethylformamide | ethyl acetate | hydrochloric acid | sodium bicarbonate | brine | magnesium sulfate | ethyl acetate | hexane | 5-(benzyloxy)-7-methoxy-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one"
US20150376204A1,"According to the procedure described in the synthesis method of Compound III-5, (S)-1,1-diethoxy-N-(quinoxalin-5-ylmethyl)propan-2-amine (Compound IX-12)(1.93 g, 6.65 mmol) was coupled with (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(4-tert-butoxyphenyl)propanoic acid (3.36 g, 7.31 mmol) and the obtained residue was purified by Büch silica gel column chromatography (eluent: chloroform:methanol=100:0 to 98:2) to obtain the title compound (2.35 g, 48%).","(S)-1,1-diethoxy-N-(quinoxalin-5-ylmethyl)propan-2-amine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(4-tert-butoxyphenyl)propanoic acid | silica gel | chloroform | methanol | title compound"
US20040230056A1,"2,3-Dihydro-benzo[1,4]dioxin-5-ylamine (31.1 g, 0.2 mol) is mixed with 2-chloroethanol (210 mL, 3.1 mol) and Hunigs base (105 mL, 0.6 mol). The resulting dark solution is heated to 120° C. and stirred at this temperature with continuous monitoring by HPLC. After 12.5 h, the reaction is stopped. Ethyl acetate (300 mL) is added and the solution is washed with diluted brine (1×250 mL) followed by brine (2×75 mL). All aqueous layers are combined, the pH adjusted to 7 with K2CO3, and solution is back-washed with ethyl acetate (2×100 mL). All organic layers are then combined and extracted with 2N HCl (3×150 mL). The resulting aqueous solution is neutralized with solid K2CO3 to pH 7 and extracted with ethyl acetate (3×100 mL). The organic phase is dried with MgSO4, concentrated and chased with toluene (2×50 mL) to remove residual chloroethanol. 39.6 g (80%) of crude product is obtained as a dark oil of 94 area % (LC-MS) purity. 1H NMR (CDCl3) δ 6.88-6.70 (m, 3H), 4.34-4.22 (m, 4H), 3.54 (t, J=7.5 Hz, 4H), 3.18 (t, J=7.5 Hz, 4H).","2,3-Dihydro-benzo[1,4]dioxin-5-ylamine | 2-chloroethanol | chloroethanol | Hunigs base | Ethyl acetate | brine | ethyl acetate | HCl | ethyl acetate | MgSO4 | crude product | 94"
US20150336921A1,"A 50 ml two-necked round-bottom flask was flame dried and allowed to be cooled under nitrogen. (1S,2R,3R,4R)-2-allyl-4-(tert-butyldimethylsilyloxy)-3-((R,E)-3-(triethylsilyloxy)-4-(3-(trifluoromethyl)phenoxy)but-1-enyl)cyclopentyl hex-5-enoate (0.2 g, 0.29 mmol) in 4 ml of dichloromethane, and 0.02 g of Grubb's catalyst were added to the reaction flask. The reaction mixture was heated at 40° C. for 18 hours. The reaction was quenched with 0.4 ml ethylamine with stirring for 1 hour. The reaction mixture was phase separated and the aqueous layer was extracted with ethyl acetate and 4 ml saturated aqueous sodium bicarbonate solution. The organic layers were combined and dried over anhydrous magnesium sulfate. The solid was filtered off and organic solvent was evaporated off under vacuum. The crude product was purified by chromatography and then concentrated under reduced pressure to provide 30 mg of the title compound (16% yield).","nitrogen | (1S,2R,3R,4R)-2-allyl-4-(tert-butyldimethylsilyloxy)-3-((R,E)-3-(triethylsilyloxy)-4-(3-(trifluoromethyl)phenoxy)but-1-enyl)cyclopentyl hex-5-enoate | dichloromethane | Grubb's catalyst | ethylamine | ethyl acetate | sodium bicarbonate | magnesium sulfate | crude product | title compound"
US07429594B2,"To a stirring solution of 1-amino-3-(4-methoxy-phenyl)-propan-2-ol (1.1 g, 6.1 mmol) and triethylamine in 25 mL dichloromethane was added 2-chloro-3-methyl-5-naphthalen-2-yl-6-pyridin-4-yl-3H-pyrimidin-4-one. The solution was stirred at room temperature for 72 h. The organic layer was washed twice with 5% sodium bicarbonate, once with brine, then dried over magnesium sulfate. The product was purified on 90 g of silica eluting with 1 to 5% methanol/dichloromethane to give a yellow foam. M+1=493.2.",1-amino-3-(4-methoxy-phenyl)-propan-2-ol | triethylamine | dichloromethane | 2-chloro-3-methyl-5-naphthalen-2-yl-6-pyridin-4-yl-3H-pyrimidin-4-one | sodium bicarbonate | brine | magnesium sulfate | silica | methanol/dichloromethane
US05582994,"This starting compound in the synthesis of Compound 2 is 4,5'-dimethyl-8-methoxypsoralen. The synthesis of this precursor compound has been described previously in the literature. See Bender, et al., J. Org. Chem. 44:2176 (1979). Alternatively, the starting compound may be synthesized by the following method: 8-acetyl-7-(2-chloroallyl)oxy-4-methylcoumarin, described in Bender, et al., J. Org. Chem. 48:2709 (1983), is initially oxidized to a phenolic compound, 7-(2-chloro-2-propenyl)oxy-8-hydroxy-4-methylcoumarin, and then methylated, providing 7-(2-chloro-2-propenyl)oxy-8-methoxy-4-methylcoumarin. Claisen rearrangement provides 6-(2-chloro-2-propenyl)-7-hydroxy-8-methoxy-4-methylcoumarin, which is then converted to 4,5'-dimethyl-8-methoxypsoralen.","Compound 2 | 4,5'-dimethyl-8-methoxypsoralen | 8-acetyl-7-(2-chloroallyl)oxy-4-methylcoumarin | 7-(2-chloro-2-propenyl)oxy-8-hydroxy-4-methylcoumarin | 7-(2-chloro-2-propenyl)oxy-8-methoxy-4-methylcoumarin"
US20120122931A1,"At room temperature, to a solution of 2,2,2-trifluoro-N-(5-methoxy-2-trimethylsilanylethynylphenyl)acetamide (360 mg) in tetrahydrofuran (2.0 mL) was added tetrabutylammonium fluoride (1.0 mol/L tetrahydrofuran solution, 1.37 mL), and the mixture was stirred for 30 minutes. The reaction mixture was concentrated under reduced pressure. The obtained crude product was purified by silica gel column chromatography (eluting solvent: hexane-ethyl acetate) to obtain the title compound (210 mg).","2,2,2-trifluoro-N-(5-methoxy-2-trimethylsilanylethynylphenyl)acetamide | tetrahydrofuran | tetrabutylammonium fluoride | crude product | silica gel | hexane-ethyl acetate | title compound"
US09434700B2,"A mixture of tert-butyl ((1S,2R)-2-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)cyclohexyl)carbamate (1.14 g, 2.1 mmol) and 4N HCl in Dioxane (5.2 mL) in dichloromethane (10 mL) was stirred at room temperature for 30 minutes. LC-MS indicated complete consumption of SM. The reaction mixture was concentrated to give (1R,2S)—N1-(6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)cyclohexane-1,2-diamine (0.94 g, 100%) which was used without further purification in the next step.","tert-butyl ((1S,2R)-2-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)cyclohexyl)carbamate | HCl | Dioxane | dichloromethane | (1R,2S)—N1-(6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)cyclohexane-1,2-diamine"
US06211223B1,"Trifluoroacetic acid (1.92 kg) was added portionwise to a stirred suspension of methyl 1-methyl-1H-indole-6-carboxylate (prepared by the same method as 1-methylindole-6-tert-butyl ester in Example 28, International Patent Application WO 97/43260, but using methanol in place of 6-tert-butanol; 1.63 kg) and 2-(1,3-benzodioxol-5-yl)-2-hydroxyacetic acid (1.67 kg) in acetonitrile (16.3 liters) at room temperature under a nitrogen atmosphere. The suspension was heated to reflux for 24 h and allowed to cool to room temperature. Filtration of the precipitated product gave the subtitle compound as a white crystalline solid (2.54 kg, 80.4%).","Trifluoroacetic acid | methyl 1-methyl-1H-indole-6-carboxylate | 1-methylindole-6-tert-butyl ester | methanol | 2-(1,3-benzodioxol-5-yl)-2-hydroxyacetic acid | acetonitrile | subtitle compound"
US08088943B2,"Under an inert atmosphere such as dry nitrogen or argon, a Ni(COD)2 solution is prepared by dissolving Ni(COD)2 (0.039 g) in toluene (2.79 g). A toluene solution, or other appropriate solvent solution, of the multidentate P-containing ligand or a ligand mixture comprising a multidentate P-containing ligand to be tested (0.230 mL of 0.062 mol total multidentate P-containing ligand/L of toluene) is treated with the Ni(COD)2 solution (0.320 mL) and thoroughly mixed to provide a catalyst solution with a zero-valent nickel/multidentate P-containing ligand molar ratio of about 1/1. A cis-2-pentenenitrile (cis-2PN)/ZnCl2 solution is prepared by dissolving ZnCl2 (0.017 g in 1.02 g cis-2PN). A sample of catalyst solution (0.100 mL) is treated with cis-2PN/ZnCl2 solution (0.025 mL); the resulting mixture has cis-2PN/nickel molar ratio of about 123 and a ZnCl2/nickel molar ratio of about 0.96/1. Over a period of 16 hours, the mixture is heated to about 50° C. and exposed to HCN vapor supplied from a reservoir of uninhibited, liquid HCN at ambient temperature (619 mm Hg or 82.5 kPa vapor pressure at 20° C). The reaction mixture is then cooled to ambient temperature, treated with acetonitrile (0.125 mL), and analyzed by gas chromatography for the amount of ADN, MGN, and 2-ethylsuccinonitrile produced, in order to calculate the percent conversion of 2PN to dinitriles.",nitrogen | argon | Ni(COD)2 | Ni(COD)2 | toluene | toluene | toluene | Ni(COD)2 | nickel
US08133889B2,"Ethyl (methylsulphanyl)acetate (27.31 mmoles) is added dropwise to a solution of the compound obtained in Step E (23.75 mmoles) in THF (200 ml) at −60° C. under a nitrogen atmosphere. tBuOCl− (27.31 mmoles) is added dropwise to the reaction mixture over 20 minutes, keeping the temperature between −60° C. and −55° C. After stirring for 3 hours at −60° C., triethylamine (29.68 mmoles) is added dropwise. The reaction mixture is brought to ambient temperature; aqueous 3M HCl solution (340 ml) is then added and stirring is carried out for a further 2 hours. The organic phase is evaporated and the aqueous suspension is extracted with DCM. The organic phases are combined, then washed with 2M HCl solution and then with saturated NaCl solution, dried over sodium sulphate, filtered and evaporated to dryness. The residue is triturated in ethyl ether, filtered and dried in vacuo to yield the title product, which is used directly in the next Step.",Ethyl (methylsulphanyl)acetate | compound | THF | nitrogen | tBuOCl | triethylamine | HCl | DCM | HCl | NaCl | sodium sulphate | ethyl ether | title product
US04863959,"To a stirred solution of 7.7 g of 2',3'-difluoro-4'-formylacetanilide in 190 mL of THF under an N2 atmosphere is added 29 mL of a 2.85M solution of MeMgBr at a temperature of 10°-20° C. The thick suspension is stirred 20 minutes at 20°-25° C., cooled to 15° C. and 5 mL of AcOH cautiously added. The mixture is then poured onto 500 mL of ice/H2O and the product extracted into 500 mL of CH2CL2. This extract is washed with H2O, saturated NaHCO3 and H2O (100 mL each) and stripped to give 8.1 g of yellow gummy 2',3'-difluoro-4'-(1-hydroxyethyl)-acetanilide. 8.1 g of the crude 2',3'-difluoro-4'-(1-hydroxyethyl)-acetanilide is stirred in acetone (175 mL) while 54 mL of Kilianis' reagent (Fieser and Fieser, ""Reagents for Organic Synthesis"", Vol. I p144) is added dropwise during 30 min. at a temperature of 20°-25° C. After stirring 30 min. longer, the reaction mixture is poured onto 200 mL of ice/H2O containing 5 g of Na2S2O5. The green suspension is extracted three times with CH2Cl2 (total volume 1 L) and the organic extract is washed with H2O, saturated NaHCO3, H2O (100 mL each) and stripped in vacuo. There is obtained 5.8 g of off-white solid which is slurried with 75 mL of Et2O to afford 5.23 g (65% yield) of 4'-acetyl-2',3'-difluoroacetanilide, m.p. 149°-152° C., (Mass spectrum shows an ion of 214).","2',3'-difluoro-4'-formylacetanilide | THF | N2 | MeMgBr | AcOH | ice/H2O | H2O | H2O | NaHCO3 | 2',3'-difluoro-4'-(1-hydroxyethyl)-acetanilide"
US20070149525A1,"Sodium hydride, 60% dispersion in mineral oil, (315 mg, 7.88 mmol) was added to a solution of 3-(1-hydroxy-2-methylpropan-2-yl)benzonitrile (635 mg, 3.62 mmol) in tetrahydrofuran (15 mL). After stirring for 1 hour, iodomethane (2.0 mL, 32.1 mmol) was added. After stirring for 1 hour, the solution was diluted with saturated aqueous ammonium chloride and extracted with diethyl ether. The combined organic extracts were dried over magnesium sulfate, filtered, and concentrated. The residue was flash chromatographed with 99:1, 49:1, 24:1, and 23:2 hexanes:ethyl acetate as the eluant to yield 654 mg (95% yield) of 3-(1-methoxy-2-methylpropan-2-yl)benzonitrile as a clear oil.",Sodium hydride | 3-(1-hydroxy-2-methylpropan-2-yl)benzonitrile | tetrahydrofuran | iodomethane | ammonium chloride | diethyl ether | magnesium sulfate | hexanes | ethyl acetate | 3-(1-methoxy-2-methylpropan-2-yl)benzonitrile
US08211892B2,"0.8 g of 4-(5-(piperazin-1-yl)pyridin-2-yl)-3,4-dihydro-2H-quinoxaline-1-carboxylic acid tert-butyl ester is placed in a 25 ml round-bottomed flask. 10 ml of dichloromethane are added, followed by 0.37 ml of triethylamine and finally 0.23 ml of ethylsulphonyl chloride. The reaction mixture is stirred at ambient temperature for 3 h, then washed twice with water and once with a saturated sodium chloride solution and then evaporated under reduced pressure. 0.98 g of 4-[5-(4-(ethanesulphonyl)piperazin-1-yl)pyridin-2-yl]-3,4-dihydro-2H-quinoxaline-1-carboxylic acid tert-butyl ester is obtained.","4-(5-(piperazin-1-yl)pyridin-2-yl)-3,4-dihydro-2H-quinoxaline-1-carboxylic acid tert-butyl ester | dichloromethane | triethylamine | ethylsulphonyl chloride | water | sodium chloride | 4-[5-(4-(ethanesulphonyl)piperazin-1-yl)pyridin-2-yl]-3,4-dihydro-2H-quinoxaline-1-carboxylic acid tert-butyl ester"
US05631280,"To a solution of 41 (440 mg) in 30 mL of methanol under a nitrogen atmosphere was added 10% Pd/C (30 mg). The solution was purged with H2 gas, then stirred at room temperature under a balloon atmosphere of H2. After 8 h, the reaction was flushed with nitrogen and filtered through celite to remove the catalyst, then concentrated in vacuo. The resulting brown oil was used without further purification.",41 | methanol | nitrogen | Pd/C | H2 | H2 | nitrogen
US20120238549A1,"Tfa (1.9 mL, 24 mmol) was added to a biphasic solution of (4a′R,10a′R)-methyl 4a′-ethyl-3′,4′,4a′,10a′-tetrahydro-1′H-spiro[[1,3]dioxolane-2,2′-phenanthrene]-7′-carboxylate; compound with (4a′S,10a′S)-methyl 4a′-ethyl-3′,4′,4a′,10a′-tetrahydro-1′H-spiro[[1,3]dioxolane-2,2′-phenanthrene]-7′-carboxylate (98, R2=Ethyl) (1.60 g, 4.87 mmol), DCM (28 mL), and water (14 mL) under air. The mixture was left to vigorously stir for about 2 h at about 40° C. Tfa (1.0 mL, 13 mmol) was added. The biphasic mixture was left to vigorously stir for about 16 h at about 40° C. TFA (1.0 mL, 13 mmol) was added. The biphasic mixture was left to vigorously stir for about 2 h at about 40° C. The reaction was cooled to rt. DCM (200 mL) was added. The layers were separated and the organics were washed with saturated aqueous NaHCO3 (150 mL) and saturated aqueous NaCl (150 mL). The organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified on silica gel (80 g) using a gradient of 5-17% EtOAc in heptane. The fractions containing product were combined and concentrated under reduced pressure to afford (4bR,8aR)-methyl 4b-ethyl-7-oxo-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate; compound with (4bS,8aS)-methyl 4b-ethyl-7-oxo-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate (98A, R2=Ethyl) (1.20 g, 87%) as an ivory foam. LC/MS, method 3, Rt=2.39 min, MS m/z 285 (M+H)+. 1H NMR (400 MHz, CDCl3) δ 7.95 (dd, J=8.0, 1.9 Hz, 1H), 7.80 (d, J=1.8 Hz, 1H), 7.37 (d, J=8.0 Hz, 1H), 6.51 (d, J=9.5 Hz, 1H), 6.00 (dd, J=9.5, 6.0 Hz, 1H), 3.93 (s, 3H), 2.75-2.67 (m, 1H), 2.67-2.59 (m, 1H), 2.54-2.43 (m, 1H), 2.39-2.29 (m, 2H), 2.07-1.98 (m, 1H), 1.96-1.78 (m, 2H), 1.43-1.32 (m, 1H), 0.70 (t, J=7.5 Hz, 3H).","(4a′R,10a′R)-methyl 4a′-ethyl-3′,4′,4a′,10a′-tetrahydro-1′H-spiro[[1,3]dioxolane-2,2′-phenanthrene]-7′-carboxylate; compound with (4a′S,10a′S)-methyl 4a′-ethyl-3′,4′,4a′,10a′-tetrahydro-1′H-spiro[[1,3]dioxolane-2,2′-phenanthrene]-7′-carboxylate | DCM | water | TFA | DCM | NaHCO3 | NaCl | MgSO4 | silica gel | (4bR,8aR)-methyl 4b-ethyl-7-oxo-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate; compound with (4bS,8aS)-methyl 4b-ethyl-7-oxo-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate"
US04378314,"To a solution of ethyl 2-azidoethoxyacetate (6.56 g, 37.9 mmol) in MeOH (80 ml) was added 1N aq. NaOH (80 ml) and the mixture was stirred at room temperature overnight (17 h). After removing the insoluble material, the methanol was evaporated in vacuo and this was saturated with sodium chloride and washed with ether (30 ml×3). The aqueous layer acidified with 3N HCl (30 ml) was extracted with ether (40 ml×4). The ether extracts were washed with brine, dried (MgSO4) and evaporated to yield 4.25 g (29.3 mmol, 77.3%) of 2-azidoethoxyacetic acid as a colourless oil: 1Hmr (CDCl3) δ: 3.3-4.0 (4H, m, --OCH2CH2N3), 4.22 (2H, s, --COCH2O--), 9.52 ppm (1H, s, --CO2H, exchanged with D2O); ir (neat) νmax : 2600-3300 (br,--CO 2 H) 2100 (azide) and 1740 cm-1C=O--CO2H). This material was used in the next step without further purification.",ethyl 2-azidoethoxyacetate | MeOH | NaOH | methanol | sodium chloride | ether | ether | ether | brine | MgSO4 | 2-azidoethoxyacetic acid
US04431643,"(a) Phenolphthalein indicator (3 drops) was added to a solution of 0-methylhydroxylamine hydrochloride (3.7 g.) in dry methanol (45 ml.). To the solution was dropwise added with stirring at ambient temperature 1 N methanol solution of sodium methoxide (39 ml.) until the color of the solution was changed to purplish red. O-Methylhydroxylamine hydrochloride was added thereto by small portions until the solution was changed to colorless solution. The mixture was stirred for 30 minutes at ambient temperature. After precipitating sodium chloride was filtered off, 2-(4-hydroxyphenyl)glyoxylic acid (6.56 g.) was added to the filtrate and the mixture was stirred for 1 hour at ambient temperature. After methanol was distilled off at low temperature, a saturated sodium chloride aqueous solution was added to the residue. The mixture was adjusted to pH 1 with 10% hydrochloric acid, subjected to salting-out and extracted with ether. The extract was dried over magnesium sulfate. Ether was distilled off at low temperature to give 2-methoxyimino-2-(4-hydroxyphenyl)acetic acid (syn isomer).",Phenolphthalein | 0-methylhydroxylamine hydrochloride | methanol | methanol | sodium methoxide | O-Methylhydroxylamine hydrochloride | sodium chloride | 2-(4-hydroxyphenyl)glyoxylic acid | methanol | sodium chloride | ether | magnesium sulfate | Ether | 2-methoxyimino-2-(4-hydroxyphenyl)acetic acid
US06313312B1,"A solution of 1-hydroxybenzotriazole monohydrate (224 mg, 1.46 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (306 mg, 1.60 mmol) in N,N-dimethylformamide (10 ml) was added to (E)-3-(2-pyridinyl)-2-propenoic acid (197 mg, 1.32 mmol). After stirring at room temperature for 15 min, the mixture was added to the hydrochloride salt of N-[3-(6-methyl-3-azabicyclo[3.1.0]hex-6-yl)phenyl]methanesulfonamide (Preparation 53, 404 mg, 1.32 mmol) and sodium hydrogen carbonate (220 mg, 2.64 mmol). The reaction mixture was stirred at room temperature for overnight and then water (20 ml) and dichloromethane (10 ml) were added. The biphasic mixture was separated by filtering through a Whatman Microfiltration Device Filter Tube, and the resulting organic extract was concentrated using a stream of nitrogen to afford 377 mg of a crude dark brown oil. This was purified by chromatography using a Biotage Flash 40S™ cartridge packed with silica gel (40 g) eluting with dichloromethane: ethanol:0.880 ammonia (100:2:1) to afford the title compound as a white solid (172 mg, 33%).","1-hydroxybenzotriazole monohydrate | 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride | N,N-dimethylformamide | (E)-3-(2-pyridinyl)-2-propenoic acid | hydrochloride salt | N-[3-(6-methyl-3-azabicyclo[3.1.0]hex-6-yl)phenyl]methanesulfonamide | sodium hydrogen carbonate | water | dichloromethane | crude dark brown oil | dichloromethane | ethanol | ammonia | title compound"
US06392059B1,"Similarly to Referential example 4, 156.0 mg(0.35 mmol) of (2S,6R)-tert-butyl 2-[(E)-2-[(1R,3R,3aS,4S,4aR,8aS,9aR)-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan-4-yl]vinyl]-6-methyl-1-piperidinecarboxylate were reacted with 0.90 ml of Jones reagent to obtain 147.1 mg of (2S,6R)-tert-butyl 2-[(E)-2-[(3R,3aS,4S,4aR,8aS,9aR)-3-methyl-1-oxo-dodecahydronaphtho[2,3-c]furan-4-yl]vinyl]-6-methyl-1-piperidinecarboxylate, and then 1.00 ml of trifluoroacetic acid was reacted to obtain 113.0 mg of crude (3R,3aS,4S,4aR,8aS,9aR)-3-methyl-4-[(E)-2-[(2S,6R)-6-methylpiperidine-2-yl]vinyl]-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one(yield after 2 processes 98%). Then, 0.30 ml of 37% formaldehyde solution and 47.1 mg (2.2 equivalents) of sodium cyanoboronhydride were reacted to obtain 100.8 mg of (3R,3aS,4S,4aR,8aS,9aR)-4-[(E)-2-[(2S,6R)-1.6-dimethylpiperidine-2-yl]vinyl]-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one (ent-himbacine)(yield after 3 processes 84%).","(2S,6R)-tert-butyl 2-[(E)-2-[(1R,3R,3aS,4S,4aR,8aS,9aR)-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan-4-yl]vinyl]-6-methyl-1-piperidinecarboxylate | Jones reagent | (2S,6R)-tert-butyl 2-[(E)-2-[(3R,3aS,4S,4aR,8aS,9aR)-3-methyl-1-oxo-dodecahydronaphtho[2,3-c]furan-4-yl]vinyl]-6-methyl-1-piperidinecarboxylate"
US08785457B2,"(S)-tert-butyl 2-(4-(3-cyclopropylureido)phenyl)-4-(3-methylmorpholino)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate was prepared by the method described for intermediate 5 using intermediate 1 and 1-cyclopropyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea as starting materials","(S)-tert-butyl 2-(4-(3-cyclopropylureido)phenyl)-4-(3-methylmorpholino)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate | intermediate 5 | using intermediate 1 | 1-cyclopropyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea"
US07879797B2,"To a solution of methylamine (65.03 mL of a 2M solution in THF, 130.06 mmol) and ethyl benzoylacetate (4.505 mL, 26.01 mmol) in EtOH (26 mL) was added HOAc (7.45 mL, 130.06 mmol). The mixture was then heated to reflux for 15 h. At this time, crude 1H NMR revealed only product and MeNH2—HOAc. The reaction mixture was then cooled to RT, and the solvent was removed in vacuo. The crude reaction was then extracted with 1 N HCl and DCM. The organic layer was then dried over MgSO4, and the solvent was removed in vacuo to yield 5.3 g (99%) of ethyl (2Z)-3-(methylamino)-3-phenylacrylate. The product was used as is in subsequent reactions. 1H NMR (500 MHz, CDCl3) ppm: 8.50 (br s, 1H), 7.40 (m, 3H), 7.35 (m, 2H), 4.59 (s, 1H), 4.15 (q, J=7.0 Hz, 2H), 2.77 (d, J=5.0 Hz, 3H), 2.50 (s, 3H), 1.27 (t, J=7.0 Hz, 3H).",methylamine | THF | ethyl benzoylacetate | EtOH | HOAc | HCl | DCM | MgSO4 | ethyl (2Z)-3-(methylamino)-3-phenylacrylate
US09346808B2,"To a solution of S2-2 (50 mg, 0.2 mmol) in DMF (2 mL) was added 8-mercaptoadenine (34 mg, 0.2 mmol), Cs2CO3 (99.4 mg, 0.3 mmol) and PdCl2(dppf) (33 mg, 0.02 mmol). The mixture was degassed for 5 minutes with argon and stirred at 80° C. under argon protection for 48 h. The resulting mixture was concentrated under reduced pressure and the residue was purified by flash chromatography (CH2Cl2:MeOH, 100:0 to 90:10) to provide S2-3 (25 mg, 44% yield) as a yellow solid.",S2-2 | DMF | 8-mercaptoadenine | Cs2CO3 | PdCl2(dppf) | argon | argon | CH2Cl2 | MeOH
US07083832B2,"To the solution of 0.5 g KOH in 40 ml MeOH, was added 6.5 mmol of ethyl 4-benzyloxybenzoate. After the resulting mixture was refluxed for 4 hrs, the excess methanol was removed. The residue was mixed with 30 ml water and extracted with ether twice. The water solution was acidified with conc. HCl and extracted with ethyl acetate. The ethyl acetate solution was washed with brine and dried. After evaporation of solvent, pure product was obtained in quantitative yield.",KOH | MeOH | ethyl 4-benzyloxybenzoate | methanol | water | ether | ethyl acetate | ethyl acetate | brine
US20140275172A1,"Into a 100-mL 3-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen was placed ethyl 3-(4-[[5-fluoro-2-(2-hydroxyethyl)-1-benzofuran-7-yl]methoxy]-2,3-dimethylphenyl)propanoate (1.3 g, 3.14 mmol, prepared as described in Example 6), dichloromethane (20 mL), triethylamine (950 mg, 9.39 mmol) and MsCl (715 mg). The resulting solution was stirred overnight at 20° C. The reaction was then quenched by the addition of water. The resulting solution was extracted with ethyl acetate (3×10 mL) and the organic layers combined. The resulting residue was purified on a silica gel column with ethyl acetate/petroleum ether (1/20). The collected fractions were combined and concentrated under vacuum to yield 1 ethyl 3-[4-([5-fluoro-2-[2-(methanesulfonyloxy)ethyl]-1-benzofuran-7-yl]methoxy)-2,3-dimethylphenyl]propanoate as colorless oil. Mass spectrum (ESI, m/z): Calculated for C25H29FO7S, 493 (M+H). found 493.","nitrogen | ethyl 3-(4-[[5-fluoro-2-(2-hydroxyethyl)-1-benzofuran-7-yl]methoxy]-2,3-dimethylphenyl)propanoate | dichloromethane | triethylamine | MsCl | water | ethyl acetate | silica gel | ethyl acetate/petroleum ether | ethyl 3-[4-([5-fluoro-2-[2-(methanesulfonyloxy)ethyl]-1-benzofuran-7-yl]methoxy)-2,3-dimethylphenyl]propanoate"
US08889671B2,"Intermediate 6 (800 mg, 1.95 mmol) and pyrimidine-2,4,6(1H,3H,5H)-trione (250 mg, 1.95 mmol) in a mixture of acetic acid (8 mL) and water (2 mL) was heated at 110° C. for 3.5 hours. The solvent was removed and the reaction mixture was purified using Super Critical Fluid Chromatography (Chiralpak IA column with 40% isopropanol and 60% CO2 mobile phase) to give the title compound (571 mg, 61.7% yield) as a solid as the first eluting compound. 1H NMR (300 MHz, DMSO-d6) δ 0.9 (d, 3H) 1.1 (d, 3H) 2.8-3.2 (m, 2H) 7.7 (s, 1H) 11.4 (s, 1H) 11.8 (s, 1H). MS (ES) MH+: 474 for C21H20FN5O7.","Intermediate 6 | pyrimidine-2,4,6(1H,3H,5H)-trione | acetic acid | water | title compound"
US07378417B2,"The title compound was prepared from 5-(3-methyl-4-trifluoromethyl-phenyl)-7-trifluoromethyl-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (example C.8) and 3-methanesulfonyl-phenylamine [commercially available as hydrochloride] according to general procedure II. Yellow solid. MS (ISP) 543.3 [(M+H)+]; mp 233° C.","title compound | 5-(3-methyl-4-trifluoromethyl-phenyl)-7-trifluoromethyl-pyrazolo[1,5-a]pyrimidine-3-carboxylic acid | 3-methanesulfonyl-phenylamine | hydrochloride"
US08324242B2,"To a solution of N-(3-amino-4-methyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide (167) (33 mg, 0.11 mmol) and DIEA (49 μL, 0.28 mmol) in THF (1 mL) was added acetyl chloride (16 μL, 0.22 mmol). The reaction was stirred at room temperature for 30 min. LCMS analysis indicated that diacylation had occurred. A solution of piperidine (81 μL, 0.82 mmol) in CH2Cl2 (2 mL) was added and the reaction stirred for a further 30 min at which time only the desired product was detected by LCMS. The reaction solution was concentrated and the residue was dissolved in DMSO and purified by HPLC (10-99% CH3CN/H2O) to yield the product, N-(3-acetylamino-4-methyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide (248) (4 mg, 11%). 1H NMR (400 MHz, DMSO-d6) δ 012.95 (d, J=6.6 Hz, 1H), 12.42 (s, 1H), 9.30 (s, 1H), 8.86 (d, J=6.8 Hz, 1H), 8.33 (dd, J=8.1, 1.3 Hz, 1H), 7.85-7.81 (m, 2H), 7.76 (d, J=7.8 Hz, 1H), 7.55 (t, J=8.1 Hz, 1H), 7.49 (dd, J=8.2, 2.2 Hz, 1H), 7.18 (d, J=8.3 Hz, 1H), 2.18 (s, 3H), 2.08 (s, 3H); HPLC ret. time 2.46 min, 10-99% CH3CN, 5 min run; ESI-MS 336.3 m/z (MH+).",N-(3-amino-4-methyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide | DIEA | THF | acetyl chloride | piperidine | CH2Cl2 | desired product
US20130053287A1,"Except that 10.0 g of 1-ethylimidazole in Preparation Example 9 was changed into 10.0 g of 1-dodecylimidazole and the amount of tributyl phosphate was changed into 13.5 g, operation was performed in the same manner to obtain 6.5 g of the titled material.",1-ethylimidazole | 1-dodecylimidazole | tributyl phosphate | titled material
US05468740,"841 g of 6-acetyl-2-(2-bromopropionylamino)-3-(2-chlorobenzoyl)-4,5,6,7-tetrahydro-thieno[2,3-C]pyridine was dissolved in 0.72 liters of dichloroethane and 1.08 liters of ethyl acetate, into which ammonia gas was introduced at -10° C. The mixture was subjected to reaction in an autoclave at 100° C. for 1 hour. After completion of the reaction, excess ammonia gas was removed and the reaction solution was poured into 3N HCl under ice-cooling conditions. After extraction with ethylacetate, the aqueous phase was neutralized with a saturated sodium carbonate aqueous solution, followed by repeating extraction with chloroform. The resultant organic phase was washed with a saturated saline solution, followed by drying with anhydrous magnesium sulfate and removal of the solvent by distillation under reduced pressure to obtain 636.8 g of the intended compound.","6-acetyl-2-(2-bromopropionylamino)-3-(2-chlorobenzoyl)-4,5,6,7-tetrahydro-thieno[2,3-C]pyridine | dichloroethane | ammonia | ammonia | HCl | ice | ethylacetate | ethylacetate | chloroform | magnesium sulfate | intended compound"
US04107074,"A solution of 40 g of 1-(o-fluorobenzyl)pyrrole and 17.2 g of chloroacetonitrile in 200 ml of anhydrous ether at a temperature between 0 and -5° C is saturated with hydrogen chloride gas and then the solution is stirred until a heavy white cake forms. This cake is broken up and permitted to sit for one hour at ambient temperature. The white solid is filtered, washed with ether and dried and then hydrolyzed in water and extracted with ether. Concentration of the ether extracts leaves white crystals, mp 76°-78° C, of 2-chloroacetyl-1-(o-fluorobenzyl)pyrrole. The analagous treatment of o-fluorophenethylpyrrole produces 2-chloroacetyl-1-(o-fluorophenethyl)pyrrole.",1-(o-fluorobenzyl)pyrrole | chloroacetonitrile | ether | hydrogen chloride | ether | water | ether | ether | 2-chloroacetyl-1-(o-fluorobenzyl)pyrrole | o-fluorophenethylpyrrole | 2-chloroacetyl-1-(o-fluorophenethyl)pyrrole
US20150307460A1,"To magnesium turnings (759 mg, 4 eq.) was added one third of a solution of 2-chloro-4-(4-chlorophenoxy)-1-iodo-benzene (total amount 2.85 g, 1 eq.) in THF (total amount 27 mL) at room temperature. After activation of the magnesium with the addition of one drop of bromine to the solution at room temperature, the rest of the solution of 2-chloro-4-(4-chlorophenoxy)-1-iodo-benzene was added slowly, and the reaction mixture was heated for 1 hour at 75° C. After cooling at 30° C., a solution the 2-(1,2,4-triazol-1-yl)cycloheptanone (770 mg, 0.55 eq.) preably dissolved for 1 hour in a commercially available solution of lanthanium trichloride complexed with lithium chloride (LaCl3.2LiCl, 0.6M in THF, V=8.5 mL, 0.65 eq.), was then added dropwise to the Grignard solution and the mixture stirred at 30° C. for 35 h. After cooling, dichloromethane was added, and the organic layer washed with an aq. solution of ammonium chloride (2×). The organic layer was then filtrated under Celite, then washed with a saturated aq. solution of sodium chloride and evaporated. After purification on column chromatography on silica gel, 1-[2-chloro-4-(4-chlorophenoxyl)phenyl]-2-(1,2,4-triazol-1-yl)cycloheptanol was obtained as a colorless oil (m=620 mg, yield=18%, HPLC-MS Rt=1.34 min; masse=418).","magnesium | 2-chloro-4-(4-chlorophenoxy)-1-iodo-benzene | THF | magnesium | bromine | 2-chloro-4-(4-chlorophenoxy)-1-iodo-benzene | 2-(1,2,4-triazol-1-yl)cycloheptanone | trichloride | lithium chloride | dichloromethane | ammonium chloride | sodium chloride | silica gel | 1-[2-chloro-4-(4-chlorophenoxyl)phenyl]-2-(1,2,4-triazol-1-yl)cycloheptanol"
US05491153,"Mix 3-[(p-fluorophenacyl)amino]-2-carbethoxy-4,6-dichloroindole (600 mg, 1.52 mmol), lithium hydroxide (191 mg, 4.55 mmol), tetrahydrofuran (20 mL)and water (20 mL). Stir overnight at room temperature. Dilute with water (20 mL) and ethyl acetate (40 mL). Acidify with 1N HCl while stirring and separate the layers. Dry the organic phase over magnesium sulfate, filter and concentrate in vacuo. Recrystallize the residue (ethyl acetate/hexane)to yield the title compound as a white powder (440 mg, 79%); mp 259°-261° C.","3-[(p-fluorophenacyl)amino]-2-carbethoxy-4,6-dichloroindole | lithium hydroxide | tetrahydrofuran | water | water | ethyl acetate | HCl | magnesium sulfate | ethyl acetate/hexane | title compound"
US20140221370A1,"(R)-tert-Butyl 2-(4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-4-yl)piperazin-1-yl)-1-cyclohexyl-2-oxoethylcarbamate (0.010 g, 0.019 mmol) was placed in DCM (3 mL) at room temperature. TFA (0.3 mL) was then added. The reaction was stirred at room temperature for 1 hour. The reaction was then concentrated to dryness, dissolved in minimal DCM, and added dropwise to a stirring solution of 1M HCl in ether. The solid product was filtered, washed with ether, and dried to give (R)-2-amino-1-(4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-4-yl)piperazin-1-yl)-2-cyclohexylethanone (0.005 g, 62% yield) as the dihydrochloride salt. MS ESI (+) m/z 421 detected.","(R)-tert-Butyl 2-(4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-4-yl)piperazin-1-yl)-1-cyclohexyl-2-oxoethylcarbamate | DCM | TFA | DCM | HCl | ether | ether | (R)-2-amino-1-(4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-4-yl)piperazin-1-yl)-2-cyclohexylethanone | dihydrochloride"
US07812037B2,"The coupling of (4-cyano-phenyl)-(5-hydroxy-4-hydroxymethyl-6-methyl-pyridin-3-ylmethyl)-carbamic acid tert-butyl ester (105) (8.7 g, 19.9 mmol) and α-bromo-m-tolunitrile (5.6 g, 28 mmol), as described in Example 1, gave [5-(3-cyano-benzyloxy)-4-hydroxymethyl-6-methyl-pyridin-3-ylmethyl]-(4-cyano-phenyl)-carbamic acid tert-butyl ester (106) (11.8 g, 68% yield).",(4-cyano-phenyl)-(5-hydroxy-4-hydroxymethyl-6-methyl-pyridin-3-ylmethyl)-carbamic acid tert-butyl ester | α-bromo-m-tolunitrile | [5-(3-cyano-benzyloxy)-4-hydroxymethyl-6-methyl-pyridin-3-ylmethyl]-(4-cyano-phenyl)-carbamic acid tert-butyl ester
US20120295894A1,"(2R,4R)-tert-butyl 4-(benzyloxy)-2-((1S,2S)-2-(3-(fluoromethyl)-5-((R)-2-(4-methylthiazol-2-yl)pyrrolidine-1-carbonyl)benzamido)-1-hydroxy-3-phenylpropyl)pyrrolidine-1-carboxylate was dissolved in 4 M HCl in dioxane (6 mL) and methanol (0.5 mL) at room temperature. The reaction mixture was stirred at room temperature for 16 h. Then saturated sodium bicarbonate solution was added and the mixture Was extracted with chloroform three times. The organic layers were dried over Na2SO4 and concentrated. The crude product thus obtained after purified by basic alumina column chromatography to provide the final compound (145 mg).","(2R,4R)-tert-butyl 4-(benzyloxy)-2-((1S,2S)-2-(3-(fluoromethyl)-5-((R)-2-(4-methylthiazol-2-yl)pyrrolidine-1-carbonyl)benzamido)-1-hydroxy-3-phenylpropyl)pyrrolidine-1-carboxylate | HCl | dioxane | methanol | sodium bicarbonate | chloroform | Na2SO4 | crude product | alumina | final compound"
US05324451,"4-[(S)-2-Propoxypropanoyloxy]benzoic acid was synthesized in the same manner as in Example 1, except for replacing 4'-hydroxybiphenyl-4-carboxylic acid as used in Example 1 with p-hydroxybenzoic acid. The resulting compound was reacted with 4'-[(S)-2-methylbutoxycarbonyl]biphenyl-4-ol to obtain 4'[(S)-2-methylbutoxycarbonyl]biphenyl-4-yl 4-[(S)-2-propoxypropanoyloxy]benzoate.",4-[(S)-2-Propoxypropanoyloxy]benzoic acid | 4'-hydroxybiphenyl-4-carboxylic acid | p-hydroxybenzoic acid | 4'-[(S)-2-methylbutoxycarbonyl]biphenyl-4-ol | 4'[(S)-2-methylbutoxycarbonyl]biphenyl-4-yl 4-[(S)-2-propoxypropanoyloxy]benzoate
US20160194291A1,"0.87 g (2.62 mmol) 4,6-dichloro-2-[(E)-2-(4-methoxyphenyl)vinyl]quinazoline was solved in 10 ml abs. dioxane. 0.45 ml (2.62 mmol) diisopropyl-ethylamine and 0.36 ml (2.88 mmol) N,N-dimethylpropane-1,3-diamine were given to this solution. The reaction was stirred 12 hours under Argon atmosphere at 80° C. The solvent was evaporated under vacuum, and the product was purified by column chromatography or preparative TLC. The product was prepared as oxalate salt.","4,6-dichloro-2-[(E)-2-(4-methoxyphenyl)vinyl]quinazoline | dioxane | diisopropyl-ethylamine | N,N-dimethylpropane-1,3-diamine | Argon | oxalate salt"
US08293902B2,"A suspension of 7-benzyloxy-4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxyquinazoline (8.2 g, 19.1 mmol), ammonium formate (12 g, 190 mmol) in DMF (50 ml) containing 10% palladium on carbon (2 g) was stirred at ambient temperature for 1.5 hours. The mixture was diluted with ethyl acetate and filtered over diatomaceous earth. A solid precipitated out of the filtrate. The solid was filtered off. The filtrate was washed with aqueous sodium hydrogen carbonate, followed by brine and dried over magnesium sulphate. The volatiles were removed under vacuum. The residual solid was combined with the solid previously isolated from the filtrate and was then triturated with acetonitrile under cooling. The precipitate was filtered, washed with acetonitrile followed by diethyl ether and dried under vacuum to give 4-(4-fluoro-2-methylindol-5-yloxy)-7-hydroxy-6-methoxyquinazoline (6.48 g, quant.).",7-benzyloxy-4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxyquinazoline | ammonium formate | DMF | palladium on carbon | ethyl acetate | sodium hydrogen carbonate | magnesium sulphate | acetonitrile | acetonitrile | 4-(4-fluoro-2-methylindol-5-yloxy)-7-hydroxy-6-methoxyquinazoline
US06077853,"4-hydroxymethyl-2-methoxy-benzonitrile (from L-819,538, step 2, 2.0 g, 12.3 mmol) was dissolved in THF (61.5 ml) and treated with Ph3P (4.82 g, 18.4 mmol) followed by CBr4 (6.1 g, 18.4 mmol). The reaction was mixture stirred at room temp. for 17 hours. The solvent was removed in vacuo and the residue was purified by flash chromatography (10% EtOAc/Hexane) to yield the desired product.",4-hydroxymethyl-2-methoxy-benzonitrile | THF | Ph3P | CBr4 | EtOAc/Hexane | desired product
US08168623B2,"To a solution of (104) (780 mg, 2.3 mmol) in dichloromethane (20 mL) was added m-chloroperoxybenzoic acid (1.03 g, 4.6 mmol) and NaHCO3 (386 mg, 4.6 mmol). After stirring for 16 h at room temperature, another batch of m-chloroperoxybenzoic acid (791 mg, 4.6 mmol) and NaHCO3 (386 mg, 4.6 mmol) was added. The resulting mixture was stirred for another 8 h and then treated with 10% citric acid. After filtration, the organic layer was separated, dried over Na2SO4, and concentrated. The residue was purified by reverse phase preparative HPLC to afford 79 mg (11%) of the title compound. 1H NMR (CDCl3, 400 MHz): δ 0.94 (t, J=7.2 Hz, 3H), 1.153 (d, J=7.2 Hz, 3H), 1.150 (d, J=7.2 Hz, 3H), 1.32-1.58 (m, 12H), 1.74 (m, 2H), 2.28 (s, 2H), 2.56 (m, 1H), 3.23 (m, 2H), 5.27 (t, J=6.8 Hz, 1H, NH), 6.71 (t, J=5.6 Hz, 1H). MS (ESI) m/z 358.30 (M+H+).",(104) | dichloromethane | m-chloroperoxybenzoic acid | NaHCO3 | m-chloroperoxybenzoic acid | NaHCO3 | citric acid | Na2SO4 | title compound
US20120238750A1,"TO a solution of hydroxylamine hydrochloride (500 mg, 1.0 mmol) in water (0.2 mL) were added sodium carbonate (1.05 g, 9.91 mmol) and a solution of 2-{4-[5-(3,4-dichlorobenzoylamino)pyridin-2-yloxy]benzylidene}malonic acid dimethyl ester (500 mg, 1.0 mmol) in THF (5 mL). To the resulting solution was subsequently added methanol (5 mL) and stirred for 8 hours at 60° C. The reaction solution was concentrated under reduced pressure. Water was added to the residue, and extracted with ethyl acetate. The ethyl acetate layer was washed with a saturated sodium bicarbonate solution and brine, dried over anhydrous magnesium sulfate, and evaporated. The residue was purified by silica gel column chromatography (dichloromethane:methanol=30:1). To the resulting white precipitate was added ethyl acetate, filtered, and the filtrate was washed with diethyl ether, to thereby yield 105 mg of the title compound.","hydroxylamine hydrochloride | water | sodium carbonate | 2-{4-[5-(3,4-dichlorobenzoylamino)pyridin-2-yloxy]benzylidene}malonic acid dimethyl ester | THF | methanol | Water | ethyl acetate | ethyl acetate | sodium bicarbonate | brine | magnesium sulfate | silica gel | dichloromethane | methanol | ethyl acetate | diethyl ether"
US06869975B2,"To a stirred solution of compound 21.4 (13.5 g, 37.7 mmol) in CHCl3 (135 mL) was successively added 4-(trifluoromethyl)aniline (6.07 g, 37.7 mmol) and AcOH (3.24 mL). After stirring at room temperature for 30 min, the reaction was cooled to 0° C., sodium triacetoxyborohydride (12.0 g, 56.6 mmol) was added, and the reaction was stirred at room temperature for 3 h. The reaction mixture was poured into 150 mL of ice-water and the product was extracted with 2×50 mL CHCl3. The organics were sequentially washed with 150 mL aqueous NaHCO3 and 150 mL brine, dried over MgSO4, and concentrated to a yellow oil, which was purified with flash chromatography (SiO2 gel 60 N, eluted with 10% EtOAc/hexanes—20% EtOAc/hexanes). The fractions containing the desired product were combined and concentrated to yield a colorless solid (18.7 g). 1H NMR (400 MHz) (CDCl3) δ 7.38 (2H, d, J=8.5 Hz); 7.20 (1H, s); 7.14 (1H, s); 6.97 (1H, d, J=8.1 Hz); 6.70-6.50 (4H, m); 4.66 (2H, s); 4.40-4.20 (5H, m); 2.38 (3H, s); 2.30 (3H, s); 2.22 (3H, s); 1.31 (3H, t, J=7.1 Hz).",compound 21.4 | CHCl3 | 4-(trifluoromethyl)aniline | AcOH | sodium triacetoxyborohydride | ice-water | CHCl3 | NaHCO3 | brine | MgSO4 | SiO2 | EtOAc/hexanes | desired product | solid
US05472973,"3-(9-Fluorenyl)propionic acid was prepared from 2-(9-fluorenyl)ethyl-1,3-dioxolane (50.0 g, 187 mmol) which was dissolved in 20 ml of acetone and 450 ml of Jones' reagent (64 g chromic acid and 64 ml of sulfuric acid in 400 ml of water). After the reaction was complete, the acetone was evaporated, the residue taken into ethyl acetate, washed with water, and organic layer extracted with 1N sodium hydroxide which was acidified with 10% HCl to yield a tan precipitate. FTIR 1954, 1913, 1707, 1429, 1316, 1257, 1208, 948, 933, 735 cm-1. 1H NMR (300 MHz, DMSO-dis) δ 1.84 (t, 2H, J=7.5 Hz), 2.21 (m, 2H), 4.03 (t, 2H, J=5.5 Hz), 7.28-7.38 (m, 4H), 7.56 (d, 2H, J=7.0 Hz), 7.84 (d, 2H, J=7.0 Hz).","3-(9-Fluorenyl)propionic acid | 2-(9-fluorenyl)ethyl-1,3-dioxolane | acetone | Jones' reagent | water | acetone | sodium hydroxide"
US03954813,"A mixture of XIII (0.91 g, 0.0025 mole), methanol (10 ml), and 20% potassium cabonate (5 ml) was stirred and refluxed for 90 minutes. The clear yellow solution was mixed with water (15 ml) and acidified to pH 5-6 with acetic acid. The emulsion was extracted with two 15-ml portions of ether. The combined ethereal extracts were dried over magnesium sulfate. Ether was distilled off from a water bath (60°C), at last under 0.1 mm Hg. The yellow, oily residue (0.86 g) was purified by chromatography on three 20 × 20 cm preparative tlc plates (Merck silica gel 60F254 --2 mm layer), and the isolated crude XII herefrom was distilled at 175°-185°C and 0.03 mm Hg to give 0.63 g XII (71%) as a light yellow oil, nD25 1.4844.",XIII | methanol | potassium cabonate | water | acetic acid | two | ether | magnesium sulfate | Ether | water | residue | silica gel | XII
US07906648B2,"575 g (1.09 mmol) of 5-bromo-3-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine was dissolved in 250 ml of dichloromethane. To this solution was added 2.50 g (3.53 mmol) of PS-thiophenol (Argonaut Technologies) and 1.5 ml of a 2 M solution of hydrochloric acid in ether. The mixture was stirred at room temperature for 3 hours before the resin was filtered off washing extensively with dichloromethane. The filtrate was evaporated to afford 389 mg (877 mmol, 81%) of 4-[5-bromo-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-phenol as a pale yellow solid. 1H-NMR (d6-DMSO) δ: 9.67 [1H] s, 8.52 [1H] d, 8.43 [1H] d, 8.11 [1H] s, 8.03 [2H] d, 7.58 [2H] d(m), 7.43 [2H] d, 6.89 [2H] d(m), 2.35 [3B] s. MS, m/z: 443 [MH+].","5-bromo-3-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine | dichloromethane | thiophenol | hydrochloric acid | ether | dichloromethane | 4-[5-bromo-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-phenol"
US04826869,"A solution of 4.6 g (15 mmol) of 1,5-dipropyl-2-(3'-ureidobenzyl)pyrrole in 150 ml of glacial acetic acid was hydrogenated at 45 p.s.i. in the presence of 3.5 g of 5% rodium on activated alumina as catalyst, during 2 hours. The catalyst was then separated by filtration and the filtrate evaporated in vacuo. The residue was suspended in 100 ml of methylene chloride and 20 ml of ammonium hydroxide were added (to adjust pH to alkaline). Anhydrous sodium sulfate was added and the solvent evaporated under reduced pressure. The residue was purified by t.l.c. using an (80:20) mixture of chloroform [chloroform-methanol-ammonium hydroxide (60:10:1)] as the eluant, thus obtaining 1.83 g (39%) of the less polar cis-1,5-dipropyl-2-(3'-ureidobenzyl)pyrrolidine isomer (as an oil), and 214 mg (5%) of the more polar trans-1,5-dipropyl-2-(3'-ureidobenzyl)pyrrolidine isomer, which was recrystallized from ether-hexane.","1,5-dipropyl-2-(3'-ureidobenzyl)pyrrole | acetic acid | alumina | ammonium hydroxide | sodium sulfate | chloroform | cis-1,5-dipropyl-2-(3'-ureidobenzyl)pyrrolidine | trans-1,5-dipropyl-2-(3'-ureidobenzyl)pyrrolidine"
US20120115869A1,"Following the general method as outlined in Example 59 (Step 1), starting from N-(3-cyano-5-fluorophenyl)-N-(4-iodobenzyl)propanamide (Intermediate 31 and 2-chlorophenylboronic acid, the title compound was obtained as a white solid in 86% yield after purification by column chromatography (silica), eluting with cyclohexane containing increasing amounts of EtOAc.",N-(3-cyano-5-fluorophenyl)-N-(4-iodobenzyl)propanamide | Intermediate 31 | 2-chlorophenylboronic acid | title compound
US06858651B2,"In analogy to examples 29.10 and 29.11, trans-Methansulfonic acid 5-(4-methyl amino-cyclohexyl)-pentyl ester.trifluoroacetic acid salt and 4-trifluoromethyl-phenyl sulfonylchloride were reacted, followed by treatment with diethylamine to give trans N-[4-(5-Diethylamino-pentyl)-cyclohexyl]-N-methyl-4-trifluoromethyl-benzenesulfonamide. MS: 463 (MH+).",trans-Methansulfonic acid 5-(4-methyl amino-cyclohexyl)-pentyl ester | trifluoroacetic acid | 4-trifluoromethyl-phenyl sulfonylchloride | diethylamine | trans N-[4-(5-Diethylamino-pentyl)-cyclohexyl]-N-methyl-4-trifluoromethyl-benzenesulfonamide
US07659268B2,"N-(6-Chloro-5-methylpyridin-2-yl)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamide (110 mg, 0.300 mmol) was dissolved in 3 mL of 1,2-dimethoxyethane (DME) in a microwave reactor tube. tert-Butyl 1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropylcarbamate (50% pure, 280 mg, 0.390 mmol), 0.4 mL of an aqueous 2 M potassium carbonate solution, and tetrakis(triphenylphospine)palladium(0) (Pd(PPh3)4, 17 mg, 0.015 mmol) were added and the reaction mixture was heated at 120° C. in a microwave reactor for 20 minutes. The resulting material was cooled to room temperature, filtered, and the layers were separated. The organic layer was evaporated to dryness and the residue was purified on silica gel utilizing a gradient of 0-30% ethyl acetate in hexanes to yield tert-butyl 1-(3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)phenyl)cyclopropylcarbamate. This material was then dissolved in 3 mL of dichloromethane containing 1 mL of trifluoroacetic acid (TFA) and was allowed to stir for 15 min at room temperature. The mixture was evaporated to dryness, dissolved in a minimum of N,N-dimethylformamide, and purified by reverse-phase preparative liquid chromatography utilizing a gradient of 0-99% acetonitrile in water containing 0.05% trifluoroacetic acid to yield N-(6-(3-(1-aminocyclopropyl)phenyl)-5-methylpyridin-2-yl)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamide. ESI-MS m/z calc. 463.2, found; 464.0 (M+1)+ Retention time 1.39 minutes.","N-(6-Chloro-5-methylpyridin-2-yl)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamide | 1,2-dimethoxyethane | tert-Butyl 1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropylcarbamate | potassium carbonate | tetrakis(triphenylphospine)palladium(0) | silica gel | ethyl acetate | hexanes | tert-butyl 1-(3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)phenyl)cyclopropylcarbamate"
US20090149468A1,"A mixture of 60 mg (0.14 mmol) {4-[4-(2,5-diaza-bicyclo[2.2.1]hept-2-yl)-quinolin-2-yl]-pyridin-2-yl}-(1-phenyl-ethyl)-amine in 5 mL chloroform was treated with 0.15 mL (2 mmol) acetone, 120 mg (2 mmol) NaBH3(CN) and 1 mL methanol. The mixture was stirred at rt for 15 h. MS showed all starting materials were converted. The mixture was diluted with 100 mL DCM, washed with 20 mL sat. NaHCO3, dried over anhydrous Na2SO4. After purification by flash chromatography, the title compound was obtained as a yellow solid. MS (ES+): 464 (M+H)+.","{4-[4-(2,5-diaza-bicyclo[2.2.1]hept-2-yl)-quinolin-2-yl]-pyridin-2-yl}-(1-phenyl-ethyl)-amine | chloroform | acetone | NaBH3(CN) | methanol | DCM | NaHCO3 | Na2SO4 | title compound"
US07220771B2,"To a solution of 1-{[3-(4-fluorophenyl)-5-amino(1H-indazoly)]methoxy}-2-methoxyethane (100 mg, 0.32 mmol) in pyridine (3 mL) was added benzoyl chloride (45 μL, 0.38 mmol). The solution was stirred for 12 hours when water (80 mL) was added and the solid filtered. The solid was then taken up in methanol (3 mL) and 6N HCl (3 mL) and heated to 80° C. for 3 hours. Water (80 mL) was then added and the solid filtered and dried to give the title compound (20 mg, 19% yield). 1H NMR (DMSO-d6) δ 13.3 (br s, 1H), 10.37 (s, 1H), 8.57 (s, 1H), 8.0–7.9 (m, 5H), 7.78 (d, 1H), 7.6–7.5 (m, 4H), 7.40 (t, 2H); ES-MS (m/z) 332 [M+1]+.",1-{[3-(4-fluorophenyl)-5-amino(1H-indazoly)]methoxy}-2-methoxyethane | pyridine | benzoyl chloride | water | HCl | Water | title compound
US08691855B2,"1-Chloro-3,5-dibromobenzene (2.70 g, 10.0 mmol) and cyclopropylboronic acid (1.72 g, 20 mmol) were reacted using K3PO4 (14.9 g, 70 mmol), tricyclohexylphosphine (56 mg, 2.0 mmol), Pd(OAc)2 (288 mg, 1.0 mmol) as described above to give 1-chloro-3,5-dicyclopropyl-benzene (1.84 g, 96%) after purification by flash chromatography on silica gel (% EtOAc in hexane=2%˜10%).","1-Chloro-3,5-dibromobenzene | cyclopropylboronic acid | K3PO4 | tricyclohexylphosphine | Pd(OAc)2 | 1-chloro-3,5-dicyclopropyl-benzene"
US07148173B2,"A suspension of 1.5 g (6.5 mmol) of lithium [1-(2-trimethylsiloxyethyl)indenide] in ether was added to a suspension of 2.2 g (6.5 mmol) of pentamethylcyclopentadienyl zirconium trichloride in 100 ml of ether at 0° C. After 30 minutes, the formation of a white solid was the volatiles were removed under vacuum to give a yellow oily-solid. This solid was recrystallized in hexane to give a mycrocristalline yellow solid, which was characterized as [1-(2-trimethylsiloxyethyl)indenyl]pentamethylcyclopentadienyl zirconium dichloride (1.7 g, 3.2 mmol, yield: 49%). 1H-NMR (CDCl3): 7.65 (m, 1H); 7.33 (m, 1H); 7.25 (m, 2H); 6.08 (m, 1H); 5.92 (m, 1H); 3.72 (dm, 2H); 3.28 (m, 1H); 2.72 (m, 1H); 2.04 (s, 15H); 0.03 (s, 9H). 13C-NMR (CDCl3): 131.4; 127.1; 126.7; 125.2; 125.1; 124.2; 123.5; 122.6; 116.1; 97.0; 62.6; 32.1; 12.5; −0.6.",lithium [1-(2-trimethylsiloxyethyl)indenide] | ether | pentamethylcyclopentadienyl zirconium trichloride | ether | hexane | [1-(2-trimethylsiloxyethyl)indenyl]pentamethylcyclopentadienyl zirconium dichloride
US20030069430A1,"The title compound was prepared from 2-oxo-3[(4-sulfamoyl-phenyl)-hydrazono]-2,3-dihydro-1H-indole-5-carboxylic acid pentafluorophenyl ester and (4-pyridyl)methylamine according to Procedure K: mp 211-215° C.; Anal. Calcd for C21H18N6O4S.¾H2O: C, 54.36; H, 4.24; N, 18.11. Found: C, 54.41; H, 4.20; N, 18.12.","title compound | 2-oxo-3[(4-sulfamoyl-phenyl)-hydrazono]-2,3-dihydro-1H-indole-5-carboxylic acid pentafluorophenyl ester | (4-pyridyl)methylamine"
US07700655B2,"Using 4′-(trifluoromethyl)acetophenone and thiourea as the raw materials, the same operation as the Example 395(1) gave the title compound.",4′-(trifluoromethyl)acetophenone | thiourea | raw materials | title compound
US20070149546A1,"A mixture of 4-(3-chloro-4-(3-fluorobenzyloxy)anilino)-5-hydroxyquinazoline (371 mg) (obtained as described in Example 11, preparation of starting materials), chloroacetone (0.197 ml) and cesium carbonate (92 mg) in acetonitrile (5 ml) was heated at 80° C. for 2 hours. Volatile material was removed by evaporation and the residue was partitioned between ethyl acetate (15 ml) and water (15 ml). The organic phase was separated, washed with water (15 ml) and saturated brine (15 ml) and dried. The solution was concentrated to give 4-(3-Chloro-4-(3-fluorobenzyloxy)anilino)-5-(acetonyloxy)quinazoline as a yellow gum (54 mg) which was used without purification or characterisation.",4-(3-chloro-4-(3-fluorobenzyloxy)anilino)-5-hydroxyquinazoline | chloroacetone | cesium carbonate | acetonitrile | ethyl acetate | water | water | brine | 4-(3-Chloro-4-(3-fluorobenzyloxy)anilino)-5-(acetonyloxy)quinazoline
US08889711B2,"To a solution of 0.15 g (0.27 mmol) of tert-butyl 4-(4-(5-cyano-6-(2-fluoro-4-nitrophenyl)-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)phenyl)piperazine-1-carboxylate in 15 ml of ethanol are added 0.037 g (0.035 mmol) of 10% Pd/C. The mixture is stirred at room temperature for 18 h under hydrogen atmospheric pressure. The mixture is then concentrated, re-dissolved in dichloromethane, filtered through Celite, and concentrated. The residue is purified by chromatography on silica (MeOH gradient in dichloromethane: 0 to 5%) to yield 0.020 g (14%) of tert-butyl 4-(4-(6-(4-amino-2-fluorophenyl)-5-cyano-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)phenyl)piperazine-1-carboxylate in the form of yellow crystals.","tert-butyl 4-(4-(5-cyano-6-(2-fluoro-4-nitrophenyl)-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)phenyl)piperazine-1-carboxylate | ethanol | Pd/C | hydrogen | dichloromethane | silica | MeOH | dichloromethane | tert-butyl 4-(4-(6-(4-amino-2-fluorophenyl)-5-cyano-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl)phenyl)piperazine-1-carboxylate"
US20100184815A1,"To a solution of N-Propyl-2-(2-(trityloxy)acetyl)hydrazinecarboxamide (7 g, 16.78 mmol, 1 equiv) in methanol, was added potassium hydroxide (14.1 g, 252 mmol, 15 equiv). The mixture was refluxed for 16 hours, concentrated in vacuo, and acidified with 10% citric acid. The product was filtered, redissolved in DCM and washed with brine. The organic layer was dried (MgSO4), filtered, and concentrated. The resulting residue was purified using column chromatography (50% ethyl acetate:hexanes) to yield the desired product as a white solid (4.7 g, 70% yield).",N-Propyl-2-(2-(trityloxy)acetyl)hydrazinecarboxamide | methanol | potassium hydroxide | DCM | brine | MgSO4 | desired product
US06458849B1,"The N-[3-(4fluorophenoxy)phenyl][[3-(1,1,2,2-tetrafluoroethoxy)phenyl]methyl]amine (612 mg, 1.5 mmol) product from EX-634C and 1,1,1-trifluoro-2,3-epoxypropane (268 mg, 2.4 mmol) were dissolved in 1.0 mL of acetonitrile. Ytterbium (III) trifluoromethanesulfonate (43 mg, 0.07 mmol) was added, and the stirred solution was warmed to 40° C. for 2.5 h under an atmosphere of nitrogen, at which time HPLC analysis indicated that no secondary amine starting material remained. The reaction was quenched with water and extracted with ether. The ether layer was washed with brine and water, then dried over anhydrous MgSO4. The ether was removed in vacuo, and the crude product was purified by flash column chromatography on silica gel eluting with ethyl acetate in hexane (1:11) to give 633 mg (81%) of the desired 3-[[3-(4-fluorophenoxy)phenyl][[3-(1,1,2,2-tetrafluoro-ethoxy)phenyl]methyl]amino]-1,1,1-trifluoro-2-propanol product as a yellow oil, 99% pure by HPLC analysis.","N-[3-(4fluorophenoxy)phenyl][[3-(1,1,2,2-tetrafluoroethoxy)phenyl]methyl]amine | 1,1,1-trifluoro-2,3-epoxypropane | acetonitrile | Ytterbium (III) trifluoromethanesulfonate | nitrogen | secondary amine | water | ether | ether | brine | water | MgSO4 | ether | crude product | silica gel | ethyl acetate | hexane | 3-[[3-(4-fluorophenoxy)phenyl][[3-(1,1,2,2-tetrafluoro-ethoxy)phenyl]methyl]amino]-1,1,1-trifluoro-2-propanol"
US08865732B2,"Following a literature procedure (Synthesis 1996, 877), n-BuLi (2.2 M in hexane, 9.1 mL, 20 mmol) was added dropwise to solution of tert-butyl 3-methylpyridin-2-ylcarbamate (1.98 g, 9.5 mmol) in dry THF (21 mL) at −5° C. The reaction was maintained at −5° C. for 1 h, then cooled to −78° C. in a dry ice-acetone bath. A solution of MeI (0.62 mL, 10 mmol) in dry THF (3 mL) was added over 20 min. The reaction was maintained at −78° C. for 1 h and then raised slowly to −55° C. The reaction was quenched with water (20 mL) and the resulting mixture was partitioned and the layers separated. The aqueous phase was extracted with EtOAc (2×20 mL) and the combined organic portions were washed with brine, dried (Na2CO3), and concentrated to furnish 1.8 g of tert-butyl 3-ethylpyridin-2-ylcarbamate: LCMS (m/z): 223.1 (MH+), tR=0.54 min",n-BuLi | tert-butyl 3-methylpyridin-2-ylcarbamate | THF | dry ice-acetone | MeI | THF | water | EtOAc | brine | Na2CO3 | tert-butyl 3-ethylpyridin-2-ylcarbamate
US06984644B2,"Methanesulfonyl chloride (0.028 ml) was added to a solution of 5-[(3-aminophenyl)thio]-3-methyl-1-(2-methylpropyl)-6-(1-naphthalenylmethyl) thieno[2,3-d]pyrimidine-2,4-(1H,3H)-dione (60 mg) and triethylamine (0.067 ml) in anhydrous dichloromethane (2 ml) at room temperature. After 1 hour, saturated sodium hydrogen carbonate solution (10 ml) was added and the mixture was extracted with ether (2×10 ml). The organic extracts were dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure. The residue was purified by preparative normal-phase HPLC with isohexane:ethyl acetate gradient elution then recrystallised from ethyl acetate:isohexane to give the title compound (28 mg).","Methanesulfonyl chloride | 5-[(3-aminophenyl)thio]-3-methyl-1-(2-methylpropyl)-6-(1-naphthalenylmethyl) thieno[2,3-d]pyrimidine-2,4-(1H,3H)-dione | triethylamine | dichloromethane | sodium hydrogen carbonate | ether | magnesium sulfate | isohexane | ethyl acetate | ethyl acetate | isohexane | title compound"
US07282588B2,"A mixture of 1-dimethylethyl 4-(5-bromo-2-pyrimidinyl)-1-piperazinecarboxylate (3.00 mmol), bis(pinacolato)diboron (3.30 mmol) and potassium acetate (9.00 mmol) was diluted with 1,4-dioxane (10 ml) and degassed with argon for 10 minutes. Dichlorobis(triphenylphosphine) palladium(II) (0.15 mmol) was added and the resulting mixture heated at 95° C. overnight under argon. Upon cooling and dilution with EtOAc (100 ml), the mixture was sonicated for 10 minutes. Filtration through a pad of silica and concentration in vacuo provided a solid residue which was purified on 40g silica gel (CHCl3/EtOAc w/0.1% MeOH). Recrystallization from diethyl ether/hexanes yielded the title product as white needles (44%). ESMS [M+H]+: 391.2","1-dimethylethyl 4-(5-bromo-2-pyrimidinyl)-1-piperazinecarboxylate | bis(pinacolato)diboron | potassium acetate | 1,4-dioxane | argon | Dichlorobis(triphenylphosphine) palladium(II) | argon | EtOAc | silica | 40g | silica gel | diethyl ether/hexanes | title product"
US20070093521A1,"In analogy to the procedure described in example 1A], 2-(piperidin-4-ylamino)-benzothiazole-6-carboxylic acid ethyl ester (example 211) was reacted with 2,6-diethoxy-4′-fluoro-biphenyl-4-carbaldehyde (example 167B]), sodium cyanoborohydride, N-ethyl-diisopropylamine and acetic acid in ethanol at 50° C. to yield the title compound as colorless amorphous solid.","2-(piperidin-4-ylamino)-benzothiazole-6-carboxylic acid ethyl ester | 2,6-diethoxy-4′-fluoro-biphenyl-4-carbaldehyde | sodium cyanoborohydride | N-ethyl-diisopropylamine | acetic acid | ethanol | title compound"
US03996286,"To a suspension of 28.5 g (1.17 g. atoms) magnesium turnings in 150 ml tetrahydrofuran under a nitrogen atmosphere there is added 10 ml (1.17 mole) of 4-bromotoluene in 650 ml dry tetrahydrofuran, the reaction is started and the remainder of the bromotoluene solution is added dropwise at a rate that maintains a moderate reflux. After the addition is complete, the mixture is refluxed for an additional 1 1/2 hours. The resulting Grignard solution is added dropwise to a cold solution of 128.0 g. pivaloyl chloride (1.06 mole) in 500 ml dry tetrahydrofuran at a rate that maintains the temperature at 0° to -5° C. The solution is stirred for an additional 1 1/2 hours at 0° and then at room temperature for 18 hours. The mixture is then cooled to 0° and hydrolyzed by the addition of 100 ml 2N hydrochloric acid. The layers are separated and 200 ml of ether is added to the organic phases which is then washed respectively with 100 ml 2N hydrochloric acid, 100 ml. 10% sodium bicarbonate solution and 100 ml saturated sodium chloride. The resulting layer is dried over anhydrous sodium sulfate, filtered, and the solvent is removed in vacuo to give p-pivaloyl toluene (b.p. 80°-84° C/0.7 mm,n21 =1.5108). A mixture of 156.3 g. (0.886 mole) of the resulting p-pivaloyl toluene is then added to 157.8 g. (0.886) mole) N-bromosuccinimide, 4.0 g (0.016 mole) benzoyl peroxide and 150 ml. carbon tetrachloride and heated at reflux for 18 hours. The mixture is cooled and filtered and the resulting precipitate is washed with carbon tetrachloride. The solvents are removed in vacuo and the resulting oil is distilled in vacuo to give α-bromo-p-pivaloyl toluene (b.p. 124° - 132°/0.7 mm, n22 =1.5546-V.P.C. 96% monobromo 4%-dibromo).",magnesium | tetrahydrofuran | nitrogen | 4-bromotoluene | bromotoluene | tetrahydrofuran | pivaloyl chloride | tetrahydrofuran | hydrochloric acid | ether | hydrochloric acid | sodium sulfate | p-pivaloyl toluene
US20110245226A1,"To a mixture of N-((2 S)-1-((4R)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylcyclohexyl)-3-methyl-1-oxobutan-2-yl)formamide (109 mg, 0.298 mmol) and TEA (0.208 mL, 1.490 mmol) in CH2Cl2 (5 mL) was added POCl3 (0.027 mL, 0.298 mmol) at 0° under N2. The mixture was stirred at 0-5° C. for 3 h. The mixture was quenched with NaHCO3(aq), extracted into CH2Cl2, and dried over Na2SO4. After concentrating, the crude residue was purified via column chromatography (CH2Cl2) to give (2S)-((4R)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylcyclohexyl)-2-isocyano-3-methylbutan-1-one (85 mg, 0.244 mmol, 82% yield) as a light yellow oil.","N-((2 S)-1-((4R)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylcyclohexyl)-3-methyl-1-oxobutan-2-yl)formamide | TEA | CH2Cl2 | POCl3 | N2 | NaHCO3 | CH2Cl2 | Na2SO4 | crude residue | CH2Cl2 | (2S)-((4R)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylcyclohexyl)-2-isocyano-3-methylbutan-1-one"
US20100305207A1,"A 10 L jacketed laboratory reactor, equipped with a mechanical stirrer, was charged with dichloromethane (6 L) and DMF (201 g, 2.75 mol). The jacket was cooled to 15° C. and oxalyl chloride (348.8 g, 2.75 mol) was added over ca. 20 min. After stirring an additional 5 min, 4-bromo-2,6-dimethylaniline (500 g, 2.50 mol) in dichloromethane (1 L) was added. The reaction mixture was stirred for 30 min and then the dichloromethane layer was washed with 2N NaOH (3 L), water (2 L) and 50% brine (1 L). The dichloromethane layer was then distilled to a volume of ca. 1 L. THF (4 L) was added, and the mixture was then distilled to a volume of 2 L, THF (4 L) was added again and the mixture was distilled to 2 L, and a final 5 L of THF was added. The resulting solution was cooled to ca. −70° C. and n-butyl lithium (2.5 M in hexanes, 1.25 L. 3.12 mol) was added over ca. 40 min, in which the internal temperature was maintain at <−50° C. After the addition was complete, the reaction was cooled to −60° C. and cyclopropanecarbaldehyde (221.45 g, 3.12 mol) was added at such a rate to maintain the internal temperature <−48° C. The mixture was then allowed to warm to RT and water (2 L) was added. The mixture was distilled to a volume of ca. 2 L, then lithium hydroxide monohydrate (315 g, 7.50 mol) in water (2 L) and ethanolamine (460 g, 7.5 mol) was added. The mixture was brought to reflux and isopropanol (1 L) was added. After refluxing for ca. 18 h the reaction was cooled to RT, and the pH was adjusted to ca. 10 with concentrated HCl. The mixture was extracted with ethyl acetate (2×2 L, 1×1 L) and the combined organics were washed with water (1 L). The resulting solution was concentrated to ca. 1 L, heated to reflux and then cooled to 0° C. The resulting solids were collected by filtration, washed with ethyl acetate and hexanes, and dried under vacuum at ca. 45° C. to give 254.4 g (53%) of the product. 1H NMR (400 MHz, DMSO-D6) δ ppm: 6.80 (s, 2H), 4.75 (brs, 1H), 4.38 (brs, 2H), 3.74 (d, J=7.2 Hz, 1H), 2.07 (s, 6H), 1.04-0.93 (m, 1H), 0.45-0.15 (m, 4H).","dichloromethane | DMF | oxalyl chloride | 4-bromo-2,6-dimethylaniline | dichloromethane | dichloromethane | NaOH | water | brine | dichloromethane | THF | THF | THF | n-butyl lithium | hexanes | cyclopropanecarbaldehyde | water | lithium hydroxide monohydrate | water | ethanolamine | isopropanol | HCl | ethyl acetate | water | ethyl acetate | product"
US04994569,"Phenyl isocyanate (2 g) is added at a temperature in the region of 20° C. to a solution, maintained under an argon atmosphere, of (5RS, 6SR)-2-(4-tert-butylphenyl)-6-phenyl-5,6-dihydro-4H-1,3-oxazin-5-ol (3.2 g) in anhydrous tetrahydrofuran (35 cc). The solution obtained is heated to 50° C. for 5 hours and then concentrated to dryness under reduced pressure (2.7 kPa). The solid obtained is purified by chromatography on silica (0.063-0.2 mm; 200 g) contained in a column 3.5 cm in diameter, collecting 20-cc fractions. Fractions 22 to 29, eluted with a mixture of cyclohexane and ethyl acetate (7:3 by volume), are concentrated to dryness under reduced pressure (2.7 kPa) at 40° C. The solid obtained is again purified by chromatography on silica (0.063-0.2 mm; 200 g) contained in a column 2.5 cm in diameter, collecting 10-cc fractions. Fractions 19 to 25, eluted with a mixture of dichloromethane and methanol (98:2 by volume), are concentrated to dryness under reduced pressure (2.7 kPa) at 40° C. After recrystallization in ethyl acetate, (5RS, 6SR)-2-(4-tert-butylphenyl)-6-phenyl-5-phenylcarbamoyloxy-5,6-dihydro-4H-1,3-oxazine (1.4 g), m.p. 80° C., is obtained.","Phenyl isocyanate | argon | (5RS, 6SR)-2-(4-tert-butylphenyl)-6-phenyl-5,6-dihydro-4H-1,3-oxazin-5-ol | tetrahydrofuran | silica | cyclohexane | ethyl acetate | silica | dichloromethane | methanol | ethyl acetate | (5RS, 6SR)-2-(4-tert-butylphenyl)-6-phenyl-5-phenylcarbamoyloxy-5,6-dihydro-4H-1,3-oxazine"
US03933890,"A solution of 1-chloroheptan-2-one (33 g.) and triphenylphosphine (60 g.) in chloroform (50 ml.) was saturated with nitrogen and refluxed under nitrogen overnight. The chloroform was removed in vacuo and the residue was dissolved in methylene chloride (150 ml.). Dry diethyl ether (600 ml.) was added to precipitate 2-oxoheptyltriphenylphosphonium chloride (60 g.), m.p. 165°-168°C. This compound (23 g.) was added portionwise to a solution of sodium carbonate (25 g.) in water (250 ml.) and the mixture was stirred vigorously for 24 hours. The solution was extracted with diethyl ether, and the ethereal extracts were dried over magnesium sulphate. The solvent was removed by evaporation and the residue was cooled and triturated with petroleum ether (b.p. 40°-60°C.). The solid thus obtained was recrystallised from petroleum ether (b.p. 60°-80°C.) to give hexanoylmethylene triphenylphosphorane (17 g.), m.p. 73°-74°C.",1-chloroheptan-2-one | triphenylphosphine | chloroform | nitrogen | chloroform | methylene chloride | diethyl ether | 2-oxoheptyltriphenylphosphonium chloride | sodium carbonate | water | diethyl ether | magnesium sulphate | petroleum ether | petroleum ether | hexanoylmethylene triphenylphosphorane
US05230826,"A solution of 0.33 g of potassium hydroxide in 7 ml of 95 percent ethanol is treated with 1.12 g of p-fluorophenol. Thereafter, the mixture is treated with a solution of 2.26 g of [trans-4-[trans-4-(2-(1,3-dioxolan-2-yl)-ethyl)cyclohexyl]cyclohexyl]methyl p-toluenesulfonate in 23 ml of ethanol and stirred at 80° C. (bath temperature) for 24 hours. Subsequently, the reaction mixture is partitioned in 1 N hydrochloric acid and methylene chloride. The organic phase is washed several times with water, dried over magnesium sulfate, filtered and evaporated. Chromatographic purification of the resulting crude product on silica gel with ethyl acetate/petroleum ether gives 1-[[trans-4-(trans-4-(2-(1,3-dioxolan-2-yl)-ethyl)cyclohexyl]cyclohexyl]methoxy]-4-fluorobenzene.","potassium hydroxide | ethanol | p-fluorophenol | [trans-4-[trans-4-(2-(1,3-dioxolan-2-yl)-ethyl)cyclohexyl]cyclohexyl]methyl p-toluenesulfonate | ethanol | hydrochloric acid | water | magnesium sulfate | crude product | silica gel | ethyl acetate/petroleum ether | 1-[[trans-4-(trans-4-(2-(1,3-dioxolan-2-yl)-ethyl)cyclohexyl]cyclohexyl]methoxy]-4-fluorobenzene"
US04163853,"To the above base, 3.2 g. (0.007 mol) in ether, a solution of 0.8 g. of oxalic acid in ether was added. The crude oxalate was recrystallized twice from ethanol to give 1.7 g. (39%) of pure (-)-3-phenoxy-N-phenethylmorphinan oxalate, m.p. 217°-219°, [α]D25 =-72.17° (c 1.06, MeOH).",ether | oxalic acid | ether | oxalate | ethanol | (-)-3-phenoxy-N-phenethylmorphinan oxalate | MeOH
US06288086B1,"2-(4-Methoxy-phenylsulfanyl)-octanoic acid ethyl ester was prepared according to the general method as outlined in example 9. Starting from ethyl-2-bromooctanoate (11.8 g, 473 mmol) and 4-methoxythiophenol (6 g, 43 mmol). Yield: 7.24 g (57%); clear oil; MS: 311.2 (M+H)+.",2-(4-Methoxy-phenylsulfanyl)-octanoic acid ethyl ester | ethyl-2-bromooctanoate | 4-methoxythiophenol
US20040204341A1,"Benzyl 4-formyl-1-piperidinecarboxylate (P. E. Maligres, Tetrahedron, 53(32):10983-10992(1997)) (100 mg, 0.40 mmol) and aminopyrazine (46 mg, 0.48 mmol) were dissolved in toluene under N2 and was heated to reflux under Dean Stark conditions for 18 h. The volatiles were removed in vacuo and the residue taken up in ethanol and treated with solid NaBH4 (76 mg, 2.00 mmol) in small portions. The reaction aged at 20° C. for 1 h then was quenched with 2N HCl. The reaction was basified with 1M NaOH and was extracted with ethyl acetate (2×). The combined organics were dried over Na2SO4, filtered and concentrated in vacuo. The resulting residue was purified by reverse phase HPLC to give 36 mg of the title compound as a yellow oil.",Benzyl 4-formyl-1-piperidinecarboxylate | aminopyrazine | toluene | N2 | NaBH4 | HCl | ethyl acetate | Na2SO4 | title compound
US06355618B1,"A mixture of 3-(2-hydroxyphenyl)propionic acid (0.57 g, 3.4 mmol), phenylbromide (0.4 ml, 3.37 mmol), and K2CO3 (2.5 g) in acetone (10 ml) was stirred at room temperature for 2 days. The mixture was diluted with 1:1 hexane/EtOAc (100 ml), washed with water and brine, dried over sodium sulfate and concentrated in vacuo. The residue was purified by chromatography (5:1 then 4:1 hexane/EtOAc) to yield phenyl 3-(2-phenyloxyphenyl)propionate (0.45 g, 1.30 mmol, 77%).",3-(2-hydroxyphenyl)propionic acid | phenylbromide | K2CO3 | acetone | hexane/EtOAc | water | brine | sodium sulfate | hexane/EtOAc | phenyl 3-(2-phenyloxyphenyl)propionate
US07265144B2,"To a solution of 5-methyl-2-{[1-(2-methylphenyl)-3-(4-methylphenyl)-1H-pyrazol-5-yl]amino}benzoic acid (Example 65), (49.5 mg, 0.13 mmol) in AcOH/DCM (1:1, v/v) (2 mL) was added a solution of NIS (28 mg, 0.13 mmol) in DCM (1 mL). The reaction was stirred at rt for 3 h. Water (1 mL) was added to the reaction mixture. The water layer was extracted with DCM (2 mL), and the combined organic layers were washed with sodium sulfite and brine, and concentrated under reduced pressure. The crude product was subjected to HPLC purification with a gradient elution from 30% to 95% acetonitrile in water to afford 9.1 mg (14%) of the title compound. 1H NMR (300 MHz, CD2Cl2) δ 8.88 (s, 1H), 7.85 (d, 2H), 7.74 (s, 1H), 7.18-7.32 (m, 7H), 6.58 (d, 1H), 2.41 (s, 3H), 2.25 (s, 3H), 2.21 (s, 3H). ES-MS m/z 524.1 (MH+); HPLC RT (min) 4.35.",5-methyl-2-{[1-(2-methylphenyl)-3-(4-methylphenyl)-1H-pyrazol-5-yl]amino}benzoic acid | AcOH/DCM | DCM | NIS | DCM | Water | water | sodium sulfite | brine | crude product | acetonitrile | water | title compound
US09238647B2,"To a solution of benzyl [(1R,2Z)-2-amino-2-(hydroxyimino)-1-methylethyl]carbamate (2.25 g, 9.48 mmol) in dioxane (80 ml) was added 1-acetyl-1H-imidazole (3.13 g, 28.5 mmol) and the mixture heated to 90° C. After 16 h, the solution was concentrated and the residue was dissolved in 200 mL of dichloromethane. The mixture was washed with 100 mL of aquous saturated sodium bicarbonate (2×) and brine (100 mL). The organic layer was dried over sodium sulfate, filtered and concentrated. The residue was purified by silica gel chromatography (100% dichloromethane→95% dichloromethane/methanol) to give the title compound (1.1 g). MS 262.1 (M+1).","benzyl [(1R,2Z)-2-amino-2-(hydroxyimino)-1-methylethyl]carbamate | dioxane | 1-acetyl-1H-imidazole | dichloromethane | sodium bicarbonate | brine | sodium sulfate | silica gel | dichloromethane | dichloromethane/methanol | title compound"
US07902400B2,"To a mixture of 5 ml of ethyl acetate and 0.30 g of 3-fluoro-4-(2-propynyloxy)benzoyl chloride were added 0.22 g of (1S)-1-(cyclohexyl)ethylamine and 0.20 g of triethylamine in order at room temperature. The mixture obtained was stirred at room temperature for 1 hour. Then, ethyl acetate was added to the reaction mixture and the mixture was filtered through Celite. The filtrate was concentrated under reduced pressure. The residue was washed with hexane to obtain 0.37 g of N-((1S)-1-cyclohexylethyl)-3-fluoro-4-(2-propynyloxy)benzamide (hereinafter, described as the compound 37 of the present invention) represented by the formula:",ethyl acetate | 3-fluoro-4-(2-propynyloxy)benzoyl chloride | (1S)-1-(cyclohexyl)ethylamine | triethylamine | ethyl acetate | hexane | N-((1S)-1-cyclohexylethyl)-3-fluoro-4-(2-propynyloxy)benzamide
US06803480B2,"335 mg (0.96 mmol) of 4-[3-(4-fluorobenzyl)-4-methoxybenzyl]-3,5-dimethylaniline (Example X) and 107 mg (1.06 mmol) of triethylamine are introduced into ml of dichloromethane and, at 0° C., 177 mg (1.29 mmol) of ethoxalyl chloride are added dropwise. The mixture is stirred for 4 h. It is shaken with NaHCO3 solution and NaCl solution, and the organic phase is dried and concentrated in a rotary evaporator. Purification by chromatography (cyclohexane/ethyl acetate=7:1) affords 231 mg of ethyl ({4-[3-(4-fluorobenzyl)-4-methoxybenzyl]-3,5-dimethylphenyl}amino)(oxo)-acetate.","4-[3-(4-fluorobenzyl)-4-methoxybenzyl]-3,5-dimethylaniline | triethylamine | dichloromethane | ethoxalyl chloride | NaHCO3 | NaCl | cyclohexane/ethyl acetate | ethyl ({4-[3-(4-fluorobenzyl)-4-methoxybenzyl]-3,5-dimethylphenyl}amino)(oxo)-acetate"
US20100120775A1,"A 2.2 M solution of zinc(II) chloride (9.88 mL, 21.74 mmol) in diethyl ether was added to tin(II) chloride (4.12 g, 21.74 mmol) and activated 4 Å molecular sieve pellets (1.00 g) in ethanol (10 mL) under argon. Then, 5-bromo-2-nitro-benzaldehyde (1.00 g, 4.35 mmol) and ethyl 3-oxobutanoate (594.0 mg, 4.56 mmol) in ethanol (12 mL) were added to the reaction mixture via canula. The mixture was heated at 70° C. in an oil bath for three hours, then allowed to cool to room temperature, and carefully quenched with saturated sodium bicarbonate. Ethyl acetate was added and the mixture was filtered through Celite®. The filtrate was extracted with ethyl acetate and the organic layer was dried over anhydrous magnesium sulfate, then filtered and concentrated. The residue was purified by silica gel chromatography eluting with 1:6 ethyl acetate:hexanes to give 697.9 mg (55%) of ethyl 6-bromo-2-methyl-3-quinolinecarboxylate as a solid. lfiNMR (400 MHz, d6-DMSO): δ 8.84 (s, 1H), 8.42 (d, J=2 Hz, 1H), 7.95 (dd, J=9, 2 Hz, 1H), 7.91 (d, J=9 Hz, 1H), 4.38 (q, J=7 Hz, 2H), 2.84 (s, 3H), 1.37 (t, J=7 Hz, 3H). ESI-LCMS m/z 294 (M+H)+.",zinc(II) chloride | diethyl ether | tin(II) chloride | ethanol | argon | 5-bromo-2-nitro-benzaldehyde | ethyl 3-oxobutanoate | ethanol | sodium bicarbonate | Ethyl acetate | ethyl acetate | magnesium sulfate | silica gel | ethyl acetate | hexanes | ethyl 6-bromo-2-methyl-3-quinolinecarboxylate
US08772288B2,"To a solution of 2-chloro-5-iodopyridin-4-amine (preparation 36a, 1.95 g, 7.66 mmol) in tetrahydrofuran (23 mL) under an argon atmosphere, was added powdered sodium hydroxide (0.92 g, 23 mmol), tetrakis(triphenylphosphine)palladium(0) (0.17 g, 0.15 mmol) and a 0.15M solution of tris[(E)-2-ethoxyvinyl]borane (20 mL, 3.0 mmol) in tetrahydrofuran and the resulting mixture was heated with stirring to 70° C. and left overnight. The mixture was poured into water and extracted with ethyl acetate. The organic layer was washed with brine, dried and the solvent was evaporated under reduced pressure. The residue was purified by flash chromatography (6:1 to 3:1 hexanes/ethyl acetate) to yield the title compound (1.00 g, 62%) as a beige solid.",2-chloro-5-iodopyridin-4-amine | tetrahydrofuran | argon | sodium hydroxide | tetrakis(triphenylphosphine)palladium(0) | tris[(E)-2-ethoxyvinyl]borane | tetrahydrofuran | water | ethyl acetate | brine | hexanes/ethyl acetate | title compound
US20100130556A1,"Phosphorous pentoxide (2.02 g, 14.20 mmol) suspended in 1,2-dichlorobenzene (60 mL) was added to a mixture of 2-phenyl-furan (23) (500 mg, 2.84 mmol) and 3-bromophenylacetic acid (24) (1.34 g, 6.25 mmol). The reaction mixture was heated to 80° C. for 2 hours and then cooled to ambient temperature. DCM was added, the organic layer washed with water and partially reduced in vacuo. The crude product was purified by Flash Master Jones Chromatography using a 50 g silica cartridge and first eluting with heptane to remove excess 1,2-dichlorobenzene, then 5-10% EtOAc in heptane to give the title compound. Yield: 278 mg, 38%; LC-MS G1.73 min; HPLC Purity: 100%; MS (ES+) m/z 341, 343 (M+H)","Phosphorous pentoxide | 1,2-dichlorobenzene | 2-phenyl-furan | 3-bromophenylacetic acid | DCM | water | crude product | heptane | 1,2-dichlorobenzene | EtOAc | heptane | title compound"
US20090270361A1,"Using 2-chloro-4-(4-formyl-3,5-dimethyl-1H-pyrazol-1-yl)benzonitrile synthesized in Reference Example 17 and 4-fluorophenylmagnesium bromide as starting materials and in the same manner as in Example 25, the title compound was obtained.","2-chloro-4-(4-formyl-3,5-dimethyl-1H-pyrazol-1-yl)benzonitrile | 4-fluorophenylmagnesium bromide | title compound"
US05919967,"A process for preparing (4,4-diphenylcyclohexyl)phosphooxymethyl diethylene triaminepenta-acetic acid comprising the steps of: (a) phosphorylating 1.0 equivalents of 4,4-diphenylcyclohexanol with about one equivalent of phosphorous trichloride to obtain 4,4-diphenylcyclohexyloxy dichlorophosphine having the formula: ##STR20## (b) coupling the 4,4-diphenylcyclohexyloxy-dichlorophosphine formed in step (a) with from about 5 to about 6 equivalents of imidazole to obtain 4,4-diphenycyclohexyloxy-diimidazolylphosphine having the formula: ##STR21## where imido refers to imidazolyl (c) coupling of the 4,4-diphenylcyclohexyloxy- diimidazolylphosphine formed in step (b) with from about 0.75 to about 1.0 equivalents of hydroxymethyl-DTPA penta tert-butyl ester to obtain 4,4-diphenylcyclohexyloxy (hydroxymethyl-DTPA -oxy, penta tert-butyl ester) imidazolyl-phosphine having the formula: ##STR22## where imido refers to imidazolyl (d) hydrolysis and oxidation of the 4,4-diphenylcyclohexyloxy (hydroxymethyl-DTPA oxy, penta tert butyl ester) imidazolylphosphine formed in step (c) with dilute HCl and from about 0.5 to about 2.0 equivalents to sodium periodate to form (4,4-diphenylcyclohexyl)phosphonooxymethyl diethylene triamine, penta t-butyl ester having the formula: ##STR23##","(4,4-diphenylcyclohexyl)phosphooxymethyl diethylene triaminepenta-acetic acid | (a) | 4,4-diphenylcyclohexanol | phosphorous trichloride | 4,4-diphenylcyclohexyloxy-dichlorophosphine"
US08304419B2,"Sodium hydrosulfite (37.7 g, 216 mmol) dissolved in water (200 mL) was added dropwise to a vigorously stirred solution of 2-[(3-bromo-5-chlorophenyl)oxy]-3-fluoro-4-methyl-1-nitrobenzene (13.0 g, 36.1 mmol) dissolved in THF (100 mL). The reaction was stirred for 16 h at 40° C. The layers were separated and the aqueous phase was extracted with EtOAc (2×100 mL). The organic extracts were combined, dried over Na2SO4, filtered and concentrated. The crude oil was purified by column chromatography (5% to 100% EtOAc/hexanes gradient) to afford the title compound (5.0 g, 42%) as a light tan solid. 1H NMR (400 MHz, DMSO-d6): δ ppm 7.39-7.38 (m, 1H), 6.98-6.97 (m, 1H), 6.90-6.85 (m, 2H), 6.54-6.52 (m, 1H), 2.08 (s, 3H).",Sodium hydrosulfite | water | 2-[(3-bromo-5-chlorophenyl)oxy]-3-fluoro-4-methyl-1-nitrobenzene | THF | EtOAc | Na2SO4 | EtOAc/hexanes | title compound
US09145410B2,"Butylhydrazine oxalate (25 g, 140 mmol) was added over a period of 15 minutes to a solution of ethyl 2,4-dioxovalerate (22.2 g, 140 mmol) and triethylamine (210 mmol) in ethanol (140 mL). The resulting solution was stirred overnight at ambient temperature and concentrated under reduced pressure. Hexane was added, and an insoluble solid was removed by filtration. The hexane was removed under reduced pressure; the residue was purified by chromatography on a HORIZON HPFC system (65I cartridge, eluting with hexanes/ethyl acetate in a gradient from 80:20 to 45:55) to provide 18.1 g of ethyl 1-butyl-5-methyl-1H-pyrazole-3-carboxylate as a pale yellow oil.","Butylhydrazine oxalate | ethyl 2,4-dioxovalerate | triethylamine | ethanol | Hexane | hexane | 65I | hexanes/ethyl acetate | ethyl 1-butyl-5-methyl-1H-pyrazole-3-carboxylate"
US08394826B2,"To methyl 3-(1,3-dioxoisoindolin-2-yl)-2-(4-((triisopropylsilyloxy)methyl)phenyl)propanoate (E134) in THF/H2O was added LiOH.H2O, and the solution was stirred for 1.5 h or until conversion to product was visible by LC-MS. The solution was then poured into EtOAc/NH4Cl(sat)/1 N HCl (3:1) and the aqueous layer was further extracted with EtOAc. The organics were dried (MgSO4), filtered, and evaporated to give crude 2-(2-carboxy-2-(4-((triisopropylsilyloxy)methyl)phenyl)ethylcarbamoyl)benzoic acid (E135).","methyl 3-(1,3-dioxoisoindolin-2-yl)-2-(4-((triisopropylsilyloxy)methyl)phenyl)propanoate | THF/H2O | LiOH.H2O | EtOAc/NH4Cl(sat) | EtOAc | MgSO4 | 2-(2-carboxy-2-(4-((triisopropylsilyloxy)methyl)phenyl)ethylcarbamoyl)benzoic acid"
US08198453B2,"A solution of (R)-tert-butyl 3-((R)-(3-chloro-5-fluorophenyl)(hydroxy)methyl)piperidine-1-carboxylate (55 g, 0.156 mol) in acetonitrile (1.2 L) was cooled to 0° C., NaH (19.2 g, 0.48 mol, 60% in oil) was added in portions, then the mixture was stirred at rt for 1 hr. The mixture was cooled to −20° C. and bromoacetonitrile (57.7 g, 0.48 mol) was added dropwise. After 0.5 hr, additional NaH (19.2 g, 0.48 mol, 60% in oil) and bromoacetonitrile (57.7 g, 0.48 mol) was added. TLC showed 80% of the starting material was reacted. The reaction was quenched with saturated NH4Cl solution (200 mL), water (1 L) was added. Acetonitrile was removed by reduced pressure, CH2Cl2 (1 L) was added, the aqueous layer was back extracted with CH2Cl2 (3×500 mL), dried over Na2SO4 and concentrated in vacuo to give the crude (R)-tert-butyl 3-((R)-(3-chloro-5-fluorophenyl)(cyanomethoxy)methyl)piperidine-1-carboxylate (90 g), which was used for the next step without further purification.",(R)-tert-butyl 3-((R)-(3-chloro-5-fluorophenyl)(hydroxy)methyl)piperidine-1-carboxylate | acetonitrile | NaH | bromoacetonitrile | NaH | bromoacetonitrile | starting material | NH4Cl | water | Acetonitrile | CH2Cl2 | CH2Cl2 | Na2SO4 | (R)-tert-butyl 3-((R)-(3-chloro-5-fluorophenyl)(cyanomethoxy)methyl)piperidine-1-carboxylate
US05441970,"Synthetic Scheme XXV shows the 8-step preparation of the alkylating reagent 2-(4-bromomethylphenyl)-3-cyanopyridine (57) from 2-amino-3-picoline (58) (Aldrich). In step 1, the aminopicoline 58 was converted to the bromopicoline 59 by reaction with bromine, concentrated hydrobromic acid, and sodium nitrite at 0° C. In step 2, the picoline 59 was oxidized with KMNO4 to give the corresponding carboxylic acid 60. In step 3, the acid 60 was reduced to the alcohol 61 with borane/THF. In step 4, the alcohol 61 was oxidized to the aldelyde 62 under Swern conditions or by using MnO2. In step 5, the aldehyde 62 was reacted with hydroxylamine to give the oxime 63. In step 6, the oxime 63 was converted to 2-bromo-3-cyanopyridine (64) with acetic anhydride at reflux. In step 7, the nitrile 64 was coupled with 4-methylphenylboronic acid (56) (Scheme XXIV) using Snieckus conditions (Scheme XIII) to give 3-cyano-2-(4-methylphenyl)pyridine (65). In step 8, 65 was brominated with NBS/AIBN in carbon-tetrachloride at reflux to give the desired alkylating reagent 57. ##STR83##",oxime | 2-bromo-3-cyanopyridine | acetic anhydride | nitrile | 4-methylphenylboronic acid | 3-cyano-2-(4-methylphenyl)pyridine
US08354427B2,"To a stirred solution of N,N-dibenzyl-6-chloro-5-(trifluoromethyl)pyridin-2-amine (100 mg, 0.27 mmol) in THF (5 mL) was added freshly produced CH3ONa (42 mg, 0.78 mmol) at room temperature. The mixture was heated to reflux for 10 h and then cooled to the room temperature, diluted with water (5 mL) and extracted with CH2Cl2 (6 mL×3). The combined organic layers were dried over anhydrous Na2SO4, filtered and concentrated under vacuum. The residue was purified by silica gel column chromatography using 2%-10% EtOAc in petroleum ether as eluant to obtain N,N-dibenzyl-6-methoxy-5-(trifluoromethyl)pyridin-2-amine (90 mg, 91%). 1H NMR (400 MHz, CDCl3) δ 7.53 (d, J=8.4 Hz, 1H), 7.35-7.22 (m, 10H), 6.02 (d, J=8.4 Hz, 1H), 4.79 (s, 4H), 3.90 (s, 3H).","N,N-dibenzyl-6-chloro-5-(trifluoromethyl)pyridin-2-amine | THF | CH3ONa | water | CH2Cl2 | Na2SO4 | silica gel | N,N-dibenzyl-6-methoxy-5-(trifluoromethyl)pyridin-2-amine"
US07829585B2,"To a tetrahydrofuran (10 mL) solution of (5-benzyloxy-benzofuran-2-yl)-methanol (561 mg, 2.21 mmol) described in Production Example 7-1-4 were added phthalimide (358 mg, 2.43 mmol), triphenylphosphine (696 mg, 2.65 mmol) and diethylazodicarboxylate (1.21 mL, 2.65 mmol) at 0° C., which was stirred at room temperature for 9 hours. Water was added to the reaction solution at room temperature followed by extraction with ethyl acetate. The organic layer was washed with sat. NaCl followed by drying over anhydrous magnesium sulfate and filtering. The filtrate was concentrated under a reduced pressure and the residue was purified by NH silica gel column chromatography (heptane:ethyl acetate=7:3) to obtain the title compound (635 mg, 75%) as a white solid.",tetrahydrofuran | (5-benzyloxy-benzofuran-2-yl)-methanol | phthalimide | triphenylphosphine | diethylazodicarboxylate | Water | ethyl acetate | NaCl | magnesium sulfate | silica gel | heptane | ethyl acetate | title compound
US08436006B2,"A mixture of (3-propyl-6-{3-[(2,4,6-trimethyl-benzylamino)-methyl]-phenoxy}-3,4-dihydro-quinazolin-2-yl)-carbamic acid tert-butyl ester (0.00041 mol) in trifluoroacetic acid (1 mL) and DCM (10 mL) was stirred overnight at room temperature and the solvent was evaporated. The obtained residue was decomposed in diisopropyl ether/CH3CN, then the desired product was filtered off and dried to yield the title compound as a solid.","(3-propyl-6-{3-[(2,4,6-trimethyl-benzylamino)-methyl]-phenoxy}-3,4-dihydro-quinazolin-2-yl)-carbamic acid tert-butyl ester | trifluoroacetic acid | DCM | desired product | title compound"
US06005103,"The title compound was prepared from the condensation of the trimethylsilyl enol ether of 3-acetyl pyridine and diethyl ester of [(phenylmethyl)thio]propanedioic acid following the same procedure outlined in Method A; m.p. 183-184° C. NMR (DMSO-d6) δ4.02 (s, 2 H), 6.83 (s, 1 H), 7.20 (m, 1 H), 7.26 (d, 4 H), 7.55 (m, 1 H), 8.16 (m, 1 H), 8.69 (m, 1 H), 8.98 (d, 1 H).",title compound | trimethylsilyl enol ether | 3-acetyl pyridine | diethyl ester | [(phenylmethyl)thio]propanedioic acid
US06645957B2,"A 5N aqueous sodium hydroxide (2 ml; 10 mmol) was added to a solution in methanol (2 ml) of methyl 1,3-bis(1-[(E)-5-(3,4,5-trimethoxyphenyl)-2-penten-4-ynoyl]-4-piperidinyl]-2-propanecarboxylate (136 mg; 0.18 mmol) synthesized by the above process, and the mixture was stirred for 1 hour in a bath controlled at 65° C. The reaction mixture was made acidic by addition of 1N hydrochloric acid and extracted with chloroform. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate and then concentrated under reduced pressure. The resultant crude oil was purified by column chromatography on silica gel, thereby obtaining 46 mg (yield: 35%) of the title compound as a pale yellow amorphous powder.","sodium hydroxide | methanol | methyl 1,3-bis(1-[(E)-5-(3,4,5-trimethoxyphenyl)-2-penten-4-ynoyl]-4-piperidinyl]-2-propanecarboxylate | hydrochloric acid | chloroform | brine | sodium sulfate | silica gel | title compound"
US08901315B2,"To a solution of 765 mg (4.99 mmol) of trans-4-cyanocyclohexane carboxylic acid in 10 mL of tert-butanol was added 766 μL (5.49 mmol) of triethylamine and 1.13 mL (5.24 mmol) of diphenylphosphorylazide at room temperature, and the mixture was refluxed for 6 hours. After the reaction mixture was cooled to room temperature, ethyl acetate was added to this mixture and the organic layer was washed with saturated sodium bicarbonate aqueous solution, then, dried over with anhydrous sodium sulfate. The solvent was removed under reduced pressure and the residue was purified by silica gel column chromatography (eluent: hexane/ethyl acetate=2/1) to give 608 mg (54%) of the title compound.",trans-4-cyanocyclohexane carboxylic acid | tert-butanol | triethylamine | diphenylphosphorylazide | ethyl acetate | sodium bicarbonate | sodium sulfate | silica gel | hexane/ethyl acetate | title compound
US07157455B2,"The same procedure as described in Example 170 was used, starting from 4-amino-2-ethylsulfanyl-pyrimidine-5-carboxylic acid methoxy-methyl-amide (Example 1) and 4-fluoro-3-methylanisole (Aldrich), to give (4-amino-2-ethylsulfanyl-pyrimidin-5-yl)-(5-fluoro-2-methoxy-4-methyl-phenyl)-methanone as a white solid, MS (M+H)+, 322 and (4-amino-2-ethylsulfanyl-pyrimidin-5-yl)-(3-fluoro-6-methoxy-2-methyl-phenyl)-methanone as a white solid, MS (M+H)+, 322",4-amino-2-ethylsulfanyl-pyrimidine-5-carboxylic acid methoxy-methyl-amide | 4-fluoro-3-methylanisole | (4-amino-2-ethylsulfanyl-pyrimidin-5-yl)-(5-fluoro-2-methoxy-4-methyl-phenyl)-methanone | (4-amino-2-ethylsulfanyl-pyrimidin-5-yl)-(3-fluoro-6-methoxy-2-methyl-phenyl)-methanone
US07241885B2,"The reaction mixture containing imipenem obtained at step (d) Example 1 was stirred with dichloromethane (900 ml) maintaining pH between 7.0 to 8.0 and the aqueous layer separated. The aqueous portion was degassed to remove dichloromethane and given activated carbon treatment. The filtered aqueous solution was mixed with isopropanol (400 ml) and stirred at 5-10° C. for 3 hours. The crystalline product so obtained was filtered, washed with isopropropanol followed by acetone and dried at 35-40° C. for 1 hour to obtain crystalline imipenem monohydrate (9.0 g, purity 99% by HPLC).",imipenem | dichloromethane | dichloromethane | isopropanol | imipenem monohydrate
US06956129B2,"Thionyl chloride (36.9 g) was added dropwise at 40° C. to a solution of 3-(2,4-di-chlorophenyl)propionic acid (43.8 g) in methylene chloride (200 ml). After reaction was complete, excess thionyl chloride and the solvent were removed by distillation. The oily residue was added dropwise at 40° C. to a suspension of aluminium chloride (53.3 g) in methylene chloride (200 ml). The reaction mixture was added to dilute hydrochloric acid after 18 hours at 40° C. The aqueous phase was separated off and extracted once with methylene chloride (250 ml). The combined organic phases were freed from the solvent. The residue was recrystallized from cyclohexane. 30 g of a colorless solid (m.p.: 115-116° C.) were obtained.","Thionyl chloride | 3-(2,4-di-chlorophenyl)propionic acid | methylene chloride | thionyl chloride | aluminium chloride | methylene chloride | hydrochloric acid | methylene chloride | cyclohexane | colorless solid"
US07348339B2,"The product of example 100 (309 mg, 1 mmol), 4-methoxystyrene (167 uL, 1.25 mmol), palladium(II) acetate (12 mg, 0.05 mmol), o-tolyltriphenylphosphine (30 mg, 0.10 mmol) and triethylamine (349 uL, 2.5 mmol) were heated at 130° C. for 4 hours. The solution was partitioned between ethyl acetate and water, extracting with ethylacetate (×3). Combined extracts were washed with water (×3), brine, dried over anhydrous magnesium sulfate and concentrated to a crude solid, 450 mg, then purified by column chromatography eluting with 1:9:90.880 ammonia:ethanol:dichloromethane affording the title product, 176 mg (49%); MS (ES+) m/e 363 [M+H]+.",product | 4-methoxystyrene | palladium(II) acetate | o-tolyltriphenylphosphine | triethylamine | water | ethylacetate | ethylacetate | water | brine | magnesium sulfate | ammonia
US09198947B2,"A solution of Fmoc-Ala-Ala-OH (1 g, 2.61 mmol, Eq: 1.00) and (4-aminophenyl)methanol (483 mg, 3.92 mmol, Eq: 1.5) in THF (20 ml) was treated with EEDQ (970 mg, 3.92 mmol, Eq: 1.5). The solution was stirred over night at room temperature. The mixture was diluted with 10% 2-propanol/ethyl acetate (100 mL) and the solution was washed with KHSO4 5%/K2SO4 10% (2×), water (1×) and brine (1×), dried over MgSO4 and evaporated in vacuo. The residue was sonicated in diethyl ether for several minutes and the solid was collected by filtration to obtain the product (1.27 g, 1.2 mmol) as light brown solid. MS (ISP): (M+H) 488.3.",Fmoc-Ala-Ala-OH | (4-aminophenyl)methanol | THF | EEDQ | 2-propanol/ethyl acetate | KHSO4 | K2SO4 | water | brine | MgSO4 | diethyl ether | product
US20130324542A1,"All used starting materials, reagents and preparation method were the same as those used in step 7 of Example 1, except that 6-phenyl-3-(6-quinolylacetylhydrazino)-1,2,4-triazine (VIII-1) was replaced with 6-phenyl-3-(4-quinolyloxyacetylhydrazino)-1,2,4-triazine (VIII-46). As a result, compound II-21 was obtained as white solid.","6-phenyl-3-(6-quinolylacetylhydrazino)-1,2,4-triazine | 6-phenyl-3-(4-quinolyloxyacetylhydrazino)-1,2,4-triazine"
US09328106B2,"Following the procedure for Example 101 starting from tert-butyl ((3S,4R,7S)-7-(4-(2-bromothiazole-4-carboxamido)-1-methyl-1H-pyrazol-5-yl)-3-fluorooxepan-4-yl)carbamate (Intermediate 99), and replacing 3,6-dihydro-2H-pyran-4-boronic acid pinacol ester with 1,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole gave 242. 1H NMR (400 MHz, DMSO-d6) δ 9.61 (s, 1H), 8.24 (s, 1H), 7.95 (s, 1H), 7.83 (s, 1H), 4.84 (dd, J=10.6, 3.8 Hz, 1H), 4.55-4.32 (m, 1H), 4.28-4.14 (m, 1H), 4.13-3.94 (m, 1H), 3.81 (s, 3H), 3.78 (s, 3H), 3.29-3.16 (m, 1H), 2.61 (s, 3H), 2.12-2.02 (m, 1H), 1.91-1.78 (m, 1H), 1.75-1.64 (m, 4H). LCMS (ES+) m/z 434 (M+1).","tert-butyl ((3S,4R,7S)-7-(4-(2-bromothiazole-4-carboxamido)-1-methyl-1H-pyrazol-5-yl)-3-fluorooxepan-4-yl)carbamate | Intermediate 99 | 1,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | 242"
US20150148340A1,"5.70 g (18.4 mmol) of the compound from Example 109A were first hydrogenated analogously to Example 105A with palladium (10% on carbon) under standard hydrogen pressure. Monitoring the reaction by means of LC-MS showed no reduction of the double bond, but about 25% debromination. The hydrogenation was stopped, the catalyst was filtered off and the solvent was removed on a rotary evaporator. The reactant thus re-covered (5.0 g) was heated in 30 ml of toluene with 87 mg (0.16 mmol) of [Rh{(S,S)-Phebox-iPr}(OAc)2].H2O (preparation: see H. Nishiyama et al, Chem. Eur. J. 2006, 12 (1), 63-71, Example 3a) to 60° C. and admixed at this temperature with 3.89 ml (24.26 mmol) of methyldiethoxysilane. The mixture was stirred further at 60° C. for 4 h, then at reflux temperature overnight. After cooling to RT, the mixture was admixed with 50 ml of 1N hydrochloric acid and extracted with 150 ml of ethyl acetate. The organic phase was washed twice with water, twice with a saturated sodium hydrogencarbonate solution and once with a saturated sodium chloride solution, dried over sodium sulphate and concentrated on a rotary evaporator. The residue corresponded to the title compound in about 80% purity (5.84 g, 93% of theory) and was converted further without purification.","compound | palladium | toluene | Rh{(S,S)-Phebox-iPr}(OAc)2 | methyldiethoxysilane | hydrochloric acid | ethyl acetate | water | sodium hydrogencarbonate | sodium chloride | sodium sulphate"
US05958910,"A mixture of 0.5 g of 4-(3,4-dichloro-phenyl)-thiazol-2-ylamine hydrobromide with 0.50 g of p-toluenesulfonyl chloride was stirred overnight with 2 ml of pyridine. The resulting, red colored suspension was poured into 30 ml of 1N hydrochloric acid and the solid which thereby separated was filtered off and dissolved in a mixture of 20 ml of ethanol and 20 ml of 2N sodium hydroxide solution. After the addition of 0.4 g of active charcoal the mixture was stirred at room temperature for 30 minutes and subsequently the active charcoal was filtered off. 0.33 g of N-[4-(3,4-dichloro-phenyl)-thiazol-2-yl]-4-methyl-benzenesulfonamide was obtained as colorless crystals upon neutralization with concentrated hydrochloric acid.","4-(3,4-dichloro-phenyl)-thiazol-2-ylamine hydrobromide | p-toluenesulfonyl chloride | pyridine | hydrochloric acid | ethanol | sodium hydroxide | charcoal | charcoal | N-[4-(3,4-dichloro-phenyl)-thiazol-2-yl]-4-methyl-benzenesulfonamide | hydrochloric acid"
US06703392B2,"prepared by reaction of 1-(3,4-Dimethoxy-benzyl)-6-methoxy-7-isopropoxy-1,2,3,4-tetrahydroisoquinoline and 2-bromoacetyl bromide with 2-ethoxy-benzylamine","1-(3,4-Dimethoxy-benzyl)-6-methoxy-7-isopropoxy-1,2,3,4-tetrahydroisoquinoline | 2-bromoacetyl bromide | 2-ethoxy-benzylamine"
US08546359B2,"Trifluoromethanesulfonic anhydride (0.144 mL, 0.000859 mol) was slowly added to a solution containing (R)-4-(6-hydroxynaphthalen-2-yl)-4-methyloxazolidin-2-one (190 mg, 0.00078 mol), pyridine (2 mL, 0.02 mol), and methylene chloride (2 mL, 0.03 mol) at 0° C. After stirring overnight TLC showed complete reaction. After concentration, the crude was purified by chromatography using a 0-100% EtOAc/hexane gradient to give (R)-6-(4-methyl-2-oxooxazolidin-4-yl)naphthalen-2-yl trifluoromethanesulfonate as a yellow gel (259 mg, 88%). 1H NMR (400 MHz, CDCl3-d) δ=7.95 (s, 1H), 7.94-7.89 (m, 2H), 7.77 (d, J=1.9 Hz, 1H), 7.59 (dd, J=1.6, 8.6 Hz, 1H), 7.42 (d, J=9.0 Hz, 1H), 4.48 (d, J=8.4 Hz, 1H), 4.43 (d, J=8.4 Hz, 1H), 1.88 (s, 3H).",Trifluoromethanesulfonic anhydride | (R)-4-(6-hydroxynaphthalen-2-yl)-4-methyloxazolidin-2-one | pyridine | methylene chloride | (R)-6-(4-methyl-2-oxooxazolidin-4-yl)naphthalen-2-yl trifluoromethanesulfonate
US20150166486A1,"To a solution of methyl trans-4-{1-[5-(3-{[4-(difluoromethyl)pyrimidin-2-yl]amino}-5-methylphenyl)pyrimidin-2-yl]ethyl}cyclohexanecarboxylate (isomer 1) (20 mg, 0.042 mmol) in THF (2 mL) and water (0.5 mL) was added lithium hydroxide (3.0 mg, 0.12 mmol), and the mixture was stirred for 8 hours at 60° C. After cooling to room temperature, the mixture was adjusted to pH 2 by adding 1 M aqueous hydrochloric acid, diluted with brine, and extracted with ethyl acetate (3×100 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by prep-TLC (ethyl acetate/petroleum ether) to give trans-4-{1-[5-(3-{ [4-(difluoromethyl)pyrimidin-2-yl]amino}-5-methylphenyl)pyrimidin-2-yl]ethyl}cyclohexanecarboxylic acid, isomer 1 (example 6.1). MS ESI calc'd for C25H28F2N5O2 [M+H]+ 468. found 468. 1H NMR: (400 MHz, DMSO-d6) δ 10.08 (s, 1H), 8.99 (s, 2H), 8.74-8.73 (m, 1H), 8.02 (s, 1H), 7.61 (s, 1H), 7.24 (s, 1H), 7.10-7.09 (m, 1H), 6.91 (t, J=54 Hz, 1H), 2.84-2.80 (m, 1H), 2.37 (s, 3H), 2.13-2.07 (m, 1H), 1.96-1.81 (m, 3H), 1.73-1.71 (m, 1H), 1.36-1.06 (m, 8H).",methyl trans-4-{1-[5-(3-{[4-(difluoromethyl)pyrimidin-2-yl]amino}-5-methylphenyl)pyrimidin-2-yl]ethyl}cyclohexanecarboxylate | THF | water | lithium hydroxide | hydrochloric acid | brine | ethyl acetate | sodium sulfate | ethyl acetate/petroleum ether | trans-4-{1-[5-(3-{ [4-(difluoromethyl)pyrimidin-2-yl]amino}-5-methylphenyl)pyrimidin-2-yl]ethyl}cyclohexanecarboxylic acid
US20150274663A1,"To a mixture of 3-(3-(octyloxy)phenyl)pyridine (500 mg, 1.8 mmol, 1.0 eq) and conc. HCl (cat) in MeOH (3 mL) was added PtO2(43 mg, 0.18 mmol, 0.1 eq). The mixture was purged with H2 for three times and then stirred at rt for 5 h. The mixture was then filtered, and the filtrate was concentrated in vacuo to give the title compound as a colorless oil (400 mg, 78% yield). LCMS m/z 290.1 [M+H]+.",3-(3-(octyloxy)phenyl)pyridine | HCl | MeOH | PtO2 | H2 | title compound
US08729269B2,"The title compound was prepared by reacting (S)—N-{3-[4-(1,4-dioxa-8-aza-spiro[4.5]dec-8-yl)-3-fluorophenyl]-2-oxo-oxazolidin-5-ylmethyl}-amine (0.2 mmol, Example I) with acetyl chloride (2.1 mmol), n-butyl lithium (0.2 mmol) in tetrahydrofuran at a temperature 0-25° C. for 3 hours followed by silica gel column chromatographic purification in % yield.","title compound | (S)—N-{3-[4-(1,4-dioxa-8-aza-spiro[4.5]dec-8-yl)-3-fluorophenyl]-2-oxo-oxazolidin-5-ylmethyl}-amine | acetyl chloride | n-butyl lithium | tetrahydrofuran | silica gel"
US07858644B2,"A degassed mixture of 5-methyl-4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxymethyl]-furan-2-carboxylic acid methyl ester (119) (200 mg, 0.54 mmoles), 4-difluoromethoxy-1-iodo-benzene (175 mg, 0.65 mmoles), 2M aqueous cesium carbonate (0.81 ml) and), [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with dichloromethane (1:1) (20 mg) in 1,4-dioxan (10 ml), under an argon atmosphere was heated at 80° C. for 20 h. Further quantities of 4-difluoromethoxy-1-iodo-benzene (87.5 mg, 0.0.27 mmoles) and [1,1′-bis(diphenylphosphino) ferrocene]dichloropalladium(II) complex with dichloromethane (1:1) (10 mg) were added and heating at 80° C. was continued for 4 hours. After cooling, the mixture was concentrated. The residue was dissolved in dichloromethane and washed with water and brine, and dried. The solvent was evaporated and the residue was purified by flash chromatography using petrol (40-60°)/diethyl ether 9:1 v/v as eluent to afford compound 128 (120 mg) as a wax. LC/MS System A; Rt=4.14 mins.","5-methyl-4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxymethyl]-furan-2-carboxylic acid methyl ester | 4-difluoromethoxy-1-iodo-benzene | cesium carbonate | [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) | [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) | dichloromethane | 1,4-dioxan | argon | 4-difluoromethoxy-1-iodo-benzene | dichloromethane | dichloromethane | water | brine | petrol | diethyl ether | compound 128"
US08952166B2,"Into a 10000-mL 4-necked round-bottom flask was placed a solution of ethyl 1-benzyl-4-(cyanomethyl)-3-oxopiperidine-4-carboxylate (180 g, 599.30 mmol) in acetic acid/methanol (1:1, 5.4 L) and platinum oxide (27 g, 118.90 mmol). The flask was then flushed and charged with hydrogen and stirred overnight at room temperature. After filtration under nitrogen through CELITE®, the filtrate was concentrated under vacuum to give the title compound.",ethyl 1-benzyl-4-(cyanomethyl)-3-oxopiperidine-4-carboxylate | acetic acid/methanol | platinum oxide | hydrogen | nitrogen | title compound
US07205408B2,"A solution of 6-fluoro-2,3-dihydro-benzo[1,4]dioxine (prepared from 6-amino-2,3-dihydro-benzo[1,4]dioxine according to the procedure of V. Daukas, P. Gaidelis, R. Martinkus, S. Urboniene, Chemija, 1999, 10 (1), 59), (154 mg, 1 mmol) in dichloromethane (0.5 ml) was treated with dichloromethyl methyl ether (0.25 ml) at 0° C. under argon. Titanium tetrachloride (0.45 ml) in dichloromethane (0.5 ml) was added over 0.25 hours. The cooling bath was removed and the mixture was stirred at ambient temperature for 1 hour before being quenched with water and extracted with ether. The ether extract was washed with aqueous sodium bicarbonate and brine. Drying and evaporation afforded a brown oil which was purified by chromatography on silica (ethyl acetate/hexane) affording a clear oil (0.12 g).","6-fluoro-2,3-dihydro-benzo[1,4]dioxine | 6-amino-2,3-dihydro-benzo[1,4]dioxine | V | (1) | dichloromethane | dichloromethyl methyl ether | ether | argon | Titanium tetrachloride | dichloromethane | water | ether | sodium bicarbonate | brine | oil | silica | ethyl acetate/hexane"
US04510086,"A solution of lithium hexamethyldisilazide was prepared by the addition of 32.9 ml of a 1.6M solution of n-butyllithium in hexane to 11.25 ml of hexamethyldisilazane in 125 ml of dry THF at -10° with stirring, under argon. The solution was cooled to -78° and added to 5.0 g of methyl 2-(4-allylthioazetidin-2-on-1-yl) acetate in 60 ml of dry tetrahydrofuran at -78°, with stirring, under argon. After 5 min, 4.23 ml of carbon disulphide was added by syringe. 885 ml of acetic anhydride were then added. The solution was allowed to warm to room temperature and evaporated to leave a yellow oil.",lithium hexamethyldisilazide | n-butyllithium | hexane | hexamethyldisilazane | THF | argon | methyl 2-(4-allylthioazetidin-2-on-1-yl) acetate | tetrahydrofuran | argon | carbon disulphide | acetic anhydride
US20150073136A1,"To a stirred solution of 3-(3,5-dibromo-2-oxo-2H-pyrazin-1-yl)-4-methyl-benzoic acid, methyl ester (Example 1 b, 0.2 g) in tetrahydrofuran (3 mL) within a microwave vial was added triethylamine (76 μL) and benzylamine (64 mg). The reaction was stirred overnight before the addition of cyclopropylamine (0.22 mL) and iso-propylmagnesium chloride (2M in tetrahydrofuran, 1.5 mL) dropwise. After stirring for 30 minutes, ethanol (2 mL), formic acid (0.4 mL) and 10% palladium on carbon (30 mg) were added. The reaction mixture was heated within a microwave for 60 minutes at 110° C. before being cooled to room temperature, filtered and washed with ethanol. The filtrate was concentrated in vacuo. Purification by preparative HPLC (Gemini column, 0.1% ammonia: acetonitrile eluent) afforded the title compound (80 mg).","3-(3,5-dibromo-2-oxo-2H-pyrazin-1-yl)-4-methyl-benzoic acid, methyl ester | tetrahydrofuran | triethylamine | benzylamine | cyclopropylamine | iso-propylmagnesium chloride | ethanol | formic acid | palladium on carbon | ethanol | ammonia | acetonitrile | title compound"
US04666923,"A solution of 3.9 g. (0.038 mol) potassium nitrate in 30 ml. concentrated sulphuric acid is added dropwise, while cooling, to a solution of 13 g. (0.038 mol) 3-ethoxycarbonyl-3-methyl-6-(4-pyridinoylamino)-indolin-2-one in 90 ml. concentrated sulphuric acid. The reaction mixture is further stirred for about 1 hour, poured on to ice, adjusted to pH 8 with a concentrated aqueous solution of ammonia, while cooling, and the crystals obtained are filtered off with suction and recrystallised from ethanol/methylen chloride. Yield: 12.81 g. (82% of theory); m.p. 217°-219° C.",potassium nitrate | sulphuric acid | 3-ethoxycarbonyl-3-methyl-6-(4-pyridinoylamino)-indolin-2-one | sulphuric acid | ice | ammonia | ethanol/methylen chloride
US04548932,"To a solution of tert-butyl 3(S)-[7-(1-benzyloxycarbonyl-4-piperidyl)-1(S)-ethoxycarbonylheptyl]amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-5-acetate (0.35 g) in acetic acid (1.5 ml) is added 30% hydrogen bromide-acetic acid solution (1.5 ml). The resulting mixture is allowed to stand for 0.5 hour at room temperature and then diluted with ethyl ether (100 ml). The supernatant layer is removed by decantation and the precipitate is dissolved in 1N sodium hydroxide solution (10 ml). The solution is allowed to stand for 30 minutes at room temperature. After addition of acetic acid (2 ml), the mixture is chromatographed on MCI gel using water-methanol (1:1) as an eluent. The eluate is concentrated in vacuo and lyophilized to give 3(S)-[1(S)-carboxy-7-(4-piperidyl)heptyl]amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-5-acetic acid (0.15 g) as colorless powder.","tert-butyl 3(S)-[7-(1-benzyloxycarbonyl-4-piperidyl)-1(S)-ethoxycarbonylheptyl]amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-5-acetate | acetic acid | hydrogen bromide-acetic acid | acetic acid | ethyl ether | sodium hydroxide | 3(S)-[1(S)-carboxy-7-(4-piperidyl)heptyl]amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-5-acetic acid"
US20160060273A1,"Using tert-butyl 7-(4-(ethoxycarbonyl)-4-methylpiperidin-1-yl)-5-oxa-2,6-diazaspiro[3.4]oct-6-ene-2-carboxylate and 5-bromo-2-ethoxy-4′-fluorobiphenyl-4-carbaldehyde, the title compound was obtained in the similar manner as in Step G of Example 1.","tert-butyl 7-(4-(ethoxycarbonyl)-4-methylpiperidin-1-yl)-5-oxa-2,6-diazaspiro[3.4]oct-6-ene-2-carboxylate | 5-bromo-2-ethoxy-4′-fluorobiphenyl-4-carbaldehyde | title compound"
US07687529B2,"1-[(1S)-3-hydroxy-1-phenylpropyl]-3,3-dimethyl-1,3-dihydro-2H-indol-2-one (1.2 g, 4.1 mmol) was dissolved in pyridine (5 mL) and toluenesufonyl chloride (0.84 g, 4.4 mmol) was added. Stirred for 16 hours then the reaction mixture was diluted with ethyl acetate and washed with water, 2N hydrochloric acid, saturated copper sulfate, 2N hydrochloric acid, and saturated brine. The organic layer was separated, dried over anhydrous magnesium sulfate, filtered, and concentrated in vacuo. A portion of the crude product (100 mg, 0.21 mmol) was immediately dissolved in methylamine (8M in ethanol, 10 mL) and stirred for 16 hours. The mixture was concentrated in vacuo and purified via chromatography (silica, 0-15% methanol saturated with ammonia in chloroform) to give 3,3-dimethyl-1-[(1R)-3-(methylamino)-1-phenylpropyl]-1,3-dihydro-2H-indol-2-one as a colorless oil. The freebase was dissolved in ether (5 mL) and treated with 1N hydrochloric acid in ether (1.0 equivalent). The white precipitate was collected and dried under vacuum to give 44 mg 3,3-dimethyl-1-[(1R)-3-(methylamino)-1-phenylpropyl]-1,3-dihydro-2H-indol-2-one hydrochloride.","1-[(1S)-3-hydroxy-1-phenylpropyl]-3,3-dimethyl-1,3-dihydro-2H-indol-2-one | pyridine | toluenesufonyl chloride | ethyl acetate | water | hydrochloric acid | copper sulfate | hydrochloric acid | brine | magnesium sulfate | crude product | methylamine | silica | methanol | ammonia | chloroform | 3,3-dimethyl-1-[(1R)-3-(methylamino)-1-phenylpropyl]-1,3-dihydro-2H-indol-2-one"
US07176316B2,"The title compound, MS (ISP): m/e=485.4 (M+H+), was prepared as for example 98, steps (A) to (F). Step (A) was performed using 3-methoxy-aniline, and yielded 4-(3-methoxy-phenylamino)-piperidine-1-carboxylic acid tert-butyl ester which was acylated with benzoyl chloride to 4-[benzoyl-(3-methoxy-phenyl)-amino]-piperidine-1-carboxylic acid tert-butyl ester (B). This was then deprotected to N-(3-methoxy-phenyl)-N-piperidin-4-yl-benzamide (C), and reacted with cyclohexene oxide to gave (+/−)-N-[trans-1-(2-hydroxy-cyclohexyl)-piperidin-4-yl]-N-(3-methoxy-phenyl)-benzamide [step (D)]. Oxidation to (+/−)-N-(3-methoxy-phenyl)-N-[1-(2-oxo-cyclohexyl)-piperidin-4-yl]-benzamide in step (E) and reaction with phenyl lithium [step (F)] led to the title compound of the example.",benzoyl chloride | 4-[benzoyl-(3-methoxy-phenyl)-amino]-piperidine-1-carboxylic acid tert-butyl ester | N-(3-methoxy-phenyl)-N-piperidin-4-yl-benzamide | cyclohexene oxide | (+/−)-N-[trans-1-(2-hydroxy-cyclohexyl)-piperidin-4-yl]-N-(3-methoxy-phenyl)-benzamide
US06737418B2,"To a solution of 3-(4-phenoxyphenyl)-1H-pyrazole (125 mg, 0.529 mmol) in pyridine (10 mL) at room temperature was added neat methanesulfonyl chloride (50 μL, 0.64 mmol). After stirring overnight at room temperature, the reaction was diluted with water. Column chromatography afforded 152 mg (91%) of the title compound as white solid, mp 136° C. 1H NMR (CDCl3): δ 8.06 (d, J=3.0 Hz, 1H), 7.84 (d, J=8.7 Hz, 2H), 7.37 (t, J=8.7 Hz, 2H), 7.14 (t, J=7.5 Hz, 1H)), 7.06 (d, J=8.7 Hz, 2H), 7.06-7.04 (m, 2H), 6.72 (d, J=3.0 Hz, 1H), 3.38 (s, 3H).",3-(4-phenoxyphenyl)-1H-pyrazole | pyridine | methanesulfonyl chloride | water | title compound
US20070155805A1,"To a solution of ethyl [4-({3-[3-methyl-6-(trifluoromethyl)-1-benzothien-2-yl]heptyl}oxy)phenyl]acetate (45 mg, 0.09 mmol) in MeOH (2 mL) and THF (2 mL) was added 2M sodium hydroxide (0.2 mL). After shaking for 3 h at 20° C., further 2M sodium hydroxide (0.2 mL) was added and the mixture was shaken for a further 1 h. The solvent was evaporated and the residue was diluted with water (4 mL), acidified with 2M HCl and extracted with EtOAc (2×3 mL). The organic extracts were filtered through a hydrophobic frit, evaporated to dryness, and purified through a 5 g silica SPE cartridge, eluting with DCM and EtOAc to afford the title compound as a colourless oil (17 mg). 1H NMR (400 MHz; DMSO-d6) δ: 0.81 (3H, t, J=7 Hz), 1.07-1.35 (4H, m), 1.63 (1H, m), 1.82 (1H, m), 1.90 (1H, m), 2.23 (1H, m), 2.28 (3H, s), 3.45 (2H, s), 3.50 (1H, m), 3.67 (1H, m), 3.90 (1H, m), 6.80 (2H, d, J=8 Hz), 7.11 (2H, d, J=8 Hz), 7.64 (1H, d, J=8 Hz), 7.85 (1H, d, J=8 Hz), 8.39 (1H, s), 12.3 (1H, s); LC/MS: m/z 463 [M−H]−, Rt 4.33 min.",ethyl [4-({3-[3-methyl-6-(trifluoromethyl)-1-benzothien-2-yl]heptyl}oxy)phenyl]acetate | MeOH | THF | sodium hydroxide | sodium hydroxide | water | EtOAc | silica | DCM | EtOAc | title compound
US20090118276A1,"A mixture of 4-chlorothieno[2,3-d]pyrimidine-6-carboxylic acid (1.22 g, 5.7 mmol) and oxalyl chloride (3 mL, 34.4 mmol) in methylene chloride (35 mL) was heated under reflux for 3.5 hours. The reaction mixture was cooled and evaporated to dryness, and the residue was evaporated twice from toluene. The residue was dissolved in methylene chloride, filtered, and filtrate was evaporated to dryness to yield 1.23 g (95%) of title compound as a white solid which was used as is in the next step.","4-chlorothieno[2,3-d]pyrimidine-6-carboxylic acid | oxalyl chloride | methylene chloride | toluene | methylene chloride | title compound"
US20110318266A1,"To a solution of 4-nitroaniline (1.00 g, 7.24 mmol) in glacial acetic acid (20 mL) was added phthalic anhydride (1.49 g, 7.24 mmol). This solution was stirred at 100° C. for 5 h, and then concentrated. The residue was crystallized in MeOH (10 mL) to give the title product (1.28 g, 65%). 1H NMR (500 MHz, DMSO) δ 8.41 (d, J=9.0 Hz, 2H); 8.03 (dd, J=5.6, 2.9 Hz, 2H); 7.95 (dd, J=5.1, 3.4 Hz, 2H); 7.81 (d, J=9.3 Hz, 2H) ppm.",4-nitroaniline | acetic acid | phthalic anhydride | MeOH | title product
US07019030B2,"To a solution of 3,4-dimethoxy-3′-nitrobenzophenone (0.5 g, 1.7 mmol) in 40 mL of ethyl acetate was added 0.05 g of 10% palladium on carbon catalyst. The mixture was hydrogenated in a Parr-Shaker apparatus at 55–60 psi of hydrogen for 1.5 hours. The reaction mixture was filtered through celite and the filtrate was concentrated in vacuo to afford the crude product. The crude product was purified by flash column chromatography (silica gel, 10% ethyl acetate/methylene chloride) to afford 0.17 g (38%) of the product as a yellow solid: mp 157–175° C.; 1H NMR (CDCl3) δ 7.56–6.80 (m, 7H); 3.95 (s, 3H), 3.94 (s, 3H); 13C NMR (CDCl3) δ 195.7, 152.9, 148.9, 146.4, 139.3, 130.3, 128.9, 125.4, 120.1, 118.4, 115.6, 112.1, 109.7, 56.0, 56.0; Anal. Calcd for C15H15NO3 . Theoretical: C, 70.02; H, 5.88; N, 5.44. Found: C, 70.00; H, 6.10; N, 5.13.","3,4-dimethoxy-3′-nitrobenzophenone | ethyl acetate | palladium on carbon | hydrogen | crude product | product | crude product | silica gel | ethyl acetate/methylene chloride"
US07115619B2,"(Method H-2) (Cyclisation) 2,2-Dimethyl-N-[2-(10-methyl-9-oxo-9,10-dihydro-acridin-1-yl)-phenyl]-propionamide, 25 (50 mg, 0.13 mmol) was dissolved in 1:1 THF/6N HCl (20 mL) and the mixture heated to reflux for 5 days giving a bright orange solution. The mixture was basified (aq. Na2CO3) and extracted with ethyl acetate (50 mL) and the organic layer dried (Na2SO4), and evaporated under reduced pressure. The crude product was purified by column chromatography (1:4 EtOAc: hexane) to give the title compound as a yellow solid (35 mg, 0.12 mmol, 95%).","2,2-Dimethyl-N-[2-(10-methyl-9-oxo-9,10-dihydro-acridin-1-yl)-phenyl]-propionamide | 25 | THF | Na2CO3 | ethyl acetate | Na2SO4 | crude product | EtOAc | hexane | title compound"
US08680159B2,"Benzyl 1-(6-(dimethylamino)pyridin-3-yl)piperidin-4-yl(methyl)carbamate (400 mg, 1.086 mmol, 1.0 eq.) was dissolved in MeOH (10 ml) and degassed with argon. Pd(OH)2 (200 mg) was then added and hydrogenation was carried out for 3 hours. After monitoring by TLC, the reaction mixture was filtered over Celite, the filtrate was concentrated under reduced pressure and the crude product was used in the next stage without being purified further. Yield: 94% (240 mg, 1.0212 mmol)",Benzyl 1-(6-(dimethylamino)pyridin-3-yl)piperidin-4-yl(methyl)carbamate | MeOH | argon | Pd(OH)2
US05587378,"Substantially the same procedure as in Example 7 was repeated using 2.5 g (12.6 mmol) of 5,6-diamino-1,3-diethyluracil and 2.3 g (13.9 mmol) of 2,3,4-trimethoxycinnamic acid. Then, the resultant crude crystals were recrystallized from dioxane/water to give 2.85 g (yield 57% of Compound 70 as white crystals.","5,6-diamino-1,3-diethyluracil | 2,3,4-trimethoxycinnamic acid | dioxane/water | Compound 70"
US08188101B2,"2-((2-(4-(1-Methyl-1H-pyrazol-4-yl)phenylamino)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)(phenyl)amino)ethanol (40 mg, 0.09 mmol, Example 38a) was dissolved in methanol (2 mL). Acetic acid (1.037 μL, 0.02 mmol) was added followed by propionaldehyde (0.013 mL, 0.18 mmol). The reaction mixture was stirred for 30 minutes at room temperature before sodium cyanoborohydride (11.39 mg, 0.18 mmol) was added. The solvent was evaporated under reduced pressure, the crude dissolved in few drops of dimethylformamide and acetonitrile, filtered and purified by preparative HPLC yielding 2-((2-(4-(1-methyl-1H-pyrazol-4-yl)phenylamino)-6-propyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)(phenyl)amino)ethanol (7.6 mg, 15.4%) as acetic acid salt.","2-((2-(4-(1-Methyl-1H-pyrazol-4-yl)phenylamino)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)(phenyl)amino)ethanol | methanol | Acetic acid | propionaldehyde | sodium cyanoborohydride | dimethylformamide | acetonitrile | 2-((2-(4-(1-methyl-1H-pyrazol-4-yl)phenylamino)-6-propyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)(phenyl)amino)ethanol | acetic acid"
US04335127,"To 5 parts of magnesium are added 2.18 parts of 1,2-dibromoethane and a small amount of iodine to initiate the reaction. Then there is added dropwise a solution of 28 parts of 4-chloro-1-methylpiperidine in 180 parts of tetrahydrofuran while the mixture is heated to 70° C. After cooling, there is added dropwise a solution of 14 parts of 3-methylbenzonitrile in 90 parts of tetrahydrofuran. Upon completion, stirring is continued for 1 hour at reflux temperature. The reaction mixture is cooled and poured onto a solution of 75 parts of ammonium chloride in water. The product is extracted with 2,2'-oxybispropane. The extract is washed with water, dried, filtered and evaporated, yielding 35 parts of (3-methylphenyl) (1-methyl-4-piperidinyl)methanone as an oily residue.","magnesium | 1,2-dibromoethane | iodine | 28 | 4-chloro-1-methylpiperidine | tetrahydrofuran | 14 | 3-methylbenzonitrile | tetrahydrofuran | 75 | ammonium chloride | water | 2,2'-oxybispropane | water | 35 | (3-methylphenyl) (1-methyl-4-piperidinyl)methanone"
US08324252B2,"A mixture of 3,6-dichloro-N-(5-isopropoxy-1H-pyrazol-3-yl)-5-nitropyridin-2-amine (Method 27, 0.25 g, 0.75 mmol), (s)-1-(4-fluoro-phenyl)-ethylamine (0.13 g, 0.90 mmol) and DIEA (0.16 ml, 0.94 mmol) in n-BuOH (3 ml) was heated in a sealed tube at 145° C. for 2 hours. The solvent was removed under reduced pressure and the residue was purified by column chromatography (hexane-EtOAc=1:1) to give the title compound as a yellow solid (0.32 g, 98%). 1H NMR (400 MHz) δ 12.22 & 11.40 (s, 1H), 9.74 & 9.37 (s, 1H), 8.93 (d, J=7.6 Hz, 1H), 8.33 & 8.27 (s, 1H), 7.34 & 7.27 (m, 2H), 7.12 & 7.05 (m, 2H), 5.75 & 5.62 (s, 1H), 5.35 & 5.25 (m, 1H), 4.66 & 4.03 (m, 1H), 1.55 (d, J=6.4 Hz, 3H), 1.29 (d, J=6.0 Hz, 6H). MS: Calcd.: 434. Found: [M+H]+ 435.","3,6-dichloro-N-(5-isopropoxy-1H-pyrazol-3-yl)-5-nitropyridin-2-amine | (s)-1-(4-fluoro-phenyl)-ethylamine | DIEA | n-BuOH | hexane-EtOAc | title compound"
US06087380,"Prepared analogously to Example 1 from 2-[2-(4-cyanophenyl)ethyl]-3-methyl-6-(2-methoxycarbonyl-2,3-dihydroindol-1-yl-carbonyl)-imidazo[4,5-b]pyridine, methanolic hydrochloric acid, methanol and ammonium carbonate. Yield: 20% of theory, C27H26N6O3 (482.54) Rf value: 0.30 (silica gel; ethyl acetate/ethanol/ammonia=50:45:5) EKA mass spectrum: (M+H)+ =483","2-[2-(4-cyanophenyl)ethyl]-3-methyl-6-(2-methoxycarbonyl-2,3-dihydroindol-1-yl-carbonyl)-imidazo[4,5-b]pyridine | hydrochloric acid | methanol | ammonium carbonate | C27H26N6O3 | ethyl acetate/ethanol/ammonia"
US08980877B2,"(−)-(E)-3-[1′-Benzyl-4-oxo-spiro(chromane-2,3′-piperidine)-6-yl]-acrylic acid methyl ester (525 mg, 1.34 mmol) was hydrolyzed with 1 M NaOH following the experimental procedure described for Example 16 STEP B, to give (−)-(E)-3-[1′-benzyl-4-oxo-spiro(chromane-2,3′-piperidine)-6-yl]-acrylic acid (435 mg).","(−)-(E)-3-[1′-Benzyl-4-oxo-spiro(chromane-2,3′-piperidine)-6-yl]-acrylic acid methyl ester | NaOH | (−)-(E)-3-[1′-benzyl-4-oxo-spiro(chromane-2,3′-piperidine)-6-yl]-acrylic acid"
US20130090323A1,"N-(5-bromo-2-morpholinopyridin-4-yl)-5,7-difluoro-3-methyl-2-(pyridin-2-yl)quinolin-4-amine (41.8 mg, 0.082 mmol), 3-cyanophenylboronic acid (18.7 mg, 0.13 mmol), tris(dibenzylideneacetone)dipalladium (0) (6.4 mg, 7 μmol), and tricyclohexylphosphine (3.8 mg, 0.014 mmol) were added to a flask then degassed and backfilled with argon. To the flask, 1,4-dioxane (2.0 mL) and aq. 1.3M potassium phosphate tribasic (0.19 mL, 0.25 mmol) were added by syringe. The resulting reaction was heated to 90° C. and monitored with TLC and LC-MS. After 19 h, the reaction was cooled to rt then poured into water. After extracting twice with EtOAc and twice with DCM, the combined organic extractions were dried over anhydrous magnesium sulfate. After filtration and concentration, the residue was purified on silica gel (0-45% of a premixed solution of 89:9:1 DCM: MeOH: ammonium hydroxide in DCM) to afford a film that was triturated with MeOH to afford a white solid as 3-(4-(5,7-difluoro-3-methyl-2-(pyridin-2-yl)quinolin-4-ylamino)-6-morpholinopyridin-3-yl)benzonitrile. 1H NMR (500 MHz, DMSO-d6) δ ppm 9.00 (1H, d, J=5.4 Hz), 8.55 (1H, t, J=7.8 Hz), 8.28 (1H, d, J=7.8 Hz), 8.01 (1H, t, J=6.5 Hz), 7.93 (3H, m), 7.81 (3H, m), 7.54 (1H, ddd, J=12.0, 9.4, 2.1 Hz), 5.81 (1H, s), 3.73 (4H, m), 3.46 (4H, m), 2.35 (3H, s). Mass Spectrum (pos.) m/e: 535.2 (M+H)+.","N-(5-bromo-2-morpholinopyridin-4-yl)-5,7-difluoro-3-methyl-2-(pyridin-2-yl)quinolin-4-amine | 3-cyanophenylboronic acid | tris(dibenzylideneacetone)dipalladium | tricyclohexylphosphine | 1,4-dioxane | potassium phosphate tribasic | water | EtOAc | DCM | magnesium sulfate | silica gel | premixed solution | DCM | MeOH | ammonium hydroxide | DCM | MeOH | 3-(4-(5,7-difluoro-3-methyl-2-(pyridin-2-yl)quinolin-4-ylamino)-6-morpholinopyridin-3-yl)benzonitrile"
US09115114B2,"For about 3 min, N2 was bubbled through the mixture of 4-bromo-2-methylisoquinolin-1(2H)-one (56 mg, 0.24 mmol), [3-(benzylsulfamoyl)-4-methoxyphenyl]boronic acid (83 mg, 0.26 mmol), aqueous 2M Na2CO3 (0.375 mL) and Pd(dppf)Cl2 (9 mg, 0.001 mmol) in dioxane (1.5 mL) which was then microwaved at 120° C. for 1 h and then filtered through a plug of anhydrous Na2SO4 using ethyl acetate to transfer and rinse. Silica gel chromatography, eluting with 0-60% EA in hexane over 6 min and continuing 60% isocratic EA gave the title compound (60 mg, 0.14 mmol) as a white solid in 58% yield. 1H NMR (400 MHz, DMSO-d6) δ 3.57 (s, 3 H), 3.89 (s, 3H), 4.11 (d, J=6.32 Hz, 2H), 7.16-7.23 (m, 6H), 7.34 (d, J=8.08 Hz, 1H), 7.47 (s, 1H), 7.53-7.59 (m, 2H), 7.65 (d, J=2.27 Hz, 1H), 7.72-7.77 (m, 1H), 7.94 (t, J=6.32 Hz, 1H), 8.34 (d, J=7.33 Hz, 1H). LCMS (M+H)+ 435.",N2 | 4-bromo-2-methylisoquinolin-1(2H)-one | [3-(benzylsulfamoyl)-4-methoxyphenyl]boronic acid | Na2CO3 | Pd(dppf)Cl2 | dioxane | Na2SO4 | Silica gel | EA | hexane | title compound
US05639881,"To a solution consisting of 40 mL of acetic acid and 4 mL of concentrated sulfuric acid, was added 394 mg (0.753 mmol) of 10. The resulting mixture was refluxed for 4 hours. After allowing the mixture to cool to room temperature, the greyish colored precipitate was collected, washed with acetic acid, and then washed with water to afford pure 14 as a yellow solid: 260 mg (71%) yield; dec pt 290° C.; TLC (ethyl acetate/methanol [9:1]), Rf =0.56; IR (KBr pellet) 2967, 1687, 1630, 1599, 1497, 1463, 1427, 1239, 1206, 1066 cm-1 ; 1H NMR (dimethyl-d6 sulfoxide) δ7.32 (4H, t, J=7.4 Hz, aromatic, no assignments made), 7.08 (4H, d, J=7.8 Hz, aromatic, no assignments made), 6.98 (4H, t, J=7.4 Hz, aromatic, no assignments made), 5.02 (4H, s, methylenes), 3.81 (6H, s, methoxys); mass spectrum (EI mode), m/z 486 (P+). Anal. Calcd for C26H22N4O6 : C, 64.19; H, 4.56; N, 11.52. Found; C, 64.09; H, 4.52; N, 11.31.",acetic acid | sulfuric acid | 10 | acetic acid | water | 14
US08524917B2,"Following General Procedure BB, 3-(3,4-difluorobenzylcarbamoyl)-2-isopropyl-1-(pyridin-2-ylmethyl)-1H-indol-6-yl trifluoromethanesulfonate (Compound 202, 39 mg, 0.07 mmol), was reacted with 1-methyl-1H-pyrazole-5-boronic acid pinocol ester (21 mg, 0.09 mmol), LiCl (9 mg, 0.18 mmol), Na2CO3 (aqueous) (2M, 0.1 ml), Pd(PPh3)4 (4 mg, 0.003 mmol) to yield the title compound as a white solid","3-(3,4-difluorobenzylcarbamoyl)-2-isopropyl-1-(pyridin-2-ylmethyl)-1H-indol-6-yl trifluoromethanesulfonate | Compound 202 | 1-methyl-1H-pyrazole-5-boronic acid | LiCl | Na2CO3 | Pd(PPh3)4 | title compound"
US07034152B2,"To an oven dried, 1-L 3-necked round bottomed flask equipped with a mechanical stirrer, a temperature probe, and an argon line was charged activated molecular sieves (35 g) and DCM (160 mL) under an atmosphere of argon. The solution was cooled to about −30° C. DIPT (2.34 g, 0.01 moles) followed by titanium (IV) isopropoxide (2.36 mL, 0.008 moles) was added to the reaction mixture. The reaction mixture was stirred at −30° C. for about 20 minutes. Crude 76 (42 g, ˜0.1 moles) in DCM (40 mL) was added to the reaction mixture and stirred for about 30 minutes. TBHP (40 mL, 0.2 moles) was added to the reaction mixture at −30° C. After complete addition of TBHP, the reaction mixture was stirred at −30° C. for about 5 hours to complete the reaction. The excess peroxide was quenched with aqueous sodium bisulfite (20 g). The mixture was filtered through a Buchner Funnel with a pad of diatomaceous earth (Hyflo Celite®). The filtrate was washed with saturated NaHCO3, solution (100 mL) and brine (100 mL). The organic layer was concentrated in vacuo to give the crude title compound (60 g, >100% material balance) as an oil.",1-L | argon | DCM | DIPT | titanium (IV) isopropoxide | 76 | TBHP | TBHP | peroxide | sodium bisulfite | NaHCO3 | brine | crude title compound
US08338447B2,"The title compound is prepared by following General Methods 1, 3, 4, 5 and 7 by using 3-chlorophenylhydrazine hydrochloride, ethyl bromoacetate, and triethylamine (General Method 1), ethyl 2-(1-(3-chlorophenyl)hydrazinyl)acetate and 4,4-diethoxy-N-methylbutan-1-amine (General Method 3), ethyl 2-(6-chloro-3-(2-(methylamino)ethyl)-1H-indol-1-yl)acetate, formaldehyde and TFA in acetonitrile (General Method 4), ethyl 2-(7-chloro-1,2,3,4-tetrahydro-2-methylpyrido[3,4-b]indol-9-yl)acetate and NaOH (General Method 5), and 2-(7-chloro-1,2,3,4-tetrahydro-2-methylpyrido[3,4-b]indol-9-yl)acetic acid, N,3-dimethylbutan-1-amine and EDCI (General Method 7).","title compound | 3-chlorophenylhydrazine hydrochloride | ethyl bromoacetate | triethylamine | ethyl 2-(1-(3-chlorophenyl)hydrazinyl)acetate | 4,4-diethoxy-N-methylbutan-1-amine | ethyl 2-(6-chloro-3-(2-(methylamino)ethyl)-1H-indol-1-yl)acetate | formaldehyde | TFA | acetonitrile | ethyl 2-(7-chloro-1,2,3,4-tetrahydro-2-methylpyrido[3,4-b]indol-9-yl)acetate | NaOH | 2-(7-chloro-1,2,3,4-tetrahydro-2-methylpyrido[3,4-b]indol-9-yl)acetic acid | N,3-dimethylbutan-1-amine | EDCI"
US06436954B1,"A mixture of 3thlorobenzyl chloride (11 mmol, 1.4 mL), ethyl pipecolinate hydrochloride (10 mmol, 1.94 g) and K2CO3 (12 mmol, 1.69 g) in DMF (10 mL) was stirred at 60° C. for 3 days. It was then diluted with ether (50 mL) and filtered. The filtrate was concentrated in vacuo to give ethyl N-(3chlorophenylmethyl)pipecolinate as a yellow oil (2.79g): 1H NMR (300 MHz) δ 7.21-7.35 (m, 4 H), 4.20 (q, J=7.1 Hz, 2 H), 3.77 (d, J=13.6 Hz, 1 H), 3.37 (d, J=13.6 Hz, 1 H), 3.14 (dd, J=7.5 Hz, 4.6 Hz, 1 H), 2.92 (dt, J=11.9, 5.4 Hz, 1 H), 2.15 (m, 1 H), 1.34-1590 (m, 6 H), 1.29 (t, J=7.1 Hz, 3 H); 13C NMR δ 173.74 (s), 140.73 (s), 134.06 (s), 129.35 (d), 128.99 (d), 127.14 (d), 64.33 (d), 60.34 (t), 59.98 (t), 50.11 (t), 29.52 (t), 25.25 (t), 22.39 (t), 14.30 (q); MS (FAB) 282 (98, M+H), 208 (100); HRMS (FAB) m/e calcd for (C15H20ClNO2+H) 282.1261, found 282.1248.",chloride | ethyl pipecolinate hydrochloride | K2CO3 | DMF | ether | ethyl N-(3chlorophenylmethyl)pipecolinate
US20150225399A1,"In a similar manner to that described in example 196, from ethyl 1-butyl-7-[(4-fluorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-1,5-naphthyridine-3-carboxylate (30 mg, 0.075 mmol) and 3-amino-2,2-dimethyl-1-propanol (0.05 mL) was prepared 1-butyl-7-[(4-fluorophenyl)methyl]-4-hydroxy-N-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2-dihydro-1,5-naphthyridine-3-carboxamide (18 mg, 53% yield) as a white solid after purification by reverse phase HPLC. 1H NMR (CDCl3) δ 10.51 (br s, 1H), 8.56 (s, 1H), 7.27 (s, 1H), 7.17-7.13 (m, 2H), 7.05-7.01 (m, 2H), 4.14 (s, 2H), 4.08 (m, 2H), 3.39 (m, 1H), 3.30 (m, 2H), 3.22 (m, 2H), 1.51 (m, 2H), 1.33 (m, 2H), 0.94 (s, 6H), 0.90 (m, 3H); MS m/z 456 (M+1).","ethyl 1-butyl-7-[(4-fluorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-1,5-naphthyridine-3-carboxylate | 3-amino-2,2-dimethyl-1-propanol | 1-butyl-7-[(4-fluorophenyl)methyl]-4-hydroxy-N-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2-dihydro-1,5-naphthyridine-3-carboxamide"
US20080108663A1,"A suspension of 4-(cyclopropylmethyl)piperidine-4-carbonitrile hydrochloride (I-3, 2.5 g, 12.5 mmol) in CH2Cl2 (130 mL) at 0° C. was treated with i-Pr2NEt (8.7 mL, 50 mmol) and EtSO2Cl (1.8 mL, 18.7 mmol) dropwise. After 2 h, the reaction was quenched with the addition of 1 M aqueous NaOH (40 mL) and stirred 18 h before being extracted with CH2Cl2 (3×50 mL). The combined organic extracts were dried (Na2SO4) and concentrated under reduced pressure to afford 4-(cyclopropylmethyl)-1-(ethylsulfonyl)piperidine4-carbonitrile (I-4, M+H+=256.1) as an off-white amorphous solid. This material was used in subsequent reactions without further purification.",4-(cyclopropylmethyl)piperidine-4-carbonitrile hydrochloride | CH2Cl2 | i-Pr2NEt | EtSO2Cl | NaOH | CH2Cl2 | Na2SO4 | 4-(cyclopropylmethyl)-1-(ethylsulfonyl)piperidine4-carbonitrile | H+
US20100009957A1,"To a solution of the product of step 2 in dimethylformamide (1 mL) was added (2-bromoethoxy)-tert-butyldimethylsilane (0.051 mL, 0.240 mmol) and Hunig's Base (0.084 mL, 0.480 mmol) at room temperature. The reaction mixture was allowed to stir at room temperature over the weekend then heated to 50° C. for 2 hours. The reaction mixture was partitioned between ethyl acetate and water. The organic layer was washed with water and brine, dried over sodium sulfate, filtered, and concentrated under vacuum to give a yellow oil. The crude intermediate was purified by preparative TLC ((1000 micron; eluted with 10% methanol/dichloromethane; iodine stain) to afford the intermediate (tert-butyl [(4S)-1-(2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)azepan-4-yl]carbamate) as a pale yellow oil (47.3 mg, 53%). This material was dissolved in dichloromethane (2 mL) and trifluoroacetic acid (1 mL) was added. The reaction was stirred at room temperature overnight then concentrated under vacuum to afford the crude title compound as a pale orange oil (18 mg, 28%) which was used without further purification.",product | dimethylformamide | (2-bromoethoxy)-tert-butyldimethylsilane | Hunig's Base | ethyl acetate | water | water | brine | sodium sulfate | oil | crude intermediate | methanol/dichloromethane | iodine | tert-butyl [(4S)-1-(2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)azepan-4-yl]carbamate
US20060211709A1,"A solution of 3-amino-6-{3-[(benzylamino)carbonyl]phenyl}-N-methoxy-N-methylpyrazine-2-carboxamide (0.10 g, 0.25 mmol) in THF (5 mL) was cooled to 0° C., and a solution of CH3MgCl (0.75 mL, 1 M in THF, 3.0 equiv.) was added slowly. The mixture was allowed to warm to room temperature over 1.5 hr. The mixture was then cooled to 0° C. and quenched slowly with saturated NH4Cl solution. The mixture was extracted with ethyl acetate, washed with brine then water. The ethyl acetate extract was evaporated to afford the corresponding methyl ketone as a yellow solid. To a portion of this residue (35 mg, 0.1 mmol) in ethanol in a pressure tube (5 mL) was added 4-methoxyphenylhydrazine hydrochloride (52 mg, 3 mmol). This mixture was then heated to for 12 h. The solvent was removed under reduced pressure and the crude mixture was dissolved in a minimal amount of methanol and run through a plug of silica gel to give the product as a white solid (33 mg, 70 % yield). 1H NMR (400 MHz, CDCl3): δ 8.40 (m, 1H), 8.0 (m, 2H), 7.80 (m, 2H), 7.25 (m,1H), 7.2 (m, 4H), 6.9 (m, 4H), 4.8 (s, 2H), 3.8 (s, 3H), 2.6 (s, 3H). MS (EI) for C27H26N6O2: 467 (MH+).",3-amino-6-{3-[(benzylamino)carbonyl]phenyl}-N-methoxy-N-methylpyrazine-2-carboxamide | THF | CH3MgCl | NH4Cl | ethyl acetate | brine | ethyl acetate | methyl ketone | residue | ethanol | 4-methoxyphenylhydrazine hydrochloride | crude mixture | methanol | product
US07517873B2,"To a solution of 2.1 g (0.014 mole) of 2-methyl-3-oxo-butanoic acid ethyl ester and 40 mL of dichloroethane was added 1.37 g (0.016 mole) of cyclopentylamine. The mixture was stirred for 1.5 hours, then 4.63 g (0.020 mole) of sodium triacetoxyborohydride and 0.84 g (0.014 mole) of acetic acid were added. The mixture was stirred at room temperature for 24 hours and then quenched by the addition of 50 mL of saturated aqueous sodium bicarbonate. After 20 minutes, the organic layer was separated and the aqueous layer was extracted twice with 30 mL of dichloromethane. The combined organic layers were dried over anhydrous magnesium sulfate, filtered, and concentrated to afford the crude product as yellow oil. Purification of the residue by silica gel chromatography, eluting with hexanes-ethyl acetate (30:70) gave 1.5 g of (rac)-3-cyclopentylamino-2-methyl-butanoic acid ethyl ester.",2-methyl-3-oxo-butanoic acid ethyl ester | dichloroethane | cyclopentylamine | sodium triacetoxyborohydride | acetic acid | sodium bicarbonate | dichloromethane | magnesium sulfate | crude product | silica gel | hexanes-ethyl acetate | (rac)-3-cyclopentylamino-2-methyl-butanoic acid ethyl ester
US08420673B2,"A solution of 1,1-dimethylethyl 4-[4-(ethoxycarbonyl)-2-thiazolyl]-1-piperidinecarboxylate (11.1 g, 32.7 mmol) (i.e. the product of Example 1, Step A) in diethyl ether (100 mL) at 0° C. was treated with a solution of hydrogen chloride in diethyl ether (2 M, 166 mL, 331 mmol). The reaction mixture then was diluted with absolute ethanol (100 mL) and stirred overnight at room temperature. The reaction mixture was concentrated under reduced pressure, re-dissolved in ethanol and evaporated again to leave a solid. The resulting solid was placed under a high vacuum for several hours to give 10.38 g of the title compound as a hygroscopic white powder. This compound was of sufficient purity to use in subsequent reactions.","1,1-dimethylethyl 4-[4-(ethoxycarbonyl)-2-thiazolyl]-1-piperidinecarboxylate | product | diethyl ether | hydrogen chloride | diethyl ether | ethanol | ethanol | title compound"
US06365611B1,"1 g (3.5 mmol) of methyl 3-nitryloxy-2,2-bis(nitryloxymethyl)propionate is heated with 3 ml of benzylamine and 100 ml of ammonium chloride for 3 hours at 130° C., cooled, taken up in 50 ml of chloroform and washed in sequence with water, dilute hydrochloric acid, aqueous bicarbonate solution and again with water. The crude product obtained after evaporating off the solvent is purified column chromatographically. 3-nitryloxy-2,2-bis(nitryloxymethyl)propionic acid N-benzylamide is obtained as a colourless oil. Yield: 73%.","methyl 3-nitryloxy-2,2-bis(nitryloxymethyl)propionate | benzylamine | ammonium chloride | chloroform | water | hydrochloric acid | bicarbonate | water | crude product | 3-nitryloxy-2,2-bis(nitryloxymethyl)propionic acid N-benzylamide"
US20120178723A1,"A mixture of (4-chlorophenyl){5-(2-fluoropyridin-4-yl)-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-1,2,4-triazol-3-yl]-3-thienyl}methanol (80.0 mg, 0.170 mmol), ethanolamine (0.104 g, 1.70 mmol) and N,N-diisopropylethylamine (0.118 mL, 0.679 mmol) in dimethylsulfoxide (0.5 mL, 7 mmol) was heated at 200° C. for 1 h under argon. The reaction mixture was cooled, diluted with water and extracted with butanol. The butanol layer was collected and evaporated to a residue which was purified by chromatography (SiO2, elution with 0-20% MeOH in DCM) to afford the intermediate. The intermediate in 1,4-dioxane (1.0 mL, 13 mmol) and conc HCl (1.0 mL, 12 mmol) was stirred at rt for 1 h. The solvent was evaporated and the residue was purified by chromatography (SiO2, elution with 0-70% (MeOH/DCM/NH4OH, 13/85/2) in DCM) to afford 2-({4-[4-[(4-chlorophenyl)(hydroxy)methyl]-5-(4H-1,2,4-triazol-3-yl)-2-thienyl]pyridin-2-yl}amino)ethanol (17.6 mg, 24.2%). LCMS: (AA) ES+428.2, 430.0; 1H NMR (400 MHz, d6-DMSO) δ: 14.66-14.13 (m, 1H), 8.68 (s, 1H), 7.94 (d, J=5.30 Hz, 1H), 7.58-7.48 (m, 3H), 7.38-7.30 (m, 2H), 6.81-6.68 (m, 3H), 6.60 (s, 1H), 4.72 (s, 1H), 3.57-3.45 (m, 2H), 3.34 (d, J=5.88 Hz, 3H).","(4-chlorophenyl){5-(2-fluoropyridin-4-yl)-2-[1-(tetrahydro-2H-pyran-2-yl)-1H-1,2,4-triazol-3-yl]-3-thienyl}methanol | ethanolamine | N,N-diisopropylethylamine | dimethylsulfoxide | argon | water | butanol | butanol | SiO2 | MeOH | DCM | 1,4-dioxane | HCl | SiO2 | MeOH/DCM/NH4OH | DCM | 2-({4-[4-[(4-chlorophenyl)(hydroxy)methyl]-5-(4H-1,2,4-triazol-3-yl)-2-thienyl]pyridin-2-yl}amino)ethanol"
US06495552B2,"Using General Procedure D; 4-bromo-1-(1-benzyloxycyclopropyl)-2-methyl-benzene (Intermediate 74, 320.0 mg, 1.00 mmol) in triethylamine (8 mL) was treated with copper(I)iodide (19.0 mg, 0.1 mmol) and then sparged with argon for 5 minutes. Trimethylsilylacetylene (0.70 g, 7.1 mmols) was then added followed by dichlorobis-(triphenylphosphine)palladium(II) (70.0 mg, 0.05 mmol). The resulting reaction mixture was heated to 70° C. for 5 d. The title compound (300.0 mg, 89%) was isolated by chromatography (0-2% EtOAc-hexanes).",4-bromo-1-(1-benzyloxycyclopropyl)-2-methyl-benzene | Intermediate 74 | triethylamine | copper(I)iodide | argon | Trimethylsilylacetylene | dichlorobis-(triphenylphosphine)palladium(II) | title compound | EtOAc-hexanes
US08309546B2,"To a solution of 5-{8-[(3S)-4-acetyl-3-methylpiperazin-1-yl]-6-morpholin-4-yl-9-(2,2,2-trifluoroethyl)-9H-purin-2-yl}pyrimidin-2-amine (33.2 mg, 0.06 mmol) in methanol/dichloromethane solution (1/1, 1 ml) was added methanesulfonic acid (3.9 μl, 0.06 mmol) at room temperature, and the mixture was stirred for 3 hr. Then the solvent was removed in reduced pressure, and the resultant solid was dried to give 5-{8-[(3S)-4-acetyl-3-methylpiperazin-1-yl]-6-morpholin-4-yl-9-(2,2,2-trifluoroethyl)-9H-purin-2-yl}pyrimidin-2-amine methanesulfonate (31.4 mg) as a yellow solid.","5-{8-[(3S)-4-acetyl-3-methylpiperazin-1-yl]-6-morpholin-4-yl-9-(2,2,2-trifluoroethyl)-9H-purin-2-yl}pyrimidin-2-amine | methanol/dichloromethane | methanesulfonic acid | 5-{8-[(3S)-4-acetyl-3-methylpiperazin-1-yl]-6-morpholin-4-yl-9-(2,2,2-trifluoroethyl)-9H-purin-2-yl}pyrimidin-2-amine methanesulfonate"
US20130165426A1,"To a solution of 5-amino-N,N-diisopentyl-6-((3-morpholinopropyl)amino)picolinamide (0.1 g, 0.238 mmol) and 1-isothiocyanato-4-methoxybenzene (0.050 ml, 0.357 mmol) in THF (2 ml) was added dicyclohexylcarbodiimide (0.108 g, 0.524 mmol) at room temperature and the mixture was stirred at 65° C. for 12 hours. The mixture was allowed to cool and treated with 1N HCl (2 ml) solution. Ethyl acetate (2 ml) was added and the resulting mixture was stirred for 30 min. The precipitate was filtered off and the filtrate was separated in two layers. The organic layer was further washed with 1N HCl (2 ml). Concentrated ammonium hydroxide was added to the combined aqueous layers which were extracted with ethyl acetate (3×10 mL). The combined organics were dried over Na2SO4, filtered and concentrated. The residue was purified by prep HPLC: 3 injections. 20% to 100% MeOH in water-TFA over 13 min. The pooled fractions were concentrated to afford N,N-diisopentyl-2-((4-methoxyphenyl)amino)-3-(3-morpholinopropyl)-3H-imidazo[4,5-b]pyridine-5-carboxamide, 2TFA (62 mg, 0.079 mmol, 33.1% yield). LCMS m/z 551.4 (M+H)+, ret. time=2.29 min","5-amino-N,N-diisopentyl-6-((3-morpholinopropyl)amino)picolinamide | 1-isothiocyanato-4-methoxybenzene | THF | dicyclohexylcarbodiimide | HCl | Ethyl acetate | HCl | ammonium hydroxide | ethyl acetate | Na2SO4 | MeOH | water-TFA | N,N-diisopentyl-2-((4-methoxyphenyl)amino)-3-(3-morpholinopropyl)-3H-imidazo[4,5-b]pyridine-5-carboxamide"
US09075058B2,"Under an argon atmosphere, to a mixture of 5-[4-(tert-butyldimethylsilyloxy)phenyl]-3-(thieno[3,2-b:2′,3′-d]thiophen-2-yl)pyrazin-2-amine (71) (370 mg, 746 μmol) and 4-(dimethylamino)pyridine (14.8 mg, 121 μmol) dissolved in anhydrous pyridine (15 mL) was added 2-[4-(tert-butyldimethylsilyloxy)phenyl]acetyl chloride (10) prepared above at 0° C. and the mixture was heated with stirring at 50° C. for 20 hours. After cooling to room temperature, to this was added water and the product was extracted with ethyl acetate (100 mL×3). The combined organic extract was washed successively with water (200 mL) and brine (200 mL), followed by drying over anhydrous sodium sulfate. After filtration and concentration under reduced pressure, the residue was purified by column chromatography (silica gel 50 g, n-hexane/ethyl acetate=3/1). The resulting solid was recrystallized (n-hexane/ethyl acetate) to give Compound 111 (116 mg, 156 μmol, 20.9%) as a brown solid. Rf=0.19 (n-hexane/ethyl acetate=3/1); 1H NMR (400 MHz, DMSO-d6) δ 0.16 (s, 6H), 0.21 (s, 6H), 0.93 (s, 9H), 0.94 (s, 9H), 3.68 (s, 2H), 6.78-6.88 (AA′BB′, 2H), 6.94-7.06 (AA′BB′, 2H), 7.20-7.30 (AA′BB′, 2H), 7.47 (d, 1H, J=5.2 Hz), 7.65 (s, 1H), 7.75 (d, 1H, J=5.2 Hz), 8.06-8.14 (AA′BB′, 2H), 8.93 (s, 1H), 10.72 (s, 1H); IR (KBr, cm−1) 530, 602, 644, 700, 779, 837, 922, 1072, 1171, 1265, 1361, 1447, 1504, 1603, 1657, 2857, 2928, 2955, 3208.","argon | 5-[4-(tert-butyldimethylsilyloxy)phenyl]-3-(thieno[3,2-b:2′,3′-d]thiophen-2-yl)pyrazin-2-amine | 4-(dimethylamino)pyridine | pyridine | 2-[4-(tert-butyldimethylsilyloxy)phenyl]acetyl chloride | water | ethyl acetate | water | brine | sodium sulfate | silica gel | n-hexane/ethyl acetate | n-hexane/ethyl acetate | Compound 111"
US20140309192A1,"1-(4,5-Dichloro-2-nitrophenyl)piperazine (6.57 g, 23.79 mmol) was dissolved in THF (40 mL) and MeOH (10 mL). DIEA (8.31 mL, 47.6 mmol) and 3-bromo-1,1,1-trifluoropropane (3.82 mL, 35.7 mmol) were added and the reaction was heated to reflux in an oil bath over night. The next day, the reaction was approximately 40% complete. Thus, more 3-bromo-1,1,1-trifluoropropane (3.82 mL, 35.7 mmol) was added. The reaction was continued to stir at reflux over the weekend. After this time, the starting material had been consumed. The solvent was evaporated to give the crude intermediate, 1-(4,5-dichloro-2-nitrophenyl)-4-(3,3,3-trifluoropropyl)piperazine. This crude material was re-dissolved in EtOH (20 mL) and cooled on ice. To the stirring solution was added tin(II) chloride (13.5 g, 71.4 mmol) portionwise (slight exotherm). After complete addition, the reaction was heated in an oil bath to 80° C. for 1 h. The reaction was cooled on an ice bath. Then, 50% w/v conc. NaOH (˜30 mL), some H2O (120 mL), and CH2Cl2 (150 mL) were added to the reaction until it was completely quenched and the tin precipitate was re-dissolved. The reaction was extracted twice. The organic layer was dried, concentrated, and the residue was purified by column chromatography (0-30% EtOAc/hexanes) to give the title compound (7.71 g, 92%) as a red oil. LC/MS m/z=342.2 [M+H]+; 1H NMR (400 MHz, DMSO-d6) δ ppm 2.43-2.48 (m, 2H), 2.53-2.61 (m, 6H), 2.76-2.82 (m, 4H), 5.10 (s, 2H), 6.84 (s, 1H), 6.99 (s, 1H).","1-(4,5-Dichloro-2-nitrophenyl)piperazine | THF | MeOH | DIEA | 3-bromo-1,1,1-trifluoropropane | 3-bromo-1,1,1-trifluoropropane | crude intermediate | 1-(4,5-dichloro-2-nitrophenyl)-4-(3,3,3-trifluoropropyl)piperazine"
US09266908B2,"2-Fluoro-4-formylphenyl boronic acid (263 mg, 1.57 mmol) was added to the mixture of 1-chloro-4-iodobenzene (250 mg, 1.05 mmol), PdCl2(PPh3)2 (36 mg, 0.5 mmol), and disodium carbonate (332 mg, 3.13 mmol) in a solution of water (1 mL) and dioxane (2 mL). The mixture was reacted at 130° C. for 22 min in a microwave reactor. After cooling, water was added, and the mixture was extracted with ethylacetate. The organic solvent was dried over Na2SO4, filtered, and concentrated. The residue was purified by column chromatography on silica gel, eluting with ethyl acetate in heptane to give the title compound (220 mg, 0.94 mmol, 90%) as a white solid. 1H NMR (D2O) δ 10.02 (s, 1H), 7.75 (d, J=7.8 Hz, 1H), 7.67 (d, J=10.4 Hz, 1H), 7.60 (t, J=7.5 Hz, 1H), 7.53 (d, J=8.3 Hz, 2H), 7.46 (d, J=8.3 Hz, 2H).",2-Fluoro-4-formylphenyl boronic acid | 1-chloro-4-iodobenzene | PdCl2(PPh3)2 | disodium carbonate | water | dioxane | water | ethylacetate | ethylacetate | Na2SO4 | silica gel | heptane | title compound
US09133129B2,"Using 2,3,5-trifluoro-4-hydroxybenzoic acid and iodoethane, and in the same manner as in Step A of Example 39, the title compound was obtained.","2,3,5-trifluoro-4-hydroxybenzoic acid | iodoethane | title compound"
US20110105491A1,prepared by reaction of 3-chloro-3-(2-methoxy-phenyl)-2-oxo-propionic acid methyl ester with thioacetamide. LC-MS: tR=0.88 min; [M+H]+=264.05.,3-chloro-3-(2-methoxy-phenyl)-2-oxo-propionic acid methyl ester | thioacetamide
US09018211B2,"To a solution of 3-bromo-2-methyl benzoic acid (35 g, 163 mmol) in THF (200 mL) was added Borane THF Complex (1.0 M, 212 mL, 212 mmol). The mixture was allowed to stir for 24 h. TLC showed one single product spot. The reaction was quenched with water. The solvent THF was removed under reduced pressure. The resulting solid was dissolved in ethyl acetate (500 mL), washed with 1N HCl, sodium carbonate, and brine. The organic layer was dried over sodium sulfate and concentrated to afford (3-bromo-2-methylphenyl)methanol.",3-bromo-2-methyl benzoic acid | THF | Borane THF | THF | water | ethyl acetate | HCl | sodium carbonate | brine | sodium sulfate | (3-bromo-2-methylphenyl)methanol
US20150099737A1,"Following general N-C coupling procedure 1, (R)-3-(6-amino-pyridin-3-yl)-2-oxo-1-oxa-3,7-diaza-spiro[4.5]decane-7-carboxylic acid tert-butyl ester was combined with 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide which gave (R)-3-[6-(7-Cyclopentyl-6-dimethylcarbamoyl-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-pyridin-3-yl]-2-oxo-1-oxa-3,7-diaza-spiro[4.5]decane-7-carboxylic acid tert-butyl ester as a white solid (0.175 g, 0.275 mmol) in 64% yield. 1H NMR (400 MHz, CDCl3) δ ppm 1.47 (s, 9H) 1.55-1.68 (m, 2H) 1.68-1.85 (m, 3H) 1.88-2.18 (m, 8H) 2.50-2.68 (m, 2H) 3.13-3.21 (m, 6H) 3.21-3.32 (m, 1H) 3.37-3.58 (m, 1H) 3.61-3.72 (m, 1H) 3.75 (d, J=8.53 Hz, 2H) 3.86 (d, J=8.53 Hz, 2H) 4.72-4.95 (m, J=8.91, 8.91, 8.78, 8.53 Hz, 1H) 6.48 (s, 1H) 8.14 (dd, J=9.29, 2.76 Hz, 1H) 8.31 (br. s., 1H) 8.53 (d, J=9.54 Hz, 1H) 8.76 (s, 1H). MS m/z 605.5 (M+H)+.","(R)-3-(6-amino-pyridin-3-yl)-2-oxo-1-oxa-3,7-diaza-spiro[4.5]decane-7-carboxylic acid tert-butyl ester | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide | (R)-3-[6-(7-Cyclopentyl-6-dimethylcarbamoyl-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-pyridin-3-yl]-2-oxo-1-oxa-3,7-diaza-spiro[4.5]decane-7-carboxylic acid tert-butyl ester"
US09265773B2,"To a solution of methyl 2-(2-(4-fluorophenyl)-3-(methylcarbamoyl)-6-(N-methylmethylsulfonamido)benzofuran-5-yl)-6H-pyrido[2′,3′:5,6][1,3]oxazino[3,4-a]indole-11-carboxylate (160 mg, 0.24 mmol) in dioxane (2 mL) and water (2 mL), LiOH.H2O (30 mg, 0.71 mmol) was added and the mixture was heated to reflux for 2 hours. Then removed dioxane and the mixture was diluted with water, adjusted to pH=3˜4 by 1 N HCl, and extracted with EtOAc. The combined organic phases were washed with brine, dried over Na2SO4, filtered and concentrated in vacuo. The resulting residue was purified using PTLC (dichloromethane:MeOH=20:1) to provide 2-(2-(4-fluorophenyl)-3-(methylcarbamoyl)-6-(N-methylmethylsulfonamido)benzofuran-5-yl)-6H-pyrido[2′,3′:5,6][1,3]oxazino[3,4-a]indole-11-carboxylic acid (120 mg, yield: 76%). 1H-NMR (Methanol-d4, 400 MHz) δ 7.97˜8.02 (m, 2H), 7.86˜7.91 (m, 3H), 7.81 (s, 1H), 7.74 (d, J=8.4 Hz, 1H), 7.59 (s, 2H), 7.31˜7.36 (m, 1H), 7.24˜7.29 (m, 2H), 6.14 (s, 2H), 3.35 (s, 3H), 2.96 (s, 3H), 2.88 (s, 3H). MS (M+H)+: 641.","methyl 2-(2-(4-fluorophenyl)-3-(methylcarbamoyl)-6-(N-methylmethylsulfonamido)benzofuran-5-yl)-6H-pyrido[2′,3′:5,6][1,3]oxazino[3,4-a]indole-11-carboxylate | dioxane | water | LiOH.H2O | dioxane | water | HCl | EtOAc | brine | Na2SO4 | 2-(2-(4-fluorophenyl)-3-(methylcarbamoyl)-6-(N-methylmethylsulfonamido)benzofuran-5-yl)-6H-pyrido[2′,3′:5,6][1,3]oxazino[3,4-a]indole-11-carboxylic acid"
US09238655B2,"A sealed tube was charged with 330d (2.145 g, 15 mmol), Cs2CO3 (978 mg, 3.0 mmol), and 2,2-dimethyloxirane (15 mL). The mixture was stirred at 70° C. for 3 h. After cooling to room temperature, the mixture was concentrated under reduced pressure. The residue was purified by silica-gel column chromatography eluting with petroleum ether/ethyl acetate (5:1 to 1:1) to afford 330e (1.2 g, 38%) as a white solid. MS-ESI: [M+H]+ 216.2","330d | Cs2CO3 | 2,2-dimethyloxirane | silica | petroleum ether/ethyl acetate | 330e"
US20150301368A1,"25 g (236 mmol) sodium carbonate is dissolved in 175 ml water and 75 ml ethanol. 29.6 g (95.2 mmol) 4-bromo-2-ethyl-1-iodo-benzene, 23.6 g (95.0 mmol) boronic ester A are dissolved in 375 ml toluene added to the reaction mixture. After adding Pd(PPh3)4 to the mixture it is refluxed for 5.5 h and cooled to room temperature. The organic phase is separated and the water phase is extracted two times with ethyl acetate. The combined organic phases are washed with brine, dried over sodium sulphate, filtered and evaporated under vacuum. The crude product is purified via silica gel chromatography (heptane/ethyl acetate 8:2) and (toluene/ethyl Acetate 95:5) to give 24.5 g (80% yield) of the product.",sodium carbonate | water | ethanol | 4-bromo-2-ethyl-1-iodo-benzene | boronic ester | toluene | Pd(PPh3)4 | water | ethyl acetate | brine | sodium sulphate | crude product | product | silica gel | heptane/ethyl acetate | toluene/ethyl Acetate
US08211910B2,"7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-8-methoxy-1,4-dihydro-4-oxoquinoline-3-carboxylic acid in which configuration of the amino group in the substituent at position 7 is the same as the one produced in Example 9 (18.07 g, 39.4 mmol) was suspended in methanol (54 mL), and 1N hydrochloric acid (43.4 mL, 43.4 mmol) was added to the suspension at room temperature. Isopropyl alcohol (180 mL) was then added, and the mixture was stirred in a water bath at 50° C. for some time until precipitated gummy material thoroughly turned to crystal. After allowing to stand at room temperature for 1 hour, the crystals were collected by filtration, and washed with a small amount of isopropyl alcohol (twice). The crystals were then dried under reduced pressure to obtain the title compound 12.91 g (27.2 mmol, 69%) as a yellow powder.","7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-8-methoxy-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | Example 9 | methanol | hydrochloric acid | Isopropyl alcohol | water | isopropyl alcohol | title compound"
US20150361099A1,"A suspension of (1,1-dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)butyl methanesulfonate (4.6 g, 13.8 mmol, 1.0 eq), 2-(piperazin-1-yl)pyrimidine (2.9 g, 17.9 mmol, 1.3 eq.), KHCO3 (2.1 g, 20.7 mmol, 1.5 eq.) and toluene (46 mL) is heated at 95-100° C. for 22 h. Deionized water (35 mL) is added, and the organic phase is separated. The aqueous phase is extracted with ethyl acetate (2×30 mL). The organic phases are combined and dried over Na2SO4. The solvent is removed under reduced pressure to give the crude product, which is purified by column chromatography on silica gel by elution with 17-33% EtOAc/petroleum ether to offer ipsapirone free base as an off-white solid (2 g, 27% yield, 96% AUC by HPLC).","(1,1-dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)butyl methanesulfonate | 2-(piperazin-1-yl)pyrimidine | KHCO3 | toluene | water | ethyl acetate | Na2SO4 | crude product"
US20160185801A1,"To a solution of tert-butyl 5-fluoro-1H-indole-3-carboxylate (500 mg, 2.125 mmol) and triethylamine (1721 mg, 17.00 mmol) in THF (5 ml) was added methanesulfonyl chloride (0.658 ml, 8.50 mmol). The mixture was stirred at RT for 2 h. The reaction mixture was then poured into water and extracted twice with Et2O. The organic extracts were combined, filtered through MgSO4, concentrated, and purified by column chromatography (SiO2, EtOAc/hex) to afford the title compound as a white solid.",tert-butyl 5-fluoro-1H-indole-3-carboxylate | triethylamine | THF | methanesulfonyl chloride | water | Et2O | MgSO4 | SiO2 | EtOAc | title compound
US20160083362A1,"A solution of 2-methylpropionaldehyde (1.19 g) and 2-bromomethyl-4-fluorobromobenzene (4.02 g) in toluene (2 mL) was added to a stirred suspension of ground NaOH (0.66 g) and tetrabutyl ammonium iodide (0.111 g) in toluene (9 mL) at 60° C. under an atmosphere of nitrogen. The mixture was stirred at 60° C. for 20 hours and then left to stand at room temperature for 3 days. The mixture was partitioned between ethyl acetate and water and the organic layer was dried (Na2SO4) and filtered. The filtrate was concentrated in vacuo and the residue was purified by chromatography on silica, eluting with a mixture of ethyl acetate and cyclohexane, with a gradient of 0-5%, to give 3-(2-bromo-5-fluorophenyl)-2,2-dimethylpropanal (2.61 g) as a colourless oil.","2-methylpropionaldehyde | 2-bromomethyl-4-fluorobromobenzene | toluene | NaOH | tetrabutyl ammonium iodide | toluene | nitrogen | ethyl acetate | water | Na2SO4 | silica | ethyl acetate | cyclohexane | 3-(2-bromo-5-fluorophenyl)-2,2-dimethylpropanal"
US07064215B2,"The title compound was synthesized as described in Example 4 from 4-fluoro-5-(4-isopropyl-piperazin-1-yl)-benzene-1,2-diamine and 5-fluoro-1H-indazole-3-carbaldehyde. LC/MS (m/z) 397.5 (MH+), Rt 2.78 minutes.","title compound | 4-fluoro-5-(4-isopropyl-piperazin-1-yl)-benzene-1,2-diamine | 5-fluoro-1H-indazole-3-carbaldehyde"
US20160152621A1,"To a stirred solution of N-(3-methoxy-4-(oxazol-5-yl)phenyl)piperidine-2-carboxamide (50 mg, 0.17 mmol) in dichloroethane (5 mL) was added triethylamine (167 mg, 1.66 mmol) followed by 2-iodopropane (84 mg, 0.49 mmol) and the resultant mixture was stirred at room temperature overnight. Upon completion of reaction the volatile organics were removed under reduced pressure and the residue was partitioned between water (4 mL) and ethyl acetate (5 mL). The organic layer was separated and washed with brine (3 mL), dried with sodium sulfate and concentrated under reduced pressure to afford crude which was purified by preparative HPLC to give 1-isopropyl-N-(3-methoxy-4-(oxazol-5-yl)phenyl)piperidine-2-carboxamide (30 mg, 53% yield) as a white solid isolated as the free base: 1H NMR (400 MHz, CD3OD) δ 8.21 (s, 1H), 7.74 (d, J=8.4 Hz, 1H), 7.65 (d, J=2.0 Hz, 1H), 7.49 (s, 1H), 7.24 (dd, J=8.4, 1.6 Hz, 1H), 4.01 (s, 3H), 3.40-3.47 (m, 1H), 3.39-3.46 (m, 1H), 2.46-2.55 (m, 1H), 1.94-2.05 (m, 2H), 1.77-1.89 (m, 2H), 1.64-1.74 (m, 1H), 1.30-1.51 (m, 2H), 1.25 (d, J=6.78 Hz, 3H), 1.11 (d, J=6.53 Hz, 3H); LCMS (ESI) m/e 344.2 [(M+H)+, calcd C19H26N3O3, 344.2]; LC/MS retention time (method A): tR=1.48 min; HPLC retention time (method L): tR=5.05 min; HPLC retention time (method M): tR=5.77 min.",N-(3-methoxy-4-(oxazol-5-yl)phenyl)piperidine-2-carboxamide | dichloroethane | triethylamine | 2-iodopropane | resultant mixture | water | ethyl acetate | brine | sodium sulfate | 1-isopropyl-N-(3-methoxy-4-(oxazol-5-yl)phenyl)piperidine-2-carboxamide
US04057647,"A mixture of 32 g. of 3-(2',4'-difluoro-4-biphenylyl)-3-hydroxybutyric acid ethyl ester, 8.7 g. of potassium iodide, 5.2 of red phosphorus and 45 ml. of 85% phosphoric acid is stirred and heated to 130° for 7 hours. It is worked up in the customary manner to give 3-(2',4'-difluoro-4-biphenylyl)butyric acid ethyl ester.","3-(2',4'-difluoro-4-biphenylyl)-3-hydroxybutyric acid ethyl ester | potassium iodide | red phosphorus | phosphoric acid | 3-(2',4'-difluoro-4-biphenylyl)butyric acid ethyl ester"
US06605626B2,"Using the procedure described in Example 93, Part A, 4-tert-butylbenzoyl chloride (1.3 mmol) and 2-amino-N-(4-methoxyphenyl)-5-methylbenzamide (1.2 mmol) yielded 0.23 g (47%) of the title compound.",4-tert-butylbenzoyl chloride | 2-amino-N-(4-methoxyphenyl)-5-methylbenzamide | title compound
US20080241949A1,"A 1 liter round bottom flask equipped with stirring rod, thermo pocket, water condenser was charged with solution of 11-piperazinyldibenzo[b,f][1,4]thiazepine in toluene 350 cc [63.0 g (0.22 moles)] and the mixture was stirred for 15 min 25-30° C., and was added sodium carbonate [41.0 gm (0.39 moles)], tetra butyl ammonium bromide [16.0 gm (0.05 mole)] and 2-(2-chloroethoxy)ethanol [32.0 gm (0.257 moles)] at room temperature. The reaction mixture was heated to reflux at 110-112° C. The reaction mixture was maintained at reflux for 10-12 hrs. The reaction mixture was analyzed by HPLC (to check for absence of compound of Formula IV) and was cooled to 25° C. to 30° C. To which, was added 150 cc DM water, then the reaction mixture was stirred for 30 min at 25-30° C. The layers were separated and the aqueous layer extracted with 50 cc toluene. The extract and the organic layer were combined, to which was added 250 cc water and was acidified with acetic acid to obtain a pH of 2-3. The reaction mixture was stirred for 30 min at 25-30° C. The layers were separated and the aqueous layer washed with 100 cc toluene twice. To the aqueous layer was added 250 cc toluene, and the pH was adjusted to 8-10 using sodium carbonate, the reaction mixture was stirred for 30 min at 25-30° C. The layers were separated and the aqueous layer extracted with 125 cc toluene. The extract and the organic layer were combined, to which was washed with DM (dimineralized) water 300 cc twice. The organic layer was distilled off under vacuum below 70° C. to afford 2-(2-(4-dibenzo[b,f]-[1,4]thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol. Purity of 2-(2-(4-dibenzo[b,f]-[1,4]thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol was 99.0% (area % by HPLC).","water | 11-piperazinyldibenzo[b,f][1,4]thiazepine | toluene | sodium carbonate | tetra butyl ammonium bromide | 2-(2-chloroethoxy)ethanol | Formula IV | water | toluene | water | toluene | toluene | toluene | water | 2-(2-(4-dibenzo[b,f]-[1,4]thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol"
US20110009421A1,"Sodium hydride (60% liquid paraffin dispersion, 324 mg, 8.12 mmol) was added at 0° C. to a DMF (50 mL) solution of 2,4-dichloropyrimidine (1.0 g, 6.71 mmol) and 2-(3,4-dimethoxyphenyl)ethanol (1.35 g, 7.38 mmol), and the mixture was stirred for 3 hours at 60° C. Water was added to the reaction solution, and the product was extracted with ethyl acetate. An ether mixture (1.06 g) was obtained. A 2 N sodium carbonate aqueous solution (20 mL)-1,2-dimethoxyethane (20 mL) mixture of tetrakis(triphenylphosphine)palladium (0) (125 mg, 0.11 mmol), (3-(ethoxycarbonyl)phenyl)boronic acid (837 mg, 4.32 mmol), and the above mixture was reacted for 16 hours at 90° C. in a nitrogen atmosphere. Water was added to the reaction solution, and the product was extracted with ethyl acetate. The combined organic layers were washed with saturated brine, then dried over anhydrous sodium sulfate, and then concentrated at reduced pressure, and the residue was purified by silica gel column chromatography (ethyl acetate-hexane 1:1) to give 840 mg (yield: 31%) of ethyl 3-(4-(2-(3,4-dimethoxyphenyl)ethoxy)pyrimidin-2-yl)benzoate and 240 mg (yield: 9%) of ethyl 3-(2-(2-(3,4-dimethoxyphenyl)ethoxy)pyrimidin-4-yl)benzoate.","Sodium hydride | DMF | 2,4-dichloropyrimidine | 2-(3,4-dimethoxyphenyl)ethanol | Water | ethyl acetate | ether | sodium carbonate | 1,2-dimethoxyethane | tetrakis(triphenylphosphine)palladium | (3-(ethoxycarbonyl)phenyl)boronic acid | nitrogen | Water | ethyl acetate | brine | sodium sulfate | silica gel | ethyl acetate-hexane | ethyl 3-(4-(2-(3,4-dimethoxyphenyl)ethoxy)pyrimidin-2-yl)benzoate | ethyl 3-(2-(2-(3,4-dimethoxyphenyl)ethoxy)pyrimidin-4-yl)benzoate"
US20050209454A1,"5-nitro indazole (1 equiv.), cesium carbonate (1.1 equiv.) and DMF (5 volumes) were charged to a vessel. The mixture was heated to 70-80° C. and 3-fluoro benzyl bromide was added over 75 mins. The reaction was assayed by HPLC for completion (<2 AP of nitro indazole vs combined isomers) and then cooled to 20° C. The salts were filtered and the cake was washed with DMF (2.7 volumes). The product was crystallized by charging water (1.35 to 1.45 volumes) between 15-21° C. The crystal slurry was held for 4 h, crystals were filtered and washed with 2:1 DMF:water mix (2.1 volumes), water (2 volumes) and finally 3:1 cold ACN:water mix (1.5 volumes). The wet cake was dried <45° C. to LOD <1% and the yield was about 49%",5-nitro indazole | nitro indazole | cesium carbonate | DMF | 3-fluoro benzyl bromide | DMF | water | DMF | water | water | ACN
US05328637,"A solution of 1 g of 1-(1-propynyl)-4-bromo-benzene (produced from 4-bromobenzaldehyde by Wittig reaction, bromination of the resulting ethane and bromine elimination analogously to Example 1e) is reacted with 700 mg of tetrakis(triphenylphosphine)palladium (0) and 1.53 g of 4-(4-pentylphenyl)-2,3-difluoro-benzeneboric acid as described under a). Chromatography on silica gel with 3% ethyl acetate in petroleum ether and fractional crystallization from ethyl acetate gives 0.84 g of 1-(4-pentylphenyl)-2,3-difluoro-4-[4-(1-propynyl)-phenyl]benzene, m.p. 102.9° C.; cl.p. (N-I) 198.9° C.",1-(1-propynyl)-4-bromo-benzene | 4-bromobenzaldehyde | ethane | bromine
US20140228358A1,"5-Bromo-2,3-dihydro-1H-isoindol-1-one (100 mg, 0.47 mmol) was dissolved in DMF (4.7 mL) and stirred at 0° C. NaH (38 mg, 0.94 mmol, 60% dispersion in oil) was carefully added in two portions, and the resulting mixture was allowed to stir at 0° C. for 15 minutes before tert-butyl bromoacetate (92 mg, 0.47 mmol) was added. The mixture was allowed to stir at 0° C. for 30 minutes before saturated aqueous NaHCO3 (10 mL) was carefully added. The mixture was extracted with EtOAc, and the organic layer was washed with water, brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The residue was purified by MPLC on silica gel (using a gradient elution of 0-20% EtOAc/hexanes). Desired fractions were identified, combined, and concentrated in vacuo to afford the title compound. LRMS (ESI) calc'd for C14H16BrNO3 [M+Na]+: 348, Found: 348.","5-Bromo-2,3-dihydro-1H-isoindol-1-one | DMF | NaH | tert-butyl bromoacetate | NaHCO3 | EtOAc | water | brine | MgSO4 | silica gel | EtOAc/hexanes | title compound"
US06875884B1,"To a solution of 4[[2-hydroxy-(3-phthalimido)propyl](1,2,3,4-tetrahydro-1-naphthyl)amino]butanoic acid (68 mg, 0.16 mmol) in EtOH (1 ml) was added hydrazine monohydrate (38 μl, 0.78 mmol), and the mixture was stirred at RT for 3 h. The reaction mixture was concentrated under vacuum to dryness, and the residue was suspended in CH2Cl2 (2 ml). To the suspension was added 4-bromophenyl isocyanate (47 mg, 0.24 mmol), and the mixture was stirred at RT for 40 h. The reaction mixture was adsorbed on a plate of silica gel and then developed with 10% methanol/chloroform to afford 4-[[3-(4-bromophenylureido)2-hydroxypropyl](1,2,3,4-tetrahydro-1-naphthyl)amino]butanoic acid (13 mg, 16%): MS(ES+) m/e 504 [M+H]+; 1H NMR (400 MHz, DMSO-d6) δ 8.74 (s, 1H), 8.07 (br, 2H), 7.62 (d, J=7.6 Hz, 1H), 7.36 (m, 4H), 7.13-7.00 (m, 3H), 6.15 (m, 1H), 3.92 (m, 1H), 3.66-3.45 (m, 3H), 2.70 (m, 1H), 2.67 (m, 2H), 2.51 (m, 2H), 2.36 (m, 2H), 2.25 (m, 1H), 2.14 (m, 1H), 2.02 (m, 1H), 1.19 (m, 1H), 1.67-1.49 (m, 3H).","4[[2-hydroxy-(3-phthalimido)propyl](1,2,3,4-tetrahydro-1-naphthyl)amino]butanoic acid | EtOH | hydrazine monohydrate | 4-bromophenyl isocyanate | methanol/chloroform | 4-[[3-(4-bromophenylureido)2-hydroxypropyl](1,2,3,4-tetrahydro-1-naphthyl)amino]butanoic acid"
US08354539B2,"To a solution of 5-bromo-2-(1-methylethyl)-1H-isoindole-1,3(2H)-dione (Intermediate 5, 4.27 g) in tetrahydrofuran (THF) (100 mL) under nitrogen at room temperature was added 1.0M borane-tetrahydrofuran complex in THF (80 mL). The reaction mixture was heated at reflux for 48 hours. More 1.0M borane-THF complex in THF (50 mL) was added and the reaction mixture was heated at reflux for a further 24 hours. The reaction mixture was allowed to cool to room temperature. The reaction was quenched by the dropwise addition of 2N hydrochloric acid (80 mL). The reaction mixture was then heated at reflux for 1 hour. The reaction mixture was separated between ethyl acetate (300 mL) and water (50 mL). The organic phase was washed with 2N hydrochloric acid (100 mL). The combined aqueous phases were basified using 2N sodium hydroxide solution and then extracted with ethyl acetate (300 mL). This organic phase was washed with brine (100 mL) and dried over magnesium sulphate. The solvent was evaporated in vacuo to give the title compound (3.0 g) as a white solid.","5-bromo-2-(1-methylethyl)-1H-isoindole-1,3(2H)-dione | Intermediate 5 | tetrahydrofuran | THF | nitrogen | borane-tetrahydrofuran | THF | borane-THF | hydrochloric acid | ethyl acetate | water | hydrochloric acid | ethyl acetate | brine | magnesium sulphate | title compound"
US20070197794A1,"1-[(2′-Methyl-1,1′-biphenyl-4-yl)carbonyl]-4-oxo-L-proline (of Step 2, 1.0 wt), O-methyl-hydroxylamine hydrochloride (0.285 wt) and dichloromethane (20 vol) were charged to a 20L flange flask and cooled to 0 to 5° C. Triethylamine (0.91 vol) was charged to the flask such that the temperature was maintained in the range 0 to 10° C., the reaction mixture was warmed to 15 to 25° C. and maintained within this temperature range for 16 to 20 hours. The reaction mixture was concentrated under vacuum at 40 to 45° C., the residue dissolved in ethyl acetate (10.0 vol) and washed with aq. hydrochloric acid (1M, 2×5.0 vol). The aqueous washes were combined and back extracted with ethyl acetate (5.0 vol), the organic extracts combined and washed with saturated brine solution (10.0 vol), dried over magnesium sulfate (0.5 wt), filtered and the filter-cake washed with ethyl acetate (5.0 vol). The filtrates were concentrated under vacuum at 40 to 45° C. to give 4-methoxyimino-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]-L-proline in the expected E:Z mixture.","1-[(2′-Methyl-1,1′-biphenyl-4-yl)carbonyl]-4-oxo-L-proline | O-methyl-hydroxylamine hydrochloride | dichloromethane | 20L | Triethylamine | ethyl acetate | hydrochloric acid | ethyl acetate | brine | magnesium sulfate | ethyl acetate | 4-methoxyimino-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]-L-proline"
US03983133,"A mixture of 2 parts of α-[2-(1,4,5,6-tetrahydro-2-pyrimidinylamino)ethyl]benzylalcohol and 27 parts of sulfuric acid 80% is stirred for 2 hours at room temperature. The reaction mixture is poured onto crushed ice and the whole is alkalized with sodium hydroxide solution. The product is extracted with toluene. The organic layer is separated, dried, filtered and evaporated. The solid residue is crystallized from acetone, yielding 3,4,6,7,8,9-hexahydro-6-phenyl-2H-pyrimido-[1,2-a]pyrimidine, m.p. 177°-179°C.","α-[2-(1,4,5,6-tetrahydro-2-pyrimidinylamino)ethyl]benzylalcohol | sulfuric acid | ice | sodium hydroxide | toluene | acetone | 3,4,6,7,8,9-hexahydro-6-phenyl-2H-pyrimido-[1,2-a]pyrimidine"
US08987268B2,"DAST (0.697 mL, 5.27 mmol) was added to a solution of (3R,4R)-benzyl 4-((6-bromo-3-cyanopyrrolo[1,2-b]pyridazin-4-yl)amino)-3-hydroxy-3-methylpyrrolidine-1-carboxylate (310 mg, 0.659 mmol) in dichloromethane (10 mL) at 0° C. After 5 min at 0° C., the mixture was carefully quenched with saturated NaHCO3 (5 mL), diluted with dichloromethane (80 mL), washed with water, brine, dried (MgSO4) and concentrated. The residue was purified by silica gel chromatography, eluting with 0 to 30% ethyl acetate in hexanes, to give (3S,4R)-benzyl 4-((6-bromo-3-cyanopyrrolo[1,2-b]pyridazin-4-yl)amino)-3-fluoro-3-methylpyrrolidine-1-carboxylate (120 mg, 39% yield). 1H NMR (400 MHz, chloroform-d) δ ppm 7.84 (s, 1H), 7.69 (s, 1H), 7.48-7.31 (m, 5H), 6.77 (d, J=8.8 Hz, 1H), 5.25-5.06 (m, 2H), 4.91-4.70 (m, 1H), 4.37-4.21 (m, 1H), 3.99-3.82 (m, 1H), 3.69-3.35 (m, 2H), 1.73-1.55 (m, 3H); MS (ES+) m/z: 472.2 (M+H).","DAST | (3R,4R)-benzyl 4-((6-bromo-3-cyanopyrrolo[1,2-b]pyridazin-4-yl)amino)-3-hydroxy-3-methylpyrrolidine-1-carboxylate | dichloromethane | NaHCO3 | dichloromethane | water | brine | MgSO4 | silica gel | ethyl acetate | hexanes | (3S,4R)-benzyl 4-((6-bromo-3-cyanopyrrolo[1,2-b]pyridazin-4-yl)amino)-3-fluoro-3-methylpyrrolidine-1-carboxylate"
US08486952B2,"2-Chloro-N-methyl-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine (220 mg, 0.640 mmol) was added to a solution of 4-(4-chloro-1H-imidazol-1-yl)-3-methoxyaniline (215 mg, 0.960 mmol) in acetic acid (2 mL) and THF (2.000 mL). The reaction mixture was heated at 80° C. overnight. The crude reaction mixture was purified by preparative HPLC. The appropriate fractions were evaporated to afford N2-(4-(4-chloro-1H-imidazol-1-yl)-3-methoxyphenyl)-N4-methyl-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine-2,4-diamine (92 mg, 0.172 mmol, 26.8% yield). LC-MS (M+H)+=531.2. 1H NMR (500 MHz, CDCl3) δ ppm 7.93 (1H, s), 7.66 (1H, br s), 7.50 (1H, s), 7.10-7.23 (4H, m), 7.02 (2H, d, J=15.3 Hz), 6.83 (1H, d, J=8.2 Hz), 4.70-4.83 (1H, m), 4.13-4.28 (1H, m), 3.12 (3H, d, J=4.9 Hz), 2.74 (1H, br. s.), 2.65 (2H, d, J=8.2 Hz), 1.97-2.08 (1H, m), 1.25 (3H, s).","2-Chloro-N-methyl-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine | 4-(4-chloro-1H-imidazol-1-yl)-3-methoxyaniline | acetic acid | THF | N2-(4-(4-chloro-1H-imidazol-1-yl)-3-methoxyphenyl)-N4-methyl-7-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine-2,4-diamine"
US20090143413A1,"The chloride (See Example 15 Step 4, 39 mg, 0.06 mmol) was dissolved in TFA (2 mL), stirred at RT for 10 minutes, and the volatiles removed in vac. The residue was dissolved in EtOAc, washed with aqueous NaOH (1N, 40 mL) and extracted (3 times) with EtOAc. The combined organic fraction was washed with brine, dried over Na2SO, filtered and the volatiles removed in vac. The material was combined with 1-HOBT (13 mg, 0.10 mmol) and the acid (See Example 34 Step 4, 17 mg, 0.08 mmol) and the resulting mixture dissolved in DMF (1 mL). Diisopropyl ethyl amine (42 mg, 0.32 mmol) and EDAC (19 mg, 0.09 mmol) were added and the solution stirred at 45° C. for 1 hour. The reaction mixture was diluted with 2:1 CH3CN:water (8 mL) and purified by RP-18 HPLC (CH3CN:H2O 15 minute gradient 10 to 100%:0.1% TFA) to give the titled compound.",chloride | TFA | EtOAc | NaOH | EtOAc | brine | Na2SO | 1-HOBT | DMF | Diisopropyl ethyl amine | EDAC | CH3CN | water | CH3CN | H2O | TFA | titled compound
US07858624B2,"(S)-tert-butyl 2-(1-(6-fluoro-3′-methylbiphenyl-2-yl)-5-methoxypent-1-enyl)morpholine-4-carboxylate (133 mg, 0.28 mmol) was dissolved in methanol and hydrogenated under 50 psi of hydrogen in the presence of 10% Pd(OH)2/C as catalyst for 48 h. The reaction mixture was filtered and evaporated to give (2S)-tert-butyl 2-(1-(6-fluoro-3′-methylbiphenyl-2-yl)-5-methoxypentyl)morpholine-4-carboxylate in nearly quantitative yield. MS m/z 470 (M+H)+.",(S)-tert-butyl 2-(1-(6-fluoro-3′-methylbiphenyl-2-yl)-5-methoxypent-1-enyl)morpholine-4-carboxylate | methanol | hydrogen | Pd(OH)2/C | (2S)-tert-butyl 2-(1-(6-fluoro-3′-methylbiphenyl-2-yl)-5-methoxypentyl)morpholine-4-carboxylate
US07732449B2,"According to the procedure described in S. Coulton et al. WO9925709 with the following modifications. N-(4-Fluoro-phenyl)-N-(2-methyl-allyl)-acetamide (5 grams, 24.12 mmol) was added to a microwave tube with aluminum trichloride (7 grams, 52.4 mmol). The tube was capped and heated to 150° C. for 20 minutes under microwave. The slurry was worked up with water and ethyl acetate, the organic layer was extracted with 3 washes of saturated sodium bicarbonate solution and the organic layer was dried over magnesium sulfate. The solution was then filtered and rotary evaporated to yield pure 1-(5-Fluoro-3,3-dimethyl-2,3-dihydro-indol-1-yl)-ethanone in quantitative yield. This was converted to the free indoline by suspending the entire 5 grams of product in 20 mL of 6 M HCl and heating in a microwave to 200° C. for 10 minutes. The resulting 5-Fluoro-3,3-dimethyl-2,3-dihydro-1H-indole crystallized on cooling as the hydrochloride salt in quantitative yield. This material was identical to the previously reported compound.","N-(4-Fluoro-phenyl)-N-(2-methyl-allyl)-acetamide | aluminum trichloride | water | ethyl acetate | sodium bicarbonate | magnesium sulfate | 1-(5-Fluoro-3,3-dimethyl-2,3-dihydro-indol-1-yl)-ethanone"
US08470982B2,"nBuLi (1.00 mL; 1.50 mmol; 1.00 equiv) was added to a solution of cyclopentenone (84 mg; 1.0 mmol) in the presence of LaCl3.2LiCl (0.33 M; 3.03 mL, 1.00 mmol, 1.00 equiv) at 0° C. After 2 min, sat. aq. NH4Cl (2 mL) and water (2 mL) was added and the aqueous layer was extracted with ether (4×10 mL). The combined extracts were dried (Na2SO4). Careful evaporation under reduced pressure afforded analytically clean 1-butylcyclopentanol (8) as colorless oil (139 mg, 98%). The analytical data were found to be in accordance with the literature data.",nBuLi | cyclopentenone | LaCl3 | NH4Cl | water | ether | Na2SO4 | 1-butylcyclopentanol
US08058282B2,"Prepared as described above in Example 11 starting from 4-chloro-6-(1-ethyl-propylamino)-2-methylsulfanyl-pyrimidine-5-carbaldehyde and 4-fluoro-2-methyl-phenylboronic acid to give the title compound 4-(1-ethyl-propylamino)-6-(4-fluoro-2-methyl-phenyl)-2-methylsulfanyl-pyrimidine-5-carbaldehyde. 1H-NMR: δ 0.92 (m, 6H), 1.54-1.71 (m, 4H), 2.21 (s, 3H), 2.53 (s, 3H), 4.28 (m, 1H), 6.63-7.05 (m, 2H), 7.21 (m, 1H), 9.05 (br s, 1H), 10.50 (s, 1H). LC MS (m/e)=348 (MH+).",4-chloro-6-(1-ethyl-propylamino)-2-methylsulfanyl-pyrimidine-5-carbaldehyde | 4-fluoro-2-methyl-phenylboronic acid | title compound | 4-(1-ethyl-propylamino)-6-(4-fluoro-2-methyl-phenyl)-2-methylsulfanyl-pyrimidine-5-carbaldehyde
US08431564B2,"A solution of 1 g of methane sulphonic acid and 1 g of 7d in 10 ml of tert-C4H9NH2 was heated at 60° C. for 24 hr in a closed vial. The reaction mixture was concentrated and the residue was diluted with 15 ml of 1M aq. K2CO3. Then, the product was extracted with ethyl acetate. The organic layer was washed once with sat. NaCl solution, dried and concentrated to provide 830 mg of 7e as a yellowish oil.",methane sulphonic acid | 7d | tert-C4H9NH2 | K2CO3 | ethyl acetate | NaCl | 7e
US06780913B2,"An aqueous solution was prepared by dissolving 72.5 g of boric acid (B2O3 content of 56.3%) in 1000 ml of pure water. To the aqueous solution were added 95.7 g of a zinc flower (ZnO content of 99.4%) and 217.5 g of boric acid (B2O3 content of 56.3%), and were stirred and mixed together such that the molar ratio of B2O3/ZnO was 2.0. Next, the solution was stirred and reacted at 60° C. for 120 minutes. The solution was further stirred and reacted at 80° C. for 8 hours. The obtained product was filtered, washed with water and was, then, dried at 105° C. to obtain a zinc borate (sample A-4). Table 3 shows the chemical composition and properties of the thus obtained zinc borate (sample A-4), FIG. 8 shows an X-ray diffraction image thereof, and FIG. 9 shows an electron microphotograph thereof.",boric acid | water | zinc | ZnO | boric acid | B2O3/ZnO | water | zinc borate
US20160172606A1,"5-Dibenzofuran-4-yl-1-(3,5-dimethylphenyl)-3-phenyl-benzimidazol-3-ium chloride (0.88 g, 1.74 mmol) is dissolved in 50 ml of methanol and the solution is cooled to 0° C. Sodium methanolate (0.47 g, 2.61 mmol in a 30% methanol solution) is added dropwise to the reaction mixture, which is then left stirring overnight at room temperature. After diluting the reaction mixture with 25 ml of methanol, sodium methanolate (0.16 g, 0.87 mmol dissolved in a 30% methanol solution) is again added dropwise. After stirring over weekend at room temperature, the suspension is cooled down to 0° C., filtered and the solid washed with cold methanol. The desired product is isolated as a white solid in 85% yield (0.73 g).","5-Dibenzofuran-4-yl-1-(3,5-dimethylphenyl)-3-phenyl-benzimidazol-3-ium chloride | methanol | Sodium methanolate | methanol | methanol | sodium methanolate | methanol | methanol | desired product"
US09290517B2,"A flask was charged with 4-[2-[[(3R,3aR,6R,6aR)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-6-chloro-1-(2-trimethylsilylethoxymethyl)-imidazo[4,5-b]pyridin-5-yl]benzonitrile (209.8 mg, 0.397 mmol), formic acid (3.6 ml, 94 mmol), and saturated aqueous KHSO4 (0.4 ml). The reaction mixture was heated to 40° C. for 16 h. Then the reaction mixture was cooled to room temperature before being cooled to 0° C. in an ice bath. A 50% weight solution of aqueous NaOH (5.3 ml, 200.7 mmol) was added to the reaction mixture, which solidified after being removed from the ice bath and was allowed to warm to room temperature. The reaction mixture was diluted with THF (2.0 ml) and water (10.0 ml) to give a hazy biphasic mixture with a pH of 14 that was stirred at room temperature for 30 min. The pH was adjusted to 5 by the addition of 2 N aqueous HCl. The reaction mixture was partitioned between EtOAc (50 ml) and water (20 ml). The aqueous layer was extracted with EtOAc (2×50 ml). The organic layers were combined, washed with brine (1×30 ml), dried over Na2SO4, filtered, and evaporated under reduced pressure to give a light pink residue. This material was purified by preparative HPLC reverse phase (C-18), using a 30×150 mm Sunfire™ column and eluting with a 20%-100% acetonitrile/water+0.05% TFA gradient, followed by a 100% acetonitrile+0.05% TFA flush. The product fractions were combined, evaporated under reduced pressure, and lyophilized from ethanol and benzene to give the title compound as a white solid. LC-MS: calculated for C19H15ClN4O4 398.08 observed m/e: 399.09 (M+H)+ (Rt 1.07/2 min); 1H NMR δ (ppm) (CD3OD): 7.84 (s, 1H), 7.84 (qt, J=8.3 Hz, 4H), 5.54 (qt, J=5.3 Hz, 1H), 4.96 (t, J=5.2 Hz, 1H), 4.46 (t, J=5.0 Hz, 1H), 4.25-4.30 (m, 1H), 4.16 (dd, J=5.6 Hz, J=10.2, 1H), 4.11 (dd, J=4.7 Hz, J=10.2 Hz, 1H), 3.89 (dd, J=7.0 Hz, J=8.1 Hz, 1H), 3.59 (t, J=8.6 Hz, 1H).","4-[2-[[(3R,3aR,6R,6aR)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]oxy]-6-chloro-1-(2-trimethylsilylethoxymethyl)-imidazo[4,5-b]pyridin-5-yl]benzonitrile | formic acid | KHSO4 | ice | NaOH | ice | THF | water | HCl | EtOAc | water | EtOAc | brine | Na2SO4 | acetonitrile/water | title compound"
US20090062358A1,"1-[4-[4-(1-Ethoxycarbonyl-1-methylethoxy)phenyl]butyryl]-2-(3-methoxyphenylmethyl)semicarbazide (4.08 g, 8.65 mmol) was dissolved in ethyl acetate (7.5 mL). IS (+)-10-camphorsulfonic acid (2.21 g, 9.51 mmol) was added in one portion and the solution was heated to reflux overnight. The solution was cooled to rt and washed with sat'd aq. NaHCO3 (40 mL×2) followed by 1N HCl (40 mL×2). The organic was concentrated to an orange oil. This oil was redissolved in ethyl acetate (40 mL). Amberlyst-15 resin (4.41 g) was added and the mixture was heated to 50° C. and stirred for 4 hours to remove de-ureated impurity. The mixture was then cooled to ambient temperature, filtered, concentrated, and purified by column chromatography (SiO2, 9:1 ethyl acetate:hexanes) to afford the title compound as an orange oil (1.93 g, 49.2%). 1H NMR (DMSO-d6) δ 11.47 (s, 1H), 7.22 (t, 1H, J=8 Hz), 7.04 (d, 2H, J=8 Hz), 6.82 (d, 1H, J=2 Hz), 6.76 (m, 2H), 6.68 (d, 2H, J=2 Hz), 4.73 (s, 2H), 4.13 (q, 2H, J=7 Hz), 3.69 (s, 3H), 2.48 (t, 2H, J=8 Hz), 2.36 (t, 2H, J=8 Hz), 1.80 (quint, 2H, J=7 Hz), 1.47 (s, 6H), 1.14 (t, 3H, J=7 Hz); 13C NMR (DMSO-d6) δ 174.0, 160.0, 155.0, 153.8, 146.7, 139.8, 135.5, 130.2, 129.8, 120.1, 119.5, 113.8, 113.2, 79.2, 61.6, 55.6, 47.8, 34.0, 28.4, 26.2, 25.7, 14.6; IR (CHCl3) 2940, 1692, 1508, 1467 cm−1; Anal. Calcd. for C25H31N3O5: C, 66.21; H, 6.89; N, 9.26. Found: C, 66.29; H, 6.75; N, 9.19.",1-[4-[4-(1-Ethoxycarbonyl-1-methylethoxy)phenyl]butyryl]-2-(3-methoxyphenylmethyl)semicarbazide | ethyl acetate | (+)-10-camphorsulfonic acid | NaHCO3 | ethyl acetate | resin | SiO2 | ethyl acetate | hexanes | title compound
US07101911B2,"EDC (14.0 g, 73.0 mmol) and DMAP (4.0 g) are added to a solution of 3,5-dibromobenzoic acid (10.0 g, 36.0 mmol) and tert-butanol (3.4 g, 46.8 mmol) in absolute CH2Cl2 (100 ml) and absolute pyridine (30 ml), and the mixture is stirred at RT for 1 h and then at 50° C. for 2 h. The reaction solution is diluted with CH2Cl2 (100 ml) and extracted with a semisaturated aqueous NH4Cl solution (200 ml) (2×), dried over MgSO4, filtered off and concentrated under reduced pressure. Further purification by chromatography [toluene/acetone (95:5)] on a silica gel column gives the title compound (7.7 g) as slightly yellow crystals. TLC, silica gel, glass plates, [toluene/acetone (7.5:2.5)], Rf=0.78.","EDC | DMAP | 3,5-dibromobenzoic acid | tert-butanol | CH2Cl2 | pyridine | CH2Cl2 | NH4Cl | MgSO4 | toluene/acetone | silica gel | title compound"
US07592373B2,Prepared analogously to Example 1.2.b. from 2-(4-iodophenyl)ethanol and methanesulfonic acid chloride. Yield: 5.7 g (77.4% of theory); C9H11IO3S (M=326.15); calc.: molecular ion peak (M)+: 326; found: molecular ion peak (M)+: 326.,2-(4-iodophenyl)ethanol | methanesulfonic acid chloride
US06512107B2,"107.0 g (0.232 mole) of the compound (13) was dissolved in 1070 ml of dichloromethane and 214 ml of dimethylformamide, to which 62.5 g (37.2 ml, 0.463 mole) of sulfuryl chloride was added dropwise at a low temperature (−10 to −78° C.). The resulting solution was stirred at room temperature for 3 hours and then cooled in an ice-bath. The solution was stirred while 157.8 g (2.32 mole) of imidazole was added portionwise at the rate keeping the temperature of reaction mixture under 5° C. The resulting mixture was stirred at room temperature for 20 hours, after which 400 ml of ice-water was added. The aqueous layer was extracted three times with 100 ml of dichloromethane (3×100 ml). The combined organic solution was washed with 200 ml of brine and dried over MgSO4. The solvent was removed under reduced pressure and dimethylformamide was removed under high vacuum. The syrupy residue was coevaporated with 100 ml of 2-propanol under reduced pressure to obtain a white solid product (14), which was used for the next reaction without further purification.",dichloromethane | dimethylformamide | sulfuryl chloride | ice | imidazole | ice-water | dichloromethane | brine | MgSO4 | dimethylformamide
US20150322024A1,"An aqueous solution (50 ml) of sodium hydroxide (0.3 g, 7.0 mmol) was added to a methanol (30 mL) solution of the compound obtained in Example 67 (0.6 g, 2.0 mmol) at room temperature, and the mixture was stirred at 80° C. for 3 hours. The reaction mixture was made acidic with a diluted hydrochloric acid, and the solvents were then distilled off under a reduced pressure. The residue was dissolved in methanol, insoluble substances were filtered away, and the solvents were then distilled off under a reduced pressure. The obtained residue was dissolved in methylene chloride (10 mL), and a 4 mol/L hydrogen chloride-dioxane solution (3 mL, equivalent to HCl 12 mmol) was added dropwise thereto at room temperature. The mixture was stirred in that state for 24 hours, and the solvents were then distilled off under a reduced pressure, to give the captioned compound (0.8 g, 99%) as crystals.",sodium hydroxide | methanol | compound | hydrochloric acid | methanol | methylene chloride | hydrogen chloride-dioxane | compound
US09303035B2,"A mixture of benzyl (1-(1,3-dimethyl-2,4-dioxo-5-phenyl-3,4-dihydro-1H-pyrrolo[3,4-d]pyrimidin-6(2H)-yl)-3-hydroxypropan-2-yl)carbamate and 1,3-dimethyl-6-((2-oxooxazolidin-4-yl)methyl)-5-phenyl-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,6H)-dione (1.67 g) and 10% palladium on carbon (200 mg, 3.61 mmol) were suspended in ethanol (50 ml) and stirred under an atmosphere of hydrogen for 18 hours. The mixture was passed through pre-packed Celite® cartridge (10 g, filter material) and the residue washed with ethanol (20 ml). The combined filtrates were evaporated under vacuum. The residue was suspended in THF (18 ml) and water (5 ml). Lithium hydroxide (20 mg) was added and the mixture stirred at room temperature for 4 hours, then quenched with 2M HCl (aq). NaHCO3(aq) solution (20 ml) was added to achieve pH 6 and the mixture extracted with DCM (3×30 ml), passed through a hydrophobic frit and evaporated under vacuum to afford the title compound.","benzyl (1-(1,3-dimethyl-2,4-dioxo-5-phenyl-3,4-dihydro-1H-pyrrolo[3,4-d]pyrimidin-6(2H)-yl)-3-hydroxypropan-2-yl)carbamate | 1,3-dimethyl-6-((2-oxooxazolidin-4-yl)methyl)-5-phenyl-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,6H)-dione | palladium on carbon | ethanol | hydrogen | ethanol | Lithium hydroxide | HCl | NaHCO3 | DCM | title compound"
US20150031670A1,"A solution of 1-phenylpiperidin-2-one (1.3 g) in THF (20 ml) is deprotonated using lithium bistrimethylsilylamide (1M in THF) (15 ml) at −78° C. under nitrogen. After one hour, ethyl chloroformate (0.806 g) is added dropwise at the temperature indicated, and the cooling bath is removed. When the reaction is complete, the mixture is worked up using ice-water and extracted with ethyl acetate. The organic phase is washed with 10% sodium bicarbonate solution and saturated sodium chloride solution. After drying and evaporation, the residue is chromatographed on silica gel, giving 600 mg (32%) of a pale-brown liquid;",1-phenylpiperidin-2-one | THF | lithium bistrimethylsilylamide | ethyl chloroformate | ethyl acetate | sodium bicarbonate | sodium chloride | silica gel | pale-brown liquid
US20090291988A1,"To a −15° C. solution of 14-bromophenyl)cyclopropanecarboxylic acid from Step 3 (1.5 g) in chloroform (60 mL) were slowly added isobutyl chloroformate (900 μL) and triethylamine (1.1 mL). The reaction mixture was stirred at −15° C. for 2 hours. Then it was saturated with ammonia gas and stirred at −15° C. for 10 minutes. The reaction mixture was allowed to stand at room temperature for 1 hour then poured into water (60 mL) and partitioned. The aqueous layer was extracted with dichloromethane (2×60 mL). The combined extracts were washed with brine, dried with magnesium sulfate and the solvent removed in vacuo. The residue was purified by swish using diethyl ether and hexanes to yield the title compound.",cyclopropanecarboxylic acid | chloroform | isobutyl chloroformate | triethylamine | ammonia | water | dichloromethane | brine | magnesium sulfate | title compound
US20150239889A1,"To a suspension of ethyl 1-[3-bromo-1-(cyclohexylmethyl)-7-methoxy-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-1H-pyrazole-4-carboxylate prepared in Reference Example 462 (76 mg), trimethylboroxine (46 μL), tripotassium phosphate (104 mg) in 1,4-dioxane (2 mL) was added bis(di-t-butyl(4-dimethylaminophenyl)phosphine)dichloropalladium(II) (12 mg), and the reaction mixture was stirred for 3 hours at 100° C. NH-silica gel (5 mL) and sodium sulfate (5 g) were added to the reaction mixture, and the insoluble materials were removed by filtration. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (solvent: hexane/ethyl acetate=85/15 to 80/20) to yield the titled compound (50 mg, 77% yield) as a colorless solid.","ethyl 1-[3-bromo-1-(cyclohexylmethyl)-7-methoxy-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-1H-pyrazole-4-carboxylate | Example 462 | trimethylboroxine | tripotassium phosphate | 1,4-dioxane | bis(di-t-butyl(4-dimethylaminophenyl)phosphine)dichloropalladium(II) | silica gel | sodium sulfate | silica gel | hexane/ethyl acetate | titled compound"
US20050137408A1,"2-Propanol (9.2 ml) and 5% aqueous sodium hydrogen carbonate solution (0.379 mg) were added to (2S,3S)-N-tert-butoxycarbonyl-3-amino-4-(4-benzyloxyphenyl)-1-chloro-2-hydroxybutane (0.915 g, (2S,3S)/(2R,3S)=84.5/15.5) obtained in the same manner as in Reference Example 8.20% palladium hydroxide on carbon (0.046 g, manufactured by Kawaken Fine Chemicals Co., Ltd., moisture content 49.1%) was added under an argon atmosphere, and the mixture was stirred under a hydrogen atmosphere at 40° C. for 30 min. Palladium hydroxide on carbon was removed by filtration, and the filtered palladium hydroxide on carbon was washed with a mixed solution of 2-propanol (1.8 ml) and 6N aqueous sodium hydroxide solution (1.08 ml). The obtained reaction mixture was stirred at 20° C. for 2 hr. Water (9.4 ml) and citric acid (0.433 g) were added to this reaction mixture to quench the reaction. This reaction mixture was stirred at 0° C. for 1 hr, and the obtained crystals were collected by filtration. The crystals were washed with a mixed solution of 2-propanol (0.75 ml) and water (2.3 ml) and then further washed with water (9.2 ml, 9.2 ml). The obtained crystals were dried under reduced pressure to give the object (2S,3S)-N-tert-butoxycarbonyl-3-amino-1,2-epoxy-4-(4-hydroxyphenyl)butane (0.466 g, yield 74%, (2S,3S)/(2R,3S)=97.712.3).","2-Propanol | sodium hydrogen carbonate | hydrogen | (2S,3S)-N-tert-butoxycarbonyl-3-amino-4-(4-benzyloxyphenyl)-1-chloro-2-hydroxybutane | palladium hydroxide on carbon | argon | Palladium hydroxide on carbon | palladium hydroxide on carbon | 2-propanol | sodium hydroxide | Water | citric acid | 2-propanol | water | water | (2S,3S)-N-tert-butoxycarbonyl-3-amino-1,2-epoxy-4-(4-hydroxyphenyl)butane"
US06835745B2,"Starting from 2-[3-bromo-5-(4-methoxy-2-methylphenyl)-4-methylthien-2-yl]-1,3-dioxolane (0.96 g, 2.6 mmol, made in Example 11, Step 1) and substituting 3-fluoro-4-methoxyphenylboronic acid (0.57 g, 3.4 mmol) in place of 3-methoxyphenylboronic acid (Step 2), the title compound (0.40 g, 67%) was synthesized in essentially the same manner as described in Example 1, Steps 2-4.","2-[3-bromo-5-(4-methoxy-2-methylphenyl)-4-methylthien-2-yl]-1,3-dioxolane | 3-fluoro-4-methoxyphenylboronic acid | title compound"
US07018998B2,"Prepared from (3-amino-2′,3′-difluoro-biphenyl-4-yl)-carbamic acid tert.-butyl ester (Example G49) (160 mg, 0.5 mmol) and 3-(2,2-dimethyl-6-oxo-6H-[1,3]dioxin-4-yl)-benzonitrile (Example J4) (115 mg, 0.5 mmol) according to the general procedure K. Obtainedas a white solid (53 mg).","(3-amino-2′,3′-difluoro-biphenyl-4-yl)-carbamic acid tert.-butyl ester | 3-(2,2-dimethyl-6-oxo-6H-[1,3]dioxin-4-yl)-benzonitrile | solid"
US08846733B2,"In a flame dried round-bottomed flask equipped with a magnetic stir bar and under inert atmosphere (N2), a solution of 2-bromo-5-(((tert-butyldimethylsilyl)oxy)methyl)thiazole (WO 2009/077990, p. 92) (2.0 g, 6.49 mmol) in Et2O (14.0 mL) was treated dropwise at −70° C. with n-BuLi (4.25 mL of a 1.6M solution in hexane, 6.81 mmol). The resulting mixture was stirred for 30 min at −70° C. DMF (0.80 mL, 10.38 mmol) was then added and the resulting mixture was stirred for 20 min at −70° C. Sat. aq. NH4Cl was added, the org. layer was extracted with EA (3×20 mL) and the combined org. layers were dried over MgSO4, filtered and the solvent was removed under reduced pressure to give 1.50 g of 5-(((tert-butyldimethylsilyl)oxy)methyl)thiazole-2-carbaldehyde as a yellow oil: TLC: rf (9:1 hept-EA)=0.31. LC-MS-conditions 07: tR=1.00 min, [M+H]+=257.93. A solution of this material in MeOH (10 mL) was treated at 0° C. with NaBH4 (286 mg, 7.25 mmol). After 30 min at 0° C., water followed by EA were added. The org. layer was extracted with EA (3×20 mL) and the combined org. layers were dried over Na2SO4, filtered and the solvent was removed under reduced pressure. Purification of the residue by FC (1:1 hept-EA) gave the title compound as a yellow oil: TLC: rf (1:1 hept-EA)=0.33. LC-MS-conditions 07: tR=0.87 min, [M+H]+=260.06.",N2 | 2-bromo-5-(((tert-butyldimethylsilyl)oxy)methyl)thiazole | Et2O | n-BuLi | hexane | DMF | NH4Cl | EA | MgSO4 | 5-(((tert-butyldimethylsilyl)oxy)methyl)thiazole-2-carbaldehyde
US08202865B2,"Oxalyl chloride (190.39 mg; 1.50 mmol; 3 eq.) was added to a suspension of Intermediate 28 (143.64 mg; 0.50 mmol; 1 eq.) and DMF (cat.) in DCM (2 mL) and the resulting mixture was stirred at RT for 1 hour. After evaporation to dryness, the residue was taken up in THF (2 mL) and added to solution of Intermediate 52 (108.62 mg; 0.50 mmol; 1 eq.) and DIEA (193.87 mg; 1.50 mmol; 3 eq.) in THF (1 mL). The resulting mixture was heated to 150° C. for 30 minutes in the microwave. It was then filtered through a SPE-NH2 column, which was further washed with THF. After evaporation, the residue was purified by FC(C-Hex/EtOAc 9:1 until 5:5), affording the title product as a off-white solid. LC/MS (Method B): 451.2 (M+H)+. HPLC (Method A) Rt 6.0 min (Purity: 89.6%).",Oxalyl chloride | Intermediate 28 | DMF | DCM | THF | Intermediate 52 | DIEA | THF | NH2 | C-Hex/EtOAc | title product
US06207677B1,"The title compound, 11a, was prepared from 3-(2,3-dihydro-5-fluoro-benzofuran-3-yl)-1-propyl methanesulfonate (4.2 g) and 4-(4-fluorophenyl)piperidine (5.5 g) by the method described in EXAMPLE 2. Yield: 1.8 g, mp: 83-85° C.","title compound | 11a | 3-(2,3-dihydro-5-fluoro-benzofuran-3-yl)-1-propyl methanesulfonate | 4-(4-fluorophenyl)piperidine"
US07741327B2,"To a solution containing (S)-3-cyclohexyl-2-(4-methoxy-2-oxo-2,5-dihydro-pyrrol-1-yl)-propionic acid methyl ester (1.82 g, 6.48 mmol) in tetrahydrofuran (15 mL) was treated with an aqueous solution of lithium hydroxide monohydrate (8.4 mL, 1.0 M, 8.42 mmol). The mixture was stirred at 25° C. for 2 h then, acidified with 2N aqueous hydrochloric acid. The mixture was extracted with ethyl acetate (2×30 mL). The combined organic layers were dried over magnesium sulfate and concentrated to afford (S)-3-cyclohexyl-2-(4-methoxy-2-oxo-2,5-dihydro-pyrrol-1-yl)-propionic acid, (1.35 g, 75%) as a yellow solid.","(S)-3-cyclohexyl-2-(4-methoxy-2-oxo-2,5-dihydro-pyrrol-1-yl)-propionic acid methyl ester | (S)-3-cyclohexyl-2-(4-methoxy-2-oxo-2,5-dihydro-pyrrol-1-yl)-propionic acid | tetrahydrofuran | lithium hydroxide monohydrate | hydrochloric acid | ethyl acetate | magnesium sulfate"
US08129398B2,"To a solution of tert-butyl 2-fluoroethylcarbamate (4.1 g, 25.1 mmol) in THF (100 mL) at 0° C. was added sodium hydride, 60 wt % in mineral oil (1.507 g, 37.7 mmol) portion-wise. The reaction was stirred under N2 for 15 minutes after which gas evolution ceased. Iodomethane (2.356 mL, 37.7 mmol) was added drop-wise and the reaction stirred under N2. After 6 h, the reaction was quenched with water (100 mL) and concentrated. The aqueous solution was washed with CH2Cl2 (3×50 mL). The CH2Cl2 extracts were combined, washed with water (2×100 mL), dried (MgSO4) and concentrated to afford the title compound (4.0 g, 90% yield) as a clear oil. 1H NMR (400 MHz, CDCl3) δ: 4.58 (1H, brs), 4.47 (1 H, brs), 3.53 (1 H, brs), 3.47 (1 H, brs), 2.94 (3 H, s), 1.45 (9 H, s).",tert-butyl 2-fluoroethylcarbamate | THF | sodium hydride | oil | N2 | Iodomethane | N2 | water | CH2Cl2 | water | MgSO4 | title compound
US20070060563A1,"Hydroxy-diphenyl-acetic acid (R)-(1-aza-bicyclo[2.2.2]oct-3-yl) ester (1 g, 2.97 mmol) and 3-(BOC-amino)propylbromide (1.06 g, 4.73 mmol) are dissolved in DMF (10 ml) and stirred to 60° C. for 4 hours. The solvent is removed in vacuo and purification of the crude residue by chromatography on C18 silica, eluting with water:acetonitrile affords the title compound as a colourless foam.",Hydroxy-diphenyl-acetic acid (R)-(1-aza-bicyclo[2.2.2]oct-3-yl) ester | 3-(BOC-amino)propylbromide | DMF | crude residue | silica | water | acetonitrile | title compound
US09045420B2,"A mixture of EXAMPLE 306C (1.4 g), methanesulfonyl chloride (1.054 mL), triethylamine (2.99 mL), and 4-(dimethylamino)pyridine (0.051 g) in CH2Cl2 (20 mL) was stirred at 0° C. for 2 hours, concentrated and chromatographed on silica gel with 30% ethyl acetate in hexanes as eluent to give the product.",mixture | methanesulfonyl chloride | triethylamine | 4-(dimethylamino)pyridine | CH2Cl2 | silica gel | ethyl acetate | hexanes
US08063249B1,"(E)-6-(4,4,5,5,5-pentafluoropentylthio)-N-(2-(4-(2-phenyl-1-(4-(triisopropylsilyloxy)phenyl)but-1-enyl)phenoxy)ethyl)hexan-1-amine from reaction 6 is dissolved in acetonitrile. To this solution is added HF/pyridine complex. The mixture is stirred until the reaction is complete (TLC). When the reaction is complete, the mixture is washed with dilute hydrochloric acid, dilute sodium bicarbonate and water. The aqueous layers are extracted with ethyl acetate. The combined organic extracts are dried over sodium sulfate, filtered, and concentrated under reduced pressure to afford (Z)-4-(1-(4-(2-(6-(4,4,5,5,5-pentafluoropentylthio)hexylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol among other products.","(E)-6-(4,4,5,5,5-pentafluoropentylthio)-N-(2-(4-(2-phenyl-1-(4-(triisopropylsilyloxy)phenyl)but-1-enyl)phenoxy)ethyl)hexan-1-amine | acetonitrile | pyridine | hydrochloric acid | sodium bicarbonate | water | ethyl acetate | sodium sulfate | (Z)-4-(1-(4-(2-(6-(4,4,5,5,5-pentafluoropentylthio)hexylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol"
US20160016908A1,"4-Methoxyaniline (200 mg, 1.624 mmol) was taken up in DCM (7 mL) under nitrogen and cyclopropanecarbaldehyde (0.182 mL, 2.436 mmol) added. The reaction was stirred at rt for 2 h with molecular sieves (25 g). The reaction was cooled in an ice-bath for 10 min then (E)-benzyl prop-1-en-1-ylcarbamate (for a preparation see Intermediate 1, 342 mg, 1.786 mmol) in DCM (3 mL) was added. (11bS)-2,6-bis(4-chlorophenyl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepine 4-oxide (for a preparation see JACS, 2011, 133, 14804, 9.38 mg, 0.016 mmol) was then added in one portion and the reaction left to stir for 16 h. The reaction mixture was filtered and washed with DCM (10 mL), then washed with sat. NaHCO3 (10 mL). The organic phase was filtered through a hydrophobic frit and evaporated in vacuo giving a white solid. The sample was loaded in dichloromethane (1 mL) and purified on silica gel (25 g) cartridge using a 0-50% ethyl acetate-cyclohexane over 10 CV. The appropriate fractions were combined and evaporated in vacuo to give the required product (287.6 mg) as a white solid. Analysis by chiral HPLC was undertaken using a 250×4.6 mm Chiralcel OJ column eluting with 25% ethanol in heptane at a flow rate of 1 mL/min. Peak 1/minor enantiomer (3% by UV) eluted at 9.6 min, and Peak 2/major enantiomer (97% by UV) eluted at 15.9 min. This indicated the product had an ee of >94%. LCMS (2 min HpH): Rt=1.21 min, [MH]+=367.","4-Methoxyaniline | DCM | cyclopropanecarbaldehyde | ice | (E)-benzyl prop-1-en-1-ylcarbamate | Intermediate 1 | DCM | (11bS)-2,6-bis(4-chlorophenyl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepine 4-oxide | DCM | NaHCO3 | dichloromethane | silica gel | required product"
US07361687B2,"A suspension of 2.55 g (37.8 mM) of methanamine hydrochloride is prepared in 120 ml of dichloromethane (DCM) and 7.5 g of 2,4-dichloro-3-methylbenzenesulphonyl chloride in solution in 30 ml of DCM, and 10.5 ml of triethylamine, are added; the reaction mixture is kept under agitation for 15 hours at ambient temperature and then washed with a solution of 1N hydrochloric acid, with a solution of sodium bicarbonate, and then with water. The organic phase is dried over magnesium sulphate and then concentrated under reduced pressure. The solid residue obtained is purified by chromatography on silica gel in eluting with the aid of a mixture of cyclohexane/ethyl acetate (8/2, v/v). 6.2 g of the expected compound are thus obtained as a white solid (yield=85%).","methanamine hydrochloride | dichloromethane | DCM | 2,4-dichloro-3-methylbenzenesulphonyl chloride | triethylamine | hydrochloric acid | sodium bicarbonate | magnesium sulphate | solid | silica gel | cyclohexane/ethyl acetate | expected compound"
US09290505B2,"X-ray powder diffraction (XRPD) analysis of the monomesylate (MSA) and succinate forms of the compound of Example 2 herein were conducted on a diffractometer (PANanalytical XPERT-PRO, PANalytical B.V., Almelo, Netherlands) using copper radiation (Cu Kα, λ=1.5418 Å). Samples were prepared for analysis by depositing the powdered sample in the center of an aluminum holder equipped with a zero background plate. The generator was operated at a voltage of 45 kV and amperage of 40 mA. Slits used were Soller 0.02 rad., antiscatter 1.0°, and divergence. The sample rotation speed was 2 sec. Scans were performed from 2 to 40° 2-theta. Data analysis was performed by X'Pert Highscore version 2.2c (PANalytical B.V., Almelo, Netherlands) and X'Pert data viewer version 1.2d (PANalytical B.V., Almelo, Netherlands). The XRPD patterns for Mono MSA Forms I & II were obtained using the instrument setting as follows: 45 KV, 40 mA, Cu Kα, λ=1.5418 Å, scan range 2.-40°, step size 0.0167°, counting time: 15.875 s. The XRPD patterns for Succinate Forms I & II were obtained using the instrument setting as follows: 45 KV, 40 mA, Cu Kα, λ=1.5418 Å, scan range 2.-40°, step size 0.0084°, counting time: 95.250 s.",monomesylate | MSA | succinate | compound | XPERT-PRO | copper | aluminum | 40 | 2.2c | 1.2d | II
US06001883,"A mixture of ethyl 6-chloro-2-methoxybenzoate (1.8 g, 8.4 mmol), bromine (1.41 g, 8.8 mmol) and acetic acid (5 ml) is stirred at room temperature for 24 hours. The reaction mixture is poured into water and extracted with ethyl acetate. The organic phase is separated and concentrated and the residue is purified by column chromatography (petrol ether:ethyl acetate, 95:5 v/v) yielding the pure product as a yellow oil, 1.7 g, (69%).",ethyl 6-chloro-2-methoxybenzoate | bromine | acetic acid | water | ethyl acetate | petrol ether | ethyl acetate | product
US20110230478A1,"At 0° C., 0.96 g (24.1 mmol) of sodium hydride (60% in paraffin) is added a little at a time to a solution of 2.04 g (20.4 mmol) of 1-methylimidazolidin-2-one in 50 ml of tetrahydrofuran, and the reaction mixture is stirred for 30 min. A solution of 4.00 g (18.5 mmol) of 3-nitrobenzyl bromide in tetrahydrofuran is added dropwise to the solution, and the mixture is allowed to warm to room temperature. After 3 h, the reaction mixture is stirred into 250 ml of ice-water/dil. hydrochloric acid (1:1) and extracted with ethyl acetate (2×100 ml). The combined organic phases are washed with 100 ml of water, dried over MgSO4, filtered through silica gel and freed from the solvent under reduced pressure. This gives 3.56 g (81%) of 1-methyl-3-(3-nitrobenzyl)imidazolidin-2-one (logP (pH 2.3): 2.03), 1H NMR (400 MHz, DMSO-d) δ=8.12 (d, 1H), 8.07 (s, 1H), 7.70 (d, 1H), 7.63 (dd, 1H), 4.40 (s, 2H), 3.30-3.18 (m, 4H), 2.70 (s, 3H), which is initially charged in an autoclave with 1 g of Pd/C (10%) in 100 ml of methanol and subjected to a hydrogen pressure of 5 bar at 30° C. After 10 h, the catalyst is filtered off and the filtrate is concentrated under reduced pressure. This gives 2.20 g (78%) of 1-(3-aminobenzyl)-3-methylimidazolidin-2-one (IV-5) (logP (pH 2.3): 0.08). 1H NMR (400 MHz, DMSO-d) δ=6.95 (dd, 1H), 6.46 (d, 1H), 6.44 (s, 1H), 6.36 (d, 1H), 4.85 (br.s, 2H), 4.09 (s, 2H), 3.23-3.09 (m, 4H), 2.67 (s, 3H).",sodium hydride | 1-methylimidazolidin-2-one | tetrahydrofuran | 3-nitrobenzyl bromide | tetrahydrofuran | ice-water | water | hydrochloric acid | ethyl acetate | MgSO4 | silica gel | 1-methyl-3-(3-nitrobenzyl)imidazolidin-2-one | Pd/C | methanol | hydrogen
US06472403B2,"A mixture of 2-6 (29.0 g, 47.0 mmol) and 10% Pd/C (7.25 g) in EtOH (500 mL) was stirred under a balloon of hydrogen for 18 h. Filtration through celite and evaporative removal of the solvent followed by purification on silica gel (90:10:1 CHCl3:MeOH:NHOH) afforded 13 g of 2-7.",2-6 | Pd/C | EtOH | hydrogen | silica gel | 2-7
US08759520B2,"A solution of 4-{3-[3-(4-fluoro-phenoxy)-propyl]-2-imino-2,3-dihydro-benzoimidazol-1-ylmethyl}-benzaldehyde, hydrobromide salt (0.25 g, 0.52 mmol), 2-amino-N-(4-chloro-phenyl)-acetamide (114 mg, 0.62 mmol) and sodium triacetoxyborohydride (0.183 g, 0.87 mmol) in 1,2-dichloroethane (25 ml) was stirred at 0° C. and then slowly warmed to rt where it was maintained for 16 h. After this time a saturated solution of KHSO4 was introduced and the suspension was filtered. The collected solid was washed with MeOH and H2O and then dried to provide N-(3-chloro-phenyl)-2-(4-{3-[3-(4-fluoro-phenoxy)-propyl]-2-imino-2,3-dihydro-benzoimidazol-1-ylmethyl}-benzylamino)-acetamide (50 mg, 17%). HPLC-MS 572 [M+1]+, 287.","4-{3-[3-(4-fluoro-phenoxy)-propyl]-2-imino-2,3-dihydro-benzoimidazol-1-ylmethyl}-benzaldehyde, hydrobromide salt | 2-amino-N-(4-chloro-phenyl)-acetamide | sodium triacetoxyborohydride | 1,2-dichloroethane | KHSO4 | MeOH | H2O | N-(3-chloro-phenyl)-2-(4-{3-[3-(4-fluoro-phenoxy)-propyl]-2-imino-2,3-dihydro-benzoimidazol-1-ylmethyl}-benzylamino)-acetamide"
US20150274767A1,"4-chloro-7H-pyrrolo[2,3-d]pyrimidine (5 g, 32.6 mmol) and SELECTFLUOR® (1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)) (17.30 g, 48.8 mmol) were placed in a 500 mL round-bottom flask under argon atmosphere. To the above was added dry acetonitrile (150 mL) and dry acetic acid (50 mL). The mixture was heated at 70° C. and stirred for 16 hours. After cooling down to room temperature, the solvents were removed under reduced pressure and the residue was co-evaporated with toluene. The crude solid was dissolved in a mixture of dichloromethane/ethyl acetate (1:1) and filtered through a pad of silica gel. The combined organic phases were evaporated under reduced pressure. The crude product was then purified by silica gel chromatography with dichloromethane/ethyl acetate (5:1) to give the title compound. 1H-NMR: (400 MHz, d6-DMSO, ppm): δ 12.48 (brs, 1H), 8.62 (s, 1H), 7.71 (t, J=2.6 Hz, 1H). F-NMR: (376 MHz, d6-DMSO, ppm): δ −170.76 (s, 1F). LC-MS: (ES, m/z): 172.00 [M+H]+.","4-chloro-7H-pyrrolo[2,3-d]pyrimidine | SELECTFLUOR | 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) | argon | acetonitrile | acetic acid | dichloromethane/ethyl acetate | silica gel | crude product | silica gel | dichloromethane/ethyl acetate | title compound"
US06759549B2,"A 2 L autoclave was charged with acetamide (VII) (129.8 g, 2.2 mole), THF (1 L), and acetic acid (45 g) and was purged with argon for 10 min. Under the argon purge, Co2(CO)8 (20.9 g, 0.06 mole) was added. After sealing the autoclave, 150 psi (1034 kPa) of CO:H2 (95:5) was established at 25° C. and was slowly vented. Then 2200 psi (15,172 kPa) of CO:H2 (95:5) was established at 25° C. with stirring at 2000 rpm. The contents of the autoclave were heated to 100° C. and 3200 psi (22,069 kPa) CO:H2 (95:5) was established. Under a constant 3200 psi (22,069 kPa), 47 Wt. % formalin (320 mL, 5.28 mole) was delivered at 40 mL/min. The reaction was stirred at 100° C. for 52 min. after the formalin addition was complete. Then the reaction was cooled to 25° C., removed from the autoclave, and assayed for N-acetyliminodiacetic acid. This resulted in a 95% yield of (XVI) and 1% glycine.",acetamide | THF | acetic acid | argon | argon | Co2(CO)8 | formalin | formalin | (XVI) | glycine
US20100105683A1,"A solution of (2-methoxy-5-nitrophenyl)-3-pyrazin-2-yl-urea (Compound 159, Example 3) (16.9 g, 55 mmol) in dimethylformamide (DMF, 320 mL) was shaken under H2 in the presence of palladium on carbon (Pd/C) catalyst (1.6 g, 10% Pd) at 80° C. for 12 h. A second portion of catalyst was added (1.6 g) and shaking was continued for an additional 8 h at the same temperature. The solution was filtered through a pad of celite using an additional 200 mL of DMF. The filtrate was concentrated in vacuo and the residue was triturated with methanol (100 mL). The solid was collected, stirred in boiling methanol, and solids present (1.8 g) were filtered off and discarded. The filtrate was cooled at 4° C. overnight. Solids (1.4 g) were removed by filtration and the filtrate was concentrated in vacuo to a tan solid (2.6 g). The crude solid product was triturated with THF (200 mL), collected by filtration, and dried in vacuo to afford the product as a tan solid (1.85 g, 13%). 1H NMR (300 Mhz, d6-DMSO) δ: 10.10 (s, 1H), 9.94 (br s, 1H), 8.89 (s, 1H), 8.32 (s, 1H), 8.22 (s, 1H), 7.58 (s, 1H), 7.75 (d, 1H), 6.21 (d, 1H), 4.70 (s, 2H), 3.76 (s, 3H). 13C NMR (75 Mhz, d6-DMSO) δ: 151.4, 149.4, 142.6, 140.9, 139.8, 137.2, 135.2, 128.7, 112.8, 107.7, 106.0, 56.8.",(2-methoxy-5-nitrophenyl)-3-pyrazin-2-yl-urea | Compound 159 | dimethylformamide | H2 | palladium on carbon | methanol | solid | Solids | product | THF
US20160002273A1,"To a solution of 2-methylthieno[3,2-d]pyrimidin-4-ol (139; 10.5 g, 63.3 mmol) in DMF (12.2 mL) and 1,2-dichloroethane (250 mL) was added POCl3 (17.6 mL) dropwise at 0° C. The reaction mixture was then heated at 150° C. for 2 h. After cooling down, the mixture was concentrated in vacuo. The residue was neutralized to pH 7 using 2N NaOH. The resulting mixture was diluted with ethyl acetate (150 mL) and water (70 mL). The organic layer was separated, and the aqueous phases were extracted with ethyl acetate (3×100 mL). The combined organic layers were washed with brine, dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified by silica gel column chromatography using 4:1 petroleum ether/ethyl acetate to obtain crude 4-chloro-2-methylthieno[3,2-d]pyrimidine (Compound 140; 11.2 g, 97%). MS (ESI) calcd for C7H5ClN2S: 183.99.","2-methylthieno[3,2-d]pyrimidin-4-ol | DMF | 1,2-dichloroethane | POCl3 | ethyl acetate | water | ethyl acetate | brine | Na2SO4 | silica gel | 4-chloro-2-methylthieno[3,2-d]pyrimidine | Compound 140"
US20150266874A1,"3-(1H-Benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid tert-butylamide (42 mg, 19%) was synthesized as an off-white solid from 3-(1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid ethyl ester (200 mg, 0.781 mmol) and tert-butyl amine (0.41 mL, 3.91 mmol) following the procedure described for 3-(1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid isopropylamide (Example 35). LCMS (EI/CI) m/z: 284.0 [M+H]+.",3-(1H-Benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid tert-butylamide | 3-(1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid ethyl ester | tert-butyl amine | 3-(1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid isopropylamide
US09326986B2,"(Boc)2O (5 g, 23 mmol) was added to a solution of methyl 2-amino-3-nitrobenzoate 11 (4.5 g, 23 mmol) and DMAP (5 g, 46 mmol) in THF. The reaction mixture was stirred at room temperature for 6 hours, concentrated and purified by flash chromatography to give 12 (6.4 g, 70% yield).",(Boc)2O | methyl 2-amino-3-nitrobenzoate | DMAP | THF | 12
US07504508B2,"(2S,4R)-4-(4-{4-[Acetyl-(4-chloro-phenyl)-amino]-2-methyl-3,4-dihydro-2H-quinoline-1-carbonyl}-phenoxy)-cyclohexanecarboxylic acid ethyl ester (0.060, 0.10 mmol) was hydrolyzed to the acid by dissolving in tetrahydrofuran and ethanol and sodium hydroxide (1N) was added. The mixture was stirred at room temperature 10 hours. The mixture was cooled to room temperature, acidified to form a white precipitate. The solid was filtered to give (2S,4R)-4-(4-{4-[acetyl(4-chloro-phenyl)-amino]-2-methyl-3,4-dihydro-2H-quinoline-1-carbonyl}-phenoxy)-cyclohexanecarboxylic acid as a white powder in 62% yield.","(2S,4R)-4-(4-{4-[Acetyl-(4-chloro-phenyl)-amino]-2-methyl-3,4-dihydro-2H-quinoline-1-carbonyl}-phenoxy)-cyclohexanecarboxylic acid ethyl ester | tetrahydrofuran | ethanol | sodium hydroxide | (2S,4R)-4-(4-{4-[acetyl(4-chloro-phenyl)-amino]-2-methyl-3,4-dihydro-2H-quinoline-1-carbonyl}-phenoxy)-cyclohexanecarboxylic acid"
US09051290B2,"To a stirring solution of 4-[2-(1-Aminomethyl-cyclopropylmethoxy)-3,4-dimethoxy-phenyl]-indan-1-one (Compound 182) (100 mg, 0.272 mmol) in dichloromethane (10 mL), were added diisopropylethylamine (0.034 g, 0.272 mmol) and butyryl chloride (29 mg, 0.272 mmol) and the resultant reaction mixture was subjected to the conditions used in the preparation of compound 183 to afford the title compound as a solid.","4-[2-(1-Aminomethyl-cyclopropylmethoxy)-3,4-dimethoxy-phenyl]-indan-1-one | Compound 182 | dichloromethane | diisopropylethylamine | butyryl chloride | compound 183 | title compound"
US09193692B2,"A mixture of 4-bromo-3-fluoro-2-methylaniline (23 g, 113 mmol) and cyanocopper (20.19 g, 225 mmol) N,N-dimethylformamide (200 mL) was heated to 140° C. for 7 h. After the mixture was cooled to room temperature filtered and poured into a separatory funnel containing water and ethyl acetate (1:1). Layers were separated and the organic layer was concentrated under reduced pressure. Flash chromatography (0-50% ethyl acetate in hexane) gave the desired product (11.4 g, 76 mmol, 67% yield) as a brown solid. 1H NMR (400 MHz, CHLOROFORM-d) δ (ppm) 7.22 (t, 1H), 6.45 (d, J=8.59 Hz, 1H), 4.23 (br. s., 2H), 2.07 (s, 3H); MS (ESI) m/z 151.1[M+1]+.",4-bromo-3-fluoro-2-methylaniline | cyanocopper | water | ethyl acetate | ethyl acetate | hexane | desired product
US20150152159A1,"To a solution of 3-hydroxybenzylalcohol (2.4 g, 20 mmol) in THF (50 mL) and water (2.5 mL) was first added powdered sodium hydroxide (1.5 g, 37.5 mmol) and then a solution of propargyl bromide, dissolved as an 80% weight solution in xylene (3.36 mL, 30 mmol), The reaction mixture was heated at reflux for 6 hours. To the mixture was added 10% citric acid (2.5 mL) and the solvent was removed under vacuum. The residue was extracted with ethyl acetate (3×15 mL) and the combined organic layers were washed with saturated NaCl solution (10 mL), dried over MgSO4 and concentrated to give the 3-propargyloxybenzyl alcohol.",3-hydroxybenzylalcohol | THF | water | sodium hydroxide | propargyl bromide | xylene | citric acid | ethyl acetate | NaCl | MgSO4 | 3-propargyloxybenzyl alcohol
US20160194316A1,"To a mixture of 2,5-dimethyl-1H-pyrazol-3(2H)-one (32 g, 285.71 mmol) and POCl3 (128 mL) at 0° C., DMF (26.35 mL, 342.85 mmol) was added slowly. The resulting reaction mixture was stirred at 100° C. for 7 h. The progress of the reaction was monitored by TLC. On completion, the reaction mixture was concentrated to dryness under reduced pressure. The residue obtained was basified with aqueous sodium bicarbonate solution and extracted with ethyl acetate. The combined organic layers were dried over anhydrous Na2SO4 and concentrated under reduced pressure to afford the crude material which then purified by column chromatography giving the title compound (28 g, 62.0%).","2,5-dimethyl-1H-pyrazol-3(2H)-one | POCl3 | DMF | sodium bicarbonate | ethyl acetate | Na2SO4 | crude material | title compound"
US08183240B2,"Ethyl 4-cyano-3-iodo-5-(methylsulfanyl)thiophene-2-carboxylate (7.2 g, 20.4 mmol) was dissolved in DCM (200 mL) and THF (100 mL) and m-CPBA (9.14 g, 40.8 mmol) was added. The reaction mixture was stirred at rt overnight. Sodium sulfite (5.14 g, 40.8 mmol) was added, stirred for 10 minutes followed by addition of potassium carbonate (8.45, 61.2 mmol). The suspension was stirred at rt for 1 hour and filtered through celite, washed with DCM and the solvent was evaporated to afford ethyl 3-iodo-4-cyano-5-(methylsulfonyl)thiophene-2-carboxylate (6.80 g, 78%). LCMS: (FA) ES+ 386. 1H NMR (400 MHz, d1-chloroform) δ: 4.45 (q, 2H), 3.38 (s, 3H), 1.43 (t, 3H).",Ethyl 4-cyano-3-iodo-5-(methylsulfanyl)thiophene-2-carboxylate | DCM | THF | m-CPBA | Sodium sulfite | potassium carbonate | DCM | ethyl 3-iodo-4-cyano-5-(methylsulfonyl)thiophene-2-carboxylate
US08110702B2,"Into a 500 ml four-neck round-bottom flask, equipped with a mechanical stirrer, a thermometer and a condenser is charged with 62.2 g (0.32 mmol) of 2-Ethylhexyl cyanoacetate (EHCA) and 81.0 g (0.45 mol) of Benzophenone (BP) (molar ratio EHCA:BP=0.71:1) and 27.7 g (0.36 mol) of ammonium acetate and 81.0 g (1.1 mol) of propionic acid and 81.0 g of heptane. The mixture is heated under stirring. When the temperature reach 110° C., a mixture of propionic acid, water, heptane is distilled off over a period of 5 hours at normal pressure. Heptane phase is returned back to the flask. Then the reactant is cooled to 90° C., and 100 ml of hot water is added to the reaction mixture. The mixture is kept at 85° C. for 10 minutes, and then transferred to a funnel for separation. To a flask equipped with a column 256.0 g of crude 2-ethylhexyl 2-cyano-3,3-diphenylacrylate solution is added. Rectification is carried out at 1 mbar. 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate is distilled out at 210° C. (vapor). After distillation, light yellow 2-ethylhexyl 2-cyano-3,3-diphenylacrylate is obtained. Reaction yields are as indicated in table 1 and assume recycle of unreacted benzophenone and 2-EHCA.","2-Ethylhexyl cyanoacetate | Benzophenone | ammonium acetate | propionic acid | heptane | propionic acid | water | heptane | water | 2-ethylhexyl 2-cyano-3,3-diphenylacrylate | 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate | 2-ethylhexyl 2-cyano-3,3-diphenylacrylate"
US08207176B2,"The title compound was prepared as described in Example 1 d from N-{3-[8-(2,6-difluorophenyl)-2-(methylsulfonyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-4-yl]-4-methylphenyl}-2-thiophenecarboxamide and (1H-imidazol-2-ylmethyl)amine dihydrochloride: LC-MS m/z 570 (M+H)+, 1.70 min (ret time).","title compound | N-{3-[8-(2,6-difluorophenyl)-2-(methylsulfonyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-4-yl]-4-methylphenyl}-2-thiophenecarboxamide | (1H-imidazol-2-ylmethyl)amine dihydrochloride"
US04894369,"A solution of (2β,3α,5α,16β,17β)-2-(4-morpholinyl)-16-(1pyrrolidinyl)-androstane-3,17-diol diacetate (6.0 g) in methanol (70 ml) was set aside at room temperature for 20 h., during which time the product partially crystallised. Water (150 ml) was added to precipitate the product as a yellow solid, which was filtered off and dried. The crude solid was recrystallised from ethanol (110 ml) to give (2β,3α,5α,16β,17β)-2-(4-morpholinyl)-16-(1pyrrolidinyl)-androstane-3,17-diol 3-acetate (4.70 g), m.p. 112°-118° C.; [α]D20 =+33.1° (c 0.97 in CHCl3)","(2β,3α,5α,16β,17β)-2-(4-morpholinyl)-16-(1pyrrolidinyl)-androstane-3,17-diol diacetate | methanol | product | Water | ethanol | (2β,3α,5α,16β,17β)-2-(4-morpholinyl)-16-(1pyrrolidinyl)-androstane-3,17-diol 3-acetate"
US20150210682A1,"To a solution of N, N-dibenzyl-2-[3-[tert-butyl(dimethyl)silyl]oxypropoxy]ethanamine (2.0 g, 4.8 mmol) in THF (20 mL) was added tetrabutylammonium fluoride (1.5 g, 5.8 mmol) at 0° C. The mixture was stirred at rt for 16 hours, and then partitioned between brine and DCM. The organic layer was dried over anhydrous Na2SO4 and concentrated. The residue was purified by column chromatography to give 3-[2-(dibenzylamino) ethoxy]propan-1-ol (1.3 g).","N, N-dibenzyl-2-[3-[tert-butyl(dimethyl)silyl]oxypropoxy]ethanamine | THF | tetrabutylammonium fluoride | brine | DCM | Na2SO4 | 3-[2-(dibenzylamino) ethoxy]propan-1-ol"
US06225311B1,"A mixture of methyl [{[4-(2-butynyloxy)phenyl]sulfonyl}(methyl)amino}(4-{3-[(ethoxycarbonyl)amino]propoxy]phenyl)acetate (0.45 g, 0.85 mmol) and 1N NaOH (4.2 ml, 4.23 mmol) in THF (5 ml) and methanol (5 ml) was stirred at room temperature for 2 h. After removing the solvent, the residue was dissolved in water, neutralized with HCl to pH˜5-6 and extracted with dichloromethane. The organic layer was washed with water and brine, dried over sodium sulfate, filtered and concentrated to provide 0.36 g of [{[4-(2-butynyloxy)phenyl]-sulfonyl}(methyl)amino}(4-{3-[(ethoxycarbonyl) amino]propoxy]phenyl)acetic acid as a solid . Yield 81.8%. Electrospray Mass Spec 519.1 (M+H)+.",methyl [{[4-(2-butynyloxy)phenyl]sulfonyl}(methyl)amino}(4-{3-[(ethoxycarbonyl)amino]propoxy]phenyl)acetate | NaOH | THF | methanol | water | dichloromethane | water | brine | sodium sulfate | [{[4-(2-butynyloxy)phenyl]-sulfonyl}(methyl)amino}(4-{3-[(ethoxycarbonyl) amino]propoxy]phenyl)acetic acid
US08952058B2,"To a stirred solution of (1R,2R)-2-((6-((6-((trimethylsilyl)ethynyl)-3H-imidazo[4,5-b]pyridin-3-yl)methyl)benzo[d]thiazol-2-yl)amino)cyclohexanol (100 mg, 0.21 mmol) from Step 3 of this Example in MeOH (5 mL) was added excess K2CO3 (150 mg). The resulting mixture was stirred at rt for 30 min. LCMS analysis showed that the reaction was complete. The reaction mixture was filtered through a Celite plug and the filtrate was purified by preparative HPLC using a mixture of water (5% CH3CN, 0.05% AcOH) and CH3CN (0.05% AcOH) as the mobile phase and Varian Pursuit XRs Diphenyl column as the stationary phase to afford (1R,2R)-2-((6-((6-ethynyl-3H-imidazo[4,5-b]pyridin-3-yl)methyl)benzo[d]thiazol-2-yl)amino)cyclohexanol as a tan powder (40 mg, 47%). 1H NMR (300 MHz, DMSO-d6) δ 8.69 (s, 1H), 8.50 (d, J=1.5 Hz, 1H), 8.23 (d, J=1.7 Hz, 1H), 8.02 (d, J=6.6 Hz, 1H), 7.66 (s, 1H), 7.26-7.34 (m, 1H), 7.15-7.26 (m, 1H), 5.49 (s, 2H), 4.29 (s, 1H), 3.26-3.38 (m, 2H), 2.03 (d, J=10.4 Hz, 1H), 1.85 (br s, 1H), 1.62 (d, J=4.7 Hz, 2H), 1.00-1.38 (m, 4H). LCMS (ESI) m/z 404 (M+H)+.","(1R,2R)-2-((6-((6-((trimethylsilyl)ethynyl)-3H-imidazo[4,5-b]pyridin-3-yl)methyl)benzo[d]thiazol-2-yl)amino)cyclohexanol | MeOH | K2CO3 | water | CH3CN | Diphenyl | (1R,2R)-2-((6-((6-ethynyl-3H-imidazo[4,5-b]pyridin-3-yl)methyl)benzo[d]thiazol-2-yl)amino)cyclohexanol"
US05624937,"2-(4-nitrophenylthio)naphthalene (9.2 moles, 2.6 g) was dissolved in 50 ml ethanol and 20 ml ethyl acetate and hydrogenated for 16 hrs at room temperature over 1.0 g 5% Pd/C. The solution was filtered through celite and concentrated to yield 2-(4-aminophenylthio)naphthalene 1.1 g, 47%.",2-(4-nitrophenylthio)naphthalene | ethanol | ethyl acetate | Pd/C | 2-(4-aminophenylthio)naphthalene
US08598211B2,The reaction was carried out in analogy to reaction step 1.3 by reacting 3-(2-(3-(4-fluorophenyl)-1H-pyrazol-1-yl)nicotinamido)-2-hydroxy-4-phenylbutanoic acid with 3-(pyridin-2-yl)propylamine; ESI-MS [M+H]+: 579.2.,3-(2-(3-(4-fluorophenyl)-1H-pyrazol-1-yl)nicotinamido)-2-hydroxy-4-phenylbutanoic acid | 3-(pyridin-2-yl)propylamine
US07276518B2,"9-Aminofluorene (362 mg, 2 mmol) and 4-dimethylamino-4-phenylcyclohexanone (434 mg, 2 mmol) were dissolved in dry 1,2-dichloroethane (10 ml) under argon. Glacial acetic acid (2 mmol) and sodium triacetoxyborohydride (600 mg) were added to this mixture and the mixture was stirred for 24 hours at RT. For working up, the mixture was concentrated and the residue was adjusted to pH 11 with five molar sodium hydroxide solution. The alkaline phase was diluted with water (10 ml) and extracted with ethyl acetate (5×20 ml). The combined extracts were dried over sodium sulfate and filtered and the filtrate was concentrated. The crude product was chromatographed over silica gel with ethyl acetate/ethanol (1:1). 440 mg N′-(9H-fluoren-9-yl)-N,N-dimethyl-1-phenyl-cyclohexane-1,4-diamine were obtained as a white solid which, for preparation of the hydrochloride, was dissolved in 2-butanone (10 ml), and 1.85 M ethanolic HCl (1.55 ml) was added. The mixture of N′-(9H-fluoren-9-yl)-N,N-dimethyl-1-phenyl-cyclohexane-1,4-diamine dihydrochloride obtained was filtered off with suction and dried (460 mg, m.p. 202-205° C.).","9-Aminofluorene | 4-dimethylamino-4-phenylcyclohexanone | 1,2-dichloroethane | argon | acetic acid | sodium triacetoxyborohydride | water | ethyl acetate | sodium sulfate | crude product | silica gel | ethyl acetate/ethanol | N′-(9H-fluoren-9-yl)-N,N-dimethyl-1-phenyl-cyclohexane-1,4-diamine | hydrochloride"
US09434695B2,"To a solution of 6-morpholinopyridin-3-amine (1.79 g, 10 mmol) in CH2Cl2 (100 mL) was added trimethylaluminium (40 mL, 40 mmol, 1 M in heptane) carefully under N2. The mixture was stirred at rt for 30 min, followed by the addition of a solution of methyl 3-acetaminocrotonate (1.89 g, 12 mmol) in CH2Cl2 (5 mL). The reaction was stirred at rt for 6 h, then quenched with saturated NH4Cl aqueous solution (100 mL). The organic phase was dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was purified by recrystallized from EtOAc to give the title compound as a pale yellow solid (1.11 g, 39%). The compound was characterized by the following spectroscopic data:",6-morpholinopyridin-3-amine | CH2Cl2 | trimethylaluminium | N2 | methyl 3-acetaminocrotonate | CH2Cl2 | NH4Cl | Na2SO4 | EtOAc | title compound
US08962842B2,"Potassium acetate (7.08 g, 72 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (7.94 g, 31 mmol) and 4-bromo-2,5-difluoro-aniline (5 g, 24 mmol) were dissolved in 1,2-dimethoxyethane (60 mL), followed by the addition of 1′-Bis-diphenylphosphine ferrocene palladium(II) dichloride (2.1 g, 2.6 mmol). The reaction mixture was heated at 90° C. for 16 h. The reaction mixture was evaporated to dryness in vacuo. The mixture was coated onto hydromatrix and purified by flash silica column chromatography (heptane:ethyl acetate, 3:1). The product was dried in vacuo and crystallized from CH2Cl2 and heptane to give the title compound as a white solid (3.5 g, 57%). ESI-MS m/z: 297 (M+MeCN+H)+, 256.2 (M+H)+; 1H NMR (400 MHz, CDCl3) δ ppm: 7.30 (dd, J=5.0 Hz and J=11.1 Hz, 1H), 6.41 (q, J=6.8 Hz, 1H), 4.06 (br s, 1H), 1.33 (s, 12H).","Potassium acetate | 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) | 4-bromo-2,5-difluoro-aniline | 1,2-dimethoxyethane | 1′-Bis-diphenylphosphine ferrocene palladium(II) dichloride | silica | heptane | ethyl acetate | CH2Cl2 | heptane | title compound"
US05028738,"A 3N aqueous solution (0.84 ml) of sodium hydroxide and 3.0 ml of tetrahydrofuran were added to 0.30 g (1.39 mmoles) of sodium 2-oxo-3-phenylpentanoate, and the mixture was stirred until a completely uniform solution formed. Then, 0.23 mg (2.8 mmoles) of methyl iodide and 36 mg (0.16 mmole) of triethylbenzylammonium chloride were added, and the mixture reacted at room temperature for 7 hours. The reaction mixture was acidified with 1N hydrochloric acid and extracted with ether. The ether layer was dried over magnesium sulfate. The drying reagent was separated by filtration, and the solvent was evaporated. The NMR spectral analysis of the resulting oily product led to the determination that the desired 2-oxo-3-methyl-3-phenylpentanoic acid formed in a yield of 62 %. Then, 1.2 ml of a 1N aqueous solution of sodium hydroxide was added to this product, and the mixture was concentrated under reduced pressure. Ether was added, and the precipitated white solid was isolated by filtration to give 0.15 g (0.63 mmole) of sodium 2-oxo-3-methyl-3-phenylpentanoate in a yield of 46 %.",aqueous solution | sodium hydroxide | tetrahydrofuran | sodium 2-oxo-3-phenylpentanoate | methyl iodide | triethylbenzylammonium chloride | hydrochloric acid | ether | ether | magnesium sulfate | aqueous solution | sodium hydroxide | Ether | sodium 2-oxo-3-methyl-3-phenylpentanoate
US08673942B2,"A mixture of 7-[2-methoxy-1-(methoxymethyl)ethoxy]-5-{[5-(methylsulfonyl)pyridin-2-yl]oxy}-1H-indole-2-carboxylic acid (1.66 g), N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.4 g), 1-hydroxybenzotriazole (1.0 g) and N,N-dimethylformamide (15 mL) was stirred at 50° C. for 30 min. The mixture was cooled to room temperature, and 25% ammonium hydroxide solution (1.5 mL) was added to the mixture. After stirring at room temperature for 14 h, the mixture was concentrated under reduced pressure. Water was added to the residue and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over magnesium sulfate, filtered and concentrated. The residue was purified by basic silica gel column chromatography (methanol/ethyl acetate/hexane=0/60/40 to 10/90/0, volume ratio) to give the title compound (1.66 g, 100%) as a colorless amorphous solid. MS 450 (MH+).","7-[2-methoxy-1-(methoxymethyl)ethoxy]-5-{[5-(methylsulfonyl)pyridin-2-yl]oxy}-1H-indole-2-carboxylic acid | N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride | 1-hydroxybenzotriazole | N,N-dimethylformamide | ammonium hydroxide | Water | ethyl acetate | brine | magnesium sulfate | silica gel | methanol/ethyl acetate/hexane | title compound"
US05073306,"In a round-bottomed flask, a solution of 2.4 g of p-hydroxybenzyl alcohol in 10 ml of ethanol and 5.3 g of ()-3-trifluoromethylheptyl p-toluenesulfonate were placed, and a solution of 0.8 g of sodium hydroxide in 10 ml of ethanol was added thereto dropwise, followed by 6 hours of heat-refluxing, cooling by standing and acidification with hydrochloric acid. The organic layer was extracted with diethyl ether. The resultant ether solution was dried with sodium sulfate and subjected to distilling-off of the solvent and purification by silica gel column chromatography to obtain 4.4 g of (+)-p-(3-trifluoromethylheptyloxy)benzyl alcohol. [α]D28 +1.0 °, [α]43527 +2.4° (c 5.0, chloroform).",p-hydroxybenzyl alcohol | ethanol | 3-trifluoromethylheptyl p-toluenesulfonate | sodium hydroxide | ethanol | hydrochloric acid | diethyl ether | ether | sodium sulfate | silica gel | (+)-p-(3-trifluoromethylheptyloxy)benzyl alcohol
US09388171B2,"A slurry of 96 (132 mg, 0.45 mmol) in THF (2.19 mL) and water (0.324 mL) was treated with solid LiOH (24 mg, 0.99 mmol) and stirred for 3 h. THF was removed in vacuo, and the mixture was suspended in water (6.0 mL) and treated with aqueous HCl (10 M, 0.27 mL). A yellow-brown precipitate was collected by vacuum filtration to afford 3-(2-methylpyridin-4-ylamino)isoquinoline-6-carboxylic acid (98) as a yellow solid, which was used in subsequent steps without further purification.",96 | THF | water | LiOH | THF | HCl | 3-(2-methylpyridin-4-ylamino)isoquinoline-6-carboxylic acid
US04443243,"A solution of 9.4 g of crude 5-methyl-2-propargyloxyphenylsulfonylisocyanate in 50 ml of absolute tetrahydrofuran is added dropwise at room temperature, within 10 minutes, to a solution of 3.7 g of 2-amino-4-chloro-6-methoxy-pyrimidine and 0.1 g of 1,4-diazadicyclo[2.2.2]octane in 60 ml of absolute tetrahydrofuran, in the course of which the temperature rises slightly. The reaction solution is stirred for 18 hours at room temperature; it is then filtered, and concentrated by evaporation. The residue is crystallised from ethyl acetate to thus obtain 5.8 g of N-(5-methyl-2-propargyloxyphenylsulfonyl)-N'-(4-chloro-6-methoxy-pyrimidin-2-yl)-urea, m.p. 202°-204° C.","5-methyl-2-propargyloxyphenylsulfonylisocyanate | tetrahydrofuran | 2-amino-4-chloro-6-methoxy-pyrimidine | 1,4-diazadicyclo[2.2.2 | octane | tetrahydrofuran | ethyl acetate | N-(5-methyl-2-propargyloxyphenylsulfonyl)-N'-(4-chloro-6-methoxy-pyrimidin-2-yl)-urea"
US08933113B2,"To a solution of methyl 2-(4-(tert-butoxycarbonylamino)-1H-indol-1-yl)-2-(4-chlorophenyl)butanoate (5 g, 11.3 mmol), as described in Example 3 Step A, in tetrahydrofuran (50 mL) was added lithium aluminium hydride (644 mg, 16.95 mmol) at 0° C. The mixture was gradually warmed to room temperature and stirred for 4 h. Water (10 mL) was carefully added to the reaction mixture, then extracted with ethyl acetate. The combined organic layers were washed with brine (30 mL), dried over anhydrous sodium sulfate, filtered and concentrated. The crude product was purified by silica gel chromatography eluting with PE/EA (30/1 to 10/1, v/v) to give the title compound as a colorless amorphous solid. LC/MS m/z=359.9 [M-tBu+H]+.",methyl 2-(4-(tert-butoxycarbonylamino)-1H-indol-1-yl)-2-(4-chlorophenyl)butanoate | tetrahydrofuran | lithium aluminium hydride | Water | ethyl acetate | brine | sodium sulfate | crude product | silica gel | EA | title compound
US08242280B2,"To a solution of N-(5-bromo-3-trimethylsilanylethynyl-pyridin-2-yl)-acetamide (4.75 g, 15.26 mmol) in THF (90 ml) was added dropwise a 1 M solution of tetra-n-butyl ammonium fluoride in THF (30.5 ml, 30.5 mmol). After stirring at reflux for 15 hours, the reaction mixture was concentrated in vacuo and water was added. The aqueous layer was extracted three times with dichloromethane with, and the combined extracts were directly adsorbed on silica gel. Purification by flash chromotography on silica gel with a gradient of ethyl acetate/hexanes afforded 2.29 g of a beige solid. Recrystallization from ethyl acetate/hexanes provided the title compound as light beige flakes (1.33 g). Further purification of the filtrate on silica gel with a gradient of ethyl acetate/hexanes afforded more of the title compound as a crystalline powder (675 mg) for a combined yield of 2.01 g; 67%. 1H NMR (DMSO-d6): δ 11.89 (s, 1H), 8.24 (d, J=2.0 Hz, 1H), 8.17 (d, J=2.5 Hz, 1H), 7.53 (t, J=3.0 Hz, 1H), 6.42 (dd, J=1.0, 3.0 Hz, 1H); HPLC/MS m/z: 197 [MH]+.",N-(5-bromo-3-trimethylsilanylethynyl-pyridin-2-yl)-acetamide | THF | tetra-n-butyl ammonium fluoride | THF | water | dichloromethane | silica gel | ethyl acetate/hexanes | beige solid
US20100093757A1,"is Sodium hydride (0.219 g, 5.48 mmol) was added to (S)-methyl 3-((S)-1-(tert-butyldimethylsilyloxy)propan-2-yloxy)-2-hydroxypropanoate (Intermediate AO1) (1.336 g, 4.57 mmol) in anhydrous THF (30 mL) at 0° C. under nitrogen. The resulting solution was stirred at 0° C. for 10 minutes and then 4-chloro-1-(3-chloropyridin-2-yl)-1H-pyrazolo[3,4-d]pyrimidine (1.216 g, 4.57 mmol) was added. The reaction mixture was allowed to warm to room temperature and stirred for 1 hour. The reaction mixture was neutralised with 1M citric acid and the majority of the THF removed in vacuo. The reaction mixture was diluted with water (20 mL) and EtOAc (50 mL). The organic layer was separated and the aqueous layer re-extracted with EtOAc (2×50 mL). The combined organics were washed with saturated brine (25 mL), dried (MgSO4) and evaporated. The crude product was purified by flash silica chromatography, eluting with 30 to 60% EtOAc in isohexane to give (2S)-methyl 3-((S)-1-(tert-butyldimethylsilyloxy)propan-2-yloxy)-2-(1-(3-chloropyridin-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)propanoate (1.658 g, 69.5%). m/z (ES+), (M+H)+=522.50; HPLC tR=3.35 min","Sodium hydride | (S)-methyl 3-((S)-1-(tert-butyldimethylsilyloxy)propan-2-yloxy)-2-hydroxypropanoate | THF | nitrogen | 4-chloro-1-(3-chloropyridin-2-yl)-1H-pyrazolo[3,4-d]pyrimidine | citric acid | THF | water | EtOAc | EtOAc | brine | MgSO4 | crude product | silica | EtOAc | isohexane | (2S)-methyl 3-((S)-1-(tert-butyldimethylsilyloxy)propan-2-yloxy)-2-(1-(3-chloropyridin-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)propanoate"
US20080318943A1,"Using Method I, 9-amino-5-bromo-2-cyclopropyl-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one (0.380 g, 1.19 mmol) and 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-3-methoxybenzonitrile (0.439 g, 1.79 mmol) were reacted to afford the title compound as an off-white solid (0.083 g, 19%). 1H NMR (500 MHz, DMSO-d6) δ ppm 8.42 (dd, J=8.32, 1.37 Hz, 1 H) 7.58-7.63 (m, 3 H) 7.40-7.48 (m,2 H) 4.20 (s, 2 H) 3.65 (s, 3) 2.82-2.94 (m, 1 H) 0.68-0.87 (m, 4 H). MS APCI, m/z=371 (M+H). HPLC 1.66 min.","9-amino-5-bromo-2-cyclopropyl-2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one | 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-3-methoxybenzonitrile | title compound"
US04343811,"In accordance with a procedure analogous to that of Example 10, the above compound was prepared from 1,2-dimethyl-3-(2-phenyl-ethyl)-1H-indole-5-ol and 2-bromo-2-methyl-propanoic acid ethylester.","1,2-dimethyl-3-(2-phenyl-ethyl)-1H-indole-5-ol | 2-bromo-2-methyl-propanoic acid ethylester"
US06693123B2,"A solution of the resultant thiophenol from Example 12A (1.0 equivalent) is treated with 2-bromopyridine hydrobromide (1.0 equivalent) in the presence of a NaH (2.0 equivalents), or K2CO3 (3.0 equivalents) in DMF or pyridine. The product is isolated by removal of the solvent and chromatography on silica gel. The resultant ester is hydrolyzed according to the procedure of Example 6C and then is coupled to methionine methyl ester according to the procedure of Example 1C to give the title compound.",thiophenol | 2-bromopyridine hydrobromide | NaH | K2CO3 | DMF | pyridine | silica gel | ester | methionine methyl ester | title compound
US08691854B2,The compound is prepared according to the method described in example 1A from 3-methylsulfonylcinnamaldehyde (3.8 mmoles) and from thiosemicarbazide (3.8 mmoles). Yield 70%.,3-methylsulfonylcinnamaldehyde | thiosemicarbazide
US07932270B2,"A mixture of benzyl 4-((R)-2-((6-chloro-2-(2-(tetrahydro-2H-pyran-2-yl)ethylamino)nicotinamido)methyl)pyrrolidin-1-yl)-4-oxobutylcarbamate (62 mg, 0.101 mmol), 2-cyanophenyl boronic acid (23 mg, 0.156 mmol), PdCl2(dppf)2 (11 mg, 0.02 mmol), K2CO3(92 g, 0.667 mmol) and anhydrous DMF (1 mL) was stirred at 125° C. for 1 hr. The mixture was filtered through the silica gel pad and washed with EtOAc. The filtrate was concentrated to dryness and purified on RP-HPLC using a mixture of acetonitrile and H2O to give benzyl 4-((R)-2-((6-(2-cyanophenyl)-2-(2-(tetrahydro-2H-pyran-2-yl)ethylamino)nicotinamido)methyl)pyrrolidin-1-yl)-4-oxobutylcarbamate (50 mg, 77%). LRMS (M+H+) m/z 653.3.",benzyl 4-((R)-2-((6-chloro-2-(2-(tetrahydro-2H-pyran-2-yl)ethylamino)nicotinamido)methyl)pyrrolidin-1-yl)-4-oxobutylcarbamate | 2-cyanophenyl boronic acid | PdCl2(dppf)2 | K2CO3 | DMF | silica gel | EtOAc | acetonitrile | H2O | benzyl 4-((R)-2-((6-(2-cyanophenyl)-2-(2-(tetrahydro-2H-pyran-2-yl)ethylamino)nicotinamido)methyl)pyrrolidin-1-yl)-4-oxobutylcarbamate
US20070142411A1,"To a stirred cooled (ice/salt, 0°) solution of carbon tetrabromide (48.82 g) in anhydrous CH2Cl2 (200 mL) was added portionwise over 3 minutes, triphenylphosphine (77.1 g), maintaining the temperature below 10°. The resulting orange suspension was stirred at 0° for 1 hour before adding to it, 3-fluorobenzaldehyde (7.8 mL). After the addition was complete, the suspension was stirred at 0° for 1 hour then quenched by the addition of water.(75 mL). The organic phase was separated and washed with brine (75 mL), dried (Na2SO4) and evaporated to dryness. The residual gum was poured into cyclohexane (1 L) and stirred for 30 minutes. The organic phase was decanted and the residue taken up into CH2Cl2 and poured into cyclohexane (1 L). This procedure was repeated twice more and the combined organic phases concentrated to ˜100 mL and passed through silica gel. The filtrate was concentrated to give the title compound as a mobile yellow oil (24 g, 100%).",ice | carbon tetrabromide | CH2Cl2 | triphenylphosphine | 3-fluorobenzaldehyde | water | brine | Na2SO4 | cyclohexane | cyclohexane | title compound
US06500863B1,"Following the general procedure for Boc deprotection in example 36, N-[3-[N″-[5-(tert-butoxycarbonylamino)-5-carboxypentyl]aminosulfonyl]-4-chloro-2-hydroxyphenyl]-N′-(2,3-dichlorophenyl) urea (100 mg, 0.16 mmol) was stirred in 1 mL of trifluoroacetic acid to form the desired product (78 mg, 74%). LC-MS (m/z) 541.0 (M+).","N-[3-[N″-[5-(tert-butoxycarbonylamino)-5-carboxypentyl]aminosulfonyl]-4-chloro-2-hydroxyphenyl]-N′-(2,3-dichlorophenyl) urea | trifluoroacetic acid | desired product"
US07834005B2,"A solution of benzyl chloroformate (50 mL, 0.35 mol) in Et2O (160 mL) was added dropwise, during 10 min, to a rapidly stirred mixture of trans-4-hydroxy-L-proline (39.8 g, 0.308 mol), NaHCO3 (63.7 g, 0.758 mol) and H2O (660 mL). The reaction mixture was stirred at room temperature for 20 h. The layers were separated, and the aqueous layer was washed with Et2O (4×200 mL), cooled, and then acidified to pH 1-2 with concentrated hydrochloric acid. The resulting emulsion was extracted with EtOAc (5×200 mL). Combined EtOAc extracts were washed in succession with H2O (3×500 mL) and brine (3×500 mL), dried over MgSO4, and then concentrated in vacuo to give intermediate (4) as a colorless foam (62.7 g, 78%). Additional reactions were carried out to give a total of 284 g of product suitable for further transformation.",benzyl chloroformate | Et2O | trans-4-hydroxy-L-proline | NaHCO3 | H2O | Et2O | EtOAc | EtOAc | H2O | brine | MgSO4
US20150368271A1,"To a mixture of 6-chloro-3-nitro-N2-(quinolin-6-ylmethyl)pyridine-2,4-diamine (658 mg, 2 mmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (500 mg, 2.4 mmol) and Na2CO3 (424 mg, 4 mmol) in dioxane (20 mL) and H2O (2 mL) under N2 was added Pd(dppf)C2 (160 mg, 0.2 mmol). The reaction mixture was stirred at 100° C. under N2 overnight. After cooled to room temperature, the mixture was concentrated and purified by chromatography to afford the title compound (300 mg). MS (m/z): 376 (M+1)+.","6-chloro-3-nitro-N2-(quinolin-6-ylmethyl)pyridine-2,4-diamine | N2 | 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | Na2CO3 | dioxane | H2O | N2 | Pd(dppf)C2 | title compound"
US06448399B1,"A solution of 3-cyclopentyl-2-(4-methanesulfonyl-3-trifluoromethyl-phenyl)-propionic acid methyl ester (2.92 g, 7.72 mmol) in tetrahydrofuran/water (3:1, 88 mL) was treated with lithium hydroxide (647 mg, 15.43 mmol). The reaction was stirred at 25° C. for 3 d. The tetrahydrofuran was then removed in vacuo. The residue was diluted with water (50 mL) and extracted with diethyl ether (25 mL). The aqueous layer was acidified to pH=l with a 3N aqueous hydrochloric acid solution. The product was extracted into ethyl acetate (3×75 mL) and diethyl ether (1×50 mL). The combined organic layers were washed with a saturated aqueous sodium chloride solution (2×100 mL), dried over magnesium sulfate and sodium sulfate, filtered, and concentrated in vacuo to give 3-cyclopentyl-2-(4-methanesulfonyl-3-trifluoromethyl-phenyl)-propionic acid (2.37 g, 84.5%) as a pale-yellow semi-solid: EI-HRMS m/e calcd for C16H19F3O4S (M+) 364.0956, found 364.0958.",3-cyclopentyl-2-(4-methanesulfonyl-3-trifluoromethyl-phenyl)-propionic acid methyl ester | 3-cyclopentyl-2-(4-methanesulfonyl-3-trifluoromethyl-phenyl)-propionic acid | tetrahydrofuran/water | tetrahydrofuran | water | lithium hydroxide | diethyl ether | ethyl acetate | diethyl ether | sodium chloride | magnesium sulfate | sodium sulfate
US05439908,"4.0 g of 4-chloro-4,4-difluoro-butyric acid chloride are added dropwise at 0° over a period of half an hour to a solution of 2.13 g of 2-aminopyridine and 4.47 g of pyridine in 50 ml of toluene. The reaction mixture is stirred for 16 hours at room temperature, diluted with 150 ml of diethyl ether, washed in succession with saturated NaHCO3 solution and saturated NaCl solution, dried over MgSO4, and concentrated by evaporation. The residue is recrystallised from toluene/hexane to give the title compound which melts at 64°-65°.","4-chloro-4,4-difluoro-butyric acid chloride | 2-aminopyridine | pyridine | toluene | diethyl ether | NaHCO3 | NaCl | MgSO4 | toluene/hexane | title compound"
US06432993B1,"In a similar manner to that described in Example (2-1), a reaction was carried out using t-butyl N-[2-amino-5-(4-methoxyphenoxy)phenyl]-N-methylcarbamate (2.0 g), 4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxyacetic acid (2.0 g), diethyl cyanophosphonate (1.3 g), triethylamine (0.81 g) and anhydrous tetrahydrofuran (50 ml) and the reaction mixture was purified to give the desired product (3.3 g).","t-butyl N-[2-amino-5-(4-methoxyphenoxy)phenyl]-N-methylcarbamate | 4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxyacetic acid | diethyl cyanophosphonate | triethylamine | tetrahydrofuran | desired product"
US08173828B2,"A total of 1.30 g (34.4 mmol) of NaBH4 were added to a solution of 5.0 g (21.5 mmol) of the resulting 3-bromo-5-methyl-4,5-dihydro-6H-cyclopenta[b]thiophen-6-one in 60 ml of THF-methanol (2:1, vol.) over 1 h at −5° C. (Caution: temperature must be lower 0° C.). The mixture was stirred for 10 h at ambient temperature, then diluted with 20 ml of water, and acidified with 10% HCl to pH=1. The crude product was extracted with 3×100 ml of CH2Cl2. The combined extracts were washed with the saturated aqueous Na2CO3, dried over K2CO3, and evaporated to dryness. To the yellow oil obtained, 150 ml of toluene were added. This toluene solution was treated with a catalytic amount of pTolSO3H (ca. 0.2 g) for 10 min at reflux, cooled to room temperature, and, then, passed through a short Silica Gel 60 column (40-63 μm, d 20 mm, l 50 mm). This column was additionally eluted with 300 ml of hexanes-methyl-tert-butyl ether mixture (10:1, vol.). The chromatographed product was evaporated to dryness. This procedure gave 4.61 g (99%) of beige crystalline product of 3-bromo-5-methyl-4H-cyclopenta[b]thiophene (containing 3-5% of 3-bromo-5-methyl-6H-cyclopenta[b]thiophene).","NaBH4 | 3-bromo-5-methyl-4,5-dihydro-6H-cyclopenta[b]thiophen-6-one | THF-methanol | water | HCl | crude product | CH2Cl2 | Na2CO3 | K2CO3 | toluene | toluene | hexanes-methyl-tert-butyl ether | beige crystalline product | 3-bromo-5-methyl-4H-cyclopenta[b]thiophene"
US05693633,"Sodium hydride (0.54 mmoles, 22 mg of 60% in mineral oil) was added to 5-[2-(4,4-dimethyloxazolin-2-yl)phenyl]indole (0.43 mmoles, 125 mg) in 2 ml THF. After stirring 20 minutes, the solution was cooled to 0° C. Ethyl 2-bromooctanoate (0.54 mmoles, 0.135 mg) was added. The solution was stirred for 15 minutes, allowed to warm to room temperature, and stirred for 1.5 hours. The solution was poured into saturated ammonium chloride and extracted with ethyl acetate. The organic phase was dried and concentrated. The oil was chromatographed over silica gel eluted with 20% ether in hexane. The reaction yielded 172 mg of ethyl 2-[5-[2-(4,4-dimethyloxazolin-2-yl)phenyl]indol-1-yl]octanoate. (MS)","Sodium hydride | 5-[2-(4,4-dimethyloxazolin-2-yl)phenyl]indole | THF | Ethyl 2-bromooctanoate | ammonium chloride | ethyl acetate | silica gel | ether | hexane | ethyl 2-[5-[2-(4,4-dimethyloxazolin-2-yl)phenyl]indol-1-yl]octanoate"
US08232297B2,0.116 g of (2{(E)-3-[1-(toluene-4-sulfonyl)-1-H-pyrrol-3-yl]-allanoylamino}-phenyl)-carbamic acid tert-butyl ester (compound A5) are dissolved in 20 ml of dichloromethane at ambient temperature. 2 ml of trifluoroacetic acid (TFA) are added and the solution is stirred for 93 hour. The solvent is evaporated to dryness and to the residue are added 25 ml of water. The water phase is extracted exhaustively with ethyl acetate. Afterwards the combined organic phases are dried over sodium sulfate and filtered. The filtrate is evaporated under vacuo. Then the residue is crystallized from methanol to give 0.050 g of the title compound as white crystals.,(2{(E)-3-[1-(toluene-4-sulfonyl)-1-H-pyrrol-3-yl]-allanoylamino}-phenyl)-carbamic acid tert-butyl ester | compound A5 | dichloromethane | trifluoroacetic acid | water | water | ethyl acetate | sodium sulfate | methanol | title compound
US05872137,"To a mixture of 10 g of 4-bromo-2-ethyl-6-methylphenol, 14.0 g of 1-(3-bromopropyloxy)-4-trifluoromethoxybenzene and 100 ml of N,N-dimethylformamide was added 7 g of potassium carbonate, while stirring at room temperature. After stirring at room temperature for 12 hours, the reaction mixture was poured into ice water, and extracted twice with 200 ml of diethyl ether. The combined ether layer was washed with water, dried with anhydrous magnesium sulfate, and concentrated to obtain a crude product. The crude product was subjected to silica gel chromatography, which afforded 18.1 g of 4-bromo-2-ethyl-6-methyl-1-[3-(4-trifluoromethoxyphenoxy)propyloxy]benzene 90% yield).","4-bromo-2-ethyl-6-methylphenol | 1-(3-bromopropyloxy)-4-trifluoromethoxybenzene | N,N-dimethylformamide | potassium carbonate | ice water | water | diethyl ether | ether | magnesium sulfate | crude product | crude product | 4-bromo-2-ethyl-6-methyl-1-[3-(4-trifluoromethoxyphenoxy)propyloxy]benzene"
US06784201B2,"A solution of 5-(4′-hydroxyphenyl)-7-(dimethylamino)tetrahydrobenzothiepine-1,1-dioxide (5.0 g, 10.9 mmol, obtained from Example 1402, Step 10) in acetone (100 mL) at 25° C. under N2 was treated with powdered K2CO3 (3.8 g, 27.2 mmol, 2.5 eq.) and 1,3-propanediol di-p-tosylate (13.0 g, 32.6 mmol, 3.0 eq.), and the resulting mixture was stirred at 65° C. for 21 hours. The cream-colored slurry was cooled to 25° C. and was filtered through a sintered glass funnel. The filtrate was concentrated and the residue was dissolved in EtOAc (150 mL). The organic layer was washed with saturated aqueous NaHCO3(2×150 mL) and saturated aqueous NaCl (2×150 mL), and was dried (MgSO4) and concentrated in vacuo to provide a pale orange oil. Purification by flash chromatography (4.4×35 cm silica, 20-30% EtOAc/hexane) afforded the propyl tosylate intermediate (6.0 g, 80%) as a white foam: 1H NMR (CDCl3) δ 0.91 (m, 6H), 1.11-1.47 (br m, 10H), 1.63 (m, 1H), 2.14 (m, 2H), 2.21 (m, 1H), 2.41 (s, 3H), 2.81 (s, 6H), 3.06 (ABq, J=15.1 Hz, J=49.0 Hz, 2H), 4.01 (t, J=5.3 Hz, 2H), 4.10 (m, 1H), 4.26 (t, J=5.9 Hz, 2H), 5.29 (s, 1H), 5.48 (s, 1H), 5.98 (s, 1H), 6.51 (dd, J=8.9, 1.8 Hz, 1H), 6.83 (d, J=8.4 Hz, 2H), 7.30 (d, J=8.1 Hz, 2H), 7.39 (d, J=8.3 Hz, 2H), 7.78 (d, J=8.3 Hz, 2H), 7.88 (d, J=8.9 Hz, 1H).","5-(4′-hydroxyphenyl)-7-(dimethylamino)tetrahydrobenzothiepine-1,1-dioxide | acetone | N2 | K2CO3 | 1,3-propanediol di-p-tosylate | EtOAc | NaHCO3 | NaCl | MgSO4 | silica | EtOAc/hexane | propyl tosylate"
US08354444B2,"To a stirred solution of rac (2R,3S,4R,5S)-3-(3-Chloro-2-fluoro-phenyl)-4-(4-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carboxylic acid (100 mg, 0.17 mmol) in methylene chloride (10 mL), HATU (Aldrich, 98 mg, 0.26 mmol) was added followed by the addition of DIPEA (0.150 mL, 0.855 mmol) and 3-chloro-4-(1H-tetrazol-5-yl) aniline (made below, 67 mg, 0.34 mmol). The mixture was stirred at rt for 1.5 hr. The reaction was quenched with addition of water. The mixture was extracted with methylene chloride (2×10 mL) and the extracts were dried with magnesium sulfate. The solvent was removed and the residue was purified on a reverse phase HPLC to give a white solid. 52 mg.","rac (2R,3S,4R,5S)-3-(3-Chloro-2-fluoro-phenyl)-4-(4-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carboxylic acid | methylene chloride | HATU | DIPEA | 3-chloro-4-(1H-tetrazol-5-yl) aniline | water | methylene chloride | magnesium sulfate"
US07759376B2,"As shown in Reaction Scheme 5, methyl 3′-fluoro-4′-[(6-fluoro-1,3-benzothiazol-2-yl)amino]biphenyl-4-carboxylate (0.64 g, 1.6 mmol) was suspended in THF (10 mL), MeOH (10 mL) and water (5 mL), and LiOH (0.39 g, 16.2 mmol) was added. The reaction mixture was heated at 50° C. until dissolution was achieved, and then the mixture was stirred for 3 days at rt. The reaction mixture was brought to pH 4 with 1N HCl and was extracted with EtOAc (3×25 mL). The combined organic phases were washed with water (2×50 mL) and brine (50 mL), dried over MgSO4, filtered, and concentrated in vacuo. This yielded 0.518 g (84%) of the desired product as an off-white solid. LC/MS m/z 383.3 (MH+), retention time 3.83 min. 1H NMR (400 MHz, DMSO-d6) δ 7.18 (t, 1H), 7.59-8.00 (m, 8H), 8.70 (t, 1H), 10.50 (bs, 1H), 12.95 (bs, 1H).","methyl 3′-fluoro-4′-[(6-fluoro-1,3-benzothiazol-2-yl)amino]biphenyl-4-carboxylate | THF | MeOH | water | LiOH | HCl | EtOAc | water | brine | MgSO4"
US04625046,"Into a 500 ml 4-neck flask, equipped with a stirrer, reflux cooler, dropping funnel and water separator, 126.5 g (1 mole) of benzylchloride, 81 g (1 mole) of 2-methyl-2-butene-nitrile, 100 ml of toluene, and 10 g of tetrabutylammonium bromide were first introduced and heated to reflux. To this mixture, 40 g (1 mole) of solid sodium hyroxide were added in portions. The reaction mixture was then maintained one more hour at reflux. Thereupon, it was washed to neutrality with water, the phases were separated and the organic phase distilled as described in Example 1. The yield in desired product was 103.5 g, corresponding to 61% of the theoretical.",water | benzylchloride | 2-methyl-2-butene-nitrile | toluene | tetrabutylammonium bromide | solid | sodium hyroxide | desired product
US08889741B2,"A solution of the (3aS,7aS)-3a-(1-methyl-1H-pyrazol-5-yl)hexahydro-1,3-benzodioxol-2-one (500 mg, 2.25 mmol) prepared in Example 167a and palladium carbon (10%; 500 mg) in THF (10 mL) was stirred at 60° C. for 12 hours under a hydrogen atmosphere. The reaction solution was filtered through celite, and the residue was purified with silica gel chromatography (hexane/ethyl acetate=2:1) to yield the title compound (85 mg, 21%) as a colorless oil.","(3aS,7aS)-3a-(1-methyl-1H-pyrazol-5-yl)hexahydro-1,3-benzodioxol-2-one | palladium carbon | THF | hydrogen | silica gel | hexane/ethyl acetate | title compound"
US20080280928A1,"A mixture of crude trifluoromethanesulfonic acid 1-(4-methoxy-2,6-dimethylphenyl)-3,6-dimethyl-1H-pyrrolo[2,3-b]pyridin-4-yl ester (1.1 g), N,N-diisopropylethylamine (0.65 g) and piperidin-4-yl-acetonitrile (1.6 g) was heated at 150° C. in a sealed tube for 7 hours. After cooling to room temperature, ethyl acetate and water were poured into the mixture, and separated. The aqueous phase was extracted with ethyl acetate, and the organic phase was dried over MgSO4 and filtered. The filtrate was concentrated under reduced pressure and the residue was purified with column chromatography (silica gel: Wako gel C200, eluent: hexane: ethyl acetate=3/1) to obtain {1-[1-(4-methoxy-2,6-dimethyl-phenyl)-3,6-dimethyl-1H-pyrrolo[2,3-b]pyridin-4-yl]-piperidin-4-yl}-acetonitrile (0.58 g) as a pale yellow crystal.","trifluoromethanesulfonic acid 1-(4-methoxy-2,6-dimethylphenyl)-3,6-dimethyl-1H-pyrrolo[2,3-b]pyridin-4-yl ester | N,N-diisopropylethylamine | piperidin-4-yl-acetonitrile | ethyl acetate | water | ethyl acetate | MgSO4 | silica gel | hexane | ethyl acetate | {1-[1-(4-methoxy-2,6-dimethyl-phenyl)-3,6-dimethyl-1H-pyrrolo[2,3-b]pyridin-4-yl]-piperidin-4-yl}-acetonitrile"
US06770648B2,"To a solution of 3-[2,6-Dichloro-4-(2,4-dichloro-benzenesulfonylamino)-phenoxy]-quinoline-6-carboxylic acid methyl ester (181) (200 mg, 0.35 mmol) in THF/MeOH(2 ml/2 ml) was added 4N NaOH (0.1 ml, 0.4 mmol). This mixture was refluxed for 2.5 hr. The reaction mixture was cooled to room temperature and was neutralized with 2N HCl, and then concentrated. The residue was extracted twice with AcOEt. Organic layer was washed by Brine, dried over anhydrous MgSO4, and concentrated to give a solid. Crude product was recrystallized by Hexane/AcOEt to afford compound 183 (153 mg, 78%).","3-[2,6-Dichloro-4-(2,4-dichloro-benzenesulfonylamino)-phenoxy]-quinoline-6-carboxylic acid methyl ester | THF/MeOH | NaOH | HCl | AcOEt | Brine | MgSO4 | Crude product | Hexane/AcOEt | compound 183"
US07842685B2,"A solution of methyl 3-(2-(3-fluoro-4-(5-(1-phenylcyclopropyl)thiazolo[5,4-b]pyridine-2-yl)phenyl)propan-2-ylamino)propanoate (0.067 g, 0.137 mmol) in tetrahydrofuran (1 mL) and methanol (0.5 mL) was added 1 M lithium hydroxide solution (0.4 mL, 0.4 mmol) and stirred at room temperature for 3 hours. The reaction mixture was concentrated in vacuo and the resulting slurry was diluted with water and neutralized (to pH=˜7) with aqueous 1 N HCl solution. The aqueous suspension was extracted with 15% MeOH/CHCl3; the organic extracts were combined, dried (K2CO3), filtered, and concentrated in vacuo to give a crude golden yellow solid (˜0.040 g). Trituration with MeOH afforded the title compound as an off-white amorphous solid. MS (ESI) m/z: Calculated: 475.5; Observed: 476.1 (M++1).","methyl 3-(2-(3-fluoro-4-(5-(1-phenylcyclopropyl)thiazolo[5,4-b]pyridine-2-yl)phenyl)propan-2-ylamino)propanoate | tetrahydrofuran | methanol | lithium hydroxide | water | HCl | MeOH/CHCl3 | MeOH | K2CO3 | crude golden yellow solid | title compound"
US08188101B2,"Trifluoroacetic acid (0.238 mL, 3.09 mmol) was added dropwise to a stirred solution of tert-butyl 2-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenylamino)-4-(2-(tetrahydrofuran-2-yl)ethyl)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate (0.330 g, 0.62 mmol) in DCM (3 mL) at rt. The reaction mixture was stirred under reflux for 1 hr. Five equivalents of trifluoroacetic acid were added and the reaction mixture was stirred at reflux for 1 hour. The reaction mixture was allowed to cool to room temperature. The organic mixture was washed with potassium carbonate (aq) and the organic layer was separated, dried (MgSO4) and concentrated giving 0.247 g (92%) of N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-phenyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine.","Trifluoroacetic acid | tert-butyl 2-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenylamino)-4-(2-(tetrahydrofuran-2-yl)ethyl)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate | DCM | trifluoroacetic acid | potassium carbonate | MgSO4 | N-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-8-phenyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine"
US06001849,"To a solution of 2-(1-methyl-2-(R)-pyrrolidinyl)-6-(bromo)-furo[3,2-b]pyridine from Example 47 in toluene are added (5-methyl3-pyridyl)tributyltin and tetrakis(triphenylphosphine)palladium(O). After being refluxed overnight, the resulting mixture is cooled to room temperature. Solvent is removed, and the residue is chromatographed on a silica gel column.","2-(1-methyl-2-(R)-pyrrolidinyl)-6-(bromo)-furo[3,2-b]pyridine | toluene | (5-methyl3-pyridyl)tributyltin | tetrakis(triphenylphosphine)palladium(O) | silica gel"
US06573270B1,"To a solution of N-[3-(2-hydroxyethoxy)-1-methyl-4-(4-methylphenyl)-1H-pyrazol-5-yl]-5-isopropyl-2-pyridinesulfonamide (Example 40) (112 mg) in anhydrous THF (5 ml) at 0° C. and under an atmosphere of nitrogen was added sodium hydride (60% dispersion in oil, 21.8 mg) and the mixture was stirred for 5 minutes. To the mixture was added 2-chloro-5-(methylsulfonyl)pyrimidine (50 mg) in dimethylacetamide (1 ml). After stirring for 150 min. the reaction mixture was partitioned between ethyl acetate (50 ml) and saturated ammonium chloride solution (50 ml). The ethyl acetate layer was washed with brine (50 ml), dried (MgSO4), filtered and evaporated to dryness. Purification of the residue on a Phenomenex Magellen™ column using a 0.1M NH4OAc:MeCN gradient (95:5 to 60:40) over 5min. and then an isocratic flow (60:40) for 15 minutes gave the title compound as a white solid (31 mg).",N-[3-(2-hydroxyethoxy)-1-methyl-4-(4-methylphenyl)-1H-pyrazol-5-yl]-5-isopropyl-2-pyridinesulfonamide | THF | nitrogen | sodium hydride | 2-chloro-5-(methylsulfonyl)pyrimidine | dimethylacetamide | ethyl acetate | ammonium chloride | ethyl acetate | brine | MgSO4 | MeCN | title compound
US07705020B2,"A mixture of 1-isopropyl-1,3-dihydro-2H-benzimidazol-2-one (486 mg, 2.8 mmol) and chloroformic acid 4-nitrophenyl ester (556 mg, 2.8 mmol) in CH2Cl2 (10 mL) was stirred at room temperature for 5 min. To this mixture, Et3N (0.84 mL, 6.1 mmol) was added slowly and this mixture became a solution. This solution was added to a mixture of 1-{[4-(aminomethyl)piperidin-1-yl]methyl}cyclobutanecarboxylic acid 4-methylbenzene sulfonate (1.1 g, 2.8 mmol, Step 7) in CH2Cl2 (5 mL) at room temperature. After stirring for 10 min, Et3N (0.38 mL, 2.8 mmol) was added and the resulting mixture was stirred at room temperature for 2 hr. This mixture was washed with 0.5 N HCl aq (10 mL) and saturated NaHCO3 aq (10 mL) then the organic layer was concentrated. To the residue, saturated NaHCO3 aq (15 mL) and heptane (15 mL) was added at room temperature and it was stirred for 6 hrs at that temperature. Solid was observed and this mixture was filtered. The obtained solid was washed with H2O and heptane. After drying, crude material was obtained (1.0 g, 82%) as white solid. This crude material (4.0 g) was purified by recrystallization from toluene (36 mL) to give 2.6 g of the titled compound (66%) as white solid.","1-isopropyl-1,3-dihydro-2H-benzimidazol-2-one | chloroformic acid 4-nitrophenyl ester | CH2Cl2 | Et3N | 1-{[4-(aminomethyl)piperidin-1-yl]methyl}cyclobutanecarboxylic acid 4-methylbenzene sulfonate | CH2Cl2 | Et3N | HCl | NaHCO3 | NaHCO3 | heptane | H2O | heptane | crude material | crude material | toluene | titled compound"
US05563141,"A solution containing 1-(4-pyridyl)-4-carboxymethylpiperazine dihydrochloride 1/4H2O(400 mg, 1.33 mMoles), triethylamine (0.4 ml, 2.66 mMoles) and HOBT (0.2 g, 1.46 mMoles) in dry dimethylformamide (20 ml) was treated with diisopropylcarbodiimide (0.23 ml, 1.46 mMoles) and the mixture was stirred for 5 minutes. Ethyl 4-carboxymethylpiperidine was added and the mixture was stirred for a further 4 hours. The mixture was concentrated to half volume under reduced pressure and then poured into water (50 ml) and extracted with ethyl acetate (3×20 ml) and dichloromethane (3×20 ml). The combined organic extracts were concentrated under reduced pressure and the residue was purified by chromatography (flash column made with grade III alumina and eluted with a gradient of 0-1% methanol in dichloromethane) to give the title compound (130 mg) as a colourless oil; NMR (d6DMSO): 0.9-1.1 (m,2H), 1.2 (t,3H), 1.65 (d,2H), 1.8-2.0 (m,1H), 2.2 (d,2H), 2.5 (m,2H), 2.9-3.4 (m,10H), 4.0 (q,2H+m,1H), 4.3 (d,1H), 6.8 (d,2H), 8.15 (d,2H); m/e 375 (M+H)+.",1-(4-pyridyl)-4-carboxymethylpiperazine dihydrochloride | triethylamine | HOBT | dimethylformamide | diisopropylcarbodiimide | Ethyl 4-carboxymethylpiperidine | water | ethyl acetate | dichloromethane | methanol | dichloromethane | title compound
US20080004263A1,"To a solution of 2,4-pentanedione (3.47 mL, 33.8 mmol) in EtOH (65.0 mL) was added Et3N (5.0 mL, 35.9 mmol). The resulting mixture was cooled to 0° C. and added a solution of the α-chloro oxime (3.96 g, 0.017 mol) of Example 1 in EtOH (10.0 mL) dropwise via cannula. The reaction mixture was stirred at 0° C. for 1 h then at room temperature for overnight at which time the reaction mixture was quenched with H2O and extracted with EtOAc. The combined organic layers were washed with H2O, brine, and dried over MgSO4 then concentrated. The crude product was purified through a silica gel column (15% EtOAc/85% hexanes) to give the title compound (3.59 g, 86% over 2 steps) as a yellow oil. LCMS m/z: 280, 282 (M+H).","2,4-pentanedione | EtOH | Et3N | α-chloro oxime | EtOH | H2O | EtOAc | H2O | brine | MgSO4 | crude product | silica gel | EtOAc | title compound"
US04464366,"32.2 g of 2-(3-BOC-methylaminophenyl)-glyoxylic acid are reacted with 13.8 g of hydroxylamine hydrochloride in the manner described in Example 4. Crystallisation from CH2Cl2 /CH3OH/ether/hexane yields 2-(3-BOC-methylaminophenyl)-2-hydroxyiminoacetic acid. M.p. 135° (decomposition). IR: 3620, 3600-2300 (wide), 1688, 1600, 1590 (shoulder) cm-1 (CH2Cl2).",2-(3-BOC-methylaminophenyl)-glyoxylic acid | hydroxylamine hydrochloride | 2-(3-BOC-methylaminophenyl)-2-hydroxyiminoacetic acid
US20150376208A1,"A solution of N-(3-amino-4-fluorophenyl)-1′-oxo-2′,3′-dihydro-1′H-spiro[cyclobutane-1,4′-pyrazino[1,2-a]indole]-7′-carboxamide (2) (70 mg, 0.18 mmol) in dry THF (5 mL) was added acryloyl chloride (0.19 mL, 2.4 mmol) at −78° C. under inert atmosphere. The resultant reaction mixture was allowed to 0° C. and stirred for 1 h. The reaction mixture was diluted with water (10 mL) and extracted with EtOAc (2×20 mL). The combined organic layers were further washed with saturated NaHCO3 (10 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The obtained residue was suspended in THF (3 mL) and treated with DBU (0.1 mL) for 3 h. Volatiles were evaporated and the residue was purified by silica gel column chromatography to obtain the desired product (50 mg, 63%) as an off white solid. 1H NMR (400 MHz, DMSO-d6): δ 2.06 (m, 1H), 2.19 (m, 1H), 2.32 (m, 2H), 3.03 (m, 2H), 3.74 (d, J=2.4 Hz, 2H), 5.77-5.80 (dd, J=1.6, 10.4 Hz, 1H), 6.27-6.31 (dd, J=1.6, 16.8 Hz, 1H), 6.59-6.66 (dd, J=10.0, 16.8 Hz, 1H), 7.18 (s, 1H), 7.27 (m, 1H), 7.62 (m, 1H), 7.76 (m, 2H), 8.29 (s, 1H), 8.45 (m, 2H), 9.93 (s, 1H), 10.40 (s, 1H). MS m/z (M+H): 433.4","N-(3-amino-4-fluorophenyl)-1′-oxo-2′,3′-dihydro-1′H-spiro[cyclobutane-1,4′-pyrazino[1,2-a]indole]-7′-carboxamide | THF | acryloyl chloride | water | EtOAc | NaHCO3 | sodium sulfate | DBU | silica gel | desired product"
US20160251361A1,"4-Fluorophenol as a starting material was used in the same manner as in Example 1-2 to obtain 6-bromo-2-(4-fluorophenoxymethyl)imidazo[1,2-a]pyrimidine. The obtained 6-bromo-2-(4-fluorophenoxymethyl)imidazo[1,2-a]pyrimidine and (4-chloro-3-pyridyl)boronic acid were used in the same manner as in Example 1-3 to obtain the title compound.","6-bromo-2-(4-fluorophenoxymethyl)imidazo[1,2-a]pyrimidine | (4-chloro-3-pyridyl)boronic acid | title compound"
US07902252B2,"To a solution of (z)-methyl 5-(3-tert-butoxy-3-oxoprop-1-enyl)-1H-pyrrole-2-carboxylate or (E)-methyl 5-(3-tert-butoxy-3-oxoprop-1-enyl)-1H-pyrrole-2-carboxylate (13.6 g, 54.1 mmol, 2 equal batches) in EtOAc (200 mL) under nitrogen was added 10% Pd/C. The flask was flushed with hydrogen three times before allowing the reaction to stir under hydrogen for about 18 h. The catalyst was filtered off using Celite and the filtrate was concentrated to give 27.4 g methyl 5-(3-tert-butoxy-3-oxopropyl)-1H-pyrrole-2-carboxylate as a white solid (100%) for each stereoisomer. 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 1.46 (s, 9H), 2.54-2.59 (m, 2H), 2.90 (t, J=6.83 Hz, 2H), 3.83 (s, 3H), 5.97 (dd, J=3.49, 2.86 Hz, 1H), 6.81 (dd, J=3.61, 2.59 Hz, 1H), 9.30 (br s, 1H); LCMS-MS (ESI+) 197.86 (M-isobutylene).",(z)-methyl 5-(3-tert-butoxy-3-oxoprop-1-enyl)-1H-pyrrole-2-carboxylate | (E)-methyl 5-(3-tert-butoxy-3-oxoprop-1-enyl)-1H-pyrrole-2-carboxylate | EtOAc | nitrogen | Pd/C | hydrogen | hydrogen | methyl 5-(3-tert-butoxy-3-oxopropyl)-1H-pyrrole-2-carboxylate
US04370480,"A mixture containing 0.85 g of N-[(4,6-dimethoxypyrimidin-2-yl)aminocarbonyl]-2-carboxybenzenesulfonamide in 50 ml of anhydrous tetrahydrofuran was treated with 40 ml of a 1.4 molar solution of methyl lithium (low halide, Aldrich) in ether at 25° under a nitrogen atmosphere. The mixture was stirred for 4 hours at 25° and was then poured into 500 ml of water containing 10 ml of concentrated hydrochloric acid. The precipitated oil was extracted into methylene chloride and the oil on evaporation of solvent was purified by preparative thin layer chromatography on silica gel (Analtec, 2000 micrron, 20×20 plates) by elution with ethyl acetate/hexane in a one to one ratio. The isolated product was recrystallized from a 1-chlorobutane and hexane mixture to give 0.1 g, m.p. 126°-8°. The infrared absorption showed a broadened carbonyl peak at 1710 cm-1, and the absence of the 3500 and 3400cm-1 peaks of the starting material. The nuclear magnetic resonance spectrum showed peaks at 2.6 ppm, s, 3H, ##STR58## 4.0 ppm, s, 6H, CH3O of pyrimidine; 5.7 ppm, s, 1H, pyrimidine proton at position 5; and 7.3-7.7 ppm and 8.0 ppm, m, 4H, aromatic, which are consistent with the desired structure.","N-[(4,6-dimethoxypyrimidin-2-yl)aminocarbonyl]-2-carboxybenzenesulfonamide | tetrahydrofuran | methyl lithium | ether | nitrogen | water | hydrochloric acid | methylene chloride | silica gel | ethyl acetate/hexane | hexane | 1-chlorobutane"
US20110105573A1,"{5-[Benzyl-(3-fluoro-benzoyl)-amino]-2-propyl-benzoimidazol-1-yl}-acetic acid tert-butyl ester (0.12 mmol) was treated with TFA (2 mL) for 2 hours, concentrated, and purified by preparative LCMS to give the title compound. 11-1 NMR (d6-DMSO) δ 7.79 (m, 1H), 7.68 (m, 1H), 7.55 (m, 2H), 7.21 (m, 6H), 7.02 (m, 1H), 6.92 (m, 1H), 5.11 (s, 2H), 4.99 (s, 2H), 2.68 (t, 2H), 1.71 (m, 2H), 0.95 (t, 3H). MS calculated for C26H24FN3O3+H: 446, observed: 446.",{5-[Benzyl-(3-fluoro-benzoyl)-amino]-2-propyl-benzoimidazol-1-yl}-acetic acid tert-butyl ester | TFA | title compound
US04987132,"To a solution of oxalylchloride (4.1 ml) in dichloromethane (100 ml) was added dropwise a solution of dimethylsufoxide (7.14 g) in dichloromethane (10 ml) at -60° C., and the mixture was stirred for 10 minutes. To the resultant mixture was added a solution of 2-methyl-2-phenylpropanol (6.16 g) in dichloromethane (15 ml) at the same temperature. After stirring for one hour, to the mixture was added triethylamine (20.7 g). The mixture was further stirred for 30 minutes and allowed to room temperature. After adding water, the mixture was extracted with dichloromethane. The extract was washed with a saturated aqueous solution of sodium chloride, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The resultant residue was subjected to silica gel (40 g) column chromatography and elution with 2% ethyl acetate hexane solution gave 4.93 g of 2-methyl-2-phenylpropanal.",oxalylchloride | dichloromethane | dichloromethane | resultant mixture | 2-methyl-2-phenylpropanol | dichloromethane | triethylamine | water | dichloromethane | sodium chloride | magnesium sulfate | resultant residue | silica gel | ethyl acetate hexane | 2-methyl-2-phenylpropanal
US08198456B2,"KOtBu (2.38 g, 21.24 mmol) was added to a solution of 1H-pyrazolo[4,3-b]pyridine (2.3 g, 19.3 mmol) in THF (60 mL) at 0° C. After stirring at 0° C. for 1 hr, trimethylsilylethoxymethyl chloride (3.54 g, 21.24 mmol) was added. The reaction mixture was kept at 0° C. for 1 hr with stirring, then 1.5 hr at rt. The mixture was diluted with EtOAc and water and extracted with EtOAc. The combined organic phases were washed with brine, dried with Na2SO4, and concentrated. The crude product was purified by flash chromatography to afford 1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrazolo[4,3-b]pyridine in (2.32 g, 48%) and the regio-isomer.","KOtBu | 1H-pyrazolo[4,3-b]pyridine | THF | trimethylsilylethoxymethyl chloride | EtOAc | water | EtOAc | brine | Na2SO4 | crude product | 1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-pyrazolo[4,3-b]pyridine"
US05149705,"Absolute ethanol was degassed by applying a vacuum while simultaneously bubbling nitrogen through it. A solution of 188 mg (0.5201 mmol) ethyl 6-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronapth-2-yl)ethynyl]nicotinoate in 2 ml absolute ethanol was treated with 800 ml of a 1.65M (1.32 mmol) solution of potassium hydroxide in ethanol and water. The mixture was stirred at room temperature for 18 hours and then the solvent removed in vacuo. The residue was dissolved in water and extracted with 50 ml ether, which was discarded. The aqueous layer was then acidified with glacial acetic acid and extracted with 4×50 ml ether. The ether extracts were combined, washed with water, saturated NaCl solution and then dried (MgSO4). Solvent was removed in vacuo to give the title compound as a pale yellow solid. PMR (CDCl3): δ1.31 (12H, s), 1.71(4H, s), 7.34 (1H, d, J~7.8 Hz), 7.40 (1H, d, J~7.8 Hz), 7.62 (1H, s), 8.39 (1H, dd, J~7.3 Hz, 2.1 Hz), 9.33 (1H, d, J~2.1 Hz).","ethanol | ethyl 6-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronapth-2-yl)ethynyl]nicotinoate | ethanol | potassium hydroxide | ethanol | water | water | ether | ether | water | NaCl | MgSO4 | title compound"
US06348474B1,"Aluminum chloride (2.52 g, 18.9 mmol) was suspended in methylene chloride (25 ml) and 2,4-dichlorobenzoyl chloride (1.98 g, 9.5 mmol) was added. Then, 5-(methoxycarbonyl)-2-methylbenzo[b]furan (1.5 g, 7.9 mmol) was added and the mixture was stirred at room temperature for 1.5 hr. The reaction mixture was poured into ice water and extracted with ethyl acetate. The organic layer was washed with a saturated aqueous solution of sodium hydrogencarbonate (twice) and then saturated brine, and dried over anhydrous sodium sulfate. The desiccant was filtered off and the filtrate was concentrated under reduced pressure to give the objective compound (2.9 g, quantitative) as colorless crystals.","Aluminum chloride | methylene chloride | 2,4-dichlorobenzoyl chloride | 5-(methoxycarbonyl)-2-methylbenzo[b]furan | ice water | ethyl acetate | sodium hydrogencarbonate | brine | sodium sulfate"
US06891044B2,"3,4-Diaminobenzoic acid (5 g, 32.9 mmol), 4-(2-aminoethyl)morpholine (5.2 mL, 39.4 mmol), triethylamine (9.2 mL, 66 mmol), and DMAP (0.40 g, 3.3 mmol) were combined in dry DMF (80 mL) at 0° C. EDC (9.45 g, 49.3 mmol) was added, and the reaction stirred for 24 h at r.t. Concentration in vacuo and purification by silica gel chromatograpy (10% MeOH(CH2Cl2 with 0.2% NH4OH) gave 2.6 g (31%) of 3,4-diamino-N-(2-morpholin-4-yl-ethyl)-benzamide as a light brown solid. 1H NMR (300 MHz, DMSO-d6) δ 7.72 (t, 1H, J=5.4 Hz), 7.02 (d, 1H, J=1.8 Hz), 6.92 (dd, 1H, J=8.1, 1.8 Hz), 6.46 (d, 1H, J=8.1 Hz), 4.89 (br s, 2H), 4.51 (br s, 2H), 3.55 (t, 4H, J=4.8 Hz), 3.29 (q, 2H, J=7.2 Hz), 2.36-2.43 (m, 6H).","3,4-Diaminobenzoic acid | 4-(2-aminoethyl)morpholine | triethylamine | DMAP | DMF | EDC | silica gel | MeOH | 3,4-diamino-N-(2-morpholin-4-yl-ethyl)-benzamide"
US04053431,0.976 G. of 4'-cyano-4-hydroxy-biphenyl are dissolved in 10 ml. of absolute pyridine and reacted with 1.07 g. of chloroformic acid n-heptyl ester as in Example 1. The 1.8 g. of yellow oil obtained according to the procedure described in Example 1 is dissolved in benzene and chromatographed on 90 g. of silica gel. Benzene elutes 1.782 g. of colorless crystals which are recrystallized from ether-hexane up to constant melting point and clearing point. The pure 4'-cyano-4-biphenylyl n-heptyl carbonate obtained melts at 50.2°-50.5° and has a clearing point of 65.2°. UV (EtOH): ε 270 = 25900.,4'-cyano-4-hydroxy-biphenyl | pyridine | chloroformic acid n-heptyl ester | benzene | ether-hexane | 4'-cyano-4-biphenylyl n-heptyl carbonate
US20070232607A1,"4-Chloro-5-fluoroquinazoline (obtained as described in Example 1, preparation of starting materials, 6.76 g, 37.0 mmol) was dissolved in iso-propanol (200 ml) and 4-amino-2-methylphenol (5.00 g, 40.7 mmol) was added. The mixture was heated under reflux for 2 hours, causing a yellow solid to precipitate. The mixture was cooled to ambient temperature; the solid was collected by filtration. The solid was dissolved in a boiling mixture of methanol (500 ml) and water (100 ml) to give a brown solution. With vigorous stirring, the solution was basified with aqueous ammonia (0.880, 10 ml), causing a light brown solid to precipitate. The mixture was concentrated in vacuo to such a volume that all of the methanol had been removed, leaving the product as a suspension in aqueous solution. The suspension was cooled; the solid was collected by filtration, triturated with ethyl acetate and dried over P2O5 in a vacuum oven to give 2-methyl-4-[(5-fluoroquinazolin-4-yl)amino]phenol as a light brown solid (8.18 g, 82%); NMR spectrum: 3.30 (s, 3H), 6.78 (d, 1H), 7.28 (m, 2H), 7.38 (dd, 1H), 7.57 (d, 1H), 7.78 (m, 1H), 8.43 (s, 1H), 8.88 (d, 1H), 9.22 (s, 1H); Mass spectrum: MH+ 270.",4-Chloro-5-fluoroquinazoline | iso-propanol | 4-amino-2-methylphenol | methanol | water | ammonia | methanol | ethyl acetate | P2O5 | 2-methyl-4-[(5-fluoroquinazolin-4-yl)amino]phenol
US09249123B2,"A 50-mL single-necked round-bottomed flask equipped with a magnetic stirrer was charged with 114e (1.10 g, 2.09 mmol), lithium hydroxide (201 mg, 8.36 mmol), THF (10 mL), ethanol (10 mL) and water (10 mL). After stirring at room temperature for 2 h, the solvent was removed under reduced pressure and the resulting residue was acidified with 2N hydrochloric acid to pH of 4. The resulting aqueous solution was extracted with ethyl acetate (3×30 mL), and the organic extracts were combined and dried over sodium sulfate, filtered and concentrated under reduced pressure. The resulting residue was purified by flash chromatography to afford 114f in 65% yield (540 mg) as a white solid: mp 68-69° C.; 1H NMR (500 MHz, CDCl3) δ 7.03-6.97 (m, 2H), 6.86 (s, 1H), 6.71 (d, 1H, J=8.0 Hz), 4.94 (s, 2H), 4.60 (s, 2H), 1.35 (s, 9H); MS (ESI+) m/z 398.0 (M+H).",114e | lithium hydroxide | THF | ethanol | water | ethyl acetate | sodium sulfate | 114f
US06995156B2,"To a solution of 2-[1-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-2-(imidazol-4-yl)ethyl]aminocarbonyl-4-methoxyquinoline (69 mg, 0.14 mmol) in DMF (2 mL) was added t-butyl bromo acetate (0.026 mL, 1.2 eq.), potassium carbonate (30 mg, 1.5 eq), NaI (2.0 mg, 0.1 eq.). The reaction mixture was heated at 50° C. for 1 hour. Evaporation followed by flash column chromatography with 2%–3% MeOH in methylene chloride afforded 2-[1-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-2-(1-(t-butoxycarbonyl)methyl)imidazol-4-yl)ethyl]-aminocarbonyl-4-methoxyquinoline (25 mg) which was treated with neat trifluoroacetic acid (0.5 mL) for 1.5 hours at ambient temperature. Repeated evaporation of the solvents and treatment with methylene chloride afforded 2-[1-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-2-(1-(carboxymethyl)imidazol-4-yl)ethyl]-aminocarbonyl-4-methoxyquinoline (27 mg) as a trifluoroacetic acide salt: NMR (DMSO) 1.20 (t, 3), 3.2–3.6 (m, 11), 4.05 (q, 2), 4.1 (s, 3), 5.0 (s, 2), 5.3 (m, 1), 7.45 (s, 1), 7.5 (s, 1), 7.65 (t, 1), 7.8 (t, 1), 8.05 (d, 1), 8.16 (d, 1), 8.95 (s, 1) ppm.",2-[1-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-2-(imidazol-4-yl)ethyl]aminocarbonyl-4-methoxyquinoline | aminocarbonyl-4-methoxyquinoline | DMF | t-butyl bromo acetate | potassium carbonate | NaI | 2-[1-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-2-(1-(t-butoxycarbonyl)methyl)imidazol-4-yl)ethyl
US04698337,"Dry N,N-dimethylformamide (1.2 g.), phosphoryl chloride (2.5 g.), 2-(2-formamidothiazol-4-yl)-2-(2-formyloxyethoxyimino)acetic acid (syn isomer, 3.8 g.) and dry ethyl acetate (49.7 ml.) were treated in a similar manner to that of Example 1-(1) to give an activated acid solution. The solution was added to a solution of 7-amino-3-(1,3,4-thiadiazol-2-yl)thiomethyl-3-cephem-4-carboxylic acid (4.4 g.) and trimethylacetamide (12.3 g.) in dry ethyl acetate (90 ml.) at -10° C., and stirred at -5° to -10° C. for an hour. Water (50 ml.) was added to the resultant solution and allowed to stand at room temperature. The ethyl acetate layer was separated, washed with a saturated aqueous solution of sodium chloride and dried over magnesium sulfate. After concentrating the solution in vacuo, the residue was pulverized with diisopropyl ether. The precipitates were collected by filtration, washed with diisopropyl ether and dried to give 7-[2-(2 -formamidothiazol-4-yl)-2-(2-formyloxyethoxyimino)acetamido]-3-(1,3,4-thiadiazol-2-yl)thiomethyl-3-cephem-4-carboxylic acid (syn isomer, 2.5 g.).","N,N-dimethylformamide | phosphoryl chloride | 2-(2-formamidothiazol-4-yl)-2-(2-formyloxyethoxyimino)acetic acid | ethyl acetate | 7-amino-3-(1,3,4-thiadiazol-2-yl)thiomethyl-3-cephem-4-carboxylic acid | trimethylacetamide | ethyl acetate | Water | resultant solution | ethyl acetate | sodium chloride | magnesium sulfate | diisopropyl ether | 7-[2-(2 -formamidothiazol-4-yl)-2-(2-formyloxyethoxyimino)acetamido]-3-(1,3,4-thiadiazol-2-yl)thiomethyl-3-cephem-4-carboxylic acid"
US07157478B2,"Prepared using the procedure described for 11-oxo-5,6,7,8,9,10-hexahydro -6,9-methanobenzocyclooctene (Justus Liebigs Ann. Chem. 1961, 650, 115) using methyl 3,4-bis(bromomethyl)benzoate in place of 1,2-bis(bromomethyl)benzene.","11-oxo-5,6,7,8,9,10-hexahydro -6,9-methanobenzocyclooctene | methyl 3,4-bis(bromomethyl)benzoate"
US20150376136A1,"Prepared in a similar manner as described in Example 2.44 starting from 5-methyl-5-(3-methylcyclohexyl)-3-(2-oxo-2-phenylethyl)imidazolidine-2,4-dione (Example 2.80a) (534 mg, 1.63 mmol) and methyl iodide (122 uL, 1.95 mmol) to obtain product as a white powder of mixture of 4 pairs of diastereomers (236 mg, 42% yield). 1H NMR (400 MHz, DMSO-d6) δ 8.02 (d, J=8 Hz, 2H), 7.69 (t, J=8 Hz, 1H), 7.55 (t, J=8 Hz, 2H), 4.94 (s, 2H), 2.80 (t, J=8 Hz, 3H), 1.86-2.08 (m, 1H), 1.39-1.80 (m, 5H), 1.35-1.38 (2s, 3H), 1.15-1.40 (m, 3H), 0.87-1.03 (m, 1H), 0.95 (dd, J=2.8 Hz, J=7.4 Hz, 1H), 0.86 (t, J=8 Hz, 2H), 0.57-0.74 (m, 1H). MS 329 (MH+).","5-methyl-5-(3-methylcyclohexyl)-3-(2-oxo-2-phenylethyl)imidazolidine-2,4-dione | methyl iodide | product"
US06660738B2,"A mixture of 2 g (3.85 mmol)(2S,4R)-2-(2,4,5-Trifluoro-benzyloxymethyl)-4-tritylsulfanyl-pyrrolidine, 1.2 g (7.7 mmol) 2-chloro5-n-propylpyrimidine, 1.98 ml (11.55 mmol) N-ethyldiisopropylamine and a catalytic amount of copper(I) iodide was heated for 10 h at 80° C. The reaction was cooled and partitioned between H2O/Et2O (3×300). The organic phases were washed with aqueous saturated NaHCO3, aqueous 10% NaCl, dried (NaSO4) and evaporated. Flash chromatography on silica gel (toluene/Et2O 99:1) gave 2 g (81%) (2S,4R)-5-Propyl-2-[2-(2,4,5-trifluoro-benzyloxymethyl)-4-tritylsulfanyl-pyrrolidin-1-yl]-pyrimidine, MS: 640 (MH+).","(2S,4R)-2-(2,4,5-Trifluoro-benzyloxymethyl)-4-tritylsulfanyl-pyrrolidine | 2-chloro5-n-propylpyrimidine | N-ethyldiisopropylamine | copper(I) iodide | H2O/Et2O | NaHCO3 | NaCl | NaSO4 | silica gel | (2S,4R)-5-Propyl-2-[2-(2,4,5-trifluoro-benzyloxymethyl)-4-tritylsulfanyl-pyrrolidin-1-yl]-pyrimidine"
US09242996B2,"(R)-1-(3-chlorophenyl)-2-(methylamino)ethanol (1.75 g, 9.43 mmol) was dissolved in THF (31.4 mL), and then Boc anhydride (2.298 mL, 9.90 mmol) was added. The reaction mixture was stirred at room temperature for 2 h. LCMS indicated that the reaction was completed. The reaction mixture was concentrated, and purified by flash chromatography to afford (R)-tert-butyl (2-(3-chlorophenyl)-2-hydroxyethyl)(methyl)carbamate (2.0 g, 7.00 mmol, 74.3%). LCMS (m/z): 212.1 (MH+-56), 0.94 min.",(R)-1-(3-chlorophenyl)-2-(methylamino)ethanol | THF | Boc anhydride | (R)-tert-butyl (2-(3-chlorophenyl)-2-hydroxyethyl)(methyl)carbamate
US09102677B2,"Intermediate 22 (383 mg, 1.00 mmol), ethylamine hydrochloride (163 mg, 2.0 mmol), HATU (457 mg, 1.20 mmol) and DIPEA (0.349 mL, 2.0 mmol) were dissolved in DMF (2 mL) and stirred at RT overnight. More ethylamine hydrochloride (163 mg, 2.0 mmol) and DIPEA (0.349 mL, 2.0 mmol) were added and the reaction stirred for a further 2 h. The reaction mixture was diluted with EtOAc (20 mL) and washed with saturated aqueous sodium bicarbonate solution (10 mL), water and brine. The organic phase was dried and evaporated under vacuum. Purification of the residue by flash chromatography on silica gel (DCM-methanol 10 to 20% gradient) gave the title compound as an off-white solid (200 mg, 0.488 mmol, 49% yield). LC/MS (M(35Cl)+H)+ 410, (M(37Cl)+H)+ 412; RT 0.76 min (using LC/MS apparatus c)).",Intermediate 22 | ethylamine hydrochloride | HATU | DIPEA | DMF | ethylamine hydrochloride | DIPEA | EtOAc | sodium bicarbonate | water | brine | silica gel | DCM-methanol | title compound
US20160052898A1,"200 mg (507 μmol) of the compound from example 12A were provided in 2 mL of DMF. 212 μL (1.52 mmol) of triethylamine, 103 mg (760 μmol) of (1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptane hydrochloride and 13.0 mg (79 μmol) of potassium iodide were added, and the mixture was stirred at room temperature over night. After filtration, purification by HPLC (method 2) yielded 32.0 mg (13% of theory) of the title compound.","compound | DMF | triethylamine | (1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptane hydrochloride | potassium iodide | title compound"
US09233108B2,"To a solution of lithium aluminium hydride (0.44 g, 0.011 mol) in diethyl ether (10 mL) was added dropwise at 0° C. solution of 3-[1-(2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)-1H-indol-3-yl]propanoic acid (Intermediate 40; 2 g, 0.011 mol) in ethyl ether (10 mL). The reaction mixture was stirred at room temperature for 45 minutes. Saturated sodium bicarbonate was added into the mixture at 0° C. The organic phase was extracted and the solvent was removed under reduced pressure giving the title compound (3.2 g, 83%), which was used in the next step without further purification.",lithium aluminium hydride | diethyl ether | 3-[1-(2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)-1H-indol-3-yl]propanoic acid | Intermediate 40 | ethyl ether | sodium bicarbonate | title compound
US06713496B2,"A solution of (R)-(−)-1-amino-2-propanol (9.00 g, 0.12 mol) in tetrahydrofuran (40 ml) and acetic acid (5 ml) was added dropwise to a solution of p-anisaldehyde (5.45 g, 0.04 mol) in tetrahydrofuran (40 ml), and once addition was complete, the solution was stirred at room temperature for 2 hours. The solution was cooled in an ice-bath, and sodium triacetoxyborohydride (9.50 g, 0.0.045 mol) was added portionwise, and then the mixture was stirred at room temperature for 18 hours. The reaction mixture was concentrated under reduced pressure and the residue was partitioned between dichloromethane (150 ml) and sodium hydroxide solution (150 ml, 0.5N). The layers were separated and the aqueous phase was saturated with sodium chloride, then extracted with further dichloromethane (3×30 ml). The combined organic solutions were dried (MgSO4) and evaporated under reduced pressure. The residue was purified by chromatography on silica gel (gradient elution 98:2:0.2 to 97:3:0.3 dichloromethane:methanol:0.88 NH3) to afford an orange oil (4.9 g). 1H-NMR (CDCl3, 400 MHz) δ: 1.12 (d, 3H), 2.39 (dd, 1H), 2.70 (dd, 1H), 3.62-3.79 (m, 6H), 6.82 (d, 2H), 7.19 (d, 2H). LRMS: m/z (ES+) 196 [MH+].",(R)-(−)-1-amino-2-propanol | tetrahydrofuran | acetic acid | p-anisaldehyde | tetrahydrofuran | ice | sodium triacetoxyborohydride | dichloromethane | sodium hydroxide | dichloromethane | MgSO4 | silica gel | dichloromethane | methanol | NH3 | oil
US07906546B2,"350 mg (0.81 mmol) of (RS,SR)-2-benzenesulfonyl-2-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)-propionic acid methyl ester (from example 3) in 10 mL of THF at 0° C., were treated with 39 mg (0.89 mmol, 1.1 eq) of NaH (55% in oil) portionwise within 30 min. 0.10 mL (1.22 mmol, 1.5 eq) of 1-chloro-2-methoxy-ethane was added and the ice bath removed. After 2 hours, the reaction was quenched by addition of aqueous NH4Cl sat., extracted with EtOAc and the organic phases dried over Na2SO4. Evaporation of the solvent afforded (RS,SR)-2-benzenesulfonyl-2-(6-chloro-9-methoxymethyl-2,3,4,9-tetrahydro-1H-carbazol-2yl)-propionic acid methyl ester as yellow solid, MS: 493 (MNH4′). The crude material was used in the next step without further purification.","(RS,SR)-2-benzenesulfonyl-2-(6-chloro-2,3,4,9-tetrahydro-1H-carbazol-2-yl)-propionic acid methyl ester | THF | NaH | 1-chloro-2-methoxy-ethane | ice | NH4Cl | EtOAc | Na2SO4 | (RS,SR)-2-benzenesulfonyl-2-(6-chloro-9-methoxymethyl-2,3,4,9-tetrahydro-1H-carbazol-2yl)-propionic acid methyl ester"
US20060100245A1,"To a solution of 4-(3-amino-pyridin-2-yl)-N-(4-tert-butyl-phenyl)-benzamide (400 mg, 1.16 mmol) and triethylamine (230 mg, 2.32 mmol) in DCM (100 ml) add methanesulfonyl chloride (266 mg, 2.32 mmol) dropwise. Stir the mixture 10 minutes at room temperature. Concentrate and partition between EtOAc and water. Dry the solution (Na2SO4), concentrate under reduced pressure, and triturate with ether-hexanes to give N-(4-tert-butyl-phenyl)-4-(3-bismethanesulfonylamino-pyridin-2-yl)-benzamide as a solid.",4-(3-amino-pyridin-2-yl)-N-(4-tert-butyl-phenyl)-benzamide | triethylamine | DCM | methanesulfonyl chloride | EtOAc | water | Na2SO4 | ether-hexanes | N-(4-tert-butyl-phenyl)-4-(3-bismethanesulfonylamino-pyridin-2-yl)-benzamide
US08106064B2,"The solution of (57) (1.1 g, 2.237 mmol) in ethanol (20 ml) was stirred in the presence of 10% palladium on carbon under an atmosphere of hydrogen. After 1.5 hr., the mixture was filtered through celite pad and the filtrate was evaporated in vacuo. The residue was purified by silica gel column chromatography (eluent, methanol:chloroform (5:95)) to afford 786 mg (quantitative) of the title compound as a white solid. m.p. 270-271° C.; 1H NMR (200 MHz, CDCl3) δ 1.00 (9H, s), 2.47 (3H, s), 7.70 (1H, s), 7.86 (1H, s), 8.02 (1H, s), 10.74 (1H, s), 11.01 (1H, s); m/z (EI) 311 (M+).",(57) | ethanol | palladium on carbon | hydrogen | silica gel | methanol:chloroform | title compound
US03951976,"The diethyl acetal of 3-[1-(1,1-dimethylprop-2-ynyl)-3-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)ureido]propionaldehyde (15 grams), water (400 ml) and hydrochloric acid (4 ml) are charged into a glass reaction vessel equipped with a mechanical stirrer, thermometer and reflux condenser. The reaction mixture is heated at reflux for a period of about 15 minutes. The reaction mixture is then filtered while hot and the filtrate is cooled to form a precipitate. The precipitate is recovered by filtration, is dried and is recrystallized to yield the desired product tetrahydro-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)-3(1,1-dimethylprop-2-ynyl)-6-hydroxy-2(1H)-pyrimidinone.","diethyl acetal | 3-[1-(1,1-dimethylprop-2-ynyl)-3-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)ureido]propionaldehyde | water | hydrochloric acid | desired product | tetrahydro-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)-3(1,1-dimethylprop-2-ynyl)-6-hydroxy-2(1H)-pyrimidinone"
US04451463,"A solution (2.75 ml.) of bromine (80 mg.) in chloroform was added to a solution of 1-(4-hydroxybutyl)-3-[2-(2,2,2-trifluoroethyl)guanidino]pyrazole (140 mg.) in HOAc (2 ml.). After stirring at room temperature for 1 hour the mixture was basified with 6 N aqueous ammonium hydroxide and then extracted with EtOAc (6×10 ml.). The combined extracts were dried (MgSO4) and evaporated to dryness in vacuo to give 4-bromo-1-(4-hydroxybutyl)-3-[2-(2,2,2-trifluoroethyl)guanidino]pyrazole (145 mg., 82%) having the following n.m.r. spectrum in d6DMSO: 7.7 (s, 1H); 4.2 (br t, 2H); 3.9 (t, 2H); 3.3 (t, 2H); 1.5 (br m, 4H).","bromine | chloroform | 1-(4-hydroxybutyl)-3-[2-(2,2,2-trifluoroethyl)guanidino]pyrazole | HOAc | ammonium hydroxide | EtOAc | MgSO4 | 4-bromo-1-(4-hydroxybutyl)-3-[2-(2,2,2-trifluoroethyl)guanidino]pyrazole"
US06706216B1,"The antiozonant mixture of claim 1 wherein the paraphenylenediamine is selected from the group consisting of paraphenylenediamine, paraaminodiphenylamine and the carbonyl compound mixture is formed from acetone and methyl ethyl ketone, cyclopentanone, cyclohexanone, methylisobutyl ketone and methylisoamyl ketone.",paraphenylenediamine | paraphenylenediamine | paraaminodiphenylamine | carbonyl | acetone | methyl ethyl ketone | cyclopentanone | cyclohexanone | methylisobutyl ketone | methylisoamyl ketone
US20150291586A1,"Prepared from (2R,5S)-4-benzyloxycarbonylmethyl-5-((R)-3-fluoro-pyrrolidin-1-ylmethyl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester using a similar method to that described in Preparation 272 (EtOH used as solvent). 1H NMR (CDCl3): 10.12-9.12 (1H, br s), 5.27 (1H, d), 4.17-3.89 (1H, m), 3.81-3.45 (3H, m), 3.45-2.78 (8H, m), 2.78-2.43 (2H, m), 2.42-1.99 (2H, m), 1.47 (9H, s), 1.23 (3H, d).","(2R,5S)-4-benzyloxycarbonylmethyl-5-((R)-3-fluoro-pyrrolidin-1-ylmethyl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester | EtOH"
US08178131B2,"A mixture of 5-bromo-4-fluoro-1H-pyrrolo[2,3-b]pyridin-3-amine (200 mg, 0.869 mmol), tetrahydrofuran-2-carboxylic acid (252 mg, 2.17 mmol), triethylamine (606 μL, 4.35 mmol), and BOP-Cl (203 mg, 2.17 mmol) in CH2Cl2 (10 mL) was stirred at room temperature for 7 hours. 2M LiOH (5 mL) was then added to the mixture and stirred at room temperature for 30 minutes. Water (25 mL) was then added to the mixture and stirred for an additional 30 minutes. The solid formed was filtered, washed with water (3×5 mL) and dried to provide N-(5-bromo-4-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)tetrahydro furan-2-carboxamide (230 mg, 80.6% yield) as a solid.","5-bromo-4-fluoro-1H-pyrrolo[2,3-b]pyridin-3-amine | tetrahydrofuran-2-carboxylic acid | triethylamine | BOP-Cl | CH2Cl2 | LiOH | Water | water | N-(5-bromo-4-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)tetrahydro furan-2-carboxamide"
US20110053931A1,"Prepared from 4-chloro-6,7-dimethoxyquinoline (prepared according to reference procedure in Example 5) (64 mg, 0.29 mmol) and 3-(3-chlorobenzyl)-5-(3-fluoro-4-hydroxyphenyl)pyrimidin-4(3H)-one (95 mg, 0.30 mmol) according to the procedure described for Example 1, Step E. The crude product was purified by silica gel flash column chromatography (1:10 MeOH/EtOAc) to yield 121 (20 mg, 13%) as a white solid. 1H NMR (DMSO-d6, 400 MHz) δ 8.80 (s, 1H), 8.50 (d, J=5.08 Hz, 1H), 8.36 (s, 1H), 7.88-7.94 (m, 1H), 7.72-7.76 (m, 1H), 7.48-7.54 (m, 3H), 7.36-7.44 (m, 4H), 6.50-6.52 (m, 1H), 5.20 (s, 3H), 3.96 (s, 3H), 3.95 (s, 3H). LRMS (ESI pos) m/e 518 (M+1).","4-chloro-6,7-dimethoxyquinoline | 3-(3-chlorobenzyl)-5-(3-fluoro-4-hydroxyphenyl)pyrimidin-4(3H)-one | crude product | silica gel | MeOH/EtOAc | 121"
US04240820,"20.4 g (0.1 mole) of 2-amino-3-cyano-4,5-dimethylfurane and 17.5 g (0.155 mole) of chloroacetyl chloride were boiled in 200 ml of toluene until the evolution of hydrogen chloride had subsided. Thereafter, the solvent was evaporated off under reduced pressure and the residue was recrystallized from ethyl acetate. 26 g of 2-chloroacetylamino-3-cyano-4,5-dimethylfurane of melting point 114° C. were obtained in this manner.","2-amino-3-cyano-4,5-dimethylfurane | chloroacetyl chloride | toluene | hydrogen chloride | ethyl acetate | 2-chloroacetylamino-3-cyano-4,5-dimethylfurane"
US09371285B2,"Into a 250-mL round-bottom flask was placed methanol (100 mL), acetic acid (42 mL), Biphenylcarboxaldehyde (7.96 g, 43.7 mmol, 1 equiv), methylamine in anhydrous ethanol (20 g, 193.2 mmol, 4.4 equiv), and NaBH3CN (8.3 g, 132.1 mmol, 3 equiv). The solution was stirred overnight at 60° C. The resulting solution was diluted with 200 mL of water and extracted with 3×200 mL of ethyl acetate. The organic phase was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1/10) to give N-methyl (3-biphenyl)methylamine as a colorless oil.",methanol | acetic acid | Biphenylcarboxaldehyde | methylamine | ethanol | NaBH3CN | water | ethyl acetate | sodium sulfate | N-methyl (3-biphenyl)methylamine
US08889906B2,"C-(6-Benzenesulfonyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-methylamine (1.0 g, 3.5 mmol), 1H-pyrazol-1-carboxamidine hydrochloride (0.5 g, 3.5 mmol) and 1.2 mL of diethyl isopropylamine (7.0 nnol) were dissolved in 10 mL of DMF. The reaction mixture was heated to 100° C. for three hours and then cooled and diluted by addition of 75 mL of water. The aqueous mixture was extracted twice with 100 mL of EtOAc, and the combined organic layers were dried over MgSO4. The solvent was removed under reduced pressure, and the resulting oil was purified by medium pressure chromatography (silica gel, MeOH/CHCl3/NH4OH 10:89:1) to yield 0.4 g (1.16 mmol, 33%) of N-(6-benzenesulfonyl-1,2,3,4-tetrahydro-naphthalen-1-ylmethyl)-guanidine, MS: 344 (M+H)+.","C-(6-Benzenesulfonyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-methylamine | 1H-pyrazol-1-carboxamidine hydrochloride | diethyl isopropylamine | DMF | water | EtOAc | MgSO4 | silica gel | MeOH/CHCl3/NH4OH | N-(6-benzenesulfonyl-1,2,3,4-tetrahydro-naphthalen-1-ylmethyl)-guanidine"
US05719176,"2-Acetamido-1,3-diacetoxy-2-tetradecylpropane (1.25 g) was dissolved in 100 ml of methanol and 19.4 ml of a 1N aqueous sodium hydroxide solution was added thereto. The mixture was refluxed under heating for 6 hours. The mixture was neutralized with a 1N aqueous hydrochloric acid solution and concentrated under reduced pressure. The concentrate was washed with water and ethyl acetate:hexane=1:1 in order to give 791 mg of 2-amino-2-tetradecyl-1,3-propanediol hydrochloride.","2-Acetamido-1,3-diacetoxy-2-tetradecylpropane | methanol | sodium hydroxide | hydrochloric acid | water | ethyl acetate | hexane | 2-amino-2-tetradecyl-1,3-propanediol hydrochloride"
US05166347,"Isopropyl N-cyano-3-pyridinecarboximidate (0.50 g, 2.6 mmol) was dissolved in methanol (10 ml), and 2-nitroxyethylamine nitrate (0.49 g, 2.9 mmol) and sodium methoxide (0.16 g, 2.9 mmol) were added. The mixture was stirred at room temperature for 10 minutes. After the reaction was completed, the reaction solution was concentrated under reduced pressure, and the residue was extracted with dichloromethane (50 ml×3). The dichloromethane layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The concentrated residue was crystallized from dichloromethane-diethyl ether to give the title compound (0.48 g, 2.1 mmol, yield: 79%) as colorless needles.",Isopropyl N-cyano-3-pyridinecarboximidate | methanol | 2-nitroxyethylamine nitrate | sodium methoxide | dichloromethane | dichloromethane | sodium sulfate | dichloromethane-diethyl ether | title compound
US20150329525A1,"Following the general method as outlined for compound 24—Step 2, starting from maleic anhydride (213 mg; 2.17 mmol), aqueous NaOH solution (4 M; 0.7 mL; 2.8 mmol), aqueous TiCl3 solution (15%; 4.46 g; 4.3 mmol), acetone (2 mL), and 7-chloronaphthalene-1-diazonium tetrafluoroborate (Step 1: 600 mg; 2.17 mmol), 500 mg (83%) of the title compound was obtained as a brown solid, which was used directly in the next step without further purification.",maleic anhydride | NaOH | TiCl3 | acetone | 7-chloronaphthalene-1-diazonium tetrafluoroborate | title compound
US20100222345A1,"A mixture of 1,3-dichloro-2-methyl-5-nitrobenzene (5.0 g, 24.3 mmol) and tin(II) chloride dihydrate (21.9 g, 97.1 mmol) in ethanol (80 mL) was heated at reflux for 2 h. The reaction was allowed to cool, then was quenched with water and saturated aq. sodium bicarbonate until slightly basic. (Addition of sodium bicarbonate caused vigorous gas emission) The thick mixture was extracted with ethyl acetate (3×) and the combined extracts were dried over sodium sulfate and concentrated in vacuo. Chromatography (20% ethyl acetate/hexanes) provided the product, 3,5-dichloro-4-methylaniline. 1H NMR (400 MHz, CDCl3) δ 2.29 (s, 3H), 2.35 (br s, 2H), 6.66 (s, 2H).","1,3-dichloro-2-methyl-5-nitrobenzene | tin(II) chloride dihydrate | ethanol | water | sodium bicarbonate | sodium bicarbonate | ethyl acetate | sodium sulfate | ethyl acetate/hexanes | 3,5-dichloro-4-methylaniline"
US04760163,"using isopropyl 2-chloro-4-fluoro-5-[5-cyano-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-benzoate and dimethyl sulphate in dimethylformamide there is obtained isopropyl 2-chloro-4-fluoro-5-[5-cyano-3,6-dihydro-3,4-dimethyl-2,6-dioxo-1(2H)-pyrimidinyl]-benzoate, m.p. 171°-173° C.,","isopropyl 2-chloro-4-fluoro-5-[5-cyano-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-benzoate | dimethyl sulphate | dimethylformamide | isopropyl 2-chloro-4-fluoro-5-[5-cyano-3,6-dihydro-3,4-dimethyl-2,6-dioxo-1(2H)-pyrimidinyl]-benzoate"
US09296740B2,"The title compound was prepared following Protocol A. 1-[4-Chloro-2-fluoro-5-(2-fluoroethoxy)phenyl]-piperazine dihydrochloride and [3-(1H-imidazol-2-yl)pyrazolo[3,4-b]pyridin-1-yl]acetic acid were used as the coupling components. The crude product was purified by silica gel chromatography (2% to 3.5% MeOH in CH2Cl2) to provide 1-{4-[4-chloro-2-fluoro-5-(2-fluoroethoxy)phenyl]piperazin-1-yl}-2,3-(1H-imidazol-2-yl)pyrazolo[3,4-b]pyridin-1-yl]ethanone as a tan solid: 1H NMR (CDCl3, 400 MHz) □δ 8.79 (dd, 0.6; H, J=8.0, 1.8 Hz), 8.67 (d, 0.4; H, J=6.4 Hz), 8.57-8.55 (m, 1H), 7.30-7.25 (m, 1H), 7.11-7.06 (m, 2H), 6.63 (d, 0.6H, J=7.6 Hz), 6.57 (d, 0.4H, J=7.6 Hz), 6.54 (d, 1H, J=7.6 Hz), 5.45 (s, 0.7H), 5.43 (s, 1.3H), 4.83-4.80 (m, 1H), 4.71-4.68 (m, 1H), 4.31-4.18 (m, 2H), 3.82-3.76 (m, 3H), 3.50 (t, 1H, J=5.2 Hz), 3.23-3.04 (m, 4H); LC/MS m/z (M+H)+ 502.4.","title compound | 1-[4-Chloro-2-fluoro-5-(2-fluoroethoxy)phenyl]-piperazine dihydrochloride | [3-(1H-imidazol-2-yl)pyrazolo[3,4-b]pyridin-1-yl]acetic acid | crude product | silica gel | MeOH | CH2Cl2 | 1-{4-[4-chloro-2-fluoro-5-(2-fluoroethoxy)phenyl]piperazin-1-yl}-2,3-(1H-imidazol-2-yl)pyrazolo[3,4-b]pyridin-1-yl | ethanone"
US05482969,"To a stirred, cooled (-20° C.) solution of 3,3,3-trifluoro-2-hydroxy-2-methylpropanoic acid (0.46 g) in N,N-dimethylacetamide (6 mL) was rapidly added thionyl chloride (0.35 g) and the mixture stirred at -15° to -20° C. for 1 hour. 3-Chloro-4-aminobenzophenone (0.45 g) was then added in one portion and the mixture allowed to stir at room temperature overnight. The solution was poured into ice water and filtered through diatomaceous earth. The diatomaceous earth was washed with methylene chloride, the organic solution dried and the solvent removed. Chromatography (eluent methylene chloride, then 5% ethyl acetate in methylene chloride) gave the title compound (0.31 g) as a white solid; mp 142°-144° C. Analysis for C17H13ClF3NO3 : Calculated: C, 54.92; H, 3.53; N, 3.77; Found: C, 54.89; H, 3.63; N, 3.68.","3,3,3-trifluoro-2-hydroxy-2-methylpropanoic acid | N,N-dimethylacetamide | thionyl chloride | 3-Chloro-4-aminobenzophenone | ice water | methylene chloride | methylene chloride | ethyl acetate | methylene chloride | title compound"
US04275206,"A mixture of 1.6 grams of (1-ethyl-2-methylindol-3-yl) (3-carboxy-pyridin-2-yl)ketone, 1.85 grams of 1,2-diphenylindolizine and 10 ml. of acetic anhydride was heated at about 40° C. for 104 minutes and then cooled in an ice bath. The reaction mixture was filtered and the product was repeatedly recrystallized from a toluene-petroleum ether mixture until a constant melting point of 206.5°-207.5° C. was obtained. A chloroform solution of the final product produced a blue color when applied to a record sheet material coated with a zinc-modified phenolic resin.","(1-ethyl-2-methylindol-3-yl) (3-carboxy-pyridin-2-yl)ketone | 1,2-diphenylindolizine | acetic anhydride | ice | toluene-petroleum ether | chloroform | final product"
US20020015916A1,"Sixty grams of t-Amylbenzene, 39.5 g of potassium iodate, 81 g of acetic anhydride, and 170 ml of dichloromethane were mixed, and 66.8 g of concentrated sulfuric acid was gradually dropwise added to the mixture with ice-cooling. After stirring the mixture with ice-cooling for 2 hours, the stirring was continued for 10 hours at room temperature. Water (500 ml) was added to the reaction solution with ice-cooling followed by extraction with dichloromethane. The organic phase was washed with sodium hydrogencarbonate and then with water, then concentrated, thereby di(4-t-amylphenyl)iodonium sulfate was obtained. This sulfate was added to an excess amount of pentafluorobenzenesulfonic acid tetramethylammonium salt. Water (500 ml) was added to this solution followed by extraction with dichloromethane. The organic phase was washed with a 5% aqueous tetramethylammonium hydroxide solution and then with water, then concentrated, thereby di (4-t-amylphenyl)iodonium pentafluorobenzenesulfonate was obtained.",dichloromethane | Water | water | sulfate | pentafluorobenzenesulfonic acid tetramethylammonium salt | tetramethylammonium hydroxide | di (4-t-amylphenyl)iodonium pentafluorobenzenesulfonate
US20050256167A1,"To a solution of 2-(2-chlorophenyl)-1-(4-chlorophenyl)-N-methoxy-N-methyl-1H-imidazole-4-carboxamide (50.0 mg, 0.133 mmol) in 1.5 mL THF was added a 1.0 M solution of 4-fluorophenylmagnesium bromide (0.27 mL, 0.27 mmol) under argon at rt with stirring. The resultant mixture was stirred for 30 minutes and a saturated aqueous solution of NH4Cl was added. The mixture was extracted with ethyl acetate. The organic layer was dried over Na2SO4 and concentrated down in vacuo. The crude product was purified on HPLC to give [2-(2-chlorophenyl)-1-(4-chlorophenyl)-1H-imidazol-4-yl](4-fluorophenyl)-methanone as a solid (38.0 mg, 69%): Rf=0.58 (1:1 ethyl acetate/hexanes).",2-(2-chlorophenyl)-1-(4-chlorophenyl)-N-methoxy-N-methyl-1H-imidazole-4-carboxamide | THF | 4-fluorophenylmagnesium bromide | argon | resultant mixture | NH4Cl | ethyl acetate | Na2SO4 | crude product | [2-(2-chlorophenyl)-1-(4-chlorophenyl)-1H-imidazol-4-yl](4-fluorophenyl)-methanone
US20160185758A1,"A mixture of 3-[(E)-(4-bromo-2-pyridyl)methyleneamino]-1-methyl-pyrrolidin-2-one (which may be prepared as described in Description 1) (564.3 mg, 2 mmol) and phenyl vinyl sulfone (339.8 mg, 2.02 mmol) in THF (10 mL) was treated with silver acetate (333.99 mg, 2 mmol). The mixture was stirred at room temp for 2 hours, filtered through Celite and concentrated to give the title compound (D2) as a brown gum; M/Z: 450, 452 (M+H+)",3-[(E)-(4-bromo-2-pyridyl)methyleneamino]-1-methyl-pyrrolidin-2-one | phenyl vinyl sulfone | THF | silver acetate
US08198309B2,"A 4 mL scintillation vial was charged with 1-[2-(4-tert-butyl-benzenesulfonylamino)-5-chloro-phenyl]-1H-[1,2,3]triazole-4-carboxylic acid ethyl ester (synthesized according to general procedure G, 10 mg, 0.02 mmol) and 3 M NaOH (aq)/THF (1:3) (1 mL). The reaction was heated to 60° C. and stirred overnight. The following day, the volatiles were removed in vacuo and the residue was purified by preparative TLC to afford 1-[2-(4-tert-butyl-benzenesulfonylamino)-5-chloro-phenyl]-1H-[1,2,3]triazole-4-carboxylic acid: MS (ES) M+H expected 435.1, found 435.0.","1-[2-(4-tert-butyl-benzenesulfonylamino)-5-chloro-phenyl]-1H-[1,2,3]triazole-4-carboxylic acid ethyl ester | 1-[2-(4-tert-butyl-benzenesulfonylamino)-5-chloro-phenyl]-1H-[1,2,3]triazole-4-carboxylic acid | NaOH | THF"
US06995172B2,"Part C. To a solution of 2-fluoro-4-iodo-1-methylbenzene (50 g, 210 mmol) in anhydrous acetone (490 mL) was added N-bromosuccinimide (42 g, 230 mmol) and 2,2′-azobisiso-butyronitrile (100 mg, 0.60 mmol). The resulting solution was heated to reflux and maintained under reflux conditions for 5 h. The reaction was then cooled, concentrated, and filtered. The filtrate was concentrated, and the resulting dark red residue was purified by flash column chromatography (10% ethyl acetate in hexanes) to afford a 4:1 mixture (58 g) of 1-(bromomethyl)-2-fluoro-4-iodobenzene (49 g, 73%) and 2-fluoro-4-iodo-1-methylbenzene (9 g, 17%) as a red solid. 1H NMR (product) (CDCl3) δ 7.40–7.49 (m, 2H), 7.13 (t, 1H), 4.45 (s, 2H).","2-fluoro-4-iodo-1-methylbenzene | acetone | N-bromosuccinimide | 2,2′-azobisiso-butyronitrile | ethyl acetate | hexanes | 1-(bromomethyl)-2-fluoro-4-iodobenzene | 2-fluoro-4-iodo-1-methylbenzene"
US07022718B2,"The title compound, MS: m/e=434.9 (M+), was prepared from dibenzofuran-2-carboxamidine and 2-(2,4-dichloro-benzylidene)-malononitrile in analogy to the process described in Example 11 as a solid.","title compound | dibenzofuran-2-carboxamidine | 2-(2,4-dichloro-benzylidene)-malononitrile"
US20130225552A1,"1-(Trans-3-aminocyclobutyl)-3,3-difluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one hydrobromide (0.084 g, 0.262 mmol), 2-chlorobenzothiazole (0.0534 g, 0.315 mmol), and N,N-diisopropylethylamine (0.183 mL, 1.050 mmol) were mixed in DMSO (0.5 mL) in a sealed tube. The reaction mixture was stirred at 120° C. for 2 hr. The reaction mixture was cooled to room temperature, diluted with water, and extracted with EtOAc. The organic layer was separated, washed with saturated aqueous sodium chloride, dried over magnesium sulfate, filtered, and concentrated in vacuo. The resulting crude product was purified by silica gel column chromatography eluting with EtOAc in hexanes to yield the title compound (0.030 g, 0.081, 30.7% yield) as a white solid. M+1: 373.1. 1H NMR (400 MHz, DMSO-d6) δ ppm 2.39-2.49 (m, 2H) 3.19-3.30 (m, 2H) 4.48-4.58 (m, 1H) 5.10 (quin, J=8.36 Hz, 1H) 7.04 (t, J=7.53 Hz, 1H) 7.21-7.26 (m, 1H) 7.29 (dd, J=7.34, 5.38 Hz, 1H) 7.43 (d, J=7.82 Hz, 1H) 7.70 (d, J=7.24 Hz, 1H) 8.20 (dd, J=7.43, 1.37 Hz, 1H) 8.51-8.56 (m, 2H).","1-(Trans-3-aminocyclobutyl)-3,3-difluoro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one hydrobromide | 2-chlorobenzothiazole | N,N-diisopropylethylamine | DMSO | water | EtOAc | sodium chloride | magnesium sulfate | crude product | silica gel | EtOAc | hexanes | title compound"
US09018381B2,"To a yellow solution of (R)-4-(4-((4′-chlorobiphenyl-2-yl)(hydroxy)methyl)piperidin-1-yl)benzoic acid (INTERMEDIATE 40, 1.64 g, 3.89 mmol), (R)-4-(4-((2-(tert-butyldimethylsilyloxy)ethyl)(methyl)amino)-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)benzenesulfonamide (INTERMEDIATE 67, 2.68 g, 4.09 mmol), DMAP (0.95 g, 7.78 mmol) and dichloromethane (41 ml) was added EDC (1.492 g, 7.78 mmol). After stirring for 16 hours, the mixture was diluted with saturated aqueous sodium bicarbonate. The layers were separated and the aqueous layer was extracted with dichloromethane (×2). The combined organic layers were washed with saturated aqueous sodium chloride, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The concentrate was purified by column chromatography (ISCO, 330 g SiO2, isocratic 50% ethyl acetate in hexanes for 50 minutes, then 50→65% ethyl acetate in hexanes over 30 minutes followed by 65→100% ethyl acetate in hexanes over 20 min and then 0→10% methanol in ethyl acetate over 20 minutes) to afford the title product (3.25 g, yield: 79%).",(R)-4-(4-((4′-chlorobiphenyl-2-yl)(hydroxy)methyl)piperidin-1-yl)benzoic acid | INTERMEDIATE 40 | (R)-4-(4-((2-(tert-butyldimethylsilyloxy)ethyl)(methyl)amino)-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)benzenesulfonamide | INTERMEDIATE 67 | DMAP | dichloromethane | EDC | sodium bicarbonate | dichloromethane | sodium chloride | sodium sulfate | SiO2 | ethyl acetate | hexanes | ethyl acetate | hexanes | ethyl acetate | hexanes | methanol | ethyl acetate | title product
US07772244B2,"To a solution of 7-methylindazole-5-carboxaldehyde (8.80 g, 54.9 mmol) and N-methyl-dicyclohexylamine (23.6 mL, 110 mmol) in tetrahydrofuran (200 mL) at 0° C. was added chloromethyl methyl ether (7.50 mL, 1.8 equiv). The reaction was allowed to gradually warm to room temperature overnight. The reaction was concentrated, dissolved in diethyl ether, washed with water, then 1 M hydrochloric acid, then water, then brine, dried over magnesium sulfate, and concentrated to give an oil. The oil was dissolved in ethyl acetate and treated with hexanes until lasting turbidity. The suspension was heated until a clear solution was obtained and the flask placed in the freezer. The resulting crystalline solid was crushed with a spatula to break it up, reheated to dissolve some of the solids, and placed in the freezer. The solids were filtered, washed with very cold diethyl ether (−78° C.), and air-dried to give 5.43 g. The mother liquor was concentrated, redissolved in diethyl ether (ca. 20 mL), cooled to −78° C., and treated with a seed crystal of the product. After 1 h, the resulting solids were filtered, washed with cold diethyl ether (−78° C.), and air-dried to give an additional 1.05 g (total yield=58%). 1H-NMR (CDCl3, 500 MHz) δ 2.66 (s, 3H), 3.44 (s, 3H), 5.73 (s, 2H), 7.59 (s, 1H), 8.09 (s, 1H), 8.32 (s, 1H), 9.97 (s, 1H). Mass spec.: 205.19 (MH)+.",7-methylindazole-5-carboxaldehyde | N-methyl-dicyclohexylamine | tetrahydrofuran | chloromethyl methyl ether | diethyl ether | water | hydrochloric acid | water | brine | magnesium sulfate | ethyl acetate | hexanes | diethyl ether | diethyl ether | diethyl ether
US20020183252A1,"N-Cycloheptylglycine was synthesized by reductive amination of cycloheptanone with glycine methyl ester following the procedure described in Gera et al., Immunopharmacology. 33:174-177 (1996). The crude product was converted to the N-Boc derivative (mp, 89-90° C).",N-Cycloheptylglycine | cycloheptanone | glycine methyl ester | crude product | N-Boc
US20150065724A1,"To a 500 mL three-neck round bottom flask equipped with a mechanical stirrer were charged: (S)-2-(tert-butyldiphenylsilyloxy)-1-((S)-3-ethynyl-4,5-dihydroisoxazol-5-yl)ethanol (2a) (5.15 g, 13.0 mmol, 1.00 equiv.), 2-picolinic acid (4.90 g, 50.5 mmol, 3.9 equiv.), triphenylphosphine (5.22 g, 19.9 mmol, 1.5 equiv.), and toluene (100 mL, KF=74 ppm). The resulting mixture was stirred and adjusted to an internal temperature of ˜20° C. The mixture was stirred for 15 min under N2. A solution of di-tert-butyl azodicarboxylate (4.58 g, 19.9 mmol, 1.5 equiv.) in toluene (17.0 mL) was added at an internal temperature of NMT 35° C. (slightly exothermic), and rinsed with toluene (3.0 mL). The reaction mixture was adjusted to 30° C., and agitated under N2 at 30° C. for NLT 4 h (note: cloudy mixture became a clear solution after 1 h). A sample was taken, and analyzed for reaction completion by HPLC. The reaction mixture was cooled to ˜20° C. 100 g of 5% NaHCO3 aqueous solution was added slowly to the reaction mixture to quench the reaction. The mixture was stirred for NLT 15 min, and allowed to settle for NLT 15 min at 25° C. The upper organic layer was separated and concentrated to ˜½ of the original volume (-60 mL). The solution was adjusted to the internal temperature of NLT 30° C., and heptane (50.0 mL) added. The solution was adjusted to 30° C. A solution (110 g) of H3PO4 in water and DMF prepared from 31.0 g of 85% H3PO4 in water (60.0 g) and DMF (19.0 g), was added to the above product solution (toluene: heptane 1:1). The mixture was stirred, and the internal temperature adjusted to about 30° C. The reaction mixture was stirred for NLT 2 h to destroy the reaction by-product, di-tert-butyl-1-picolinoylhydrazine-1,2-dicarboxylate. The reaction mixture was slowly cooled to ˜10° C., and stirred for 1 h more. Triphenylphosphine oxide was removed by filtration, and washed with heptane-toluene (10 mL, 1:1). The filtrate was adjusted to the internal temperature of NLT 25° C. The mixture was allowed to settle, and the upper organic phase separated. The organic was washed with 5% NaHCO3 (100 g), and 25% brine (50 g) at 25° C. respectively. The organic was dried over MgSO4, filtered, and rinsed with toluene (5 mL). The organic was concentrated to ˜20 mL volume, purified by a silica gel column eluting gradient from 100% heptane to 55% heptane −45% EtOAc. The product's fraction were pooled together and concentrated to dryness to give a slight-brown oil (6.02 g, potency=92.9%, 90% isolated yield). MS-ESI: 499 (M+1) ; 1HNMR in CDCl3 δ1.03 (s, 9H), 3.19 (m, 2H), 3.36 (s, 1H), 3.94 (dd, J=11.3, 4.5 Hz, 1H), 4.02 (dd, J=11.3, 4.5 Hz, 1H), 5.16 (ddd, J=10.7, 7.9, 5.6 Hz, 1H), 5.41 (q, J=5.0 Hz, 1H), 7.26 (m, 2H), 7.3-7.40 (m, 4H), 7.48 (ddd, J=7.6, 4.7, 1.0 Hz, 1H), 7.62 (m, 4H), 7.82 (td, J=7.6, 1.8 Hz, 1H), 8.02 (dt, J=7.6, 1.0 Hz, 1H), 8.78 (ddd, J=4.7, 1.8, 1.0 Hz, 1H).","(S)-2-(tert-butyldiphenylsilyloxy)-1-((S)-3-ethynyl-4,5-dihydroisoxazol-5-yl)ethanol | 2-picolinic acid | triphenylphosphine | toluene | N2 | di-tert-butyl azodicarboxylate | toluene | toluene | N2 | NaHCO3 | heptane | H3PO4 | water | DMF | H3PO4 | water | DMF | toluene | heptane | di-tert-butyl-1-picolinoylhydrazine-1,2-dicarboxylate | Triphenylphosphine oxide | heptane-toluene | heptane | NaHCO3 | brine | MgSO4 | silica gel"
US20060025474A1,"1-{4-[1-Ethyl-1-(4-hydroxy-3-methyl-phenyl)-propyl]-2-methyl-phenyl}-4,4-dimethyl-pentan-3-one (compound prepared in Example 18-(3)) (200 mg, 0.52 mmol) was dissolved in methanol (5 ml) under nitrogen atmosphere. To this solution was added sodium borohydride (29.8 mg, 0.78 mmol) at 0 degrees C. After stirring 1.0 h at room temperature, the solution was evaporated under reduced pressure and the obtained residue was purified by silica-gel chromatography (hexane/ethyl acetate=7:1) to give the title compound (190 mg, 0.50 mmol, 95%).","1-{4-[1-Ethyl-1-(4-hydroxy-3-methyl-phenyl)-propyl]-2-methyl-phenyl}-4,4-dimethyl-pentan-3-one | methanol | sodium borohydride | silica | hexane/ethyl acetate | title compound"
US07632838B2,"A stirred solution of (R)-4-(4-fluoro-2-(trifluoromethyl)phenyl)-1-(3-methoxyphenylsulfonyl)-2-methylpiperazine (2.22 g, 5.13 mmol) in anhydrous dichloromethane (60 mL) was cooled down to −50° C. (acetone+dry ice bath). BBr3 (1M in CH2Cl2) was added dropwise via addition funnel while keeping the temperature between −50° C. and −55° C. Then the reaction mixture was stirred at −50° C. to −20° C. for 3 hours. Reaction was complete as determined by TLC. The reaction mixture was quenched with water and diluted with dichloromethane. pH was adjusted to 7 using saturated NaHCO3 (aqueous) and it was allowed to stir for 20 minutes. The layers were separated; the organic layer was dried over MgSO4 and concentrated. The reaction was repeated in 2.85 g scale. The combined crud products were purified via flash column chromatography to yield 3-({(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methylpiperazin-1-yl}sulfonyl)phenol in 96% yield (4.07 g) as a white solid. HRMS: calcd for C18H18F4N2O3S+H+, 419.10470. found (ESI-FTMS, [M+H]1+), 419.104. HPLC Method 1: room temperature, 6.318 min, 100%, HPLC Method 2: room temperature, 7.220 min, 99.48%.",(R)-4-(4-fluoro-2-(trifluoromethyl)phenyl)-1-(3-methoxyphenylsulfonyl)-2-methylpiperazine | dichloromethane | BBr3 | water | dichloromethane | MgSO4 | 3-({(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methylpiperazin-1-yl}sulfonyl)phenol
US03956360,"0.29 gram of lithium hydroxide, 0.72 gram of acetic acid, 0.25 gram of sulfur, 0.25 gram of selenium metal, 10 milliliters of nitrobenzene, 15 milliliters of methanol and 15 milliliters of dioxane were charged into a 110 milliliter autoclave maintained under an initial carbon monoxide pressure of 2600 psig and at a temperature of 200° C. for 45 minutes. A nitrobenzene conversion of 98 per cent and a urethane product yield of 88.4 per cent were obtained as determined by gas chromatographic analysis.",lithium hydroxide | acetic acid | sulfur | selenium | nitrobenzene | methanol | dioxane | carbon monoxide | nitrobenzene | 98 | urethane | 88.4
US20040067540A1,"A solution of 3-(4-{[2-(1H-indol-3-yl)-ethylamino]-methyl}-phenyl)-(2E)-2-propenoic acid methyl ester (12.6 g, 37.7 mmol), (2-bromoethoxy)-tert-butyldimethylsilane (12.8 g, 53.6 mmol), (i-Pr)2NEt, (7.42 g, 57.4 mmol) in dimethylsulfoxide (100 mL) is heated to 50° C. After 8 hours the mixture is partitioned with CH2Cl2/H2O. The organic layer is dried (Na2SO4) and evaporated. The residue is chromatographed on silica gel to produce 3-[4-({[2-(tert-butyldimethylsilanyloxy)-ethyl]-[2-(1H-indol-3-yl)-ethyl]-amino}-methyl)-phenyl]-(2E)-2-propenoic acid methyl ester (13.1 g). A solution of KOH (12.9 g 87%, 0.2 mol) in methanol (MeOH) (100 mL) is added to a solution of HONH2.HCl (13.9 g, 0.2 mol) in MeOH (200 mL) and a precipitate results. After 15 minutes the mixture is filtered, the filter cake washed with MeOH and the filtrate evaporated under vacuum to approximately 75 mL. The mixture is filtered and the volume adjusted to 100 mL with MeOH. The resulting solution 2M HONH2 is stored under N2 at −20° C. for up to 2 weeks. Then 3-[4-({[2-(tert-butyldimethylsilanyloxy)-ethyl]-[2-(1H-indol-3-yl)-ethyl]-amino}-methyl)-phenyl]-(2E)-2-propenoic acid methyl ester (6.50 mmol) is added to 2 M HONH2 in MeOH (30 mL, 60 mmol) followed by a solution of KOH (420 mg, 6.5 mmol) in MeOH (5 mL). After 2 hours dry ice is added to the reaction and the mixture is evaporated to dryness. The residue is dissolved in hot MeOH (20 mL), cooled and stored at −20° C. overnight. The resulting suspension is filtered, the solids washed with ice cold MeOH and dried under vacuum, producing N-hydroxy-3-[4-({[2-(tert-butyldimethylsilanyloxy)-ethyl]-[2-(1H-indol-3-yl)-ethyl]-amino}-methyl)-phenyl]-(2E)-2-propenamide. The hydroxamic acid (5.0 g, 13.3 mmol) is then dissolved in 95% trifluoroacetic acid/H2O (59 mL) and heated to 40-50° C. for 4 hours. The mixture is evaporated and the residue purified by reverse phase HPLC to produce N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide as the trifluoroacetate salt (m/z 380 [MH+]), which can then be converted into the free base.",3-(4-{[2-(1H-indol-3-yl)-ethylamino]-methyl}-phenyl)-(2E)-2-propenoic acid methyl ester | (2-bromoethoxy)-tert-butyldimethylsilane | (i-Pr)2NEt | dimethylsulfoxide | CH2Cl2/H2O | Na2SO4 | silica gel | 3-[4-({[2-(tert-butyldimethylsilanyloxy)-ethyl]-[2-(1H-indol-3-yl)-ethyl]-amino}-methyl)-phenyl]-(2E)-2-propenoic acid methyl ester
US08399472B2,"A mixture of N2-(3-Aminosulfonylphenyl)-5-fluoro-N4-[4-(4-pyridylmethyl)phenyl]-2,4-pyrimidinediamine (50 mg) and methyltrioxorhenium (VII) (5 mg) in THF (15 mL) was treated with 30% aq. H2O2 (23 μL). After 24 h stirring, 30% aq. H2O2 (23 μL) was added and stirred for 24 h. The reaction mixture was filtered through Celite, washed the bed with methanol and concentrated. The residue was purified by HPLC yielded 10 mg of desired product. 1H NMR (DMSO d6, 300 MHz): δ 9.47 (s, 1H), 9.35 (s, 1H), 8.10 (m, 4H), 7.92 (m, 1H), 7.73 (d, 2H, J=8.4 Hz), 7.32-7.18 (m, 8H), 3.91 (s, 2H); LCMS (m/z): 467 (MH+).","N2-(3-Aminosulfonylphenyl)-5-fluoro-N4-[4-(4-pyridylmethyl)phenyl]-2,4-pyrimidinediamine | methyltrioxorhenium (VII) | THF | H2O2 | H2O2 | methanol | desired product"
US20030139409A1,"4-(4-Chloro-benzyloxy)-benzo[a]phenazine-11-carboxylic acid (2-dimethylamino-ethyl)-amide was prepared from 4-(4-chloro-benzyloxy)-benzo[a]phenazine-11-carboxylic acid (II.16) and N,N-dimethylethylenediamine;","4-(4-Chloro-benzyloxy)-benzo[a]phenazine-11-carboxylic acid (2-dimethylamino-ethyl)-amide | 4-(4-chloro-benzyloxy)-benzo[a]phenazine-11-carboxylic acid | N,N-dimethylethylenediamine"
US06124314,"A solution of 4-methanesulfonylamino-butyric acid ethyl ester (7.08 g, 33.8 mmol) in concentrated NH4OH (200 mL) was stirred at room temperature for 66 h. The reaction mixture was concentrated to afford the title compound of Step B as a white solid (6.16 g). The product was used in the next step without further purification. 1H NMR (400 MHz, CDCl3) δ 3.30 (s, 3H), 3.05-3.09 (m, 2H), 2.91 (s, 3H), 2.24-2.30 (m, 2H), 1.80-1.85 (m, 2H); MS 181 (M+ +1).",4-methanesulfonylamino-butyric acid ethyl ester | NH4OH | title compound
US20150175584A1,"A solution of 7,8-dimethoxy-N-(2-methyltetrahydrofuran-3-yl)quinazolin-4-amine (750 mg, 2.59 mmol) in DMF/THF (2 mL/10 mL) was cooled to 0° C. NaH (207 mg, 5.18 mmol, 60% in mineral oil) was added. The mixture was stirred at 0° C. for 10 min. Then Mel (736 mg, 5.18 mmol) was added. After the addition, the mixture was allowed to warm to rt and stirred for 1 h. The mixture was quenched with sat. NH4Cl (aq), extracted with DCM (2×50 mL). The combined organic phases were washed with brine, dried over Na2SO4 and concentrated. The residue purified by preparative-HPLC to afford 250 mg of 7,8-dimethoxy-N-methyl-N-(2-methyltetrahydrofuran-3-yl)quinazolin-4-amine (32%).","7,8-dimethoxy-N-(2-methyltetrahydrofuran-3-yl)quinazolin-4-amine | DMF/THF | NaH | NH4Cl | DCM | brine | Na2SO4 | 7,8-dimethoxy-N-methyl-N-(2-methyltetrahydrofuran-3-yl)quinazolin-4-amine"
US04126687,"To a stirred solution of 8.5 parts of 1,3-dihydro-1-(1-methylethenyl)-2H-benzimidazol-2-one in 45 parts of N,N-dimethylformamide are added portionwise 1.7 parts of a sodium hydride dispersion of 78%. After stirring for 1 hour at room temperature, the whole is cooled to 0°-5° C. and 8.65 parts of 1-bromo-3-chloropropane are added dropwise (slowly). Upon completion, stirring is continued for 3 hours at room temperature. The reaction mixture is poured onto crushed ice and the product is extracted with methylbenzene. The extract is washed with water, dried, filtered and evaporated. The residue is crystallized from 2-propanol, yielding 5.5 parts (44%) of 1-(3-chloropropyl)-1,3-dihydro-3-(1-methylethenyl)-2H-benzimidazol-2-one; mp. 115° C.","1,3-dihydro-1-(1-methylethenyl)-2H-benzimidazol-2-one | N,N-dimethylformamide | sodium hydride | 1-bromo-3-chloropropane | ice | methylbenzene | water | 2-propanol | 1-(3-chloropropyl)-1,3-dihydro-3-(1-methylethenyl)-2H-benzimidazol-2-one"
US04202981,"2,6-Diaminopyridine (43.6 g., 0.4 mole), 40.0 g (0.4 mole) of 2,4-pentanedione, 200 ml. of glacial acetic acid and 5 ml. of 96% sulfuric acid were mixed, then refluxed with stirring for 24 hours. The cold solution was added slowly with good stirring and ice bath cooling to 160 g of sodium hydroxide in enough water to make 600 ml. The brown solid, which crystallized, was filtered after the solution had been cooled overnight at 5°, washed twice with cold water and dried, 25.3 g., m.p. 125°-200°. This crude material was dissolved in 130 ml. of boiling 95% ethanol and the solution chilled overnight at -15°, 19.5 g. (28%), m.p. 215°-220°. This material was suitable for the following experiment.","2,6-Diaminopyridine | 2,4-pentanedione | acetic acid | sulfuric acid | ice | sodium hydroxide | water | water | crude material"
US05130334,"2-Methyl-6-nitroquinoline (18.8 g) was stirred under a hydrogen atmosphere at 206.8 kPa (30 p.s.i.) for 2 hours in ethanol solution containing 5% Pd/C. The catalyst was then removed by filtration, the filtrate evaporated to small volume in vacuo, and the resultant precipitate collected by filtration, washed with ethanol and ether, and dried to give the title compound, yield 13.2 g, m.p. 188°-189°.",2-Methyl-6-nitroquinoline | hydrogen | ethanol | Pd/C | resultant precipitate | ethanol | ether | title compound
US08796256B2,"(5Z)-5-({1-[4-Chloro-2-(trifluoromethyl)benzyl]-1H-indazol-5-yl}methylidene)-3-[(1-methylpiperidin-4-yl)methyl]-1,3-thiazolidine-2,4-dione was prepared from (5Z)-5-({1-[4-chloro-2-(trifluoromethyl)benzyl]-1H-indazol-5-yl}methylidene)-3-(piperidin-4-ylmethyl)-1,3-thiazolidine-2,4-dione (Example 130) and formaldehyde following General Procedure R.","(5Z)-5-({1-[4-Chloro-2-(trifluoromethyl)benzyl]-1H-indazol-5-yl}methylidene)-3-[(1-methylpiperidin-4-yl)methyl]-1,3-thiazolidine-2,4-dione | (5Z)-5-({1-[4-chloro-2-(trifluoromethyl)benzyl]-1H-indazol-5-yl}methylidene)-3-(piperidin-4-ylmethyl)-1,3-thiazolidine-2,4-dione | formaldehyde"
US07230099B2,"To a solution of 3,3-dimethyl-1,2-epoxybutane (5.0 mL, 41.0 mmol) in DMF (100 mL) was added N-hydroxyphthalimide (8.03 g, 49.2 mmol) and triethylamine (6.90 mL, 49.2 mmol). The solution was heated at 75° C. for two days. The solution was cooled to room temperature, diluted with ethyl acetate and washed with water (2×), saturated potassium carbonate (3×), brine (2×), dried over Na2SO4 and concentrated to an orange solid. Purification using flash column chromatography (dichloromethane) provided the desired product as a white solid (1.50 g, 14%).","3,3-dimethyl-1,2-epoxybutane | DMF | N-hydroxyphthalimide | triethylamine | ethyl acetate | water | potassium carbonate | brine | Na2SO4 | desired product"
US08633134B2,"To a solution of 2-Chloro-4-[5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-benzoic acid methyl ester (i.e. the product of Step 1, 2.20 g) in CH2Cl2 was added a solution of diisobutyl aluminium hydride (1 M in CH2Cl2 , 10.7 mL) at −78° C. and kept at this temperature for 30 min. MeOH (25 mL) was added carefully and the mixture was allowed to warm to room temp, when aqueous K-Na-tartrate solution was added. The layers were separated and the aqueous phase was extracted with CH2Cl2, combined organic layers were washed with water, dried (Na2SO4) and evaporated. The residue was purified by flash chromatography on silica gel to obtain the title compound (1.35 g, 66%) and 2-Chloro-4-[5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-benzyl alcohol (0.49 g, 24%).","2-Chloro-4-[5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-benzoic acid methyl ester | product | CH2Cl2 | diisobutyl aluminium hydride | CH2Cl2 | MeOH | K-Na-tartrate | water | Na2SO4 | silica gel | title compound | 2-Chloro-4-[5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-benzyl alcohol"
US06605618B2,"4-[4-(2-{[(2S)-3-(4-{[tert-Butyl(diphenyl)silyl]oxy}phenoxy)-2-hydroxy-propyl]amino]ethyl)anilino]-N-(2-fluorobenzyl)-1-piperidinecarboxamide (0.21 g, 0.27 mmol) was reacted according to Procedure H (eluant: 5:1 chloroform-methanol containing 1% ammonium hydroxide) to give the title compound (0.085 g, 0.15 mmol)",4-[4-(2-{[(2S)-3-(4-{[tert-Butyl(diphenyl)silyl]oxy}phenoxy)-2-hydroxy-propyl]amino]ethyl)anilino]-N-(2-fluorobenzyl)-1-piperidinecarboxamide | chloroform-methanol | title compound
US06867203B2,"The title compound was prepared by the procedures described in Example 1 substituting 2,4-dichlorothiophenol with 2-bromothiophenol, 2-chlorobenzaldehyde with 3-chloro-4-fluoro-benzaldehyde, and 6-amino-1-hexanol with 4-acetylhomopiperazine. 1H NMR (DMSO-d6, 300 MHz) δ 8.10 (m, 1H), 7.81 (d, J=7.7 Hz, 1H), 7.64 (m, 1H), 7.24-7.51 (m, 5H), 7.05 (m, 1H), 3.39-3.77 (m, 8H), 1.97 (m, 3H), 1.68 (m, 2H). HRMS calculated for C22H22N2O2S1Br1Cl1: 493.0352. Observed: 493.0352.","title compound | 2,4-dichlorothiophenol | 2-bromothiophenol | 2-chlorobenzaldehyde | 3-chloro-4-fluoro-benzaldehyde | 6-amino-1-hexanol | 4-acetylhomopiperazine"
US08962620B2,"Aqueous NaOH (0.065 g, 1.634 mmol) was added to a solution of ethyl 6-(1-(tert-butoxycarbonyl)piperidin-4-yl)-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylate (0.34 g, 0.817 mmol) in EtOH (4 mL) and stirred at 60° C. for 1 h. After completion of the reaction, ethanol was removed under reduced pressure and it was acidified using 10% citric acid solution. Extraction was carried out using ethyl acetate; the combined organic layers were washed with water, brine and dried over anhydrous Na2SO4; filtered and concentrated under reduced pressure. The crude acid (0.3 g, 0.773 mmol) was then dissolved in DMSO (3 mL) and 3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one (0.235 g, 1.546 mmol) was added to it. The reaction mixture was stirred at room temperature for 15 min before PYBOP (0.603 g, 1.159 mmol) was added to it and stirring was continued overnight. After completion of the reaction, reaction mass was poured into ice to obtain solid, which was filtered and washed with acetonitrile followed by ether to provide the desired intermediate (0.2 g, 50.0%).","NaOH | ethyl 6-(1-(tert-butoxycarbonyl)piperidin-4-yl)-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylate | EtOH | ethanol | water | brine | Na2SO4 | crude acid | DMSO | 3-(aminomethyl)-4,6-dimethylpyridin-2(1H)-one | PYBOP | ice | acetonitrile | desired intermediate"
US20050239841A1,"4-Bromo-N-methylaniline (20 mg, 0.1097 mmol) was added to the isocyanate (Example 192) (0.1097 mmol) solution. The mixture was stirred at room temperature under N2 atmosphere over night. Volatiles were evaporated and the crude product was purified by preparative HPLC which gave 31 mg (56%) of the title compound. MS (ESI+) m/z 502 (splitt 1:1) (M+H)+. HRMS (EI) calc for C25H32BrN3O3: 501.1627 found 501.1616.",4-Bromo-N-methylaniline | isocyanate | N2 | crude product | title compound
US07470803B2,"The compound produced in Example 2 was refluxed with a chloroplatinic catalyst in methanol for 3 hours, and was then concentrated to give the desired product as a maize oily material.",compound | methanol | desired product
US08927536B2,"A reaction was performed on a 384-well plate (Greiner Bio One) using a reaction volume of 24 μL, and all the samples were diluted with an assay buffer (50 mM tris buffer, pH 7.4, 10% glycerol). 0.8 mM NADPH, 6 mM glucose 6-phosphate, 0.35 units/mL glucose 6-phosphate dehydrogenase (Sigma Chemical), and 3 mM magnesium chloride and a microsome fraction as an enzyme source were added to the plate, and a solution containing a test compound dissolved in a dimethyl sulfoxide/methanol solution was added at a final concentration of 0.1%. After the addition of the test compound, cortisone at a final concentration of 160 nM was added to start the reaction, and the reaction was performed at room temperature for 3 h. 25 μL of 100 mM carbenoxolone (Sigma Chemical) was added to terminate the reaction, and the amount of cortisol produced was measured with RUBYstar (BMG LABTECH JAPAN Ltd.) using a cortisol prototype kit (Cisbio International) according to the package insert. The IC50 values of the compounds of Examples are shown below.",glycerol | NADPH | glucose 6-phosphate | glucose 6-phosphate | magnesium chloride | dimethyl sulfoxide/methanol | cortisone | carbenoxolone | cortisol
US07932246B2,"Ethyl 2-[6-(quinolin-2-ylamino)-3-azabicyclo[3.1.0]hex-3-yl]pyrimidine-5-carboxylate (0.98 mmol) was stirred in THF (10 ml) and H2O (10 ml) at r.t. for 64 h. The reaction was then acidified to pH˜3 and the solvent removed in vacuo to give a brown solid. The solid was collected and washed with a little H2O to give the title compound as a brown solid (103 mg, 30% over 3 steps). LCMS purity 90%, m/z 348 [M+H]+.",Ethyl 2-[6-(quinolin-2-ylamino)-3-azabicyclo[3.1.0]hex-3-yl]pyrimidine-5-carboxylate | THF | H2O | H2O | title compound
US06057350,"4-Cyano-4-(2-ethoxy)phenyl-2-methoxycarbonylcyclohexanone (1.06 g, 3.5 mmol) was heated at reflux in acetic acid (24 mL) and 10% H2SO4 (13 mL) for 6 h. Extraction with benzene (3×10 mL), which was washed with K2CO3 solution, dried (Na2SO4), filtered and concentrated, gave a white solid (0.755 g, 88%): mp 116-121 C.",4-Cyano-4-(2-ethoxy)phenyl-2-methoxycarbonylcyclohexanone | acetic acid | H2SO4 | benzene | K2CO3 | Na2SO4 | solid
US04992474,"(2.19 g) T.l.c. [K] Rf 0.48, from 1,5-dibromopentane (7.8 g) and 4- ethylbenzeneethanol (1.7 g).","1,5-dibromopentane | 4- ethylbenzeneethanol"
US08697708B2,"To a stirred solution of (E)-methyl 3-(2-(2-chloro-6-fluorophenyl)thiazol-4-yl)acrylate (6.0 g, 20 mmol) in MeOH (100 mL) and H2O (20 mL) was added lithium hydroxide (1.5 g, 61 mmol). The resulting mixture was stirred at room temperature for 24 hours and then partially concentrated under reduced pressure. The pH of the residue was adjusted to 5 by the addition of 2N HCl and the aqueous phase extracted with EtOAc (3×100 mL). The combined organic extract was washed with brine (100 mL), dried over Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography, eluting with a 0-20% gradient of MeOH in DCM to give the desired product as a white solid (5.4 g, 94% yield). LCMS (ESI) m/z: 284.0 [M+H+].",(E)-methyl 3-(2-(2-chloro-6-fluorophenyl)thiazol-4-yl)acrylate | MeOH | H2O | lithium hydroxide | HCl | EtOAc | brine | Na2SO4 | silica gel | MeOH | DCM | desired product
US20110275613A1,"POCl3 (2.43 mL, 26.53 mmol) was added dropwise to N,N-dimethylformamide (15.0 mL) at −20° C. and stirred below −5° C. for one hour. A solution of 6-chloro-5-fluoroindole (3.0 g, 17.69 mmol) in dimethylformamide (5.0 mL) was added dropwise to the above reaction mixture at −20° C. The salt-ice bath was removed and the reaction mixture was warmed to 35° C. After one hour, the reaction was poured onto ice and basified by solid sodium bicarbonate and extracted with ethyl acetate. The combined organic layer was washed with water and then concentrated to give 6-chloro-5-fluoro-1H-indole-3-carbaldehyde (3.4 g, 97%) as a light brown solid. 1H NMR (500 MHz, CDCl3): δ 10.02 (s, 1H), 8.10 (d, 1H, J=9.5 Hz), 7.87 (s, 1H), 7.49 (d, 1H, J=5.5 Hz).","POCl3 | N,N-dimethylformamide | dimethylformamide | 6-chloro-5-fluoroindole | salt-ice | ice | ethyl acetate | water | 6-chloro-5-fluoro-1H-indole-3-carbaldehyde"
US06649642B2,"A suspension of LiAlH4 (0.56 g, 14.8 mmol, 2.0 equiv) was prepared under argon in 50 mL of anhydrous THF (50 mL) kept at 0° C. A solution of 4-phenyl-cyclohexanecarboxylic acid (1.5 g, 7.34 mmol, 1.0 equiv) in 50 mL of THF was added dropwise over a 20 min period. The reaction mixture was stirred at ambient temperature for 1.5 h and then cooled to 0° C. The excess hydride reagent was carefully quenched under argon by dropwise addition of 1 N HCl. After quenching, the reaction mixture was extracted with EtOAc. The organic layer was dried over MgSO4, filtered and concentrated to give the title product as a colorless oil (1.9 g crude) which was used without further purification.",LiAlH4 | argon | THF | 4-phenyl-cyclohexanecarboxylic acid | THF | hydride | argon | HCl | EtOAc | MgSO4 | title product
US06451740B2,"Into 10 ml of boron trifluoride methanol complex, methanol solution was added 0.25 g of methyl [2-(5-acetylamino-2-chloro-4-fluorophenoxy)phenoxy]acetate, and the mixture was heated for 3 hours while stirring. Thereafter, the reaction solution was concentrated, the residue was dissolved in ethyl acetate, and washed with saturated aqueous sodium bicarbonate, dried over magnesium sulfate, and concentrated to obtain 0.2 g of methyl [2-(5-amino-2-chloro-4-fluorophenoxy)phenoxy]acetate [Intermediate compound A3-22].",boron trifluoride methanol | methanol | methyl [2-(5-acetylamino-2-chloro-4-fluorophenoxy)phenoxy]acetate | ethyl acetate | sodium bicarbonate | magnesium sulfate | methyl [2-(5-amino-2-chloro-4-fluorophenoxy)phenoxy]acetate
US20130296330A1,"Diisopropyl ethyl amine (42.9 mmol) was added to a solution of methyl 8-(benzyloxy)-5-bromo-1,6-naphthyridine-7-carboxylate (Example 1; 10.7 mmol) in DMA (270 ml) at room temperature. The reaction was stirred at 5 min at piperazine (16.1 mmol) was added and the reaction mixture was heated at 110° C. for 12 hr. The reaction was cooled, water and ethyl acetate was added. The organic layer was separated and washed with water (×2) and with brine. The organic layer was dried (MgSO4), filtered and evaporated.","Diisopropyl ethyl amine | methyl 8-(benzyloxy)-5-bromo-1,6-naphthyridine-7-carboxylate | DMA | piperazine | water | ethyl acetate | water | brine | MgSO4"
US08853427B2,"(2S,4R)-4-Amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid (76 mg, 242 μmol) in MeCN (0.4 mL, 8 mmol) and 4 M HCl in 1,4-dioxane (242 μL, 969 μmol) was combined with pentan-1-ol (0.5 mL) at 60° C. The resulting mixture was stirred until solid precipitation was observed (˜30 minutes). The solvent was evaporated under vacuum and the solids were azeotroped in toluene and dried under vacuum. 1,2,3-Triazole-4-carboxylic acid (0.0274 g, 0.242 mmol), DIPEA (169 μL, 969 μmol) and HATU (92 mg, 242 μmol) were combined in DMF (0.2 mL) and stirred for 5 minutes at room temperature. This was then combined with the dried solids, predissolved in DMF (0.2 mL) and DIPEA (0.5 eq.). The resulting mixture was stirred for 15 minutes and the reaction was quenched with AcOH. The product was purified by preparative HPLC and lyophilized to yield the title compound (30 mg; purity 95%. MS m/z [M+H]+ calc'd for C27H34N4O4, 479.26. found 479.4.","(2S,4R)-4-Amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid | MeCN | HCl | 1,4-dioxane | pentan-1-ol | toluene | 1,2,3-Triazole-4-carboxylic acid | DIPEA | HATU | DMF | DMF | DIPEA | AcOH | title compound"
US07176199B2,"To a solution of 1-(2-methoxyphenyl)piperazine (30 g) in dichloromethane (500 ml) are added triethylamine (22.9 ml) and ethyl chloroformate (15.8 ml), and the mixture is stirred at 25° C. overnight. The reaction solution is concentrated under reduced pressure, diluted with ethyl acetate, washed successively with 10% aqueous citric acid solution and saturated brine, and dried over magnesium sulfate. The solvent is evaporated under reduced pressure to give ethyl 4-(2-methoxyphenyl)piperazine-1-carboxylate. (2) To a solution of the above product (5 g) in conc. sulfuric acid (18 ml) is added conc. nitric acid (1.31 ml) at 0° C., and the mixture is stirred at around 10° C. for 2 hours. The reaction solution is poured into cold water, and the pH value thereof is adjusted to pH 3 with 2M aqueous sodium hydroxide solution. The resulting precipitates are collected by filtration to give ethyl 4-(2-methoxy-5-nitrophenyl)piperazine-1-carboxylate. (3) The above product (5 g) is dissolved in a mixture of methanol (50 ml) and tetrahydrofuran (50 ml), and thereto is added 2M aqueous sodium hydroxide solution (50 ml), and the mixture is heated under reflux for 18 hours. The reaction solution is diluted with water and ethyl acetate, and the organic layer is washed with saturated brine, dried over magnesium sulfate. To the organic layer is added a 30% solution of hydrogen chloride in ethanol, and the resulting precipitates are collected by filtration to give the title compound (3.52 g).",1-(2-methoxyphenyl)piperazine | dichloromethane | triethylamine | ethyl chloroformate | ethyl acetate | citric acid | brine | magnesium sulfate | ethyl 4-(2-methoxyphenyl)piperazine-1-carboxylate
US20130203718A1,"The 3β,20-diacetoxypregn-4-ene (1) (1 g, 2.48 mmol) was dissolved in THF (30 mL) and methanol (30 mL). To this solution was added 5% aqueous KOH (2.85 mL) and the mixture was stirred for 3 h at room temperature, concentrated to ⅓ of its volume, diluted with water and extracted with dichloromethane. The organic layer was dried over MgSO4, filtered and evaporated. The amorphous solid was purified by flash chromatography (eluant: cyclohexane/EtOAc, 80/20) to give (2) (710 mg, 79%) as a white solid. Rf=0.31 (eluant: cyclohexane/EtOAc, 80/20). IR (v cm−1): 1027, 1246, 1370, 1449, 1719, 2930, 3330. 1H NMR (CDCl3, 300 MHz): δ 0.65 (s, 3H, Me-18), 1.04 (s, 3H, Me-19), 1.14 (d, 3H, J=6.1 Hz, Me-21), 2.01 (s, 3H, OAc), 0.58-2.09 (m, 19H), 2.14-2.25 (m, 1H), 4.14 (m, 1H, H-3), 4.83 (m, 1H, H-20), 5.28 (m, 1H, H-4). From the 13C NMR data this product was determined to be 9:1 mixture of epimers at C20, the 13C NMR (CDCl3, 75 MHz) for the major β-isomer were δ 12.6, 19.0, 20.0, 21.1, 21.7, 24.4, 25.6, 29.6, 32.3, 33.2, 35.5, 35.9, 37.5, 39.4, 42.4, 54.6, 55.1, 55.7, 68.1, 73.0, 123.6, 147.6, 170.6. MS (APCI+) m/z 383.0 (M+Na)+.","3β,20-diacetoxypregn-4-ene | THF | methanol | KOH | water | dichloromethane | MgSO4 | cyclohexane/EtOAc | (2)"
US08569528B2,"16.74 g (80 mmol) of the “4-hydroxymethyl-biphenyl-2-carbonitrile” is suspended in 100 ml of dry xylene (isomer mixture) under argon. To this suspension is added at room temperature under stirring 0.636 g (80 mmol) of lithium hydride. The suspension is stirred for an additional 4 hours at 120° C. external temperature and a solution of 160 mmol diethylaluminium azide in toluene (which is prepared separately by stirring 160 mmol of diethylaluminium chloride and 160 mmol of sodium azide in xylene [isomer mixture] at room temperature overnight) is added via syringe. The reaction mixture is heated to reflux (˜120° C.), external temperature ca. 140° C. Conversion is controlled by HPLC analysis. After refluxing for 24 hours the reaction mixture is cooled to room temperature and finally quenched with a solution of 300 mmol of sodium nitrite and of 15% sodium hydroxide (240 mmol). Finally 95 ml of conc. HCl is added under stirring. To the resulting suspension is added at room temperature under stirring 31 g (320 mmol) of 65% nitric acid. The suspension is stirred for an additional 6 hours at 60° C. external temperature (internal Temperature=55° C.). Finally the product is isolated by filtration. The crude 2′-(1H-tetrazol-5-yl)-biphenyl-4-carbaldehyde is obtained.",4-hydroxymethyl-biphenyl-2-carbonitrile | xylene | lithium hydride | diethylaluminium azide | toluene | diethylaluminium chloride | sodium azide | xylene | sodium nitrite | sodium hydroxide | HCl | nitric acid | 2′-(1H-tetrazol-5-yl)-biphenyl-4-carbaldehyde
US09133148B2,"A 1000 mL 3-necked round-bottom flask was charged with bis(4-chlorophenyl)methanol (49.6 g, 196 mmol, 1.00 equiv), N,N-dimethylformamide (5 mL), dichloromethane (100 mL). Liquid thionyl chloride (93.3 g, 790 mmol, 4.00 equiv) was added dropwise. The resulting solution was stirred overnight at 40° C. in an oil bath. The resulting mixture was concentrated under reduced pressure. The residue was chromatographed on a silica gel column with ethyl acetate/petroleum ether (1/5) to provide 47.8 g (88% yield) of 1-chloro-4-[chloro(4-chlorophenyl)methyl]benzene as a gray solid. 1HNMR 300 MHz (CDCl3) δ 7.30-7.39 (m, 8H), 6.07 (s, 1H). GCMS (EI, m/z): 270 [M]+.","bis(4-chlorophenyl)methanol | N,N-dimethylformamide | dichloromethane | thionyl chloride | silica gel | ethyl acetate/petroleum ether | 1-chloro-4-[chloro(4-chlorophenyl)methyl]benzene"
US20100160335A1,"The compound of Example 105 (800 mg) was dissolved in THF (20.0 mL) under an argon gas atmosphere, and a 1.58 mol/L n-butyl lithium/hexane solution (3.90 mL) was added dropwise thereto at −78° C., followed by stirring for 1 hour as it was. Thereafter, N,N-dimethyl propionamide (0.890 mL) was added thereto at the same temperature, followed by stirring for 3 hours while warming to room temperature. To the reaction liquid was added a saturated aqueous ammonium chloride solution, followed by extraction with ethyl acetate. The organic layer was washed with water and saturated brine, and then dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the residue was then purified by silica gel column chromatography (chloroform) to obtain the desired product (342 mg) as a white powder.","compound | THF | argon | n-butyl lithium/hexane | N,N-dimethyl propionamide | ammonium chloride | ethyl acetate | water | brine | sodium sulfate | silica gel | chloroform | desired product"
US20160107997A1,"To a solution of 5-bromo-1,2,3,4-tetrahydroisoquinolin-1-one [CAS#: 1109230-25-2](500 mg, 2.21 mmol) in 20 mL DMF cooled to 0° C. is added 60% dispersion NaH in mineral oil (79.6 mg, 3.32 mmol). After gas evolution ceased bromomethylcyclopropane (299 mg, 2.21 mmol) is added and the resulting suspension is allowed to stir overnight at RT. Then another 60% dispersion NaH in mineral oil (79.6 mg, 3.32 mmol) and bromomethylcyclopropane (299 mg, 2.21 mmol) are added and the mixture is allowed to stir at RT for 3 h. The mixture is filtered and the remaining solid rinsed with DMF. The DMF is removed under reduced pressure and HV. Purification of the crude residue by HPLC (Method D) yields 209 mg (34%) of the sub-title compound as a yellow solid. LC-A: tR=0.86 min; [M+H]+=282.0","5-bromo-1,2,3,4-tetrahydroisoquinolin-1-one | DMF | NaH | oil | bromomethylcyclopropane | NaH | oil | bromomethylcyclopropane | DMF | DMF | crude residue | sub-title compound"
US09266835B2,"To a mixture of thiazole-4-carboxylic acid (1 g, 7.74 mmol), N,O-dimethylhydroxylamine (1.51 g, 15.5 mmol), and HATU (3.83 g, 10.07 mmol) in CH2Cl2 (25 mL) was added TEA (4.84 mL, 34.85 mmol). The reaction was stirred at room temperature overnight. The reaction was diluted with CH2Cl2 and water. The organics were concentrated and purified by chromatography (60-70% EtOAc/hexanes) to yield N-methoxy-N-methylthiazole-4-carboxamide as a clear oil. 1H NMR (CDCl3) δ: 8.83 (s, 1H), 8.10 (s, 1H), 3.79 (s, 3H), 3.46 (s, 3H)","thiazole-4-carboxylic acid | N,O-dimethylhydroxylamine | HATU | CH2Cl2 | TEA | CH2Cl2 | water | EtOAc/hexanes | N-methoxy-N-methylthiazole-4-carboxamide"
US08957068B2,"To a solution of compound (S)-3-(2-Chloro-pyrimidin-4-yl)-4-isopropyl-oxazolidin-2-one (1.03 g, 4.3 mmol) in DMSO (12 mL) was added methyl-prop-2-ynylamine HCl salt (450 mg, 4.3 mmol) and diisopropylethylamine (2.2 mL, 12.6 mmol). The reaction was heated to 110 C for 18 hours. The reaction mixture was diluted with EtOAc (50 mL) and washed with water (25 mL) and brine (25 mL). The organic layer was dried over Na2SO4, filtered and concentrated. The crude material was purified on silica gel column chromatography (EtOAc/Heptane 0 to 75%) provided (S)-4-Isopropyl-3-[2-((S)-1-methyl-prop-2-ynylamino)-pyrimidin-4-yl]-oxazolidin-2-one (360 mg) in 31% yield. LC-MS m/z: 275.1 (M−Boc)+; RT.: 1.33 min.",(S)-3-(2-Chloro-pyrimidin-4-yl)-4-isopropyl-oxazolidin-2-one | DMSO | methyl-prop-2-ynylamine HCl salt | diisopropylethylamine | EtOAc | water | brine | Na2SO4 | crude material | silica gel | EtOAc/Heptane | (S)-4-Isopropyl-3-[2-((S)-1-methyl-prop-2-ynylamino)-pyrimidin-4-yl]-oxazolidin-2-one
US06673956B2,"2-(2,6-Dichloro-4-trifluoromethylphenylhydrazono)succinonitrile (0.296 g, 1 mmol), sodium cyanide (0.196 g, 4 equivalents), water (1 ml) and acetic acid (5 ml) were added successively to a tube, which was sealed and reacted at 20° C. for 40 hours. The mixture was added to saturated sodium bicarbonate solution, extracted (dichloromethane), washed (water), dried (magnesium sulfate) and evaporated to give a mixture which contained 40% of the desired title compound, NMR 3.1 (m, 2H), 4.5 (m, 1H), 5.89 (m, 1H), 6.94 (d, 1H), 7.71 (s, 2H), together with 60% of unchanged starting hydrazone.","2-(2,6-Dichloro-4-trifluoromethylphenylhydrazono)succinonitrile | sodium cyanide | water | acetic acid | sodium bicarbonate | dichloromethane | water | magnesium sulfate | desired title compound"
US06229011B1,"To a suspension of 4-nitro-N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanine (226.2 mmol, 70.2 g) and sodium carbonate (1.13 mmol, 95 g) in DMF (500 mL) was added methyl iodide (1.13 mmol, 70.4 mL) at room temperature. The suspension was stirred for 15 h at room temperature at this time TLC analysis of the mixture indicated the absence of starting acid and the excess methyl iodide and some DMF were removed under high vacuum. The mixture was poured into water (2 L) and stirred at room temperature as a precipitate formed slowly over weekend. The precipitated solids were collected by filtration and washed with water (2 L). After air and vacuum drying, 72 g (98%) of of 4-nitro-N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanine methyl ester was isolated as a light yellow solid. mp 95-96° C. 1H NMR, DMSO-d6 (400 MHz) δ8.16 (d, 2H, J=20 Hz), 7.53 (d, 2H, J=20 Hz), 7.39 (d, 1H, J=22 Hz), 4.26-4.28 (m, 1H), 3.6 (s, 3H), 2.96-3.19 (m, 2H), 1.25 (s, 9H), 13C NMR, CDCl3 (100 Mhz) d 172.04, 155.29, 146.27, 145.96, 130.48, 123.18, 78.36, 54.44, 51.9, 36.1, 27.99. HR MS: Obs. mass. 325.1404. Calcd. mass, 325.1400 (M+H).","4-nitro-N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanine | sodium carbonate | DMF | methyl iodide | methyl iodide | DMF | water | water | 4-nitro-N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanine methyl ester"
US20020040025A1,"6-Bromopicolinic acid (Aldrich) was coupled with methyl amine using carbonyl diimidazole (CDI) as coupling reagent to afford 6-bromopyridine-2-carboxylic acid methylamide. The 6-bromopyridine-2-carboxylic acid methylamide underwent Suzuki coupling with 4-phenoxyphenylboronic acid, in the presence of tetrakis(triphenylphosphine)palladium as catalyst to give 6-(4-phenoxyphenyl)pyridine-2-carboxylic acid methylamide as a solid. 1H NMR (CDCl3): δ 8.12 (d, J=7.8 Hz, lH), 7.98 (d, J=8.7 Hz, 2H), 7.90 (t, J=7.8 Hz, 1H), 7.81 (d, J=7.8 Hz, 1H), 7.38 (t, J=8.4 Hz, 2H), 7.18-7.06 (m, 5H), 3.08 (d, J=5.4 Hz, 3H).",6-Bromopicolinic acid | methyl amine | carbonyl diimidazole | 6-bromopyridine-2-carboxylic acid methylamide
US08987297B2,"To a clear solution of trans-3-{N′-(6-carboxymethoxy-7-oxo-1,6-diaza-bicyclo[3.2.1]octane-2-carbonyl)-hydrazinocarbonyl}-(R)-piperidin-1-carboxylic acid tert-butyl ester (150 mg, 0.32 mmol) in dichloromethane (2 ml) was added trifluoroacetic acid under stirring at −10° C. The reaction mixture was stirred for about 1 hour at −10° C. and the solvents were evaporated under vacuum to provide a residue. The residue was triturated successively with diethyl ether (25 ml) and acetonitrile (25 ml) and solvents were decanted to provide solid that was dried under vacuum to provide 59 mg of titled compound in 50% yield.","trans-3-{N′-(6-carboxymethoxy-7-oxo-1,6-diaza-bicyclo[3.2.1]octane-2-carbonyl)-hydrazinocarbonyl}-(R)-piperidin-1-carboxylic acid tert-butyl ester | dichloromethane | trifluoroacetic acid | diethyl ether | acetonitrile | titled compound"
US06515011B2,"To a stirred solution of diastereomer A of 1-(tert-butoxylcarbonyl)-3-phenylprolyl-N-(2-{[(tert-butoxycarbonyl)amino]methyl}-5-chlorobenzyl)-L-prolinamide (60 mg, 0.09 mmol) from the previous step in approx. 2 mL MeOH at room temperature was added excess of a solution of 1.0 M HCl in ether. The reaction was monitored for completeness by LCMS. The solvent was removed in vacuo to give the HCl salt of the title compound as a white solid. LCMS RT=0.94 min. LCMS (M+H)=441.1. 1H NMR (CD3OD, 500 MHz): δ 7.50-7.23 (m, 8H), 4.58-4.51 (m, 1H), 4.41-4.24 (m, 3H), 4.08-3.96 (m, 1H), 3.80-3.74 (m, 1H), 3.49-3.43 (m, 1H), 3.39-3.31 (m, 3H), 3.05-2.92 (m, 1H), 2.57-2.37 (m, 2H), 2.06-1.64 (m, 2H), 1.56-1.26 (m, 2H). Diastereomer B (73 mg, 0.11 mmol) was deprotected in similar fashion to afford the HCl salt of the title compound as a white solid. LCMS RT=0.98 min. LCMS (M+H)=441.2. 1H NMR (CD3OD, 400 MHz): δ 8.90 (m, 1H), 7.49-7.32 (m, 8H), 4.49 (d, J=15.6 Hz, 1H), 4.31 (d, J=15.6 Hz, 1H), 4.23 (s, 2H), 4.02-3.95 (m, 1H), 3.90-3.87 (m, 1H), 3.79-3.75 (m, 1H), 3.48-3.30 (m, 2H), 3.13-3.03 (m, 1H), 2.91-2.85 (m, 1H), 2.50-2.43 (m, 1H), 2.39-2.28 (m, 1H), 1.73-1.59 (m, 3H), 1.18-1.12 (m, 1H).",1-(tert-butoxylcarbonyl)-3-phenylprolyl-N-(2-{[(tert-butoxycarbonyl)amino]methyl}-5-chlorobenzyl)-L-prolinamide | MeOH | HCl | ether | HCl | title compound
US20090036448A1,The title compound (3.21 g) was prepared from diethyl fluoromalonate (5.27 g) and acetamidine hydrochloride (2.80 g) using the procedure for the step A of example 180.,title compound | diethyl fluoromalonate | acetamidine hydrochloride
US06255326B1,"Cyclopentyl bromide (20 g, 134 mmol) is added slowly (over 30 minutes) to a stirred suspension of potassium carbonate (27.6 g, 200 mmol) in N,N′-dimethylimidazolidinone (75 mL) containing 3-hydroxy-4-nitrobenzoic acid (9.15 g, 50 mmol) at 85° C. and then stirring is continued for 14 hours. The mixture is allowed to cool and then filtered. The filtrate is diluted with water (100 mL) then extracted with toluene (2×100 mL). The combined organic extract is dried over magnesium sulfate and then the solvent is removed under reduced pressure to give a brown mobile oil. This oil is subjected by flash chromatography on silica gel (dichloromethane as eluent) and the eluent evaporated under reduced pressure to give cyclopentyl 3-cyclopentyloxy-4-nitrobenzoate (10.2 g, 81.6%) as a yellow solid m.p. 45.5-46.5° C. [Elemental analysis: C,63.7; H,6.66; N,4.37%; calculated: C,63.93; H,6.63; N, 4.39%].","Cyclopentyl bromide | potassium carbonate | N,N′-dimethylimidazolidinone | 3-hydroxy-4-nitrobenzoic acid | water | toluene | magnesium sulfate | cyclopentyl 3-cyclopentyloxy-4-nitrobenzoate"
US20090233937A1,"A mixture of 5-(2-aminoethyl)-N-[4-(1,2-benzoisothiazol-4-yloxy)-3-methylphenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine dihydrochloride (350 mg), 2,2-dimethylpropanoic acid anhydride (0.75 mL), triethylamine (1.5 mL) and N,N-dimethylformamide (25 mL) was stirred at room temperature for 2 hr. Water was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was washed successively with water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure and the obtained residue was subjected to silica gel column chromatography (eluent, methanol:ethyl acetate=0:100→10:90), and the object fraction was concentrated under reduced pressure. The residue was crystallized from ethyl acetate/diisopropyl ether to give the title compound (250 mg) as a white powder.","5-(2-aminoethyl)-N-[4-(1,2-benzoisothiazol-4-yloxy)-3-methylphenyl]-5H-pyrrolo[3,2-d]pyrimidin-4-amine dihydrochloride | 2,2-dimethylpropanoic acid anhydride | triethylamine | N,N-dimethylformamide | Water | ethyl acetate | water | brine | magnesium sulfate | ethyl acetate/diisopropyl ether | title compound"
US20060148797A1,"According to the procedure described for the synthesis of example 1, the title compound has been synthesized from 2-morpholin-4-yl-5-nitro-benzoyl chloride and 4-(1,2,3,6-Tetrahydro-pyridin-4-yl)-benzonitrile (CAS: 460365-22-4). MS (m/e): 417.0 (M-H, 100%)","title compound | 2-morpholin-4-yl-5-nitro-benzoyl chloride | 4-(1,2,3,6-Tetrahydro-pyridin-4-yl)-benzonitrile"
US04728651,"To a solution of 3-(2-methoxyphenyl)-1-methyl-1H-thieno[3,2-c]pyrazole (4.2 g) in 30 ml of dichloromethane was added dropwise 24 ml of a stock solution of BBr3 in dichloromethane. The mixture warmed up spontaneously and a precipitate began to deposit. After stirring at ambient temperature for 2 hours, the reaction mixture was quenched with 50 ml of 1N hydrochloric acid. Stirring was continued overnight whereupon the mixture became almost clear. The organic layer was diluted with ether, the phases were separated, and the aqueous layer was basified with concentrated NH3 and extracted three times with 200 ml total of ether. The combined organic solution was washed with water, dried (over anhydrous magnesium sulfate) and concentrated to a solid. Purifcation of the crude product was effected by passing it through a column of silica gel packed in dichloromethane, which afforded 3.48 g of crystals. They were further purified by recrystallization from ether/hexane, m.p. 112°-113° C.","3-(2-methoxyphenyl)-1-methyl-1H-thieno[3,2-c]pyrazole | dichloromethane | stock solution | BBr3 | dichloromethane | hydrochloric acid | ether | ether | water | magnesium sulfate | crystals"
US20130172339A1,"The product was prepared from 3-{[(5-chloro-3-methyl-1-benzothien-2-yl)sulfonyl]amino}benzoic acid (21 mg, 0.055 mmol) (Intermediate 19) and benzyl alcohol (10.8 mg, 0.100 mmol) according to the General Procedure 7, described in Example 107, using a slightly modified reaction time (2 days). The title compound was obtained in 68% yield (17.6 mg). 1H NMR (500 MHz, CDCl3) δ ppm 2.44 (s, 3H) 5.31 (s, 2H) 6.96 (s, 1H) 7.33-7.40 (m, 5H) 7.36 (dd, J=8.05, 7.70 Hz, 1H) 7.43 (ddd, J=8.05, 2.36, 1.20 Hz, 1H) 7.43 (dd, J=8.63, 2.06 Hz, 1H) 7.68 (dd, J=8.63, 0.58 Hz, 1H) 7.69 (dd, J=2.06, 0.58 Hz, 1H) 7.74 (dd, J=2.36, 1.58 Hz, 1H) 7.86 (ddd, J=7.70, 1.58, 1.20 Hz, 1H). MS (ESI+) m/z 472 [M+H]+.",3-{[(5-chloro-3-methyl-1-benzothien-2-yl)sulfonyl]amino}benzoic acid | Intermediate 19 | benzyl alcohol | title compound
US06894061B2,"The title compound was prepared from N-[1-(2′,4′-difluoro-1,1′-biphenyl-2-yl)ethyl]-3-methoxybenzenesulfonamide (454 mg, 1.12 mmol), anhydrous N,N-dimethylformamide (2 mL), and potassium carbonate (311 mg, 2.25 mmol) according to the procedure and in the same manner as described in Example 105, step d, and the product (426 mg, 99%) isolated as a white solid, m.p. 115-117° C.;","title compound | N-[1-(2′,4′-difluoro-1,1′-biphenyl-2-yl)ethyl]-3-methoxybenzenesulfonamide | N,N-dimethylformamide | potassium carbonate | product"
US07511152B2,"6-(trifluoromethyl)-3,9,10,11-tetrahydro-8,10a-methanocyclohepta-[1,2]indeno[4,5-d][1,2,3]triazol-7(8H)-one [1.8 g, (8R,10aS): (8S,10aR) enantiomeric ratio ˜2:1] was dissolved in 1/1 ethanol/methanol (130 mL) and resolved by chiral HPLC on a 2.0×25 cm Daicel Chiralcel OJ column (4 mL injections, elution with 35% EtOH:Heptane at 7.5 mL/min, fractions monitored at 310 nm). The pure fractions containing the first enantiomer to elute (enantiomer A) were combined and concentrated to give (8R,10aS)-6-(trifluoromethyl)-3,9,10,11-tetrahydro-8,10a-methanocyclohepta[1,2]indeno[4,5-d][1,2,3]triazol-7(8H)-one as a white solid which had a negative rotation. The fractions containing the second enantiomer to elute (enantiomer B) were combined and concentrated to give(8S,10aR)-6-(trifluoromethyl)-3,9,10,11-tetrahydro-8,10a-methanocyclohepta[1,2]indeno[4,5-d][1,2,3]triazol-7(8H)- one as a solid which had a positive rotation.","6-(trifluoromethyl)-3,9,10,11-tetrahydro-8,10a-methanocyclohepta-[1,2]indeno[4,5-d][1,2,3]triazol-7(8H)-one | ethanol/methanol | EtOH | Heptane | (8R,10aS)-6-(trifluoromethyl)-3,9,10,11-tetrahydro-8,10a-methanocyclohepta[1,2]indeno[4,5-d][1,2,3]triazol-7(8H)-one"
US06608070B1,"The title compound was prepared according to the procedure described in Example 57 from methyl trans-4-chloro-2-(phenylsulfonylamino)cinnamate (step 1 of Example 8, Method A) and 4-chloro-3-fluorophenacyl bromide* .",title compound | methyl trans-4-chloro-2-(phenylsulfonylamino)cinnamate | 4-chloro-3-fluorophenacyl bromide
US20070213311A1,"Dimethyl sulfoxide (0.558 mL, 0.00786 mol) was added to a solution of oxalyl chloride (0.332 mL, 0.00393 mol) in methylene chloride (20.0 mL, 0.312 mol) at −78° C. After 10 min, a solution of 1′-[(4-bromo-2-fluorophenyl)(hydroxy)acetyl]-3H-spiro[2-benzofuran-1,3′-pyrrolidin]-3-one (1.38 g, 0.00327 mol) in methylene chloride (10.0 mL, 0.156 mol) was added and the resultant mixture was stirred at −78° C. for 30 min. Triethylamine (2.28 mL, 0.0164 mol) was then added and the mixture was stirred for 5 h with the reaction temperature allowed to gradually warm up to rt. After quenched with water, the mixture was extracted with methylene chloride. The organic layers were combined, washed with brine, dried and evaporated to dryness. The residue was crystallized from methylene chloride to give the pure keton compound. The mother liquor was concentrated to dryness and purified on silica gel, eluting with 0 to 60% EtOAc in hexane to yield additional product (total: 1.18 g, 86.16%). LCMS (M+H) 418.0.","Dimethyl sulfoxide | oxalyl chloride | methylene chloride | 1′-[(4-bromo-2-fluorophenyl)(hydroxy)acetyl]-3H-spiro[2-benzofuran-1,3′-pyrrolidin]-3-one | methylene chloride | resultant mixture | Triethylamine | water | methylene chloride | brine | methylene chloride | silica gel | EtOAc | hexane"
US09062048B2,"Into a 100 mL round-bottom flask, was placed a solution of 3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride (5 g, 18.21 mmol, 1.00 equiv) in dichloromethane (40 mL), di-tert-butyl dicarbonate (4.76 g, 21.83 mmol, 1.20 equiv) and triethylamine (5.45 g, 53.96 mmol, 5.00 equiv). The resulting solution was stirred for 1.5 h at room temperature, and then was washed with 2×30 mL of H2O. The organic portions was dried over sodium sulfate and concentrated under vacuum. The residue was purified by chromatography over a silica gel column with ethyl acetate/petroleum ether (1:50-1:10). The title compound was obtained as a white solid.","3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride | dichloromethane | di-tert-butyl dicarbonate | triethylamine | H2O | sodium sulfate | silica gel | ethyl acetate/petroleum ether | title compound"
US05658997,"A 300-ml three-necked round flask equipped with a stirring bar, a Dimroth condenser, a dropping funnel and a thermometer was charged with 34.4 g (127.8 mmol) of 4-bromo-2-1-butyl-1-hydoxyindane, 23.1 ml (166.2 mmol) of triethylamine and 118 ml of methylene chloride. To the mixture was added dropwise 20 ml of a methylene chloride solution containing 19.45 ml (153.4 mmol) of trimethylsilyl chloride under a nitrogen atmosphere while cooling with ice bath. After the addition was completed, the temperature was elevated to room temperature, and the mixture was further stirred for 1.5 hours. The reaction mixture was poured onto a mixture of 200 ml of ice water and 20 ml of a saturated aqueous solution of sodium bicarbonate. Then, the organic phase was separated, and the aqueous phase was further extracted with 50 ml of methylene chloride two times. The combined organic phase was washed with 100 ml of a saturated NaCl aq., followed by dried over anhydrous Na2SO4. The solvent was evaporated under reduced pressure. The residue was distilled under reduced pressure to obtain 41.8 g of the desired product (mixture of two isomers) as a pale yellow liquid (yield: 96%).",4-bromo-2-1-butyl-1-hydoxyindane | triethylamine | methylene chloride | methylene chloride | trimethylsilyl chloride | nitrogen | ice | ice water | saturated aqueous solution | sodium bicarbonate | methylene chloride | NaCl | Na2SO4 | desired product
US04439513,14.9 g of Compound [2-a] was benzenesulfonylated in the same manner as described in Step 1-h using 12 g of benzenesulfonyl chloride in 50 ml of pyridine and 20 ml of dimethylacetamide to obtain 10.8 g of Compound [2-b].,Compound | benzenesulfonyl chloride | pyridine | dimethylacetamide | Compound
US07662839B2,"Carboxylic acid (56) (23 mg, 0.12 mmol) was coupled to 5-amino-1-methyl-1H-indole-2-carboxylic acid methyl ester (25 mg, 0.12 mmol) using Method D to give the title compound.",Carboxylic acid | 5-amino-1-methyl-1H-indole-2-carboxylic acid methyl ester | title compound
US20080255143A1,"1H-Pyrazole-1-carboximidamide hydrochloride (19 mg, 0.13 mmol) was added to a solution of the compound of Example 115 (50 mg, 0.13 mmol) and diisopropylamine (91 uL, 0.52 mmol) in DMF (1.5 mL). After 18 h, the solvent was removed in vacuo and the residue subjected to preparative reverse phase HPLC (YMC Combiscreen ODS-A 50×20 mm, 20 mL/min, gradient, A:acetonitrile-0.1% TFA, B:water-01% TFA, 10-65% A during 7 min, UV detection at 214) to afford the title compound (35 mg). MS (ES)+ m/z 436.0 [M+H]+.",1H-Pyrazole-1-carboximidamide hydrochloride | compound | diisopropylamine | DMF | acetonitrile | TFA | water-01 | title compound
US04863922,"4-Methoxybenzylmalonic acid, (20.2 g., 0.09 mol) was suspended in N,N,N1,N1 -tetramethylmethanediamine (45 ml). Acetic anhydride (45 ml) was added dropwise, keeping the temperature below 45° C. by cooling in an ice bath as necessary. The resulting clear solution was stirred for 11/2 hour at ambient temperature and then was poured into ice and water. The white solid product was collected, combined with comparable product from a second 0.083 mol run, and dried at 0.1 mm at room temperature to give 22.4 g. (68%) of product, m.p. 88°-91° C. A sample recrystallized from ether-petroleum ether melted at 90°-93° C.","4-Methoxybenzylmalonic acid | N,N,N1,N1 -tetramethylmethanediamine | Acetic anhydride | ice | ice | water | product | ether-petroleum ether"
US05114465,"Reaction of the Product of Step 3 with 2,6-Lutidine in the Presence of a Catalytic Amount of DBU. A mixture of 5.0 g of product of Step 3 and 2.13 g 2,6-lutidine is heated at 143° C. for 30 minutes. Two drops of DBU are added and the reaction mixture is heated for additional 1.5 hours, cooled and worked up as in (b) above to give 4.23 g of the desired product. The reaction can also be carried out with an excess of 2,6-lutidine and a catalytic amount of DBU without solvent or in the presence of toluene as a solvent giving similar results.","DBU | 2,6-lutidine | toluene"
US20150191463A1,"The titled compound (825 mg) as a white solid was prepared from 2-chloro-6-iodotoluene (1.26 g), N-bromosuccinimide (1.07 g) and 2,2′-azobis(isobutyronitrile) (85 mg) according to the method of the process (2) in Example 5.","titled compound | 2-chloro-6-iodotoluene | N-bromosuccinimide | 2,2′-azobis(isobutyronitrile) | (2)"
US04528282,"The process described in Example 17 was repeated using ethyl 5,5-ethylenedioxy-2-oxo-5-phenylpentanoate and L-alanyl-L-proline as starting materials. There was thus obtained as an oil N-[1-ethoxycarbonyl-4,4-ethylenedioxy-4-phenylbutyl]-L-alanyl-L-proline.","ethyl 5,5-ethylenedioxy-2-oxo-5-phenylpentanoate | L-alanyl-L-proline | N-[1-ethoxycarbonyl-4,4-ethylenedioxy-4-phenylbutyl]-L-alanyl-L-proline"
US09409864B2,"Compound 9A (1 g, 3.0 mmol) dissolved in DMF (10 ml) was added with K2CO3 (1.1 equiv., 456 mg) and ethyl iodide (1.1 equiv., 0.316 ml) and the reaction was stirred at rt overnight. The reaction was diluted with ethyl acetate and washed several times with water and finally with Brine. The organic phase was dried over sodium sulfate and concentrated under vacuum. The purification of the crude residue by crystallization from ethyl ether and petroleum ether afforded 895 mg of a semisolid. Yield=93%. 1HNMR (DMSO, 200 MHz) δ 1.13 (3H, d, J=6.2 Hz), 1.26 (3H, t, J=7 Hz), 3.32 (3H, s), 3.41 (2H, q, J=7.8 Hz), 4.02 (1H, bs), 4.23 (1H, m), 5.13 (1H, d, J=4.6 Hz), 7.42 (2H, m), 7.84 (2H, m)",Compound 9A | DMF | K2CO3 | ethyl iodide | ethyl acetate | water | sodium sulfate | crude residue | ethyl ether | petroleum ether | semisolid
US07973069B2,"1-Ethyl-6-methoxy-1H-indole-3-carboxamide (120 mg, 0.55 mmol), Lawesson's reagent (240 mg, 0.6 mmol), and toluene (2 mL) are heated at 90° C. for 90 min. The reaction mixture is concentrated and purified by silica gel chromatography (EtOAc/CH2Cl2, 1/9) to yield 1-ethyl-6-methoxy-1H-indole-3-thiocarboxamide as a yellow solid (92 mg, 71%).",1-Ethyl-6-methoxy-1H-indole-3-carboxamide | Lawesson's reagent | toluene | silica gel | EtOAc/CH2Cl2 | 1-ethyl-6-methoxy-1H-indole-3-thiocarboxamide
US08829040B2,"To a solution of 4-(5-carboxy-3-cyanoindol-1-yl)benzoic acid ethyl ester (0.057 g) in tetrahydrofuran (2 mL) was added borane-tetrahydrofuran complex (1.2 mol/L tetrahydrofuran solution 0.2 mL) at 0° C. and this mixture was stirred at room temperature for 2 hours. To this reaction mixture was added a saturated aqueous sodium bicarbonate solution, this mixture was extracted with diethyl ether. This organic layer was washed with brine, and dried over anhydrous magnesium sulfate. The solvent was removed under reduced pressure. The residue was purified by column chromatography on silica gel (eluent: ethyl acetate/n-hexane=1/1) to give the title compound (0.032 g).",4-(5-carboxy-3-cyanoindol-1-yl)benzoic acid ethyl ester | tetrahydrofuran | borane-tetrahydrofuran | sodium bicarbonate | diethyl ether | brine | magnesium sulfate | silica gel | ethyl acetate/n-hexane | title compound
US07294635B2,"A mixture of 5-fluoro-2-nitro-phenol (464 mg, 2.95 mmol), benzyl bromide (0.37 ml, 3.10 mmol) and cesium carbonate (1.055 g, 3.24 mmol) in MeCN (10 mL) was stirred room temperature under argon for 48 hours. The reaction mixture was diluted with ethyl acetate and washed with brine. The organic layers were combined and concentrated in vacuo to give a crude residue, which was purified by column chromatography (silica 5-25% EtOAc/hexane) to give 2-benzyloxy-4-fluoro-1-nitro-benzene.",5-fluoro-2-nitro-phenol | benzyl bromide | cesium carbonate | MeCN | argon | ethyl acetate | brine | crude residue | silica | 2-benzyloxy-4-fluoro-1-nitro-benzene
US06340685B1,"1.95 g (6.13 mmol) of 4-benzylpiperidinyl indole-5-carboxamide was dissolved in 30 mL dry DMF and was treated with 320 mg (8 mmol, 60% suspension in oil) sodium hydride for 30 minutes. The reaction mixture was cooled to 0° C. and 1.225 g (8 mmol) bromomethylacetate was added and stirring continued for 1 h at 0° C. The ice-bath was removed and stirring continued for another 6 h at room temperature. The reaction was quenched by the addition of sat. ammonium chloride solution, diluted with water and extracted with dichloromethane. The extract was dried, evaporated and the residue purified by column chromatography on silica gel eluting with ethylacetate-hexane (25 -35% ethylacetate) to yield 2.2 g ( 92%) of the desired product. MS: M+, 390; M+-1, 389. 1HNMR (CDCl3): □ 7.7 (s, 1H); 7.35-7.1 (m, 8H); 6.6 (s, 1H); 5.1 (s, 2H); 3.75 (s, 3H); 3.0-2.7 (br, m, 4H); 2.6 ( d, 2H); 1.9-1.2 9m, 5H).",4-benzylpiperidinyl indole-5-carboxamide | DMF | sodium hydride | bromomethylacetate | ice | ammonium chloride | water | dichloromethane | silica gel | ethylacetate-hexane | ethylacetate | desired product
US07615570B2,"The title compound was prepared by reacting the product of Example 1B (0.1523 g, 0.52 mmol) and 2-(4-tert-butylphenyl)ethylamine (0.1210 g, 0.68 mmol) using the procedure as described in Example 1C. MS (ESI+) m/z 454 (M+H)+; (ESI−) m/z 452 (M−H)−; 1H NMR (300 MHz, CDCl3) δ 1.33 (s, 9H), 3.04 (t, J=7.0 Hz, 2H), 3.92 (q, J=6.6 Hz, 2H), 6.15 (s, 1H), 7.19 (m, 2H), 7.33 (dd,J=8.1, 4.7 Hz, 1H), 7.38 (m, 2H), 7.51 (d, J=7.8 Hz, 1H), 7.86 (dd, J=8.1, 1.0 Hz, 1H), 8.03 (dd, J=8.1, 1.4 Hz, 1H), 8.33 (d, J=1.4 Hz, 1H), 8.62 (dd, J=4.6, 0.8 Hz, 1H).",title compound | product | 2-(4-tert-butylphenyl)ethylamine
US20110294776A1,"Using a procedure similar to that of Example 5 and 7-(3-aminomethyl-phenyl)-5-(2-benzyl-2H-indazol-6-yl)-pyrrolo[2,1-f][1,2,4]triazin-4-ylamine and methanesulfonyl chloride as starting materials, 18 mg (8%) of the desired product was isolated. 1H NMR (300 MHz, DMSO-d6) δ 8.80 (s, 1H), 8.05 (d, 2H), 8.0 (s, 1H), 7.90 (d, 1H), 7.70 (s, 1H), 7.60-7.40 (m, 7H), 7.25 (d, 1H), 7.20 (s, 1H), 5.70 (s, 2H), 4.20 (s, 2H), 2.90 (s, 2H), 2.80 (s, 3H); ES-MS m/z 524.3 [M+H]+, HPLC RT (min) 2.84.","7-(3-aminomethyl-phenyl)-5-(2-benzyl-2H-indazol-6-yl)-pyrrolo[2,1-f][1,2,4]triazin-4-ylamine | methanesulfonyl chloride | desired product"
US20110082157A1,"The title compound was prepared (611 mg, 82%) from 4,6-dichloro-5-methylthieno[2,3-d]pyrimidine (425 mg, 1.94 mmol) and tert-butyl 4-aminopiperidine-1-carboxylate (582 mg, 2.9 mmol) by following the general procedure described for Preparation 9. 1H NMR (400 MHz, CDCl3): d 8.40 (s, 1H), 5.25 (d, 1H), 4.35 (m, 1H), 4.30 (m, 2H), 3.00 (m, 2H), 2.55 (s, 3H), 2.15 (m, 2H), 1.45 (s, 9H), 1.35-1.55 (m, 2H).","title compound | 4,6-dichloro-5-methylthieno[2,3-d]pyrimidine | tert-butyl 4-aminopiperidine-1-carboxylate"
US20060194778A1,"4-Methylbenzylamine (1.21 g, 10 mmol) and Tropinone (1.39 g, 10 mmol) were placed in 100 ml flask and dissolved in 50 ml toluene. Mixture was heated to reflux for 3 hrs and water was removed using a Dean/Stark water separator. Crude product was concentrated on Rotavapor (40° C.) giving 47AKU-38. TLC (10% methanol in dichloromethane): Rf=0.3. 1H-NMR (400 MHz, CDCl3, isomers): 7.20-7.09 (4H, m); 4.47 (1H, m); 3.81 (1H, s); 3.42 (1H, m); 3.31 (1H, m); 2.77-2.56 (2H, m); 2.47 and 2.41 (3H, 2s); 2.33 and 2.31 (3H, 2s); 2.27-1.97 (4H, m); 1.69-1.54 (2H, m).",4-Methylbenzylamine | Tropinone | toluene | water | Crude product | methanol | dichloromethane
US20070021434A1,"(S)-{5-((9H-Fluoren-9-ylmethoxycarbonyl)amino)-5-[2-( 1H-indol-3-yl)-ethylcarbamoyl]-pentyl}-carbamic acid tert-butyl ester from Example 56 was deprotected as described in the method for Intermediate #2 of Example 1. Purification by HPLC produced the title compound. 1H NMR (400 MHz, DMSO-d6) δ 7.88 (d, J=7.6 Hz, 2H), 7.71 (t, J=6.5 Hz, 2H), 7.52(d, J=7.9 Hz, 1H), 7.41 (t, J=7.3 Hz, 2H), 7.35-7.27 (m, 3H), 7.11 (s, 1H), 7.05 (dd, J=7.3, 7.6 Hz, 1H), 6.96 (dd, J=7.1, 7.7 Hz, 1H), 4.28 (d, J=7.1 Hz, 2H), 4.24-4.16 (m, 1H), 3.90 (dd, J=5.1, 9.0 Hz, 1H), 3.37-3.24 (m, 2H), 2.79 (dd, J=7.3, 7.5 Hz, 2H), 2.75-2.65 (m, 2H), 1.65-1.39 (m, 4H), 1.37-1.12 (m, 2H); Low resolution mass spectrum (ES) m/e 512[(M+1)+, calcd for C31H35N4O3: 512]; 100% purity based on HPLC.",(S)-{5-((9H-Fluoren-9-ylmethoxycarbonyl)amino)-5-[2-( 1H-indol-3-yl)-ethylcarbamoyl]-pentyl}-carbamic acid tert-butyl ester | Intermediate #2 | title compound
US06579875B1,"A mixture of 3,6-dichloro-4-cyclobutylpyridazine from above (3.0 g, 14.7 mmol), 2-fluorobenzhydrazide (3.0 g, 19.5 mmol) and triethylamine hydrochloride (3.0 g, 21.8 mmol) in p-xylene (50 ml) was stirred and heated at reflux under a stream of nitrogen for 20 hours. Upon cooling the volatiles were removed in vacuo. The residue was partitioned between dichloromethane and water. The aqueous was basified by the addition of solid potassium carbonate. Some dark insoluble material was removed by filtration at, this stage. The aqueous was further extracted with dichloromethane (×2). The combined extracts were dried (MgSO4), filtered and evaporated. The residue was purified by chromatography on silica gel eluting with 20%→30% ethyl acetate/dichloromethane to give the title compound (2.2 g, 49%) as a light-brown solid. Data for the title compound: 1H NMR (250 MHz, CDCl3) δ1.85-2.08 (1H, m), 2.08-2.30 (3H, m), 2.38-2.64 (2H, m), 3.62-3.84 (1H, m), 7.19-7.46 (2H, m), 7.46-7.67 (1H, m), 7.80-7.96 (1H, m), 7.99 (1H, s), MS (ES+) m/e 303 [MH]+, 305 [MH]+.","3,6-dichloro-4-cyclobutylpyridazine | 2-fluorobenzhydrazide | triethylamine hydrochloride | p-xylene | nitrogen | dichloromethane | water | potassium carbonate | dichloromethane | MgSO4 | silica gel | ethyl acetate/dichloromethane | title compound"
US08835436B2,"To a mixture of ethyl 2-(hydroxyimino)-3-oxobutanoate (compound 8, 9.32 g, 58.5 mmol), Pd/C (400 mg, palladium on carbon, 10 wt %, support activated carbon, wet, Degussa type E101 NE/W) in EtOH was added acetic anhydride (compound 9, 11.0 mL, 117.0 mmol) at room temperature. The reaction mixture was stirred at room temperature under H2 for 15 hrs. The palladium was filtered off (filter aid, Celite 521 AW), then the filtrate was concentrated in vacuo. The crude product was purified by flash column chromatography (Biotage SP1™ FLASH Purification System was used for normal phase column chromatography with tetrahydrofuran and hexane) to provide the title compound (9.48 g, 86%) as a white solid.",ethyl 2-(hydroxyimino)-3-oxobutanoate | compound 8 | Pd/C | palladium | EtOH | acetic anhydride | compound 9 | H2 | crude product | tetrahydrofuran | hexane | title compound
US20100249145A1,"A mixture of 268 (20 mg, 0.08 mmol) and 2-phenylacetyl isothiocyanate (16 μL, 0.08 mmol) in THF (1 mL) was stirred at room temperature for 2 hours and concentrated. The residue was purified by flash column chromatography (eluent EtOAc) followed by preparative HPLC (column Aquasil C18, gradient elution with 60-95% MeOH in water, 45 min) to afford the title compound 269a (13 mg, 40% yield) as an off-white solid. 1H NMR (CD3OD) δ (ppm): 8.41 (s, 1H), 8.16 (d. 1H, J=5.6 Hz), 8.02 (dd, 1H, J1=2.3 Hz, J2=12.2 Hz), 7.62 (d, 1H, J=3.3 Hz), 7.44 (m, 1H), 7.37-7.33 (m, 4H) 7.31-7.26 (m, 1H), 6.65 (d, 1H, J=3.1 Hz), 6.52 (d, 1H, J=5.7 Hz), 3.76 (s, 2H), MS (m/z): 421.1 (M+H) (found).",268 | 2-phenylacetyl isothiocyanate | THF | EtOAc | MeOH | water | title compound 269a
US03936470,"A mixture of 13.4 parts of 2-bromo-2',4'-dichloroacetophenone, 8.4 parts of α-(hydroxymethyl)benzyl alcohol, 1.15 parts of p-toluenesulfonic acid, 160 parts of benzene and 140 parts of n-butanol is stirred and refluxed for 48 hours with a water-separator. The solvent is removed in vacuo. The residue is purified by column-chromatography over silica gel, using chloroform as eluent. The pure fractions are collected and the eluent is evaporated, yielding 2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-phenyl-1,3-dioxolane as residue.","13.4 | 2-bromo-2',4'-dichloroacetophenone | α-(hydroxymethyl)benzyl alcohol | p-toluenesulfonic acid | benzene | n-butanol | water | silica gel | 2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-phenyl-1,3-dioxolane"
US08163952B2,"In a manner analogous to example 1 e, the process is carried out by a reaction of 300 mg (1 mmol) of 1-[3-tert-butyl-4-(ethylisobutylamino)phenyl]prop-2-yn-1-ol with 216 mg (0.87 mmol) of 4-iodobenzoic acid, 12 mg (0.04 mmol) of copper iodide and 15 mg (0.02 mmol) of bis(triphenylphosphine)palladium chloride. 190 mg of 4-{[tert-butyl(ethylisobutylamino)phenyl]hydroxyprop-1-ynyl}benzoic acid are obtained in the form of a beige solid (Mp=117° C., yield=53%).",1-[3-tert-butyl-4-(ethylisobutylamino)phenyl]prop-2-yn-1-ol | 4-iodobenzoic acid | copper iodide | bis(triphenylphosphine)palladium chloride | 4-{[tert-butyl(ethylisobutylamino)phenyl]hydroxyprop-1-ynyl}benzoic acid | solid
US09181247B2,"4-[5-Bromo-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-benzylamine (Intermediate CB, 45 mg, 0.1 mmol) was combined with triethylamine (45 μl, 0.3 mmol) and acetic anhydride (11 μl, 0.11 mmol) in anh. DCM (2 ml). The mixture was stirred for 2 hrs, EtOAc, was added and washed with 0.5 N HCl, saturated NaHCO3, water and brine. Evaporation yielded the title compound (48 mg, 96%). MS ESI (m/z): 498.1/500.1 (M+1)+, calc. 497/499.","4-[5-Bromo-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-benzylamine | triethylamine | acetic anhydride | DCM | EtOAc | HCl | NaHCO3 | water | brine | title compound"
US04416687,"A stirred charge containing 0.05 mole of ethyl-4-[3,5-bis-(trifluoromethyl)phenoxy]butyrate, 150 ml of ethyl alcohol, 8 g (0.1 mole) of 50% aqueous solution of sodium hydroxide and 25 ml of water was heated at reflux for 5 hours and at 25°-30° C. for 18 hours. After cooling to 5° C., 800 ml of water containing 15 g (0.15 mole) of concentrated hydrochloric acid was added slowly. After stirring at 0°-10° C. for one hour, the resulting solid was collected by filtration, washed with cold water and air dried at 25°-30° C. A product with a melting point of 85°-87° C. was obtained with a yield of 87%.","ethyl-4-[3,5-bis-(trifluoromethyl)phenoxy]butyrate | ethyl alcohol | aqueous solution | sodium hydroxide | water | water | hydrochloric acid | water"
US07378414B2,"A solution of Example 157F (1.06 g, 2.00 mmol) in dichloromethane (10 mL) was treated with trifluoroacetic acid (10 mL) at room temperature for 1 hour. After concentrating in. vacuo, the resulting oil was partitioned between ethyl acetate and aqueous NaHCO3, the organic layer was removed and the aqueous layer extracted 3 times with ethyl acetate. The combined organic layers were dried over MgSO4, filtered, and concentrated in. vacuo to yield a solid that was used without further purification. 1H NMR (300 MHz, DMSO-d6): δ ppm −0.25 (m, 2 H) 0.25 (m, 2 H) 0.46 (m, 2 H) 0.80 (m, 1 H) 1.57 (s, 3 H) 2.15 (m, 1 H) 2.32 (m, 1 H) 6.99 (m, 2 H) 7.44 (d, J=8.82 Hz, 1 H) 7.54 (m, 1 H) 7.77 (d, J=4.04 Hz, 2 H) 8.15 (d, J=7.72 Hz, 1 H) 13.55 (s, 1 H). MS (ESI+) m/z-438 (M+H)+, 455 (M+NH4)+.",dichloromethane | trifluoroacetic acid | ethyl acetate | NaHCO3 | ethyl acetate | MgSO4
US08088368B2,"Followed the procedure used to prepare 4,4,5,5-tetramethyl-2-[7-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-9,10-dihydro-phenanthren-2-yl]-[1,3,2]dioxaborolane, except that 2,7-dibromo-9-fluorenone was used instead of 2,7-dibromo-9,10-dihydro-phenanthrene.","4,4,5,5-tetramethyl-2-[7-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-9,10-dihydro-phenanthren-2-yl]-[1,3,2]dioxaborolane | 2,7-dibromo-9-fluorenone"
US06093821,"To a suspension of NaH 60% dispersion in oil (97 mg, 0.0023 mol) in 2 mL of anhydrous THF at 0° C. was added 2-bromo-5-nitroaniline (500 mg, 0.0023 mol) in 2 mL of THF dropwise, the temperature was raised to rt to complete deprotonation then lowered to 0° C. 3-bromo-2-methylpropene (232 mL, 0.0023 mol) was added very slowly and the reaction mixture was stirred at 0° C. for 3 h then neutralized with water (5 mL). The mixture was extracted with ethyl acetate (2×10 mL), dried (Na2SO4) and concentrated in vacuo to an oil that was subjected to flash column chromatography (silica gel, hexanes/ethyl acetate, 8:2) to give 200 mg (32%) of 2-bromo-N-(2-methyl-2-propenyl)-5-nitroaniline (structure 55A of Scheme XLVII, where R1 =methyl, R2 =H). Data for 2-bromo-N-(2-methyl-2-propenyl)-5-nitroaniline: 1H NMR (400 MHz, CDCl3) 7.55 (d, J=8.5, 1H), 7.40 (dd, J=8.5, 2.8, 1H), 7.39 (d, J=2.8, 1H), 4.96 (s, 2H), 4.95 (bs, 1H), 3.82 (d, J=5.9, 2H), 1.81 (s, 3H).",NaH | oil | THF | 2-bromo-5-nitroaniline | THF | 3-bromo-2-methylpropene | water | ethyl acetate | Na2SO4 | 2-bromo-N-(2-methyl-2-propenyl)-5-nitroaniline
US07348359B2,"To a mixture of 91 mg (0.078 mmol, 5%) of Pd(PPh3)4 and 252 mg (1.26 mmol) of 5-bromo salicylaldehyde in 10 mL of dry toluene was added 685 mmol (2.5 mmol, 2 equivalents) of 2-methoxymethoxy-3-tert-butyl-5-ethyl phenylboronic acid diluted in 5 mL of ethanol followed by 1.3 mL of a 2N aqueous solution of Na2CO3. The mixture was stirred at reflux for 3 hours and after cooling extracted with ethyl acetate. The organic layer was dried over MgSO4 and evaporated under reduced pressure. The residual oil was purified over silica gel (eluent: ethyl acetate/hexane: 10/90) to give 333 mg (0.969 mmol, yield: 77%) of 2-hydroxy-5-(5-ethyl-3-tert-butyl-2-methoxymethoxyphenyl)-benzaldehyde a pale brownb oil. 1H NMR (CDCl3), δ: 11.04 (s, 1H), 9.95 (s, 1H), 7.75 (dd, J=8.9, 2.1 Hz, 1H), 7.74 (d, J=2.1 Hz, 1H), 7.19 (d, J=2.1 Hz, 1H), 7.06 (d, J=8.9 Hz, 1H), 6.98 (d, J=1.9 Hz, 1H), 4.52 (s, 2H), 3.29 (s, 3H), 2.64 (dd, J=15.2, 7.6 Hz, 2H), 1.47 (s, 9H), 1.26 (t, J=7.4 Hz, 3H).",Pd(PPh3)4 | 5-bromo salicylaldehyde | toluene | 2-methoxymethoxy-3-tert-butyl-5-ethyl phenylboronic acid | ethanol | aqueous solution | Na2CO3 | ethyl acetate | MgSO4 | silica gel | 2-hydroxy-5-(5-ethyl-3-tert-butyl-2-methoxymethoxyphenyl)-benzaldehyde
US05716964,"Following the procedure of Example 2, the product from Example 25 (6.07 g, 22 mmol) was reacted with NBS (3.96 g, 22 mmol) in CH2Cl2 (150 mL). The crude title product (8.98 g, >100%) was obtained and used without further purification.",product | NBS | CH2Cl2 | crude title product
US20150353553A1,"CDI (1.48 g, 9.13 mmol) was added to a solution of 6-(((R)-1-cyclobutylethyl)amino)-N-hydroxy-7-((trans-4-methylcyclohexyl)methyl)-7H-purine-2-carboximidamide (3.20 g, 8.30 mmol) in acetonitrile (35 mL) at room temperature. The reaction mixture was stirred at room temperature for 1 hour. The reaction mixture was concentrated to dryness. The residue was dissolved in CH2Cl2 (150 mL) and the organic layer was washed 1M HCl solution (30 mL) and brine (30 mL), dried over anhydrous Na2SO4, filtered and concentrated to dryness. Purification of the residue by reverse phase column chromatography (10 to 90% water/CH3CN) afforded 3-(6-(((R)-1-cyclobutylethyl)amino)-7-((trans-4-methylcyclohexyl)methyl)-7H-purin-2-yl)-1,2,4-oxadiazol-5(4H)-one. 1H NMR (400 MHz, DMSO-d6) δ 12.90 (br s, 1H), 8.36 (s, 1H), 6.52 (d, J=8.4 Hz, 1H), 4.52-4.66 (m, 2H), 4.17 (dd, J=14.4, 8.8 Hz, 1H), 2.53-2.64 (m, 1H), 1.99-2.09 (m, 1H), 1.89-1.97 (m, 1H), 1.73-1.87 (m, 4H), 1.47-1.71 (m, 4H), 1.09-1.32 (m, 2H), 1.13 (d, J=6.4 Hz, 3H), 0.89-1.08 (m, 2H), 0.81 (d, J=6.4 Hz, 3H), 0.62-0.80 (m, 2H). MS (ES)=412 (M+1)+.","CDI | 6-(((R)-1-cyclobutylethyl)amino)-N-hydroxy-7-((trans-4-methylcyclohexyl)methyl)-7H-purine-2-carboximidamide | acetonitrile | CH2Cl2 | HCl | brine | Na2SO4 | water/CH3CN | 3-(6-(((R)-1-cyclobutylethyl)amino)-7-((trans-4-methylcyclohexyl)methyl)-7H-purin-2-yl)-1,2,4-oxadiazol-5(4H)-one"
US07727988B2,"A mixture of 5-(2-fluoro-6-methyl-pyridin-3-yl)-1H-pyrimidine-2,4-dione hydrochloride (Prep 15, 667 mg, 2.59 mmol), and K2CO3 (358 mg, 2.59 mmol) in DMF (25 ml) was stirred 30 minutes at room temperature. Then 90% 3-Bromo-1,1dimethoxy-propane (432 μl, 2.85 mmol) was added in three portions during 3 days. Solvent was then removed under vacuum at 40° C. and the residue washed with ethyl acetate. The organic phase was dried (Na2SO4), filtered and evaporated. The crude was purified by flash chromatography eluting with DCM-MeOH—NH4OH (98-2-0.2) to give 291 mg of the title compound as a white solid (35% yield).","5-(2-fluoro-6-methyl-pyridin-3-yl)-1H-pyrimidine-2,4-dione hydrochloride | K2CO3 | DMF | 3-Bromo-1,1dimethoxy-propane | ethyl acetate | Na2SO4 | title compound"
US05468742,"3.72 g of ethyl 8-bromo-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylate, 4.4 g of tributylvinyl stannan and 0.46 g of tetrakis(triphenylphosphine)palladium(0) are refluxed in 40 ml of absolute toluene for 2 to 3 hours under a nitrogen atmosphere. The mixture is filtered under hot conditions, and the product which has precipitated at room temperature is filtered off with suction, washed with toluene and dried. 2.55 g of ethyl 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-8-vinyl-3-quinolinecarboxylate are obtained (79% of theory).","ethyl 8-bromo-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylate | tributylvinyl stannan | tetrakis(triphenylphosphine)palladium(0) | toluene | nitrogen | toluene | ethyl 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-8-vinyl-3-quinolinecarboxylate"
US08546391B2,"3.2 g of tert-butyl trans-[4-(4-hydroxyphenyl)cyclohexyloxy]acetate (10.44 mmol, 1 eq.) are dissolved in 50 mL of dichloromethane and cooled in an ice bath. 4.4 mL of triethylamine (31.33 mmol. 3 eq.) are added, followed by dropwise addition of 2.6 mL of triflic anhydride (15.67 mmol, 1.5 eq.). After stirring for 30 minutes, the ice bath is removed and stirring is continued for 16 hours. The reaction medium is diluted with dichloromethane and washed with saturated aqueous ammonium chloride solution. The aqueous phase is extracted with dichloromethane. The organic phases are combined, washed with saturated aqueous sodium hydrogen carbonate solution, dried over magnesium sulfate, filtered and evaporated. The residue is chromatographed on silica gel, eluting with a gradient of ethyl acetate in heptane ranging from 4% to 40%. 3.3 g of tert-butyl trans-[4-(4-trifluoromethanesulfonyloxyphenyl)cyclohexyloxy]acetate are obtained.",tert-butyl trans-[4-(4-hydroxyphenyl)cyclohexyloxy]acetate | dichloromethane | ice | triethylamine | triflic anhydride | ice | dichloromethane | ammonium chloride | dichloromethane | sodium hydrogen carbonate | magnesium sulfate | silica gel | ethyl acetate | heptane | tert-butyl trans-[4-(4-trifluoromethanesulfonyloxyphenyl)cyclohexyloxy]acetate
US20030220355A1,"6.3 g (150 mmol) of LiOH.H2O are added to a stirred solution of 15.7 g (75 mmol) of methyl 4-amino-isophtalate in 300 ml of dioxane and 1200 ml of water. The reaction mixture is heated for 1 hour to 100° C., cooled and acidified to pH═1 by the addition of concentrated HCl. A precipitate is obtained then filtered off, washed, and dried under vacuum to yield 13 g (yield=95.7%) of the desired compound.",LiOH.H2O | methyl 4-amino-isophtalate | dioxane | water | HCl | desired compound
US04827006,"Acetyl chloride (6.82 g, 86.88 mmole) was added dropwise to (2S, 3R)-2-bromo-3-hydroxybutyric acid (neat) with stirring. The reaction mixture was cooled in a bath at 5° C. as exotherm began. After completion of addition, the cooling bath was removed. After 45 minutes the mixture was heated at 45°-50° C. for 1.5 hours. Heating was discontinued and 10 mL toluene was added. The mixture was cooled in an ice bath and oxalyl chloride (11.4 80 g, 90.44 mmole) was added dropwise. After completion of addition, the mixture was allowed to warm to room temperature then heated at reflux for 30 minutes. Toluene and excess of reagents were removed by fractional distillation. The residue was subjected to bulb-to-bulb distillation at 80°-90° C. under high vacuum (1mm/Hg) to yield the title compound. 1H NMR (200 MHz, CDC/3) w 1.44 (d, J=6.0Hz, 3H), 2.11 (s, 3H), 4.67 (d, J=6.0 Hz, 1H), 5.41 (m, 1H); 1R (neat) 1810, 1790, 1740 cm-1.","Acetyl chloride | (2S, 3R)-2-bromo-3-hydroxybutyric acid | toluene | ice | oxalyl chloride | Toluene | Hg | title compound"
US07348425B2,"The title compound was prepared as described above for N-(4-(1H-1,2,4-triazol-1-yl)phenyl)-1-aminocyclopentanecarboxamide using 4-(oxazol-5-yl)benzenamine as the amine counterpart. LCMS: m/e 272 (M+H)+, ret time 1.03 min, column 3, 2 minute gradient.","title compound | N-(4-(1H-1,2,4-triazol-1-yl)phenyl)-1-aminocyclopentanecarboxamide | 4-(oxazol-5-yl)benzenamine | amine"
US07326791B2,"Prepared analogously to Example 1g from 4-(4-methoxyimidazo[4,5-c]pyridin-1-yl)-3-trifluoromethylbenzoic acid, TBTU, diisopropylethylamine, and (1S)-1-(5-chloro-1H-benzimidazol-2-yl)ethylamine in dimethylsulfoxide. Yield: 46%; Rf value: 0.39 (silica gel: dichloromethane/methanol=10:1); C24H18ClF3N6O2 (514.893); mass spectrum: (M+H)+=515/517 (chlorine isotope).","4-(4-methoxyimidazo[4,5-c]pyridin-1-yl)-3-trifluoromethylbenzoic acid | TBTU | diisopropylethylamine | (1S)-1-(5-chloro-1H-benzimidazol-2-yl)ethylamine | dimethylsulfoxide | dichloromethane/methanol | C24H18ClF3N6O2 | chlorine"
US08853218B2,"To a stirred solution of 1,1-dimethylethyl (2S)-4-[(4-aminophenyl)methyl]-2-methyl-1-piperazinecarboxylate (D2) (0.30 g, 1 mmol) in dry 1,2 DCE (5 mL) was added sequentially 2-methoxypropene (0.141 mL, 1.5 mmol), acetic acid (0.056 mL, 1 mmol) and sodium triacetoxyborohydride (0.313 g, 1.5 mmol). Further 1,2 DCE (5 mL) was added and the reaction mixture was stirred under argon at room temperature for 16 hours. Saturated NaHCO3 (15 mL) was added and reaction mixture stirred for a further 1 hour. The aqueous layer was then extracted with DCM (×3) and the combined organic layers were dried (Na2SO4) and concentrated in vacuo. The crude material was purified by column chromatography eluting with 0-100% ether/petroleum ether to give the title compound (0.265 g). δH (CDCl3, 400 MHz) 7.09 (2H, d), 6.54 (2H, d), 4.16 (1H, br.s), 3.78 (1H, d), 3.61 (1H, sp), 3.49 (1H, s), 3.42 (2H, m), 3.28 (1H, d), 3.08 (1H, td), 2.75 (1H, d), 2.59 (1H, d), 1.95 (1H, dd), 1.94 (1H, m), 1.45 (9H, s), 1.20 (9H, m). MS (AP+): 370.3 (MNa+), 248.3, no molecular ion (MH+) observed.","1,1-dimethylethyl (2S)-4-[(4-aminophenyl)methyl]-2-methyl-1-piperazinecarboxylate | DCE | 2-methoxypropene | acetic acid | sodium triacetoxyborohydride | DCE | argon | NaHCO3 | DCM | Na2SO4 | crude material | ether/petroleum ether | title compound"
US07514432B2,"The compound was prepared according to example 11 using 5-hydroxy-2-(tetrahydro-pyran-2-yloxymethyl)-4H-pyran-4-one (1.00 g, 4.42 mmol), Cs2CO3 (1.58 g, 4.86 mmol) and 1,4-dibromobutane (2.00 mL, 16.7 mmol). The sealed tube was heated at 80° C. for 2 h 30. A white solid 2 was obtained (1.14 g, 71% yield).","5-hydroxy-2-(tetrahydro-pyran-2-yloxymethyl)-4H-pyran-4-one | Cs2CO3 | 1,4-dibromobutane | solid 2"
US07718675B2,"Sodium azide (0.761 g) is added to a solution of 0.898 g of cis-2-(4-methanesulfonyloxy-cyclohexyl)-2-methyl-propionic acid methyl ester in 7 ml of N,N-dimethylformamide. The reaction mixture is warmed to 100° C. for 16 hours. The mixture is cooled to room temperature, diluted with 20 ml of water and extracted with tert-butyl methyl ether (3×30 ml). The combined organic phases are washed with brine (20 ml), dried over sodium sulphate and concentrated by evaporation. The title compound is identified from the residue by means of flash chromatography (SiO2 60F) based on its Rf value.","Sodium azide | cis-2-(4-methanesulfonyloxy-cyclohexyl)-2-methyl-propionic acid methyl ester | N,N-dimethylformamide | water | tert-butyl methyl ether | brine | sodium sulphate"
US20090186879A1,"A mixture of 9-chloro-6-(1-chloro-2,2,2-trifluoroethyl)-1(2,4,6-trichlorophenyl)-1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazole (290 mg, 0.576 mmol) and sodium azide (74.9 mg, 1.15 mmol) in dimethylsulfoxide (2.8 mL) was stirred at 100° C. for 2 h. After the mixture was diluted with ethyl acetate, the resultant mixture was washed with water and brine, dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel eluting with a 0-30% ethyl acetate/n-hexane gradient mixture to give the title compound as a colorless amorphous solid (286 mg, 0.560 mmol, 97%).","9-chloro-6-(1-chloro-2,2,2-trifluoroethyl)-1(2,4,6-trichlorophenyl)-1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazole | sodium azide | dimethylsulfoxide | ethyl acetate | resultant mixture | water | brine | sodium sulfate | silica gel | ethyl acetate/n-hexane | title compound"
US20030087955A1,"A solution of 2,4-dimethoxyphenyl acetic acid (7.9 g, 38 mmol) in CH2Cl2 (50 mL) plus a few drops of DMF was treated with SOCl2 (5.0 mL, 76 mmol) and the reaction was allowed to stir for 3 h at rt. The reaction mixture was then concentrated and taken up in a small amount of dichloroethane and added dropwise, at 0° C., to a solution of 1,3,5-trimethoxybenzene (12.8 g, 76 mmol) and AlCl3 (7.3 g, 57 mmol) in 50 mL dichloroethane. After 20 minutes at 0° C., the reaction was carefully quenched with 2 N HCl aq. The organic layer was separated, dried over MgSO4, filtered and concentrated to give a dark oil which was chromatographed on SiO2 (3:7 EtOAc/hexanes to 1:1 EtOAc/hexanes) to yield the desired product as a white solid (6.2 g): Mp 109-111° C.; 1H NMR (CDCl3)δ7.06 (d, 1H, J=8.1 Hz), 6.41 (dd, 1H, J=8.1 Hz, 2.4 Hz), 6.39 (d, 1H, J=2.4 Hz), 6.04 (s, 2H), 3.97 (s, 2H), 3.80 (s, 3H), 3.78 (s, 3H), 3.74 (s, 6H), 3.71 (s, 3H); MS Fl 347 (M+H)+.","2,4-dimethoxyphenyl acetic acid | CH2Cl2 | DMF | SOCl2 | dichloroethane | 1,3,5-trimethoxybenzene | AlCl3 | HCl | MgSO4 | SiO2 | desired product"
US20150141400A1,The title compound was synthesized from 2-amino-4-chloro-3-fluoro-5-trifluoromethyl-benzoic acid ethyl ester (Compound h1) under the same conditions as for Compound b1.,title compound | 2-amino-4-chloro-3-fluoro-5-trifluoromethyl-benzoic acid ethyl ester | Compound b1
US09193707B2,"Into a 500-mL 3-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen, was placed methyl 2-(benzyloxy)-3-(dimethylamino)benzoate (9.1 g, 31.89 mmol, 1.00 equiv) and oxolane (180 mL). This was followed by the addition of LiBH4 (3.31 g, 152.10 mmol, 4.77 equiv) in several batches. The resulting solution was stirred for 8 h at 57° C. in an oil bath. The reaction was poured into 400 mL of water/ice. The resulting solution was extracted with 2×500 mL of ethyl acetate and the organic layers combined. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1:20). This resulted in 4.5 g (55%) of [2-(benzyloxy)-3-(dimethylamino)phenyl]methanol as yellow oil. MS (ESI) m/z 258 ([M+H]+).",nitrogen | methyl 2-(benzyloxy)-3-(dimethylamino)benzoate | oxolane | LiBH4 | water/ice | ethyl acetate | sodium sulfate | [2-(benzyloxy)-3-(dimethylamino)phenyl]methanol
US08664257B2,150 mg (0.675 mmol) of 1-(2-fluoro-phenyl)-5-hydroxy-1H-pyrazole-3-carboxylic acid were dissolved in 5 ml of THF. 440 mg (1.35 mmol) of cesium carbonate and 90.2 mg (0.675 mmol) of pyrrolidine-1-carbonyl chloride were added and the mixture was heated to 50° C. for 4 h. Then the mixture was filtrated and the filtrate containing the title compound directly used in the next step.,1-(2-fluoro-phenyl)-5-hydroxy-1H-pyrazole-3-carboxylic acid | THF | cesium carbonate | pyrrolidine-1-carbonyl chloride | title compound
US08354406B2,"Following the general procedure of example 1, 3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(3-formylphenyl)-1H-indole-7-carboxamide (50.0 mg, 0.112 mmol), 2-(methylamino)-1-phenylethanol (129.9 mg, 0.86 mmol) and NaBH(OAc)3 (58.0 mg, 0.303 mmol) were reacted to give the title compound (22.1 mg, 36.6%).",3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(3-formylphenyl)-1H-indole-7-carboxamide | 2-(methylamino)-1-phenylethanol | NaBH(OAc)3 | title compound
US07423051B2,"A solution of piperidin-4-yl-carbamic acid tert-butyl ester (1.0 g, 5.0 mmol, Astratech, Inc.) and diisopropylethylamine (4 mL) in tetrahydrofuran (40 mL) was stirred at +5° C. To this was added methanesulfonyl chloride (1.0 g, 8.8 mmol) in a bolus. The reaction was brought to room temperature for 1 hour, poured into water and extracted into methylene chloride (2×50 mL). The combined organic extracts were washed with 5% aqueous sodium bicarbonate. The organic solution was dried (Na2SO4) and solvent was removed under vacuum to give a crude solid. Purification was by trituration with ether/hexane to give (1-methanesulfonyl-piperidin4-yl)-carbamic acid tert-butyl ester as a white solid. Mass spectrum (ES) H+: 278",piperidin-4-yl-carbamic acid tert-butyl ester | diisopropylethylamine | tetrahydrofuran | methanesulfonyl chloride | water | methylene chloride | sodium bicarbonate | Na2SO4 | (1-methanesulfonyl-piperidin4-yl)-carbamic acid tert-butyl ester
US08552188B2,"4-Nitropyridine-N-oxide (84.00 g), 4-Trifluoromethoxyphenol (107.8 g), K2CO3 (165.7 g) and DMF (420 mL) were placed in a vessel and stirred at 80-90° C. for 4.5 hr. The reaction mixture was then cooled to room temperature and water (2500 mL) and ethyl acetate (2500 mL) were added. The organic material was taken up in ethyl acetate and then the aqueous layer was extracted with ethyl acetate (1000 mL). The all organic extracts were washed three times with water (1000 mL×3). And then the organic extracts were condensed under reduced pressure to give the crude products (150.7 g). The crude products (150.7 g) and n-hexane (1500 mL) were placed in a vessel and stirred at 60° C. for 0.5 hr and then the mixture was allowed to cool to under 10° C. for 1 hr. The mixture was then filtered and the crystalline powder washed with n-hexane (168 mL) and dried at 50° C. for 17 hr to afford 139.4 g (85.73% yield) of a brown crystal target compound.",4-Nitropyridine-N-oxide | 4-Trifluoromethoxyphenol | K2CO3 | DMF | water | ethyl acetate | ethyl acetate | ethyl acetate | water | crude products | crude products | n-hexane | n-hexane | brown crystal
US07858622B2,"A solution of 2.4 mg (0.10 mmol) LiOH in 0.8 mL water was added to 50 mg (0.06 mmol) (R)-1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-{4-[1-(1-ethoxycarbonyl-ethyl)-piperidin-4-yl]-piperazin-1-yl}-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate in 1 mL THF and the reaction mixture was shaken for 2 h at RT and for 4 h at 50° C. It was then purified by HPLC without working up; the fractions containing the product were combined and lyophilised.","LiOH | water | (R)-1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-{4-[1-(1-ethoxycarbonyl-ethyl)-piperidin-4-yl]-piperazin-1-yl}-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate | THF"
US20150320718A1,"A solution of 4-{2-[(3-bromomethylbenzofuran-2-carbonyl)amino]ethoxy}benzoic acid methyl ester (0.340 mol) in chlorobenzene (200 ml) and dichloromethane (800 ml) was added dropwise to a 0-5° C. solution of 2M dimethylamine in tetrahydrofuran (510 ml, 1.022 mol) over 30 minutes with the temperature below 20° C. The resulting mixture was stirred for one hour and allowed to warm to ambient temperature. After completion of reaction, the reaction mixture was washed with 5% potassium carbonate and water. Solvent was distilled at atmospheric pressure until the pot temperature reached 100° C. After cooling to −50° C., acetonitrile (400 ml) and ethyl Acetate (400 ml) were added to the pot. The reaction mixture was heated to reflux until all solids dissolved. The reaction mixture was allowed to cool to give 4-{2-[(3-dimethylaminomethyl-benzofuran-2-carbonyl)amino]ethoxy}benzoic acid methyl ester (76.6 g) as an off white powder.",4-{2-[(3-bromomethylbenzofuran-2-carbonyl)amino]ethoxy}benzoic acid methyl ester | chlorobenzene | dichloromethane | dimethylamine | tetrahydrofuran | potassium carbonate | water | acetonitrile | ethyl Acetate | 4-{2-[(3-dimethylaminomethyl-benzofuran-2-carbonyl)amino]ethoxy}benzoic acid methyl ester
US04130649,"A solution of diethyl acetylenedicarboxylate (183.5 g) and 5-amino-2-hydroxy-2,4,6-cycloheptatriene-1-one [147.5 g, described by T. Nozoe et al., Science Repts. Tokoku Univ., First ser., 35, 274(1952)] in ethanol (2,700 ml) is stirred at room temperature for 16 hours. The mixture is filtered and the precipitate is crystallized from ethanol to obtain crystals of the title compound, mp 108.5° C.","diethyl acetylenedicarboxylate | 5-amino-2-hydroxy-2,4,6-cycloheptatriene-1-one | ethanol | ethanol | title compound"
US09249086B2,"A stirred mixture of nonanedioic acid (18.8 g; 0.10 mol), benzyl alcohol (10.8 g; 0.10 mol), and p-toluenesulphonic acid (0.2 g) in toluene (200 mL) was refluxed through a Dean-Stark trap overnight. The mixture was cooled to ambient temperature and extracted with 10% aqueous N-methyl-D-glucamine (4×25 mL). The last extract was a milky emulsion. The first three extracts were combined, acidified with 1 M HCl (50 mL), and filtered to give recovered nonanedioic acid (3.8 g). The emulsion was acidified with 1 M HCl and allowed to separate overnight. The organic layer was evaporated and the residue dissolved in hexane (200 mL) and diethyl ether (50 mL). The solution was extracted with 10% N-methyl-D-glucamine (2×50 mL) (emulsions broken by adding a little ethanol). The organic solution was washed with water (1×25 mL) and the combined aqueous solution was acidified with 1 M HCl (150 mL). After extraction with dichloromethane-tetrahydrofuran (4:1) (5×10 mL), the combined extracts were dried (Na2SO4), filtered, and evaporated. 13.0 g (47%) product was obtained (oil that solidified on standing).",nonanedioic acid | benzyl alcohol | p-toluenesulphonic acid | toluene | N-methyl-D-glucamine | nonanedioic acid | hexane | N-methyl-D-glucamine | ethanol | water | dichloromethane-tetrahydrofuran | Na2SO4 | product
US04812562,"To a solution of 0.56 g (0.8 mM) of benzhydryl 7β-tritylamino-3-carbamoylmethylthio-3-cephem-4-carboxylate obtained in Example 2(a) in 10 ml of ethyl acetate, 0.18 g (0.96 mM) of p-toluenesulfonic acid monohydrate was added under ice-cooling, and the mixture was stirred for 4 hours. After the reaction, the white crystals which formed were collected by filtration to give 0.392 g of 7β-amino-3-carbamoylmethylthio-3-cephem-4-carboxylic acid benzhydryl ester p-toluenesulfonate.",benzhydryl 7β-tritylamino-3-carbamoylmethylthio-3-cephem-4-carboxylate | ethyl acetate | p-toluenesulfonic acid monohydrate | ice | 7β-amino-3-carbamoylmethylthio-3-cephem-4-carboxylic acid benzhydryl ester p-toluenesulfonate
US05990101,"A 47 mg potion of 3-(N-methylamino)methylimidazo[5,1-b]thiazole was dissolved in 1 ml of DMF, and 0.305 ml of N,N-diisopropylethylamine and 100 mg of sulfamoyl chloride were further added at -45° C., followed by stirring for 8 hours, while the solution was heated up to room temperature. Then, the reaction solution was concentrated under reduced pressure, and 10 ml of water and an aqueous sodium hydrogencarbonate solution were then added to adjust the solution to pH 9.0. Afterward, extraction was carried out four times with dichloromethane. The organic layer was dried over anhydrous magnesium sulfate and then filtered, and the solvent was evaporated under reduced pressure. The resulting residue was purified by a silica gel column chromatograph to obtain 37.4 mg of the title compound.","3-(N-methylamino)methylimidazo[5,1-b]thiazole | DMF | N,N-diisopropylethylamine | sulfamoyl chloride | water | sodium hydrogencarbonate | magnesium sulfate | silica gel | title compound"
US05801170,"2'-Methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carboxylic acid (E. P. 0533268A 1) (0.212 g, 0.721 mmol) was suspended in dichloromethane (5 ml) and treated with oxalyl chloride (0.094 ml, 1.08 mmol), followed by a drop of dry DMF with stirring. After 4 h, the reaction mixture was evaporated under reduced pressure and dried in vacuo to give the crude acid chloride as a yellow solid. Meanwhile to a solution of the product from description 2 (0.142 g, 0.683 mmol) in dichloromethane (10 ml); triethylamine (0.095 ml, 0.683 mmol) was added, followed by a solution of the crude acid chloride in dichloromethane (4 ml), with stirring. After 1 h, the reaction mixture was washed with water (1×), followed by sodium bicarbonate solution (1×). The organic layer was then dried (Na2SO4) and evaporated under reduced pressure to give a brown oil which was dried in vacuo. The oil was purified by SiO2 chromatography (7.5% MeOH in CH2Cl2 as eluant) to give the title compound as a pale yellow oil (0.052 g, 16%) which was converted to its oxalate salt. m.pt 144°-148° C. (oxalate salt)","2'-Methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carboxylic acid | 2 | dichloromethane | oxalyl chloride | DMF | acid chloride | dichloromethane | triethylamine | acid chloride | dichloromethane | water | Na2SO4 | SiO2 | MeOH | CH2Cl2 | title compound"
US05008416,"To chloroform solution (16.0 ml) saturated with ammonia, 2-trichlorogermylethanesulfonylchloride (500 mg, obtained by Example 7) in chloroform solution (2.0 ml) was added dropwise and stirred for 22 hours at room temperature.",chloroform | ammonia | 2-trichlorogermylethanesulfonylchloride | chloroform
US20150099277A1,"To a stirred solution of 1,3,4,6-tetra-O-acety-N-Boc-D-mannosamine (70.0 mg, 0.16 mmol) in CH2Cl2 (2.0 mL) at room temperature was added CF3COOH (0.5 mL). The reaction solution was stirred for 2.0 hours at room temperature and then evaporated to afford 1,3,4,6-tetra-O-acety-D-mannosamine TFA salt. This product could be stained by ninhydrin and formed a red colored spot on the TLC plate which indicated that the product possessed a free —NH2 group. 1,3,4,6-tetra-O-acety-D-mannosamine TFA salt was dissolved in CH2Cl2, after adding Et3N (32 mg, 0.32 mmol), and DMAP (3.9 mg, 0.032). Methyl cyclopropene acid chloride[1] (4.0 mg, 0.312 mmol) was added and the resulting solution was stirred for 30 minutes at room temperature. LC-MS showed the reaction was finished, and the reaction solution was evaporated to afford the crude product. The crude product was purified by preparative TLC (Hexanes:EtOAc=1:1) to afford 40 mg compound as a white foam, in 60% yield.","1,3,4,6-tetra-O-acety-N-Boc-D-mannosamine | CH2Cl2 | CF3COOH | 1,3,4,6-tetra-O-acety-D-mannosamine TFA salt"
US06562811B1,"To a cooled solution of tert-butyl 2-amino-4-[1-(tert-butoxycarbonyl)-3-piperidinyl]-6-{2-(cyclopropylmethoxy)-6-[(4-methoxybenzyl)oxy]phenyl}nicotinate (4.9 g, 7.426 mmol) in tetrahydrofuran (60 mL) was added dropwise Vitride® (10 mL) under an argon atmosphere. The stirring was continued at 0° C. for 1 hr. After quenched by saturated aqueous NH4Cl solution, saturated aqueous potassium sodium tartrate was added to the mixture, then the mixture was stirred vigorously. The mixture was extracted with ethyl acetate, washed with water and brine, dried over MgSO4, filtered, and concentrated under reduced pressure to give tert-butyl 3-[2-amino-6-{2-(cyclopropylmethoxy)-6-[(4-methoxybenzyl)oxy]phenyl}-3-(hydroxymethyl)-4-pyridinyl]-1-piperidinecarboxylate, which was used for the next step without further purification (4.38 g, yield; quant.).",tert-butyl 2-amino-4-[1-(tert-butoxycarbonyl)-3-piperidinyl]-6-{2-(cyclopropylmethoxy)-6-[(4-methoxybenzyl)oxy]phenyl}nicotinate | tetrahydrofuran | Vitride | argon | NH4Cl | potassium sodium tartrate | ethyl acetate | water | brine | MgSO4 | tert-butyl 3-[2-amino-6-{2-(cyclopropylmethoxy)-6-[(4-methoxybenzyl)oxy]phenyl}-3-(hydroxymethyl)-4-pyridinyl]-1-piperidinecarboxylate
US20140187542A1,"A crude product of 2-Fluoro-3-(7-methoxy-2-oxoquinoxalin-1(2H)-yl)propanol (196 mg) and 6-(4-amino-2-oxopyrrolidin-1-yl)-2H-1,4-benzoxazin-3(4H)-one (Reference Example 6; 147 mg, 0.595 mmol) were dissolved in a mixed solution of dichloromethane (20 ml) and N,N-dimethylformamide (2 ml). Acetic acid (0.068 ml, 1.190 mmol) and anhydrous sodium sulfate (300 mg) were added to the solution at room temperature and the mixture was stirred for 14 hours. Sodium triacetoxyborohydride (252 mg, 1.190 mmol) was added to the reaction solution, the mixture was stirred for 4 hours and then the solvent was removed under reduced pressure. A lower layer solvent of chloroform/methanol/water (7:3:1) was added to the residue and the resultant was alkalized by adding saturated sodium bicarbonate water under cooling on ice. The mixture was extracted with a lower layer solvent of chloroform/methanol/water (7:3:1), the extract was dried over anhydrous sodium sulfate and the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (chloroform/methanol) and preparative thin layer chromatography (silica gel, chloroform/methanol=20:1) to yield 50 mg (18%) of the title compound in the form of a white solid.","crude product | 2-Fluoro-3-(7-methoxy-2-oxoquinoxalin-1(2H)-yl)propanol | 6-(4-amino-2-oxopyrrolidin-1-yl)-2H-1,4-benzoxazin-3(4H)-one | dichloromethane | N,N-dimethylformamide | Acetic acid | sodium sulfate | Sodium triacetoxyborohydride | chloroform/methanol/water | chloroform/methanol | sodium bicarbonate water | ice | chloroform/methanol/water | chloroform/methanol | sodium sulfate | silica gel | silica gel | title compound"
US20130090298A1,"To a solution of indoline 75 (8.5 g, 44.2 mmol) in MeOH (150 mL) was added α-D-glucose (27 g, 146 mmol) at room temperature. The mixture was stirred at 70° C. for 60 h, cooled to room temperature and concentrated in vacuo to remove solvent. The residue was purified by silica column chromatography to provide the titled compound 76 (13.7 g, 88%). MH+ 354.",indoline | MeOH | α-D-glucose | silica | titled compound 76
US07951958B2,"2-Methyl-2-(4-nitro-imidazol-1-yl)-propionaldehyde was reacted with dimethyl amine to provide the title compound: H1 NMR (400 MHz, CDCl3) 1.50 (s, 6H), 2.00 (s, 6H), 2.40 (s, 2H), 7.55 (s, 1H), 7.89 (s, 1H).",2-Methyl-2-(4-nitro-imidazol-1-yl)-propionaldehyde | dimethyl amine | title compound
US20130210802A1,"A mixture of methyl 3-amino-1-methyl-1H-pyrazole-5-carboxylate (155 mg, 0.999 mmol), 8-bromo-6-chloroimidazo[1,2-a]pyridine hydrochloride salt (268 mg, 1.00 mmol), 2,2′-bis(diphenylphosphino)-1,1′-binaphthalene (135 mg, 0.216 mmol) and cesium carbonate (997 mg, 3.05 mmol) in toluene (5 mL) and 1,4-dioxane (5 mL) was sparged with nitrogen while stirring for 10 min. Palladium(II) acetate (25 mg, 0.11 mmol) was then added and the reaction stirred at reflux for 18 h. After this time, the reaction was cooled to room temperature, diluted with a mixture of 1:1 ethyl acetate/water (100 mL) and filtered through diatomaceous earth. The filtrate was concentrated under reduced pressure and the resulting residue purified by chromatography (silica, gradient, heptane to 3:7 heptane/ethyl acetate) to afford methyl 3-(6-chloroimidazo[1,2-a]pyridin-8-ylamino)-1-methyl-1H-pyrazole-5-carboxylate as a brown solid: 1H NMR (400 MHz, DMSO-d) 9.37 (s, 1H), 8.24 (d, J=1.6 Hz, 1H), 7.89 (d, J=1.2 Hz, 1H), 7.73 (d, J=1.6 Hz, 1H), 7.55 (d, J=1.2 Hz, 1H), 6.72 (s, 1H), 4.06 (s, 3H), 3.84 (s, 3H); ESI MS m/z 306.2 [M+H]+.","methyl 3-amino-1-methyl-1H-pyrazole-5-carboxylate | 8-bromo-6-chloroimidazo[1,2-a]pyridine hydrochloride salt | 2,2′-bis(diphenylphosphino)-1,1′-binaphthalene | cesium carbonate | toluene | 1,4-dioxane | nitrogen | Palladium(II) acetate | ethyl acetate/water | silica | heptane | heptane/ethyl acetate | methyl 3-(6-chloroimidazo[1,2-a]pyridin-8-ylamino)-1-methyl-1H-pyrazole-5-carboxylate"
US06620977B1,"(S)-1-Trityloxy-2,4-butanediol (1.64 g, 4.7 mmol) and imidazole (0.321 g, 4.715 mmol) were dissolved in DMF (20 ml) and the solution was cooled to 0° C. To the solution was dropped tert-butyldimethylsilyl chloride (0.5 ml, 1.44 mmol, 50% in toluene). After stirring for 1 hour, again to the solution was dropped tert-butyldimethylsilyl chloride (0.5 ml, 1.44 mmol) and the solution was stirred for 1 hour. Further tert-butyldimethylsilyl chloride (0.6 ml, 1.73 mmol) was added to the solution and the solution was stirred over night at room temperature. After dilution with toluene (100 ml), the solution was washed with water (100 ml) twice and saturated brine once, dried on magnesium sulfate, filtered and condensed in vacuo. The residue was subjected to silica gel chromatography to give (S)-4-tert-butyldimethylsilyloxy-1-trityloxy-2-butanol (1.80 g, yield 82.6%).","(S)-1-Trityloxy-2,4-butanediol | imidazole | DMF | tert-butyldimethylsilyl chloride | toluene | tert-butyldimethylsilyl chloride | tert-butyldimethylsilyl chloride | water | brine | magnesium sulfate | (S)-4-tert-butyldimethylsilyloxy-1-trityloxy-2-butanol"
US08541425B2,"Dimethyl 3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]pentanedioate (43.0 g, 0.0908 mol) was dissolved in methanol (271.2 mL, 6.695 mol) and lithium hydroxide monohydrate (15 g, 0.36 mol) dissolved in water (125 mL) was added. The reaction was stirred at rt for 2 h. The methanol was removed in vacuo and a resulting aqueous layer was cooled in an ice bath. The solution was made acidic pH-4 with 1N HCl to give a white precipitate. The solid precipitate was collected, washed with water, dried to give 3-[4-(7-[2-(trimethylsilyl)ethoxy]methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]pentanedioic acid as a white crystalline powder (31.8 gm, 80%), LC/MS (M+H)+: 446, 1H NMR (DMSO-d6) δ 8.85s 1H), 8.75 (s, 1H), 8.42 (s, 1H), 7.85 (d, 1H), 7.17 (d, 1H), 5.71 (s, 2H), 5.18 (m, 1H), 3.65 (t, 2H), 3.05 (m, 4H), 0.92 (t, 2H), 0.1 (s, 9H).","Dimethyl 3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]pentanedioate | methanol | lithium hydroxide monohydrate | water | methanol | ice | water | 3-[4-(7-[2-(trimethylsilyl)ethoxy]methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]pentanedioic acid"
US08440710B2,"A solution of 0.251 g (0.89 mmol) 2-(4-cyclopropyl-phenyl)-8-methylene-2-aza-spiro[4.5]decan-1-one in 3 mL DCM was added at 0° C. to a solution of 0.157 g (0.91 mmol) m-chloroperbenzoic acid and 0.098 mg (1.1 mmol) NaHCO3 in 3 mL DCM and allowed to stir to room temperature and continued for another hour at room temperature. The mixture was poured onto water and extracted with DCM. The combined organic phases were dried with MgSO4, filtered and evaporated. The title compound (0.312 g) was used in the consecutive step without further purification. MS (m/e): 298.8 [MH+].",2-(4-cyclopropyl-phenyl)-8-methylene-2-aza-spiro[4.5]decan-1-one | DCM | m-chloroperbenzoic acid | NaHCO3 | DCM | water | DCM | MgSO4 | title compound
US07173045B2,"In a water separator, 5-fluoroindole (5.0 g, 37 mmol.), δ-valerolactone (3.83 ml, 42 mmol.), potassium hydroxide (3.09 g, 55 mmol.) in p-cymene (120 ml) were heated to boiling, with stirring. The water separation was stopped after 80 h. For working up, water (50 ml) was added to the mixture at RT and stirring was carried out for 30 min. The phases were then separated in a separating funnel. The aqueous phase was washed with ether (3×20 ml), adjusted to pH 1 with 2M HCl and extracted with ether (5×25 ml). The combined extracts were washed with water (5×10 ml), dried, filtered and concentrated. The residue was purified by flash chromatography on silica gel (375 g) (eluant: 2700 ml of cyclohexane/EE 4:1 followed by 1500 ml of cyclohexane/EE 1:1 and 650 ml of EE). 1.9 g of 5-(5-fluoro-1H-indol-3-yl)pentanoic acid were obtained (beige solid, m.p. 86–92° C.).",water | 5-fluoroindole | δ-valerolactone | potassium hydroxide | p-cymene | water | water | ether | ether | water | silica gel | cyclohexane | cyclohexane | 5-(5-fluoro-1H-indol-3-yl)pentanoic acid
US03975411,"2.6 Grams (0.01 mol) of 5-nitrotetrahydroanthraquinone, 52 grams (0.032 mol) of a 2.5% aqueous sodium hydroxide solution and 0.07 gram of a Raney nickel catalyst were placed in an electromagnetic agitation-type autocalve with an inner volume of 160 ml, followed by hydrogenation while agitating under a pressure of 3 to 6 kg/cm2G at room temperature. The hydrogenation reaction proceeded smoothly. 6 Hours after commencement of the reaction, 0.02 mol of hydrogen was absorbed and the absorption was stopped. Then, the hydrogen in the reaction system was replaced by nitrogen and the resultant reaction solution was filtered in a flow of nitrogen for separating the catalyst therefrom. Air was passed into the resultant filtrate for oxidation to obtain 2.1 grams of 1-aminoanthraquinone (at a yield of 93.1%). The purity was 97%.",5-nitrotetrahydroanthraquinone | sodium hydroxide | Raney nickel | hydrogen | nitrogen | 1-aminoanthraquinone
US07557127B2,"A mixture of (2E)-3-(5-{[(3R)-1-cyclohexyl-3-piperidinyl]amino}-2-pyrazinyl)acrylic acid (209 mg), 0-(tetrahydro-2H-pyran-2-yl)-mL) hydroxylamine (89 mg), HOBt (111 mg) and EDCI (158 mg) in DMF (4.5 mL) was stirred at 0° C. for 1 hr and the mixture was stirred at ambient temperature for 18 hrs. The reaction mixture was evaporated in vacuo and the residue was partitioned between saturated sodium bicarbonate solution and EtOAc. The organic layer was separated, washed water and brine, dried over magnesium sulfate, and evaporated in vacuo. The residue was purified by silica gel column chromatography (chloroform-MeOH=95-5) to give (2E)-3-(5-{[(3R)-1-cyclohexyl-3-piperidinyl]amino}-2-pyrazinyl)-N-(tetrahydro-2H-pyran-2-yloxy)acrylamide (198 mg) as an amorphous powder.",(2E)-3-(5-{[(3R)-1-cyclohexyl-3-piperidinyl]amino}-2-pyrazinyl)acrylic acid | 0-(tetrahydro-2H-pyran-2-yl) | hydroxylamine | HOBt | EDCI | DMF | sodium bicarbonate | EtOAc | water | brine | magnesium sulfate | silica gel | chloroform-MeOH | (2E)-3-(5-{[(3R)-1-cyclohexyl-3-piperidinyl]amino}-2-pyrazinyl)-N-(tetrahydro-2H-pyran-2-yloxy)acrylamide
US05840732,"To a solution of 0.40 g (0.722 mmol) of 7-[4-(3-dimethylaminomethylimidazo[1,2-a]pyridin-5-ylthio)butyl]-1,1-dioxo-9-phenyl-3,4-dihydro-2H,6H-pyrimido[6,1-b][1,3]thiazine-6,8(7H)-dione in 10 ml of methanol, 0.18 ml (2.2 mmol) of concentrated hydrochloric acid was added. After the reaction mixture was concentrated to dryness, the residue was washed with diethyl ether to yield 0.36 g (79.5%, light white foamy substance) of the desired product.","7-[4-(3-dimethylaminomethylimidazo[1,2-a]pyridin-5-ylthio)butyl]-1,1-dioxo-9-phenyl-3,4-dihydro-2H,6H-pyrimido[6,1-b][1,3]thiazine-6,8(7H)-dione | methanol | hydrochloric acid | diethyl ether | desired product"
US06331637B1,"N-14-bromo-3-methyl-5-isoxazolyl)-5-(1-naphthyl)thiophene-sulfonamide N-(4-bromo-3-methyl-5-isoxazolyl)-5-(1-naphthyl)thiophene-sulfonamide was prepared in the same manner as described in Example 2. Reaction of 2-chlorosulfonyl-5-(1-naphthyl)thiophene (200 mg, 0.65 mmol) with 5-amino-4-bromo-3-methylisoxazole (0.65 mmol), after purification by column chromatography using 1% MeOH/CHCl3, gave 65.3 mg of pure N-(4-bromo-3-methyl-5-isoxazolyl)-5-(1-naphthyl)thiophene-sulfonamide as a brown solid, (22% yield, m.p. 118° C.).",N-14-bromo-3-methyl-5-isoxazolyl | 5-(1-naphthyl)thiophene-sulfonamide N-(4-bromo-3-methyl-5-isoxazolyl)-5-(1-naphthyl)thiophene-sulfonamide | N-(4-bromo-3-methyl-5-isoxazolyl)-5-(1-naphthyl)thiophene-sulfonamide | 2-chlorosulfonyl-5-(1-naphthyl)thiophene | 5-amino-4-bromo-3-methylisoxazole
US08759535B2,"2-(6-Chloro-benzothiazol-2-ylamino)-1-methyl-1H-benzoimidazole-5-carboxylic acid (2-methoxy-ethyl)-amide (51 mg) was prepared by following General Procedure F starting from 2-(6-chloro-benzothiazol-2-ylamino)-1-methyl-1H-benzo-imidazole-5-carboxylic acid (90 mg), 2-methoxyethylamine (21 mg), HBTU (114 mg), and DIEA (66 uL). LC/MS: m/z 416.8. 1H NMR (DMSO-d6, 400 MHz): δ 12.36 (bs, 1H), 8.46 (s, 1H), 8.06 (s, 1H), 7.91 (s, 1H), 7.75 (s, 1H), 7.64 (s, 1H), 7.46 (d, 1H), 7.38 (dd, 1H), 3.62 (bs, 3H), 3.50-3.39 (m, 4H), 3.27 (s, 3H).",2-(6-Chloro-benzothiazol-2-ylamino)-1-methyl-1H-benzoimidazole-5-carboxylic acid (2-methoxy-ethyl)-amide | 2-(6-chloro-benzothiazol-2-ylamino)-1-methyl-1H-benzo-imidazole-5-carboxylic acid | 2-methoxyethylamine | HBTU | DIEA
US08003785B2,"A mixture of 0.0605 g (0.20 mmole) 2-chloro-9-cyclobutyl-7,7-difluoro-5-methyl-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one (VII-1), 0.0571 g (0.30 mmole) of toluenesulfonic acid monohydrate, 0.0501 g (0.20 mmole) of 4-amino-3-methoxy-N-(tetrahydro-2H-pyran-4-yl) benzamide and 1 mL of isopropanol was heated in a sealed vessel at 140 degrees for 19.5 hours, cooled and concentrated under reduced pressure. The residue taken up in ethyl acetate and washed successively with 50 mL of saturated aqueous sodium bicarbonate, 50 mL of water, 50 mL of brine. The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was recrystallized from acetonitrile-methanol to give 0.0452 g 4-(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-N-(tetrahydro-pyran-4-yl)-benzamide (I-7).","2-chloro-9-cyclobutyl-7,7-difluoro-5-methyl-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one | toluenesulfonic acid monohydrate | 4-amino-3-methoxy-N-(tetrahydro-2H-pyran-4-yl) benzamide | isopropanol | sodium bicarbonate | water | brine | sodium sulfate | acetonitrile-methanol | 4-(9-cyclobutyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-N-(tetrahydro-pyran-4-yl)-benzamide"
US06605626B2,"Using the procedure described in Example 93, Part A, 4-tert-butylbenzoyl chloride (0.81 mmol) and 2-amino-N-(4-methoxyphenyl)-3-methoxybenzamide (0.73 mmol) yielded 0.18 g (57%) of the title compound.",4-tert-butylbenzoyl chloride | 2-amino-N-(4-methoxyphenyl)-3-methoxybenzamide | title compound
US07705023B2,The title compound was prepared in accordance with Example 1 using 5-(4-tert-butylphenyl)indole-2-carboxylic acid ethyl ester and 2-(4-bromophenoxy)-2-methylpropan-1-ol.,title compound | 5-(4-tert-butylphenyl)indole-2-carboxylic acid ethyl ester | 2-(4-bromophenoxy)-2-methylpropan-1-ol
US07662831B2,"A solution of 2-nitro-8-oxo-5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinoline (0.17 g, 0.60 mmol; prepared in Example 23, Step 1) in dioxane (5 mL) is added dropwise to a refluxing slurry of LiAlH4 (0.24 g, 6 mmol) in dioxane (20 mL). The reaction mixture was refluxed overnight. After cooling to ambient temperature, the mixture was poured onto ice water and extracted with ethyl acetate. The combined organic extracts were dried over MgSO4 and concentrated to give 0.11 g of 5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinolin-2-amine.","2-nitro-8-oxo-5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinoline | dioxane | LiAlH4 | dioxane | ice water | ethyl acetate | MgSO4 | 5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinolin-2-amine"
US20150197530A1,"In a flask placed under an argon flow, were introduced with magnetic stirring: 20 ml of dichloromethane, 0.5 g (2.237 mmol) of 2-(4-fluorophenyl)-3-methylthiophene, 0.265 ml (2.68 mmol) of 2-furoyl chloride. The obtained mixture was cooled to 5° C. before adding portion wise 0.328 g (2.46 mmol) of trialuminium chloride. The mixture was stirred at r.t. for 16 h before being poured onto 150 ml of a mixture consisting of water and of dichloromethane (2/1, v/v) and being stirred at r.t. for 30 min. This mixture was filtered on celite. After separation, the aqueous phase was extracted with 50 ml of dichloromethane, the combined organic phases were washed with 50 ml of water and then dried on MgSO4 which was then removed by filtration. The obtained filtrate was concentrated in vacuo. The crude residue was purified by flash chromatography on a silica gel cartridge (eluent: petroleum ether/ethyl acetate gradient), from 100 to 75% of petroleum ether, v/v). 0.58 g (yield=89%) of (5-(4-fluorophenyl)-4-methylthiophen-2-yl)(furan-2-yl)methanone as a foam. LC-MS: m/z=287 (MH+); UV purity at 254 nm=88%. 1H NMR (300 MHz, DMSO) δ 8.13 (dd, J=1.6, 0.7 Hz, 1H), 8.09 (s, 1H), 7.62 (ddd, J=6.3, 4.2, 3.0 Hz, 3H), 7.36 (t, J=8.9 Hz, 2H), 6.83 (dd, J=3.6, 1.7 Hz, 1H), 2.34 (s, 3H).",argon | dichloromethane | 2-(4-fluorophenyl)-3-methylthiophene | 2-furoyl chloride | mixture | trialuminium chloride | water | dichloromethane | dichloromethane | water | MgSO4 | crude residue | silica gel | petroleum ether/ethyl acetate | petroleum ether | (5-(4-fluorophenyl)-4-methylthiophen-2-yl)(furan-2-yl)methanone
US08618119B2,"1.0 g (3.04 mmol) of 7-amino-2,4-dioxo-5-phenyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile [Assy, M. G. et al., J. Indian Chem. Soc. 1996, 73 (11), 623-624] was dissolved in 8 ml of DMSO, 0.82 ml (713 mg, 6.09 mmol) of isopentyl nitrite and 818 mg (6.09 mmol) of copper(II) chloride were added and the mixture was stirred at 80° C. overnight. The reaction mixture was cooled, and 6 ml of 1 N hydrochloric acid solution followed by 100 ml of water were then added. The precipitate formed was filtered off and dried under high vacuum. The product was not purified any further (purity according to LC-MS: about 82%).","7-amino-2,4-dioxo-5-phenyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile | DMSO | isopentyl nitrite | copper(II) chloride | hydrochloric acid | water"
US06677368B2,"2-[4-(3-Fluoro-phenyl)-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-5-methyl-1H-pyrrole-3-carboxylic acid (90.5 mg) was coupled with C-(1-methyl-piperidin-4-yl)-methylamine (1.5 eq.), HOBt (1 eq.), EDC (1.5 eq.) and TEA (3 drops) in THF (2 mL), DMF (0.3 mL) at rt for overnight to give 65 mg (55%) of the titled compound as a yellow solid.","2-[4-(3-Fluoro-phenyl)-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-5-methyl-1H-pyrrole-3-carboxylic acid | C-(1-methyl-piperidin-4-yl)-methylamine | HOBt | EDC | TEA | THF | DMF | titled compound"
US07935699B2,"In a round bottom flask under argon was placed triphenylphosphine (120 mg, 0.46 mmol) and methylene chloride (10 mL) and it was cooled to 0° C. in an ice bath. To this was added N-bromosuccinimide (81 mg, 0.46 mmol) and it was stirred for 15 minutes at 0° C. To this was then added 3-cyclopentyl-2(R)-(3,4-dichloro-phenyl)-propionic acid (prepared as in PCT WO 2002/046173 A1, Example 3, 100 mg, 0.35 mmol) and it was stirred for an additional 5 minutes at 0° C. and then warmed to 25° C. and stirred for 10 minutes. The solution was recooled to 0° C. and then 1-methyl-1H-pyrazol-3-ylamine (68 mg, 0.70 mmol) in methylene chloride (500 μL) and 2,6-lutidine (160 μL, 1.4 mmol) were added to the flask and it was stirred at 0° C. and then warmed to 25° C. and stirred for 2.5 h. After this time the reaction was diluted with methylene chloride and then washed with an aqueous 1 N hydrochloric acid solution and saturated aqueous brine solution. Flash chromatography using Biotage system (40S column, Silica gel, 50% ethyl acetate/hexanes) provided a white foam, this material was then lyophilized to afford 3-cyclopentyl-2(R)-(3,4-dichloro-phenyl)-N-(1-methyl-1H-pyrazol-3-yl)-propionamide (62 mg, 48%) as a white powder: [α]27589=−15.6° (c=0.27, methanol); ES-HRMS m/e calcd for C18H21N30Cl2 (M+H)+ 366.1135, observed 366.1135; 1H NMR (300 MHz, DMSO-d6) δ ppm 1.01-1.19 (m, 2H, CH2), 1.34-1.80 (m, 8H, 4×CH2), 1.95-2.14 (m, 1H, CH), 3.70 (s, 3H, NCH3), 3.79 (dd, J=8.6, 6.0 Hz, 1H, ArCH), 6.30-6.44 (m, 1H, Ar), 7.34 (dd, Jo=8.4 Hz, Jm=1.3 Hz, 1H, Ar), 7.51 (d, Jm=1.3 Hz, 1H, Ar), 7.54-7.65 (m, 2H, Ar), 10.66 (s, 1H, NH).","argon | triphenylphosphine | methylene chloride | ice | N-bromosuccinimide | 3-cyclopentyl-2(R)-(3,4-dichloro-phenyl)-propionic acid | 1-methyl-1H-pyrazol-3-ylamine | methylene chloride | 2,6-lutidine | methylene chloride | hydrochloric acid | brine | 3-cyclopentyl-2(R)-(3,4-dichloro-phenyl)-N-(1-methyl-1H-pyrazol-3-yl)-propionamide"
US05292720,"The 1,1,2,3,3,4-hexamethyl-6-methoxyindane (10.8 g) is then heated with copper(II) sulfate pentahydrate (18.04 g) and potassium peroxydisulfate (60.55 g) in acetonitrile and water (1:1, 500 ml) at reflux for about 15 to 20 minutes, following procedures similar to those described in Hauser et al., Synthesis, pp. 723-724 (1987). The mixture is then cooled to room temperature and methylene chloride (150 ml) is added. The layers are separated and the aqueous phase is further extracted with additional methylene chloride (2×70 ml). The combined organic solutions are dried with anhydrous sodium sulfate, filtered, and evaporated at reduced pressure to yield 5-formyl-1,1,2,3,3,4-hexamethyl-6-methoxyindane.","1,1,2,3,3,4-hexamethyl-6-methoxyindane | copper(II) sulfate pentahydrate | potassium peroxydisulfate | acetonitrile | water | methylene chloride | methylene chloride | sodium sulfate | 5-formyl-1,1,2,3,3,4-hexamethyl-6-methoxyindane"
US20150291572A1,"To a stirred solution of 5-bromo-3-chloro-2-(4-methyl-4-((3-(trifluoromethyl)phenyl)sulfonyl)tetrahydrofuran-2-yl)pyridine (1.6 g, 3.30 mmol, 1 eq) in DMSO (30 mL) was added sodium methanesulfinate (404 mg, 3.96 mmol, 1.2 eq), and L-proline sodium salt (90 mg, 0.661 mmol, 0.2 eq) and the mixture was degassed with N2 for 10 min. CuI (62 mg, 0.330 mmol, 0.1 eq) was added and the RM was heated to 100° C. for 16 h in a sealed tube. After completion of reaction (monitored by TLC), the reaction mass was diluted with H2O (75 mL), extracted with EtOAc (2×75 mL), organic layer was washed with H2O (60 mL), brine (60 mL), dried over anhydr. Na2SO4, filtered and the solvent was evaporated under reduced pressure to get crude product which was further purified by CC to afford 3-chloro-2-(4-methyl-4-((3-(trifluoromethyl)phenyl)sulfonyl)tetrahydrofuran-2-yl)-5-(methylsulfonyl)pyridine as a mixture of diastereoisomers. Diastereomers were separated by reverse phase prep HPLC to give trans isomer (600 mg) and cis isomer (100 mg) and the relative configuration of both isomers was confirmed by NOE experiment.",5-bromo-3-chloro-2-(4-methyl-4-((3-(trifluoromethyl)phenyl)sulfonyl)tetrahydrofuran-2-yl)pyridine | DMSO | sodium methanesulfinate | L-proline sodium salt | N2 | CuI | H2O | EtOAc | H2O | brine | Na2SO4 | crude product | 3-chloro-2-(4-methyl-4-((3-(trifluoromethyl)phenyl)sulfonyl)tetrahydrofuran-2-yl)-5-(methylsulfonyl)pyridine
US08859768B2,"To a solution of ethyl 2,5-dibromo-3-furoate (0.21 g, 0.722 mmol) in 1,4-dioxane (2.2 mL) and water (0.50 mL) were added tetrakis(triphenylphosphine) palladium(0) (0.08 g, 0.07 mmol), N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]acetamide (0.19 g, 0.72 mmol) and cesium carbonate (0.71 g, 2.2 mmol). The reaction mixture was subjected to microwave irradiation at 95° C. for 15 min. The reaction mixture was diluted with water (10 mL) and extracted with EtOAc. The organic solutions were combined, washed with brine, dried over Na2SO4, filtered and concentrated. The residue was purified by column chromatography to give ethyl 5-[2-(acetylamino)pyridin-4-yl]-2-bromo-3-furoate (0.035 g, 14%) as a white solid. LCMS (FA): m/z=339.1 (M+H).","ethyl 2,5-dibromo-3-furoate | 1,4-dioxane | water | tetrakis(triphenylphosphine) palladium(0) | N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]acetamide | cesium carbonate | water | EtOAc | brine | Na2SO4 | ethyl 5-[2-(acetylamino)pyridin-4-yl]-2-bromo-3-furoate"
US09309254B2,"To a stirred solution of 3-amino-1-methyl-3-prop-2-ynyl-pyrrolidin-2-one (which may be prepared as described in Description 3) (2.3 g, 15.11 mmol) in tert-butyl methyl ether (50 mL) was added 2-iodo-4-methyl-6-[4-(trifluoromethyl)-phenyl]pyrimidine (which may be prepared as described in Description 12) (6.05 g, 16.62 mmol). diisopropylamine (6.35 mL, 45.34 mmol) was then added, followed by copper iodide (57.56 mg, 0.300 mmol) and bis(triphenylphosphine)palladium (II) dichloride (106.07 mg, 0.1500 mmol). The reaction was then stirred at room temperature for 5 days. The reaction mixture was transferred to a separating funnel and the flask washed with an additional quantity of tert-butyl methyl ether (15 ml). The organic solution was washed with water (2×50 mL) and brine (50 mL). The organic phase was dried over magnesium sulphate, filtered, and then the magnesium sulphate washed with dichloromethane (30 ml). The filtrate was concentrated at reduced pressure to give a yellow foam. The product was purified by silica gel chromatography eluting with ethyl acetate followed by an increasing percentage of a solution of 10% 0.880 ammonia in methanol, to give the title compound (D14b) as a yellow foam (4.71 g). This racemate was consistent by NMR and mass spectroscopy with the R isomer prepared in Description 14.",3-amino-1-methyl-3-prop-2-ynyl-pyrrolidin-2-one | tert-butyl methyl ether | 2-iodo-4-methyl-6-[4-(trifluoromethyl)-phenyl]pyrimidine | diisopropylamine | copper iodide | bis(triphenylphosphine)palladium | tert-butyl methyl ether | water | brine | magnesium sulphate | magnesium sulphate | dichloromethane | silica gel | ethyl acetate | title compound
US04272449,"To a solution of 4.25 g (20 mmol) of 2-(4-chlorophenyl)-3-methylbutanoic acid in 30 ml of ether containing one drop of N,N-dimethylformamide is added dropwise 3.81 g (30 mmol) of oxalyl chloride. The solution is stirred at RT until gas evolution ceases. The solvent and excess oxalyl chloride are removed in vacuo and the residue is taken up in 30 ml of ether. This solution is then added dropwise at 0°-5° to 4.86 g (40 mmol) of a 14% w/w aqueous solution of ammonia. After stirring the mixture for 30 minutes at 0°-5°, the aqueous layer is removed. The ethereal solution is washed with water, dried over sodium sulfate, filtered and concentrated in vacuo to obtain 2-(4-chlorophenyl)-3-methylbutyramide.","2-(4-chlorophenyl)-3-methylbutanoic acid | ether | N,N-dimethylformamide | oxalyl chloride | oxalyl chloride | ammonia | water | sodium sulfate | 2-(4-chlorophenyl)-3-methylbutyramide"
US20050192277A1,"A solution of Example 67A (0.5 g, 1.8 mmol) in acetone (10 mL) and p-toluenesulfonic acid monohydrate (0.51 g, 2.7 mmol) was stirred for 45 minutes, diluted with CH2Cl2 (150 mL), washed with cold aqueous sodium bicarbonate (2×100 mL, 10% solution), water (2×100 mL), dried (Na2SO4), filtered and concentrated under reduced pressure. The residue was purified on silica using CH2Cl2 to give the titled compound (0.41 g, 87%). 1H NMR (CDCl3): 2.95 (m, 2H), 3.65 (m, 3H), 6.82 (d, J=7 Hz, 1H), 7.40 (m, 2H), 7.62 (m, 4H), 9.55 (d, J=7 Hz, 1H); MS (DCI) 263 (M+), 281 (M+NH4).",acetone | p-toluenesulfonic acid monohydrate | CH2Cl2 | sodium bicarbonate | water | Na2SO4 | silica | titled compound
US07928080B2,"2,5,6-Trichloro-3-formyl-1-(β-D-ribofuranosyl)indole (4.3, 109 mg, 0.29 mmol) was dissolved in MeOH (5 mL) to which was added acethydrazine (85 mg, 1.1 mmol). The resulting solution was heated on a 45 C oil bath for 16 h, then cooled to room temperature and poured into 15 mL of water. The resulting suspension was cooled to 4 C, then filtered and the solids rinsed with cold water (25 mL). The solids were dissolved in DMF (0.5 mL) and subjected to column chromatography (40×350 mm) on C18-reverse phase silica gel with 75% MeOH/H2O. Fractions containing product were pooled and evaporated to yield a white crystalline solid, which was recrystallized from acetone/MeOH to yield 70 mg (56%) of 4.32 as a white microcrystalline solid which is an inseparable mixture of isomers in a ratio of 60:40: mp 270-271 C; Rf 0.2 (10% MeOH/CHCl3); 1H-NMR (500 MHz, DMSO-d6): (major isomer) δ 11.25 (s, 1H, D2O exch.), 8.56 (s, 1H), 8.27 (s, 1H), 8.18 (s, 1H), 5.94 (d, 1H), 5.40-5.36 (m, 2H, D2O exch.), 5.25 (d, 1H, D2O exch.), 4.42 (q, 1H), 4.13 (s, 1H), 3.98 (s, 1H), 3.70 (s, 2H), 2.24 (s, 3H); (minor isomer) δ 11.41 (s, 1H, D2O exch.), 8.56 (s, 1H), 8.44 (s, 1H), 8.32 (s, 1H), 5.94 (d, 1H), 5.40-5.36 (m, 2H, D2O exch.), 5.25 (d, 1H, D2O exch.), 4.42 (q, 1H), 4.13 (s, 1H), 3.98 (s, 1H), 3.70 (s, 2H), 1.95 (s, 3H). 13C-NMR (125 MHz, DMSO-d6): (major isomer) δ 171.39, 135.98, 133.15, 129.73, 126.01, 124.96, 123.86, 121.69, 115.41, 108.31, 88.78, 86.09, 71.41, 69.66, 61.10, 20.36; (minor isomer) δ 165.24, 138.70, 133.12, 129.82, 126.06, 124.96, 123.99, 122.17, 115.33, 108.51, 88.78, 86.09, 71.41, 69.66, 61.10, 21.67. HRMS (ES) m/z calcd. for C16H16Cl3N3O5.Na 458.0053, found 458.0043. Anal calcd for C16H16Cl3N3O5: C, 44.01; H, 3.69; N, 9.62. Found: C, 43.76; H, 3.75; N, 9.67.","2,5,6-Trichloro-3-formyl-1-(β-D-ribofuranosyl)indole | MeOH | acethydrazine | water | water | DMF | acetone/MeOH | 4.32"
US20110136797A1,"A solution of (4-morpholin-4-ylmethyl-phenyl)-piperazin-1-yl-methanone (0.128 g) in methanol (7.5 mL) was treated with (1-ethoxy-cyclopropoxy)-trimethyl-silane (1.5 mL), acetic acid (0.2 mL), and NaBH3CN (˜400 mg). The mixture was heated at 60° C. for 18 h, and then was cooled to rt and concentrated. The residue was diluted with 1 N NaOH and extracted with CH2Cl2. The organic layer was dried (Na2SO4) and concentrated. The residue was purified by column chromatography (SiO2) to give the title compound (0.0548 g, 38%). MS (ESI): mass calcd. for C19H27N3O2, 329.21; m/z. found, 330.4 [M+H]+. 1H NMR (CDCl3): 7.36 (s, 4H), 3.79-3.68 (m, 6H), 3.50 (s, 2H), 3.44-3.32 (m, 2H), 2.74-2.61 (m, 2H), 2.60-2.50 (s, 2H), 2.45-2.40 (m, 4H), 1.66-1.62 (m, 1H), 0.49-0.44 (m, 2H), 0.44-0.39 (m, 2H).",(4-morpholin-4-ylmethyl-phenyl)-piperazin-1-yl-methanone | methanol | (1-ethoxy-cyclopropoxy)-trimethyl-silane | acetic acid | NaBH3CN | NaOH | CH2Cl2 | Na2SO4 | SiO2 | title compound
US09079930B2,"To a solution of diethyl (S)-4-(1-(4-hydroxy-2-(pyridin-2-yl)pyrimidine-5-carboxamido)ethyl)phenylphosphonate, 3-6, (400 mg, 0.88 mmol) in DCM (10 ml) was added dropwisely TMSBr (2.0 g, 13.15 mmol) at 0° C. The reaction mixture was stirred at room temperature overnight. The reaction mixture was evaporated to dryness and the residue was treated with MeCN and water at room temperature. The resulting solid was collected via filtration to give the product, 3-7, (200 mg). 1H NMR (DMSO-d6, 300 MHz,): δ 10.71 (s, 4H), 9.93-9.96 (m, 1H), 8.80-8.81 (m, 1H), 8.56 (s, 1H), 8.37-8.39 (m, 1H), 8.08-8.13 (m, 1H), 7.61-7.74 (m, 3H), 7.42-7.46 (m, 2H), 5.12-5.17 (t, 1H), 2.07 (s, 1H), 1.49-1.51 (d, 3H).",diethyl (S)-4-(1-(4-hydroxy-2-(pyridin-2-yl)pyrimidine-5-carboxamido)ethyl)phenylphosphonate | DCM | TMSBr | MeCN | water
US06710054B2,"A mixture of 1-[4-(2-chloroethyl)phenyl]-2-ethyl-5-methoxy-1H-benzimidazole (step 5 of Example 71, 600 mg, 1.9 mmol) in 48% hydrobromic acid (60 mL) was stirred at 100° C. for 6 h. After cooling, the mixture was neutralized with 2N aqueous NaOH and extracted with ethyl acetate (100 mL). The organic layer was washed with brine (50 mL), dried (Na2SO4), and concentrated to afford 890 mg (quant.) of the title compound as pale yellow solids: 1H-NMR (CDCl3) δ 7.64 (4H, s), 7.16 (2H, m), 6.97-7.01 (1H, m), 3.86 (2H, t, J=7.1 Hz), 3.30 (2H, t, J=7.1 Hz), 2.92 (2H, q, J=7.8 Hz), 1.29 (3H, t, J=7.8 Hz).",1-[4-(2-chloroethyl)phenyl]-2-ethyl-5-methoxy-1H-benzimidazole | hydrobromic acid | NaOH | ethyl acetate | brine | Na2SO4 | title compound
US20100056502A1,"cis-4-tert-Butoxycarbonylamino-3-hydroxy-piperidine-1-carboxylic acid benzyl ester enantiomer 1 (for a synthesis see WO2004058144 Example 5(b)) (10.0 g, 28.5 mmol) was dissolved in dry dichloromethane (50 ml) and treated dropwise with TFA (25 ml). After stirring under argon for 1 h, the excess TFA was removed in vacuo and the residue partitioned between 10% methanol in DCM and water. Solid potassium carbonate was added until the aqueous layer was saturated, and the aqueous phase then washed with 10% methanol in DCM (×3). The combined organic layers were dried and evaporated to a white solid. (5.98 g). This material (5.75 g, 23 mmol) was dissolved in chloroform (100 ml) and methanol (100 ml), treated with 2,3-dihydro[1,4]dioxino[2,3-c]pyridine-7-carboxaldehyde (0.94 g, 5.7 mmole) (for a synthesis see WO2004058144, Example 2(c) or WO2003087098 Example 19(d)) (3.71 g, 22.5 mmol). 3A sieves were added and the reaction heated to 65° C. for 4 h. The reaction was cooled and treated with sodium triacetoxy borohydride (9.75, 46 mmol). After 15 min, the reaction was filtered through Kieselguhr and the filtrate concentrated in vacuo. The residues was partitioned between saturated sodium bicarbonate and 20% methanol in DCM. The aqueous layer was extracted with 20% methanol in DCM and the combined organic layers dried and evaporated. Chromatography of the residue on silica gel eluting with 0-5% methanol in DCM gave the title product (4.3 g, 46%)","cis-4-tert-Butoxycarbonylamino-3-hydroxy-piperidine-1-carboxylic acid benzyl ester | dichloromethane | TFA | argon | TFA | methanol | DCM | water | potassium carbonate | methanol | DCM | material | chloroform | methanol | 2,3-dihydro[1,4]dioxino[2,3-c]pyridine-7-carboxaldehyde | 3A | sodium triacetoxy borohydride | sodium bicarbonate | methanol | DCM | methanol | DCM | silica gel | methanol | DCM | title product"
US06451842B1,"A mixture of (R)-3-[{N-(2-amino-5-trifluoromethylbenzoyl)glycyl}amino]-1-(4,5-methylenedioxy-2-nitrobenzyl)pyrrolidine (30.5 mg), 10% Pd-activated carbone (6 mg), and methanol (3 mL) was stirred under a hydrogen atmosphere at room temperature for 10 h. The Pd catalyst was filtered off through Celite, and the filtrate was concentrated. Solid phase extraction (Bond Elut™ SI, 20% methanol/AcOEt) afforded (R)-1-(2-amino-4,5-methylenedioxybenzyl)-3-[{N-(2-amino-5-trifluoromethylbenzoyl)glycyl}amino]pyrrolidine (Compound No. 2127) (21.9 mg, 76%): The purity was determined by RPLC/MS (95%); ESI/MS m/e 480.1 (M++H, C22H24F3N5O4).","(R)-3-[{N-(2-amino-5-trifluoromethylbenzoyl)glycyl}amino]-1-(4,5-methylenedioxy-2-nitrobenzyl)pyrrolidine | Pd | methanol | hydrogen | Pd | methanol/AcOEt | (R)-1-(2-amino-4,5-methylenedioxybenzyl)-3-[{N-(2-amino-5-trifluoromethylbenzoyl)glycyl}amino]pyrrolidine"
US06972288B1,"5.60 g tetrabutylammonium fluoride-trihydrate are added to 2.50 g of 4-[(3-bromophenyl)amino]-7-[3-(tert. butyldimethylsilyloxy)-propyloxy]-6-nitro-quinazoline in 25 ml of tetrahydrofuran. The reaction mixture is stirred for about 2 hours at ambient temperature. After the cleavage is complete, the reaction mixture is combined with 150 ml of a 2% ammonium chloride solution and cooled in the ice bath. A yellow precipitate is formed which is suction filtered and washed with water. The precipitate, while still damp, is dissolved in methylene chloride/methanol (6:4), dried over sodium sulphate and concentrated by evaporation. The yellow residue is stirred with a little petroleum ether and suction filtered, washed with petroleum ether and dried in vacuo. Yield: 1.29 g (66% of theory) Rf value: 0.63 (silica gel, methylene chloride/methanol=9:1) Mass spectrum (ESI*): m/z=417, 419 [M−H]−",tetrabutylammonium fluoride-trihydrate | 4-[(3-bromophenyl)amino]-7-[3-(tert. butyldimethylsilyloxy)-propyloxy]-6-nitro-quinazoline | tetrahydrofuran | ammonium chloride | ice | water | methylene chloride/methanol | sodium sulphate | petroleum ether | petroleum ether
US20150057265A1,"A mixture of tert-butyl [(3S)-1-(3-nitro-5-methyl-pyridin-4-yl)pyrrolidin-3-yl]carbamate (0.556 g, 1.69 mmol), iron powder (0.38 g, 6.8 mmol), AcOH (10 mL) and water (1 mL) was heated at 60° C. for 60 min. When the reaction was complete, the mixture was allowed to cool, concentrated under reduced pressure and diluted with EtOAc. The resulting mixture was filtered through a diatomaceous earth pad. The filtrate was concentrated under reduced pressure and the residue was dissolved in 1 M aq. NaOH, extracted with EtOAc (100 mL×3). The combined organic layers were washed with water and brine, dried over Na2SO4, filtered and concentrated under reduced pressure to give 0.435 g (91% yield) of the title compound as a brown solid. LCMS calc. for C15H25N4O2(M+H)+: m/z=293.1. found: 293.1.",tert-butyl [(3S)-1-(3-nitro-5-methyl-pyridin-4-yl)pyrrolidin-3-yl]carbamate | iron | AcOH | water | EtOAc | NaOH | EtOAc | water | brine | Na2SO4 | title compound
US07956074B2,"To a suspension of 4-[5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-benzoic acid (1.90 g, 5.48 mmol) in tetrahydrofuran (20 mL) was added 1,1′-carbonyl-diimidazole (978 mg, 6.03 mmol) and the mixture was stirred for 0.5 h at 80° C. After cooling to ambient temperature the resulting suspension was poured onto water (100 mL), stirred for 15 min at ambient temperature and was filtered. Washing with water and drying afforded the title compound (1.51 g, 69%) which was obtained as a yellow solid. MS: m/e=398.2 [M+H]+.","4-[5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-benzoic acid | tetrahydrofuran | 1,1′-carbonyl-diimidazole | water | water | title compound"
US08633312B2,"In accordance with general method AA, 0.67 g (1.8 mmol) of 2-chloro-7-(3-morpholin-4-yl-propoxy-10,11-dihydrodibenzo[a,d]-cyclohepten-5-one (36i), 0.25 g (1.9 mmol) of 2,4-difluoroaniline, 0.05 g (0.22 mmol) of Pd(OAc)2, 0.10 g (0.21 mmol) of 2-(dicyclohexylphosphino)-2′-,4′-,6′-triisopropyl-biphenyl, 0.60 g (6.2 mmol) of Na—O-tert-butylate, 5 ml of toluene and 1 ml of tert-BuOH are used. Reaction time: 1 h. Purification is carried out via flash chromatography (SiO2, hexane/ethyl acetate 7+3). C28H28F2N2O3 (Mr=478.54); yield 43%; m.p. 114° C.","3-morpholin-4-yl-propoxy-10,11-dihydrodibenzo[a,d]-cyclohepten-5-one | 2,4-difluoroaniline | Pd(OAc)2 | 2-(dicyclohexylphosphino)-2′-,4′-,6′-triisopropyl-biphenyl | Na—O-tert-butylate | toluene | tert-BuOH"
US20050096312A1,"This compound was prepared from 8-(4-Methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid hydrochloride (Reference Example 1) and 5-amino-2-morpholin-4-yl-benzonitrile (Reference Example 15) as prepared in Example 12, yielding a yellow solid. (120 mg=82%), LCMS—m/z=474.5.",8-(4-Methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid hydrochloride | 5-amino-2-morpholin-4-yl-benzonitrile
US20040102450A1,"A solution of 4-(4-chloroquinazoline-7-ylmethyl)-3-oxopiperazine-1-carboxylic acid tert-butyl ester (1.84 g, 4.9 mmol) in 120 mL of ethanol is saturated with NH3 gas. To the resulting solution is added acetic acid (0.03 mL). The solution is heated to reflux. After 16 hours, the solution is concentrated. The resulting solid is dissolved in CH2Cl2 and the inorganic salts are filtered off. The organic solution is concentrated. The resulting solid is triturated with EtOAc. The title compound is obtained a a white solid (1.59 g, 4.5 mmol). MS (FAB) m/z 356, (M+H).",4-(4-chloroquinazoline-7-ylmethyl)-3-oxopiperazine-1-carboxylic acid tert-butyl ester | ethanol | NH3 | acetic acid | solid | CH2Cl2 | EtOAc | title compound
US09328192B2,"To a solution of 4-Nitro-benzoic acid 1-hexyl-11-(4-nitro-phenoxy carbonyl)-undecyl ester (290 g) in a mixture of Ethyl acetate (1.5 L) and DMF (300 mL) taken in a pressure vessel was added Raney Nickel (80 g). The reaction mixture was stirred under an atmosphere of Hydrogen (8-10 Kg) for 4 hours at a temperature of 60-65° C. The catalyst was removed by filtration. 75% of the solvent was distilled off and poured into cold water (2 L). The resulting solid was filtered off and washed with chilled water (100 mL) and do the slurry with 1 lit diisopropylether and filtered off, then dried the material properly in vacuum oven at 60-80° C. to yield pure 4-amino-benzoic acid 11-(4-amino-phenoxycarbonyl)-1-hexyl-undecyl ester product as off white powder (190 g) with a melting point of 156-159° C. The resulting compound was characterized by 1H NMR (CDCl3) δ 0.83 (t, 3H, CH3), 1.2-1.65 (m, 26H, 13×CH2), 1.81 (m, 2H, CH2), 2.12 (t, 2H, COCH2), 3.50 (m, 1H, CH), 5.5-6.1 (m, 4H, 2×NH2) 6.8-7.2 (m, 4H, Ar), 7.2-7.8 (m, 4H, Ar). The hydrolytic degradation of the compound was carried out in pH 9.0 buffer solution. The study showed that 1% solution is 100% hydrolyzed in 15 hours at 50° C.",4-Nitro-benzoic acid 1-hexyl-11-(4-nitro-phenoxy carbonyl)-undecyl ester | Ethyl acetate | DMF | Raney Nickel | Hydrogen | solvent | water | water | 4-amino-benzoic acid 11-(4-amino-phenoxycarbonyl)-1-hexyl-undecyl ester | powder
US09131694B2,"Pyridine-2-carboxaldehyde (207 mg, 1.9 mmol) was added to a toluene solution (15 mL) of 2-chloro-6-[[1-(hydroxymethyl)-2-methyl-propyl]amino]-4-(trifluoromethyl)pyridine-3-carbonitrile (400 mg, 1.3 mmol) (Compound 13) followed by a catalytic amount of para-toluene sulfonic acid (50 mg). The reactants were refluxed for 6 hours in a Dean-Stark apparatus, concentrated under reduced pressure, adsorbed onto silica and purified using a neutral alumina column, eluting with a mobile phase of 10% ethyl acetate in hexane. 2-Chloro-6-[4-isopropyl-2-(2-pyridyl)oxazolidin-3-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile (Compound 12) was isolated as a solid in 20% yield. mp 112-115° C.",Pyridine-2-carboxaldehyde | toluene | 2-chloro-6-[[1-(hydroxymethyl)-2-methyl-propyl]amino]-4-(trifluoromethyl)pyridine-3-carbonitrile | Compound 13 | para-toluene sulfonic acid | ethyl acetate | hexane | 2-Chloro-6-[4-isopropyl-2-(2-pyridyl)oxazolidin-3-yl]-4-(trifluoromethyl)pyridine-3-carbonitrile | Compound 12
US08044052B2,"To a solution of 2-(5-bromo-2-chlorophenoxy)-5-(trifluoromethyl)pyridine (2.6 g, 7.3 mmol) and triisopropylborate (2.0 mL, 8.76 mmol) in toluene (15 mL) and THF (7 mL) under a N2 atmosphere was added n-BuLi (6.8 mL, 10.95 mmol) while maintaining the reaction at −70° C. The reaction was stirred for 1 h at −40° C. Gradually the temperature was increased to −20° C. and then 0° C. The reaction was quenched with 2N HCl and allowed to warm to RT. The reaction mixture was concentrated and extracted with EtOAc. The organic extract was dried over Na2SO4 and concentrated under reduced pressure to give the title compound (2.8 g). 1H NMR (500 MHz, DMSO-d6): δ 8.56 (s, 1H), 8.29 (m, 3H), 7.94 (s, 1H), 7.81 (d, J=7.9 Hz, 1H), 7.36 (d, J=8.05 Hz, 2H); m/z (316.4, M− H−).",2-(5-bromo-2-chlorophenoxy)-5-(trifluoromethyl)pyridine | triisopropylborate | toluene | THF | N2 | n-BuLi | HCl | EtOAc | Na2SO4 | title compound
US08252781B2,"2-Cyclohexyl-4,4-dimethyl-1,2-diazetidin-3-one prepared in Process 5 of Example 68 and 2-methylbenzoyl chloride were used for a similar reaction and treatment as Example 96, and the title compound was obtained as a colorless oil.","2-Cyclohexyl-4,4-dimethyl-1,2-diazetidin-3-one | 2-methylbenzoyl chloride | title compound"
US07858658B2,"To sodium cyanide (18.4 g, 375 mmol) and ammonium carbonate (39.0 g, 500 mmol) in H2O (450 mL) was added 2-methyl-4,4,4-trifluorobutanal (17.5 g, 125 mmol) in ethanol (450 mL). The reaction mixture was heated to 90° C. for 17 h. After cooling to 25° C., about 500 mL of solvent was removed in vacuo. Concentrated HCl was added to acidify the mixture to a pH of about 1 to about 2 and a precipitate formed. The mixture was filtered and washed with aqueous 1 N HCl to give 5-(3,3,3-trifluoro-1-methylpropyl)imidazolidine-2,4-dione as a white solid (15.5 g, 59%).","sodium cyanide | ammonium carbonate | H2O | 2-methyl-4,4,4-trifluorobutanal | ethanol | solvent | HCl | HCl | 5-(3,3,3-trifluoro-1-methylpropyl)imidazolidine-2,4-dione"
US06818644B1,"Prepared analogously to Example 2 b from 1-(3-trifluoromethyl-phenyl)-piperazine and 9-(4-bromo-butyl)-9H-fluorene-9-carboxylic acid-(2,2,2-trifluoroethyl)-amide.","1-(3-trifluoromethyl-phenyl)-piperazine | 9-(4-bromo-butyl)-9H-fluorene-9-carboxylic acid-(2,2,2-trifluoroethyl)-amide"
US06448247B1,"0.88 ml (10.1 mmole) of oxalyl chloride was dissolved in 10 ml of methylene chloride, and 5 ml of a methylene chloride solution containing 0.79 ml (11.1 mmole) of dimethyl sulfoxide were added dropwise to the resulting solution at −78° C. under a nitrogen atmosphere. The mixture was then stirred for 30 minutes. 10 ml of a methylene chloride solution containing 950 mg (2.02 mmole) of 2-[(2R)-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl)morpholin-2-yl]ethanol [prepared as described in step (d) above] were added dropwise to the resulting mixture, and the mixture was stirred for 4 hours. At the end of this time, a further 2.24 ml (16.2 mmole) of triethylamine was added, and the mixture was stirred at room temperature for 2 hours. The reaction mixture was then poured into water and extracted with methylene chloride. The organic extract was washed with water, and then with a saturated aqueous solution of sodium chloride, after which it was dried over anhydrous sodium sulfate. The solvent was removed by distillation under reduced pressure, and the resulting residue was purified by silica gel column chromatography, using a gradient elution method, with mixtures of methylene chloride and acetone ranging from 23:2 to 21:4 by volume as the eluent, to give 878 mg of the title compound.","oxalyl chloride | methylene chloride | methylene chloride | dimethyl sulfoxide | nitrogen | methylene chloride | 2-[(2R)-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl)morpholin-2-yl]ethanol | triethylamine | water | methylene chloride | water | sodium chloride | sodium sulfate | silica gel | methylene chloride | acetone | title compound"
US06624162B2,"To a suspension of the 5-amino-6-chloroimidazo[1,2-a]pyridine-8-carboxylic acid (EXAMPLE 1, METHOD A, Step 4, 210 mg, 0.99 mmol) in N,N-dimethylformamide (5 mL) was added 1,1′-carbonyldiimidazole (177 mg, 1.09 mmol) and stirred at room temperature for 20 min. To this resulting solution was added 1-(3-methoxypropyl)-4-piperidinamine (A. Karasawa et al., WO 9950264, 188 mg, 1.09 mmol) and the mixture was stirred overnight under nitrogen at room temperature. The mixture was concentrated in vacuo, chromatographed on a column of silica gel eluting with dichloromethane/methanol/25% aqueous ammonia (95:5:0.5) to afford a yellow oil, which was dissolved in dichloromethane (300 mL), washed with water (75 mL×3), brine (75 mL) and dried over magnesium sulfate. After treatment with charcoal, removal of solvent gave a cream solid, which was recrystallized from diethyl ether to afford 175 mg (48%) of the title compound as a solid.","5-amino-6-chloroimidazo[1,2-a]pyridine-8-carboxylic acid | N,N-dimethylformamide | 1,1′-carbonyldiimidazole | 1-(3-methoxypropyl)-4-piperidinamine | nitrogen | silica gel | dichloromethane/methanol | dichloromethane | water | brine | magnesium sulfate | charcoal | diethyl ether | title compound"
US08207176B2,"To the compound 4-chloro-2-{[3-(diethylamino)propyl]amino}-8-(2,6-difluorophenyl)pyrido[2,3-d]pyrimidin-7(8H)-one (168.75 mg, 0.40 mmol) in dioxane (12 mL) and water (4 mL) were added 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid (148.85 mg, 0.60 mol), potassium carbonate (208 mg, 1.20 mmol) and tetrakis(triphenylphosphine)palladium(0) (23 mg, 0.02 mmol). The mixture was heated with microwave at 150° C. for 15 min. The mixture was concentrated. It was mixed with DMSO (0.75 mL) and water (0.25 mL). Separation by HPLC afforded the title compound (147 mg, 72%). LC-MS m/z 508 (M+H)+.","4-chloro-2-{[3-(diethylamino)propyl]amino}-8-(2,6-difluorophenyl)pyrido[2,3-d]pyrimidin-7(8H)-one | dioxane | water | 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid | potassium carbonate | tetrakis(triphenylphosphine)palladium(0) | DMSO | water | title compound"
US20060135771A1,"Following the general procedure described in Example 1d, {4-[4-((S)-1-Cyclohexyl-ethylcarbamoyl)-2-thiophen-2-yl-quinolin-3-ylmethyl]-2-oxo-piperazin-1-yl}-acetic acid (Example 1c) was coupled with (R)-1-Pyrrolidin-2-yl-methanol to give the title compound (51%). MS (m/z) 618.2 (M+), 1.95 min.",{4-[4-((S)-1-Cyclohexyl-ethylcarbamoyl)-2-thiophen-2-yl-quinolin-3-ylmethyl]-2-oxo-piperazin-1-yl}-acetic acid | (R)-1-Pyrrolidin-2-yl-methanol | title compound
US08987473B2,"The compound [78] obtained in Example 78 (26 mg) was optically resolved by chiral column chromatography (CHIRALCEL (registered trademark) OD CHIRALCEL OD) manufactured by Daicel Corporation, 2 cm ×25 cm; 0.1% trifluoroacetic acid, hexane/isopropyl alcohol=85/15; flow rate 20 mL/min). (3R*)-2-[1-(2,6-dimethylbenzyl)-2,3-dihydro-3-methyl-1H-indole-6-yl]acetic acid [79A] (15 mg) as a pale brown solid was obtained from the preceding fraction (retention time: 5.3 minutes), and (3S*)-2-[1-(2,6-dimethylbenzyl)-2,3-dihydro-3-methyl-1H-indole-6-yl]lacetic acid [79B] of the same (16 mg) as a pale brown solid was obtained from the posterior fraction (retention time: 10.8 minutes). (Both of them were un-identified, and thus one of them was referred to as 3R*, and the other one as 3S* for convenience.)","trifluoroacetic acid | hexane/isopropyl alcohol | (3R*)-2-[1-(2,6-dimethylbenzyl)-2,3-dihydro-3-methyl-1H-indole-6-yl]acetic acid | (3S*)-2-[1-(2,6-dimethylbenzyl)-2,3-dihydro-3-methyl-1H-indole-6-yl]lacetic"
US08026234B2,"A mixture of methyl 2-methylglycidate (3.18 g, 27 mmol) and cyclopentylamine (4 mL, 41 mmol) in ethanol (50 mL) was heated at 80° C. for 3 d. The reaction mixture was then concentrated, diluted to EtOAc, washed by NaHCO3, brine and water. Organic layer was dried, concentrated to give a residue which is used for next step without further purification (3.9 g, 60%). [M+H] calc'd for C11H21NO3, 216. found 216.",methyl 2-methylglycidate | cyclopentylamine | ethanol | EtOAc | NaHCO3 | brine | water
US09181277B2,"Tert-butyl 3,4-bis(hydroxymethyl)piperidine-1-carboxylate (1.00 g, 4 mmol) and concentrated hydrochloric acid (8 mL) were added to a sealed tube (50 mL). The reaction mixture was heated at 95° C. overnight, cooled to room temperature and concentrated in vacuo. The pH was adjusted to 8 by adding aqueous solution of NaOH. The mixture was extracted with CH2Cl2 (30 mL×2). The organic phase was washed with water (30 mL), dried over anhydrous Na2SO4 and concentrated in vacuo to afford the crude product as yellow oil (300 mg, 52.00%). The compound was characterized by the following spectroscopic data: MS (ESI, pos. ion) m/z: 128.2 (M+1).","Tert-butyl 3,4-bis(hydroxymethyl)piperidine-1-carboxylate | hydrochloric acid | NaOH | CH2Cl2 | water | Na2SO4 | crude product"
US20160272645A1,"1-[2-[(4-Chlorophenyl)methylamino]ethyl]-3-iodo-pyrazolo[3,4-d]pyrimidin-4-amine (155 mg, 0.362 mmol, 1 eq.) was suspended in 10 mL of DCM maintained at 0° C., then acryloyl chloride (32.5 mg, 1 eq.) was added and the mixture stirred for 10 min at 0° C. The reaction was monitored by TLC and LCMS. The reaction was quenched by 50 mL of chilled water and 5 mL of saturated NaHCO3 solution, then extracted with DCM (3×100 mL), and dried by anhydrous sodium sulfate then concentrated under reduced pressure to give the product as a viscous solid (150 mg), which was directly used as such for the next step of synthesis.","1-[2-[(4-Chlorophenyl)methylamino]ethyl]-3-iodo-pyrazolo[3,4-d]pyrimidin-4-amine | DCM | acryloyl chloride | water | NaHCO3 | DCM | sodium sulfate | product"
US08865726B2,"To a stirred solution of (S)-3-methyl-2-(3-(4-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazol-2-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-ylamino)butan-1-ol (0.41 g, 0.83 mmol) in dichloromethane (6 mL) was added Et3N (0.58 mL, 4.2 mmol) at −15° C. A solution of pyridine-sulfur trioxide complex (0.66 g, 4.2 mmol) in DMSO (6 mL) was added in one portion. After stirring at −15° C. for 30 minutes, the mixture was poured into cold brine solution and extracted with ether. The combined organic extracts were washed with brine, dried and concentrated. The residue was purified by column chromatography (5% MeOH in dichloromethane) to give (S)-3-methyl-2-(3-(4-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazol-2-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-ylamino)butanal (0.36 g, 88%). LCMS (APCI+) m/z 491 [M+H]+.","(S)-3-methyl-2-(3-(4-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazol-2-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-ylamino)butan-1-ol | dichloromethane | Et3N | pyridine-sulfur trioxide | DMSO | brine | ether | brine | MeOH | dichloromethane | (S)-3-methyl-2-(3-(4-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazol-2-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-ylamino)butanal"
US06506747B1,"To a solution of 3-(tetrahydropyran-2-yloxy)methyl-5-ethylpyrazole (27.0 g, 0.13 mol) in dry THF (250 mL) was added tert-BuOK (14.4g, 0.13 mol) under nitrogen. After 10 min, 4-fluoronitrobenzene (18.1 g, 0.13 mol) was added. The mixture was heated to reflux for 10 hr, the solvent was then removed under vacuum The residue was taken up in ethyl acetate and washed with water, The organic layer was dried over MgSO4 and filtered. The filtrate was treated with active carbon (3.0 g, norit A alkaline) at reflux for 10 min and filtered through a pad of diatomaceous earth. The filtrate was concentrated to give a crude 7:1 mixture of regioisomers, which was dissolved in a 101: mixture of methanol and water (175 mL) and p-toluenesulfonic acid (1.2 g, 6.4 mmol) was added. The solution was stirred at room temperature for 12 hours and concentrated. The residue was taken up in ethyl acetate and washed with water. The organic layer was dried over MgSO4, filtered and concentrated to a crude solid. Recrystallization in a 1:1 mixture of hexane and ethyl acetate gave the title compound (15.6 g, 45%). mp: 151-152° C.",3-(tetrahydropyran-2-yloxy)methyl-5-ethylpyrazole | THF | tert-BuOK | nitrogen | 4-fluoronitrobenzene | ethyl acetate | water | MgSO4 | carbon | norit | methanol | water | p-toluenesulfonic acid | water | MgSO4 | hexane | title compound
US06395718B1,"2,4-Di(benzyloxycarbonyl)butyl(phenethyl)phosphinic acid (1.1 g, 2.2 mmol) in 20 mL of water containing 120 mg of 10% Pd/C was hydrogenated at 40 psi overnight. Filtration through a Celite pad followed by evaporation on high vacuum gave 0.8 g (114%) of 2-[(phenethylhydroxyphosphinyl)methyl]pentanedioic acid (4, R=CH2CH2Ph) as a white solid.","2,4-Di(benzyloxycarbonyl)butyl(phenethyl)phosphinic acid | water | Pd/C | 2-[(phenethylhydroxyphosphinyl)methyl]pentanedioic acid"
US20060106019A1,"640 μl (1.52 mmol, 1.2 eq) of n-butyllithium (2.37 M in heptane) are added, under an inert atmosphere and at −78° C., to a solution of 8-iodo-4-(N-methyl-N-phenylamino)-2-n-propylpyrazolo[1,5-a]-1,3,5-triazine (500 mg, 1.27 mmol) in 30 ml of THF. The reaction mixture is stirred at −78° for 5 min. A solution of 2-chlorobenzaldehyde (0.17 ml, 1.52 mmol, 1.2 eq) in 5 ml of THF is then added dropwise and the reaction medium is stirred at −78° C. for a further 1 h, and is then hydrolyzed by means of the addition of water, and concentrated under reduced pressure. The oily residue obtained is divided between ethyl acetate and water. The organic phase is washed with a saturated sodium chloride solution, dried (Na2SO4) and evaporated. The residue is purified by flash chromatography on silica gel (eluent: petroleum ether/EtOAc, 8:2) so as to give the title product (383 mg, 74%) in the form of a colorless solid: Mp=153-155° C. (methanol); 1H-NMR (300 MHz, CDCl3) d 1.01 (t, 3H, J=7.3 Hz, CH3), 1.78-1.91 (m, 2H, CH2), 2.73 (t, 2H, J=7.3 Hz, CH2), 3.71 (s, 3H, CH3), 4.63 (d, 1H, J=4.3 Hz, OH), 6.49 (d, 1H, J=4.3 Hz, CH), 7.13-7.20 (m, 3H, H Ar), 7.28-7.38 (m, 6H, H Ar), 7.74-7.78 (m, 1H, H Ar); 13C-NMR (75 MHz, CDCl3) d 14.0 (CH3), 21.2 (CH2), 40.6 (CH2), 42.1 (CH3), 65.0 (CH), 109.4 (C), 126.3 (2 CH), 127.1 (CH), 127.2 (CH), 127.8 (CH), 128.5 (CH), 129.0 (2 CH), 129.3 (CH), 132.0 (C), 141.2 (C), 143.6 (CH), 144.6 (C), 148.6 (C), 149.1 (C), 165.6 (C); MS (SI) m/z 390 (M++1, 35Cl), 392 (M++1, 37Cl).","n-butyllithium | 8-iodo-4-(N-methyl-N-phenylamino)-2-n-propylpyrazolo[1,5-a]-1,3,5-triazine | THF | 2-chlorobenzaldehyde | THF | water | ethyl acetate | water | sodium chloride | Na2SO4 | silica gel | petroleum ether/EtOAc | title product"
US07635715B2,"To 1,1-dimethylethyl N-((4′-hydroxy-2′-oxo-6′-chloro-spiro[cyclopentane-1,1′-naphthalen]-3′-yl)carbonyl)glycinate (250 mg, 616 μmol, Example 25A-B) and phenylboronic acid (113 mg, 924 μmol) were added 1,4-dioxane (3080 μL) and K2CO3 in water (924 μL, 1848 μmol). The reaction was then flushed with nitrogen for 10 minutes. Pd2(dba)3 (56.4 mg, 61.6 μmol) and X-Phos (58.7 mg, 123 μmol) were then added, and the reaction mixture was stirred at 110° C. for 6 hours. The reaction mixture was diluted with 75 mL of EtOAc, added to a separatory funnel, partitioned with NaHCO3 (saturated, aqueous), washed 2 times with 50 mL of NaHCO3 (saturated, aqueous), separated, dried over Na2SO4, and concentrated in vacuo to give the title compound (115 mg) as an oil after preparatory LC. MS (m/z)=392(M+H-tBu)+.","1,1-dimethylethyl N-((4′-hydroxy-2′-oxo-6′-chloro-spiro[cyclopentane-1,1′-naphthalen]-3′-yl)carbonyl)glycinate | phenylboronic acid | 1,4-dioxane | K2CO3 | water | nitrogen | Pd2(dba)3 | X-Phos | EtOAc | NaHCO3 | NaHCO3 | Na2SO4 | title compound"
US20140171430A1,"The title compound was prepared in a manner analogous to Example 15 utilizing Intermediate 23 and 5-fluoro-2-methylbenzoic acid. MS (ESI): mass calculated for C20H23FN4O, 354.4. m/z found 355.3 [M+H]+. 1H NMR (400 MHz, CDCl3): 7.16 (dd, J=8.5, 5.4 Hz, 1H), 6.98-6.92 (m, 1H), 6.90 (dd, J=8.5, 2.7 Hz, 1H), 6.30 (s, 1H), 3.98-3.87 (m 2H), 3.79 (dd, J=11.6, 7.3 Hz, 1H), 3.68-3.57 (m, 2H), 3.50-3.43 (m, 2H), 3.16-2.94 (m, 3H), 2.30 (s, 6H), 2.26 (d, J=8.6 Hz, 3H).",title compound | Intermediate 23 | 5-fluoro-2-methylbenzoic acid
US20120245136A1,"To a 100 mL flask was added 5-[(4R)-6-fluoro-4-isopropoxy-spiro[chromane-2,4′-piperidine]-1′-carbonyl]-2-isopropoxy-benzonitrile (450 mg, 0.97 mmol) Pd on C, wet, Degussa (127 mg) and isopropanol (10 mL). The reaction was purged with nitrogen and a balloon of hydrogen was attached. The reaction was heated overnight at 40° C. and showed product by lcms. The reaction was filtered and the solvent was evaporated. The crude reaction mixture was purified via hplc (10%-99%) ACN:H2O with no modifier. ESI-MS m/z calc. 470.2, found 471.2 (M+1)+; Retention time: 1.6 minutes (3 min run).","5-[(4R)-6-fluoro-4-isopropoxy-spiro[chromane-2,4′-piperidine]-1′-carbonyl]-2-isopropoxy-benzonitrile | isopropanol | nitrogen | ACN"
US07091228B2,"In 250-mL round-bottom flask, methyl (1R,2R)-2-[(3′-fluoro-4′-{[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]amino}-1,1′-biphenyl-4-yl)carbonyl]cyclopentanecarboxylate (2.53 g, 4.53 mmol) was dissolved in 100 mL of 1:1 THF/dioxane containing 5.0 molar equivalents of 1 N aqueous NaOH. The mixture was stirred at rt overnight. The mixture was concentrated under reduced pressure to a volume of about 20 mL. Ethyl acetate (100 mL), water (30 mL), and 5.1 molar equivalents of 1 N aqueous HCl were added to the mixture. The mixture was transferred to a separation funnel. The organic layer was washed with water (1×50 mL), dried (Na2SO4), and concentrated under reduced pressure. The solid was ultrasonicated in 30 mL acetonitrile and filtered to give the desired compound as a white solid (1.96 g, 80%, 94.5% ee). 1H NMR (400 MHz, DMSO-d6) δ 12.20 (br s, 1 H), 10.60 (bs, 1 H), 8.70 (t, 1 H), 7.60–8.20 (m, 8 H), 7.30 (d, 2 H), 4.70 (q, 1 H), 3.20 (q, 1 H), 2.20 (m, 1 H), 2.00 (m, 1 H), 1.50–1.90 (m, 4 H); LC-MS m/z 545.3 (MH+), ret. time 3.93 min.","methyl (1R,2R)-2-[(3′-fluoro-4′-{[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl]amino}-1,1′-biphenyl-4-yl)carbonyl]cyclopentanecarboxylate | THF/dioxane | NaOH | Ethyl acetate | water | HCl | water | Na2SO4 | acetonitrile | desired compound"
US08957049B2,"4-Bromophenethylamine (2 mL, 13 mmol) in DCM (12 mL) was treated with K2CO3 (2.7 g, 20 mmol, 1.5 eq.) and Boc2O (3.1 g, 14 mmol, 1.1 eq.). The mixture was diluted with water, extracted with MTBE, washed with brine, dried on Na2SO4, and concentrated to give clean N-Boc-4-bromophenethylamine (4 g, quant.).",4-Bromophenethylamine | DCM | K2CO3 | Boc2O | water | MTBE | brine | Na2SO4 | N-Boc-4-bromophenethylamine
US20160108047A1,"The title compound was prepared in analogy to the procedure described in Step 36.3 using dimethyl 2-bromo-1H-imidazole-4,5-dicarboxylate (Step 38.1) and 4-methoxybenzyl chloride at 50° C. for 14 hr. The reaction mixture was concentrated under reduced pressure. The residue was diluted with aq. 10% Na2CO3 solution and ice and extracted with EtOAc. Combined extracts were washed with brine, dried over MgSO4, filtered and concentrated under reduced pressure to afford a yellow oil. tR: 0.97 min (LC-MS 2); ESI-MS: 383/385 [M+H]+ (LC-MS 2); TLC (EtOAc) Rf=0.75.","title compound | dimethyl 2-bromo-1H-imidazole-4,5-dicarboxylate | 4-methoxybenzyl chloride | Na2CO3 | ice | EtOAc | brine | MgSO4 | EtOAc"
US08188139B2,"A solution of 13.5 mmol N—BOC-3-pyrrolidone and 13.5 mmol N,N-dimethylformamide-dimethylacetal in 50 ml N,N-dimethylformamide was hold overnight at 60° C. The reaction mixture was quenched by addition of 50 ml water and extracted 3 times with ethyl acetate. The extract was dried over magnesium sulfate and concentrated to give the crude title compound as a yellowish oil. Yield=90%. MS (m/e): 241.4 ([M+H]+, 100%).","N—BOC-3-pyrrolidone | N,N-dimethylformamide-dimethylacetal | N,N-dimethylformamide | water | ethyl acetate | magnesium sulfate | crude title compound"
US04258187,"A stirred mixture of 12.11 g (0.04 mole) of 6-chloro-3-ethyl-3,4-dihydro-4-hydroxy-4-phenyl-2(1H)quinazolinone and 8.34 g (0.12 mole) of hydroxylamine hydrochloride in 200 ml ethanol was refluxed for 3 days and then cooled. The solid portion of the reaction mixture was collected on a filter, washed with ethanol, and dried to give 9.27 g (85%) of 6-chloro-4-phenyl-2(1H)quinazolinone 3-oxide as yellow crystals, mp 267°-269°.","6-chloro-3-ethyl-3,4-dihydro-4-hydroxy-4-phenyl-2(1H)quinazolinone | hydroxylamine hydrochloride | ethanol | ethanol | 6-chloro-4-phenyl-2(1H)quinazolinone 3-oxide"
US05965546,"A mixture of 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole (4.3 g, 19.5 mmol), 4-(3-chloropropoxy)-3-hydroxy-α-methylbenzenemethanol (4.5 g, 19.5 mmol), KI (200 mg), NaHCO3 (1.8 g, 21.5 mmol) and CH3CN (125 ml) was stirred at reflux under nitrogen for 24 hours. The cooled reaction was filtered and the filter cake was washed with CH3CN. The filtrate was concentrated to afford an oily residue, which was partitioned between water and ethyl acetate. The ethyl acetate extract was washed with water, dried with MgSO4, and concentrated to yield 8.6 g of a dark oil. The oil was purified by preparative HPLC (Waters Associates prep LC/system 500) to yield 5.0 g. The compound was recrystallized twice from ethanol to provide 3.9 g (49%) of 4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-propoxy]-3-hydroxy-α-methyl-benzene methanol as a light beige solid, m.p.=142-144° C.","6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole | 4-(3-chloropropoxy)-3-hydroxy-α-methylbenzenemethanol | NaHCO3 | CH3CN | nitrogen | CH3CN | water | ethyl acetate | ethyl acetate | water | MgSO4 | dark oil"
US04957927,"A solution of 6.6 g (15.9 mmole) of 1-[(diphenylmethoxy)acetyl]-3-(methoxyphenyl)piperidine in 50 cm3 of tetrahydrofuran was added dropwise to a solution of 0.96 g (25.4 mmole) of lithium aluminum hydride in 100 cm3 of tetrahydrofuran. The mixture was brought to reflux for 5 hours, allowed to stand overnight, then hydrolyzed by the addition of 5 cm3 of water. The alkaline residues were separated. The solution was concentrated under reduced pressure. The residue was treated with a solution of 1.5 g (16.7 mmole) of oxalic acid in 100 cm3 of acetone. The 1-[2-(diphenylmethoxy)ethyl]-3-(3-methoxyphenyl)piperidine oxalate precipitate was filtered and recrystallized from acetone.",1-[(diphenylmethoxy)acetyl]-3-(methoxyphenyl)piperidine | tetrahydrofuran | lithium aluminum hydride | tetrahydrofuran | water | oxalic acid | acetone | 1-[2-(diphenylmethoxy)ethyl]-3-(3-methoxyphenyl)piperidine oxalate | 1-[2-(diphenylmethoxy)ethyl]-3-(3-methoxyphenyl)piperidine oxalate | acetone
US06878705B2,"N-(4-Chlorobenzyl)-2-(4-hydroxybut-1-ynyl)-7-methyl-4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide (Example 82, 0.219 g) was dissolved in ethanol (50 mL) with heating and then allowed to cool to room temperature. The mixture was hydrogenated over 10% Pd/C (0.065 g) at 35 psi for 2 h. The reaction mixture was filtered through a Celite pad and the pad was washed with CH2Cl2 (75 mL). The filtrate was concentrated in vacuo. The resulting solid was purified by column chromatography (CH2Cl2/methanol, 98/2) to yield 0.190 g of the title compound as a pale yellow solid. Physical characteristics. M.p. 157-160° C.; 1H NMR (400 MHz, DMSO-d6) δ 10.69, 8.52, 7.41-7.32, 6.67, 4.55, 4.43, 3.92, 3.45-3.41, 2.74, 1.73-1.65, 1.53-1.46; 3C NMR (100 MHz, CDCl3) δ 173.6, 165.0, 155.3, 152.6, 140.4, 137.4, 132.8, 128.9, 128.6, 127.5, 116.5, 115.2, 102.7, 62.2, 43.2, 42.5, 37.7, 31.9, 27.8, 23.9; MS (ESI+) m/z 389 (M+H)+.","N-(4-Chlorobenzyl)-2-(4-hydroxybut-1-ynyl)-7-methyl-4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide | ethanol | Pd/C | CH2Cl2 | CH2Cl2/methanol | title compound"
US04260816,"A solution of 4.3 g. of ethyl 4-[N-trifluoroacetyl-2-(4-cyano-1-naphthyloxy)ethylamino]benzoate and 4.3 g. of potassium hydroxide in 100 ml. of 95% ethanol is refluxed for 3 hours. After cooling, diluting with 100 ml. of water and acidification to pH 4 with concentrated hydrochloric acid, the white solid is collected, washed with water and dried, m.p. 254°-256° C.",ethyl 4-[N-trifluoroacetyl-2-(4-cyano-1-naphthyloxy)ethylamino]benzoate | potassium hydroxide | ethanol | water | hydrochloric acid | water
US04691049,"Add cold trifluoroacetic acid (600 ml) (ice bath) to N[1(S)-ethoxycarbonyl-2-(4-nitrophenyl)ethyl]-(S)-alanine, t-butyl ester (25.5 g) and stir the resulting mixture at room temperature under a nitrogen atmosphere for 4 hours. Concentrate the solution in vacuo to give a viscous oil. Triturate the viscous oil with hexane (3 1) and then ether to yield N-[1(S)-ethoxycarbonyl-2-(4-nitrophenyl)ethyl]-(S)-alanine.","trifluoroacetic acid | N[1(S)-ethoxycarbonyl-2-(4-nitrophenyl)ethyl]-(S)-alanine, t-butyl ester | nitrogen | hexane | ether | N-[1(S)-ethoxycarbonyl-2-(4-nitrophenyl)ethyl]-(S)-alanine"
US03965200,"6 parts of diatomaceous earth the same as in Example 1 was thoroughly mixed with 5 parts of toluene-2,4-disulfonic acid and 10 parts of water. The mixture was dried at 100° to 105°C and further at 110°C under a pressure of 30 mm Hg for 5 hours, whereby dried solid catalyst was obtained. To the solid catalyst was added 40 parts of o-xylene and the mixture was cooled to -10°C. One part of fuming nitric acid having a specific gravity of 1.52 was added dropwise to the cooled mixture with stirring over a period of in 30 minutes. After the addition the mixture was stirred at -10°C for 3 hours and further at 20° to 25°C for 2 hours, whereby mononitroxylene was obtained with p/o ratio of 3.02. Yield was 91%.","toluene-2,4-disulfonic acid | water | o-xylene | nitric acid | mononitroxylene"
US09346840B2,"To a solution of tert-butyl 3-((S)-3-((2,2,2-trifluoro-N-((1R,2S)-2-phenylcyclopropyl)acetamido)methyl)pyrrolidin-1-yl)propanoate (108 mg, 0.245 mmol) in methanol (3 mL) was added sodium hydroxide (6M, 0.5 mL, 3.00 mmol) and the mixture was stirred at r room temperature for 18 h. The mixture was purified using reverse-phase HPLC. The fractions containing the product were combined, treated with 1N HCl and concentrated. The residue was dried under vacuum to give 51 mg of product (HCl salt) as off-white solid.","tert-butyl 3-((S)-3-((2,2,2-trifluoro-N-((1R,2S)-2-phenylcyclopropyl)acetamido)methyl)pyrrolidin-1-yl)propanoate | methanol | sodium hydroxide | product | HCl"
US07622469B2,"160 ml of ethanol, 13.0 g (70.5 mmol) of 1-dodecanal and 1.5 ml of concentrated hydrochloric acid were added to 8.0 g (35.1 mmol) of N1-benzyl-biguanide hydrochloride. The mixture was refluxed for 16 hours, and concentrated under reduced pressure to remove the solvent. The residue was purified by silica gel column chromatography, and the first main fraction eluted with a mixture of chloroform and methanol (9:1.5) was recrystallized from 80% aqueous ethanol to obtain 3.1 g of colorless crystals (1) having a melting point of 152 to 155° C. The second main fraction was recrystallized from 80% aqueous ethanol to obtain 0.9 g of colorless crystals (2) having a melting point of 153 to 156° C.",ethanol | 1-dodecanal | hydrochloric acid | N1-benzyl-biguanide hydrochloride | silica gel | chloroform | methanol | ethanol
US20070004736A1,"A 1N aqueous sodium hydroxide solution (11 mL) was added to a solution of methyl(2-oxo-1-pyrrolidinyl)acetate (1.4 mL) in methanol (20 mL), and the mixture was stirred at 70° C. for 2 hours. The solvent was distilled off under reduced pressure, and the residue was diluted with water, washed with ether, and extracted with dichloromethane. The extract was dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the title compound (0.16 g, 11%) as a white solid.",sodium hydroxide | methyl(2-oxo-1-pyrrolidinyl)acetate | methanol | water | ether | dichloromethane | magnesium sulfate | title compound
US07767665B2,"2-Benzylthio-6-cyanopyridine (1.63 g, 7.22 mmol) and methyl thiosalicylate (1.21 g, 7.22 mmol) were dissolved in toluene (30 ml), and triethylamine (1.52 ml, 10.8 mmol) was added thereto. The reaction mixture was refluxed for 48 hrs. The solvent was evaporated and the residue was recrystallized from ethanol to give the titled compound (1.03 g, 44%) as white crystals.",2-Benzylthio-6-cyanopyridine | methyl thiosalicylate | toluene | triethylamine | ethanol | titled compound
US20050148627A1,"The tricyclohexylphosphine (0.01 g, 0.04 mmole) and Pd (dba) (0.01 g, 0.02 mmole) suspended in anhydrous dioxane (3 mL) was stirred for 15 minutes resulting in a red colored solution. Ethyl 6-bromo-8-methoxy-2-(trifluoromethyl)-2H-chromene-3-carboxylate prepared as in Example 605o, Step 2 (0.2 g, 0.52 mmole), potassium acetate (0.78 g, 0.78 mmole), and bis(pinacolato)diboron (0.15 g, 0.57 mmole) was added and the resulting mixture was heated to 80° C. (oil bath) for 18 hours. The contents were poured into water (10 ml) and extracted with EtOAc (2×20 mL). The combined extracts were washed with brine (20 mL), dried over MgSO4, filtered and concentrated in vacuo to give a dark green oil (0.21 g, 95%). No further purification was performed. GCMS m/z 428.0 (M+). LCMS m/z 429.0 (M+H).",tricyclohexylphosphine | Pd | dioxane | Ethyl 6-bromo-8-methoxy-2-(trifluoromethyl)-2H-chromene-3-carboxylate | potassium acetate | bis(pinacolato)diboron | oil | water | EtOAc | brine | MgSO4
US05006520,"In 400 ml of dimethylformamide were suspended 39.3 g of 3-(4-hydroxyphenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine, 34.4 g of ethyl bromoacetate and 28.4 g of potassium carbonate. The mixture was stirred under heating at 70° C. for 2 hours. The reaction mixture was concentrated under reduced pressure and the residue was extracted with benzene-water. The organic layer was concentrated. Hexane was added to the residue for crystallization. The obtained crude crystals were recrystallized from isopropyl ether to give 28 g of ethyl 4-(1-phenyl-1H-pyrazolo[3,4-b]pyridin-3-yl)phenoxyacetate, m.p. 118°-120° C.","dimethylformamide | 3-(4-hydroxyphenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine | ethyl bromoacetate | potassium carbonate | benzene-water | Hexane | isopropyl ether | ethyl 4-(1-phenyl-1H-pyrazolo[3,4-b]pyridin-3-yl)phenoxyacetate"
US08389521B2,"N-(3-Methoxy-propyl)-C-(3-nitro-phenyl)-methanesulfonamide (0.31 g, 1.08 mmol) was hydrogenated over Raney nickel (0.05 g) in methanol at 50° C. and 70 psi for 4 h. Then, the catalyst was filtered off, washed with warm methanol, and the combined filtrates were evaporated to give 0.14 g (50%) of C-(3-amino-phenyl)-N-(3-methoxy-propyl)-methanesulfonamide",N-(3-Methoxy-propyl)-C-(3-nitro-phenyl)-methanesulfonamide | Raney nickel | methanol | methanol | C-(3-amino-phenyl)-N-(3-methoxy-propyl)-methanesulfonamide
US20070269405A1,"To a stirred solution of 1-b (9.0 g, 25 mmol) in MeOH (20 mL) was added 3N NaOH (75 mmol). The resulting solution was heated in a microwave reactor (150 watts) at 100° C. for 60 minutes. While still basic, the reaction mixture was diluted with water (75 mL) and extracted with ethyl acetate (50 mL ×2). The aqueous layer was then carefully neutralized to pH=6 with 3 N HCl to afford a large amount of solid precipitate. After filtration, the solid was collected as the desired product 1-c. The filtrate was subsequently concentrated and dissolved in MeOH (30 mL). Upon filtration, the solution was dried over MgSO4 and concentrated to yield 2nd crop of the desired product 1-c as a white solid. 1H-NMR (CD3OD); □ 0.77 (s, 3H), 0.876 (s, 3H), 1.19-1.65 (m, 71), 1.74-2.17 (m, 7H), 2.40-2.46 (m, 2H), 4.05 (dd, 1H), 6.62 (d, 1H), 7.02 (d, 1H), 7.50 (s, 1H), 7.60(s, 1H). Measured [M+H]=340.9.",1-b | MeOH | NaOH | water | ethyl acetate | desired product 1-c | MeOH | MgSO4 | desired product 1-c
US20030171380A1,"Prepared in a similar fashion as described for Example 413 using 3,5-dichloro-1-[(1S)-1-cyclopropylpropyl]-2 (1H)-pyrazinone and 7-bromo-5-methoxyindoline hydrochloride as the starting materials. mp 138-140° C.; 1H NMR (300 MHz, CDCl3): δ 6.94 (s, 1H), 6.89 (d, J=2.2 Hz, 1H), 6.76 (d, J=2.2 Hz, 1H), 4.34-4.24 (m, 2H), 4.10-4.01 (m, 1H), 3.76 (s, 3H), 3.09 (t, J=7.9 Hz, 2H), 1.94-1.74 (m, 2H), 1.06-0.98 (m, 1H), 0.95-0.86 (m, 3H), 0.79-0.72 (m, 1H), 0.54-0.44 (m, 2H), 0.35-0.22 (m, 1H); HRMS (ESI) calcd for C19H22N3O2BrCl (M+H)+: 438.0584; found m/z 438.0605.","3,5-dichloro-1-[(1S)-1-cyclopropylpropyl]-2 (1H)-pyrazinone | 7-bromo-5-methoxyindoline hydrochloride"
US20160002221A1,"To a stirred mixture of 1,1-dimethylisochroman-6-ol (1.78 g, 10 mmol) and triethylamine (3.03 g, 30 mmol) in dry dichloromethane (30 mL) under argon at 0° C. was added drop-wise trifluoromethanesulfonic anhydride (8.46 g, 30 mmol). The resulting mixture was allowed to warm slowly to 20° C. over 16 hours, then was poured into saturated aqueous sodium bicarbonate (50 mL) and extracted with dichloromethane (2×30 mL). The combined organic extracts were washed with brine (50 mL), dried over Na2SO4 and evaporated in vacuo. The residue was purified by silica gel chromatography eluting with ethyl acetate in hexane (10%-30%) to give 1,1-dimethylisochroman-6-yl trifluoromethanesulfonate as oil, which was used directly in the next step.","1,1-dimethylisochroman-6-ol | triethylamine | dichloromethane | argon | trifluoromethanesulfonic anhydride | sodium bicarbonate | dichloromethane | brine | Na2SO4 | silica gel | ethyl acetate | hexane | 1,1-dimethylisochroman-6-yl trifluoromethanesulfonate"
US20160207922A1,"A solution of 4-bromo-N,N-diethyl-2-[(2R)-2-hydroxypropyl]benzamide (12.2 g, 38.8 mmol) dissolved in 4N HCl in Dioxane (200 mL) was stirred at room temperature and monitored by tlc. After 3 days the reaction was partitioned between EtOAc (300 mL) and water (300 mL). The aqueous phase was further extracted with EtOAc (2×250 mL). The combined organic layers were then washed with water (200 mL), brine (200 mL), dried over magnesium sulfate, filtered and concentrated. The crude material was then purified via MPLC (15-30% EtOAc/Hexane) to afford (3R)-6-bromo-3-methyl-3,4-dihydro-1H-isochromen-1-one. 1H NMR (500 MHz; CDCl3): 7.98 (d, J=8.2 Hz, 1H), 7.56 (dd, J=1.5, 8.2 Hz, 1H), 7.45 (s, 1H), 4.71 (m, 1H), 2.94 (m, 2H), 1.55 (d, J=6.3 Hz, 3H). (M+1)+ 241.","4-bromo-N,N-diethyl-2-[(2R)-2-hydroxypropyl]benzamide | HCl | Dioxane | EtOAc | water | EtOAc | water | brine | magnesium sulfate | crude material | EtOAc/Hexane | (3R)-6-bromo-3-methyl-3,4-dihydro-1H-isochromen-1-one"
US09359326B2,"Charge a 500 mL round bottom 3-neck flask that equipped with a thermocouple, mechanical stirrer, nitrogen inlet/outlet and cooling bath with 202.8 g (0.622 mol) of cesium carbonate and 260 g (260 mL) of water. Stir and cool the resulting solution to 22±3° C. Transfer the solution to the addition funnel. Charge a nitrogen-flushed 3 L reactor that equipped with an overhead stirrer, condenser, pH probe, nitrogen inlet/outlet and 500 mL addition funnel with 50.0 g (0.207 mol) of 5-bromo-4-(trifluoromethyl) pyridin-2-amine 4a, 190.9 g (0.456 mol) of 4,4′-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine-2,4-diyl]di[morpholine] 4, 6.75 g (0.0103 mol) of 1,1′-bis(di-tert-butylphosphino) ferrocene palladium dichloride and 556 g (625 mL) of thf. Stir the slurry at 22±3° C. Add the aqueous cesium carbonate solution via the addition funnel to the slurry over 1-2 min. Stir rapidly (to ensure good mixing), heat to 45±3° C. over 15 min and hold at this temperature for at least 30 minutes. Check for completeness of the reaction. Cool to 22±3° C. Separate the phases. Partially concentrate the THF (25° C., 90 mbar) to a volume of 400 mL. Add 654 g (750 mL) of isopropyl acetate, resume the vacuum distillation and concentrate to a volume of 400 mL. Add 610 g (700 mL) of isopropyl acetate, stir and filter the hazy solution through a 25 g pad of Celite. Wash the reactor and filter cake with 87 g (100 mL) of isopropyl acetate and add the wash to the batch. Add 1 L of 0.125N aqueous N-acetyl-L-cysteine solution and stir at 60±3° C. for 1 h. Cool to 22±3° C. and drain the aqueous wash. Add 1 L of 0.25N aqueous N-acetyl-L-cysteine pH=7 solution and stir at 60±3° C. for 1 h. Cool to 22±3° C. and drain the aqueous wash. Again, add 1 L of 0.25N aqueous N-acetyl-L-cysteine pH=7 solution and stir at 60±3° C. for 1 h. Cool to 22±3° C. and drain the aqueous wash. Charge 34.5 g of Si-Thiol functionalized silica gel and stir the suspension at 60±3° C. for 1 h. Cool to 22±3° C. and filter to remove the silica gel. Add 1 L of 1N aqueous hydrochloric acid solution and stir for 15 minutes. Separate the phases and retain the aqueous phase which now contains product. Extract the organic phase again by adding 500 mL of 1N aqueous HCl solution and stirring for 15 minutes. Separate the phases and combine the aqueous extracts. Adjust the pH to 2.3±0.2 by the addition of ˜280 mL of 4N aqueous sodium hydroxide solution. Charge 17.2 g of Si-Thiol functionalized silica gel and stir the suspension at 50±3° C. for 1 h. Cool to 22±3° C. and filter to remove the silica gel. Adjust the pH to 5.0±0.2 by the slow addition of ˜75 mL of 4N aqueous sodium hydroxide solution maintaining a batch temperature of 15±3° C. Stir the slurry for at least 16 h at 22±3° C. to allow the product to completely solidify. Filter the solids and wash the filter cake once with 250 g (250 mL) of water. Dry the solids (50° C., 35 mbar) for 16 h to obtain 75 g (89% yield) of 5 as a tan solid. Following this procedure, Compound 5 is the hemihydrate polymorph form HA of the Compound of Formula A.","nitrogen | cesium carbonate | water | nitrogen | nitrogen | 5-bromo-4-(trifluoromethyl) pyridin-2-amine | 5 | 4,4′-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine-2,4-diyl]di[morpholine] | 1,1′-bis(di-tert-butylphosphino) ferrocene palladium dichloride | cesium carbonate | THF | isopropyl acetate | isopropyl acetate | isopropyl acetate | N-acetyl-L-cysteine | N-acetyl-L-cysteine | N-acetyl-L-cysteine | Si-Thiol | silica gel | silica gel | hydrochloric acid | HCl | sodium hydroxide | Si-Thiol | sodium hydroxide | water"
US08546357B2,"A mixture of crude compound (E)-1-(1-hydroxy-3,3-dimethyl-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)ethanone oxime (0.93 mmol) and zinc dust (260 mg, 4.0 mmol) in AcOH (8 mL) was heated to 40° C. and stirred for 0.5 h. LC-MS showed SM disappeared. The reaction mixture was used for next reaction directly without being purified.","crude compound | (E)-1-(1-hydroxy-3,3-dimethyl-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)ethanone oxime | zinc | AcOH"
US08901072B2,"To a solution of tert-butyl 3-aminopropylcarbamate (85b, 2 g, 11.48 mmoles) in toluene (8 mL), in a pressure tube, was added 900 μL of thioglycolic acid (12.95 mmoles). Argon was bubbled through the solution for 15 min, and the mixture was capped and heated to 115° C. (bath temperature) for 24 h. The solution was then concentrated to dryness in vacuo and the residue was subjected to SiO2 chromatography on a Biotage™ flash chromatography system using 25-0% hexanes in EtOAc as the eluent to furnish 91 (1.19 g, 4.77 mmoles, 42% yield) as a colourless oil. 1H NMR (400 MHz, CDCl3) δ 1.65 (quintet, J=6.3 Hz, 2H), 1.94 (t, J=9.0 Hz, 1H), 3.17 (t, J=6.2, 2H), 3.24 (d, J=8.9 Hz, 2H), 3.33 (q, J=6.3 Hz, 2H), 4.11 (q, J=7.1 Hz, 1H), 4.87 (broad s, 1H), 7.12 (broad s, 1H).",tert-butyl 3-aminopropylcarbamate | toluene | thioglycolic acid | Argon | 91
US04256891,"methanesulfonate by (a) reacting diglycolic anhydride and 4-aminobutanol to produce [2-(4-hydroxybutyl]amino-2-oxoethoxy]acetic acid, (b) heating to cyclize the latter to obtain 4-(4-hydroxybutyl)-3,5-dioxomorpholine, (c) esterifying the latter with methanesulfonyl chloride to produce 4-(3,5-dioxomorpholino)butyl methanesulfonate and (d) reacting the mesylate with 3[bis(4-butoxy-o-tolyl)methyl]piperidine.",methanesulfonate | (a) | diglycolic anhydride | 4-aminobutanol | [2-(4-hydroxybutyl]amino-2-oxoethoxy]acetic acid | (b)
US07790725B2,"Ethyl trifluoroacetate (6.32 g) was dissolved in tert-butyl methyl ether (10 mL) and a 28% sodium methoxide-methanol solution (9.40 g) and a solution of 4-acetylpyridine (4.90 g) in tert-butyl methyl ether (20 mL) were added successively at room temperature. The mixture was stirred for 22 hr. A 10% a aqueous citric acid solution was added until the reaction solution became about pH 4, and the precipitate was collected by filtration, washed with water and dried to give 4-trifluoroacetoacetylpyridine (5.46 g) as a yellow solid.",Ethyl trifluoroacetate | tert-butyl methyl ether | sodium methoxide-methanol | 4-acetylpyridine | tert-butyl methyl ether | citric acid | water | 4-trifluoroacetoacetylpyridine
US20060276433A1,"3-(Oxazol-5-yl)nitrobenzene (3.56 g) was dissolved in ethanol (80 ml) and ethyl acetate (80 ml), 5% palladium-carbon (1.9 g) was added to the mixture and stirred at room temperature for 15 hours in an atmosphere of hydrogen. After filtration of the catalyst, the solvent was evaporated, and the thus obtained crystals were washed with hexane to obtain the title compound (2.80 g) as a white solid.",3-(Oxazol-5-yl)nitrobenzene | ethanol | ethyl acetate | palladium-carbon | hydrogen | hexane | title compound
